<PAGE> 1
AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON OCTOBER 15, 1999
REGISTRATION NO. 333-
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
------------------------
FORM S-1
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
------------------------
NEOFORMA.COM, INC.
(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
<TABLE>
<S> <C> <C>
DELAWARE 5961 77-0424252
(STATE OR OTHER JURISDICTION OF (PRIMARY STANDARD INDUSTRIAL (I.R.S. EMPLOYER
INCORPORATION OR ORGANIZATION) CLASSIFICATION CODE NUMBER) IDENTIFICATION NUMBER)
</TABLE>
3255-7 SCOTT BLVD.
SANTA CLARA, CALIFORNIA 95054
(408) 654-5700
(ADDRESS, INCLUDING ZIP CODE, AND TELEPHONE NUMBER, INCLUDING AREA CODE, OF
REGISTRANT'S PRINCIPAL EXECUTIVE OFFICES)
ROBERT J. ZOLLARS
CHAIRMAN, PRESIDENT AND CHIEF EXECUTIVE OFFICER
3255-7 SCOTT BLVD.
SANTA CLARA, CALIFORNIA 95054
(408) 654-5700
(NAME, ADDRESS, INCLUDING ZIP CODE, AND TELEPHONE NUMBER, INCLUDING AREA CODE,
OF AGENT FOR SERVICE)
COPIES TO:
<TABLE>
<S> <C>
GORDON K. DAVIDSON, ESQ. WILLIAM H. HINMAN, JR., ESQ.
DAVID K. MICHAELS, ESQ. SHEARMAN & STERLING
SCOTT J. LEICHTNER, ESQ. 1550 EL CAMINO REAL
FENWICK & WEST LLP MENLO PARK, CA 94025
TWO PALO ALTO SQUARE (650) 330-2200
PALO ALTO, CA 94306
(650) 494-0600
</TABLE>
APPROXIMATE DATE OF COMMENCEMENT OF PROPOSED SALE TO THE PUBLIC:
As soon as practicable after the effective date of this Registration Statement.
If any of the securities being registered on this Form are to be offered on
a delayed or continuous basis pursuant to Rule 415 under the Securities Act of
1933, check the following box. [ ]
If this Form is filed to register additional securities for an offering
pursuant to Rule 462(b) under the Securities Act of 1933, check the following
box and list the Securities Act registration statement number of the earlier
effective registration statement for the same offering. [
] ________________ .
If this Form is a post-effective amendment filed pursuant to Rule 462(c)
under the Securities Act of 1933, check the following box and list the
Securities Act registration statement number of the earlier effective
registration statement for the same offering. [ ] ________________ .
If this Form is a post-effective amendment filed pursuant to Rule 462(d)
under the Securities Act of 1933, check the following box and list the
Securities Act registration statement number of the earlier effective
registration statement for the same offering. [ ] ________________ .
If delivery of the prospectus is expected to be made pursuant to Rule 434,
please check the following box. [ ]
CALCULATION OF REGISTRATION FEE
<TABLE>
<S> <C> <C>
- ----------------------------------------------------------------------------------------------------------------------
- ----------------------------------------------------------------------------------------------------------------------
TITLE OF EACH CLASS OF SECURITIES TO BE PROPOSED MAXIMUM AMOUNT OF
REGISTERED AGGREGATE OFFERING PRICE(1) REGISTRATION FEE
- ----------------------------------------------------------------------------------------------------------------------
Common Stock, $0.001 par value per share...... $75,000,000 $20,850
- ----------------------------------------------------------------------------------------------------------------------
- ----------------------------------------------------------------------------------------------------------------------
</TABLE>
(1) Estimated solely for the purpose of computing the amount of the registration
fee pursuant to Rule 457(o) under the Securities Act of 1933.
THE REGISTRANT HEREBY AMENDS THIS REGISTRATION STATEMENT ON SUCH DATE OR
DATES AS MAY BE NECESSARY TO DELAY ITS EFFECTIVE DATE UNTIL THE REGISTRANT SHALL
FILE A FURTHER AMENDMENT WHICH SPECIFICALLY STATES THAT THIS REGISTRATION
STATEMENT SHALL THEREAFTER BECOME EFFECTIVE IN ACCORDANCE WITH SECTION 8(a) OF
THE SECURITIES ACT OF 1933 OR UNTIL THE REGISTRATION STATEMENT SHALL BECOME
EFFECTIVE ON SUCH DATE AS THE COMMISSION, ACTING PURSUANT TO SAID SECTION 8(a),
MAY DETERMINE.
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
<PAGE> 2
THE INFORMATION IN THIS PROSPECTUS IS NOT COMPLETE AND MAY BE CHANGED. WE MAY
NOT SELL THESE SECURITIES UNTIL THE REGISTRATION STATEMENT FILED WITH THE
SECURITIES AND EXCHANGE COMMISSION IS EFFECTIVE. THIS PROSPECTUS IS NOT AN OFFER
TO SELL THESE SECURITIES AND IT IS NOT SOLICITING AN OFFER TO BUY THESE
SECURITIES IN ANY STATE WHERE THE OFFER OR SALE IS NOT PERMITTED.
SUBJECT TO COMPLETION
PRELIMINARY PROSPECTUS DATED OCTOBER 15, 1999
PROSPECTUS
SHARES
[NEOFORMA.COM LOGO]
COMMON STOCK
------------------------
This is Neoforma.com, Inc.'s initial public offering of common stock.
We expect the public offering price to be between $ and $ per
share. Currently, no public market exists for the shares. After pricing of the
offering, we expect that the common stock will be quoted on the Nasdaq National
Market under the symbol "NEOF."
INVESTING IN OUR COMMON STOCK INVOLVES RISKS WHICH ARE DESCRIBED IN THE
"RISK FACTORS" SECTION BEGINNING ON PAGE 6 OF THIS PROSPECTUS.
------------------------
<TABLE>
<CAPTION>
PER SHARE TOTAL
--------- -----
<S> <C> <C>
Public offering price...................................... $ $
Underwriting discount...................................... $ $
Proceeds, before expenses, to Neoforma.com, Inc............ $ $
</TABLE>
The underwriters may also purchase up to an additional shares
at the public offering price, less the underwriting discount, within 30 days
from the date of this prospectus to cover over-allotments.
Neither the Securities and Exchange Commission nor any state securities
commission has approved or disapproved of these securities or determined if this
prospectus is truthful or complete. Any representation to the contrary is a
criminal offense.
The shares of common stock will be ready for delivery in New York, New York
on or about , 1999.
------------------------
MERRILL LYNCH & CO.
BEAR, STEARNS & CO. INC.
ROBERTSON STEPHENS
VOLPE BROWN WHELAN & COMPANY
WILLIAM BLAIR & COMPANY
------------------------
The date of this prospectus is , 1999.
<PAGE> 3
Cover Artwork
[To come.]
<PAGE> 4
TABLE OF CONTENTS
<TABLE>
<S> <C>
Prospectus Summary.......................................... 3
Risk Factors................................................ 6
Special Note Regarding Forward-Looking Statements and
Industry Data............................................. 18
Use of Proceeds............................................. 19
Dividend Policy............................................. 19
Capitalization.............................................. 20
Dilution.................................................... 22
Selected Financial Data..................................... 23
Management's Discussion and Analysis of Financial Condition
and Results of Operations................................. 24
Business.................................................... 32
Management.................................................. 47
Certain Transactions........................................ 58
Principal Stockholders...................................... 62
Description of Capital Stock................................ 64
Shares Eligible for Future Sale............................. 67
Underwriting................................................ 69
Legal Matters............................................... 72
Experts..................................................... 72
Where You Can Find More Information......................... 72
Index to Financial Statements............................... F-1
</TABLE>
------------------------
You should rely only on the information contained in this prospectus. We
have not, and the underwriters have not, authorized any other person to provide
you with different information. If anyone provides you with different or
inconsistent information, you should not rely on it. We are not, and the
underwriters are not, making an offer to sell these securities in any
jurisdiction where the offer or sale is not permitted. You should assume that
the information appearing in this prospectus is accurate only as of the date of
this prospectus. Our business, financial condition, results of operations and
prospects may have changed since that date.
Except as otherwise indicated, all information in this prospectus assumes:
- the conversion of each outstanding share of preferred stock into one
share of common stock upon the consummation of this offering; and
- no exercise of the underwriters' over-allotment option.
Neoforma, Neoforma.com, the Neoforma.com logo, Shop, Auction and Plan are
our trademarks or service marks. Each trademark or service mark of any other
company appearing in this prospectus belongs to its holder.
We incorporated in California on March 4, 1996 and reincorporated in
Delaware on November 4, 1998. Our address is 3255-7 Scott Boulevard, Santa
Clara, California, 95054, and our telephone number is (408) 654-5700.
2
<PAGE> 5
PROSPECTUS SUMMARY
This summary may not contain all of the information that may be important
to you. You should carefully read the entire prospectus, including "Risk
Factors" and our financial statements, before making an investment decision.
NEOFORMA.COM, INC.
Neoforma.com is a leading provider of business-to-business e-commerce
services in the large and highly fragmented market for medical products,
supplies and equipment. Our services provide an open, online marketplace where
any manufacturer or distributor may list and sell medical products. By
aggregating a large number of suppliers and products, our services enable
physicians, hospitals and other healthcare providers to efficiently purchase a
wide range of new and used medical products. To increase the breadth and usage
of our services, we have entered into strategic alliances with leading Internet,
technology and healthcare-related organizations and medical products suppliers,
such as Dell, General Electric Medical Systems, Healtheon, Owens & Minor, SAP
and Superior Consultant.
We offer three primary services that together address the entire healthcare
purchasing lifecycle. Our Shop service, introduced in late August 1999, provides
a unified marketplace where purchasers can easily locate and buy new medical
products, and suppliers can access new customers and markets. Our Auction
service, introduced in May 1999, creates an efficient marketplace for idle
assets by enabling users to list, sell and buy used, refurbished and surplus
medical products. Our Plan service, introduced in July 1998, provides
interactive content to healthcare facility planners to reduce the complexities
of planning and outfitting healthcare facilities.
The worldwide market for new medical products, supplies and equipment is
approximately $140 billion, and is growing at an estimated 6% per year. In the
U.S. alone, there are over 20,000 manufacturers and distributors that supply new
medical products to over 200,000 healthcare providers, including hospitals,
physicians' offices and other healthcare delivery sites. In the market for used
or surplus medical products, sellers typically are manufacturers and large
healthcare providers located in U.S. urban centers, while buyers typically are
healthcare providers located outside of the U.S. or in rural markets in the U.S.
The high degree of buyer and supplier fragmentation in the market for both new
and used medical products results in significant supply-chain inefficiencies.
Our online marketplace provides significant benefits to both purchasers and
sellers of new and used medical products, supplies and equipment. By aggregating
product information from numerous suppliers, we offer healthcare providers a
central, easy-to-use location for the purchase of medical products, enabling
them to significantly reduce transaction and procurement costs. By aggregating a
wide range of purchasers, we enable any supplier to offer its new and used
medical products on a global basis, significantly expanding its market exposure
without the expense associated with building or extending traditional
distribution channels.
Our objective is to become the leading online marketplace for new and used
medical products. Key elements of our strategy to meet this objective include:
- Build on our position as one of the first to offer comprehensive
e-commerce services to our market and increase recognition of our brand;
- Increase adoption of our online marketplace to create a network effect
where the value of our marketplace significantly increases with each
additional user;
- Increase functionality of our services to drive broad market adoption;
- Establish strategic alliances with leading industry participants; and
- Expand internationally.
3
<PAGE> 6
THE OFFERING
<TABLE>
<S> <C>
Common stock offered............................... shares
Common stock to be outstanding after this shares
offering.........................................
Use of proceeds.................................... For general corporate purposes, including
sales and marketing, product development and
working capital.
Proposed Nasdaq National Market symbol............. NEOF
</TABLE>
The number of shares of our common stock that will be outstanding after
this offering is based on the actual number outstanding on September 30, 1999
and assumes the conversion into common stock of all our preferred stock
outstanding on that date. The number of shares outstanding includes 12,693,663
shares of common stock issuable upon conversion of our Series E and Series E-1
preferred stock that we issued in October 1999. The number of shares outstanding
excludes:
- 6,765,709 shares issuable upon the exercise of stock options outstanding
as of September 30, 1999, at a weighted average exercise price of $0.18
per share;
- 421,525 shares issuable upon the exercise of warrants outstanding as of
September 30, 1999, at a weighted average exercise price of $0.61 per
share; and
- shares available for future issuance under our stock plans
as described under "Management -- Employee Benefit Plans."
4
<PAGE> 7
SUMMARY FINANCIAL INFORMATION
(IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)
The summary financial information below should be read together with
"Management's Discussion and Analysis of Financial Condition and Results of
Operations" and the financial statements and the related notes included
elsewhere in this prospectus.
<TABLE>
<CAPTION>
PERIOD FROM
INCEPTION YEAR ENDED SIX MONTHS ENDED
(MARCH 6, 1996) DECEMBER 31, JUNE 30,
TO DECEMBER 31, ---------------- -----------------
1996 1997 1998 1998 1999
---------------- ------ ------- ------- -------
(UNAUDITED)
<S> <C> <C> <C> <C> <C>
STATEMENTS OF OPERATIONS DATA:
Total revenue........................ $ -- $ -- $ -- $ -- $ 7
Loss from operations................. (196) (408) (4,607) (1,065) (8,160)
Net loss............................. (54) (416) (4,563) (1,061) (8,127)
Basic and diluted net loss per
share.............................. (0.01) (0.05) (1.65) (0.21) (7.95)
Weighted-average shares -- basic and
diluted............................ 8,000 8,083 2,762 5,077 1,022
Pro forma basic and diluted loss per
share.............................. (0.36) (0.32)
Weighted-average shares -- pro forma
basic and diluted.................. 12,848 25,696
</TABLE>
<TABLE>
<CAPTION>
JUNE 30, 1999
(UNAUDITED)
------------------------------------
PRO FORMA
ACTUAL PRO FORMA AS ADJUSTED
-------- --------- -----------
<S> <C> <C> <C>
BALANCE SHEET DATA:
Cash and cash equivalents............................ $ 7,063 $77,601 $
Working capital...................................... 4,869 76,969
Total assets......................................... 9,759 81,859
Notes payable, less current portion.................. 1,624 1,624
Mandatorily redeemable convertible preferred stock... 15,870 --
Total stockholders' equity (deficit)................. (10,955) 77,694
</TABLE>
See Note 2 of notes to financial statements for a description of the method
we used to compute our basic and diluted net loss per share.
The above table summarizes our balance sheet as of June 30, 1999:
- on an actual basis;
- on a pro forma basis to reflect the sale in October 1999 of 12,418,663
shares of our Series E and Series E-1 preferred stock for net proceeds of
approximately $70.5 million, the issuance of 275,000 shares of our Series
E-1 preferred stock in connection with a strategic alliance we entered
into in October 1999 and the conversion of all outstanding shares of
preferred stock into 39,814,961 shares of common stock; and
- on a pro forma as adjusted basis to further reflect the application of
the net proceeds from the sale of shares of common stock
in this offering at an assumed initial public offering price of $ per
share, after deducting the estimated underwriting discount and estimated
offering expenses.
5
<PAGE> 8
RISK FACTORS
Before you invest in our common stock, you should carefully consider the
risks described below, together with all of the other information included in
this prospectus.
RISKS RELATED TO OUR BUSINESS
OUR PROSPECTS ARE DIFFICULT TO EVALUATE BECAUSE OUR OPERATING HISTORY IS LIMITED
We incorporated in March 1996. Prior to May 1999, our operations consisted
primarily of the initial planning and development of our marketplace and the
building of our operating infrastructure. We introduced our Auction service in
May 1999, and we introduced our Shop service in late August 1999. Because we
have only recently introduced our services, it is difficult to evaluate our
business and our future prospects. For example, it is difficult to predict
whether the market will accept our services and the level of revenue we can
expect to derive from our services. An investor in our common stock should
consider the risks and difficulties frequently encountered by early stage
companies in new and rapidly evolving markets such as the online market for the
purchase and sale of new and used medical products, supplies and equipment. We
cannot be certain that our business strategy will be successful or that we will
successfully address these risks. In addition, due to our limited operating
history, we believe that period-to-period comparisons of our revenue and results
of operations are not meaningful. As a result, you should not rely on our
revenue or results of operations as an indication of future performance or
prospects.
WE HAVE A HISTORY OF LOSSES, ANTICIPATE INCURRING LOSSES IN THE FORESEEABLE
FUTURE AND MAY NEVER ACHIEVE PROFITABILITY
We have experienced losses from operations in each period since our
inception. As of June 30, 1999, we had an accumulated deficit of approximately
$13.2 million. We have not achieved profitability and we expect to continue to
incur substantial operating losses for the foreseeable future. We have generated
limited revenue to date. If our revenue does not increase substantially or if
our expenses increase further than we expect, we may never become profitable.
We anticipate that our operating losses will increase in the future, as we
expect substantial increases in our costs and expenses in a number of areas,
including:
- marketing and promotion of our company and our services, including
building recognition of our brand name;
- expanding our direct field sales force;
- expanding and enhancing our operating infrastructure, including hardware
and software systems and administrative personnel;
- extending the functionality of our online marketplace; and
- expanding our services.
6
<PAGE> 9
OUR OPERATING RESULTS ARE VOLATILE AND DIFFICULT TO PREDICT, AND IF WE FAIL TO
MEET THE EXPECTATIONS OF INVESTORS OR SECURITIES ANALYSTS, THE MARKET PRICE OF
OUR COMMON STOCK WOULD LIKELY DECLINE SIGNIFICANTLY
Our revenue and operating results are likely to fluctuate significantly
from quarter to quarter, due to a number of factors. These factors include:
- demand for and market acceptance of our services;
- the amount and timing of payments to our strategic partners;
- variability in the amount of equipment that we auction in a given
quarter;
- changes in the fees we charge users of our services;
- the amount and timing of capital expenditures and other costs relating to
the expansion of our operations;
- the loss of one or more of our strategic partners or key suppliers or
purchasers;
- budgetary fluctuations of purchasers of medical products, supplies and
equipment;
- the timing and number of employee hires or departures;
- technical difficulties with our online marketplace; and
- changes in general economic and market conditions.
Due to all of the above factors, fluctuations in our operating results may
cause us to fail to meet the expectations of investors or securities analysts.
If this were to happen, the market price of our common stock would likely
decline significantly.
In addition, as a result of our limited operating history, the emerging
nature of our market and the evolving nature of our business model, we are
unable to accurately forecast our revenue. We incur expenses based predominantly
on operating plans and estimates of future revenue. Our expenses are to a large
extent fixed. We may be unable to adjust our spending in a timely manner to
compensate for any unexpected revenue shortfalls. Accordingly, a failure to meet
our revenue projections would have an immediate and negative impact on
profitability.
OUR BUSINESS MODEL IS NEW AND MAY NOT BE ACCEPTED BY PURCHASERS AND SUPPLIERS OF
MEDICAL PRODUCTS
We offer an online marketplace that aggregates a number of suppliers and
purchasers of medical products. This business model is new and unproven and
depends upon buyers and sellers in this market adopting a new way to purchase
and sell medical products, supplies and equipment. Suppliers and purchasers of
medical products could be reluctant to accept our new, unproven approach, which
involves new technologies and may not be consistent with their existing internal
organization and procurement processes. Suppliers and purchasers may prefer to
use traditional methods of selling and buying medical products, such as using
paper catalogs and interacting in person or by phone with representatives of
manufacturers or distributors. In addition, many of the individuals responsible
for purchasing medical products do not have ready access to the Internet and may
be unwilling to use the Internet to purchase medical products. Even if suppliers
and purchasers accept the Internet as a means of selling and buying medical
products, they may not accept our online marketplace for conducting this type of
business. Instead, they may choose to establish and operate their own websites
to purchase or sell new and used medical products. Reluctance of suppliers and
purchasers to use our services would seriously harm our business.
7
<PAGE> 10
IF WE CANNOT QUICKLY BUILD A CRITICAL MASS OF PURCHASERS AND SUPPLIERS OF
MEDICAL PRODUCTS, SUPPLIES AND EQUIPMENT, WE WILL NOT ACHIEVE A NETWORK EFFECT
AND OUR BUSINESS MAY NOT SUCCEED
To encourage suppliers to list their products on our online marketplace, we
need to increase the number of purchasers who use our services. However, to
encourage purchasers to use our marketplace, it must offer a broad range of
products from a large number of suppliers. If we are unable to quickly build a
critical mass of purchasers and suppliers, we will not be able to benefit from a
network effect, where the value of our services to each participant
significantly increases with the addition of each new participant. Our inability
to achieve a network effect would reduce the overall value of our Shop and
Auction services to purchasers and suppliers and, consequently, would harm our
business.
IN ORDER FOR LARGE HEALTHCARE ORGANIZATIONS TO ACCEPT OUR SERVICES, WE MUST
EXPAND THE BASE OF SUPPLIERS USING OUR SERVICES AND THE FUNCTIONALITY OF OUR
SERVICES
Currently, most of the registered users of our website are relatively small
healthcare providers such as physicians offices, and these users have accounted
for most of the purchases of new medical products through Shop. It is important
to our success that our services be used by large healthcare organizations, such
as hospitals, integrated delivery networks and members of large purchasing
organizations. In order for these large organizations to accept our services, we
must integrate our services with their information systems. In addition, we will
need to develop customer-specific pricing capabilities before these
organizations can use our services to purchase products covered by their
negotiated agreements with suppliers. Finally, we will need to significantly
increase the number of suppliers using our services to address the needs of
these large organizations, which typically require a wide range of medical
products. Many of these large healthcare organizations have established, or may
establish, websites or electronic data interchange systems designed specifically
for their needs and integrated with their existing processes and technologies.
If we are unable to extend our capabilities and expand our base of suppliers as
described above, we may not provide an attractive alternative to these websites
or systems and may not achieve market acceptance by these large organizations.
IF WE ARE UNABLE TO EXPAND THE BREADTH OF THE PRODUCTS OFFERED THROUGH OUR
MARKETPLACE, THE ATTRACTIVENESS OF OUR SERVICES TO PURCHASERS WILL BE DIMINISHED
The future success of our Shop service depends upon our ability to offer
purchasers a wide range of medical products. The products currently listed on
our Shop service are primarily oriented to the physicians' office market. Large
healthcare organizations generally require a much broader range of products. To
increase the breadth of the products listed on Shop, we must establish
relationships with additional suppliers and expand the number and variety of
products listed by existing suppliers. If we are unable to maintain and expand
the breadth of medical products, supplies and equipment listed on Shop, the
attractiveness of our services to purchasers will be diminished.
A number of factors could significantly reduce, or prevent us from
increasing, the number of suppliers and products offered on our online
marketplace, including:
- reluctance of suppliers to offer medical products in an online
marketplace that potentially includes their competitors;
- exclusive or preferential arrangements signed by suppliers with our
competitors;
- perceptions by suppliers that we give other suppliers preferred treatment
on our online marketplace; and
- consolidation among suppliers, which we believe is currently occurring.
8
<PAGE> 11
WE DEPEND ON A LIMITED NUMBER OF KEY MANUFACTURERS AND DISTRIBUTORS TO PROVIDE
MEDICAL PRODUCTS, SUPPLIES AND EQUIPMENT SOLD THROUGH OUR SHOP SERVICE, AND THE
LOSS OF A KEY MANUFACTURER OR DISTRIBUTOR COULD RESULT IN A REDUCTION IN THE
REVENUE WE GENERATE THROUGH THIS SERVICE
We expect that a significant portion of the products sold through and
revenue generated from our Shop service will come from a limited number of key
manufacturers and distributors. These parties are generally not obligated to
list any medical products on our Shop service. If any of these key manufacturers
or distributors cease doing business with us or reduce the number of products
they list on our Shop service, the revenue we generate through this service
could be significantly reduced. Our supplier agreements are nonexclusive and,
accordingly, these suppliers can sell their medical products, supplies and
equipment to purchasers directly or through our competitors.
IF WE DO NOT TIMELY ADD PRODUCT INFORMATION TO OUR ONLINE MARKETPLACE OR IF THAT
INFORMATION IS NOT ACCURATE, OUR REPUTATION MAY BE HARMED, AND WE MAY LOSE USERS
OF OUR ONLINE SERVICES
Currently, we are responsible for entering product information into our
database and categorizing the information for search purposes. If we do not do
so in a timely manner, we will encounter difficulties in expanding our online
marketplace. We currently have a backlog of products to be entered in our
system. We will not derive revenue from the sale of products by these suppliers
until the information is entered in our system. Timely entering of this
information in our database depends upon a number of factors, including the
format of the data provided to us by suppliers and our ability to accurately
enter the data in our product database, any of which could delay the actual
entering of the data. We use an independent company to input data provided to us
by suppliers, and we rely on this company to accurately input the data. If this
company fails to input data accurately, our reputation could be damaged, and we
could lose users of our online services.
If suppliers do not provide us in a timely manner with accurate, complete
and current information about the products they offer and promptly update this
information when it changes, our database will be less useful to purchasers. We
cannot guarantee that the product information available from our services will
always be accurate, complete and current, or that it will comply with
governmental regulations. This could expose us to liability if this incorrect
information harms users of our services or result in decreased adoption and use
of our online marketplace.
BECAUSE SOME OF THE PARTICIPANTS IN OUR ONLINE MARKETPLACE ARE STOCKHOLDERS OR
HAVE STRATEGIC RELATIONSHIPS WITH US, WE MAY FIND IT DIFFICULT TO ATTRACT
COMPETING COMPANIES WHICH COULD LIMIT THE BREADTH OF PRODUCTS OFFERED ON AND
USERS OF OUR ONLINE MARKETPLACE
Some suppliers participating in our online marketplace are our stockholders
or have strategic relationships with us. For example, General Electric Medical
Systems is entitled to sponsor rooms in our Plan service and has agreed to
conduct other activities with us, and an affiliated entity has recently acquired
shares of our preferred stock. See "Business -- Suppliers." These relationships
may deter other suppliers, particularly those that compete directly with these
participants, from participating in our online marketplace due to perceptions of
bias in favor of one supplier over another. This could limit the array of
products offered on our online marketplace, damage our reputation and limit our
ability to maintain or increase our user base.
IF WE ARE NOT ABLE TO KEEP UP WITH RAPIDLY CHANGING TECHNOLOGY AND DEVELOP
ENHANCEMENTS TO OUR SERVICES, WE MAY NOT BE ABLE TO ATTRACT OR RETAIN PURCHASERS
AND SUPPLIERS OF MEDICAL PRODUCTS
If we do not maintain and expand the functionality and reliability of our
services, purchasers and suppliers of medical products may not use our
marketplace. There are rapid technological changes taking place in the
business-to-business e-commerce market. To keep up with our competitors and
9
<PAGE> 12
provide an attractive solution to purchasers and sellers of medical products,
supplies and equipment, we must:
- adapt to rapidly developing technologies;
- comply with changing industry standards; and
- constantly improve the functionality and reliability of our services.
In particular, we believe that we must develop the capability to integrate
our online services with enterprise software systems used by many suppliers of
medical products and by many large healthcare organizations, and to enable our
services to support customer-specific pricing. We may incur significant expenses
to develop these capabilities, and may not succeed in developing them in a
timely manner. In addition, developing the capability to integrate our services
with suppliers' and purchasers' enterprise software systems will require the
cooperation of and collaboration with the companies that develop and market
these systems. Suppliers and purchasers use a variety of different enterprise
software systems provided by a number of different vendors or developed
internally. This lack of uniformity increases the difficulty and cost of
developing the capability to integrate with the systems of a large number of
suppliers and purchasers. Failure to provide these capabilities would limit the
efficiencies that our services provide, and may deter many purchasers and
suppliers from using our online marketplace, particularly large healthcare
organizations.
WE FACE INTENSE COMPETITION THAT COULD LIMIT OUR ABILITY TO MAINTAIN OR EXPAND
THE BASE OF PURCHASERS AND SELLERS OF MEDICAL PRODUCTS USING OUR SERVICES
The online market for medical products, supplies and equipment is new,
rapidly evolving and intensely competitive. Our primary competition includes
e-commerce providers that have established online marketplaces for medical
products, supplies and equipment. We also face potential competition from a
number of sources. Many companies have created websites to serve the information
needs of healthcare professionals. Many of these companies are introducing
e-commerce functions that may compete with our services. In addition, providers
of online marketplaces and online auction services that currently focus on other
industries could expand the scope of their services to include medical products.
Existing suppliers of medical products may also establish online marketplaces
that offer services to suppliers and purchasers, either on their own or by
partnering with other companies. Moreover, live auction houses focusing on
medical products may establish online auction services. See
"Business -- Competition" for more information about our current and potential
competitors.
Competition is likely to intensify as our market matures. As competitive
conditions intensify, competitors may:
- enter into strategic or commercial relationships with larger, more
established healthcare, medical products and Internet companies;
- secure services and products from suppliers on more favorable terms;
- devote greater resources to marketing and promotional campaigns;
- secure exclusive or preferential arrangements with purchasers or
suppliers that limit sales through our marketplace; and
- devote substantially more resources to website and systems development.
Many of our existing and potential competitors have longer operating
histories in the medical products market, greater name recognition, larger
customer bases and greater financial, technical and marketing resources than we
do. As a result of these factors, our competitors and potential competitors may
be able to respond more quickly to market forces, undertake more extensive
marketing campaigns for their brands and services and make more attractive
offers to purchasers and
10
<PAGE> 13
suppliers, potential employees and strategic partners. In addition, new
technologies may increase competitive pressures. We cannot be certain that we
will be able to maintain or expand our user base. We may not be able to compete
successfully against current and future competitors and competition could result
in price reductions, reduced sales, gross margins and operating margins and loss
of market share.
IF WE ARE NOT ABLE TO INCREASE RECOGNITION OF THE NEOFORMA.COM BRAND NAME, OUR
ABILITY TO ATTRACT USERS TO OUR ONLINE MARKETPLACE WILL BE LIMITED
We believe that recognition and positive perception of the Neoforma.com
brand name in the healthcare industry are important to our success. We intend to
significantly expand our advertising and publicity efforts in the near future.
However, we may not achieve our desired goal of increasing the awareness of the
Neoforma.com brand name. Even if recognition of our name increases, it may not
lead to an increase in the number of visitors to our online marketplace or
increase the number of users of our services.
IF PARTICIPATING SELLERS ON OUR SHOP AND AUCTION SERVICES DO NOT PROVIDE TIMELY
AND PROFESSIONAL DELIVERY OF MEDICAL PRODUCTS, SUPPLIES AND EQUIPMENT,
PURCHASERS MAY NOT CONTINUE USING OUR SERVICES
We rely on suppliers to deliver the medical products, supplies and
equipment sold through our Shop service to purchasers. We also often rely on
sellers to deliver products sold through our Auction service. In addition,
suppliers do not guarantee the availability or timely delivery of products
listed on to Shop. If these sellers fail to make delivery in a professional,
safe and timely manner, then our services will not meet the expectations of
purchasers, and our reputation and brand will be damaged. In addition,
deliveries that are non-conforming, late or are not accompanied by information
required by applicable law or regulations could expose us to liability or result
in decreased adoption and use of our services.
WE MAY BE SUBJECT TO LITIGATION FOR DEFECTS IN PRODUCTS SUPPLIED BY SELLERS
USING OUR SERVICES, AND THIS TYPE OF LITIGATION MAY BE COSTLY AND TIME-CONSUMING
TO DEFEND
Because we facilitate the sale of new and used medical products by sellers
using our services, we may become subject to legal proceedings regarding defects
in these medical products, even though we do not take title to these products.
Any claims, with or without merit, could:
- be time-consuming to defend;
- result in costly litigation; or
- divert management's attention and resources.
IF WE ARE UNABLE TO ATTRACT QUALIFIED PERSONNEL OR RETAIN OUR EXECUTIVE OFFICERS
AND OTHER KEY PERSONNEL, WE MAY NOT BE ABLE TO COMPETE SUCCESSFULLY IN OUR
INDUSTRY
Our success depends on our ability to attract and retain qualified,
experienced employees. Competition for qualified, experienced employees in both
the Internet and the healthcare industry, particularly in the San Francisco Bay
Area, is intense, and we may not be able to compete effectively to retain and
attract employees. Should we fail to retain or attract qualified personnel, we
may not be able to compete successfully in our industry, and our business would
be harmed.
We believe that our success will depend on the continued services of
executive officers and other key employees. Other than initial offer letters
containing information regarding compensation, we currently have employment
agreements with only two members of our senior management. However, these
agreements do not prevent these executives from terminating their employment at
any time. As
11
<PAGE> 14
a result, our employees, including these executives, serve at-will and may elect
to pursue other opportunities at any time. The loss of any of our executive
officers or other key employees could harm our business.
We currently do not have an Executive Vice President of Sales, as we are
involved in litigation with respect to the services of Daniel A. Eckert, an
individual whom we had hired to serve in that position. If we are unable to
resolve this litigation in a timely fashion, or are unable to hire an adequate
replacement for Mr. Eckert if we are unsuccessful in this litigation, our
business could be harmed.
Other than the limited key person life insurance policies we have with our
founders, Jeffrey H. Kleck and Wayne D. McVicker, we do not maintain any key
person life insurance.
WE ARE INVOLVED IN LITIGATION INVOLVING OUR RECENT HIRE OF AN EXECUTIVE OFFICER
AND IF WE LOSE IN THIS LITIGATION, WE MAY NOT BE ABLE TO HIRE THIS EXECUTIVE
OFFICER AND WE MAY HAVE TO PAY MONEY DAMAGES
On August 6, 1999, Fisher Scientific International, Inc. filed a petition
in the District Court of Montgomery County, Texas, against us and Daniel A.
Eckert, an individual that we had hired to serve as our Executive Vice President
of Sales. Fisher alleged that Mr. Eckert, previously President of one of
Fisher's divisions, Fisher HealthCare, would be in breach of a covenant not to
compete if he were to work for us. Fisher also alleged that Mr. Eckert had
disclosed, and in working for us would inevitably disclose, Fisher's
confidential and proprietary information, and that by hiring Mr. Eckert, we were
interfering with Fisher's business relations. Finally, Fisher alleged that these
actions constituted unfair competition. The outcome of litigation is uncertain
and cannot be predicted. If Fisher prevails in this litigation, it could prevent
Mr. Eckert from joining us in any capacity, and could require that we pay money
damages to Fisher. In addition, litigation can divert management's attention and
resources.
MANY OF OUR EXECUTIVES AND OTHER EMPLOYEES RECENTLY JOINED OUR COMPANY, AND WE
CANNOT ASSURE YOU THAT THEY WILL WORK TOGETHER EFFECTIVELY
Many of our executive officers and other employees joined us only recently
and have had a limited time to work together. For example, our Chief Executive
Officer, Robert J. Zollars, joined Neoforma.com in July 1999, our Chief
Financial Officer, Frederick J. Ruegsegger, joined Neoforma.com in July 1999,
and our Executive Vice President of Products and Services, Bhagwan D. Goel,
joined Neoforma.com in October 1999. We cannot assure you that they will be able
to work effectively together to manage our growth and continuing operations.
WE PLAN TO EXPAND OUR SERVICES INTERNATIONALLY, AND IF WE ARE UNABLE TO DO SO,
OUR GROWTH WILL BE LIMITED
An important part of our business strategy is to expand our services
internationally. We have limited experience with the healthcare industry outside
the U.S. and with marketing our services internationally. Our entry into
international markets may require significant management attention and financial
resources, which may harm our ability to effectively manage our existing
business. Furthermore, entry into some international markets would require us to
develop foreign language versions of our services. Accordingly, our planned
international expansion may not be successful. We cannot be sure that we will be
able to attract purchasers and sellers of medical products in foreign
jurisdictions to our online marketplace. In addition, the market for the
purchase and sale of medical products in many foreign countries is different
from that in the U.S. For example, in many foreign countries, the government or
a government-controlled entity is the principal purchaser of medical products.
Competitors which have greater local market knowledge may exist or arise in
these international markets and impede our ability to successfully expand in
these markets.
12
<PAGE> 15
WE MAY MAKE NEW ACQUISITIONS, WHICH COULD HARM OUR PROFITABILITY, PUT A STRAIN
ON OUR RESOURCES, OR CAUSE DILUTION TO OUR STOCKHOLDERS
We may find it necessary to make acquisitions of technologies and other
companies in order to expand our business and the services we offer. For
example, on August 6, 1999, we acquired General Asset Recovery, LLC, a live
auction house and asset management company focused on medical products.
Integrating newly acquired organizations and technologies into our company could
be expensive, time consuming and may strain our resources. In addition, we may
lose current users of our services if any acquired companies have relationships
with competitors of our users. Consequently, we may not be successful in
integrating any acquired businesses or technologies and may not achieve
anticipated revenue and cost benefits. In addition, future acquisitions could
result in potentially dilutive issuances of equity securities or the incurrence
of debt, contingent liabilities or amortization expenses related to goodwill and
other intangible assets, any of which could harm our business. For example, in
connection with the acquisition of General Asset Recovery, we recorded
approximately $9.7 million in goodwill, which will be amortized over a period of
seven years.
IF WE ARE UNABLE TO MAINTAIN OUR STRATEGIC ALLIANCES OR ENTER INTO NEW
ALLIANCES, WE MAY BE UNABLE TO INCREASE THE ATTRACTIVENESS OF OUR ONLINE
MARKETPLACE OR PROVIDE SATISFACTORY SERVICES TO USERS OF OUR SERVICES
Our business strategy includes entering into strategic alliances with
leading technology and healthcare-related companies to increase users of our
online marketplace, increase the number and variety of products that we offer
and provide additional services and content to our users. We may not achieve our
objectives through these alliances. These agreements do not, and future
relationships may not, afford us any exclusive marketing or distribution rights.
Many of these companies have multiple relationships and they may not regard us
as significant for their business. These companies may pursue relationships with
our competitors or develop or acquire services that compete with our services.
In addition, in many cases these companies may terminate these relationships
with little or no notice. If any existing alliance is terminated or we are
unable to enter into alliances with leading technology and healthcare-related
companies, we may be unable to increase the attractiveness of our online
marketplace or provide satisfactory services to purchasers and suppliers of
medical products.
OUR RECENT GROWTH HAS PLACED A SIGNIFICANT STRAIN ON OUR MANAGEMENT SYSTEMS AND
RESOURCES, AND WE MAY EXPERIENCE A SIMILAR OR INCREASED STRAIN IN MANAGING OUR
EXPECTED GROWTH IN THE FUTURE
We have grown rapidly and will need to continue to grow to execute our
business strategy. Our total number of employees grew from four as of December
31, 1997, to 48 as of December 31, 1998, and to 148 as of September 30, 1999,
and we anticipate further significant increases in the number of our employees.
Our growth has placed significant demands on management as well as on our
administrative, operational and financial resources and controls. We expect our
future growth to cause similar, and perhaps increased, strain on our systems and
controls. For example, our rapid growth requires that we integrate and manage a
large number of new employees. In addition, we will need to substantially
upgrade our information systems including our accounting system. We also will
need to institute new systems such as an auction inventory tracking system. Any
failure to successfully upgrade our systems and controls could result in errors
in our financial or other reporting, or could result in inefficiencies in our
business.
OUR SYSTEMS MAY NOT BE ABLE TO PROVIDE ACCEPTABLE PERFORMANCE WITH INCREASED USE
To date, we have processed a limited number and variety of transactions on
our website. Our systems may not accommodate increased use while providing
acceptable overall performance. We must continue to expand and adapt our network
infrastructure to accommodate additional users and
13
<PAGE> 16
increased transaction volumes. This expansion and adaptation will be expensive
and will divert our attention from other activities.
SYSTEM FAILURE MAY CAUSE INTERRUPTION OF OUR SERVICES, WHICH COULD IMPAIR OUR
REPUTATION AND THE ATTRACTIVENESS OF OUR SERVICES
The performance of our server and networking hardware and software
infrastructure is critical to our business and reputation and our ability to
process transactions, provide high quality customer service and attract and
retain users of our services. Currently, our infrastructure and systems are
located at one site at Exodus Communications in Sunnyvale, California, which is
an area susceptible to earthquakes. We depend on our single-site infrastructure
and any disruption to this infrastructure resulting from a natural disaster or
other event could result in an interruption in our service, reduce the number of
transactions we are able to process and, if sustained or repeated, could impair
our reputation and the attractiveness of our services.
Our systems and operations are vulnerable to damage or interruption from
human error, natural disasters, power loss, telecommunications failures,
break-ins, sabotage, computer viruses, intentional acts of vandalism and similar
events. We do not have a formal disaster recovery plan or alternative provider
of hosting services. In addition, we do not carry sufficient business
interruption insurance to compensate us for losses that could occur. Any failure
on our part to expand our system or Internet infrastructure to keep up with the
demands of our users, or any system failure that causes an interruption in
service or a decrease in responsiveness of our online services or website, could
result in fewer transactions and, if sustained or repeated, could impair our
reputation and the attractiveness of our services.
IF WE ARE UNABLE TO SAFEGUARD THE SECURITY AND PRIVACY OF THE CONFIDENTIAL
INFORMATION OF THE USERS OF OUR ONLINE MARKETPLACE, THESE USERS MAY DISCONTINUE
USING OUR SERVICES
A significant barrier to the widespread adoption of e-commerce is the
secure transmission of personally identifiable information of Internet users as
well as other confidential information over public networks. If any compromise
or breach of security were to occur, it could harm our reputation and expose us
to possible liability. A party who is able to circumvent our security measures
could misappropriate proprietary information or cause interruptions in our
operations. We may be required to make significant expenditures to protect
against security breaches or to alleviate problems caused by any breaches.
THE SUCCESS OF OUR BUSINESS DEPENDS ON OUR ABILITY TO PROTECT OUR INTELLECTUAL
PROPERTY RIGHTS
We regard our intellectual property as critical to our success. If we are
unable to protect our intellectual property rights, our business would be
harmed. We rely on trademark, copyright and trade secret laws to protect our
proprietary rights. We have applied for registration of several marks including
the Neoforma.com logo. Our trademark registration applications may not be
approved or granted, or, if granted, may be successfully challenged by others or
invalidated through administrative process or litigation.
WE MAY BE SUBJECT TO INTELLECTUAL PROPERTY CLAIMS AND WE COULD SUBSEQUENTLY LOSE
OUR INTELLECTUAL PROPERTY RIGHTS, WHICH COULD RESULT IN OUR INABILITY TO OPERATE
OUR CURRENT BUSINESS
We may from time to time be subject to claims of infringement of other
parties' proprietary rights or claims that our own trademarks, patents or other
intellectual property rights are invalid. Any claims of this type, with or
without merit, could be time consuming to defend, result in costly litigation,
divert management attention and resources or require us to enter into royalty or
license agreements. License agreements may not be available on commercially
reasonable terms, if at all.
14
<PAGE> 17
The loss of access to any key intellectual property right could result in our
inability to operate our current business.
IF WE FAIL TO LICENSE THIRD-PARTY SOFTWARE INCORPORATED IN OUR SERVICES, WE MAY
NOT BE ABLE TO OPERATE OUR ONLINE MARKETPLACE
We currently rely on software that we have licensed from a number of
suppliers. For example, we use software that we license from NetDynamics, Inc.,
a subsidiary of Sun Microsystems, to provide part of our website infrastructure
and we use information retrieval software that we license from SearchCafe
Development Corporation to provide part of our search capabilities. These
licenses may not continue to be available to us on commercially reasonable
terms, or at all. In addition, the licensors may not continue to support or
enhance the licensed software. In the future, we expect to license other third
party technologies to enhance our services, to meet evolving user needs or to
adapt to changing technology standards. Failure to license, or the loss of any
licenses of, necessary technologies could impair our ability to operate our
online marketplace until equivalent software is identified, licensed and
integrated or developed by us. In addition, we may fail to successfully
integrate licensed technology into our services, which could similarly harm
development and market acceptance of our services.
RISKS RELATED TO OUR INDUSTRY
THE SUCCESS OF OUR BUSINESS DEPENDS ON THE PARTICIPANTS IN THE MARKET FOR
MEDICAL PRODUCTS, SUPPLIES AND EQUIPMENT ACCEPTING THE INTERNET FOR DISTRIBUTION
AND PROCUREMENT
Business-to-business e-commerce is currently not a significant sector of
the market for medical products, supplies and equipment. The Internet may not be
adopted by purchasers and suppliers in the medical products, supplies and
equipment market for many reasons, including:
- reluctance by the healthcare industry to adopt the technology necessary
to engage in the online purchase and sale of medical products;
- failure of the market to develop the necessary infrastructure for
Internet-based communications, such as wide-spread Internet access,
high-speed modems, high-speed communication lines and computer
availability;
- their comfort with existing purchasing habits, such as ordering through
paper-based catalogs and representatives of medical manufacturers and
distributors;
- their concern with respect to security and confidentiality; and
- their investment in existing purchasing and distribution methods and the
costs required to switch methods.
Should healthcare providers and suppliers of medical products choose not to
utilize or accept the Internet as a means of purchasing and selling medical
products, our business model would not be viable.
REGULATION OF THE INTERNET IS UNSETTLED, AND FUTURE REGULATIONS COULD INHIBIT
THE GROWTH OF THE INTERNET AND OTHERWISE HARM OUR BUSINESS
A number of legislative and regulatory proposals under consideration by
federal, state, local and foreign governmental organizations may lead to laws or
regulations concerning various aspects of the Internet, such as user privacy,
taxation of goods and services provided over the Internet and the pricing,
content and quality of services. Legislation could dampen the growth in Internet
usage and decrease or limit its acceptance as a communications and commercial
medium. If enacted, these laws
15
<PAGE> 18
and regulations could limit the market for our services. In addition, existing
laws could be applied to the Internet, including consumer privacy laws.
Legislation or application of existing laws could expose companies involved in
e-commerce to increased liability, which could limit the growth of e-commerce.
Furthermore, numerous states have regulations regarding how auctions may be
conducted and the liability of auctioneers in conducting these auctions. No
legal determination has been made with respect to the applicability of these
regulations to our online business to date and little precedent exists in this
area. One or more states may attempt to impose these regulations upon us in the
future.
CHANGES IN THE REGULATORY AND ECONOMIC ENVIRONMENT AND CONSOLIDATION IN THE
HEALTHCARE INDUSTRY COULD HARM OUR BUSINESS
The healthcare industry is highly regulated and is subject to changing
political, economic and regulatory influences. These factors affect the
purchasing practices and operation of healthcare organizations. Changes in
current healthcare financing and reimbursement systems could require us to make
unplanned enhancements of our services, or result in delays or cancellations of
orders or reduce demand for our services. Federal and state legislatures have
periodically considered programs to reform or amend the U.S. healthcare system
at both the federal and state level. These programs may contain proposals to
increase governmental involvement in healthcare, lower reimbursement rates or
otherwise change the environment in which healthcare industry providers operate.
We do not know what effect any proposals would have on our business.
Many healthcare industry participants are consolidating to create
integrated healthcare delivery systems with greater market power. As the
healthcare industry consolidates, competition to provide services to industry
participants will become more intense and the importance of establishing a
relationship with each industry participant will become greater. These industry
participants may try to use their market power to negotiate fee reductions of
our services. If we were forced to reduce our fees, our operating results could
suffer if we cannot achieve corresponding reductions in our expenses.
WE FACE YEAR 2000 RISKS ASSOCIATED WITH OUR OWN SYSTEMS AND THOSE OF PURCHASERS,
SUPPLIERS AND THE INTERNET
Significant uncertainty exists concerning the potential costs and effects
associated with any year 2000 compliance problems. Any year 2000 compliance
problems faced by us, users of our online marketplace and strategic partners
could seriously harm our business. In addition, our ability to operate our
business depends upon delivery of accurate, electronic information via the
Internet. To the extent year 2000 issues result in the long-term inoperability
of the Internet or our online marketplace, our business would be seriously
harmed. For more information regarding this risk, see "Management's Discussion
and Analysis of Financial Condition and Results of Operations -- Year 2000."
16
<PAGE> 19
RISKS RELATED TO THIS OFFERING
THE PRICE OF OUR COMMON STOCK MAY FLUCTUATE SIGNIFICANTLY, WHICH COULD LEAD TO
LOSSES FOR INDIVIDUAL STOCKHOLDERS
Although the initial public offering price of our common stock will be
determined based on several factors, the market price after the offering will
vary from the initial offering price. The market price of the common stock may
fluctuate significantly in response to a number of factors, some which are
beyond our control, including:
- variations in our reported operating results;
- changes in estimates of our financial performance by securities analysts;
- changes in market valuation of business-to-business e-commerce companies
generally;
- announcements by us of significant contracts, acquisitions, strategic
relationships, joint ventures or capital commitments;
- loss of a major participant in our online marketplace or of a strategic
partner;
- departures of any of our key personnel; and
- future sales of our common stock.
The trading prices of many stocks of Internet-related companies have
experienced extreme price and volume fluctuations. These fluctuations often have
been unrelated or disproportionate to the operating performance of these
companies. These fluctuations may continue and could harm our stock price. Any
negative change in the public's perception of the prospects of Internet-related
companies could also depress our stock price, regardless of our results.
WE COULD BE SUBJECT TO SECURITIES CLASS ACTION LITIGATION IF OUR STOCK PRICE IS
VOLATILE
In the past, there have been class action lawsuits filed against companies
after periods of fluctuations in the market price of their securities. If we
were subject to this type of litigation, it would be a strain on our personnel
and financial resources, and divert management's attention from running our
company and could negatively affect our public image and reputation.
OUR EXECUTIVE OFFICERS, DIRECTORS AND MAJOR STOCKHOLDERS WILL RETAIN SIGNIFICANT
CONTROL OVER OUR BUSINESS AFTER THIS OFFERING
After this offering, executive officers, directors and current holders of
5% or more of our outstanding common stock will, in the aggregate, own
approximately % of our outstanding common stock. As a result, these
stockholders will be able to influence significantly all matters requiring
approval by our stockholders, including the election of directors and the
approval of significant corporate transactions. This concentration of ownership
may also delay, deter or prevent a change in control of our company and may make
some transactions more difficult or impossible without the support of these
stockholders.
WE HAVE ADOPTED ANTI-TAKEOVER DEFENSES THAT COULD DELAY OR PREVENT THE SALE OF
OUR COMPANY AND DIMINISH THE VOTING RIGHTS OF THE HOLDERS OF OUR COMMON STOCK
Provisions of our certificate of incorporation, bylaws and Delaware law
could make it more difficult for a third party to acquire us, even if doing so
would be beneficial to our stockholders. For a description of these provisions,
see "Description of Capital Stock -- Anti-Takeover Provisions."
17
<PAGE> 20
AN AGGREGATE OF SHARES, OR %, OF OUR OUTSTANDING STOCK, WILL
BECOME ELIGIBLE FOR RESALE IN THE PUBLIC MARKET BETWEEN 180 DAYS AND ONE YEAR
AFTER THIS OFFERING, AND FUTURE SALES OF THIS STOCK MAY CAUSE OUR STOCK PRICE TO
DECLINE
Sales of substantial amounts of our common stock in the public market after
this offering could reduce the prevailing market prices for our common stock. Of
the shares of common stock to be outstanding upon the closing of this
offering, the shares offered in this offering will be freely tradable
without restriction or further registration, other than shares purchased by our
officers, directors or other affiliates within the meaning of Rule 144 under the
Securities Act of 1933, which will be restricted from sale until 180 days after
the date of this prospectus under the terms of agreements between these
affiliates and the underwriters. An additional shares held by existing
stockholders prior to this offering will be eligible for immediate sale in the
public market without restriction. The remaining shares of our common
stock held by existing stockholders upon the completion of this offering will
become eligible for resale in the public market as follows:
<TABLE>
<CAPTION>
NUMBER OF
SHARES/PERCENT
OUTSTANDING AFTER
THE OFFERING DATE WHEN SHARES BECOME AVAILABLE FOR RESALE IN THE PUBLIC MARKET
- ----------------- -----------------------------------------------------------------
<C> <S>
180 days after the date of this prospectus under the terms of
agreements between the stockholders and the underwriters or us,
provided that the underwriters can waive this restriction at any
time. of these shares will also be subject to
sales volume restrictions under Rule 144 under the Securities
Act.
Upon expiration of applicable one-year holding periods under Rule
144, which will expire between and
, subject to sales volume restrictions under Rule
144.
</TABLE>
In addition, we intend to file a registration statement on Form S-8 under
the Securities Act after the date of this offering to register an aggregate of
shares of common stock issued or reserved for issuance under our
various stock plans.
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS AND INDUSTRY DATA
This prospectus contains forward-looking statements that relate to future
events or our future financial performance. In some cases, you can identify
forward-looking statements by terminology such as "may," "will," "should,"
"expect," "plan," "anticipate," "believe," "estimate," "predict," "intend,"
"potential" or "continue" or the negative of these terms or other comparable
terminology. These statements are only predictions. We cannot guarantee future
results, levels of activity, performance or achievements. We undertake no
obligation to publicly update or revise any forward-looking statements, whether
as a result of new information, future events or otherwise. Our actual results
could differ materially from those anticipated in these forward-looking
statements as a result of various factors, including the risks outlined under
"Risk Factors" and elsewhere in this prospectus.
This prospectus contains estimates of market growth related to the
Internet. These estimates have been included in studies published by Forrester
Research, Efficient Healthcare Consumer Response and the Health Industry
Manufacturers' Association. These estimates assume that certain events, trends
and activities will occur. Although we believe that these estimates are
generally indicative of the matters reflected in those studies, these estimates
are inherently imprecise, and we caution you to read these estimates in
conjunction with the rest of the disclosure in this prospectus, particularly the
"Risk Factors" section.
18
<PAGE> 21
USE OF PROCEEDS
The net proceeds to us from the sale of the shares of common
stock offered by us will be approximately $ million, or approximately
$ million if the underwriters' over-allotment option is exercised in
full, based on an assumed initial public offering price of $ per share
and after deducting the estimated underwriting discount and estimated offering
expenses.
We intend to use the net proceeds from this offering primarily for general
corporate purposes, including sales and marketing, product development and
working capital. We may use a portion of the net proceeds from this offering to
acquire or invest in businesses, technologies or services that are complementary
to our business. However, we have no present commitments with respect to any
transactions of this type. We will retain broad discretion in the allocation and
use of the net proceeds of this offering. Pending these uses, we intend to
invest the net proceeds in short-term, investment-grade, interest-bearing
securities.
DIVIDEND POLICY
We have never declared or paid cash dividends on our capital stock. We
intend to retain any future earnings to finance future growth and do not
anticipate paying cash dividends for the foreseeable future. In addition, the
terms of our credit facilities prohibit us from paying cash dividends on our
capital stock without prior consent of the lender.
19
<PAGE> 22
CAPITALIZATION
The following table sets forth our cash and cash equivalents and
capitalization as of June 30, 1999:
- on an actual basis;
- on a pro forma basis to reflect the sale in October 1999 of 12,418,663
shares of our Series E and Series E-1 preferred stock for net proceeds of
approximately $70.5 million, the issuance of 275,000 shares of our Series
E-1 preferred stock in connection with a strategic alliance we entered
into in October 1999 and the conversion of all outstanding shares of
preferred stock into 39,814,961 shares of common stock; and
- on a pro forma as adjusted basis to further reflect the application of
the net proceeds from the sale of shares of common stock
in this offering at an assumed initial public offering price of $ per
share and the filing of our amended and restated certificate of
incorporation prior to the completion of this offering, after deducting
the estimated underwriting discount and estimated offering expenses.
<TABLE>
<CAPTION>
JUNE 30, 1999
(UNAUDITED)
---------------------------------------------------
PRO FORMA
ACTUAL PRO FORMA AS ADJUSTED
------------- -------------- ----------------
(IN THOUSANDS, EXCEPT SHARE AND PER SHARE AMOUNTS)
<S> <C> <C> <C>
Cash and cash equivalents................................. $ 7,063 $ 77,763 $
======== ======== =======
Notes payable, less current portion....................... 1,624 1,624
-------- -------- -------
Mandatorily redeemable convertible preferred stock, $0.001
par value, 15,682,822 shares authorized, 15,261,298
issued and outstanding, actual; 15,682,822 shares
authorized, no shares issued and outstanding, pro forma
and pro forma as adjusted............................... 15,870 --
-------- --------
Valuation of warrants issued in conjunction with debt..... 679 --
-------- --------
Stockholders' equity (deficit):
Preferred stock, $0.001 par value; 11,860,000 shares
authorized, 11,860,000 shares issued and outstanding,
actual; 11,860,000 shares authorized, no shares
issued and outstanding, pro forma; 5,000,000 shares
authorized, no shares issued and outstanding, pro
forma as adjusted.................................... 12 --
Common stock, $0.001 par value; 75,000,000 shares
authorized, 1,380,611 shares issued and outstanding,
actual; 200,000,000 shares authorized, 41,195,572
shares issued and outstanding, pro forma; 200,000,000
shares authorized, shares issued and
outstanding, pro forma as adjusted................... 1 41
Additional paid-in capital................................ 7,043 95,664
Valuation of warrants to purchase common stock............ 17 17
Notes receivable from stockholders........................ (17) (17)
Deferred compensation..................................... (4,851) (4,851)
Deficit accumulated during the development stage.......... (13,160) (13,160)
-------- -------- -------
Total stockholders' equity (deficit)................. (10,955) 77,694
-------- -------- -------
Total capitalization............................ $ 7,218 $ 79,318 $
======== ======== =======
</TABLE>
20
<PAGE> 23
- -------------------------
The number of shares of common stock outstanding set forth in the table
above excludes the following:
- 6,765,709 shares issuable upon the exercise of stock options outstanding
as of September 30, 1999, at a weighted average exercise price of $0.18
per share;
- 421,525 shares issuable upon the exercise of warrants outstanding as of
September 30, 1999, at a weighted average exercise price of $0.61 per
share; and
- shares available for future issuance under our stock plans as
described under "Management -- Employee Benefit Plans."
The number of shares of common stock into which each share of our Series E
and Series E-1 preferred stock will be converted upon completion of this
offering may be adjusted under some circumstances as described in Note 13 of
notes to financial statements.
21
<PAGE> 24
DILUTION
As of June 30, 1999, our pro forma net tangible book value was
approximately $(10,926) million, or $(0.27) per share of common stock. Pro forma
net tangible book value per share represents the amount of our total tangible
assets less total liabilities, divided by 41,195,572 shares of common stock
outstanding after giving effect to the sale of 12,693,663 shares of our Series E
and Series E-1 preferred stock in October 1999 and the conversion of all
outstanding shares of preferred stock into shares of common stock upon
completion of this offering.
After giving effect to the receipt of the proceeds from the sale of shares
of our common stock in this offering and after deducting the estimated
underwriting discount and estimated offering expenses, our pro forma net
tangible book value as of June 30, 1999 would have been approximately $
million, or $ per share. This represents an immediate increase in pro forma
net tangible book value of $ per share to existing stockholders and an
immediate dilution of $ per share to new investors purchasing shares at the
initial public offering price. The following table illustrates the per share
dilution:
<TABLE>
<S> <C> <C>
Assumed initial public offering price per share............. $
Pro forma net tangible book value per share as of June 30,
1999................................................... $
Increase per share attributable to new investors..........
Pro forma net tangible book value per share after this
offering..................................................
------
Dilution per share to new investors......................... $
======
</TABLE>
The following table summarizes as of June 30, 1999, on the pro forma basis
described above, the number of shares of common stock purchased from us, the
total consideration paid to us and the average price per share paid by existing
stockholders and by new investors purchasing shares of common stock in this
offering, before deducting the estimated underwriting discount and estimated
offering expenses:
<TABLE>
<CAPTION>
TOTAL
SHARES PURCHASED CONSIDERATION
----------------- ----------------- AVERAGE PRICE
NUMBER PERCENT AMOUNT PERCENT PER SHARE
------- ------- ------- ------- -------------
<S> <C> <C> <C> <C> <C>
Existing stockholders...................... % $ % $
New investors..............................
------- ---- ------- ----
Total............................ % $ %
======= ==== ======= ====
</TABLE>
The above discussion and tables assume no exercise of any stock options or
warrants outstanding as of June 30, 1999. As of June 30, 1999, there were
options outstanding to purchase a total of 4,109,392 shares of common stock at a
weighted average price of $0.10 per share and warrants outstanding to purchase a
total of 273,814 shares of common stock with a weighted average exercise price
of $1.11 per share. As of September 30, 1999, we had outstanding options to
purchase 6,765,709 shares of our common stock at a weighted average exercise
price of $0.18 per share and warrants to purchase 421,525 shares of our common
stock at a weighted average exercise price of $1.14 per share. If any of these
options or warrants are exercised, there will be further dilution to new public
investors. Please see "Capitalization," "Management -- Employee Benefit Plans"
and Notes 9 and 10 of notes to financial statements.
22
<PAGE> 25
SELECTED FINANCIAL DATA
The selected financial data as of and for the years ended December 31, 1997
and 1998 and for the period from inception (March 6, 1996) through December 31,
1996, are derived from our financial statements, which have been audited by
Arthur Andersen LLP, independent public accountants, and are included elsewhere
in this prospectus. The selected financial data as of and for the six months
ended June 30, 1998 and 1999 are derived from unaudited financial statements
included elsewhere in this prospectus. We have prepared this unaudited
information on the same basis as the audited financial statements and have
included all adjustments, consisting only of normal recurring adjustments that
we consider necessary for a fair presentation of our financial position and
operating results for such periods. When you read this selected financial data,
it is important that you also read the historical financial statements and
related notes included in this prospectus, as well as the section of this
prospectus entitled "Management's Discussion and Analysis of Financial Condition
and Results of Operations." Historical results are not necessarily indicative of
future results.
See Note 2 of notes to financial statements for an explanation of the
determination of the number of shares used in computing per share amounts.
<TABLE>
<CAPTION>
PERIOD FROM INCEPTION YEAR ENDED SIX MONTHS ENDED
(MARCH 6, 1996) TO DECEMBER 31, JUNE 30,
DECEMBER 31, ------------------- -------------------
1996 1997 1998 1998 1999
--------------------- ------ -------- ------- --------
(UNAUDITED)
(IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)
<S> <C> <C> <C> <C> <C>
STATEMENTS OF OPERATIONS DATA:
Revenue:
Transaction fees................................ $ -- $ -- $ -- $ -- $ --
Website sponsorship fees and other.............. -- -- -- -- 7
------ ------ -------- ------- --------
Total revenue................................. -- -- -- -- 7
Operating Expenses:
Operations...................................... -- -- 627 190 1,319
Product development............................. 31 179 1,491 327 2,568
Selling and marketing........................... 111 153 1,409 321 2,382
General and administrative...................... 54 76 1,075 227 1,591
Amortization of deferred compensation........... -- -- 5 -- 307
------ ------ -------- ------- --------
Loss from operations.......................... (196) (408) (4,607) (1,065) (8,160)
Other Income (Expense):
Interest income................................. -- -- 66 13 128
Interest expense................................ -- (15) (22) (9) (95)
Other........................................... 142 7 -- -- --
------ ------ -------- ------- --------
Net loss...................................... $ (54) $ (416) $ (4,563) $(1,061) $ (8,127)
====== ====== ======== ======= ========
Basic and diluted net loss per share.............. $(0.01) $(0.05) $ (1.65) $ (0.21) $ (7.95)
====== ====== ======== ======= ========
Weighted-average shares -- basic and diluted...... 8,000 8,083 2,762 5,077 1,022
====== ====== ======== ======= ========
Pro forma basic and diluted loss per share
(unaudited)..................................... $ (0.36) $ (0.32)
======== ========
Weighted-average shares -- pro forma basic and
diluted (unaudited)............................. 12,848 25,696
======== ========
</TABLE>
<TABLE>
<CAPTION>
DECEMBER 31,
------------------------ JUNE 30,
1996 1997 1998 1999
---- ----- ------- -----------
(IN THOUSANDS) (UNAUDITED)
<S> <C> <C> <C> <C>
BALANCE SHEET DATA:
Cash and cash equivalents................................... $ 7 $ 32 $ 812 $ 7,063
Working capital............................................. 38 (23) 214 4,869
Total assets................................................ 51 55 1,672 9,759
Notes payable, less current portion......................... 75 385 279 1,624
Mandatorily redeemable convertible preferred stock.......... -- -- 3,884 15,870
Total stockholders' equity (deficit)........................ (34) (390) (3,155) (10,955)
</TABLE>
23
<PAGE> 26
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITION AND RESULTS OF OPERATIONS
You should read the following discussion of our financial condition and
results of operations in conjunction with our financial statements and related
notes. This discussion contains forward-looking statements that involve risks
and uncertainties. Our actual results may differ materially from those
anticipated in these forward-looking statements as a result of factors including
those discussed in "Risk Factors" and elsewhere in this prospectus.
OVERVIEW
Neoforma.com is a leading provider of business-to-business e-commerce
services in the large and highly fragmented market for medical products,
supplies and equipment. Our marketplace aggregates suppliers of a wide range of
new and used medical products and presents their offerings to the physicians,
hospitals and other healthcare organizations that purchase these products. We
believe that our services will streamline procurement processes and extend the
reach of existing sales and distribution channels, as well as reduce transaction
costs for both buyers and sellers of medical products, supplies and equipment.
We offer three primary services. Our Shop service provides a unified
marketplace where purchasers can easily identify, locate and purchase new
medical products and suppliers can access new customers and markets. Our Auction
service creates an efficient marketplace for idle assets by enabling users to
list, sell and buy used, refurbished and surplus medical products. Our Plan
service provides interactive content to healthcare facility planners to reduce
the complexities of planning and outfitting facilities.
We incorporated on March 4, 1996. From inception, our operating activities
have related primarily to the initial planning and development of our
marketplace and the building of our operating infrastructure. We first
introduced the Neoforma.com website in 1997 and have since released a number of
enhancements to provide new services and content. Initially, our website
provided only information for healthcare professionals. We began offering
e-commerce services with the introduction of Auction in May 1999 and expanded
our services with the introduction of Shop in late August 1999. Since we
introduced our Auction and Shop services, we have focused on expanding and
enhancing our services, establishing relationships with suppliers of medical
products, expanding our purchaser base, developing strategic alliances,
promoting our brand name and building our operating infrastructure.
We have recognized limited revenue to date. We expect that our principal
source of revenue will be transaction fees paid by the sellers of medical
products that use our Shop and Auction services. We recognize transaction fees
as revenue when the seller confirms a purchaser's order. For live auction
services, we recognize seller transaction fees, as well as a buyer's premium,
when the product is sold. We also expect to receive revenue from sponsorship
fees in connection with suppliers' sponsoring of content on our Plan service,
subscription fees for asset management and facilities planning services,
development fees from participating sellers to digitize their product
information for display on our website and service fees for maintenance of
product information and content on our website. Development fees are recognized
as development services are performed. Sponsorship, subscription and service
fees will be recognized ratably over the period of the service agreement.
Our operating expenses have increased significantly since our inception,
and the rate of this increase has accelerated since our introduction of our
Auction and Shop services. These increases are primarily due to additions to our
staff as we have expanded all aspects of our operations. As a result
24
<PAGE> 27
of our expansion, we have grown from four employees as of December 31, 1997, to
48 full-time employees as of December 31, 1998 to 148 full-time employees as of
September 30, 1999.
On August 6, 1999, we acquired General Asset Recovery, LLC, or GAR, a live
auction house and asset management company focused on medical products. The
total purchase price was approximately $9.7 million, including $1.7 million in
cash, the issuance of a promissory note in the principal sum of $7.8 million,
the assumption of $100,000 in liabilities and acquisition-related expenses of
approximately $100,000. The promissory note is payable over five years and bears
interest at 7% per annum. This acquisition was accounted for using the purchase
method of accounting. As a result of this acquisition, we will record an
aggregate of approximately $9.7 million in goodwill beginning in the third
quarter of fiscal year 1999, which will be amortized on a straight-line basis
over a seven-year period.
Since inception, we have incurred significant losses and, as of June 30,
1999, had an accumulated deficit of $13.2 million. We expect operating losses
and negative cash flow to continue for the foreseeable future. We anticipate our
losses will increase significantly due to substantial increases in our expenses
for sales and marketing, product development, operating infrastructure, general
and administrative staff and development of strategic alliances.
We have a limited operating history on which to base an evaluation of our
business and prospects. You must consider our prospects in light of the risks,
expenses and difficulties frequently encountered by companies in their early
stage of development, particularly companies in new and rapidly evolving markets
such as the online market for the purchase and sale of new and used medical
products, supplies and equipment. To address these risks, we must, among other
things, expand the number of users of our online services, enter into new
strategic alliances, increase the functionality of our services, implement and
successfully execute our business and marketing strategy, respond to competitive
developments and attract, retain and motivate qualified personnel. We may not be
successful in addressing these risks, and our failure to do so could seriously
harm our business.
RESULTS OF OPERATIONS
Due to our limited operating history, we believe that period-to-period
comparisons of our results of operations are not meaningful and should not be
relied upon as an indication of future performance.
SIX MONTHS ENDED JUNE 30, 1998 AS COMPARED TO SIX MONTHS ENDED JUNE 30, 1999
Revenue. Since inception, we have been in the development stage and have
had only limited revenue. We derived revenue of $7,000 for the six months ended
June 30, 1999 primarily from subscription fees for asset management services. We
did not have any revenue for the six months ended June 30, 1998.
Operations. Operations expenses consist primarily of expenditures for the
acquisition and processing of content and the operation and maintenance of our
website. These expenditures include fees for independent contractors, personnel
expenses for our customer support and site operations personnel, Internet access
and hosting charges and depreciation of the equipment required for operating our
website. Operations expenses increased from $190,000 for the six months ended
June 30, 1998 to $1.3 million for the six months ended June 30, 1999. The
increase was primarily due to increased expenditures for the acquisition and
processing of content and enhancement of the infrastructure of our website. We
expect our operations expenses to significantly increase as we expand our
operating infrastructure and add content and functionality to our website.
Product Development. Product development expenses consist primarily of
personnel expenses, consulting fees and depreciation of the equipment associated
with the development and enhancement
25
<PAGE> 28
of our services and website. Product development expenses increased from
$327,000 for the six months ended June 30, 1998 to $2.6 million for the six
months ended June 30, 1999. The increase was primarily due to increased
personnel expenses incurred during development of our Auction and Shop services.
We believe that continued investment in product development is critical to
attaining our strategic objectives and, as a result, expect product development
expenses to increase significantly in future periods. We expense product
development costs as they are incurred.
Selling and Marketing. Selling and marketing expenses consist primarily of
salaries, commissions, advertising, payments to strategic partners, promotions
and related product marketing costs. Selling and marketing expenses increased
from $321,000 for the six months ended June 30, 1998 to $2.4 million for the six
months ended June 30, 1999. The increase was primarily due to significant
expansion of our sales and marketing efforts and the hiring of additional sales
and marketing personnel. We intend to significantly increase our selling and
marketing expenses as we expand our sales force and invest in new marketing
campaigns. In addition, we expect to make significant payments to strategic
partners which will further increase our selling and marketing expenses in the
periods in which these payments are made. See "-- Liquidity and Capital
Resources."
General and Administrative. General and administrative expenses consist of
expenses for executive and administrative personnel, facilities, professional
services, travel and other general corporate activities, and the depreciation
and amortization of office furniture and leasehold improvements. This category
will also include goodwill amortization related to corporate acquisitions.
General and administrative expenses increased from $227,000 for the six months
ended June 30, 1998 to $1.6 million for the six months ended June 30, 1999. The
increase was primarily due to increased personnel, professional service fees and
facility expenses necessary to support our growth. We expect general and
administrative expenses to increase as we continue to expand our staff and incur
additional costs to support the growth of our business and the costs of being a
public company. We further expect our general and administrative expenses to
increase due to the amortization of goodwill associated with the GAR acquisition
and the integration of GAR with our business.
Amortization of Deferred Compensation. Deferred compensation represents the
aggregate difference, at the date of grant, between the exercise price of stock
options and the estimated fair value for accounting purposes of the underlying
stock. Deferred compensation is amortized over the vesting period of the
underlying options, generally four years, based on an accelerated vesting method
consistent with Financial Accounting Standards Board Interpretation No. 28. In
connection with the grant of stock options to employees during fiscal 1998 and
for the six months ended June 30, 1999, we recorded deferred compensation of
$3.5 million. For the six months ended June 30, 1999, we recognized amortization
of deferred compensation of $307,000.
For the three months ended September 30, 1999, we recorded additional
deferred compensation of approximately $40.9 million and will amortize
approximately $4.4 million for the same period. At September 30, 1999, the
remaining deferred compensation of approximately $39.7 million will be amortized
as follows: $5.8 million in the last quarter of fiscal 1999, $18.1 million
during fiscal 2000, $9.5 million during fiscal 2001, $4.8 million during fiscal
2002 and $1.5 million during fiscal 2003. The amortization expense relates to
options awarded to employees in all operating expense categories. The amount of
deferred compensation has not been separately allocated to these categories. The
amount of deferred compensation expense to be recorded in future periods could
decrease if options for which accrued but unvested compensation has been
recorded are forfeited.
During the year ended December 31, 1998 and the six months ended June 30,
1999, we recorded stock-based compensation of $52,000 and $1.6 million related
to equity instruments issued to non-employees as determined based upon the fair
value at the date of issuance.
26
<PAGE> 29
Other Income (Expense). Other income (expense) consists of interest and
other income and expense. Interest income for the six months ended June 30, 1999
was $128,000 compared to $13,000 for the six months ended June 30, 1998. The
increase in interest income was due to an increase in our average net cash and
cash equivalents balance as a result of our issuance of preferred stock in
February 1999. Interest expense increased from $9,000 for the six months ended
June 30, 1998 to $95,000 for the six months ended June 30, 1999, primarily as a
result of the amortization of the fair value of a warrant issued in connection
with a loan received during the period, together with an increase in debt.
PERIOD FROM INCEPTION TO DECEMBER 31, 1996, AS COMPARED TO YEAR ENDED DECEMBER
31, 1997 AS COMPARED TO YEAR ENDED DECEMBER 31, 1998
Revenue. We had no revenue for the period from inception to December 31,
1998.
Operations. We had no operations expenses in 1996 and 1997. We began
operating and maintaining our website and acquiring and processing content in
1998, and as a result, incurred operations expenses of $627,000.
Product Development. Product development expenses increased from $31,000 in
1996 to $179,000 in 1997 to $1.5 million in 1998. The increase in 1998 was
primarily due to increased personnel expenses as we developed features and added
functionality to our website.
Selling and Marketing. Selling and marketing expenses increased from
$111,000 in 1996 to $153,000 in 1997 to $1.4 million in 1998. The increase in
1998 was primarily due to the significant expansion of our sales and marketing
efforts and the hiring of additional sales and marketing personnel.
General and Administrative. General and administrative expenses increased
from $54,000 in 1996 to $76,000 in 1997 to $1.1 million in 1998. The increase in
1998 was primarily due to expenses related to increased personnel, professional
service fees and facility expenses associated with our growth.
Amortization of Deferred Compensation. Amortization of deferred
compensation for the fiscal year ended December 31, 1998 was $5,000. No
amortization of deferred compensation was expensed for fiscal years 1997 or
1996.
Other Income (Expense). Interest income increased from none in 1996 and
1997 to $66,000 in 1998. The increase in interest income was due to an increase
in cash and cash equivalents that resulted from our issuance of preferred stock
during 1998. Interest expense increased from none in 1996 to $15,000 in 1997 to
$22,000 in 1998. Other income was $142,000 in 1996, $7,000 in 1997 and none in
1998. Other income was primarily related to fees received from projects
unrelated to our current business model.
Income Taxes. As of December 31, 1998, we had federal and state net
operating loss carryforwards of approximately $4.5 million which will be
available to reduce future taxable income. The federal net operating loss
carryforwards expire beginning in 2013 through 2018. A valuation allowance has
been recorded for the entire deferred tax asset as a result of uncertainties
regarding the realization of the asset due to our lack of earnings history.
Federal and state tax laws impose significant restrictions on the amount of the
net operating loss carryfowards that we may utilize in a given year. See Note 11
of notes to financial statements.
LIQUIDITY AND CAPITAL RESOURCES
We have funded our operations since inception primarily through the private
placement of equity securities, through which we have raised net proceeds of
$17.4 million through June 30, 1999. We
27
<PAGE> 30
have also financed our operations through an equipment loan and lease financing
and bank and other borrowings. As of June 30, 1999, we had outstanding bank and
other borrowings of $2.6 million. As of June 30, 1999, we had approximately $7.1
million of cash and cash equivalents. Since June 30, 1999, we have raised
additional net proceeds of $70.5 million from our October 1999 sale of
approximately 12,693,663 shares of our Series E and Series E-1 preferred stock,
which includes the issuance of 275,000 shares of our Series E-1 preferred stock
in connection with a strategic alliance we entered into in October 1999.
In June 1998, we entered into a $750,000 secured credit facility with
Silicon Valley Bank. This facility included a $225,000 term loan due December
1999 and an equipment loan facility providing for up to $525,000 of equipment
loans. In July 1999, we converted the $433,000 of outstanding equipment loans
into a term loan due July 2000. Our term loans from Silicon Valley Bank bear
interest at the lender's prime rate (8.25% as of September 30, 1999). This
facility is secured by substantially all of our assets other than equipment. In
consideration for this credit facility, we granted Silicon Valley Bank a warrant
to purchase 45,000 shares of our Series C preferred stock at an exercise price
of $0.77 per share. In consideration for the conversion of our equipment loan to
a term loan and the release of its security interest in equipment, we granted
Silicon Valley Bank a warrant to purchase 10,000 shares of our Series D
preferred stock at an exercise price of $1.18 per share.
In May 1999, Comdisco provided us with a $2.0 million subordinated loan to
provide working capital. We agreed to pay Comdisco principal and interest at a
rate of 12.5% per annum in 36 equal monthly installments, commencing July 1999.
This loan is secured by all of our assets. In connection with this loan, we
issued Comdisco a warrant to purchase 228,813 shares of our Series D preferred
stock at $1.18 per share. As of September 30, 1999, the outstanding balance on
the note was approximately $1.9 million.
In July 1999, Comdisco provided us with a $2.5 million loan and lease
facility to finance computer hardware and software equipment. Amounts borrowed
to purchase hardware bear interest at 9% per annum and are payable in 48 monthly
installments consisting of interest only payments for the first nine months and
principal and interest payments for the remaining 39 months, with a balloon
payment of the remaining principal payable at maturity. Amounts borrowed to
purchase software bear interest at 8% per annum and are payable in 30 monthly
installments consisting of interest only payments for the first four months and
principal and interest payments for the remaining 26 months, with a balloon
payment of the remaining principal payable at maturity. As of September 30,
1999, we had outstanding approximately $1.3 million in hardware loans due
September 2003 and approximately $254,000 in software loans due March 2002. This
facility is secured by the computer equipment purchased with the loans. In
connection with this facility, we issued Comdisco a warrant to purchase 137,711
shares of our Series D preferred stock at $1.18 per share.
In August 1999, as a result of the GAR acquisition, we issued a promissory
note in the principal amount of $7.8 million payable monthly over five years
bearing interest at a rate of 7% per annum. As of September 30, 1999, the
outstanding balance on the note was $7.6 million.
In May 1999, we entered into an agreement with ECRI, a non-profit health
services research agency focusing on healthcare technology. The agreement
provides us with content from ECRI's database of information about medical
products and manufacturers and a license to use elements of its classification
system. In addition, the agreement provides for joint marketing activities and
collaboration in the development of Plan's database of product and vendor
information. This agreement requires us to make revenue sharing payments to ECRI
during the three-year term of the agreement and for two years following
expiration or termination of the agreement with respect to revenue derived from
our Plan service. During the second and third years of the term of the
agreement, we are required to pay to ECRI a nonrefundable fee equal to $600,000
per year, which shall be credited against any revenue sharing payments payable
to ECRI.
28
<PAGE> 31
In October 1999 we entered into an agreement with Superior Consultant
Company, Inc., a wholly owned subsidiary of Superior Consultant Holdings
Corporation, providing for collaboration between us and Superior. Superior is a
supplier of Digital Business Transformation(TM) services to large healthcare
organizations, including Internet-related services, systems integration,
outsourcing and consulting, which enable Superior clients to utilize digital
technologies and process innovations to improve their businesses. Under the
agreement, we have agreed to market Superior's services to our users, and
Superior has agreed to introduce our services to appropriate clients, based on
their interests, and to incorporate our services into its Digital Business
Transformation(TM) offerings. The agreement also provides for joint marketing
activities. In consideration, we have agreed to make payments to Superior in an
aggregate amount of up to approximately $2.0 million, as well as a percentage of
specified Neoforma.com e-commerce transaction revenue and other payments. We
have also agreed to utilize Superior's services on a preferred basis for systems
integration, development, infrastructure, process improvement and consulting
assistance, totaling at least $1.5 million of services from Superior, at a
discount from Superior's standard fees. Our agreement with Superior expires in
October 2002. See "Certain Transactions -- Commercial Transactions" for more
information regarding this agreement and our relationship with Superior.
In October 1999, we entered into an agreement with Dell Marketing, L.P.
pursuant to which we agreed to develop complementary marketing programs with
Dell and establish hyperlinks between our respective internet websites. We
agreed to use Dell as our exclusive supplier of desktops, portables,
workstations, servers and storage devices unless such products did not meet our
reasonable technical requirements. We also agreed to purchase at least $5.0
million of Dell products and $100,000 of data center consulting services. See
"Certain Transaction -- Commercial Transactions" for more information regarding
this agreement and our relationship with Dell.
Net cash used in operating activities was $87,000 for the period from
inception through December 31, 1996, $322,000 for the year ended December 31,
1997 and $4.0 million for the year ended December 31, 1998. Net cash used in
operating activities for the six months ended June 30, 1999 was $6.7 million.
Net cash used in operating activities from inception through June 30, 1999
related primarily to funding net operating losses and increases in prepaid
expenses, which were partially offset by increases in accrued expenses and
accounts payable.
Net cash used in investing activities was $1,000 for the period from
inception through December 31, 1996, $13,000 for the year ended December 31,
1997 and $825,000 for the year ended December 31, 1998. Net cash used in
investing activities for the six months ended June 30, 1999 was $1.3 million.
Net cash used in investing activities for the six months ended June 30, 1999
related primarily to the purchase of equipment to operate our website.
Net cash provided by financing activities was $95,000 for the period from
inception through December 31, 1996, $360,000 for the year ended December 31,
1997 and $5.6 million for the year ended December 31, 1998. For the six months
ended June 30, 1999, net cash provided by financing activities was $14.2
million. Net cash provided from financing activities for the period from
inception to June 30, 1999 related primarily to preferred stock issuances of
approximately $17.1 million.
We currently anticipate that the net proceeds of this offering, together
with our available funds, will be sufficient to meet our anticipated needs for
working capital and capital expenditures through the next 12 months. Our future
long-term capital needs will depend significantly on the rate of growth of our
business, the timing of expanded service offerings and the success of these
services once they are launched. Any projections of future long-term cash needs
and cash flows are subject to substantial uncertainty. If the net proceeds of
this offering, together with our available funds and cash generated from
operations, are insufficient to satisfy our long-term liquidity requirements, we
may seek to sell additional equity or debt securities, obtain a line of credit
or curtail expansion of our services. If we issue additional securities to raise
funds, those securities may have rights, preferences
29
<PAGE> 32
or privileges senior to those of the rights of our common stock and our
stockholders may experience dilution. We cannot be certain that additional
financing will be available to us on favorable terms when required, or at all.
YEAR 2000
Many existing computer programs use only two digits to identify a year.
These programs were designed and developed without addressing the impact of the
upcoming change in the century. If not corrected, many computer software
applications could fail or create erroneous results by, at or beyond the year
2000.
We use software, computer technology and other services internally
developed and provided by third-party vendors that may fail due to the year 2000
phenomenon. We depend on a third party to host our servers, telecommunications
vendors to maintain our network and other third-party carriers to deliver orders
to customers. Because we are a comparatively new enterprise, the majority of
software and hardware we use to manage our business has all been recently
purchased or developed by us. While this does not completely protect us against
year 2000 exposure, we believe our exposure is limited because the technology we
use to manage our business is not based upon legacy hardware and software
systems.
State of Readiness. We are in the process of reviewing the year 2000
compliance of both internally developed and third-party systems. Internally
developed systems include the software used to provide our website's search,
customer interaction, transaction-processing and monitoring capabilities. Our
third-party systems include software and hardware, and computer technology,
back-up, hosting, accounting, database and security systems. We are working with
vendors of these third-party systems to obtain assurances that their software,
hardware or services are year 2000 compliant. To ensure that both our internally
developed and third-party systems are year 2000 compliant, we continually
assess, analyze and, where necessary, correct potential non-compliance issues.
We expect to complete this assessment process during the fourth quarter of 1999.
Based on our assessment to date and our planned activities, we believe that
our internally developed and third-party systems will be year 2000 compliant.
The failure of our software and computer systems, or those of our third-party
suppliers, to be year 2000 compliant, would seriously harm our business.
The year 2000 readiness of the general system necessary to support our
operations is difficult to assess. For instance, we depend on the integrity and
stability of the Internet to provide our services. We also depend on the year
2000 compliance of the computer systems used by consumers. Thus, the system
necessary to support our operations consists of a network of computers and
telecommunications systems located throughout the world and operated by numerous
unrelated entities and individuals, none of which has the ability to control or
manage the potential year 2000 issues that may impact the entire system. Our
ability to assess the reliability of this system is limited and relies on
generally available news reports, surveys and industry data. Based on these
sources, we believe most entities and individuals that rely significantly on the
Internet are reviewing and attempting to remediate issues relating to year 2000
compliance, but it is not possible to predict whether these efforts will be
successful in reducing or eliminating the potential negative impact of year 2000
issues. The failure of our software and computer systems and those of our
third-party suppliers to be year 2000 complaint would seriously harm our
business.
Cost. As of September 30, 1999, we had incurred immaterial costs in
connection with identifying, evaluating and addressing year 2000 compliance
issues. We anticipate that any future costs will not exceed $500,000. Most of
these expenses are expected to relate to operating costs associated with time
spent by our employees in the evaluation process. There may be some charges
30
<PAGE> 33
related to remediation if any issues are identified during our assessment
process. If these expenses are higher than anticipated, our business could
suffer.
Risks. We cannot assure you that we will achieve full year 2000 compliance
before the end of 1999. A failure of our computer systems or the failure of
purchasers or suppliers of medical products to effectively upgrade their
software and systems for transition to the year 2000 could seriously harm our
business.
In addition, we cannot be certain that governmental agencies, utility
companies, Internet access companies, third-party service providers and others
outside of our control will be year 2000 compliant. The failure by these
entities to be year 2000 compliant could result in a systemic failure beyond our
control, such as a prolonged Internet, telecommunications or electrical failure,
that could prevent us from delivering our services to our customers, decrease
the use of the Internet or prevent users from accessing our website, any of
which could seriously harm our business.
Contingency Plan. At this time, we are developing a contingency plan to
address situations that may result if we or our vendors are unable to achieve
year 2000 compliance. The cost of developing and implementing such a plan, if
necessary, could be material. Any failure of our material systems, our vendors'
material systems or the Internet to be year 2000 compliant could have material
adverse consequences for us. Such consequences could include difficulties in
operating our website effectively, taking product orders, making product
deliveries or conducting other fundamental parts of our business.
RECENT ACCOUNTING PRONOUNCEMENTS
In June 1998, the Financial Accounting Standards Board issued Statement of
Financial Accounting Standards (SFAS) No. 133, Accounting for Derivative
Instruments and Hedging Activities, which we will be required to adopt for the
year ending December 31, 2000. This statement establishes a new model for
accounting for derivatives and hedging activities. SFAS No. 133 establishes
methods of accounting for derivative financial instruments and hedging
activities related to those instruments as well as other hedging activities.
Because we currently hold no derivative financial instruments and do not
currently engage in hedging activities, adoption of SFAS No. 133 is expected to
have no material impact on our financial condition or results of operations.
In March 1998, the American Institute of Certified Public Accountants
(AICPA) issued Statement of Position (SOP) No. 98-1, Accounting for the Costs of
Computer Software Developed or Obtained for Internal Use. SOP No. 98-1 requires
entities to capitalize some of the costs related to internal-use software once
the applicable criteria have been met. SOP No. 98-1 is effective for our 1999
financial statements. The adoption of SOP No. 98-1 did not have a material
impact on our June 30, 1999 financial statements.
In April 1998, the AICPA issued SOP 98-5, Reporting for the Costs of
Start-Up Activities. SOP No. 98-5 requires that all start-up costs related to
new operations to be expensed as incurred. In addition, all start-up costs that
were capitalized in the past must be written off when SOP No. 98-5 is adopted.
SOP No. 98-5 is effective for our 1999 financial statements. The adoption of SOP
No. 98-5 did not have a material impact on our June 30, 1999 financial
statements.
31
<PAGE> 34
BUSINESS
Neoforma.com is a leading provider of business-to-business e-commerce
services in the large and highly fragmented market for medical products,
supplies and equipment. Our services enable users to efficiently and
cost-effectively buy and sell new and used medical products in an open, online
marketplace. Our marketplace aggregates suppliers of a wide range of medical
products and presents their offerings to the physicians, hospitals and other
healthcare organizations that purchase these products. We believe that our
services provide supply chain efficiencies for both suppliers and purchasers of
medical products and extend the reach of existing sales and distribution
channels.
Neoforma.com offers three primary services that together address the entire
healthcare purchasing lifecycle, from planning through procurement to
liquidation. Our Shop service provides a unified marketplace where purchasers
can easily locate and buy new medical products, and suppliers can access new
customers and markets. Our Auction service creates an efficient marketplace for
idle assets by enabling users to list, sell and buy used, refurbished and
surplus medical products. Our Plan service provides interactive content to
healthcare facility planners to reduce the complexities of planning and
outfitting facilities.
INDUSTRY BACKGROUND
GROWTH OF THE INTERNET AND BUSINESS-TO-BUSINESS ELECTRONIC COMMERCE
The Internet is rapidly changing the competitive landscape of many
industries, creating significant opportunities for companies to expand and
improve their businesses. Companies have increasingly begun to use the Internet
to create business-to-business networks to streamline complex processes,
purchase and sell goods and exchange information among fragmented groups of
customers, manufacturers and distributors. Forrester Research has estimated that
business-to-business e-commerce in the U.S. will increase from $109 billion in
1999 to $1.3 trillion in 2003.
Business-to-business e-commerce enables purchasers and sellers in
fragmented markets to reduce supply chain inefficiencies. Sellers are able to
cost-effectively access global markets, streamline their sales, marketing and
distribution operations, reduce their time to market and efficiently distribute
updated product information. Buyers can improve their purchasing process and
easily access current product information and a broad range of products and
services. Because a growing number of businesses are establishing their own
e-commerce websites, it is difficult for any individual business to attract a
significant number of online customers. As a result, companies are increasingly
realizing the value of a global online marketplace that aggregates purchasers
and sellers.
MEDICAL PRODUCTS, SUPPLIES AND EQUIPMENT MARKET
Market for New Products
The market for new medical products, supplies and equipment totaled an
estimated $140 billion worldwide in 1998, including approximately $60 billion in
the U.S. This market is growing at a rate of 6% per year worldwide and 7% per
year in the U.S. This market is comprised of a wide range of products, including
consumable supplies such as syringes and gloves, reusable medical products such
as surgical instruments, and sophisticated diagnostic equipment such as magnetic
resonance imaging systems.
The traditional supply chain for new medical products is highly fragmented
and inefficient. In the U.S. alone, products are supplied by over 20,000
manufacturers and distributors, ranging from small companies offering single
products to Fortune 500 corporations with comprehensive offerings. These
suppliers serve a diverse group of buyers, including hospitals, physician
practices and clinics. The U.S. market includes approximately 6,000 hospitals,
175,000 physicians' offices and thousands of non-hospital healthcare delivery
sites such as outpatient care facilities, nursing homes and ambulatory
32
<PAGE> 35
surgery centers. These organizations may purchase medical products directly or
through centralized buying organizations such as group purchasing organizations,
or GPOs, and integrated delivery networks of care providers, or IDNs. Buyers
within each of these organizations may purchase products from thousands of
suppliers. The high degree of buyer and supplier fragmentation results in
significant inefficiencies at each step of the procurement process.
In the U.S., healthcare providers are under increasing pressure to reduce
costs because of increased competition, as well as the ongoing tightening of
reimbursement policies by private payors and the government. According to
Efficient Healthcare Consumer Response, an independent study commissioned by a
number of industry participants, the supply-chain costs of distributing medical
products total approximately $23 billion per year, of which an estimated $11
billion could be eliminated by more efficient sharing of information, management
of orders and movement of products. As a result, healthcare providers are
increasingly seeking new ways to make their supply chain more efficient.
Market for Used and Surplus Products
Healthcare providers must continuously upgrade their medical equipment in
order to remain competitive and keep up with advances in medical technology.
Without an efficient, global market for the sale of replaced equipment, these
organizations are left with idle equipment for either storage or disposal.
Manufacturers taking trade-ins of existing equipment in connection with sales of
new products also generate significant used equipment inventory. For both
healthcare providers and manufacturers, an inability to efficiently dispose of
idle assets increases their operational costs and ties up capital that could be
used for more productive purposes.
We believe that a significant opportunity to connect buyers and sellers
exists in the market for used, refurbished and surplus medical products,
supplies and equipment. We believe that this market, which is currently served
primarily by local auction houses, equipment brokers and refurbishers, is
significantly under-served and highly inefficient. While much of the demand for
used equipment comes from healthcare providers located outside of the U.S. or in
rural markets in the U.S., much of the supply comes from healthcare providers in
urban centers in the U.S. or from manufacturers. As a result, traditionally it
has been difficult for buyers and sellers to locate one another.
LIMITATIONS OF TRADITIONAL APPROACHES TO BUYING AND SELLING MEDICAL PRODUCTS
Healthcare Providers
Purchasing decisions in physicians' offices and other small healthcare
facilities are generally made by nurses, office managers or administrative
staff. Purchasing activities include searching through paper catalogs, placing
and tracking orders via telephone or fax machines and receiving frequent,
time-consuming visits from numerous medical supply representatives. This
approach makes it difficult and time-consuming for buyers to identify, compare
and purchase specific items. Moreover, these inefficiencies can lead to clinical
delays and purchases that are based on convenience instead of best practices or
cost.
Large healthcare organizations manage their buying activity through a
centralized purchasing group as well as at the departmental level. Pricing is
either negotiated or based on long term contracts, depending on the
institution's buying power, membership in an IDN or GPO affiliations. The
purchasing process involves evaluating products, negotiating price and delivery,
ensuring compliance with purchasing contracts and placing and tracking orders
through a variety of paper and electronic means. Outdated product and price
information, lack of compliance with negotiated contracts and the significant
effort required to manage a multitude of suppliers and orders can result in
errors and inefficiencies.
33
<PAGE> 36
Manufacturers and Distributors
Manufacturers and distributors have limited resources to support the
growing challenge of marketing and selling to the increasingly complex worldwide
healthcare market. Many organizations lack the necessary infrastructure to
establish a worldwide sales and marketing presence. In addition, the high cost
of printing and distributing paper catalogs limits the ability of suppliers to
cost-effectively provide timely updates of important catalog product and pricing
information. Although many suppliers offer online versions of their catalogs,
this does not address the primary cause of inefficiency for buyers -- the
inability to quickly and easily find products and consolidate orders from
different suppliers through a single source.
MARKET OPPORTUNITY
We believe that a significant opportunity exists for a business-to-business
e-commerce solution that creates an open and efficient marketplace for
purchasers and sellers of both new and used medical products, supplies and
equipment. A unified online marketplace can offer several important advantages:
- Purchasers and sellers of new and used medical products can have global
access to each other, creating new levels of efficiency in the supply
chain;
- Industry, product and pricing information can be centralized, updated and
organized for simplified access; and
- The time and costs involved with traditional paper, telephone and fax
purchasing methods can be significantly reduced.
THE NEOFORMA.COM SOLUTION
Neoforma.com is a leading provider of business-to-business e-commerce
solutions for purchasers and suppliers of medical products, supplies and
equipment. Our services address the traditional limitations of the medical
products supply chain by enabling our users to efficiently and cost-effectively
buy and sell new and used medical products in an open, online marketplace. Shop,
Auction and Plan together address the entire healthcare purchasing lifecycle,
from planning through procurement to liquidation.
We believe that our services provide a number of benefits that will attract
a growing number of purchasers and suppliers of new and used medical products to
our marketplace. As more purchasers realize these benefits and use our services,
we believe that they will attract more suppliers to our marketplace. As more
suppliers offer products and content through our marketplace, we believe that
more buyers will be encouraged to use our services, resulting in a network
effect, where the value of our services to each participant increases
significantly with the addition of each new participant.
BENEFITS TO HEALTHCARE PROVIDERS:
- Convenient, Unified Marketplace. We provide healthcare providers a
central, easy-to-use location to identify and purchase a wide range of
medical products from many suppliers. This reduces the time required
to contact multiple distributors and suppliers using traditional paper
or telephone approaches, or single-supplier Internet-based or
electronic data interchange solutions.
- Reduced Processing Costs. Our services streamline the purchasing
process, allowing healthcare providers to reduce their procurement
costs and benefit from centralized purchasing, tracking and
record-keeping.
34
<PAGE> 37
- Improved Access to Current Information. We provide online access to
current product information, which is a significant improvement over
paper-based catalogs that are often outdated. Our easy-to-use search
capabilities enable healthcare providers to quickly locate products
and obtain current information from multiple suppliers. Additionally,
we provide previously unavailable information regarding used,
refurbished and surplus medical products.
- Efficient Marketplace for Idle Assets. Our Auction service provides an
efficient marketplace for the purchase and sale of used and surplus
medical products, allowing healthcare providers to maximize the value
of their idle assets.
BENEFITS TO MANUFACTURERS AND DISTRIBUTORS:
- Access to New Customers and Markets. Our Shop and Auction services
allow sellers to offer new and used products globally, extending their
reach to new customers and markets. Our Plan service provides a new
way for suppliers to feature their products being used in a best
practices environment.
- Participation in an Open Marketplace. We believe that by providing an
open marketplace where any supplier can list and sell its products, we
increase the attractiveness of our marketplace to a large number of
suppliers. By providing purchasers with access to products from a wide
range of suppliers, we can attract more purchasers to our marketplace,
further increasing the value of our services to suppliers.
- Increased Efficiencies and Reduced Transaction Costs. Because our
services streamline and extend their distribution channels, suppliers
can reduce their selling and marketing costs and time to market. For
example, suppliers can reduce their costs of printing and distributing
paper catalogs and taking individual orders by fax or by telephone. In
addition, our services eliminate the costs and expenditures required
for suppliers to establish and maintain their own e-commerce sites.
- Efficiency in Distributing New Information. Our marketplace allows
suppliers to efficiently reach customers and distribute product
information, reducing the delays associated with printed catalog
distribution. We enable suppliers to quickly and easily update
product, pricing and other information on our website to address
changes in their product line and respond to market requirements.
STRATEGY
Our objective is to become the leading online marketplace for new and used
medical products, supplies and equipment. Our goal is to provide comprehensive
services that together address the entire healthcare purchasing lifecycle, from
planning through procurement to liquidation. Key elements of our strategy
include:
Build on First Mover Advantage and Increase Brand Recognition. We believe
that our position as one of the first companies to offer comprehensive
business-to-business e-commerce services for new and used medical products,
supplies and equipment provides us with a first mover advantage that can enable
us to attract a critical mass of suppliers and purchasers. To increase the
number of purchasers and sellers that use our services, we intend to
aggressively promote the Neoforma.com brand by advertising, participating in
industry events and trade shows and conducting targeted promotions and public
relations.
Increase Adoption of Our Online Marketplace to Create Network Effect. We
intend to continue to add suppliers and purchasers to become the most
comprehensive online marketplace for medical products, supplies and equipment.
By adding suppliers and broadening the range of products available
35
<PAGE> 38
in our marketplace, we create additional value for purchasers. By attracting
more purchasers to our marketplace, we create additional value for suppliers. As
a result, we believe that we can create a network effect, where the value of our
services to each participant increases significantly with the addition of each
new participant.
Increase Functionality to Drive Broad Market Adoption. We plan to expand
the functionality of our services, increasing their value to both current and
future purchasers and suppliers. For example, we intend to develop new
information reporting and order management features as well as the capability to
integrate our services with the information systems used by many suppliers and
purchasers. In addition, we intend to develop the functionality to allow
suppliers to provide customer-specific pricing. We believe that these
enhancements will allow our services to become more closely integrated into the
supply chain processes of distributors and group purchasing organizations and
will be particularly important to large purchasers of medical products.
Establish Strategic Alliances With Leading Industry Participants. We intend
to continue to enter into alliances with leading Internet, technology and
healthcare-related organizations to increase usage of our services, broaden the
scope of our content, extend our technology and gain additional marketing
resources. Our current strategic partners include Cisco, Dell, Healtheon, SAP
and Superior Consultant. In addition, we have strategic relationships with key
suppliers, such as General Electric Medical Systems and Owens & Minor. We plan
to strengthen and broaden these relationships and enter into new strategic
alliances and key supplier relationships.
Expand Internationally. We believe that the capabilities of the Internet
and the fragmented nature of many international markets for new and used medical
products provide a significant opportunity for the creation of a global
marketplace. We intend to capitalize on this opportunity by developing
country-specific web pages for selected international markets and actively
marketing and promoting our services. We believe that our registered user base
already includes users located in over 100 countries.
NEOFORMA SERVICES
We offer three primary services -- Shop, Auction, and Plan -- that together
address the entire healthcare purchasing lifecycle, from planning through
procurement to liquidation. We also offer a wide range of content to healthcare
practitioners and purchasers to enable them to make more informed purchasing
decisions.
Shop
Our Shop service, released in late August 1999, provides a unified
marketplace where purchasers can easily identify, locate and purchase new
medical products, and suppliers can access new customers and markets. Shop
currently has over 60,000 different stockkeeping units, or SKUs, available for
purchase under agreements with 65 manufacturers and distributors. Our agreements
with distributors provide listings of products from an additional 140
manufacturers. We have agreements with approximately 40 additional manufacturers
and distributors that will provide us with access to an estimated 55,000
additional SKUs, which we are currently adding to Shop. The products currently
available through Shop range from disposable gloves to surgical instruments and
diagnostic equipment. We believe that these products represent a significant
portion of the products commonly used in physicians' offices, our initial target
market.
Shop provides detailed descriptions, photographic images and vendors'
shipping and billing policies for listed products, and we are currently adding
pricing information for these products. Listings are displayed in a consistent
format and organized by standard classification schemes to facilitate the
selection of products. Shop's search capabilities further assist purchasers in
locating and selecting products from multiple suppliers. Moreover, we also
provide suppliers the ability to directly
36
<PAGE> 39
update their product information on our website to include revised pricing, new
product introductions or additional information.
Purchasers can use Shop to order products at listed prices or to obtain
price quotes from the supplier. Shop accelerates the process of negotiating and
completing transactions between purchasers and sellers. Our system automatically
notifies the supplier via an email when the purchaser places an order through
Shop. When the supplier responds to or updates the order in any fashion, our
system automatically notifies the buyer. This process is aided by our customer
service organization, which answers questions about our system as necessary.
We do not take ownership or possession of the products sold through Shop.
Suppliers are responsible for providing product availability and delivery
information through our website. They are also responsible for shipping,
delivery, and returns. Suppliers can choose to accept payment by open accounts
with the purchasers, payment upon delivery, letter of credit, or credit card.
The purchaser is required to provide payment information to the supplier through
our website when placing the order, and the supplier is responsible for payment
processing and collection. We derive our revenue from Shop from transaction fees
charged to suppliers for confirmed orders, and fees to digitize their product
information for display on our website and for maintenance of product
information and content on our website.
Shop product information is provided to us by suppliers in a variety of
electronic formats or in paper form, and is internally reviewed and categorized
by our medical editors. We use an independent firm to convert this information
into a consistent electronic format that conforms to our classification systems.
We believe that our ability to process large volumes of product information
allows us to rapidly increase our product database and provides significant
flexibility to suppliers in loading and updating information.
We plan to extend Shop's functionality by introducing new information
reporting and order management features, allowing users to track their use of
our services and helping them better ensure compliance with their procurement
procedures and policies. We also intend to enable Shop to electronically
transmit information directly to the order management and purchasing systems
used by many large suppliers and medical product purchasers. In addition, we
intend to develop customer-specific pricing capabilities, allowing our services
to better integrate with the processes of distributors and large purchasing
organizations. We believe these enhancements will be particularly important to
large purchasing organizations, such as hospitals, IDNs and members of GPOs,
that are focused on achieving new efficiencies and frequently rely on
pre-negotiated pricing. Our future success relies on our ability to address the
needs of large healthcare providers by successfully developing and introducing
these capabilities in a timely manner. See "Risk Factors -- In order for large
healthcare organizations to accept our services, we must expand the base of
suppliers using our services and the functionality of our services."
Auction
Our Auction service, introduced in May 1999, enables users to list, sell
and buy used, refurbished and surplus medical products. Our Auction service
includes both online listings of used and surplus products for bids through our
website, as well as live auctions through GAR. Our online auction service
aggregates medical products from sellers in otherwise isolated local markets. On
September 30, 1999, Auction offered online listings of 1,528 items from 85
sellers.
When a buyer submits a bid for a listed product, the seller is
automatically notified via an email from our website that a buyer has placed a
bid for one of its products. The seller can then access our website to obtain
information about the bid, including the identity of the buyer, the amount of
the bid and the period of time that the buyer has indicated that it will keep
its bid open. The seller can
37
<PAGE> 40
accept the bid it finds most attractive. The buyer is automatically notified via
an email if a seller has accepted its bid. The payment alternatives and
shipping, delivery and return obligations are substantially identical to those
for Shop described above.
We also provide a service that allows sellers to specify that their
products initially be offered to their other departments and facilities and
subsequently to the public. In addition, the seller may choose to offer unsold
products for charitable donation. We have entered into agreements with several
IDNs and a number of other healthcare providers to allow them to use this asset
management service.
We augmented our Auction service through our August 1999 acquisition of
General Asset Recovery, a live auction house and asset management company
focused on medical products. The combination of Auction's online services and
GAR's live services allows us to provide a complete solution for managing used
and surplus healthcare equipment. We work with sellers to determine the best
method, whether online listings or live auctions, for selling their used,
refurbished or surplus products.
We derive revenue from our Auction service primarily from commissions and
asset management fees paid by sellers. In addition, in our live auctions, the
purchaser also typically pays a fee, commonly referred to as a buyer's premium,
equal to a percentage of the purchase price.
We plan to expand the functionality of our Auction service to automatically
identify the winning bidder at the end of a selected time period and notify the
seller and winning bidder of the transaction. In addition, we plan to make
available on our Auction service photographs and more detailed information
regarding products that will be offered in future live auctions. Further, we
intend to enable sellers to list their products on Auction in lots, which will
help them to efficiently sell large quantities of the same products.
Plan
Our Plan service, introduced in July 1998, provides interactive content to
healthcare facility planners to reduce the complexities of planning and
outfitting facilities. Plan offers interactive photographic images of actual
rooms and suites from medical facilities that we believe represent industry best
practices. This service allows facilities and equipment planners to conduct
virtual tours of these facilities, providing rich information for considering
room plans and equipment purchases. Visitors can zoom in to see room details,
including equipment placement, and can navigate to view different parts of the
room in these 360 degree panoramic images. Plan currently displays more than
1,000 rooms from the University of Chicago's Center for Advanced Medicine and we
intend to add rooms from other advanced medical facilities. Site visitors can
browse a list of departments or can search to find specific rooms. Plan also
provides links from rooms to associated categories of products that are
available for purchase through Shop. We have recently begun offering suppliers
the ability, for a fee, to sponsor rooms on Plan that feature one or more of
their products. The supplier can then use these rooms as part of their own
marketing campaigns.
We intend to introduce an enhanced version of our Plan service in November
1999, designed to more closely integrate Plan with Shop and Auction, to inform
users when products in the room are available on Shop or Auction and allow them
to immediately access information about that product to order it through Shop or
place a bid on Auction. Finally, we plan to add new fee-based services to Plan,
such as subscription-based access to more detailed content and data and the
ability to download blueprints for a fee.
38
<PAGE> 41
Resources
In addition to our three principal services, since July 1998, we have
provided healthcare professionals with information resources to assist them in
making informed and efficient purchasing decisions. Healthcare professionals can
receive personalized news, review online product and vendor information and
obtain information from other websites. In addition, users can access online
continuing medical education courses and research regulatory and shipping
requirements that may affect the price or delivery of their purchases. In
September 1999, we significantly expanded the amount of information that we
provide, and organized this information into a separate Resources section of our
website to facilitate its use.
SUPPLIERS
Shop. As of September 30, 1999, we had agreements with 65 manufacturers and
distributors to list their products on Shop. On September 30, 1999, the
following suppliers had products listed directly on Shop:
<TABLE>
<CAPTION>
DISTRIBUTORS MANUFACTURERS
------------ -------------
<S> <C>
Alimed Accurate Surgical
Independence Medical ARO Surgical Instruments
Maintenance Warehouse Critikon
Medline General Electric Medical Systems
Optimal Wholesale Medical Hospital Associates
Owens & Minor Howard Instruments
PSS World Medical Protocol Systems
Sammons Preston Sparta Surgical
Ves International
</TABLE>
Our agreements with distributors provide listings of products from an additional
140 manufacturers, including 3M, Beckman Coulter, Becton Dickinson, C.R. Bard
and Smith & Nephew. We have agreements with approximately 40 additional
suppliers that provide access to a large number of additional products which we
plan to add to Shop.
Auction. On Auction, suppliers include hospitals and healthcare
organizations liquidating used equipment, manufacturers and distributors selling
surplus products and finance companies selling leased equipment at the end of
the lease term. Our acquisition of GAR provides us with the opportunity to offer
our online services to its existing supplier base. We have entered into
agreements with a number of Auction suppliers for whom we provide asset
management and auction services, including manufacturers such as General
Electric Medical Systems and Stryker and large healthcare organizations such as
Banner Health System, Saint Barnabas Health Care System and Voluntary Hospitals
of America.
Strategic Supplier Relationships. We work with a number of key suppliers,
including Owens & Minor and General Electric Medical Systems, or GEMS. Owens &
Minor is a leading distributor of medical products, and we are working with
Owens & Minor to list a wide range of products aimed at traditional physician's
offices for sale through Shop.
Under our October 1999 agreement with General Electric Medical Systems,
GEMS has agreed to list products on Shop. GEMS also has the option to sponsor
rooms on Plan on mutually agreed upon terms, and in the event that it sponsors
any rooms, GEMS has agreed to promote Plan to its customers. In addition, GEMS
is a customer of GAR, and has agreed to use Auction to sell a specified number
of items of equipment. This agreement expires in December 2000, subject to
automatic renewal unless either party elects to terminate. In connection with
this agreement, we issued approximately 275,000 shares of our preferred stock to
GE Capital Equity Investments, an
39
<PAGE> 42
affiliate of GEMS, in October 1999. GE Capital Equity Investments, Inc., also
purchased 1,760,563 additional shares of preferred stock in our October 1999
financing.
PURCHASERS
Purchasers currently using Shop include physician offices, multi-specialty
groups, clinics and other healthcare providers. Buyers for large organizations,
such as hospitals, IDNs and GPOs that purchase a large volume of products under
negotiated contracts with suppliers, currently use Shop primarily to purchase
products for which they do not have existing supplier contracts. We plan to add
customer-specific pricing capabilities in order to enable these organizations to
use Shop for their purchases of products for which they have contracts.
Our Auction services have been used by a wide range of healthcare providers
to purchase used, refurbished and surplus medical products. We believe that a
large percentage of the products that are sold through our Auction services are
purchased for use outside the U.S. or in rural communities in the U.S.
If we are not able to quickly build a critical mass of purchasers who use
our services, and increase the use of our services by large healthcare
providers, our ability to expand our business would be seriously harmed.
STRATEGIC ALLIANCES
We enter into alliances with leading Internet, technology and
healthcare-related organizations and medical products suppliers to increase
usage of our services, broaden the scope of our content, extend the
functionality of our technology and build additional marketing resources. We
have entered into strategic alliances in the following areas.
Healthcare-Focused Websites. Many healthcare professionals use specific
healthcare-focused websites to obtain a variety of information. We believe that,
by entering into relationships with companies that operate these websites, we
can attract their visitors to use our services. We have developed strategic
alliances with Healtheon Corporation and MD On-Line to provide us with increased
market visibility and site traffic. We are an e-commerce provider of medical
supplies and equipment for Healtheon's registered users, which include
physicians and hospital and clinical administrators. Healtheon's registered
users can purchase medical products, supplies and equipment in a co-branded
environment on Neoforma.com without the need to register on our site. We also
provide e-commerce services for MD On-Line, an Internet-based content provider
for the physician market. Our agreements with Healtheon and MD On-Line require
us to pay these companies specified percentages of our revenue generated by
their users. These agreements each expire in 2000, subject to automatic renewals
for additional one-year periods unless either party elects to terminate.
Computer Hardware Providers. We believe that alliances with computer
hardware providers will help us build recognition of our brand. We have
established relationships with Dell Marketing, an affiliate of Dell Computer,
and Cisco Systems. We have entered into an agreement with Dell to develop and
undertake complementary marketing programs and to link our websites. See
"Certain Transactions -- Commercial Agreements" for more information about our
agreement with Dell. Cisco uses our services as a means of demonstrating its
equipment to healthcare providers. As a result, we gain increased exposure of
our services to large healthcare organizations.
Information Technology Partners. We believe that by integrating our
services with existing information systems used by many purchasers and sellers
of medical products, we will further streamline their medical products supply
chains. We have entered into an agreement with Superior Consultant, a supplier
of Digital Business Transformation(TM) services to large healthcare
organizations, including Internet-related services, systems integration,
outsourcing and consulting, which enable
40
<PAGE> 43
Superior clients to utilize digital technologies and process innovations to
improve their businesses. Under the agreement, we have agreed to market
Superior's services to our users, and Superior has agreed to introduce our
services to appropriate clients, based on their interests, and to incorporate
our services into its Digital Business Transformation(TM) offerings. The
agreement also provides for joint marketing activities. See "Certain
Transactions -- Commercial Agreements" for more information about our agreement
with Superior Consultant.
We are collaborating with SAP, a leading provider of enterprise software,
to integrate our services with SAP's R/3 enterprise software products. This
integration is intended to further automate the procurement process by allowing
transactions to be communicated directly to these systems. In addition, we are
integrating our services with MySAP.com, SAP's Internet business service.
Content Providers. We believe that as we increase the breadth and depth of
our content for our online marketplace, we will be able to attract and retain
more users. Since content is often expensive and time-consuming to develop, we
enter into relationships with other companies to provide content for our
marketplace. ECRI, a leading non-profit health services research agency focusing
on healthcare technology, provides us with detailed information about medical
products and technology and facility planning. NewsReal has created a
specialized healthcare headlines service to provide our users with personalized
healthcare business news from over 60 different sources. Reuters provides us
with its standard healthcare business news feed. See "Management's Discussion
and Analysis of Financial Condition and Results of Operations -- Liquidity and
Capital Resources" for a description of our agreement with ECRI.
Medical Product Suppliers. We believe that by establishing relationships
with key suppliers of medical products, we increase the depth and breadth of the
products listed on our online marketplace, and benefit from their marketing
resources. We have entered into agreements with Owens & Minor and General
Electric Medical Systems. See "Suppliers -- Strategic Supplier Relationships"
for more information about our strategic supplier relationships.
TECHNOLOGY
In order to establish a secure and reliable marketplace for suppliers and
purchasers of new and used medical products, our underlying infrastructure is
built on an open, multi-tier, distributed architecture using well-established
applications and hardware from leading technology companies such as Sun
Microsystems, Netscape and Oracle. Our infrastructure enables us to continuously
enhance the features and functionality of our services to meet the evolving
needs of our users.
INFRASTRUCTURE
Open Architecture. Our open architecture supports integration with our
users' many existing legacy systems. The ability to integrate these diverse
systems has enabled us to aggregate a wide range of purchasers and suppliers in
our marketplace. Our architecture is based on industry standards such as Java,
enabling us to rapidly introduce new features and functionality.
Scalability, Performance and Availability. Our highly modular, distributed
architecture is designed to enable us to readily add capacity as the number of
users and transactions increase on our system. We have fully redundant hardware
systems, which when combined with our distributed architecture, enables us to
provide our services on an uninterrupted basis, even in the event of partial
system failure. By locating our data center at an Exodus Communications hosted
facility, we are able to easily and rapidly expand our network bandwidth and
maintain the physical security of our systems.
Secure e-Commerce Marketplace. Our platform contains a variety of features
to ensure the secure transmission of business information among multiple trading
partners and to protect against
41
<PAGE> 44
communication failures. We use SSL, or secure sockets layer, an Internet
security technology, at appropriate points in the transaction flow to protect
user information during transactions. User information is encrypted to provide a
high degree of security. Our employees do not have access to user information,
except as necessary to perform customer service functions. The system
authenticates users through standard secure login and password technologies.
FUNCTIONALITY
Our systems are designed to capture the real-world processes and workflows
used by purchasers and suppliers using our services. We have incorporated these
processes into an easy-to-use, intuitive online marketplace that can be accessed
with standard web browsers, without requiring any special software.
To support our online marketplace, we have developed customized search
technologies to meet the requirements of purchasers of medical products,
supplies and equipment. In order to enable users to quickly navigate to
individual products, we have incorporated industry standard classifications,
which support the purchasing process by grouping items that are similar and by
mapping to other industry standard classification systems. Our search function
allows users to continually refine and hone their searches to help them to
quickly and efficiently locate a particular item. Additionally, we use
three-dimensional visualization technologies which enhance suppliers' ability to
display and feature their medical products, supplies and equipment.
Although to date we have not experienced unscheduled system interruptions
of our online marketplace, outages may occur from time to time as system usage
increases. The volume of traffic on our website and the number of transactions
being conducted by users has been increasing and will require us to expand and
upgrade our technology, transaction processing systems and network
infrastructure and add new engineering personnel. We may be unable to accurately
project the rate or timing of increases, if any, in the use of our services or
timely expand and upgrade our systems and infrastructure to accommodate such
increases in a timely manner. Any failure to expand or upgrade our systems to
keep pace with the growth in demand for capacity could cause the website to
become unstable and possibly cease to operate for periods of time. Unscheduled
downtime could harm our business.
SALES, MARKETING AND SUPPORT
We sell our services through our direct field sales force and our internal
telemarketing staff. Our direct field sales force focuses on purchasers in
physician offices, clinics, hospitals and large healthcare organizations. Our
direct field sales force has significant experience in the sale of medical
products, equipment and information technology systems. Our telemarketing
programs are directed primarily at suppliers of medical products, supplies and
equipment. We plan to augment our internal sales resources by working with the
sales forces of our strategic partners.
Our marketing programs include traditional and Internet-based marketing
initiatives to increase awareness of the Neoforma.com brand and attract new
purchasers and suppliers to our services. These programs include a variety of
public relations initiatives, such as participation in industry conferences and
trade shows, and ongoing relationships with healthcare, Internet and technology
reporters and industry analysts. We also promote our services through
advertising in healthcare industry trade journals and business publications. In
addition, we conduct web-based marketing activities to attract new users to our
online marketplace.
Our relationships with Internet healthcare companies such as Healtheon and
MD On-Line, suppliers such as General Electric Medical Systems and Owens &
Minor, technology companies such as Cisco, Dell and SAP, and professional
services providers such as Superior Consultant provide us
42
<PAGE> 45
with additional marketing resources. These companies conduct a number of
activities designed to strengthen awareness of our brand and our services.
Our worldwide sales and marketing group consisted of 41 full-time employees
as of September 30, 1999. We intend to expand our sales and marketing group and
to establish additional sales offices. Competition for sales and marketing
personnel is intense, and we may not be able to attract, assimilate or retain
additional qualified personnel in the future.
We believe that we can strengthen our relationships with purchasers and
suppliers by providing good account management, customer support and service.
Our customer service group provides ongoing support to customers, including site
assistance, product searches, basic product questions and order processing
questions.
PRODUCT DEVELOPMENT
We intend to continue to expand and enhance the functionality of our
services. We are currently focusing our product development resources on
integrating our services with other information systems used by suppliers and
purchasers of healthcare products. In addition, we are developing the capability
to allow suppliers to provide customer-specific pricing through Shop, and
providing increased functionality to our online Auction service. Our future
success, and in particular, our ability to fully address the needs of large
healthcare providers, depends on our ability to successfully develop and
introduce these capabilities in a timely manner. There are a number of risks and
challenges involved in the development of new features and technologies. See
"Risk Factors -- If we are not able to keep up with rapidly changing technology
and develop enhancements to our services, we may not be able to attract or
retain purchasers and suppliers of medical products."
Our product development organization includes our product strategy group
and our engineering group. The product strategy group is responsible for
translating user needs into specifications and prototypes for new functions and
services. Our engineering group is responsible for developing the technology
that implements these initiatives, and maintaining and improving the technology,
infrastructure and databases that we use to provide our services. As of
September 30, 1999, our product development organization included 45 full-time
employees. Our quality assurance group works with our product development
organization throughout the development cycle to ensure that the new features
and functions of our website meet our standards. In addition, we have a five
person group that focuses on emerging technologies and market opportunities. In
cases requiring specialized expertise, we have augmented the resources of our
product development organization with independent contractors.
Our product development expenses were $179,000 in 1997, $1.5 million in
1998 and $2.6 million in the first six months of 1999. To date, substantially
all software development costs related to our services have been expensed as
incurred. We believe that significant investments in product development will be
required to remain competitive.
PROPRIETARY RIGHTS AND LICENSING
Our success and ability to compete depend on our ability to develop and
maintain the proprietary aspects of our technology. We rely on a combination of
copyright, trademark and trade secret laws
43
<PAGE> 46
and contractual restrictions to establish and protect the proprietary aspects of
our technology. We seek to protect our source code for our software,
documentation and other written materials under trade secret and copyright laws.
Finally, we seek to avoid disclosure of our intellectual property by restricting
access to our source code and by requiring employees and consultants with access
to our proprietary information to execute confidentiality agreements with us.
Despite our efforts to protect our proprietary rights, unauthorized parties
may attempt to copy aspects of our products or to obtain and use information
that we regard as proprietary. Litigation may be necessary in the future to
enforce our intellectual property rights, to protect our trade secrets, and to
determine the validity and scope of the proprietary rights of others. Any
resulting litigation could result in substantial costs and diversion of
resources and could seriously harm our business.
Our success and ability to compete also depend on our ability to operate
without infringing upon the proprietary rights of others. In the event of a
successful claim of infringement against us and our failure or inability to
license the infringed technology, our business would be seriously harmed.
COMPETITION
The online market for medical products, supplies and equipment is new,
rapidly evolving and intensely competitive. Our primary competition includes
e-commerce providers that have established online marketplaces for medical
products, supplies and equipment. These competitors include companies such as
Medibuy, Promedix and Cimtek Medical. Medibuy provides an auction site for the
sale of used, refurbished and surplus products, and has announced plans to
introduce e-commerce services for new products. Cimtek Medical and Promedix have
websites for the sale of new products. Promedix has recently entered into an
agreement to be acquired by Chemdex, a leading provider of e-commerce solutions
to the life sciences industry.
We also face potential competition from a number of sources. Many companies
have created websites to serve the information needs of healthcare
professionals, providing medical information, discussion groups, bulletin boards
and directories. Many of these companies are introducing e-commerce functions
that may compete with our services. In addition, providers of online
marketplaces and online auction services that currently focus on other
industries could expand the scope of their services to include medical products.
Existing suppliers of medical products may also establish online marketplaces
that offer services to suppliers and purchasers, either on their own or by
partnering with other companies. Moreover, live auction houses focusing on
medical products may establish online auction services. New companies may also
be formed that compete with us.
We believe that companies in our market compete to provide services to
suppliers based on:
- brand recognition;
- number of purchasers using their services, and the volume of their
purchases;
- level of bias, or perceived bias, towards particular suppliers;
- compatibility with suppliers' existing distribution methods;
- the amount of the fees charged to suppliers;
- ease of use and convenience;
- ability to integrate their services with suppliers' existing systems and
software; and
- quality and reliability of their services.
In addition, we believe that companies in our market compete to provide
services to purchasers based on:
- brand recognition;
- breadth, depth and quality of product offerings;
- ease of use and convenience;
- ability to integrate their services with purchasers' existing systems and
software;
44
<PAGE> 47
- quality and reliability of their services; and
- customer service.
Competition is likely to intensify as our market matures. As competitive
conditions intensify, competitors may:
- enter into strategic or commercial relationships with larger, more
established healthcare, medical products and Internet companies;
- secure services and products from suppliers on more favorable terms;
- devote greater resources to marketing and promotional campaigns;
- secure exclusive arrangements with buyers that impede our sales; and
- devote substantially more resources to website and systems development.
Our current and potential competitors' services may achieve greater market
acceptance than ours. Our existing and potential competitors may have longer
operating histories in the medical products market, greater name recognition,
larger customer bases or greater financial, technical and marketing resources
than we do. As a result of these factors, our competitors and potential
competitors may be able to respond more quickly to market forces, undertake more
extensive marketing campaigns for their brands and services and make more
attractive offers to purchasers and suppliers, potential employees and strategic
partners. In addition, new technologies may increase competitive pressures. We
cannot be certain that we will be able to expand our purchaser and supplier
base, or retain our current purchasers and suppliers. We may not be able to
compete successfully against current and future competitors and competition
could seriously harm our revenue, gross margins and market share.
EMPLOYEES
As of September 30, 1999, we had 148 full-time employees, including 45 in
product development, 45 in sales, marketing and customer service, nine in
business development, 29 in operations, and 20 in general and administrative
functions. Our future success will depend in part on our ability to attract,
train, retain, integrate and motivate highly qualified sales, technical and
management personnel, for whom competition is intense. Our employees are not
represented by any collective bargaining unit, and we have never experienced a
work stoppage. We believe our relations with our employees are good. We also use
independent contractors to support our services. We use a firm based in India to
digitize and format product information for our Shop service. We plan to use a
third party specializing in Internet support to respond to our most common
customer service requests. We also use independent contractors for specific
product development services requiring specialized expertise.
FACILITIES
Our executive, administrative and operating offices are located in
approximately 33,378 square feet of leased office space located in Santa Clara,
California under leases expiring in April 2004 and September 2006. We also
maintain 19,765 square feet of office space and approximately 22,000 square feet
of warehouse space for GAR in the metropolitan areas of Chicago, Illinois. We
are currently negotiating the terms of a lease for a second warehouse in the
Chicago, Illinois metropolitan area to provide an additional 120,000 square feet
of space to store consigned items until they are sold in auctions.
LEGAL PROCEEDINGS
On August 6, 1999, Fisher Scientific International, Inc. filed a petition
in the District Court of Montgomery County, Texas, against Neoforma and Daniel
A. Eckert, an individual that we had hired to serve as our Executive Vice
President of Sales. Fisher alleged that Mr. Eckert, previously President
45
<PAGE> 48
of one of Fisher's divisions, Fisher HealthCare, would be in breach of a
covenant not to compete if he were to work for us. Fisher also alleged that Mr.
Eckert had disclosed, and in working for us would inevitably disclose, Fisher's
confidential and proprietary information, and that by hiring Mr. Eckert, we were
interfering with Fisher's business relations. Finally, Fisher alleged that these
actions constituted unfair competition.
On September 9, 1999, the court granted a temporary injunction until trial
prohibiting Mr. Eckert from working for us and prohibiting us from interfering
with Fisher Healthcare's business through the use of any of Fisher's
confidential and proprietary information, among other things. In granting the
injunction, the court determined, among other things, that Mr. Eckert's covenant
not to compete might bar him from working for us.
On September 27, 1999, we filed suit against Fisher in the Superior Court
of Santa Clara County, California for misappropriation of trade secrets. On
September 28, 1999, the court granted a temporary restraining order against
Fisher prohibiting Fisher from acquiring, using or disclosing a document that we
consider a trade secret and believe that Fisher has misappropriated.
We intend to vigorously defend this litigation, and have filed a notice of
appeal relating to the court's issuance of the temporary injunction. However,
the outcome of complex litigation is uncertain and cannot be predicted. If
Fisher prevails in this litigation, it would prevent Mr. Eckert from joining us
in any capacity, and could require that we pay money damages to Fisher.
46
<PAGE> 49
MANAGEMENT
EXECUTIVE OFFICERS, DIRECTORS AND KEY EMPLOYEES
The following table sets forth information regarding our executive
officers, directors and other key employees as of October 12, 1999:
<TABLE>
<CAPTION>
NAME AGE POSITION
---- --- --------
<S> <C> <C>
EXECUTIVE OFFICERS AND DIRECTORS:
Robert J. Zollars.................... 42 Chairman, President and Chief Executive Officer
Jeffrey H. Kleck..................... 38 Co-founder, Company Evangelist
Wayne D. McVicker.................... 39 Co-founder, Senior Vice President of Research and
Development and Director
Frederick J. Ruegsegger.............. 44 Chief Financial Officer
Bhagwan D. Goel...................... 35 Executive Vice President of Products and Services
Robert Flury......................... 49 Senior Vice President of Business Development
Erik Tivin........................... 34 Vice President of Auction Services and President of
Neoforma GAR, Inc.
David Douglass....................... 47 Director
Terence Garnett...................... 42 Director
Madhavan Rangaswami.................. 44 Director
Richard D. Helppie................... 43 Director
Andrew J. Filipowski................. 49 Director
OTHER EMPLOYEES:
Leigh D. Orlov....................... 43 Vice President of Sales
John F. Duddy........................ 41 Vice President of Marketing
</TABLE>
Robert J. Zollars has served as our Chairman, President and Chief Executive
Officer since July 1999. From January 1997 to July 1999, he served as Executive
Vice President and Group President of Cardinal Health, Inc., a healthcare
products and services company, where he was responsible for four of its
wholly-owned subsidiaries: Pyxis Corporation, Owen Healthcare, Inc., Medicine
Shoppe International and Cardinal Information Corporation. From January 1992 to
December 1996, he served as President of Hospital Supply, Scientific Products
and U.S. Distribution of Baxter Healthcare Corporation, which in October of 1996
was spun off as Allegiance Corporation, a healthcare products and service
company. Mr. Zollars holds an M.B.A. in finance from John F. Kennedy University
and a B.S. in marketing from Arizona State University.
Jeffrey H. Kleck has served as our Company Evangelist since July 1999, and
co-founded Neoforma.com in April 1996. Dr. Kleck served as our Chief Executive
Officer from March 1996 to July 1999 and as one of our directors from April 1996
to October 1999. Dr. Kleck was a senior engineer from June 1991 to February 1997
and Marketing Product Manager from February 1997 to February 1998 at Varian
Associates, Inc., a manufacturer of medical radiology equipment. He is a
visiting scientist at Los Alamos Laboratory. Dr. Kleck holds a Ph.D. in
biomedical physics from, and is a member of the faculty of the School of
Medicine at, the University of California, Los Angeles. He holds an M.S. in
engineering management from Stanford University and M.S. and B.S. degrees in
nuclear engineering from Texas A&M University.
Wayne D. McVicker has served as our Senior Vice President of Research and
Development since October 1999 and as a director since April 1996. Mr. McVicker
co-founded Neoforma.com in April 1996, and served as our President from April
1996 to February 1999 and as our Vice President of Strategy from February 1999
to October 1999. From September 1987 to February 1997,
47
<PAGE> 50
Mr. McVicker worked at Varian Associates, Inc., as manager of its architectural
planning department. In addition, Mr. McVicker is a licensed architect.
Frederick J. Ruegsegger has served as our Chief Financial Officer since
July 1999. From December 1996 to July 1999, Mr. Ruegsgegger worked at Axys
Pharmaceuticals, Inc., a biopharmaceutical company, most recently as Senior Vice
President of Finance and Corporate Development and Chief Financial Officer. From
July 1993 to December 1996, Mr. Ruegsegger was President, Chief Executive
Officer and a director of EyeSys Technologies Inc., an eye care diagnostic
equipment and software company. Mr. Ruegsegger holds a Master of Management from
J. L. Kellogg Graduate School of Management, Northwestern University, and a B.S.
in economics from the University of Illinois.
Bhagwan D. Goel has served as our Executive Vice President of Products and
Services since October 1999. From October 1998 to September 1999, Mr. Goel was
Senior Vice President and General Manager, Commerce at InfoSeek Corporation, a
provider of Internet services and software. From October 1996 to September 1998,
Mr. Goel was Vice President of Products and Services at Internet Shopping
Network Inc., an online retailer. From November 1993 to October 1995, Mr. Goel
was Vice President of Product Development at Worldview Systems Corporation, a
provider of online travel information. From October 1989 to October 1995, Mr.
Goel worked at Knowledgeset Corporation, a software company that provides
electronic retrieval systems, most recently as Director of Product Development.
Mr. Goel holds an M.S. in electrical engineering from the University of Toledo
and a B.S. in electrical engineering from the Indian Institute of Technology,
New Delhi.
Robert Flury has served as our Senior Vice President of Business
Development since February 1999. From December 1997 to January 1999, Mr. Flury
was Vice President and General Manager of the healthcare business unit at
PeopleSoft Inc., an enterprise software company. From February 1997 to December
1997, Mr. Flury was a senior vice president at Visix Software Inc., a software
company. From October 1994 to February 1997, Mr. Flury was a Senior Vice
President of the middleware line of business at Software AG, an enterprise
software company. Mr. Flury is a C.P.A. and holds an M.B.A. and a B.B.A. in
accounting from Georgia State University.
Erik Tivin has served as our Vice President of Auction Services and
President of Neoforma GAR, Inc. since August 1999. From July 1998 to August
1999, Mr. Tivin served as owner and President of General Asset Recovery, LLC., a
live auction house, which was acquired by Neoforma.com. From January 1990 to
July 1998, he served as President of General Industrial Tool, a wholesale
industrial equipment company.
David Douglass has served as one of our directors since February 1999.
Since February 1990, Mr. Douglass has served as a General Partner at Delphi
Ventures L.P., a venture capital firm. Mr. Douglass holds an M.B.A. from
Stanford University and a B.A. in political science from Amherst College.
Terence Garnett has served as one of our directors since April 1998. Since
April 1995, Mr. Garnett has served as a Venture Partner at Venrock Associates, a
venture capital firm. From August 1994 to April 1995, he was an independent
consultant. Mr. Garnett holds an M.B.A. from Stanford University and a B.S. in
computer science from the University of California, Berkeley.
Madhavan Rangaswami has served as one of our directors since April 1998.
Since February 1997, Mr. Rangaswami has served as a Managing Director at Sand
Hill Group LLC, a consulting and private investment company. From March 1995 to
June 1996, Mr. Rangaswami served as Vice President of Worldwide Marketing at the
Baan Company N.V., an enterprise software company. From February 1992 to
February 1995, he served as Vice President of Marketing at Avalon Software Inc.,
a software company. Mr. Rangaswami holds an M.B.A. from Kent State University,
and degrees in law and accounting from the University of Madras.
48
<PAGE> 51
Richard D. Helppie has served as one of our directors since October 1999.
Since August 1996, he has served as Chairman of the board of directors and Chief
Executive Officer of Superior Consultant Holdings Corporation, a consulting firm
comprised of two subsidiaries founded by Mr. Helppie, Superior Consultant
Company, Inc. and UNITIVE Corporation. He has served as Chairman of the board of
directors and Chief Executive Officer of Superior Consultant Company, a
healthcare management and information systems consulting firm, since 1984 and as
Chief Executive Officer of UNITIVE Corporation, a information technology
consulting firm, since 1993. He has also served as President of Clearwater
Aviation Company, Inc. since 1993. In addition, Mr. Helppie is a director of
drkoop.com, Inc.
Andrew J. Filipowski has served as one of our directors since October 1999.
He is the President, Chief Executive Officer and Chairman of the Board of divine
interVentures, inc., a venture investment firm that he co-founded in May 1999.
He is also Chairman of the Board of PLATINUM Venture Partners, Inc., a venture
investment firm that he founded in February 1992. Mr. Filipowski founded
PLATINUM technology, inc. in April 1987 and served as its President, Chief
Executive Officer and Chairman of the Board until it was acquired by Computer
Associates in June 1999. PLATINUM technology, inc. was a software company that
produced, acquired and distributed system software tools. Mr. Filipowski serves
on the board of directors of Blue Rhino Corporation, Bluestone Software, Inc.,
eShare Technologies, Inc., Platinum Entertainment, Inc., and System Software
Associates, Inc.
Leigh D. Orlov has served as our Vice President of Sales since September
1999. He joined Neoforma.com as a Director of Sales in May 1999. Mr. Orlov
worked at PeopleSoft Inc. as Vice President of Sales from January 1999 to May
1999 and as Regions Sales Manager from June 1994 to January 1999.
John F. Duddy has served as our Vice President of Marketing since February
1999. From June 1998 to February 1999, Mr. Duddy was Vice President of Sales and
Marketing at Metrika Inc., a medical device company. From April 1996 to June
1998, Mr. Duddy was director of sales and marketing at SmithKline Diagnostics,
Inc., a medical instruments company. From February 1993 to April 1996, Mr. Duddy
held sales management positions at Hybritech, a life sciences and diagnostic
company and a subsidiary of Beckman Coulter. Mr. Duddy holds a B.S. in business
administration from the University of Southern California.
BOARD COMPOSITION
Our amended and restated bylaws provide for a board of directors consisting
of seven members. Our amended and restated certificate of incorporation and
bylaws, each of which will become effective following the completion of this
offering, provide that our board of directors will be divided into three
classes, each serving staggered three-years terms: Class I, whose term will
expire at the annual meeting of stockholders to be held in 2000; Class II, whose
term will expire at the annual meeting of stockholders to be held in 2001; and
Class III, whose term will expire at the annual meeting of stockholders to be
held in 2002. As a result, only one class of directors will be elected at each
annual meeting of our stockholders, with the other classes continuing for the
remainder of their terms. Messrs. Douglass, McVicker and Rangaswami have been
designated as Class I directors; Messrs. Filipowski and Garnett have been
designated as Class II directors; and Messrs. Helppie and Zollars have been
designated as Class III directors.
49
<PAGE> 52
BOARD COMMITTEES
The audit committee consists of Messrs. Filipowski, Garnett and Rangaswami.
The audit committee:
- reviews our financial statements and accounting practices;
- makes recommendations to the board of directors regarding the selection
of independent accountants; and
- reviews the results and scope of the audit and other services provided by
our independent accountants.
The compensation committee consists of Messrs. Douglass, Filipowski and
Helppie. The compensation committee:
- reviews and recommends to the board of directors the compensation and
benefits of all of our officers, directors and consultants; and
- reviews general policy relating to compensation and benefits.
COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION
The compensation committee of our board of directors is currently comprised
of Messrs. Douglass, Filipowski and Helppie. None of these individuals has at
any time been one of our officers or employees. For a description of the
transactions between Neoforma.com and members of the compensation committee and
entities affiliated with the compensation committee members, see "Certain
Transactions." Robert J. Zollars, our President and Chief Executive Officer, is
a member of the board of directors of divine interVentures, inc., of which Mr.
Filipowski is President, Chief Executive Officer and Chairman of the board of
directors.
EMPLOYMENT CONTRACTS AND CHANGE OF CONTROL ARRANGEMENTS
Mr. Zollars. In July 1999, we entered into an at-will employment agreement
with Robert J. Zollars for him to serve as our Chairman, President and Chief
Executive Officer. Under this agreement, Mr. Zollars receives a salary equal to
$500,000 for the first year of the agreement, which can be increased by us in
subsequent years. Mr. Zollars is also entitled to a $250,000 bonus if he
continues to be employed by us on December 31, 1999. Beginning in 2000 and for
each following year while he is employed by us, Mr. Zollars is eligible to
receive a bonus payment of at least $500,000 for that fiscal year, based upon
whether we achieve revenue and profitability targets and/or other organizational
milestones to be specified by our board of directors.
Upon entering into this employment agreement, Mr. Zollars received an
option to purchase 1,637,160 shares of our common stock and an option to
purchase 3,602,315 shares of our common stock, each at an exercise price of
$0.10 per share. Both options were immediately exercisable and Mr. Zollars
exercised these options in full in July 1999. As of September 30, 1999, all of
the shares purchased under the option for 3,602,315 shares were subject to a
repurchase right that lapses at a rate of 900,578 shares after his first year of
employment and 75,048 shares per month thereafter. If we are acquired or if a
change in control of Neoforma.com occurs, the then unvested portion of his
option will become vested.
Mr. Zollars is eligible to receive from us a moving assistance loan of $2.5
million, which will be forgiven in equal monthly installments on the last day of
each month from the date of closing on his new home through June 30, 2003. Mr.
Zollars also has the right to be reimbursed by us up to $300,000 for any loss on
the sale of his previous home. We are obligated to reimburse Mr. Zollars for an
additional $338,000 plus additional moving expenses incurred in connection with
his joining us.
50
<PAGE> 53
If Mr. Zollars' employment is terminated other than for disability or
cause, or if Mr. Zollars resigns for good reason, he will be entitled to receive
an amount equal to his annual salary, bonus and benefits. In addition, our right
to repurchase all outstanding stock held by Mr. Zollars will lapse and the
forgiveness of the home loan will be treated as if he had been employed by us
for 12 additional months after the termination of employment. Good reason
includes a reduction in his duties or responsibilities or a reduction in his
salary, bonus or other benefits.
Mr. Tivin. In August 1999, we entered into an employment agreement with
Erik Tivin for him to serve as our Vice President of Auction Services and
President of Neoforma GAR, Inc. This agreement expires on December 31, 2001.
Under this agreement, Mr. Tivin receives a salary equal to $100,000 per year.
Mr. Tivin is also eligible to receive a bonus payment of at least $50,000 per
year that he is still employed by us, based upon our financial performance. Upon
entering into this employment agreement, Mr. Tivin received an option to
purchase 550,000 shares of our common stock at $0.10 per share. This option is
immediately exercisable. As of September 30, 1999, 33,333 of the shares
underlying the option had vested and none had been exercised. The shares
underlying the option vest at a rate of 33,333 shares per month for the first 12
months of his employment and at a rate of 4,167 shares per month during each of
months 13 through 47, with the balance of the remaining options vesting in month
48, so long as he is employed by us. In addition, in the event of a change of
control of Neoforma.com and termination of Mr. Tivin's employment, 50% of the
then unvested portion of Mr. Tivin's option shall immediately vest.
Mr. Ruegsegger. In June 1999, we entered into an offer letter with
Frederick J. Ruegsegger for him to serve as our Chief Financial Officer. Under
this offer letter, Mr. Ruegsegger receives a salary equal to $200,000 per year.
Mr. Ruegsegger is eligible to receive a bonus of up to $12,500 each quarter,
based upon performance milestones to be specified by our president and assessed
by our board of directors. Mr. Ruegsegger is also entitled to repayment of the
outstanding amount of a $25,000 relocation loan. Upon entering into employment
with us, Mr. Ruegsegger received an option to purchase 604,555 shares of our
common stock at $0.50 per share. This option is immediately exercisable and Mr.
Ruegsegger has exercised the option in full. As of September 30, 1999, all of
the shares underlying the option were subject to a right of repurchase. The
shares underlying the option vest over four years, with one fourth of the shares
vesting at the end of the first year of employment with us and an additional one
forty-eighth vesting each month thereafter, for so long as he is employed by us.
If Mr. Ruegsegger's employment is terminated other than for cause, he will be
entitled to receive an amount equal to three months of his salary. In addition,
in the event of a change of control of Neoforma.com and termination of Mr.
Ruegsegger's employment, 50% of the then unvested portion of Mr. Ruegsegger's
option shall immediately vest.
Mr. Goel. In September 1999, we entered into an offer letter with Bhagwan
D. Goel for him to serve as our Executive Vice President of Products and
Services. Under this offer letter, Mr. Goel receives a salary equal to $225,000
per year. Mr. Goel received a $50,000 bonus when he commenced his employment
with us and is entitled to receive a bonus of $50,000 after one year of
employment. Upon entering into employment with us, Mr. Goel received an option
to purchase 595,000 shares of our common stock at $3.00 per share. This option
is immediately exercisable. As of September 30, 1999, this option had not yet
been granted. The shares underlying the option vest in equal monthly
installments over four years, for so long as he is employed by us. If Mr. Goel's
employment is terminated other than for cause, he will be entitled to receive an
amount equal to 12 months of his salary. In addition, in the event of a change
of control of Neoforma.com and termination of Mr. Goel's employment, 50% of the
then unvested portion of Mr. Goel's option shall immediately vest.
Mr. Flury. In December 1998, we entered into an offer letter with Robert
Flury for him to serve as our Vice President of Enterprise Sales. Under this
offer letter, Mr. Flury receives a salary equal to
51
<PAGE> 54
$175,000 per year. Mr. Flury is entitled to receive a bonus of $25,000 each
quarter during his first year with us, and thereafter is eligible to earn a
bonus of up to $25,000 each quarter, based upon performance milestones to be
specified by our president and assessed by our board of directors. Upon entering
into employment with us, Mr. Flury received an option to purchase 609,392 shares
at $0.10 per share. This option is immediately exercisable. As of September 30,
1999, none of the shares underlying the option had vested and none had been
exercised. The shares underlying the option vest over four years, with one
fourth of the shares vesting at the end of the first year of employment with us
and an additional one forty-eighth vesting each month thereafter, for so long as
he is employed by us. If Mr. Flury's employment is terminated other than for
cause, he will be entitled to receive an amount equal to three months of his
salary. In addition, in the event of a change of control of Neoforma.com and
termination of Mr. Flury's employment, 50% of the then unvested portion of Mr.
Flury's option shall immediately vest.
DIRECTOR COMPENSATION
Our directors do not receive cash compensation for their services as
directors but are reimbursed for their reasonable and necessary expenses for
attending board and board committee meetings.
Each eligible director who is not our employee and who is or becomes a
member of our board will be automatically granted an option to purchase
shares of common stock under our 1999 Equity Incentive Plan, unless
that director has previously received an option grant. Immediately following
each annual meeting of stockholders, each eligible director will automatically
be granted an option to purchase shares of common stock under our 1999
Equity Incentive Plan, provided that the director is a member of the board on
that date and has served continuously as a member of the board for a period of
at least one year since the date of the director's initial grant. All options
will have an exercise price equal to the fair market value of our common stock
on the date of grant. The options will have 10-year terms and will terminate
three months following the date the director ceases to be one of our directors
or consultants or 12 months after any termination due to death or disability.
Options granted under the plan will generally vest over four years. Any unvested
shares subject to these options will become immediately vested and exercisable
upon a transaction which results in a change in our control.
EXECUTIVE COMPENSATION
The following table shows all compensation awarded to, earned by or paid
for services rendered to us in all capacities during 1998 by our then chief
executive officer and our other current or former executive officers who earned
at least $100,000 in 1998.
SUMMARY COMPENSATION TABLE
<TABLE>
<CAPTION>
LONG TERM
ANNUAL COMPENSATION COMPENSATION
------------------- SECURITIES
NAME AND PRINCIPAL POSITION SALARY BONUS UNDERLYING OPTIONS
--------------------------- -------- -------- ------------------
<S> <C> <C> <C>
Jeffrey H. Kleck.................................... $ 91,929 $ -- --
Co-founder, Company Evangelist(1)
Wayne D. McVicker................................... 122,150 -- --
Co-founder, Senior Vice President of Research and
Development and a director(2)
Stephen A. Pieraldi................................. 104,421 -- 175,000
Vice President of Business Development(3)
</TABLE>
52
<PAGE> 55
- ---------------
(1) Mr. Kleck was our Chief Executive Officer and a director in 1998.
(2) Mr. McVicker was our President in 1998.
(3) Mr. Pieraldi was our Vice President of Sales in 1998.
The executive officers listed below joined us after 1998 and are not
included in the tables relating to summary compensation and option grants in
1998.
Robert J. Zollars, our Chairman, President and Chief Executive Officer,
joined us in July 1999. Mr. Zollars is compensated at an annual rate of
$500,000. He will receive a bonus of $250,000 if he continues to be employed by
us on December 31, 1999. Mr. Zollars received an option to purchase 1,637,160
shares of our common stock and an option to purchase 3,602,315 shares of our
common stock, each at $0.10 per share. Both options were immediately exercisable
and Mr. Zollars exercised these options in full in July 1999. As of September
30, 1999, all of the shares underlying the option for 3,602,315 shares were
subject to a repurchase right that lapses at a rate of 900,578 after his first
year of employment and 75,048 shares per month thereafter.
Frederick J. Ruegsegger, our Chief Financial Officer, joined us in July
1999. Mr. Ruegsegger is compensated at an annual rate of $200,000. He is
eligible to receive a bonus of up to $12,500 each quarter. Mr. Ruegsegger was
also granted an option to purchase 604,555 shares of our common stock at $0.50
per share. This option is immediately exercisable and Mr. Ruegsegger has
exercised the option in full. As of September 30, 1999, all of the shares
underlying the option were subject to a repurchase right that lapses at a rate
of 151,138 shares after his first year of employment and 12,594 shares per month
thereafter.
Bhagwan D. Goel, our Executive Vice President of Products and Services,
joined us in October 1999. Mr. Goel is compensated at an annual rate of
$225,000. He received a $50,000 bonus upon joining us. Mr. Goel was also granted
an option to purchase 595,000 shares of our common stock at $3.00 per share.
This option is immediately exercisable. The shares underlying the option will
vest at a rate of 12,395 shares per month.
Robert Flury, our Senior Vice President of Business Development, joined us
in February 1999. Mr. Flury is compensated at an annual rate of $175,000. He is
entitled to receive a bonus of $25,000 each quarter. Mr. Flury was also granted
an option to purchase 609,392 shares of our common stock at $0.10 per share.
This option is immediately exercisable. As of September 30, 1999, the option had
not yet been exercised. The shares underlying the option will vest at a rate of
152,348 shares after his first year of employment and 12,695 shares per month
thereafter.
For more information regarding the terms of employment agreements and offer
letters with our executive officers, see "-- Employment Contracts and Change of
Control Arrangements."
OPTION GRANTS IN LAST FISCAL YEAR
The following table sets forth each grant of stock options during the
fiscal year ended December 31, 1998 to each of the executive officers named in
the Summary Compensation Table above. We granted the option listed below at an
exercise price equal to the fair market value of our common stock, as determined
by our board of directors on the date of grant. The option becomes exercisable
as to 25% of the underlying shares upon the first anniversary of the date of
grant and an
53
<PAGE> 56
additional 2.083% per month thereafter. The option expires on the earlier of 10
years from the date of grant or three months after termination of employment.
<TABLE>
<CAPTION>
POTENTIAL REALIZABLE
NUMBER PERCENTAGE OF VALUE AT ASSUMED
OF TOTAL ANNUAL RATES OF STOCK
SECURITIES OPTIONS PRICE APPRECIATION FOR
UNDERLYING GRANTED TO EXERCISE OPTION TERM(2)
OPTIONS EMPLOYEES PRICE EXPIRATION ----------------------
NAME GRANTED IN 1998(1) PER SHARE DATE 5% 10%
---- ---------- ------------- --------- ---------- --------- ---------
<S> <C> <C> <C> <C> <C> <C>
Jeffrey H. Kleck................ -- -- -- -- -- --
Wayne D. McVicker............... -- -- -- -- -- --
Stephen A. Pieraldi............. 175,000 12.2% $0.05 05/26/2008 $11,756 $36,640
</TABLE>
- -------------------------
(1) Based on an aggregate of 1,457,700 shares underlying the options granted to
our employees during fiscal 1998.
(2) Potential realizable values are computed by (a) multiplying the number of
shares of common stock subject to a given option by the deemed fair market
value of the underlying common stock at December 31, 1999, (b) compounding
the aggregate stock value derived from the foregoing calculation at an
annual rate of 5% or 10% over the 10 year term of the option, and (c)
subtracting from that result the aggregate option exercise price. The 5% and
10% assumed annual rates of compounded stock price appreciation are mandated
by the rules of the Securities and Exchange Commission and do not represent
our estimates or projections of future common stock prices.
AGGREGATED OPTION EXERCISES IN LAST FISCAL YEAR AND
FISCAL YEAR END OPTION VALUES
The following table sets forth the number of shares of common stock
acquired and the value realized upon exercise of stock options during 1998 and
the number of shares of common stock subject to exercisable and unexercisable
stock options held as of December 31, 1998 by each of the executive officers
named in the Summary Compensation Table. Value at fiscal year end is the
difference between the exercise price and the deemed fair market value of the
underlying common stock at December 31, 1998.
<TABLE>
<CAPTION>
NUMBER OF SECURITIES VALUE OF UNEXERCISED
NUMBER OF UNDERLYING UNEXERCISED IN-THE-MONEY OPTIONS AT
SHARES OPTIONS AT FISCAL YEAR END FISCAL YEAR END
ACQUIRED ON VALUE --------------------------- ---------------------------
NAME EXERCISE REALIZED EXERCISABLE UNEXERCISABLE EXERCISABLE UNEXERCISABLE
---- ----------- -------- ----------- ------------- ----------- -------------
<S> <C> <C> <C> <C> <C> <C>
Jeffrey H. Kleck............... -- -- -- -- -- --
Wayne D. McVicker.............. -- -- -- -- -- --
Stephen A. Pieraldi............ -- -- -- 175,000 -- $8,750
</TABLE>
EMPLOYEE BENEFIT PLANS
1997 Stock Plan
Our 1997 Stock Plan was adopted by our board of directors in January 1997.
As of September 30, 1999, there were outstanding options to purchase a total of
5,128,549 shares of common stock under this plan, and 2,659,309 shares remained
available for future grants. This plan will terminate immediately prior to this
offering, and no further options will be granted. However, the termination of
this plan will not affect any outstanding options, which will remain outstanding
until they are exercised, terminate or expire.
54
<PAGE> 57
1999 Equity Incentive Plan
Our 1999 Equity Incentive Plan will become effective on the date of this
prospectus and will serve as the successor to our 1997 Stock Plan. We have
reserved shares of common stock for issuance under this plan. The
number of shares reserved for issuance under this plan will be increased to
include:
- any shares reserved under our 1997 Stock Plan not issued or subject to
outstanding grants on the date of this prospectus;
- any shares issued under our 1997 Stock Plan that are repurchased by us at
the original purchase price; and
- any shares issuable upon exercise of options granted under our 1997 Stock
Plan that expire or become unexercisable without having been exercised in
full.
The number of shares reserved under this plan will be increased
automatically on January 1 of each year by an amount equal to % of our
total outstanding shares as of the immediately preceding December 31. Our board
of directors or compensation committee may reduce the amount of the increase in
any particular year. The following shares will be available for grant and
issuance under our 1999 Equity Incentive Plan:
- shares issuable upon exercise of an option granted under this plan that
is terminated or cancelled before the option is exercised;
- shares issued upon exercise of an option granted under this plan that are
subsequently repurchased by us at the original purchase price;
- shares subject to awards granted under this plan that are subsequently
forfeited or repurchased by us at the original issue price; and
- shares subject to stock bonuses granted under this plan that otherwise
terminate without shares being issued.
Our 1999 Equity Incentive Plan will terminate in 2009, unless earlier
terminated in accordance with the terms of the plan. Our 1999 Equity Incentive
Plan authorizes the award of options, restricted stock awards and stock bonuses.
No person will be eligible to receive more than shares in any calendar
year under this plan ( in the case of new employees). This plan is
administered by the compensation committee of our board of directors, which
currently consists of Messrs. Douglass, Filipowski and Helppie, all of whom are
outside directors, as defined under applicable federal tax laws. The committee
has the authority to interpret this plan and any agreement made under the plan,
grant awards and make all other determinations for the administration of this
plan. Also, our outside directors are entitled to receive automatic annual
grants of options to purchase shares of our common stock, as described under
"-- Director Compensation." Our 1999 Equity Incentive Plan provides for the
grant of both incentive stock options that qualify under Section 422 of the
Internal Revenue Code, and nonqualified stock options. Incentive stock options
may be granted only to employees. Nonqualified stock options, and all other
awards other than incentive stock options, may be granted to employees,
officers, directors, consultants, independent contractors and advisors of
Neoforma.com or subsidiary of Neoforma.com. However, consultants, independent
contractors and advisors are only eligible to receive awards if they render bona
fide services not in connection with the offer and sale of securities in a
capital-raising transaction. The exercise price of incentive stock options must
be at least equal to the fair market value of our common stock on the date of
grant. The exercise price of incentive stock options granted to 10% stockholders
must be at least equal to 110% of that value. The exercise price of nonqualified
stock options must be at least equal to 85% of the fair market value of the our
common stock on the date of grant. The maximum term of options granted under our
1999 Equity Incentive Plan is 10 years. Except as provided under the 1999 Equity
Incentive Plan, awards
55
<PAGE> 58
granted under the plan may not be transferred in any manner other than by will
or by the laws of descent and distribution. The compensation committee may allow
exceptions to this restriction with respect to awards that are not incentive
stock options. Options granted under our 1999 Equity Incentive Plan generally
expire three months after the termination of the optionee's service. Except for
options granted to outside directors, in the event of a change in control of
Neoforma.com, if the successor does not assume outstanding options, they will
expire upon conditions determined by the compensation committee. Alternatively,
the compensation committee may accelerate the vesting of awards upon a change in
control.
1999 Employee Stock Purchase Plan
Our 1999 Employee Stock Purchase Plan will become effective on the first
day on which price quotations are available for our common stock on the Nasdaq
National Market. We have initially reserved shares of common stock for
issuance under this plan. The number of shares reserved for issuance under our
1999 Employee Stock Purchase Plan will be increased automatically on January 1
of each year by an amount equal to % of our total outstanding shares as of
the immediately preceding December 31. Our board of directors or compensation
committee may reduce the amount of the increase in any particular year. Our
compensation committee will administer our 1999 Employee Stock Purchase Plan.
Employees generally will be eligible to participate in our 1999 Employee Stock
Purchase Plan if they are employed by Neoforma.com, or any subsidiaries that
Neoforma.com designates, for more than 20 hours per week and more than five
months in a calendar year. Employees are not eligible to participate in our 1999
Employee Stock Purchase Plan if they are 5% stockholders, or would become 5%
stockholders as a result of their participation in this plan. Under our 1999
Employee Stock Purchase Plan, eligible employees may acquire shares of our
common stock through payroll deductions. Eligible employees may select a rate of
payroll deduction between % and % of their cash compensation and are subject
to maximum purchase limitations. Participation in this plan will end
automatically upon termination of employment for any reason. A participant will
not be able to purchase shares having a fair market value of more than $ ,
determined as of the first day of the applicable offering period, for each
calendar year in which the employee participates in this plan. Each offering
period under this plan will be for two years and will consist of four six-month
purchase periods. The first offering period is expected to begin on the first
business day on which price quotations for our common stock are available on the
Nasdaq National Market. The first purchase period may be more or less than six
months long. Offering periods thereafter will begin on and
. The purchase price for common stock purchased under this plan
will be 85% of the lesser of the fair market value of our common stock on the
first day of the applicable offering period or the last day of each purchase
period. The compensation committee will have the power to change the duration of
offering periods. Our 1999 Employee Stock Purchase Plan is intended to qualify
as an employee stock purchase plan under Section 423 of the Internal Revenue
Code. This plan will terminate in 2009, unless it is terminated earlier pursuant
to its terms.
401(k) Plan.
We sponsor a defined contribution plan intended to qualify under Section
401 of the Internal Revenue Code. Participants may make pre-tax contributions to
the plan of up to 15% of their eligible earnings, subject to a statutorily
prescribed annual limit. Participants are fully vested in their contributions
and the investment earnings. We do not make matching contributions to the 401(k)
plan. Contributions by the participants to the 401(k) plan, and the income
earned on these contributions, are generally not taxable to the participants
until withdrawn. Contributions are held in trust as required by law. Individual
participants may direct the trustee to invest their accounts in authorized
investment alternatives.
56
<PAGE> 59
INDEMNIFICATION OF DIRECTORS AND EXECUTIVE OFFICERS AND LIMITATION OF LIABILITY
Our amended and restated certificate of incorporation includes a provision
that eliminates the personal liability of a director for monetary damages
resulting from breach of his fiduciary duty as a director, except for liability:
- for any breach of the director's duty of loyalty to us or our
stockholders;
- for acts or omissions not in good faith or that involve intentional
misconduct or a knowing violation of law;
- under section 174 of the Delaware General Corporation Law regarding
unlawful dividends and stock purchases; or
- for any transaction from which the director derived an improper personal
benefit.
Our amended and restated bylaws provide that:
- we are required to indemnify our directors and officers to the fullest
extent permitted by the Delaware General Corporation law, subject to
limited exceptions;
- the rights conferred in the amended and restated bylaws are not
exclusive; and
- we are required to advance expenses, as incurred, to our directors and
executive officers in connection with a legal proceeding to the fullest
extent permitted by the Delaware General Corporation Law, subject to
limited exceptions.
In addition to the indemnification required by our amended and restated
certificate of incorporation and bylaws, before the completion of this offering,
we intend to enter into indemnity agreements with each of our current directors
and officers. These agreements provide for the indemnification of our officers
and directors for all expenses and liabilities incurred in connection with any
action or proceeding brought against them by reason of the fact that they are or
were our agents. We also intend to obtain directors' and officers' insurance to
cover our directors, officers and some of our employees for certain liabilities,
including public securities matters. We believe that these indemnification
provisions and agreements and this insurance are necessary to attract and retain
qualified directors and officers.
The limitation of liability and indemnification provisions in our amended
and restated certificate of incorporation and bylaws may discourage stockholders
from bringing a lawsuit against our directors for breach of their fiduciary
duty. They may also reduce the likelihood of derivative litigation against
directors and officers, even though an action, if successful, might benefit us
and other stockholders. Furthermore, the value of a stockholder's investment may
decline to the extent we pay the costs of settlement and damage awards against
directors and officers as required by these indemnification provisions. At
present, there is no pending litigation or proceeding involving any of our
directors, officers or employees regarding which indemnification from us is
sought, nor are we aware of any threatened litigation that may result in claims
for indemnification by us.
57
<PAGE> 60
CERTAIN TRANSACTIONS
Other than compensation agreements and other arrangements, which are
described in "Management," and the transactions described below, since we
incorporated in March 1996, there has not been, nor is there currently proposed,
any transaction or series of similar transactions to which we were or will be a
party:
- in which the amount involved exceeded or will exceed $60,000, and
- in which any director, executive officer, holder of more than 5% of our
common stock or any member of their immediate family had or will have a
direct or indirect material interest.
The agreements described below are included as exhibits to the registration
statement of which this prospectus forms a part.
TRANSACTIONS WITH PROMOTER
In May 1996, in connection with our formation and initial financing,
Jeffrey H. Kleck, our co-founder and Company Evangelist, purchased four million
shares of our common stock at $0.00375 per share in exchange for $10,000 in cash
and specified intellectual property and Wayne D. McVicker, our co-founder and
Senior Vice President of Research and Development and a director, purchased four
million shares of our common stock at $0.00375 per share in exchange for $10,000
in cash and specified intellectual property. Messrs. Kleck and McVicker each
hold more than 5% of our common stock.
STOCK FINANCINGS/STOCK EXCHANGES
Series A preferred stock exchange
In April 1998, we issued 9,000,000 shares of our Series A preferred stock
in exchange for 9,000,000 shares of previously issued common stock. The holders
of the Series A preferred stock included, among others:
- Wayne D. McVicker -- 4,000,000 shares; and
- Jeffrey H. Kleck -- 4,000,000 shares.
Series B preferred stock financing
In April 1998, we sold 2,860,000 shares of our Series B preferred stock for
approximately $0.50 per share. The purchasers of the Series B preferred stock
included, among others:
- Terence J. and Katrina A. Garnett, Trustees of the Garnett Family Trust
UDT 4/2/97 -- 500,000 shares; and
- Madhavan Rangaswami -- 200,000 shares.
Terence J. Garnett is one of our directors. Mr. Garnett also holds,
personally or through trusts of which he is a trustee, more than 5% of our
common stock.
Madhavan Rangaswami is one of our directors.
Series C preferred stock financing
In June 1998, we sold 5,064,937 shares of our Series C preferred stock for
approximately $0.77 per share. The purchasers of the Series C preferred stock
included, among others:
- Terence J. and Katrina A. Garnett, Trustees of the Garnett Family Trust
UDT 4/2/97 -- 754,870 shares;
58
<PAGE> 61
- Venrock Associates -- 1,467,073 shares;
- Venrock Associates II, L.P. -- 1,944,724 shares; and
- Madhavan Rangaswami -- 351,732 shares.
Terence J. Garnett, one of our directors, is a Venture Partner of the
general partner of Venrock Associates and Venrock Associates II, L.P. These
entities, in the aggregate, hold more than 5% of our common stock.
Series D preferred stock financing
In February 1999, we sold 10,196,361 shares of our Series D preferred stock
for approximately $1.18 per share. The purchasers of the Series D preferred
stock included, among others:
- Delphi BioInvestments IV, L.P. -- 59,915 shares;
- Delphi Ventures IV, L.P. -- 2,906,187 shares;
- Terence J. Garnett -- 50,848 shares;
- Terence J. and Katrina A. Garnett, Trustees of the Garnett Family Trust
UDT 4/2/97 -- 423,728 shares;
- Venrock Associates -- 694,915 shares; and
- Venrock Associates II, L.P. -- 1,000,000 shares.
David Douglass, one of our directors, is a General Partner of Delphi
Ventures, L.P.
Series E and Series E-1 preferred stock financing
In October 1999, we sold an aggregate of 12,693,663 shares of our Series E
and Series E-1 preferred stock for approximately $5.68 per share and issued an
additional 275,000 shares of Series E-1 preferred stock in connection with
entering into a strategic alliance in October 1999. The purchasers of the Series
E and Series E-1 preferred stock included, among others:
- Dell USA L.P. -- 4,401,408 shares;
- Venrock Associates -- 133,033 shares;
- Venrock Associates II, L.P. -- 191,438 shares;
- Venrock Entrepreneurs Fund -- 17,077 shares;
- Superior Consultant Company -- 880,282 shares;
- divine interVentures, inc. -- 1,056,338 shares; and
- Terence J. and Katrina A. Garnett, Trustees of the Garnett Family Trust
UDT 4/2/97 -- 10,563 shares.
Dell USA L.P. holds more than 5% of our common stock.
Richard D. Helppie, one of our directors, is Chairman of the Board and
Chief Executive Officer of Superior Consultant Holdings Corporation.
Andrew J. Filipowski, one of our directors, is the President, Chief
Executive Officer and Chairman of the Board of divine interVentures, inc.
59
<PAGE> 62
Appointment of Board Members. Messrs. McVicker, Garnett, Douglass, Helppie
and Filipowski were appointed to our board of directors pursuant to rights held
by our preferred stockholders. These rights terminate upon the closing of this
offering.
Investor Rights Agreement. In October 1999, we entered into a Second
Amended and Restated Investor Rights Agreement with some of our stockholders,
including some of our officers and directors, or their affiliated entities,
under which they have registration rights with respect to their stock. See
"Description of Capital Stock -- Registration Rights."
CONSULTING AGREEMENTS
In April 1998, we entered into a consulting agreement with Sand Hill Group
LLC. Madhavan Rangaswami, one of our directors, is a member of Sand Hill Group
LLC. Sand Hill Group LLC provides 16 hours per month of services to us through
the end of 1999 in exchange for our sale of 250,000 shares of our common stock
to each of Mr. Rangaswami and another member of Sand Hill Group LLC and our
reimbursement of Sand Hill's out-of-pocket expenses. We retained a right to
repurchase these shares, which right lapses ratably over six quarters after the
issuance of the shares.
In July 1999, we entered into a consulting agreement with Mr. Rangaswami.
Under the agreement, Mr. Rangaswami agreed to provide us with consulting
services for a period of three months in exchange for an option to purchase
95,325 shares of our common stock at an exercise price of $0.10, which vested at
the end of the three month period.
LOANS
On July 10, 1999, we made a loan to Robert J. Zollars in connection with
his exercise of a stock option granted to him under the terms of his employment
agreement. The loan is evidenced by a promissory note in the principal amount of
$162,078.84, with interest compounded quarterly on the unpaid balance at a rate
of 5.70% per year.
On July 10, 1999, we made a loan to Robert J. Zollars in connection with
his exercise of a stock option granted to him under the terms of his employment
agreement. The loan is evidenced by a promissory note in the principal amount of
$356,629.19, with interest compounded quarterly on the unpaid balance at a rate
of 5.70% per year.
On September 7, 1999, we made a loan to Frederick J. Ruegsegger, in
connection with his exercise of a stock option granted to him under the terms of
his offer letter. The loan is evidenced by a promissory note in the principal
amount of $301,672.95, with interest compounded quarterly on the unpaid balance
at a rate of 5.85% per year.
On October 4, 1999, we made a loan to Bhagwan D. Goel in connection with
his exercise of a stock option granted to him under the terms of his offer
letter. The loan is evidenced by a promissory note in the principal amount of
$1,484,505.00, with interest compounded quarterly on the unpaid balance at a
rate of 5.89% per year.
On various dates from March 1997 through December 1997, Wayne D. McVicker
made loans to us in an aggregate amount of $190,000. In April 1998, we issued a
convertible note for $197,047.80 to Mr. McVicker in consideration of his
agreement to cancel the outstanding promissory notes representing these loans.
The convertible note paid interest at a rate of 8% per year. This note has been
paid in full.
On various dates from September 1996 through November 1997, Jeffrey H.
Kleck made loans to us in an aggregate amount of $195,000. In April 1998, we
issued a convertible note for $206,670.95 to Dr. Kleck in consideration of his
agreement to cancel the promissory notes representing these loans. The
convertible note paid interest at a rate of 8% per year. The convertible note
was converted into
60
<PAGE> 63
60,000 shares of Series B preferred stock at a price per share of $0.50 and the
remaining balance was paid in full.
In August 1999, we issued a promissory note to Erik Tivin in the amount of
$7.8 million as partial payment of the purchase price of our acquisition of GAR.
The note is payable over a five year period.
COMMERCIAL TRANSACTIONS
In connection with our October 1999 sale of Series E preferred stock,
Richard D. Helppie, the Chairman and Chief Executive Officer of Superior
Consultant Holdings Corporation, joined our board of directors. In addition, in
October 1999 we entered into an agreement with Superior Consultant Company,
Inc., a wholly owned subsidiary of Superior Consultant Holdings Corporation,
providing for collaboration between us and Superior. Superior is a supplier of
Digital Business Transformation(TM) services to large healthcare organizations,
including Internet-related services, systems integration, outsourcing and
consulting, which enable Superior clients to utilize digital technologies and
process innovations to improve their businesses. Under the agreement, we have
agreed to market Superior's services to our users, and Superior has agreed to
introduce our services to appropriate clients, based on their interests, and to
incorporate our services into its Digital Business Transformation(TM) offerings.
The agreement also provides for joint marketing activities. In consideration, we
have agreed to make payments to Superior in an aggregate amount of up to
approximately $2.0 million, as well as a percentage of specified Neoforma.com
e-commerce transaction revenue and other payments. We have also agreed to
utilize Superior's services on a preferred basis for systems integration,
development, infrastructure, process improvement and consulting assistance,
totaling at least $1.5 million of services from Superior, at a discount from
Superior's standard fees. Our agreement with Superior expires in October 2002.
In October 1999, we entered into an agreement with Dell Marketing, L.P., an
affiliate of Dell Computer, under which we agreed to develop complementary
marketing programs with Dell and to establish links between our respective
internet websites. We agreed to use Dell as our exclusive supplier of desktops,
portables, workstations, servers and storage devices unless its products did not
meet our reasonable technical requirements. We also agreed to purchase at least
$5.0 million of Dell products and $100,000 of data center consulting services.
Our agreement with Dell expires in 2001, subject to renewal for additional
one-year periods. In addition, Dell purchased approximately 4.4 million shares
of our preferred stock in October 1999.
61
<PAGE> 64
PRINCIPAL STOCKHOLDERS
The following table sets forth certain information with respect to
beneficial ownership of our common stock as of September 30, 1999 and as
adjusted to reflect the sale of the common stock in this offering by:
- each stockholder known by us to be the beneficial owner of more than 5%
of our common stock;
- each of our directors;
- each executive officer listed in the Summary Compensation Table; and
- all executive officers and directors as a group.
The percentage of outstanding shares beneficially owned before this
offering in the following table is based on 48,841,241 shares of common stock
outstanding as of September 30, 1999, assuming conversion of all outstanding
shares of preferred stock into common stock, and also including 12,693,663
shares of common stock issuable upon conversion of our Series E and Series E-1
preferred stock that we issued in October 1999. The percentage of outstanding
shares beneficially owned after this offering in the following table is based on
shares of common stock outstanding after the completion of this
offering.
Under the rules of the Securities and Exchange Commission, beneficial
ownership includes voting or investment power with respect to securities and
includes the shares issuable under stock options or warrants that are
exercisable within 60 days of September 30, 1999. Shares issuable under stock
options or warrants are deemed outstanding for computing the percentage held by
the person holding options but are not outstanding for computing the percentage
of any other person. Unless otherwise indicated, the address for each listed
stockholder is: c/o Neoforma.com, Inc., 3255-7 Scott Boulevard, Santa Clara,
California 95054. To our knowledge, except as indicated in the footnotes to this
table and under applicable community property laws, the persons named in the
table have sole voting and investment power with respect to all shares of common
stock.
<TABLE>
<CAPTION>
PERCENTAGE OF OUTSTANDING
SHARES BENEFICIALLY OWNED
NUMBER OF SHARES ---------------------------------
NAME OF BENEFICIAL OWNER BENEFICIALLY OWNED BEFORE OFFERING AFTER OFFERING
------------------------ ------------------ --------------- --------------
<S> <C> <C> <C>
EXECUTIVE OFFICERS AND DIRECTORS
Robert J. Zollars(1)...................... 5,239,475 10.7%
Jeffrey H. Kleck.......................... 4,000,000 8.2%
Wayne D. McVicker......................... 4,000,000 8.2%
Stephen J. Pieraldi(2).................... 175,000 *
David Douglass(3)......................... 3,066,102 6.3%
Terence J. Garnett(4)..................... 7,688,269 15.7%
Madhavan Rangaswami(5).................... 997,057 2.0%
Richard D. Helppie(6)..................... 880,282 1.8%
Andrew J. Filipowski(7)................... 1,056,338 2.2%
All 12 executive officers and directors as
a group(8).............................. 27,632,077 56.5%
OTHER 5% STOCKHOLDERS
Dell USA L.P.(9).......................... 4,401,408 9.0%
Delphi Ventures(3)(10).................... 3,066,102 6.3%
Venrock Associates(11).................... 5,448,260 11.2%
</TABLE>
- -------------------------
* Represents beneficial ownership of less than 1%.
62
<PAGE> 65
(1) Includes 3,452,219 shares of common stock subject to a repurchase right
that lapses at a rate of 75,048 shares per month.
(2) Represents 175,000 of common stock shares issuable under an option held by
Mr. Pieraldi that is presently exercisable in full. 102,083 of these shares
are subject to a repurchase right that lapses at a rate of 3,645 shares per
month.
(3) Includes 100,000 shares of common stock held of record by Mr. Douglass,
58,333 of which are subject to repurchase rights that lapse over time. Also
includes 59,915 and 2,906,187 shares of common stock held of record by
Delphi BioInvestments IV, L.P. and Delphi Ventures IV, L.P. Mr. Douglass,
one of our directors, is a General Partner at Delphi Ventures, the general
partner of Delphi BioInvestments IV, L.P. and Delphi Ventures IV, L.P. Mr.
Douglass disclaims beneficial ownership of the shares held by Delphi.
(4) Includes 550,848 shares of common stock held by Terence J. Garnett and
1,689,161 shares of common stock held by Terence J. and Katrina A. Garnett,
Trustees of the Garnett Family Trust UDT 4/2/97. Also includes 52,778
shares of common stock that are subject to a repurchase right that lapses
over time. This number further includes 2,295,021, 3,136,162 and 17,077
shares of common stock held by Venrock Associates, Venrock Associates II,
L.P. and Venrock Entrepreneurs Fund. Mr. Garnett, one of our directors, is
a Venture Partner at Venrock Associates, the general partner of Venrock
Associates, L.P., Venrock Associates II, L.P. and Venrock Entrepreneurs
Fund. Mr. Garnett disclaims beneficial ownership of the shares held by
Venrock.
(5) Includes 52,778 shares of common stock that are subject to a repurchase
right that lapses over time.
(6) Represents 880,282 shares of common stock held by Superior Consultant
Holdings Corporation. Mr. Helppie, one of our directors, is the Chairman,
Chief Executive Officer and President of Superior. Mr. Helppie disclaims
beneficial ownership of the shares held by Superior.
(7) Represents 1,056,338 shares of common stock held by divine interVentures,
Inc. Mr. Filipowski, one of our directors, is President, Chief Executive
Officer and Chairman of the Board of divine interVentures, Inc. Mr.
Filipowski disclaims beneficial ownership of the shares held by divine
interVentures, Inc.
(8) Includes 99,999 shares of common stock issuable under options held by
directors and executive officers that are presently exercisable within 60
days of September 30, 1999. Also includes 4,056,774 outstanding shares that
are subject to repurchase rights that lapse over time. Does not include
595,000 shares of our common stock issued to Bhagwan D. Goel after
September 30, 1999. These shares are subject to a repurchase right that
lapses over time.
(9) The address of Dell USA L.P. Corporation is One Dell Way, Round Rock, TX
78682.
(10) The address of Delphi Ventures is 3000 Sand Hill Road, Bldg. 1 #135, Menlo
Park, CA 94025.
(11) Includes 2,295,021, 3,136,162 and 17,077 shares of common stock held by
Venrock Associates, Venrock Associates II, L.P. and Venrock Entrepreneurs
Fund. Venrock Associates is the general partner of each of these funds. The
address of Venrock Associates is 2494 Sand Hill Road, Suite 200, Menlo
Park, CA 94025.
63
<PAGE> 66
DESCRIPTION OF CAPITAL STOCK
Immediately following the closing of this offering, our authorized capital
stock will consist of 200 million shares of common stock, $0.001 par value per
share, and five million shares of preferred stock, $0.001 par value per share.
As of September 30, 1999, assuming the conversion of all outstanding preferred
stock into common stock upon the closing of this offering and including the
12,693,663 shares of common stock issuable upon conversion of the Series E and
Series E-1 preferred stock that we issued in October 1999, there were
outstanding 48,841,241 shares of common stock held of record by approximately 80
stockholders, options to purchase 6,765,709 shares of our common stock and
warrants to purchase 421,525 shares of our common stock. The number of shares of
common stock into which each share of our Series E and Series E-1 preferred
stock will be converted upon completion of this offering may be adjusted under
some circumstances as described in Note 13 of notes to financial statements.
COMMON STOCK
Subject to preferences that may apply to shares of preferred stock
outstanding at the time, the holders of outstanding shares of common stock are
entitled to receive dividends out of assets legally available at the times and
in the amounts as our board of directors may determine.
Each holder of common stock is entitled to one vote for each share of
common stock held on all matters submitted to a vote of stockholders. Cumulative
voting for the election of directors is not provided for in our amended and
restated certificate of incorporation. As a result, commencing at our first
annual meeting of stockholders, the holders of a majority of the shares voted
can elect all of the directors then standing for election.
Our common stock is not entitled to preemptive rights and is not subject to
conversion or redemption.
Upon our liquidation, dissolution or winding-up, the holders of our common
stock are entitled to share ratably with holders of any participating preferred
stock in all assets remaining after payment of all liabilities and the
liquidation preferences of any outstanding preferred stock. Each outstanding
share of common stock is, and all shares of common stock to be outstanding upon
completion of this offering will be, fully paid and nonassessable.
PREFERRED STOCK
Upon the closing of this offering, each outstanding share of preferred
stock will be converted into shares of common stock. See Notes 7 and 8 of notes
to financial statements for a description of our outstanding preferred stock.
Following this offering, our board of directors will be authorized, subject
to limitations prescribed by Delaware law, without stockholder approval, to
issue up to five million shares of preferred stock in one or more series, to
establish from time to time the number of shares to be included in each series,
to fix the rights, preferences and privileges of the shares of each wholly
unissued series and any of its qualifications, limitations or restrictions. The
board of directors can also increase or decrease the number of shares of any
series, but not below the number of shares of such series then outstanding,
without any further vote or action by the stockholders. The board of directors
may authorize the issuance of preferred stock with voting, conversion or other
rights that are superior to the rights of the holders of the common stock. The
issuance of preferred stock, while providing flexibility in connection with
possible acquisitions and other corporate purposes, could, among other things,
have the effect of delaying, deferring or preventing a change in control of
Neoforma.com and may adversely affect the market price of the common stock and
the voting and other rights of the holders of common stock. We have no current
plan to issue any shares of preferred stock after the offering.
64
<PAGE> 67
WARRANTS
As of September 30, 1999, we had issued warrants to purchase an aggregate
of 421,525 shares of our common stock at a weighted average exercise price of
$1.14. These warrants will remain outstanding after the completion of this
offering and will represent warrants to purchase shares of our common stock.
These warrants have expiration dates from 2003 to 2009. See Note 9 of notes to
financial statements.
REGISTRATION RIGHTS
As a result of an investors' rights agreement between Neoforma.com and some
of our stockholders, the holders of approximately 39,814,961 shares of common
stock are entitled to rights with respect to the registration of these shares
under the Securities Act, as described below.
Demand Registration Rights. At any time beginning six months after the
completion of this offering, the holders of at least 75% of the shares of common
stock issuable upon conversion of our preferred stock can request that we
register all or a portion of their shares. We will only be required to file two
registration statements in response to their demand registration rights. We may
postpone the filing of a registration statement for up to 90 days once in a 12
month period if we determine that the filing would be seriously detrimental to
us or our stockholders.
Piggyback Registration Rights. If we register any securities for public
sale, the holders of the shares of common stock issuable upon conversion of our
preferred stock will have the right to include their shares in the registration
statement. However, this right does not apply to a registration relating to any
of our employee benefit plans or a corporate reorganization. The managing
underwriter of any underwritten offering will have the right to limit the number
of shares registered by these holders to 15% of the total shares covered by the
registration statement due to marketing reasons.
Form S-3 Registration Rights. The holders of the shares of common stock
issuable upon conversion of our preferred stock can request that we register
their shares if we are eligible to file a registration statement on Form S-3 and
if the aggregate price of the shares offered to the public is at least $1.0
million. The holders may only require us to file three registration statements
on Form S-3 per calendar year.
We will pay all expenses incurred in connection with the registrations
described above, except for underwriters' and brokers' discounts and
commissions, which will be paid by the selling stockholders.
The registration rights will expire with respect to a particular
stockholder if it can sell all of its shares in a three month period under Rule
144 of the Securities Act. In any event, the registration rights described above
will expire five years after this offering is completed.
Holders of these registration rights have waived the exercise of these
registration rights for 180 days following the date of this prospectus.
ANTI-TAKEOVER PROVISIONS
The provisions of Delaware law, our amended and restated certificate of
incorporation and bylaws may have the effect of delaying, deferring or
discouraging another person from acquiring control of our company.
Delaware Law
We will be subject to the provisions of Section 203 of the Delaware General
Corporation Law regulating corporate takeovers. This section prevents some
Delaware corporations from engaging, under some circumstances, in a business
combination, which includes a merger or sale of more than 10% of the
corporation's assets with any interested stockholder, or a stockholder who owns
15% or
65
<PAGE> 68
more of the corporation's outstanding voting stock, as well as affiliates and
associates of stockholder, for three years following the date that stockholder
became an interested stockholder unless:
- the transaction is approved by the board of directors prior to the date
the interested stockholder attained that status;
- upon consummation of the transaction that resulted in the stockholder's
becoming an interested stockholder, the interested stockholder owned at
least 85% of the voting stock of the corporation outstanding at the time
the transaction commenced; or
- on or subsequent to such date the business combination is approved by the
board and authorized at an annual or special meeting of stockholders by
at least two-thirds of the outstanding voting stock that is not owned by
the interested stockholder.
A Delaware corporation may opt out of this provision with an express
provision in its original certificate of incorporation or an express provision
in its certificate or incorporation or bylaws resulting from a stockholders'
amendment approved by at least a majority of the outstanding voting shares.
However, we have not opted out of this provision. The statute could prohibit or
delay mergers or other takeover or change in control attempts and, accordingly,
may discourage attempts to acquire us.
Charter and Bylaw Provisions
Our amended and restated certificate of incorporation and bylaws provide
that:
- following the completion of this offering, no action shall be taken by
stockholders except at an annual or special meeting of the stockholders
called in accordance with our bylaws and that stockholders may not act by
written consent;
- following the completion of this offering, the approval of two-thirds of
the stockholders shall be required to adopt, amend or repeal our bylaws;
- stockholders may not call special meetings of the stockholders or fill
vacancies on the board;
- following the completion of this offering, our board of directors will be
divided into three classes, each serving staggered three-year terms,
which means that only one class of directors will be elected at each
annual meeting of stockholders, with the other classes continuing for the
remainder of their respective terms, and directors may only be removed
for cause; and
- we will indemnify officers and directors against losses that they may
incur in investigations and legal proceedings resulting from their
services to us, which may include services in connection with takeover
defense measures.
These provisions of our certificate of incorporation and bylaws may have
the effect of delaying, deferring or discouraging another person from acquiring
control of our company.
TRANSFER AGENT AND REGISTRAR
The transfer agent and registrar for our common stock is . Its
address is and its telephone number is .
LISTING
We have applied to list our common stock on The Nasdaq National Market
under the trading symbol "NEOF."
66
<PAGE> 69
SHARES ELIGIBLE FOR FUTURE SALE
Before this offering, there has been no public market for our common stock.
A significant public market for our common stock may not develop or be sustained
after this offering. Future sales of substantial amounts of our common stock in
the public market, or the possibility of these sales occurring, could adversely
affect prevailing market prices for our common stock or our future ability to
raise capital through an offering of equity securities.
Upon completion of this offering, we will have shares of common
stock outstanding, assuming no exercise of options and warrants outstanding as
of September 30, 1999, and the conversion of all outstanding shares of preferred
stock. Of these shares, the shares sold in this offering ( if
the underwriters' over-allotment option is exercised in full) will be freely
tradable in the public market without restriction or registration under the
Securities Act, unless the shares are held by our "affiliates", as that term is
defined in Rule 144 under the Securities Act.
The remaining shares of common stock outstanding upon completion
of this offering will be "restricted securities" as defined in Rule 144. We
issued and sold these restricted securities in private transactions in reliance
on exemptions from registration under the Securities Act. Restricted securities
may be sold in the public market only if they are registered or if they qualify
for an exemption from registration under Rule 144 or Rule 701 under the
Securities Act, as summarized below.
Under the terms of "lock-up" agreements, all the executive officers,
directors and stockholders of Neoforma.com, who collectively hold an aggregate
of of these restricted securities, have agreed not to offer, sell,
contract to sell, grant any option to purchase or otherwise dispose of any of
these shares for a period of 180 days from the date of this prospectus, subject
to limited exceptions. However, Merrill Lynch, Pierce, Fenner & Smith
Incorporated may, in its sole discretion, at any time without notice, release
all or any portion of the shares subject to lock-up agreements.
Taking into account the lock-up agreements, and assuming Merrill Lynch,
Pierce, Fenner & Smith Incorporated does not release stockholders from these
agreements, the following shares will be eligible for sale in the public market
at the following times:
- on the date of this prospectus, the shares sold in the offering
will be immediately available for sale in the public market;
- 180 days after the date of this prospectus, approximately
shares will be eligible for sale, of which will be subject to
volume, manner of sale and other limitations under Rule 144; and
- of the remaining shares, will be eligible for sale under Rule
701 upon the expiration of our repurchase right with respect to those
shares, and will be eligible for sale under Rule 144 upon the
expiration of various one-year holding periods.
Following the expiration of the lock-up period, shares issued upon exercise
of options we granted prior to the date of this prospectus will also be
available for sale in the public market pursuant to Rule 701 under the
Securities Act. Rule 701 permits resales of these shares beginning 90 days after
the date of this prospectus. In general, under Rule 144, after expiration of the
lock-up period, a person who has beneficially owned restricted securities for at
least one year would be entitled to sell, within any three-month period, a
number of shares that does not exceed the greater of:
- 1% of the then outstanding shares of our common stock, or
- the average weekly trading volume of our common stock during the four
calendar weeks preceding the sale.
67
<PAGE> 70
Sales under Rule 144 are also subject to manner of sale and notice
requirements and the availability of current public information about us. Under
Rule 144(k), a person who has not been our affiliate at any time during the
three months before a sale and who has beneficially owned the shares proposed to
be sold for at least two years can sell these shares without complying with the
manner of sale, public information, volume limitation or notice provisions of
Rule 144.
After the effective date of this offering, we intend to file a registration
statement on Form S-8 to register approximately shares of common stock
outstanding or reserved for issuance under our various stock plans. The
registration statement will become effective automatically upon filing. Shares
issued under the foregoing employee benefit plans, after the filing of a
registration statement on Form S-8, may be sold in the open market, subject, in
the case of some holders, to the Rule 144 limitations applicable to affiliates,
the lock-up agreements and our repurchase rights held by us.
In addition, following this offering, the holders of 39,591,518 shares of
outstanding common stock will, under some circumstances, have right to require
us to register their shares for future sale. See "Description of Capital
Stock -- Registration Rights."
68
<PAGE> 71
UNDERWRITING
We intend to offer our common stock through a number of underwriters.
Merrill Lynch, Pierce, Fenner & Smith Incorporated, Bear, Stearns & Co., Inc.,
BancBoston Robertson Stephens Inc., Volpe Brown Whelan & Company, LLC and
William Blair & Company, L.L.C. are acting as representatives of each of the
underwriters named below. Subject to the terms and conditions set forth in a
purchase agreement between us and the underwriters, we have agreed to sell to
the underwriters, and each of the underwriters severally and not jointly has
agreed to purchase from us, the number of shares of common stock set forth
opposite its name below.
<TABLE>
<CAPTION>
NUMBER OF
SHARES
UNDERWRITERS ---------
<S> <C>
Merrill Lynch, Pierce, Fenner & Smith
Incorporated...................................
Bear, Stearns & Co., Inc. ..................................
BancBoston Robertson Stephens Inc. .........................
Volpe Brown Whelan & Company, LLC...........................
William Blair & Company, L.L.C..............................
--------
Total.........................................
========
</TABLE>
In the purchase agreement, the several underwriters have agreed, subject to
the terms and conditions set forth in that agreement, to purchase all of the
shares of our common stock being sold pursuant to the agreement if any of the
shares of common stock being sold pursuant to the agreement are purchased. In
the event of a default by an underwriter, the purchase agreement provides that,
in some circumstances, the purchase commitments of the nondefaulting
underwriters may be increased or the purchase agreement may be terminated.
We have agreed to indemnify the underwriters against some liabilities,
including some liabilities under the Securities Act, or to contribute to
payments the underwriters may be required to make in respect of those
liabilities.
The shares of common stock are being offered by the several underwriters,
subject to prior sale, when, as and if issued to and accepted by them, subject
to approval of various legal matters by counsel for the underwriters and other
conditions. The underwriters reserve the right to withdraw, cancel or modify
such offer and to reject orders in whole or in part.
COMMISSIONS AND DISCOUNTS
The representatives have advised us that the underwriters propose initially
to offer the shares of our common stock to the public at the initial public
offering price set forth on the cover page of this prospectus, and to dealers at
such price less a concession not in excess of $ per share of common stock.
The underwriters may allow, and such dealers may re-allow, a discount not in
excess of $ per share of common stock to other dealers. After the initial
public offering, the public offering price, concession and discount may be
changed.
69
<PAGE> 72
The following table shows the per share and total public offering price,
underwriting discount to be paid by us to the underwriters and the proceeds
before expenses to us. This information is presented assuming either no exercise
or full exercise by the underwriters of their over-allotment options.
<TABLE>
<CAPTION>
PER SHARE WITHOUT OPTION WITH OPTION
--------- -------------- -----------
<S> <C> <C> <C>
Public offering price................................ $ $ $
Underwriting discount................................ $ $ $
Proceeds, before expenses, to Neoforma.com........... $ $ $
</TABLE>
The expenses of this offering, exclusive of the underwriting discount, are
estimated at $ and are payable by us.
OVER-ALLOTMENT OPTION
We have granted an option to the underwriters, exercisable for 30 days
after the date of this prospectus, to purchase up to an aggregate of an
additional shares of our common stock at the public offering price set
forth on the cover of this prospectus, less the underwriting discount. The
underwriters may exercise this option solely to cover over-allotments, if any,
made on the sale of our common stock offered hereby. To the extent that the
underwriters exercise this option, each underwriter will be obligated to
purchase a number of additional shares of our common stock proportionate to such
underwriter's initial amount reflected in the foregoing table.
RESERVED SHARES
At our request, the underwriters have reserved for sale, at the initial
public offering price, up to of the shares offered hereby to be
sold to individuals and entities designated by us. The number of shares of
common stock available for sale to the general public will be reduced to the
extent such persons purchase such reserved shares. Any reserved shares which are
not orally confirmed for purchase within one day of the pricing of the offering
will be offered by the underwriters to the general public on the same terms as
the other shares offered by this prospectus.
NO SALES OF SIMILAR SECURITIES
We, and our executive officers and directors and existing stockholders have
agreed, with certain exceptions, without the prior written consent of Merrill
Lynch on behalf of the underwriters for a period of 180 days after the date of
this prospectus, not to directly or indirectly:
- offer, pledge, sell, contract to sell, sell any option or contract to
purchase, purchase any option or contract to sell, grant any option,
right or warrant for the sale of, lend or otherwise dispose of or
transfer any shares of our common stock or securities convertible into or
exchangeable or exercisable for or repayable with our common stock,
whether now owned or later acquired by the person executing the agreement
or with respect to which the person executing the agreement later
acquires the power of disposition, or file any registration statement
under the Securities Act of 1933 relating to any shares of our common
stock, or
- enter into an swap or other agreement that transfers, in whole or in
part, the economic consequence of ownership of our common stock whether
any such swap or transaction is to be settled by delivery of our common
stock or other securities, in cash or otherwise;
provided that we may at any time and from time to time grant options to purchase
shares of our common stock under our existing stock plans and issue shares of
our common stock upon the exercise of outstanding options.
70
<PAGE> 73
QUOTATION ON THE NASDAQ NATIONAL MARKET
We expect our common stock to be approved for quotation on the Nasdaq
National Market, subject to official notice of issuance, under the symbol
"NEOF."
Before this offering, there has been no public market for our common stock.
The initial public offering price will be determined through negotiations
between us and the representatives of the underwriters. The factors to be
considered in determining the initial public offering price, in addition to
prevailing market conditions, are the valuation multiples of publicly traded
companies that the representatives believe to be comparable to us, some of our
financial information, the history of, and the prospects for, our company and
the industry in which we compete, and an assessment of our management, its past
and present operations, the prospects for, and timing of, our future revenue and
the present state of our development, and the above factors in relation to
market values and various valuation measures of other companies engaged in
activities similar to ours. There can be no assurance that an active trading
market will develop for our common stock or that our common stock will trade in
the public market subsequent to the offering at or above the initial public
offering price.
The underwriters do not expect sales of our common stock to be made to any
accounts over which they exercise discretionary authority to exceed 5% of the
number of shares being offered hereby.
PRICE STABILIZATION, SHORT POSITIONS AND PENALTY BIDS
Until the distribution of our common stock is completed, rules of the
Securities and Exchange Commission may limit the ability of the underwriters and
some selling group members to bid for and purchase our common stock. As an
exception to these rules, the representatives are permitted to engage in
transactions that stabilize the price of our common stock. Such transactions
consist of bids or purchases for the purpose of pegging, fixing or maintaining
the price of our common stock.
If the underwriters create a short position in our common stock in
connection with the offering, i.e., if they sell more shares of our common stock
than are set forth on the cover page of this prospectus, the representatives may
reduce that short position by purchasing our common stock in the open market.
The representatives may also elect to reduce any short position by exercising
all or part of the over-allotment options described above.
The representatives may also impose a penalty bid on underwriters and
selling group members. This means that if the representatives purchase shares of
our common stock in the open market to reduce the underwriters' short position
or to stabilize the price of our common stock, they may reclaim the amount of
the selling concession from the underwriters and selling group members who sold
those shares.
In general, purchases of a security for the purpose of stabilization or to
reduce a short position could cause the price of the security to be higher than
it might be in the absence of such purchases. The imposition of a penalty bid
might also have an effect on the price of our common stock to the extent that it
discourages resales of our common stock.
Neither our company nor any of the underwriters makes any representation or
prediction as to the direction or magnitude of any effect that the transactions
described above may have on the price of our common stock. In addition, neither
we nor any of the underwriters makes any representation that the representatives
will engage in such transaction or that such transactions, once commenced, will
not be discontinued without notice.
71
<PAGE> 74
LEGAL MATTERS
Fenwick & West LLP, Palo Alto, California, will pass upon the validity of
the issuance of the shares of common stock offered by this prospectus for
Neoforma.com. Shearman & Sterling, Menlo Park, California, will pass upon
specified legal matters in connection with this offering for the underwriters.
An entity affiliated with Fenwick & West LLP holds 35,212 shares of our common
stock.
EXPERTS
The financial statements of Neoforma.com, Inc. from inception (March 6,
1996) to December 31, 1998 and of General Asset Recovery, LLC for the years
ended December 31, 1997 and 1998 included in this prospectus and elsewhere in
the registration statement have been audited by Arthur Andersen LLP, independent
public accountants, as indicated in their reports with respect thereto, and are
included herein in reliance upon the authority of said firm as experts in giving
said reports.
WHERE YOU CAN FIND MORE INFORMATION
We have filed with the Securities and Exchange Commission, a registration
statement on Form S-1 under the Securities Act with respect to the common stock
offered hereby. This prospectus does not contain all of the information set
forth in the registration statement and the exhibits and schedules to the
registration statement. For further information with respect to Neoforma.com and
our common stock, we refer you to the registration statement and the exhibits
and schedules filed as a part of the registration statement. Statements
contained in this prospectus concerning the contents of any contract or any
other document referred to are not necessarily complete; we refer you to the
copy of each contract or document filed as an exhibit to the registration
statement. Each such statement is qualified in all respects by reference to that
exhibit. Upon completion of the offering, we will be subject to the
informational requirements of the Securities Exchange Act of 1934, as amended,
and will file reports, proxy statements and other information with the
Commission. Such reports, proxy statements and other information, as well as the
registration statement, exhibits and schedules, may be inspected, without
charge, or copied, at prescribed rates, at the public reference facility
maintained by the Commission at Room 1024, Judiciary Plaza, 450 Fifth Street,
N.W., Washington, D.C. 20549. The public may obtain information on the operation
of the Public Reference Room by calling the Commission at 1-800-SEC-0330. In
addition, the Commission maintains an Internet site that contains reports, proxy
and information statements, and other information, regarding issuers that file
electronically with the Commission. The address of the Commission's site is
http://www.sec.gov.
72
<PAGE> 75
NEOFORMA.COM, INC.
INDEX TO FINANCIAL STATEMENTS
<TABLE>
<CAPTION>
PAGE
----
<S> <C>
NEOFORMA.COM, INC. FINANCIAL STATEMENTS
Report of Independent Public Accountants.................. F-2
Balance Sheets............................................ F-3
Statements of Operations.................................. F-4
Statements of Changes in Stockholders' Equity (Deficit)... F-5
Statements of Cash Flows.................................. F-6
Notes to Financial Statements............................. F-7
UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION
Overview.................................................. F-24
Unaudited Pro Forma Condensed Combined Statements of
Operations............................................. F-25
Notes to the Unaudited Pro Forma Condensed Combined
Financial Information.................................. F-28
GENERAL ASSET RECOVERY, LLC
Report of Independent Public Accountants.................. F-29
Balance Sheets............................................ F-30
Statements of Operations.................................. F-31
Statements of Members' Equity (Deficit)................... F-32
Statements of Cash Flows.................................. F-33
Notes to Financial Statements............................. F-34
</TABLE>
F-1
<PAGE> 76
REPORT OF INDEPENDENT PUBLIC ACCOUNTANTS
To the Board of Directors
of Neoforma.com, Inc.:
We have audited the accompanying balance sheets of Neoforma.com, Inc. (a
Delaware corporation in the development stage) as of December 31, 1998 and 1997,
and the related statements of operations, changes in stockholders' deficit and
cash flows for the three years in the period ended December 31, 1998 and for the
period from inception (March 6, 1996) to December 31, 1998. These financial
statements are the responsibility of the Company's management. Our
responsibility is to express an opinion on these financial statements based on
our audits.
We conducted our audits in accordance with generally accepted auditing
standards. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material
misstatement. An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements. An audit also includes
assessing the accounting principles used and significant estimates made by
management, as well as evaluating the overall financial statement presentation.
We believe that our audits provide a reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly,
in all material respects, the financial position of Neoforma.com, Inc. as of
December 31, 1998 and 1997, and the results of its operations and its cash flows
for the three years in the period ended December 31, 1998 and for the period
from inception (March 6, 1996) to December 31, 1998 in conformity with generally
accepted accounting principles.
/s/ ARTHUR ANDERSEN LLP
San Jose, California
October 8, 1999
(except with respect to the
matters discussed in Note 13,
as to which the date is
October 14, 1999)
F-2
<PAGE> 77
NEOFORMA.COM, INC.
(A DEVELOPMENT STAGE COMPANY)
BALANCE SHEETS
(IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)
<TABLE>
<CAPTION>
PRO FORMA
STOCKHOLDERS'
DECEMBER 31, EQUITY AT
--------------- JUNE 30, JUNE 30,
1997 1998 1999 1999 (NOTE 7)
----- ------- -------- -------------
(UNAUDITED)
<S> <C> <C> <C> <C>
ASSETS
CURRENT ASSETS:
Cash and cash equivalents................................. $ 32 $ 812 $ 7,063
Prepaid expenses and other current assets................. 5 45 124
Deferred debt costs, current portion...................... -- 11 223
----- ------- --------
Total current assets................................ 37 868 7,410
PROPERTY AND EQUIPMENT, net................................. 12 741 1,777
OTHER ASSETS................................................ 6 63 145
DEFERRED DEBT COSTS, less current portion................... -- -- 427
----- ------- --------
Total assets........................................ $ 55 $ 1,672 $ 9,759
===== ======= ========
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
CURRENT LIABILITIES:
Notes payable, current portion............................ $ -- $ 139 $ 991
Accounts payable.......................................... 22 285 1,311
Accrued payroll........................................... 13 141 149
Other accrued liabilities................................. 25 89 90
----- ------- --------
Total current liabilities........................... 60 654 2,541
----- ------- --------
NOTES PAYABLE, less current portion......................... 385 279 1,624
----- ------- --------
COMMITMENTS (Note 6)
MANDATORILY REDEEMABLE CONVERTIBLE PREFERRED STOCK:
Series C --
Authorized -- 5,110 shares at June 30, 1999
Issued and outstanding: none at December 31, 1997; 5,065
shares at December 31, 1998 and June 30, 1999 (none pro
forma); par value -- $0.001; liquidation
preference -- $3,900................................... -- 3,884 3,884 $ --
----- ------- -------- --------
Series D --
Authorized -- 10,573 shares at June 30, 1999
Issued and outstanding; none at December 31, 1997 and
December 31, 1998; 10,196 shares at June 30, 1999 (none
pro forma); par value $0.001; liquidation
preference -- $12,032.................................. -- -- 11,986 --
----- ------- -------- --------
Warrants to purchase Series C............................. -- 10 10 --
----- ------- -------- --------
Warrants to purchase Series D............................. -- -- 669 --
----- ------- -------- --------
STOCKHOLDERS' EQUITY (DEFICIT):
Series A --
convertible preferred stock; Authorized -- 9,000
shares at June 30, 1999
Issued and outstanding -- none at December 31, 1997;
9,000 shares at December 31, 1998 and June 30, 1999
(none pro forma); par value -- $0.001; liquidation
preference -- $2,250................................. -- 9 9 --
Series B --
convertible preferred stock; Authorized -- 2,860
shares at June 30, 1999
Issued and outstanding -- none at December 31, 1997;
2,860 shares at December 31, 1998 and June 30, 1999
(none pro forma); par value -- $0.001; liquidation
preference -- $1,430................................. -- 3 3 --
Common stock, $0.001 par value:
Authorized -- 75,000 shares at June 30, 1999
Issued and outstanding -- 8,200 shares at December 31,
1997; 1,216 shares at December 31, 1998 and 1,381
shares at June 30, 1999 and 28,502 shares pro
forma................................................ 8 1 1 29
Warrants to purchase common stock......................... -- 7 17 --
Additional paid-in capital................................ 72 1,915 7,043 23,593
Notes receivable from stockholders........................ -- (10) (17) (17)
Deferred compensation..................................... -- (47) (4,851) (4,851)
Deficit accumulated during the development stage.......... (470) (5,033) (13,160) (13,160)
----- ------- -------- --------
Total stockholders' equity (deficit)................ (390) (3,155) (10,955) $ 5,594
----- ------- -------- ========
Total liabilities and stockholders' equity (deficit) $ 55 $ 1,672 $ 9,759
===== ======= ========
</TABLE>
The accompanying notes are an integral part of these balance sheets.
F-3
<PAGE> 78
NEOFORMA.COM, INC.
(A DEVELOPMENT STAGE COMPANY)
STATEMENTS OF OPERATIONS
(IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)
<TABLE>
<CAPTION>
FROM INCEPTION
SIX MONTHS ENDED (MARCH 6, 1996) THROUGH
YEARS ENDED DECEMBER 31, JUNE 30, --------------------------
------------------------- ----------------- DECEMBER 31, JUNE 30,
1996 1997 1998 1998 1999 1998 1999
------ ------ ------- ------- ------- ------------ -----------
(UNAUDITED) (UNAUDITED)
<S> <C> <C> <C> <C> <C> <C> <C>
REVENUE:
Transaction fees................ $ -- $ -- $ -- $ -- $ -- $ -- $ --
Website sponsorship fees and
other........................ -- -- -- -- 7 -- 7
------ ------ ------- ------- ------- ------- --------
Total revenue.............. -- -- -- -- 7 -- 7
OPERATING EXPENSES:
Operations...................... -- -- 627 190 1,319 627 1,946
Product development............. 31 179 1,491 327 2,568 1,701 4,269
Selling and marketing........... 111 153 1,409 321 2,382 1,673 4,055
General and administrative...... 54 76 1,075 227 1,591 1,205 2,796
Amortization of deferred
compensation................. -- -- 5 -- 307 5 312
------ ------ ------- ------- ------- ------- --------
Total operating expenses... 196 408 4,607 1,065 8,167 5,211 13,378
------ ------ ------- ------- ------- ------- --------
Loss from operations....... (196) (408) (4,607) (1,065) (8,160) (5,211) (13,371)
OTHER INCOME (EXPENSE):
Interest income................. -- -- 66 13 128 66 194
Interest expense................ -- (15) (22) (9) (95) (37) (132)
Other........................... 142 7 -- -- -- 149 149
------ ------ ------- ------- ------- ------- --------
Net loss................... $ (54) $ (416) $(4,563) $(1,061) $(8,127) $(5,033) $(13,160)
====== ====== ======= ======= ======= ======= ========
NET LOSS PER SHARE:
Basic and diluted............... $(0.01) $(0.05) $ (1.65) $ (0.21) $ (7.95)
====== ====== ======= ======= =======
Weighted-average shares -- basic
and diluted.................. 8,000 8,083 2,762 5,077 1,022
====== ====== ======= ======= =======
PRO FORMA NET LOSS PER SHARE
(unaudited):
Basic and diluted............... $ (0.36) $ (0.32)
======= =======
Weighted-average shares -- basic
and diluted.................. 12,848 25,696
======= =======
</TABLE>
The accompanying notes are an integral part of these financial statements.
F-4
<PAGE> 79
NEOFORMA.COM, INC.
(A DEVELOPMENT STAGE COMPANY)
STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT)
FOR THE PERIOD FROM INCEPTION (MARCH 6, 1996) THROUGH JUNE 30, 1999
(IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)
<TABLE>
<CAPTION>
PREFERRED STOCK
---------------------------------
SERIES A SERIES B COMMON STOCK ADDITIONAL NOTES RECEIVABLE
--------------- --------------- -------------------------- PAID-IN FROM
SHARES AMOUNT SHARES AMOUNT SHARES AMOUNT WARRANTS CAPITAL STOCKHOLDERS
------ ------ ------ ------ ------ ------ -------- ---------- -----------------
<S> <C> <C> <C> <C> <C> <C> <C> <C> <C>
BALANCE, March 6, 1996
(inception)...................... -- $-- -- $-- -- $-- $ -- $ -- $ --
Common stock issued for cash of
$20 and intellectual property
valued at $10 at $0.00375 per
share in March 1996............ -- -- -- -- 8,000 8 -- 22 --
Net loss......................... -- -- -- -- -- -- -- -- --
----- --- ----- --- ------ --- ---- ------- ----
BALANCE, DECEMBER 31, 1996........ -- -- -- -- 8,000 8 -- 22 --
----- --- ----- --- ------ --- ---- ------- ----
Common stock issued for cash at
$0.25 per share in May 1997.... -- -- -- -- 100 -- -- 25 --
Common stock issued for cash at
$0.25 per share in October
1997........................... -- -- -- -- 100 -- -- 25 --
Net loss......................... -- -- -- -- -- -- -- -- --
----- --- ----- --- ------ --- ---- ------- ----
BALANCE, DECEMBER 31, 1997........ -- -- -- -- 8,200 8 -- 72 --
----- --- ----- --- ------ --- ---- ------- ----
Common stock issued for cash at
$0.25 per share in February
1998........................... -- -- -- -- 800 1 -- 199 --
Common stock issued in exchange
for consulting services valued
at $0.25 per share in March
1998........................... -- -- -- -- 500 -- -- 125 --
Conversion of founders stock to
preferred stock at $0.00375 per
share in April 1998............ 8,000 8 -- -- (8,000) (8) -- -- --
Conversion of common stock to
preferred stock at $0.25 per
share in April 1998............ 1,000 1 -- -- (1,000) (1) -- -- --
Preferred stock issued for cash
at $0.50 per share in April and
May 1998, net of issuance
costs.......................... -- -- 2,520 3 -- -- -- 1,252 --
Conversion of notes payable to
Series B preferred stock at
$0.50 per share in May 1998.... -- -- 340 -- -- -- -- 170 --
Common stock issued for cash as a
result of options exercised at
$0.05 per share in May 1998.... -- -- -- -- 516 1 -- 25 --
Common stock issued for cash as a
result of options exercised at
$0.10 per share in November
1998........................... -- -- -- -- 200 -- -- 20 (10)
Issuance of warrants to purchase
common stock in November
1998........................... -- -- -- -- -- -- 7 -- --
Deferred compensation............ -- -- -- -- -- -- -- 52 --
Amortization of deferred
compensation................... -- -- -- -- -- -- -- -- --
Net loss......................... -- -- -- -- -- -- -- -- --
----- --- ----- --- ------ --- ---- ------- ----
BALANCE, DECEMBER 31, 1998........ 9,000 9 2,860 3 1,216 1 7 1,915 (10)
----- --- ----- --- ------ --- ---- ------- ----
UNAUDITED:
Repayment of note receivable from
shareholder.................... -- -- -- -- -- -- -- -- 10
Common stock issued as a result
of options exercised at $0.10
per share, February 1999....... -- -- -- -- 39 -- -- 4 (4)
Issuance of warrants to purchase
common stock in February
1999........................... -- -- -- -- -- -- 10 -- --
Common stock issued as a result
of options exercised at $0.10
per share, April 1999.......... -- -- -- -- 30 -- -- 3 (3)
Common stock issued as a result
of options exercised at $0.10
per share, June 1999........... -- -- -- -- 96 -- -- 10 (10)
Deferred compensation............ -- -- -- -- -- -- -- 5,111 --
Amortization of deferred
compensation................... -- -- -- -- -- -- -- -- --
Net loss......................... -- -- -- -- -- -- -- -- --
----- --- ----- --- ------ --- ---- ------- ----
BALANCE, JUNE 30, 1999
(unaudited)...................... 9,000 $ 9 2,860 $ 3 1,381 $ 1 $ 17 $ 7,043 $(17)
===== === ===== === ====== === ==== ======= ====
<CAPTION>
DEFICIT ACCUMULATED TOTAL
DEFERRED DURING THE STOCKHOLDERS'
COMPENSATION DEVELOPMENT STAGE DEFICIT
------------ -------------------- --------------
<S> <C> <C> <C>
BALANCE, March 6, 1996
(inception)...................... $ -- $ -- $ --
Common stock issued for cash of
$20 and intellectual property
valued at $10 at $0.00375 per
share in March 1996............ -- -- 30
Net loss......................... -- (54) (54)
-------- -------- --------
BALANCE, DECEMBER 31, 1996........ -- (54) (24)
-------- -------- --------
Common stock issued for cash at
$0.25 per share in May 1997.... -- -- 25
Common stock issued for cash at
$0.25 per share in October
1997........................... -- -- 25
Net loss......................... -- (416) (416)
-------- -------- --------
BALANCE, DECEMBER 31, 1997........ -- (470) (390)
-------- -------- --------
Common stock issued for cash at
$0.25 per share in February
1998........................... -- -- 200
Common stock issued in exchange
for consulting services valued
at $0.25 per share in March
1998........................... -- -- 125
Conversion of founders stock to
preferred stock at $0.00375 per
share in April 1998............ -- -- --
Conversion of common stock to
preferred stock at $0.25 per
share in April 1998............ -- -- --
Preferred stock issued for cash
at $0.50 per share in April and
May 1998, net of issuance
costs.......................... -- -- 1,255
Conversion of notes payable to
Series B preferred stock at
$0.50 per share in May 1998.... -- -- 170
Common stock issued for cash as a
result of options exercised at
$0.05 per share in May 1998.... -- -- 26
Common stock issued for cash as a
result of options exercised at
$0.10 per share in November
1998........................... -- -- 10
Issuance of warrants to purchase
common stock in November
1998........................... -- -- 7
Deferred compensation............ (52) -- --
Amortization of deferred
compensation................... 5 -- 5
Net loss......................... -- (4,563) (4,563)
-------- -------- --------
BALANCE, DECEMBER 31, 1998........ (47) (5,033) (3,155)
-------- -------- --------
UNAUDITED:
Repayment of note receivable from
shareholder.................... -- -- 10
Common stock issued as a result
of options exercised at $0.10
per share, February 1999....... -- -- --
Issuance of warrants to purchase
common stock in February
1999........................... -- -- 10
Common stock issued as a result
of options exercised at $0.10
per share, April 1999.......... -- -- --
Common stock issued as a result
of options exercised at $0.10
per share, June 1999........... -- -- --
Deferred compensation............ (5,111) -- --
Amortization of deferred
compensation................... 307 -- 307
Net loss......................... -- (8,127) (8,127)
-------- -------- --------
BALANCE, JUNE 30, 1999
(unaudited)...................... $ (4,851) $(13,160) $(10,955)
======== ======== ========
</TABLE>
The accompanying notes are an integral part of these financial statements.
F-5
<PAGE> 80
NEOFORMA.COM, INC.
(A DEVELOPMENT STAGE COMPANY)
STATEMENTS OF CASH FLOWS
(IN THOUSANDS)
<TABLE>
<CAPTION>
SIX MONTHS FROM INCEPTION
ENDED (MARCH 6, 1996) THROUGH
YEARS ENDED DECEMBER 31, JUNE 30, --------------------------
------------------------ ----------------- DECEMBER 31, JUNE 30,
1996 1997 1998 1998 1999 1998 1999
---- ----- ------- ------- ------- ------------ -----------
(UNAUDITED) (UNAUDITED)
<S> <C> <C> <C> <C> <C> <C> <C>
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss............................................ $(54) $(416) $(4,563) $(1,061) $(8,127) $(5,033) $(13,160)
Adjustments to reconcile net loss to net cash used
in operating activities:
Common stock issued in connection with consulting
services.......................................... -- -- 125 125 -- 125 125
Amortization of deferred compensation -- -- 5 -- 307 5 312
Amortization of deferred debt costs................. -- -- 6 -- 41 6 47
Depreciation and amortization....................... 1 1 96 10 235 98 332
Changes in assets and liabilities:
Prepaid expenses and other assets................. (44) 43 (97) (5) (164) (98) (249)
Accounts payable.................................. 10 12 263 143 1,026 285 1,311
Accrued liabilities and accrued payroll........... -- 38 192 6 10 230 231
---- ----- ------- ------- ------- ------- --------
Net cash used in operating activities......... (87) (322) (3,973) (782) (6,672) (4,382) (11,051)
---- ----- ------- ------- ------- ------- --------
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment................. (1) (13) (825) (300) (1,270) (839) (2,109)
---- ----- ------- ------- ------- ------- --------
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from the issuance of notes payable......... 75 358 418 -- 2,197 851 3,047
Repayments of notes payable......................... -- (48) (215) (215) -- (263) (263)
Proceeds from the issuance of Series B preferred
stock, net of issuance costs...................... -- -- 1,255 1,255 -- 1,255 1,255
Proceeds from the issuance of Series C mandatorily
redeemable convertible preferred stock, net of
issuance costs.................................... -- -- 3,884 3,884 -- 3,884 3,884
Proceeds from the issuance of Series D mandatorily
redeemable convertible preferred stock, net of
issuance costs.................................... -- -- -- -- 11,986 -- 11,986
Proceeds from the issuance of common stock.......... 20 50 236 226 10 306 316
---- ----- ------- ------- ------- ------- --------
Net cash provided by financing activities..... 95 360 5,578 5,150 14,193 6,033 20,225
---- ----- ------- ------- ------- ------- --------
Net increase in cash and cash equivalents..... 7 25 780 4,068 6,251 812 7,063
CASH AND CASH EQUIVALENTS, beginning of period........ -- 7 32 32 812 -- --
---- ----- ------- ------- ------- ------- --------
CASH AND CASH EQUIVALENTS, end of period.............. $ 7 $ 32 $ 812 $ 4,100 $ 7,063 $ 812 $ 7,063
==== ===== ======= ======= ======= ======= ========
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Intellectual property acquired from founders in
exchange for common stock......................... $ 10 $ -- $ -- $ -- $ -- $ 10 $ 10
==== ===== ======= ======= ======= ======= ========
Cash paid during the period for interest............ $ -- $ -- $ 14 $ 9 $ 49 $ 14 $ 63
==== ===== ======= ======= ======= ======= ========
SUPPLEMENTAL SCHEDULE OF NONCASH FINANCING ACTIVITIES:
Conversion of common stock into Series A preferred
stock............................................. $ -- $ -- $ 280 $ 280 $ -- $ 280 $ 280
==== ===== ======= ======= ======= ======= ========
Conversion of notes payable into Series B preferred
stock............................................. $ -- $ -- $ 170 $ 170 $ -- $ 170 $ 170
==== ===== ======= ======= ======= ======= ========
Issuance of warrants to purchase common stock....... $ -- $ -- $ 7 $ -- $ 10 $ 7 $ 17
==== ===== ======= ======= ======= ======= ========
Issuance of warrants to purchase Series C
mandatorily redeemable convertible preferred
stock............................................. $ -- $ -- $ 10 $ -- $ -- $ 10 $ 10
==== ===== ======= ======= ======= ======= ========
Issuance of warrants to purchase Series D
mandatorily redeemable convertible preferred
stock............................................. $ -- $ -- $ -- $ -- $ 1,046 $ -- $ 1,046
==== ===== ======= ======= ======= ======= ========
</TABLE>
The accompanying notes are an integral part of these financial statements.
F-6
<PAGE> 81
NEOFORMA.COM, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO FINANCIAL STATEMENTS
1. ORGANIZATION AND DEVELOPMENT STAGE RISKS:
Neoforma, Inc. (the "Company"), was incorporated on March 4, 1996 in the
state of California for the purpose of providing business-to-business e-commerce
services for the medical products, supplies and equipment marketplace. On
November 4, 1998, the Company re-incorporated in the state of Delaware. On
September 14, 1999, the Company changed its name to Neoforma.com, Inc. All
information for the year ended December 31, 1996 represents the period from
inception (March 6, 1996) to December 31, 1996.
From inception, the Company has been primarily engaged in organizational
activities, including designing and developing its website, recruiting
personnel, establishing office facilities, raising capital and developing a
marketing plan. The Company began revenue generation activities in 1999 but no
significant revenue has been generated as of June 30, 1999. Accordingly, the
Company is classified as a development stage company. Successful completion of
the Company's development program and, ultimately, the attainment of profitable
operations is dependent upon future events, including obtaining adequate
financing to fulfill its development activities, increasing its customer base,
implementing and successfully executing its business and marketing strategy and
hiring and retaining quality personnel. Negative developments in any of these
conditions could have a material adverse effect on the Company's business,
financial condition and results of operations.
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:
UNAUDITED INTERIM FINANCIAL DATA
The interim financial statements for the six months ended June 30, 1998 and
1999, and the period from inception (March 6, 1996) to June 30, 1999, are
unaudited and have been prepared on the same basis as the audited financial
statements. In the opinion of management, such unaudited financial information
includes all adjustments (consisting only of normal recurring adjustments)
necessary to present fairly the financial information set forth therein, in
accordance with generally accepted accounting principles. Operating results for
the six months ended June 30, 1999 are not necessarily indicative of the results
that may be expected for the year ending December 31, 1999.
USE OF ESTIMATES
The preparation of financial statements in conformity with generally
accepted accounting principles requires management to make estimates and
assumptions that affect the reported amounts of assets and liabilities and
disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenue and expense during the reporting
period. Actual results could differ from those estimates.
REVENUE RECOGNITION
The Company expects to derive revenue from several sources. These include:
(i) transaction fees paid by sellers of medical products on the Company's
website, (ii) development fees from participating sellers to digitize the
seller's product information for display on the Company's website, (iii) service
fees for maintenance of product information and content on the site, (iv) fees
for
F-7
<PAGE> 82
NEOFORMA.COM, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
sponsorship of certain content and (v) subscription fees for asset management
and facilities planning services.
Transaction fees are recognized at the time the buyer's order is confirmed
by the seller. Development fees are recognized as development services are
performed. Sponsorship, subscription and maintenance fees are recognized ratably
over the period of the service agreement.
CONCENTRATION OF CREDIT RISK
Financial instruments that may subject the Company to concentrations of
credit risk consist primarily of cash and cash equivalents. Cash is on deposit
with one financial institution. Cash investments include high quality short-term
money market instruments through a high credit quality financial institution.
CASH AND CASH EQUIVALENTS
For purposes of the statement of cash flows, the Company considers all
highly liquid debt instruments purchased with a maturity of three months or less
to be cash equivalents.
Cash and cash equivalents consist of cash in banks, investments in money
market accounts and treasury bills and are stated at cost which approximates
fair market value.
PROPERTY AND EQUIPMENT
Property and equipment are stated at cost, and are depreciated on a
straight-line basis over two to four years. Leasehold improvements are
amortized, using the straight-line method, over the shorter of the lease term or
the useful lives of the improvements. Repairs and maintenance costs are expensed
as incurred.
IMPAIRMENT OF LONG-LIVED ASSETS
The Company evaluates the recoverability of long-lived assets in accordance
with Statement of Financial Accounting Standards ("SFAS") No. 121, "Accounting
for the Impairment of Long-Lived Assets and for Long-Lived Assets to be Disposed
of." SFAS No. 121 requires recognition of impairment of long-lived assets in the
event the net book value of such assets exceeds the future undiscounted cash
flows attributable to such assets.
PRODUCT DEVELOPMENT COSTS
Product development costs include expenses incurred by the Company to
develop and enhance the Company's website. Product development costs are
expensed as incurred.
STOCK BASED COMPENSATION PLAN
In October 1995, the Financial Accounting Standards Board ("FASB") issued
SFAS No. 123, "Accounting for Stock-Based Compensation," which became effective
for the Company's 1996 fiscal year. SFAS No. 123 allows companies which have
stock-based compensation arrangements with
F-8
<PAGE> 83
NEOFORMA.COM, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
employees to adopt a new fair-value basis of accounting for stock options and
other equity instruments or to continue to apply the existing accounting rules
under Accounting Principles Board ("APB") Opinion No. 25, "Accounting for Stock
Issued to Employees," but with additional financial statement disclosure (see
Note 10). The Company has elected to account for stock-based compensation
expense under APB No. 25 and make the required pro forma disclosures for
compensation expense (see Note 10).
COMPREHENSIVE INCOME
Effective January 1, 1998 the Company adopted the provisions of SFAS No.
130, "Reporting Comprehensive Income." SFAS No. 130 establishes standards for
reporting comprehensive income and its components in financial statements.
Comprehensive income, as defined, includes all changes in equity (net assets)
during a period from non-owner sources. Through June 30, 1999 the Company has
not had any transactions that are required to be reported in comprehensive
income.
SEGMENT INFORMATION
Effective January 1, 1998, the Company adopted the provisions of SFAS No.
131, "Disclosures about Segments of an Enterprise and Related Information." The
Company identifies its operating segments based on business activities,
management responsibility and geographical location. During the years ended
December 31, 1996, 1997 and 1998, the Company operated in a single business
segment providing content to healthcare professionals in the medical products,
supplies and equipment industry, primarily in the United States. Through June
30, 1999, foreign operations have not been significant in either revenue or
investment in long-lived assets.
BASIC AND DILUTED NET LOSS PER SHARE AND PRO FORMA BASIC AND DILUTED NET LOSS
PER SHARE
Basic net loss per share on a historical basis is computed using the
weighted-average number of shares of common stock outstanding. Diluted net loss
per common share was the same as basic net loss per share for all periods
presented since the effect of any potentially dilutive security is excluded as
they are anti-dilutive because of the Company's net losses. The total number of
shares excluded from the diluted loss per share calculation relating to these
securities was approximately none, 225,000, 12.0 million, 4.8 million and 28.2
million shares for the years ended December 31, 1996, 1997 and 1998 and for the
six months ended June 30, 1998 and 1999, respectively.
Pursuant to the Securities and Exchange Commission Staff Accounting
Bulletin No. 98, convertible preferred stock and common stock issued or granted
for nominal consideration prior to the anticipated effective date of the initial
public offering must be included in the calculation of basic and diluted net
loss per common share as if they had been outstanding for all periods presented.
To date, the Company has not had any issuance or grants for nominal
consideration.
Pro forma basic and diluted net loss per common share is computed by
dividing net loss by the weighted-average number of common shares outstanding
for the period (excluding shares subject to repurchase) plus the
weighted-average number of common shares resulting from the automatic conversion
of outstanding shares of convertible preferred stock, which will occur upon the
closing of the planned initial public offering.
F-9
<PAGE> 84
NEOFORMA.COM, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
The following table presents the calculation of basic and diluted and pro
forma basic and diluted net loss per share (in thousands, except per share
amounts):
<TABLE>
<CAPTION>
SIX MONTHS ENDED
YEAR ENDED DECEMBER 31, JUNE 30,
------------------------------ -------------------
1996 1997 1998 1998 1999
-------- -------- -------- -------- --------
(UNAUDITED)
<S> <C> <C> <C> <C> <C>
Net loss.................................... $ (54) $ (416) $ (4,563) $ (1,061) $ (8,127)
======== ======== ======== ======== ========
Basic and diluted:
Weighted-average shares of common stock
outstanding.......................... 8,000 8,083 2,977 5,179 1,259
Less: Weighted-average shares of common
stock subject to repurchase.......... -- -- (215) (102) (237)
-------- -------- -------- -------- --------
Weighted-average shares used in
computing basic and diluted net loss
per share............................ 8,000 8,083 2,762 5,077 1,022
======== ======== ======== ======== ========
Basic and diluted net loss per common
share................................ $ (0.01) $ (0.05) $ (1.65) $ (0.21) $ (7.95)
======== ======== ======== ======== ========
Pro forma:
Net loss............................... $ (4,563) $ (8,127)
======== ========
Shares used above...................... 2,762 1,022
Pro forma adjustment to reflect
weighted-average effect of assumed
conversion of convertible preferred
stock (unaudited).................... 10,086 24,674
-------- --------
Weighted-average shares used in
computing pro forma basic and diluted
net loss per share (unaudited)....... 12,848 25,696
======== ========
Pro forma basic and diluted net loss
per share (unaudited)................ $ (0.36) $ (0.32)
======== ========
</TABLE>
RECENT ACCOUNTING PRONOUNCEMENTS
In March 1998, the American Institute of Certified Public Accountants
("AICPA") issued Statement of Position ("SOP") No. 98-1, "Accounting for the
Cost of Computer Software Developed or Obtained for Internal use." SOP No. 98-1
requires entities to capitalize certain costs related to internal-use software
once certain criteria has been met. Neoforma.com adopted SOP No. 98-1 in fiscal
1999. The adoption of SOP No. 98-1 did not have a material impact on the
Company's financial position or results of operations.
In April 1998, the AICPA issued SOP No. 98-5, "Reporting on the Costs of
Start-Up Activities." SOP No. 98-5 requires that all start-up costs related to
new operations must be expensed as incurred. In addition, all start-up costs
that were previously capitalized must be written off when SOP No. 98-5 is
adopted. Neoforma.com adopted SOP No. 98-5 in fiscal 1999. The adoption of SOP
No. 98-5 did not have a material impact on the Company's financial position or
results of operations.
F-10
<PAGE> 85
NEOFORMA.COM, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
In June 1998, the FASB issued SFAS No. 133, "Accounting for Derivative
Instruments and Hedging Activities." SFAS No. 133 will be effective for
Neoforma.com on January 1, 2000. SFAS No. 133 requires certain accounting and
reporting standards for derivative financial instruments and hedging activities.
Because the Company does not currently hold any derivative instruments and does
not engage in hedging activities, management does not believe that the adoption
of SFAS No. 133 will have a material impact on the Company's financial position
or results of operations.
3. ACQUISITION:
In August 1999, the Company acquired General Asset Recovery, LLC ("GAR"), a
live auction house and asset management company focused on medical products. The
acquisition will be accounted for using the purchase method of accounting and
accordingly, the purchase price will be allocated to the tangible and intangible
assets acquired and liabilities assumed on the basis of their respective fair
values on the acquisition date.
The total purchase price of approximately $9.7 million consisted of $1.7
million in cash, a note payable of $7.8 million, the assumption of $100,000 of
liabilities and acquisition-related expenses of approximately $100,000. In the
initial allocation of the purchase price, $25,000 was allocated to tangible
assets and $9,675,000 was allocated to intangible assets. The intangible assets
will be amortized over an estimated life of seven years. The note payable is due
over a five-year period and bears interest at 7% per annum.
4. PROPERTY AND EQUIPMENT:
As of December 31, 1997 and 1998, property and equipment consisted of the
following (in thousands):
<TABLE>
<CAPTION>
1997 1998
---- ----
<S> <C> <C>
Computers and test equipment............................. $ 10 $580
Software................................................. 4 78
Furniture and fixtures................................... -- 140
Leasehold improvements................................... -- 41
---- ----
14 839
Less: Accumulated depreciation and amortization.......... (2) (98)
---- ----
Property and equipment, net.............................. $ 12 $741
==== ====
</TABLE>
5. LOANS AND NOTES PAYABLE:
In 1996 and 1997, certain stockholders exchanged cash for notes payable.
The interest rate for the notes was 5.6%. These notes were convertible into
Series B preferred stock. As of December 31, 1998, $170,000 of the $385,000
notes payable were converted and the remainder was paid in full.
In June 1998, the Company entered into a $750,000 secured credit facility
with a bank. This facility included a $225,000 term loan due December 1999 and
an equipment loan facility providing for up to $525,000 of equipment loans. At
June 30, 1999, there were borrowings of approximately $225,000 and $433,000
under the term loan and equipment loan, respectively. In July 1999, the
F-11
<PAGE> 86
NEOFORMA.COM, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
Company converted $433,000 of outstanding equipment loans into a term loan due
June 2000 which bears interest at the lender's prime rate (8.25% as of September
30, 1999). This facility is secured by substantially all of the Company's assets
other than equipment. In consideration for this credit facility, the Company
granted the bank a warrant to purchase 45,000 shares of Series C preferred stock
at an exercise price of $0.77 per share. In July 1999, in consideration for the
conversion of the equipment loan to a term loan and the release of the security
interest in equipment, the Company granted the bank a warrant to purchase 10,000
shares of Series D preferred stock at an exercise price of $1.18 per share (Note
9).
In May 1999, the Company entered into a subordinated loan agreement (loan
agreement) with a lender under which it can borrow up to $2.0 million. The loan
agreement bears interest at 12.5% and expires in July 2002. At June 30, 1999
there were borrowings of approximately $2.0 million outstanding under the loan
agreement. The loan agreement is collateralized by all of the assets of the
Company. In addition, a warrant to purchase 228,813 shares of preferred Series D
stock at an exercise price of $1.18 per share was issued in conjunction with the
loan agreement (Note 9).
In July 1999, the Company entered into a $2.5 million loan/lease facility
with a lender to finance computer hardware and software equipment. Hardware
amounts bear interest at 9% per annum and are payable in 48 monthly installments
consisting of interest-only payments for the first nine months and principal and
interest payments for the remaining 39 months, with a balloon payment of the
remaining principal payable at maturity. Software amounts bear interest at 8%
per annum and are payable in 30 monthly installments consisting of interest-only
for the first four months and principal and interest-for the remaining 26
months, with a balloon payment of the remaining principal payable at maturity.
This facility is secured by the computer equipment purchased. In connection with
this facility, the Company issued the lender a warrant to purchase 137,711
shares of our Series D preferred stock at $1.18 per share (Note 9).
Future maturities of principal on the loans and notes payable as of
December 31, 1998 are as follows (in thousands):
<TABLE>
<S> <C>
1999..................................... $139
2000..................................... 139
2001..................................... 140
----
$418
====
</TABLE>
6. COMMITMENTS
The Company leases its office facilities under an operating lease. Rent
expense for the years ended December 31, 1996, 1997 and 1998 was approximately
$22,000, $40,000, and $304,000, respectively.
F-12
<PAGE> 87
NEOFORMA.COM, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
Future minimum obligations under the non-cancelable operating lease at
December 31, 1998 are as follows (in thousands):
<TABLE>
<S> <C>
1999.................................... $ 331
2000.................................... 344
2001.................................... 357
2002.................................... 370
2003.................................... 252
------
$1,654
======
</TABLE>
In May 1999, the Company entered into an agreement with a non-profit health
services research organization (the "organization"), which allows the Company to
use content from the organization's database of information about medical
products and manufacturers and obtain a license to use elements of its
classification system. Additionally, the agreement provides for joint marketing
activities and collaboration in the creation of a database of product and vendor
information. This agreement requires the Company to make revenue sharing
payments to the organization during the three-year term of the agreement and for
two years following expiration or termination of the agreement with respect to
revenue derived from the Company's Plan service. During the second and third
years, the Company is required to pay a nonrefundable fee of $600,000 per year,
in equal monthly installments, which shall be credited against any revenue
sharing profits payable.
7. STOCKHOLDERS' EQUITY
UNAUDITED PRO FORMA STOCKHOLDERS' EQUITY
In October 1999, the Company's board of directors authorized the filing of
a registration statement with the Securities and Exchange Commission to register
shares of its common stock in connection with the proposed initial public
offering ("IPO"). If the IPO is consummated under the terms presently
anticipated, all of the currently outstanding shares of preferred stock and the
mandatorily redeemable convertible preferred stock will be converted into shares
of common stock upon the closing of the IPO. The effect of this conversion has
been reflected as unaudited pro forma stockholders' equity in the accompanying
balance sheet as of June 30, 1999.
COMMON STOCK
As of December 31, 1998, the Company has reserved the following shares of
common stock for future issuance as follows (in thousands):
<TABLE>
<S> <C>
Conversion of Series A outstanding preferred stock.......... 9,000
Conversion of Series B outstanding preferred stock.......... 2,860
Conversion of Series C outstanding redeemable preferred
stock..................................................... 5,065
1997 Stock Option Plan...................................... 1,284
Conversion of warrants/consultant's options outstanding..... 62
------
18,271
======
</TABLE>
During the year ended December 31, 1998, the Company amended an agreement
to issue approximately 26,000 shares of common stock in exchange for services
rendered. As of December 31,
F-13
<PAGE> 88
NEOFORMA.COM, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
1998 approximately 17,000 of the shares were due but had not been issued. In
February 1999, approximately 13,000 of the shares were issued. Approximately
9,000 additional shares of common stock were due under the terms of the same
agreement for the period ended June 30, 1999. As of June 30, 1999, such shares
had not been issued; however, the related expense associated with the issued
shares is included in the accompanying statements of operations.
PREFERRED STOCK
Preferred stock consists of 9,000,000 shares designated as Series A
preferred stock ("Series A") and 2,860,000 shares designated as Series B
preferred stock ("Series B"). The Series A preferred stock was issued in
exchange for 9,000,000 shares of previously issued common stock. The Series B
preferred stock was issued for cash at $0.50 per share.
The rights and preferences of the outstanding Series A and Series B are as
follows:
DIVIDENDS
The holders of Series A and Series B are entitled to receive non-cumulative
dividends at $0.02 and $0.04 per share, respectively, or, if greater, an amount
equal to that paid on any other outstanding shares of the Company, except that
the shares of a given series of preferred stock shall not receive any greater
dividend as a result of the Company's payment of a dividend on any such series
of preferred stock. Such dividends shall be payable only when, as, and if
declared by the board of directors. No dividends shall be payable on any common
stock until dividends to Series A and Series B have been paid or declared by the
board of directors. As of June 30, 1999, no dividends had been declared.
LIQUIDATION PREFERENCE
In the event of any liquidation, dissolution or winding up of the Company,
holders of Series A and Series B are entitled to receive (along with the
liquidation preference available to Series C and Series D stockholders -- see
Note 8), in preference to holders of common stock, the amount of $0.25 and $0.50
per share, respectively, plus all declared but unpaid dividends. Such amounts
will be adjusted for any stock splits, stock dividends and recapitalizations. If
such assets of the Company are not available to sufficiently satisfy the full
preferential amount of all series of preferred stock then the entire assets and
funds of the Company shall be distributed among the holders of all series of the
preferred stock in accordance with the aggregate preference payment to which
they are entitled. After the payment or the setting aside of the payment set
forth above, the remaining assets of the corporation shall be distributed on a
pro-rata basis to the holders of the preferred stock, on an as-converted basis,
and the holders of common stock until the holders of the Series A, B, C and D
have received an additional $0.25, $0.50, $0.77 and $1.18 per share,
respectively. After the distributions to the holders of preferred stock and
redeemable preferred stock have been made, the remaining assets of the
corporation available for distribution to shareholders shall be distributed pro
rata among the holders of common stock.
F-14
<PAGE> 89
NEOFORMA.COM, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
VOTING RIGHTS
The holders of the Series A and Series B are entitled to a number of votes
equal to the number of shares of common stock into which such preferred stock is
convertible.
CONVERSION
Each share of Series A and Series B is convertible into one share of common
stock at the option of the holder at any time after the date of issuance of such
shares, and automatically converts at the consummation of the Company's sale of
common stock in an underwritten public offering which results in net cash
proceeds to the Company of at least $60,000,000 and an offering price to the
public of at least $7.00 per share. The conversion rate is subject to adjustment
for dilution, including, but not limited to, stock splits, stock dividends and
stock combinations.
8. MANDATORILY REDEEMABLE PREFERRED STOCK:
In August 1998, the Company completed an offering of 5,064,937 shares of
Series C mandatorily redeemable preferred stock ("Series C") at $0.77 per share.
Total proceeds of the offering amounted to approximately $3.9 million.
In February 1999, the Company completed an offering of 10,196,361 shares of
Series D mandatorily redeemable preferred stock ("Series D") at $1.18 per share.
Total proceeds of the offering amounted to approximately $12.0 million.
The rights and preferences of the outstanding Series C and Series D are as
follows:
DIVIDENDS
The holders of Series C and Series D are entitled to receive non-cumulative
dividends at $0.062 and $0.0944 per share, respectively, or, if greater, an
amount equal to that paid on any other outstanding shares of the Company, except
that the shares of a given series of preferred stock shall not receive any
greater dividend as a result of the Company's payment of a dividend on any such
series of preferred stock. Such dividends shall be payable only when, as, and if
declared by the board of directors. As of June 30, 1999, no dividends had been
declared.
LIQUIDATION PREFERENCE
In the event of any liquidation, dissolution or winding up of the Company,
holders of Series C and Series D are entitled to receive (along with the
liquidation preference available and Series A and Series B stockholders -- See
Note 7) in preference to holders of common stock, the amount of $0.77 and $1.18
per share, respectively, plus all declared but unpaid dividends. Such amounts
will be adjusted for any stock splits, stock dividends and recapitalizations. If
such assets of the Company are not available to sufficiently satisfy the full
preferential amount of all series of preferred stock, then the entire assets and
funds of the Company shall be distributed among the holders of all series of
preferred stock in accordance with the aggregate preference payment to which
they are entitled. After the payment or the setting aside of the payment set
forth above, the remaining assets of the corporation shall be distributed on a
pro-rata basis to the holders of the preferred stock, on an
F-15
<PAGE> 90
NEOFORMA.COM, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
as-converted basis, and the holders of common stock until the holders of the
Series A and B and Series C and Series D have received an additional $0.25,
$0.50, $0.77 and $1.18 per share, respectively. After the distributions to the
holders of preferred stock and redeemable preferred stock have been made, the
remaining assets of the corporation available for distribution to shareholders
shall be distributed pro rata among the holders of common stock.
VOTING RIGHTS
The holders of the Series C and Series D are entitled to the number of
votes equal to the number of shares of common stock into which such redeemable
preferred stock is convertible.
CONVERSION
Each share of Series C and Series D is convertible into one share of common
stock at the option of the holder at any time after the date of issuance of such
shares, and automatically converts at the consummation of the Company's sale of
common stock in an underwritten public offering which results in net cash
proceeds to the Company of at least $60,000,000 and an offering price to the
public of at least $7.00 per share. The conversion rate is subject to adjustment
for dilution, including, but not limited to, stock splits, stock dividends and
stock combinations.
MANDATORY REDEMPTION
Upon the affirmative vote of the holders of the majority of the Series C
and Series D, the Company can be required to redeem all shares of Series C and
Series D outstanding as of the date of such demand, which date shall hereinafter
be referred to as the "Redemption Date." The Redemption Price of the Series C
and Series D will be $0.77 and $1.18 per share, respectively, subject to
adjustment for dilution. The stockholders cannot require redemption prior to
seven years after the issuance of the Series C and Series D.
Beginning with the first year anniversary of the Redemption Date, the
Company shall be required to redeem annually no more than that number of shares
of Series C and Series D equal to 25% of the Series C and Series D outstanding
as of the Redemption Date. From and after the Redemption Date, all rights of the
shares designated for redemption shall cease with respect to such shares. If the
funds of the Company legally available for redemption of Series C and Series D
on any Redemption Date are insufficient to redeem the total number of shares of
the Series C and Series D to be redeemed on such date, those funds which are
legally available will be used to redeem the maximum number of such shares on a
pro rata basis among the holders of Series C and Series D based on each holder's
share of the total redemption price. At any time thereafter when additional
funds of the Company are legally available for the redemption of the shares of
the Series C and Series D, such funds will immediately be set aside for the
redemption of the balance of the shares which the Company was obligated to
redeem on any Redemption Date but which it has not redeemed.
F-16
<PAGE> 91
NEOFORMA.COM, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
9. WARRANTS:
In June 1998, the Company issued a warrant to purchase 45,000 shares of
Series C at an exercise price of $0.77 per share in conjunction with a loan
agreement. The fair value of the warrant at the date of issuance was determined
to be approximately $10,000 and was estimated using the Black-Scholes model with
the following assumptions: risk-free rate of 5.6%; expected life of one year;
and expected volatility of 70%. This amount is being recognized as additional
interest expense over the expected life of the loan agreement.
In February 1999, the Company issued warrants in exchange for certain
consulting services to purchase 25,974 shares of the Company's common stock at
exercise price of $0.10 per share. The deemed fair value of the warrants issued
was approximately $11,000.
In May 1999, the Company issued a warrant to purchase 228,813 shares of
Series D at $1.18 per share in connection with a loan agreement. The warrant is
exercisable immediately and expires the later of May 12, 2006 or three years
from the effective date of an initial public offering. The fair value of the
warrant at the date of issuance was determined to be approximately $640,000 and
was estimated using the Black-Scholes model with the following assumptions:
risk-free interest rate of 5.0%; expected life of one year; and expected
volatility of 70%. This amount will be recognized as additional interest expense
over the expected life of the loan agreement.
As of June 30, 1999, none of the warrants mentioned above had been
exercised.
In July 1999, the Company issued a warrant to purchase 10,000 shares of
Series D at an exercise price of $1.18 per share in conjunction with a loan
agreement. The fair value of the warrant at the date of issuance was determined
to be approximately $40,000 and was estimated using the Black-Scholes model with
the following assumptions: risk-free rate of 5.3%; expected life of one year;
and expected volatility of 70%. This amount will be recognized as additional
interest expense over the expected life of the loan agreement.
In July 1999, the Company issued a warrant to purchase 137,711 shares of
Series D at $1.18 per share in connection with an equipment lease line. The
warrant is exercisable immediately and expires the later of July 7, 2006 or
three years from the effective date of an initial public offering. The fair
value of the warrant at the date of issuance was determined to be approximately
$559,000 and was estimated using the Black-Scholes model with the following
assumptions: risk-free interest rate of 5.3%; expected life of one year; and
expected volatility of 70%. This amount will be recognized as additional
interest expense over the expected life of the lease line.
In October 1999, the Company issued to a retained executive search firm a
warrant to purchase 436,623 shares of the Company's common stock at an exercise
price of $0.10 per share. The warrant is exercisable immediately and expires on
September 9, 2009. The fair value of the warrant was determined to be
approximately $2.4 million and was estimated using the Black-Scholes model with
the following assumptions: risk-free interest rate of 5.5%; expected life of
four months; and expected volatility of 70%.
F-17
<PAGE> 92
NEOFORMA.COM, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
10. STOCK OPTIONS
1997 STOCK PLAN
The Company, under the 1997 Stock Plan (the "Plan"), reserved approximately
14.7 million shares of common stock. The stock is reserved for employees,
directors, and consultants. The term of each option will be stated in the option
agreement, not to exceed 10 years after the grant date. If the optionee owns
stock representing more than 10% of the voting power, the term of the option
will not exceed 5 years after the grant date.
Option pricing will not be less than 85% of the fair market value per share
on the date of the grant. If the optionee owns stock representing more than 10%
of the voting power, the option price will not be less than 110% of the fair
market value per share on the date of the grant. If the stock option is an
incentive stock option, then the price for the stock cannot be less than 100% of
the fair market value per share on the date of the grant.
Any option granted shall be exercisable at such times and under such
conditions as determined by the board of directors. However, for most options,
25% of the shares subject to the option will vest 12 months after the vesting
commencement date, and 1/48 of the shares will vest each month thereafter.
Options under the Plan are exercisable immediately, subject to repurchase rights
held by the Company, which lapse over the vesting period as determined.
The Company's right of repurchase will lapse at a rate determined by the
board of directors. However, for most options, the Company's right to repurchase
will lapse at a rate of 25% of the shares after the first 12 months and 1/48 of
the shares, per month, after the vesting commencement date.
Activity under the Plan is as follows (in thousands, except per share
amounts):
<TABLE>
<CAPTION>
OUTSTANDING OPTIONS
------------------------
SHARES WEIGHTED-
AVAILABLE AVERAGE
FOR GRANT NUMBER EXERCISE PRICE
--------- ------ --------------
<S> <C> <C> <C>
BALANCE, JANUARY 24, 1997............................. 1,000
Granted............................................. (300) 300 $0.05
------ ------ -----
BALANCE, DECEMBER 31, 1997............................ 700 300 $0.05
Authorized.......................................... 1,000
Granted............................................. (1,458) 1,458 $0.08
Exercised........................................... -- (716) $0.06
Canceled............................................ 30 (30) $0.10
------ ------ -----
BALANCE, DECEMBER 31, 1998............................ 272 1,012 $0.09
Authorized (unaudited).............................. 12,656
Granted (unaudited)................................. (3,896) 3,896 $0.10
Exercised (unaudited)............................... -- (165) $0.10
Canceled (unaudited)................................ 633 (633) $0.10
------ ------ -----
BALANCE, JUNE 30, 1999 (unaudited).................... 9,665 4,110 $0.10
====== ====== =====
</TABLE>
F-18
<PAGE> 93
NEOFORMA.COM, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
The Company accounts for the Plan under the provisions of APB No. 25. Had
compensation expense for the stock option plans been determined consistent with
SFAS No. 123, net losses would have increased to the following pro forma amounts
(in thousands, except per share amounts):
<TABLE>
<CAPTION>
SIX
YEAR ENDED MONTHS
DECEMBER 31, ENDED
---------------- JUNE 30,
1997 1998 1999
----- ------- -----------
(UNAUDITED)
<S> <C> <C> <C>
Net loss as reported................................... $(416) $(4,563) $(8,127)
Net loss pro forma..................................... (424) (4,597) (9,544)
Net loss per share as reported......................... (0.05) (1.65) (7.95)
Net loss per share pro forma........................... (0.05) (1.66) (9.34)
</TABLE>
The weighted-average fair value of options granted during the years ended
December 31, 1997 and 1998 and the six months ended June 30, 1999 was $0.03,
$0.09 and $3.08, respectively. The fair value of each option grant was estimated
on the date of grant using the Black-Scholes option pricing model using the
following assumptions: risk-free interest rates ranging from 4.64 to 6.12
percent; expected dividend yields of zero percent for all four periods; an
average expected life of four years; and expected volatility of 0.001% for all
periods except the six months ended June 30, 1999, for which a volatility factor
of 70% was used.
The following table summarizes the stock options outstanding and
exercisable as of June 30, 1999 (unaudited) (shares in thousands):
<TABLE>
<CAPTION>
OPTIONS OUTSTANDING OPTIONS EXERCISABLE
-------------------------------------------- -------------------
WEIGHTED- WEIGHTED- WEIGHTED-
RANGE OF AVERAGE AVERAGE AVERAGE
EXERCISE REMAINING EXERCISE EXERCISE
PRICE NUMBER YEARS PRICE NUMBER PRICE
-------- ------ --------- --------- ------ ---------
<S> <C> <C> <C> <C> <C>
$0.05 265 8.6 $0.05 152 $0.05
$0.10 3,845 9.7 $0.10 136 $0.10
----- --- ----- --- -----
4,110 9.6 $0.10 288 $0.07
===== === ===== === =====
</TABLE>
At June 30, 1999, 383,000 shares previously issued under the Plan were
subject to repurchase at a weighted-average exercise price of $0.07.
DEFERRED COMPENSATION
In connection with the grant of certain stock options to employees during
fiscal 1998 and for the six months ended June 30, 1999, the Company recorded
deferred compensation of approximately $3.5 million, representing the difference
between the estimated fair value of the common stock for accounting purposes and
the option exercise price of these options at the date of grant. Such amount is
presented as a reduction of stockholders' equity and amortized over the vesting
period and the applicable options in a manner consistent with FASB
Interpretation No. 28. The Company recorded amortization of deferred
compensation of $307,000 during the six months ended June 30, 1999. For
F-19
<PAGE> 94
NEOFORMA.COM, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
the three months ended September 30, 1999 the Company recorded additional
deferred compensation of approximately $40.9 million and will amortize
approximately $4.4 million for the same period. At September 30, 1999, the
remaining deferred compensation of approximately $39.7 million will be amortized
as follows: $5.8 million in the last quarter of fiscal 1999, $18.1 million
during fiscal 2000, $9.5 million during fiscal 2001, $4.8 million during fiscal
2002 and $1.5 million during fiscal 2003. The amortization expense relates to
options awarded to employees in all operating expense categories. The amount of
deferred compensation has not been separately allocated to these categories. The
amount of deferred compensation expense to be recorded in future periods could
decrease if options for which accrued but unvested compensation has been
recorded are forfeited.
During the year ended December 31, 1998 and the six months ended June 30,
1998 and 1999, the Company recorded stock-based compensation of $52,000, $9,000
and $1.6 million, respectively, related to equity instruments issued to
non-employees as determined based upon the fair value at the date of issuance.
11. INCOME TAXES:
Effective January 1, 1998, the Company accounts for income taxes pursuant
to the provisions of SFAS No. 109, "Accounting for Income Taxes." SFAS 109
requires recognition of deferred tax assets and liabilities for the expected
future tax consequences of events that have been included in the financial
statements or tax returns. Under this method, deferred tax assets and
liabilities are determined using the current applicable enacted tax rate and
provisions of the enacted tax law.
Due to the Company's loss position, there was no provision for income taxes
for the year ended December 31, 1998 and six months ended June 30, 1999.
At inception, the Company elected S-Corporation status. As of January 1,
1998, the Company elected C-Corporation status for Federal and state purposes.
As a result, the Company is not entitled to any tax benefits associated with the
period prior to C-Corporation election.
At June 30, 1999, the Company had cumulative net operating loss
carryforwards of approximately $8.7 million for Federal and state income tax
purposes expiring in the years ended 2018 and 2006, respectively.
At June 30, 1999, the Company had cumulative research and development
credit carryforwards of approximately $116,000 and $107,000 for Federal and
state income tax purposes, respectively. These credits are subject to expiration
through various periods through 2018.
The Tax Reform Act of 1986 contains provisions which may limit the net
operating loss and credit carryfowards to be used in any given year upon the
occurrence of certain events, including a significant change in ownership.
F-20
<PAGE> 95
NEOFORMA.COM, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
The estimated tax effects of significant temporary differences and
carryforwards that give rise to deferred income tax assets as of December 31,
1998 and for the six months ended June 30, 1999 are as follows (in thousands):
<TABLE>
<CAPTION>
SIX
MONTHS
YEAR ENDED ENDED
DECEMBER 31, JUNE 30,
1998 1999
------------ -----------
(UNAUDITED)
<S> <C> <C>
Temporary differences.................................. $ 943 $ 2,442
Net operating loss carryforwards....................... 1,845 3,582
Research and development tax carryforwards............. 102 223
------- -------
2,890 6,247
Valuation allowance.................................... (2,890) (6,247)
------- -------
$ -- $ --
======= =======
</TABLE>
Due to uncertainty surrounding the realization of the deferred tax
attributes in future years, the Company has recorded a valuation allowance
against its net deferred tax assets.
The provision for income taxes at the Company's effective tax rate differed
from the benefit from income taxes at the statutory rate due mainly to the
increase in valuation allowance and no benefit of the operating losses was
recognized.
The provision for income taxes differs from the expected tax benefit amount
computed by applying the statutory federal income tax rate of 35% to loss before
taxes is as follows:
<TABLE>
<CAPTION>
SIX
YEAR MONTHS
ENDED ENDED
DECEMBER 31, JUNE 30,
1998 1999
------------ -----------
(UNAUDITED)
<S> <C> <C>
Federal statutory rate................................. 35.0% 35.0%
State taxes, net of federal benefit.................... 5.8 5.8
Change in valuation allowance.......................... (40.8) (40.8)
------------ -----
0.0% 0.0%
============ =====
</TABLE>
12. RELATED PARTY TRANSACTIONS
During 1996 and 1997, the Company borrowed a total of $433,000 from certain
shareholders and officers. During 1997, $48,000 of the loans from these
individuals was repaid in cash. At December 31, 1997, $385,000 of the loans from
these individuals is included in notes payable. During 1998, $170,000 of the
notes payable were converted to 340,000 shares of Series B and the remaining
$215,000 was repaid in cash.
F-21
<PAGE> 96
NEOFORMA.COM, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
13. SUBSEQUENT EVENTS (UNAUDITED)
SERIES E
In October 1999, the Company completed an offering of 12,693,663 shares of
Series E mandatorily redeemable preferred stock ("Series E") and Series E-1
mandatorily redeemable preferred stock ("Series E-1") at $5.68 per share, of
which 275,000 shares were issued to a manufacturer of medical equipment in
connection with a marketing and commercial alliance agreement between the
manufacturer and the Company. Total proceeds of the offering amounted to
approximately $70.5 million. Series E-1 is identical in all respects to Series
E, except as specifically noted.
Each share of Series E and Series E-1 is convertible into one share of
common stock at the option of the holder at any time after the date of issuance
of such shares, and automatically converts at the consummation of the Company's
sale of common stock in an underwritten public offering which results in net
cash proceeds to the Company of at least $60,000,000 and, if the closing of the
IPO occurs prior to December 31, 2000, an offering price to the public of at
least $7.00 per share. The conversion rate is subject to adjustment for
dilution, as well as for stock splits, stock dividends and stock combinations.
The Series E and E-1 will be subject to the following adjustment:
If the offering price to the public of the Company's common stock in the
IPO is at least $7.00 per share but less than $10.00 per share, each share of
Series E and Series E-1 will convert into the number of shares of common stock
determined by (1) dividing the offering price to the public by $10.00 and
multiplying the quotient obtained by the conversion price of the Series E-1 then
in effect (the "Conversion Price") and (2) dividing $5.68 by the Conversion
Price.
The Series E-1 Preferred Stock will be subject to the following additional
adjustments:
(1) If the Company achieves $11.75 million or more of combined revenue from
its "Shop" and "Plan" operations for fiscal year 2000, as set forth in the
financial plan provided to the Investors by the Company (the "Financial Plan"),
then each share of Series E-1 Preferred will be converted into 0.7143 shares of
Common Stock; and
(2) If the Company achieves $5 million or less of combined revenue from its
"Shop" and "Plan" operations for fiscal year 2000, as set forth in the Financial
Plan, and a holder of E-1 shares is in compliance with the terms of its
commercial agreement with the Company, then each share of Series E-1 Preferred
will be converted into 1.6667 shares of Common Stock.
COMMITMENTS
In October 1999, the Company entered into a three-year agreement with a
consulting firm (the "Consultant"), which is a stockholder as a result of the
Series E financing, in which the Consultant agreed to introduce the Company's
services to appropriate clients, based on their interests, and to incorporate
the Company's services into certain of its service offerings. The agreement also
provides for joint marketing activities. In consideration, the Company has
agreed to make payments to the Consultant in an aggregate amount of up to
approximately $2.0 million, as well as a percentage of specified Neoforma.com
e-commerce transaction revenue and other payments. The Company has also
F-22
<PAGE> 97
NEOFORMA.COM, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
agreed to utilize the Consultant's services on a preferred basis for systems
integration, development, infrastructure, process improvement and consulting
assistance, totaling at least $1.5 million of services from the Consultant, at a
discount from the Consultant's standard fees.
In October 1999, the Company entered into an agreement with a hardware
vendor, which is a stockholder as a result of the Series E financing, pursuant
to which the Company agreed to develop complementary marketing programs with the
vendor and establish hyperlinks between their respective internet websites. The
Company agreed to use the vendor as its exclusive supplier of certain hardware
products and agreed to purchase at least $5,000,000 of the vendor's products and
$100,000 of consulting services on a mutually agreed upon schedule.
F-23
<PAGE> 98
NEOFORMA.COM, INC. AND GENERAL ASSET RECOVERY, LLC
UNAUDITED PRO FORMA
CONDENSED COMBINED FINANCIAL INFORMATION
On August 6, 1999, Neoforma.com, Inc. ("Neoforma.com") completed the
acquisition of General Asset Recovery, LLC ("GAR"). The acquisition of GAR has
been accounted for as a purchase. Accordingly, the results of operations of GAR
have been included in the consolidated statement of operations of Neoforma.com
commencing on the date of acquisition.
The accompanying pro forma condensed combined statements of operations of
Neoforma.com for the twelve months ended December 31, 1998 and for the six
months ended June 30, 1999 assume that the acquisition took place as of the
beginning of each of these periods and combine GAR's statements of operations
for the twelve months ended December 31, 1998 and for the six months ended June
30, 1999, respectively, with Neoforma.com's statements of operations for the
twelve months ended December 31, 1998 and for the six months ended June 30,
1999, respectively. The pro forma condensed combined balance sheet as of June
30, 1999 assumes that the acquisition took place as of June 30, 1999 and
combines Neoforma.com's June 30, 1999 balance sheet with GAR's July 31, 1999
balance sheet.
The unaudited pro forma condensed combined information is presented for
illustrative purposes only and is not necessarily indicative of the operating
results or financial position that would have actually occurred if the
acquisition had been consummated as of the date indicated, nor is it necessarily
indicative of future operating results or financial position. The pro forma
adjustments are based on the information available at the time of the printing
of this prospectus.
The historical financial statements of Neoforma.com and GAR are included
elsewhere in this prospectus and the unaudited pro forma condensed combined
information presented herein should be read in conjunction with those financial
statements and related notes.
F-24
<PAGE> 99
NEOFORMA.COM, INC. AND GAR
(A DEVELOPMENT STAGE COMPANY)
UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENTS OF OPERATIONS
(IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)
<TABLE>
<CAPTION>
YEAR ENDED
DECEMBER 31, 1998
--------------------- PRO FORMA PRO FORMA
NEOFORMA.COM GAR ADJUSTMENTS COMBINED
------------ ------ ----------- ---------
<S> <C> <C> <C> <C>
REVENUE................................... $ -- $2,986 $ (1,472)(B) $ 1,514
COST OF SALES............................. -- 1,273 (754)(B) 519
------- ------ -------- --------
-- 1,713 (718) 995
------- ------ -------- --------
OPERATING EXPENSES:
Operations.............................. 627 -- -- 627
Product development..................... 1,491 -- -- 1,491
Selling and marketing................... 1,409 345 (91)(B) 1,663
General and administrative.............. 1,075 1,756 (607)(B) 2,224
Amortization of goodwill................ -- -- 1,386(A) 1,386
Amortization of deferred compensation... 5 -- -- 5
------- ------ -------- --------
Total costs and expenses............. 4,607 2,101 688 7,396
Income (loss) from operations........ (4,607) (388) (1,406) (6,401)
OTHER INCOME (EXPENSE), net............... 44 100 (132)(B) 12
------- ------ -------- --------
Net loss............................. $(4,563) $ (288) $ (1,538) $ (6,389)
======= ====== ======== ========
NET LOSS PER SHARE:
Basic and diluted....................... $ (1.65) $ (2.31)
======= ========
Weighted average shares -- basic and
diluted.............................. 2,762 2,762
======= ========
</TABLE>
F-25
<PAGE> 100
NEOFORMA.COM, INC. AND GAR
(A DEVELOPMENT STAGE COMPANY)
UNAUDITED PRO FORMA CONDENSED
COMBINED STATEMENTS OF OPERATIONS
(IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)
<TABLE>
<CAPTION>
SIX MONTHS ENDED
JUNE 30, 1999
----------------------- PRO FORMA PRO FORMA
NEOFORMA.COM GAR ADJUSTMENTS COMBINED
------------ ------- ----------- ---------
<S> <C> <C> <C> <C>
REVENUE............................ $ 7 $ 1,676 $(554)(B) $ 1,129
COST OF SALES...................... -- 886 (262)(B) 624
------- ------- ----- -------
7 790 (292) 505
------- ------- ----- -------
OPERATING EXPENSES:
Operations....................... 1,319 -- -- 1,319
Product development.............. 2,568 -- -- 2,568
Selling and marketing............ 2,382 363 (168)(B) 2,577
General and administrative....... 1,591 700 (58)(B) 2,233
Amortization of goodwill......... -- -- 693(A) 693
Amortization of deferred
compensation.................. 307 -- -- 307
------- ------- ----- -------
Total operating expenses...... 8,167 1,063 467 9697
Income (loss) from
operations.................. (8,160) (273) (759) (9,192)
OTHER INCOME (EXPENSES), net....... 33 (11) -- 22
------- ------- ----- -------
Net loss...................... $(8,127) $ (284) $(759) $(9,170)
======= ======= ===== =======
NET LOSS PER SHARE:
Basic and diluted................ $ (7.95) $ (8.97)
======= =======
Weighted-average shares -- basic
and diluted................... 1,022 1,022
======= =======
</TABLE>
F-26
<PAGE> 101
NEOFORMA.COM, INC. AND GAR
(A DEVELOPMENT STAGE COMPANY)
UNAUDITED PRO FORMA CONDENSED COMBINED BALANCE SHEETS
(IN THOUSANDS)
<TABLE>
<CAPTION>
NEOFORMA.COM GAR
------------- ------------- PRO FORMA PRO FORMA
JUNE 30, 1999 JULY 31, 1999 ADJUSTMENTS COMBINED
------------- ------------- ----------- ---------
<S> <C> <C> <C> <C>
ASSETS
CURRENT ASSETS:
Cash and cash equivalents........... $ 7,063 $ 5 $(1,700)(C) $ 5,368
Accounts receivable................. -- 71 (46)(D) 25
Prepaid expenses and other current
assets........................... 124 2 -- 126
Deferred debt costs, current
portion.......................... 223 -- -- 223
-------- ---- ------- --------
Total current assets............. 7,410 78 (1,746) 5,742
PROPERTY AND EQUIPMENT, net........... 1,777 107 (107)(D) 1,777
OTHER ASSETS.......................... 145 13 (13)(D) 145
DEFERRED DEBT COSTS, less current
portion............................. 427 -- -- 427
GOODWILL.............................. -- -- 9,675(E) 9,675
-------- ---- ------- --------
Total assets $ 9,759 $198 $ 7,809 $ 17,766
======== ==== ======= ========
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
CURRENT LIABILITIES:
Notes payable, current portion...... $ 991 $481 $ (481)(C) $ 3,187
2,196(C)
Accounts payable.................... 1,311 147 (47)(C) 1,411
Accrued liabilities................. 239 -- 107(C) 346
-------- ---- ------- --------
Total current liabilities........ 2,541 628 1,775 4,944
NOTES PAYABLE, less current portion... 1,624 -- 5,604(C) 7,228
SERIES C AND D MANDATORILY REDEEMABLE
CONVERTIBLE PREFERRED STOCK......... 15,870 -- -- 15,870
SERIES C AND D WARRANTS............... 679 -- -- 679
STOCKHOLDERS EQUITY
(DEFICIT)........................... (10,955) (430) 430 (10,955)
-------- ---- ------- --------
Total liabilities and
stockholders' equity
(deficit)...................... $ 9,759 $198 $ 7,809 $ 17,766
======== ==== ======= ========
</TABLE>
F-27
<PAGE> 102
NOTES TO THE UNAUDITED PRO FORMA CONDENSED
COMBINED FINANCIAL INFORMATION
The total purchase price of the GAR acquisition has been allocated to
acquired assets and liabilities based on estimates of their fair values. The
excess of the purchase price over the fair value of the tangible net assets
acquired has been allocated to goodwill.
The adjustments to the unaudited pro forma condensed combined statements of
operations for the year ended December 31, 1998 and for the six months ended
June 30, 1999, assume the acquisition occurred as of January 1, 1998 and January
1, 1999, respectively, and are as follows:
(A) To reflect the amortization of approximately $9.7 million of estimated
goodwill resulting from the acquisition. The goodwill will be amortized
over seven years.
(B) To remove the results of GAR's industrial products operations which
were sold back to one of the members of GAR for nominal consideration.
The adjustments to the unaudited pro forma condensed combined balance sheet
as of June 30, 1999 assumes that the acquisition occurred as of June 30, 1999
and are as follows:
(C) To reflect the purchase price paid as follows: cash paid of $1.7
million, issuance of notes payable of $7.8 million, the assumption of
$100,000 of liabilities, and acquisition-related expenses of
approximately $100,000. Liabilities in excess of $100,000 were not
assumed and are thus deducted from outstanding liabilities to reduce
them to $100,000.
(D) To adjust asset values to fair value at the acquisition date.
(E) To reflect goodwill of approximately $9.7 million resulting from the
acquisition of GAR.
F-28
<PAGE> 103
REPORT OF INDEPENDENT PUBLIC ACCOUNTANTS
To the Members of
General Asset Recovery, LLC:
We have audited the accompanying balance sheets of GENERAL ASSET RECOVERY,
LLC (an Illinois limited liability company) as of December 31, 1997 and 1998,
and the related statements of operations, members' equity (deficit) and cash
flows for the years then ended. These financial statements are the
responsibility of the Company's management. Our responsibility is to express an
opinion on these financial statements based on our audits.
We conducted our audits in accordance with generally accepted auditing
standards. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material
misstatement. An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements. An audit also includes
assessing the accounting principles used and significant estimates made by
management, as well as evaluating the overall financial statement presentation.
We believe that our audits provide a reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly,
in all material respects, the financial position of General Asset Recovery, LLC
as of December 31, 1997 and 1998, and the results of its operations and its cash
flows for the years then ended, in conformity with generally accepted accounting
principles.
ARTHUR ANDERSEN LLP
Chicago, Illinois
October 1, 1999
F-29
<PAGE> 104
GENERAL ASSET RECOVERY, LLC
BALANCE SHEETS
ASSETS
<TABLE>
<CAPTION>
DECEMBER 31,
--------------------- JUNE 30,
1997 1998 1999
--------- -------- -----------
(UNAUDITED)
<S> <C> <C> <C>
CURRENT ASSETS:
Cash.............................................. $ 29,712 $ 24,805 $ 88,146
Accounts receivable............................... 78,523 49,288 718,314
Prepaid expenses.................................. -- 2,587 --
--------- -------- ----------
Total current assets......................... 108,235 76,680 806,460
--------- -------- ----------
PROPERTY AND EQUIPMENT, NET......................... 30,479 60,188 83,665
--------- -------- ----------
OTHER ASSETS:
Employee advances................................. -- -- 26,674
--------- -------- ----------
Deposits.......................................... 17,310 21,223 21,223
--------- -------- ----------
Total assets................................. $ 156,024 $158,091 $ 938,022
========= ======== ==========
LIABILITIES AND MEMBERS' EQUITY (DEFICIT)
CURRENT LIABILITIES:
Line of credit.................................... $ 374,540 $147,500 $ 125,000
Accounts payable.................................. 68,749 67,445 1,208,885
Accrued expenses.................................. 164,156 36,771 38,695
--------- -------- ----------
Total current liabilities.................... 607,445 251,716 1,372,580
COMMITMENTS AND CONTINGENCIES (NOTE 7)
MEMBERS' EQUITY (DEFICIT):
Total members' equity (deficit).............. (451,421) (93,625) (434,558)
--------- -------- ----------
Total liabilities and members' equity
(deficit)................................. $ 156,024 $158,091 $ 938,022
========= ======== ==========
</TABLE>
The accompanying notes are an integral part of these balance sheets.
F-30
<PAGE> 105
GENERAL ASSET RECOVERY, LLC
STATEMENTS OF OPERATIONS
<TABLE>
<CAPTION>
SIX MONTHS ENDED
YEARS ENDED DECEMBER 31, JUNE 30,
------------------------ -------------------------
1997 1998 1998 1999
---------- ---------- ---------- -----------
(UNAUDITED)
<S> <C> <C> <C> <C>
REVENUE............................... $2,404,654 $2,986,099 $1,667,908 $1,675,852
COST OF SALES......................... 1,349,462 1,273,333 696,072 885,714
---------- ---------- ---------- ----------
1,055,192 1,712,766 971,836 790,138
OPERATING EXPENSES:
Selling and marketing............... 296,885 344,365 239,806 363,053
General and administrative.......... 1,059,130 1,756,355 720,551 700,140
---------- ---------- ---------- ----------
Total operating expenses.... 1,356,015 2,100,170 960,357 1,063,193
---------- ---------- ---------- ----------
Operating income (loss)..... (300,823) (387,954) 11,479 (273,055)
---------- ---------- ---------- ----------
OTHER INCOME (EXPENSE):
Other income........................ 2,357 13,425 13,425 --
Rental income....................... 210,047 134,150 57,172 --
Interest expense.................... (35,326) (47,768) (6,073) (11,287)
---------- ---------- ---------- ----------
Total other income
(expense)................ 177,078 99,807 64,524 (11,287)
---------- ---------- ---------- ----------
Net income (loss)........... $ (123,745) $ (288,147) $ 76,003 $ (284,342)
========== ========== ========== ==========
</TABLE>
The accompanying notes are an integral part of these statements.
F-31
<PAGE> 106
GENERAL ASSET RECOVERY, LLC
STATEMENTS OF MEMBERS' EQUITY (DEFICIT)
FOR THE YEARS ENDED DECEMBER 31, 1997 AND 1998 AND THE SIX MONTHS ENDED JUNE 30,
1999
<TABLE>
<CAPTION>
TOTAL
MEMBERS'
EQUITY (DEFICIT)
-----------------
<S> <C>
BALANCE, December 31, 1996.................................. $(218,525)
Net loss.................................................. (123,745)
Member distributions...................................... (109,151)
---------
BALANCE, December 31, 1997.................................. (451,421)
---------
Net loss.................................................. (288,147)
Member distributions...................................... (37,612)
Member contributed capital................................ 683,555
---------
BALANCE, December 31, 1998.................................. (93,625)
---------
Net loss.................................................. (284,342)
Member distributions...................................... (56,591)
---------
BALANCE, June 30, 1999 (unaudited).......................... $(434,558)
=========
</TABLE>
The accompanying notes are an integral part of these statements.
F-32
<PAGE> 107
GENERAL ASSET RECOVERY, LLC
STATEMENTS OF CASH FLOWS
<TABLE>
<CAPTION>
YEARS ENDED SIX MONTHS ENDED
DECEMBER 31, JUNE 30,
--------------------- ----------------------
1997 1998 1998 1999
--------- --------- --------- ----------
(UNAUDITED)
<S> <C> <C> <C> <C>
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income(loss)............................. $(123,745) $(288,147) $ 76,003 $ (284,342)
Adjustments to reconcile net income(loss) to
net cash provided by (used in) operating
activities
Depreciation and amortization........... 2,458 27,814 3,294 11,560
Changes in operating assets and
liabilities..........................
Accounts receivable.................. 123,380 29,235 46,645 (669,026)
Prepaid expenses..................... -- (2,587) 2,587
Other assets......................... -- (3,913) (19,175) (26,674)
Accounts payable..................... 35,914 (1,304) 26,318 1,141,440
Accrued expenses..................... 118,671 (127,385) (163,156) 1,924
--------- --------- --------- ----------
Net cash provided by (used in)
operating activities......... 156,678 (366,287) (30,071) 177,469
--------- --------- --------- ----------
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment, net...... (32,937) (57,523) (148) (35,037)
--------- --------- --------- ----------
CASH FLOWS FROM FINANCING ACTIVITIES:
Contributed capital.......................... -- 683,555 -- --
Dividends.................................... (109,151) (37,612) (16,500) (56,591)
Net borrowings (repayments) under
line-of-credit agreement.................. (10,460) (227,040) 17,007 (22,500)
--------- --------- --------- ----------
Net cash provided by (used in)
financing activities......... (119,611) 418,903 507 (79,091)
--------- --------- --------- ----------
Net increase (decrease) in cash
and cash equivalents......... 4,130 (4,907) (29,712) 63,341
CASH AND CASH EQUIVALENTS, beginning of year... 25,582 29,712 29,712 24,805
--------- --------- --------- ----------
CASH AND CASH EQUIVALENTS, end of year......... $ 29,712 $ 24,805 $ -- $ 88,146
========= ========= ========= ==========
SUPPLEMENTAL DISCLOSURES OF CASH FLOW
INFORMATION:
Cash paid for interest.................... $ 35,326 $ 32,767 $ 11,287 $ 21,074
========= ========= ========= ==========
Cash paid for taxes....................... $ -- $ -- $ -- $ --
========= ========= ========= ==========
SUPPLEMENTAL SCHEDULE OF NONCASH FINANCING
ACTIVITIES:
Assumption of debt by majority member........ $ -- $ 683,555 $ -- $ --
========= ========= ========= ==========
</TABLE>
The accompanying notes are an integral part of these statements.
F-33
<PAGE> 108
GENERAL ASSET RECOVERY, LLC
NOTES TO FINANCIAL STATEMENTS
1. DESCRIPTION OF BUSINESS
General Asset Recovery, LLC (the "Company") is in the business of
conducting live auctions and appraisals of medical equipment.
2. SIGNIFICANT ACCOUNTING POLICIES
The principal accounting policies of the Company are as follows:
REVENUE RECOGNITION
Auction revenue is recognized when the equipment is sold which is
represented by an auction commission received from the buyer and seller. Auction
commissions represent a percentage of the final price at auction sales. Buyers
pay an additional percentage of the final price as a buyer's premium. The
Company does not provide any guarantee with respect to the authenticity of
property offered for sale at auction. Each item is sold on an "as-is" basis with
guarantee only of title.
Upon completion of a final appraisal or inventory report, the Company
recognizes appraisal and inventory revenue. Typically a final payment is due
upon delivery of the report.
MANAGEMENT'S USE OF ESTIMATES
The preparation of financial statements in conformity with generally
accepted accounting principles requires management to make estimates and
assumptions that affect the reported amounts of assets and liabilities and
disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenue and expenses during the reporting
period. Actual results could differ from those estimates.
CONCENTRATION OF CREDIT RISK
The Company may extend trade credit in connection with its auction sales
which are held throughout the United States. The Company evaluates each
customer's creditworthiness on a case-by-case basis; generally, the customers
who receive trade credit are professional dealers who have regularly purchased
property at the Company's auctions or whose reputation within the industry is
known and respected by the Company.
In situations where trade credit is extended, the purchaser does not take
possession of the property before payment is made by the purchaser to the
Company, and the Company is liable to the consignor for the net sales proceeds
(final auction price less commission to the Company). The Company pays the
consignor generally not later than the 10th day after the sale, and when trade
credit is extended, the Company assumes all risk of loss associated with the
trade credit, and the responsibility of collection of the trade credit amount
from the purchaser. Losses to date under these situations have not been
material.
INVENTORY
The majority of the warehouse inventory is on consignment from the seller.
For purchased inventory, the Company periodically reviews the age and turnover
of its inventory to determine whether any inventory has become obsolete or has
declined in value and incurs a charge to operations for known and anticipated
inventory obsolescence. Inventories are stated at the lower of cost or market.
Cost is determined by specific identification.
F-34
<PAGE> 109
GENERAL ASSET RECOVERY, LLC
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
PROPERTY AND EQUIPMENT
Property and equipment are stated at cost. Depreciation is recognized using
both accelerated and straight-line methods. When assets are retired or otherwise
disposed of, the cost and related accumulated depreciation are removed from the
accounts, and any resulting gain or loss is recognized in results of operations
for the period. The cost of repairs and maintenance is charged to operations as
incurred.
3. RECEIVABLES
Receivables represent advance payments, or loans, to the consignor prior to
the auction sale, collateralized by the items received and held by the Company
for the auction sale and the proceeds from such sale. Such advances generally
are not outstanding for more than one month from the date of the note.
4. PROPERTY AND EQUIPMENT, NET
As of December 31, 1998, property and equipment consisted of the following:
<TABLE>
<CAPTION>
ESTIMATED
USEFUL
AMOUNT LIFE
------- -----------
<S> <C> <C>
Computer equipment........................................ $11,074 5 - 7 years
Furniture and fixtures.................................... 79,387 5 - 7 years
Less accumulated depreciation............................. (30,273)
-------
Net property and equipment.............................. $60,188
=======
</TABLE>
Depreciation expense for the years ended December 31, 1997 and 1998 was
approximately $3,000 and $28,000, respectively.
5. LEASES
The Company conducts its business on premises leased under leases that
expire through the year 2004. Future minimum lease payments under noncancellable
leases in effect at December 31, 1998, are set forth below:
<TABLE>
<S> <C>
1999.................................................. $ 83,309
2000.................................................. 50,198
2001.................................................. 45,060
2002.................................................. 45,828
2003.................................................. 46,786
2004.................................................. 7,826
--------
Total future minimum lease payments................. $279,007
========
</TABLE>
Rent expense was approximately $97,000 and $111,000 for the years ended
December 31, 1997 and 1998, respectively.
6. LINE OF CREDIT
As of December 31, 1998, the Company had a line of credit agreement with a
bank that allowed for maximum borrowings of $400,000. Interest was at the bank's
prime rate plus 0.5%. Borrowings
F-35
<PAGE> 110
GENERAL ASSET RECOVERY, LLC
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
were collateralized by all assets of the Company. At December 31, 1998,
borrowings outstanding on the line of credit were $147,500 with a final payment
due July 30, 1999. The Company paid off and terminated the entire line of credit
on July 30, 1999.
7. COMMITMENTS AND CONTINGENCIES
From time to time, the Company is subject to occasional lawsuits,
investigations and claims arising out of the normal conduct of business.
Management does not believe the outcome of any pending claims will have a
material adverse effect on the Company's financial position or results of
operations.
8. AGREEMENTS
In March 1997, the Company entered into an agreement with a hospital to
sell the hospital's surplus assets. The hospital engaged the Company to be its
exclusive agent for a five-year period for the purpose of selling the surplus
assets. In the event that an item does not sell within thirty days of the
possession by the Company, the Company will return such items to the hospital.
The gross sales, less a fee to the Company, are required to be disbursed to the
hospital within five days of the end of the month of the sale.
In December 1998, the Company entered into a one-year services agreement
with a hospital organization to market and promote the Company's services to
members and affiliates of the hospital organization. The Company is required to
pay a marketing fee equal to a percentage of the total net proceeds, as defined,
received from the current month's sale of the assets. During 1999, various
auction agreements have been signed with hospitals in the organization. The
agreements appoint the Company as the exclusive independent agent for periods up
to three years for the purpose of selling the assets privately or at public
auction. The Company must move the assets, catalog the assets, advertise the
auction by publication and mailing of circulars and auction the assets for cash,
"as is" and "where is", among other obligations. The net proceeds are required
to be paid within 10 days of the auction sale. The Company receives a percentage
of the net proceeds as a commission.
In June 1999, a hospital appointed the Company as its exclusive agent for
the purposes of selling auction assets. The Company receives a percentage of the
net proceeds, less expenses and any buyers premium as a commission. The Company
must, among other obligations, advertise the auction sale by publication and
mailing of circulars, sell the assets for cash, keep accurate records of the
auction sale and provide the records to the hospital within ten days of the sale
and provide adequate personnel to supervise the removal of the assets sold.
9. INCOME TAXES
The Company has elected to include its income and expenses with those of
its members for federal income tax purposes. Accordingly, the statements of
operations for the years ended December 31, 1997 and 1998 do not include a
provision for federal income taxes.
10. SUBSEQUENT EVENT
In August 1999, Neoforma.com, Inc. acquired the Company. The acquisition
will be accounted for using the purchase method of accounting on Neoforma.com,
Inc.'s financial statements.
F-36
<PAGE> 111
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
Through and including , 1999 (the 25th day after the date of
this prospectus), all dealers effecting transactions in these securities,
whether or not participating in this offering, may be required to deliver a
prospectus. This is in addition to the dealers' obligation to deliver a
prospectus when acting as underwriters and with respect to their unsold
allotments or subscriptions.
SHARES
[NEOFORMA.COM LOGO]
COMMON STOCK
---------------------
PROSPECTUS
---------------------
MERRILL LYNCH & CO.
BEAR, STEARNS & CO. INC.
ROBERTSON STEPHENS
VOLPE BROWN WHELAN & COMPANY
WILLIAM BLAIR & COMPANY
, 1999
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
<PAGE> 112
PART II
INFORMATION NOT REQUIRED IN PROSPECTUS
ITEM 13. OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION.
The following table sets forth the costs and expenses to be paid by
Neoforma.com in connection with the sale of the shares of common stock being
registered hereby. All amounts are estimates except for the SEC registration
fee, the NASD filing fee and the Nasdaq National Market filing fee.
<TABLE>
<S> <C>
SEC registration fee........................................ $ 20,850
NASD filing fee............................................. 8,000
Nasdaq National Market initial filing fee................... 5,000
Printing and engraving...................................... *
Legal fees and expenses of the Registrant................... *
Accounting fees and expenses................................ *
Directors and officers liability insurance.................. *
Blue sky fees and expenses.................................. *
Transfer agent and registrar fees and expenses.............. *
Miscellaneous............................................... *
----------
Total............................................. $ *
==========
</TABLE>
- -------------------------
* To be filed by amendment
ITEM 14. INDEMNIFICATION OF DIRECTORS AND OFFICERS.
Section 145 of the Delaware General Corporation Law authorizes a court to
award, or a corporation's board of directors to grant, indemnity to directors
and officers under certain circumstances and subject to certain limitations. The
terms of Section 145 of the Delaware General Corporation Law are sufficiently
broad to permit indemnification under certain circumstances for liabilities,
including reimbursement of expenses incurred, arising under the Securities Act
of 1933.
As permitted by the Delaware General Corporation Law, the Registrant's
amended and restated certificate of incorporation includes a provision that
eliminates the personal liability of its directors for monetary damages for
breach of fiduciary duty as a directory, except for liability:
- for any breach of the director's duty of loyalty to the Registrant or its
stockholders;
- for acts or omissions not in good faith or that involve intentional
misconduct or a knowing violation of law;
- under Section 174 of the Delaware General Corporation Law regarding
unlawful dividends and stock purchases; or
- for any transaction from which the director derived an improper personal
benefit.
As permitted by the Delaware General Corporation Law, the Registrant's
amended and restated bylaws provide that:
- the Registrant is required to indemnify its directors and officers to the
fullest extent permitted by the Delaware General Corporation Law, subject
to certain very limited exceptions;
- the Registrant is required to advance expenses, as incurred, to its
directors and officers in connection with a legal proceeding to the
fullest extent permitted by the Delaware General Corporation Law, subject
to certain very limited exceptions; and
II-1
<PAGE> 113
- the rights conferred in the bylaws are not exclusive.
In addition, the Registrant intends to enter into indemnity agreements with
each of our current directors and officers. These agreements provide for the
indemnification of officers and directors for all expenses and liabilities
incurred in connection with any action or proceeding brought against them by
reason of the fact that they are or were agents of the Registrant.
The Registrant intends to obtain directors' and officers' insurance to
cover its directors, officers and some of its employees for certain liabilities,
including public securities matters.
The Underwriting Agreement filed as Exhibit 1.01 to this Registration
Statement provides for indemnification by the underwriters of the Registrant and
its directors and officers for certain liabilities under the Securities Act of
1933, or otherwise.
Reference is made to the following documents filed as exhibits to the
Registration Statement regarding relevant indemnification provisions described
above and elsewhere herein.
<TABLE>
<CAPTION>
EXHIBIT DOCUMENT NUMBER
---------------- ------
<S> <C>
Underwriting Agreement...................................... 1.01
Registrant's Amended and Restated Certificate of
Incorporation............................................. 3.02
Registrant's Amended and Restated Bylaws.................... 3.04
Form of Indemnity Agreement................................. 10.01
</TABLE>
ITEM 15. RECENT SALES OF UNREGISTERED SECURITIES.
In the three years prior to the effective date of this Registration
Statement, we have issued and sold the following unregistered securities:
(1) In May 1996, the Registrant sold 8,000,000 shares of Common Stock to
two founders of the Registrant for $0.00375 per share.
(2) In April 1998, the Registrant issued 9,000,000 shares of our Series A
preferred stock in exchange for 9,000,000 shares of previously issued
common stock.
(3) In April 1998, the Registrant sold 2,860,000 shares of our Series B
preferred stock for approximately $0.50 per share.
(4) In June 1998, the Registrant sold 5,064,937 shares of our Series C
Preferred Stock for approximately $0.77 per share.
(5) In February 1999, the Registrant sold 10,196,361 shares of our Series
D Preferred Stock for approximately $1.18 per share.
(6) In October 1999, the Registrant sold 12,693,663 shares of our Series E
and Series E-1 preferred stock for approximately $5.68 per share.
(7) As of September 30, 1999, the Registrant had issued an aggregate of
12,660,161 shares of Common Stock pursuant to exercises of stock
options and stock purchase rights granted under the Registrant's 1997
Stock Plan at prices ranging from $0.05 to $0.50 per share.
(8) In October 1999, the Registrant issued a warrant to purchase 436,623
shares of Common Stock at a price of $0.10 per share to an executive
search firm in connection with recruitment services.
II-2
<PAGE> 114
(9) In June 1998, the Registrant issued a warrant to purchase 45,000
shares of Series C Preferred Stock at a price of $0.77 per share to
Silicon Valley Bank in connection with a financing transaction.
(10) In May 1999, the Registrant issued a warrant to purchase 228,814
shares of Series D Preferred Stock at a price of $1.18 per share to
Comdisco, Inc. in connection with a financing transaction.
(11) In July 1999, the Registrant issued a warrant to purchase 10,000
shares of Series D Preferred Stock at a price of $1.18 per share to
Silicon Valley Bank in connection with a financing transaction.
(12) In July 1999, the Registrant issued a warrant to purchase 137,711
shares of Series D Preferred Stock at a price of $1.18 per share to
Comdisco, Inc. in connection with a financing transaction.
All sales of common stock made pursuant to the exercise of stock options were
made in reliance on Rule 701 of the Securities Act or on Section 4(2) of the
Securities Act.
All other sales were made in reliance on Section 4(2) of the Securities Act
and/or Regulation D promulgated under the Securities Act. These sales were made
without general solicitation or advertising. Each purchaser was a sophisticated
investor with access to all relevant information necessary to evaluate the
investment and represented to the Registrant that the shares were being acquired
for investment.
ITEM 16. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES.
(a) The following exhibits are filed herewith:
<TABLE>
<CAPTION>
NUMBER EXHIBIT TITLE
------ -------------
<S> <C>
1.01* Form of Underwriting Agreement.
2.01 Securities Purchase Agreement By and Among Neoforma GAR,
Inc. and Neoforma, Inc. and General Asset Recovery, LLC,
Erik Tivin and Fred Tivin dated as of July 16, 1999.
3.01 Amended and Restated Certificate of Incorporation of the
Registrant, as amended through October 12, 1999.
3.02* Form of Amended and Restated Certificate of Incorporation of
the Registrant to be effective upon the closing of the
offering made pursuant to this Registration Statement.
3.03 Bylaws of the Registrant, as amended through June 29, 1999.
3.04* Amended and Restated Bylaws of the Registrant to be
effective upon the closing of the offering made pursuant to
this Registration Statement.
4.01* Form of Specimen Certificate for Registrant's common stock.
4.02* Second Amended and Restated Investors' Rights Agreement.
4.03* Warrant to Purchase Common Stock of Registrant issued to
Heidrick & Struggles.
4.04 QuickStart Warrant to Purchase Series C Preferred Stock of
Registrant dated June 25, 1998 issued to Silicon Valley
Bank, as amended on March 5, 1999.
4.05 Warrant Agreement to Purchase Series D Preferred Stock of
Registrant dated as of May 12, 1999 issued to Comdisco, Inc.
4.06 QuickStart Warrant to Purchase Series D Preferred Stock of
Registrant dated July 20, 1999 issued to Silicon Valley
Bank.
4.07 Warrant to Purchase Series D Preferred Stock of Registrant
dated as of July 7, 1999 issued to Comdisco, Inc.
</TABLE>
II-3
<PAGE> 115
<TABLE>
<CAPTION>
NUMBER EXHIBIT TITLE
------ -------------
<S> <C>
5.01* Opinion of Fenwick & West LLP regarding legality of the
securities being registered.
10.01 Form of Indemnity Agreement between the Registrant and its
directors and officers.
10.02 1997 Stock Plan, as amended.
10.03 Form of 1999 Equity Incentive Plan.
10.04 Form of 1999 Employee Stock Purchase Plan.
10.05* Development and License Agreement dated May 14, 1999 between
ECRI and the Registrant.
10.06* Distribution and Services Agreement dated October 1, 1999
between Superior Consultant Company, Inc. and the
Registrant.
10.07* Strategic Alliance Agreement dated October 11, 1999 between
Dell Marketing L.P. and the Registrant.
10.08 Consulting Agreement dated July 1, 1999 between Madhavan
Rangaswami and the Registrant.
10.09* Employment Agreement dated July 1, 1999 between Robert J.
Zollars and the Registrant.
10.10 Employment Agreement dated August 1999 between Erik Tivin
and the Registrant.
10.11 Offer Letter dated September 17, 1999 with Bhagwan D. Goel.
10.12 Offer Letter dated December 19, 1998 with Robert Flury, as
amended on January 5, 1999.
10.13 Offer Letter dated June 29, 1999 with Frederick Ruegsegger.
10.14 Consulting Agreement dated August 1999 between Fred Tivin
and the Registrant.
10.15 Promissory Note for $7,800,000 dated August 1999 payable to
Erik Tivin.
10.16 Quickstart Loan and Security Agreement dated June 25, 1998
between Silicon Valley Bank and the Registrant, as amended
on July 20, 1999.
10.17* Subordinated Loan and Security Agreement dated May 12, 1999
between Comdisco, Inc. and the Registrant.
10.18 Subordinated Promissory Note for $2,000,000 dated May 27,
1999 payable to Comdisco, Inc.
10.19 Loan and Security Agreement dated as of July 7, 1999 between
Comdisco, Inc. and the Registrant.
10.20 Hardware Secured Promissory Note for $1,032,001.98 dated
September 3, 1999 payable to Comdisco, Inc.
10.21 Softcost Secured Promissory Note for $240,363.61 dated
September 3, 1999 payable to Comdisco, Inc.
10.22 Lease Agreement dated July 30, 1998 between the Registrant
and John Arrillaga, Trustee, or his Successor Trustee, UTA
dated 7/20/77 (John Arrillaga Survivor's Trust) as amended,
and Richard T. Peery, Trustee, or his Successor Trustee, UTA
dated 7/20/77 (Richard T. Peery Separate Property Trust) as
amended.
10.23 Amendment No. 1 dated March 1, 1999 to Lease Agreement dated
July 30, 1998 between the Registrant and John Arrillaga,
Trustee, or his Successor Trustee, UTA dated 7/20/77 (John
Arrillaga Survivor's Trust) as amended, and Richard T.
Peery, Trustee, or his Successor Trustee, UTA dated 7/20/77
(Richard T. Peery Separate Property Trust) as amended.
10.24 Lease Agreement dated March 1, 1999 between the Registrant
and John Arrillaga, Trustee, or his Successor Trustee, UTA
dated 7/20/77 (John Arrillaga Survivor's Trust) as amended,
and Richard T. Peery, Trustee, or his Successor Trustee, UTA
dated 7/20/77 (Richard T. Peery Separate Property Trust) as
amended.
</TABLE>
II-4
<PAGE> 116
<TABLE>
<CAPTION>
NUMBER EXHIBIT TITLE
------ -------------
<S> <C>
10.25 Lease Agreement dated August 16, 1999 between the Registrant
and John Arrillaga, Trustee, or his Successor Trustee, UTA
dated 7/20/77 (John Arrillaga Survivor's Trust) as amended,
and Richard T. Peery, Trustee, or his Successor Trustee, UTA
dated 7/20/77 (Richard T. Peery Separate Property Trust) as
amended.
21.01 Subsidiary of the Registrant.
23.01* Consent of Fenwick & West LLP (included in Exhibit 5.01).
23.02 Consent of Arthur Andersen LLP independent public
accountants.
24.01 Power of Attorney (included on signature page).
27.01 Financial Data Schedule.
</TABLE>
- -------------------------
* To be supplied by amendment.
Other financial statement schedules are omitted because the information
called for is not required or is shown either in the financial statements or the
notes thereto.
ITEM 17. UNDERTAKINGS.
The undersigned Registrant hereby undertakes to provide to the Underwriters
at the closing specified in the Underwriting Agreement certificates in such
denominations and registered in such names as required by the Underwriters to
permit prompt delivery to each purchaser.
Insofar as indemnification for liabilities arising under the Securities Act
may be permitted to directors, officers and controlling persons of the
Registrant pursuant to the provisions described under Item 14 above, or
otherwise, the Registrant has been advised that in the opinion of the Securities
and Exchange Commission such indemnification is against public policy as
expressed in the Securities Act and is, therefore, unenforceable. In the event
that a claim for indemnification against such liabilities (other than the
payment by the Registrant of expenses incurred or paid by a director, officer or
controlling person of the Registrant in the successful defense of any action,
suit or proceeding) is asserted by such director, officer or controlling person
in connection with the securities being registered, the Registrant will, unless
in the opinion of its counsel the matter has been settled by controlling
precedent, submit to a court of appropriate jurisdiction the question whether
such indemnification by it is against public policy as expressed in the
Securities Act and will be governed by the final adjudication of such issue.
The undersigned Registrant hereby undertakes that:
(1) For purposes of determining any liability under the Securities
Act, the information omitted from the form of prospectus filed as part of
this Registration Statement in reliance upon Rule 430A and contained in a
form of prospectus filed by the Registrant pursuant to Rule 424(b)(1) or
(4) or 497(h) under the Securities Act shall be deemed to be part of this
Registration Statement as of the time it was declared effective.
(2) For the purpose of determining any liability under the Securities
Act, each post-effective amendment that contains a form of prospectus shall
be deemed to be a new registration statement relating to the securities
offered therein, and the offering of such securities at that time shall be
deemed to be the initial bona fide offering thereof.
II-5
<PAGE> 117
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended, the
Registrant has duly caused this Registration Statement to be signed on its
behalf by the undersigned, thereunto duly authorized, in the City of Santa
Clara, State of California, on the 15th day of October, 1999.
NEOFORMA.COM, INC.
By: /s/ ROBERT J. ZOLLARS
------------------------------------
ROBERT J. ZOLLARS
Chief Executive Officer
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS that each individual whose signature
appears below constitutes and appoints Robert J. Zollars and Frederick J.
Ruegsegger, and each of them, his true and lawful attorneys-in-fact and agents
with full power of substitution, for him and in his name, place and stead, in
any and all capacities, to sign any and all amendments (including post-
effective amendments) to this Registration Statement, and to sign any
registration statement for the same offering covered by the Registration
Statement that is to be effective upon filing pursuant to Rule 462(b)
promulgated under the Securities Act of 1933, as amended, and all post-effective
amendments thereto, and to file the same, with all exhibits thereto and all
documents in connection therewith, with the Securities and Exchange Commission,
granting unto said attorneys-in-fact and agents, and each of them, full power
and authority to do and perform each and every act and thing requisite and
necessary to be done in and about the premises, as fully to all intents and
purposes as he or she might or could do in person, hereby ratifying and
confirming all that said attorneys-in-fact and agents or any of them, or his,
her or their substitute or substitutes, may lawfully do or cause to be done or
by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, as amended,
this Registration Statement has been signed by the following persons in the
capacities and on the date indicated.
<TABLE>
<CAPTION>
NAME TITLE DATE
---- ----- ----
<C> <C> <S>
/s/ ROBERT J. ZOLLARS President, Chief October 15, 1999
- ----------------------------------------------------- Executive Officer,
ROBERT J. ZOLLARS Chairman of the Board
and Director
/s/ FREDERICK J. RUEGSEGGER Chief Financial Officer October 15, 1999
- -----------------------------------------------------
FREDERICK J. RUEGSEGGER
/s/ DAVID DOUGLASS Director October 15, 1999
- -----------------------------------------------------
DAVID DOUGLASS
/s/ TERENCE GARNETT Director October 15, 1999
- -----------------------------------------------------
TERENCE GARNETT
</TABLE>
II-6
<PAGE> 118
<TABLE>
<CAPTION>
NAME TITLE DATE
---- ----- ----
<C> <C> <S>
/s/ RICHARD D. HELPPIE Director October 15, 1999
- -----------------------------------------------------
RICHARD D. HELPPIE
/s/ WAYNE D. MCVICKER Director October 15, 1999
- -----------------------------------------------------
WAYNE D. MCVICKER
/s/ ANDREW J. FILIPOWSKI Director October 15, 1999
- -----------------------------------------------------
ANDREW J. FILIPOWSKI
/s/ MADHAVAN RANGASWAMI Director October 15, 1999
- -----------------------------------------------------
MADHAVAN RANGASWAMI
</TABLE>
II-7
<PAGE> 119
EXHIBIT INDEX
<TABLE>
<CAPTION>
NUMBER EXHIBIT TITLE
------ -------------
<S> <C>
1.01* Form of Underwriting Agreement.
2.01 Securities Purchase Agreement By and Among Neoforma GAR,
Inc. and Neoforma, Inc. and General Asset Recovery, LLC,
Erik Tivin and Fred Tivin dated as of July 16, 1999.
3.01 Amended and Restated Certificate of Incorporation of the
Registrant, as amended through October 12, 1999.
3.02* Form of Amended and Restated Certificate of Incorporation of
the Registrant to be effective upon the closing of the
offering made pursuant to this Registration Statement.
3.03 Bylaws of the Registrant, as amended through June 29, 1999.
3.04* Amended and Restated Bylaws of the Registrant to be
effective upon the closing of the offering made pursuant to
this Registration Statement.
4.01* Form of Specimen Certificate for Registrant's common stock.
4.02* Second Amended and Restated Investors' Rights Agreement.
4.03* Warrant to Purchase Common Stock of Registrant issued to
Heidrick & Struggles.
4.04 QuickStart Warrant to Purchase Series C Preferred Stock of
Registrant dated June 25, 1998 issued to Silicon Valley
Bank, as amended on March 5, 1999.
4.05 Warrant Agreement to Purchase Series D Preferred Stock of
Registrant dated as of May 12, 1999 issued to Comdisco, Inc.
4.06 QuickStart Warrant to Purchase Series D Preferred Stock of
Registrant dated July 20, 1999 issued to Silicon Valley
Bank.
4.07 Warrant to Purchase Series D Preferred Stock of Registrant
dated as of July 7, 1999 issued to Comdisco, Inc.
5.01* Opinion of Fenwick & West LLP regarding legality of the
securities being registered.
10.01 Form of Indemnity Agreement between the Registrant and its
directors and officers.
10.02 1997 Stock Plan, as amended.
10.03 Form of 1999 Equity Incentive Plan.
10.04 Form of 1999 Employee Stock Purchase Plan.
10.05* Development and License Agreement dated May 14, 1999 between
ECRI and the Registrant.
10.06* Distribution and Services Agreement dated October 1, 1999
between Superior Consultant Company, Inc. and the
Registrant.
10.07* Strategic Alliance Agreement dated October 11, 1999 between
Dell Marketing L.P. and the Registrant.
10.08 Consulting Agreement dated July 1, 1999 between Madhavan
Rangaswami and the Registrant.
10.09* Employment Agreement dated July 1, 1999 between Robert J.
Zollars and the Registrant.
10.10 Employment Agreement dated August 1999 between Erik Tivin
and the Registrant.
10.11 Offer Letter dated September 17, 1999 with Bhagwan D. Goel.
10.12 Offer Letter dated December 19, 1998 with Robert Flury, as
amended on January 5, 1999.
10.13 Offer Letter dated June 29, 1999 with Frederick Ruegsegger.
10.14 Consulting Agreement dated August 1999 between Fred Tivin
and the Registrant.
10.15 Promissory Note for $7,800,000 dated August 1999 payable to
Erik Tivin.
10.16 Quickstart Loan and Security Agreement dated June 25, 1998
between Silicon Valley Bank and the Registrant, as amended
on July 20, 1999.
</TABLE>
<PAGE> 120
<TABLE>
<CAPTION>
NUMBER EXHIBIT TITLE
------ -------------
<S> <C>
10.17* Subordinated Loan and Security Agreement dated May 12, 1999
between Comdisco, Inc. and the Registrant.
10.18 Subordinated Promissory Note for $2,000,000 dated May 27,
1999 payable to Comdisco, Inc.
10.19 Loan and Security Agreement dated as of July 7, 1999 between
Comdisco, Inc. and the Registrant.
10.20 Hardware Secured Promissory Note for $1,032,001.98 dated
September 3, 1999 payable to Comdisco, Inc.
10.21 Softcost Secured Promissory Note for $240,363.61 dated
September 3, 1999 payable to Comdisco, Inc.
10.22 Lease Agreement dated July 30, 1998 between the Registrant
and John Arrillaga, Trustee, or his Successor Trustee, UTA
dated 7/20/77 (John Arrillaga Survivor's Trust) as amended,
and Richard T. Peery, Trustee, or his Successor Trustee, UTA
dated 7/20/77 (Richard T. Peery Separate Property Trust) as
amended.
10.23 Amendment No. 1 dated March 1, 1999 to Lease Agreement dated
July 30, 1998 between the Registrant and John Arrillaga,
Trustee, or his Successor Trustee, UTA dated 7/20/77 (John
Arrillaga Survivor's Trust) as amended, and Richard T.
Peery, Trustee, or his Successor Trustee, UTA dated 7/20/77
(Richard T. Peery Separate Property Trust) as amended.
10.24 Lease Agreement dated March 1, 1999 between the Registrant
and John Arrillaga, Trustee, or his Successor Trustee, UTA
dated 7/20/77 (John Arrillaga Survivor's Trust) as amended,
and Richard T. Peery, Trustee, or his Successor Trustee, UTA
dated 7/20/77 (Richard T. Peery Separate Property Trust) as
amended.
10.25 Lease Agreement dated August 16, 1999 between the Registrant
and John Arrillaga, Trustee, or his Successor Trustee, UTA
dated 7/20/77 (John Arrillaga Survivor's Trust) as amended,
and Richard T. Peery, Trustee, or his Successor Trustee, UTA
dated 7/20/77 (Richard T. Peery Separate Property Trust) as
amended.
21.01 Subsidiary of the Registrant.
23.01* Consent of Fenwick & West LLP (included in Exhibit 5.01).
23.02 Consent of Arthur Andersen LLP, independent public
accountants.
24.01 Power of Attorney (included on signature page).
27.01 Financial Data Schedule.
</TABLE>
- -------------------------
* To be supplied by amendment.
<PAGE> 1
EXHIBIT 2.01
SECURITIES PURCHASE AGREEMENT
BY AND AMONG
NEOFORMA GAR, INC.
AND
NEOFORMA, INC.
AND
GENERAL ASSET RECOVERY, LLC, ERIK TIVIN AND FRED TIVIN
DATED AS OF JULY 16TH, 1999
<PAGE> 2
SECURITIES PURCHASE AGREEMENT
This Securities Purchase Agreement entered into as of July 16th, 1999
by and among Neoforma GAR, Inc., a Delaware corporation (the "ACQUISITION SUB")
and Neoforma, Inc., a Delaware corporation ("NEOFORMA"), on the one hand, and
General Asset Recovery, LLC, an Illinois limited liability company ("GAR"), Erik
Tivin ("TIVIN") and Fred Tivin ("FTIVIN"), on the other.
RECITALS
Tivin and FTivin (collectively, the "MEMBERS") are the only members of
GAR and hold all of the Member Interests (defined in Section 2.2 below) in GAR.
The Members desire to sell to the Acquisition Sub, all of the Member
Interests in GAR held by them, and the Acquisition Sub desires to purchase such
Member Interests from the Members (the "SECURITIES PURCHASE"). Tivin desires to
assist Neoforma and the Acquisition Sub in operating the business operated by
GAR prior to the Closing Date, with the exception of the industrial auction
business (the "BUSINESS"). The Business shall include all assets used in the
medical equipment auction business of GAR but shall exclude the Excluded Assets
referred to in Section 5.9 below. It is intended by the parties that these
transactions be carried out all upon the terms and conditions set forth in this
Agreement and, in furtherance thereof, each of such parties have approved the
Securities Purchase and entered into this Agreement.
GAR, Tivin and Neoforma desire to make certain representations and
warranties and other agreements in connection with the Securities Purchase,
which are set forth in this Agreement.
NOW, THEREFORE, in consideration of the covenants, promises and
representations set forth herein, and for other good and valuable consideration,
intending to be legally bound hereby the parties agree as follows:
ARTICLE I
PURCHASE
1.1 PURCHASE OF SECURITIES. Upon the terms and subject to the
conditions contained in this Agreement, at the Closing, the Members shall sell,
assign, transfer and convey to the Acquisition Sub, and the Acquisition Sub
shall purchase, acquire and accept from the Members, all of the issued and
outstanding Member Interests in GAR held by them, which constitute all of the
issued and outstanding Member Interests of GAR (the "PURCHASED SECURITIES").
1.2 PURCHASE PRICE. The purchase price for the Purchased Securities
(the "PURCHASE PRICE") shall be Nine Million Five Hundred Thousand Dollars
($9,500,000) which amount shall be paid as follows:
2
<PAGE> 3
(a) Cash Payment. One Million Seven Hundred Thousand Dollars
($1,700,000) shall be paid the Acquisition Sub to Tivin and FTivin on the
Closing Date (defined below) in immediately available funds, provided however
that in the event the amount of GAR's aggregate accounts payable and
indebtedness shall exceed the amount of One Hundred Thousand Dollars ($100,000)
on the Closing Date, the amount of such cash payment payable to Tivin shall be
reduced by the amount of such excess.
(b) Promissory Note. Seven Million Eight Hundred Thousand Dollars
($7,800,000) shall be paid to Tivin in the form of a promissory note,
substantially in the form attached as Exhibit A hereto, from the Acquisition Sub
to Tivin in such principal amount (the "NOTE"), bearing interest at a rate of
seven percent (7%) per annum, which note shall be guaranteed by Neoforma and be
repayable as follows:
(i) During the first twelve months following the Closing Date,
the Acquisition Sub shall make payments beginning on the first day of the month
following the Closing Date and on the first day of each month thereafter in an
amount equal to the amount of interest accrued on the outstanding balance under
the Note during the preceding month plus a principal payment of One Hundred
Eighty Three Thousand Three Hundred Thirty Three Dollars ($183,333); and
(ii) During the thirteenth through the forty-eighth month
following the Closing Date, the Acquisition Sub shall make payments on the first
day of each month in an amount equal to the amount of interest accrued on the
outstanding balance under the Note during the preceding month plus a principal
payment of One Hundred Thirty Seven Thousand Five Hundred Dollars ($137,500).
(iii) During the forty-ninth through the sixtieth month
following the Closing Date, the Acquisition Sub shall make payments on the first
day of each month in an amount equal to the amount of interest accrued on the
outstanding balance under the Note during the preceding month plus a principal
payment of Fifty Four Thousand One Hundred Sixty Seven Dollars ($54,167).
The Note may be prepaid without penalty and shall not be convertible
into shares of Neoforma or the Acquisition Sub. The Note shall be secured by a
first priority security interest in all assets of the Acquisition Sub. Payment
of the Note shall be guaranteed by Neoforma pursuant to a guaranty,
substantially in the form attached as Exhibit B hereto. The Note's terms shall
provide for its immediately becoming due and payable upon the occurrence of one
of the following events: (i) the dissolution or termination of existence of
Neoforma or the Acquisition Sub; or (ii) the making of an assignment for the
benefit of creditors, insolvency, appointment of a receiver (not discharged
within sixty (60) days) of any part of the property of, or the filing of a
petition in bankruptcy, or the commencement of any proceedings under any
bankruptcy or insolvency law or any law relating to the relief of debtors,
readjustment or indebtedness, reorganization, composition or extension, by or
(if not discharged within sixty (60) days) against, Neoforma or the Acquisition
Sub. In the event of the termination of the Employment Agreement (as defined in
Section 5.7 hereof) by the Acquisition Sub or Neoforma without cause, an amount
equal to fifty percent (50%) of the unpaid portion of the Note shall become
immediately payable,
3
<PAGE> 4
with the balance of the Note continuing to be payable in the same manner and
over the same time period over the balance of the term of the Note, except that
each monthly principal payment shall be reduced by fifty percent (50%).
1.3 CLOSING. Unless this Agreement is earlier terminated pursuant to
Section 8.1, the closing of the Acquisition (the "CLOSING") will take place as
promptly as practicable, but no later than five (5) business days, following
satisfaction or waiver of the conditions set forth in Article VI, at a location
mutually agreed upon by Neoforma and GAR, unless another place or time is agreed
to by Neoforma and GAR. The date upon which the Closing actually occurs is
herein referred to as the "CLOSING DATE." The parties currently intend that the
Closing Date will occur on or before to September 17, 1999.
ARTICLE II
REPRESENTATIONS AND WARRANTIES OF GAR
GAR and Tivin hereby jointly and severally represent and warrant to
Neoforma, subject to such exceptions as are specifically disclosed in any
Schedule to this Agreement supplied by GAR or Tivin to Neoforma (the "GAR
SCHEDULES") and dated as of the date hereof, as follows:
2.1 ORGANIZATION OF GAR. GAR is a limited liability company duly
organized, validly existing and in good standing under the laws of the State of
Illinois. GAR also maintains an office in the State of North Carolina. GAR has
the power to own its properties and to carry on its business as now being
conducted. GAR is not qualified as a foreign limited liability company in any
jurisdiction. To the best of Tivin's or GAR's knowledge, GAR is duly qualified
to do business in each jurisdiction in which it operates and in which the
failure to qualify as a foreign limited liability company would have a material
adverse effect on the business, assets (including intangible assets), financial
condition or results of operations of GAR (hereinafter referred to as a "GAR
MATERIAL ADVERSE EFFECT"). GAR has delivered a true and correct copy of its
Organizational Documents, each as amended to date, to Neoforma.
2.2 GAR CAPITAL STRUCTURE.
(a) The authorized capitalization of GAR consists of member
interests issued and outstanding to Tivin and FTivin (the "MEMBER INTERESTS"),
which at the Closing shall be conveyed to the Acquisition Sub, free and clear
from any liens or encumbrances. Tivin and FTivin shall be permitted to clear any
liens or encumbrances against the Member Interests at the Closing by their
directing the Acquisition Sub to pay a portion of the cash portion of the
Purchase Price to any party holding a lien against or pledge of any Member
Interest. All of the issued and outstanding Member Interests are owned either by
Tivin or FTivin. GAR does not have any other class or category of equity
security authorized or outstanding. All of the outstanding Member Interests are
duly authorized, validly issued, fully paid and non-assessable and not subject
to preemptive rights created by statute, any Operating Agreement of General
Asset Recovery, LLC (as in effect, including any amendments or restatements) and
the Articles of Organization (together, the "ORGANIZATIONAL DOCUMENTS") of GAR
or any agreement to which GAR is a party or by which it is bound. All of the
Member Interests have been issued in compliance with the terms of GAR's
Organizational Documents. Upon the transfer of all
4
<PAGE> 5
Member Interests owned by Tivin and FTivin to the Acquisition Sub, the
Acquisition will have full ownership of all outstanding equity interests in GAR.
(b) There are no options, warrants, calls, rights, commitments or
agreements of any character, written or oral, to which GAR is a party or by
which it is bound obligating GAR to issue, deliver, sell, repurchase or redeem,
or cause to be issued, delivered, sold, repurchased or redeemed, any ownership
interests of GAR (each, a "GAR MEMBER INTEREST EQUIVALENT") or obligating GAR to
grant, extend, accelerate the vesting of, change the price of, otherwise amend
or enter into any such GAR Member Interest Equivalent.
2.3 SUBSIDIARIES. Except as set forth on Schedule 2.3, GAR does not
have and has never had any subsidiaries or affiliated organizations and does not
otherwise own and has never otherwise owned any shares of capital stock or any
interest in, or control, directly or indirectly, any other corporation,
partnership, limited liability, company, association, joint venture or other
business entity. The status with the regard to the existence as of the Closing
Date of each such subsidiary or affiliated organization is set forth on Schedule
2.3.
2.4 AUTHORITY. GAR and Tivin have all requisite power and authority to
enter into this Agreement and to consummate the transactions contemplated
hereby. The vote required of GAR's Members to duly approve the Securities
Purchase and this Agreement is a Majority in Interest of the Members (as defined
in the Organizational Documents). The execution and delivery of this Agreement
and the consummation of the transactions contemplated hereby have been duly
authorized by all necessary action on the part of GAR. This Agreement has been
duly executed and delivered by GAR and constitutes the valid and binding
obligation of GAR, enforceable in accordance with its terms. The execution and
delivery of this Agreement by GAR and Tivin does not, and, as of the Closing,
the consummation of the transactions contemplated hereby (including the
Securities Purchase) will not, conflict with, or result in any violation of, or
default under (with or without notice or lapse of time, or both), or give rise
to a right of termination, cancellation or acceleration of any obligation or
loss of any benefit under (any such event, a "GAR CONFLICT") (i) any provision
of the Organizational Documents of GAR, or (ii) any mortgage, indenture, lease,
contract or other agreement or instrument, permit, concession, franchise,
license, judgment, order, decree, statute, law, ordinance, rule or regulation
applicable to GAR or its properties or assets. No consent, waiver, approval,
order or authorization of, or registration, declaration or filing with, any
court, administrative agency or commission or other federal, state, county,
local or foreign governmental authority, instrumentality, agency or commission
("GOVERNMENTAL ENTITY") or any third party (so as not to trigger any GAR
Conflict) is required by or with respect to GAR in connection with the execution
and delivery of this Agreement or the consummation of the transactions
contemplated hereby, except for (i) such consents, waivers, approvals, orders,
authorizations, registrations, declarations and filings as may be required under
applicable federal and state securities laws, and (ii) such other consents,
waivers, authorizations, filings, approvals and registrations as are set forth
on Schedule 2.4.
2.5 FINANCIAL STATEMENTS. Schedule 2.5 sets forth GAR's unaudited
balance sheet as of December 31, 1998 and the related unaudited statement of
income and cash flow for the period from inception to December 31, 1998 (the
"GAR 1998 FINANCIALS") and GAR's unaudited balance sheet as of May 31, 1999 and
the related unaudited statements of income and
5
<PAGE> 6
cash flow for the period then ended (the "GAR UNAUDITED FINANCIALS")
(collectively, such financial statements are sometimes referred to herein as
"GAR FINANCIAL STATEMENTS"). The GAR 1998 Financials and GAR Unaudited
Financials present fairly the financial condition, operating results and cash
flows of GAR as of the dates and during the periods indicated therein, subject
in the case of GAR Unaudited Financials, to normal year-end adjustments, which
will not be material in amount or significance. GAR's unaudited balance sheet
dated as of May 31, 1999 shall be referred to as the "GAR CURRENT BALANCE
SHEET". GAR has no reason to believe that any of its accounts receivable are not
fully collectible. Since December 31, 1998, GAR has not changed its methodology
for valuation of accounts receivable.
2.6 NO UNDISCLOSED LIABILITIES. Except as set forth in Schedule 2.6,
GAR does not have any liability, indebtedness, obligation, expense, claim,
deficiency, guaranty or endorsement of any type, whether accrued, absolute,
contingent, matured, unmatured or other (whether or not required to be reflected
in financial statements in accordance with generally accepted accounting
principles), which individually or in the aggregate, (i) has not been reflected
in the GAR Current Balance Sheet, or (ii) has not arisen in the ordinary course
of GAR's business since the date of the GAR Current Balance Sheet, consistent
with past practices.
2.7 NO CHANGES. Except as set forth in Schedule 2.7, since the date of
the GAR Current Balance Sheet, there has not been, occurred or arisen any:
(a) transaction by GAR except in the ordinary course of business as
conducted as of the date of the GAR Current Balance Sheet and consistent with
past practices;
(b) amendments or changes to the Organizational Documents of GAR;
(c) capital expenditure or commitment by GAR, either individually
or in the aggregate, exceeding $5,000;
(d) destruction of, damage to or loss of any material assets,
business or customer of GAR (whether or not covered by insurance);
(e) labor trouble or claim of wrongful discharge or other unlawful
labor practice or action;
(f) change in accounting methods or practices (including any change
in depreciation or amortization policies or rates) by GAR;
(g) revaluation by GAR of any of its assets;
(h) declaration, setting aside or payment of a dividend or other
distribution with respect to any units of GAR, or any direct or indirect
redemption, purchase or other acquisition by GAR of any of its units;
(i) increase in the salary or other compensation payable or to
become payable to any of its officers, directors, employees or advisors, or the
declaration, payment or
6
<PAGE> 7
commitment or obligation of any kind for the payment of a bonus or other
additional salary or compensation to any such person except as otherwise
contemplated by this Agreement;
(j) sale, lease, license or other disposition of any of the assets
or properties of GAR, except in the ordinary course of business as conducted on
that date and consistent with past practices;
(k) any Lien placed on any of GAR's assets which remains in
existence on the date hereof and which has not been disclosed in writing to
Neoforma;
(l) amendment or termination of any material contract, agreement or
license to which GAR is a party or by which it is bound;
(m) loan by GAR to any person or entity, the incurrance by GAR of
any indebtedness, the guaranty by GAR of any indebtedness, issuance or sale of
any debt securities of GAR or the guaranty of any debt securities of others,
except for advances to employees for travel and business expenses in the
ordinary course of business, consistent with past practices;
(n) waiver or release of any right or claim of GAR, including any
write-off or other compromise of any account receivable of GAR;
(o) any contingent liabilities incurred by GAR with respect to the
obligations of any other person that would be assumed hereunder;
(p) commencement or notice or threat of commencement of any lawsuit
or proceeding against or investigation of GAR or its affairs;
(q) notice of any claim of ownership by a third party of GAR's
Intellectual Property (as defined in Section 2.11 below) or of infringement by
GAR of any third party's Intellectual Property rights;
(r) issuance or sale by GAR of any of its Member Interests, or
securities exchangeable, convertible or exercisable therefor, or of any other of
its securities;
(s) change in pricing or royalties set or charged by GAR to its
customers or licensees or in pricing or royalties set or charged by persons who
have licensed Intellectual Property to GAR;
(t) event or condition of any character that has or could be
reasonably expected to have a GAR Material Adverse Effect on GAR;
(u) any postponement or delay in payment of any accounts payable or
other liabilities of GAR; or
(v) negotiation or agreement by GAR or any officer or employees
thereof to do any of the things described in the preceding clauses (a) through
(u) (other than negotiations
7
<PAGE> 8
with Neoforma and its representatives regarding the transactions contemplated by
this Agreement).
2.8 TAX AND OTHER RETURNS AND REPORTS.
(a) Definition of Taxes. For the purposes of this Agreement, "TAX"
or, collectively, "TAXES", means any and all federal, state, local and foreign
taxes, assessments and other governmental charges, duties, impositions and
liabilities, including taxes based upon or measured by gross receipts, income,
profits, sales, use and occupation, and value added, ad valorem, transfer,
franchise, withholding, payroll, recapture, employment, excise and property
taxes, together with all interest, penalties and additions imposed with respect
to such amounts and any obligations under any agreements or arrangements with
any other person with respect to such amounts and including any liability for
taxes of a predecessor entity.
(b) Tax Returns and Audits. Except as set forth in Schedule 2.8:
(i) GAR as of the Closing will have prepared and filed all
required federal, state, local and foreign returns, estimates, information
statements and reports ("RETURNS") relating to any and all Taxes concerning or
attributable to GAR or its operations and such Returns are true and correct and
have been completed in accordance with applicable law.
(ii) As of the Closing, GAR (A) will have paid or accrued all
Taxes it is required to pay or accrue, and (B) will have withheld with respect
to its employees all federal and state income taxes, FICA, FUTA and other Taxes
required to be withheld.
(iii) GAR has not been delinquent in the payment of any Tax
nor is there any Tax deficiency outstanding, proposed or assessed against GAR,
nor has GAR executed any waiver of any statute of limitations on or extending
the period for the assessment or collection of any Tax.
(iv) No audit or other examination of any Return of GAR is
currently in progress, nor has GAR been notified of any request for such an
audit or other examination.
(v) GAR does not have any liabilities for unpaid federal,
state, local and foreign Taxes which have not been accrued or reserved against
on GAR Current Balance Sheet, whether asserted or unasserted, contingent or
otherwise, and Tivin and GAR have no knowledge of any basis for the assertion of
any such liability attributable to GAR, its assets or operations.
(vi) GAR has made available to Neoforma copies of all federal
and state income and all state sales and use Tax Returns for all periods since
the date of GAR's organization.
8
<PAGE> 9
(vii) There are (and as of immediately following the Effective
Date there will be) no liens, pledges, charges, claims, security interests or
other encumbrances of any sort ("LIENS") on the assets of GAR relating to or
attributable to Taxes.
(viii) Tivin and GAR have no knowledge of any basis for the
assertion of any claim relating or attributable to Taxes which, if adversely
determined, would result in any Lien on the assets of GAR.
(ix) None of GAR's assets are treated as "tax-exempt use
property" within the meaning of Section 168(h) of the Code.
(x) As of the Closing, there will not be any contract,
agreement, plan or arrangement, including but not limited to the provisions of
this Agreement, covering any employee or former employee of GAR that,
individually or collectively, could give rise to the payment of any amount that
would not be deductible pursuant to Section 280G or 162 of the Code.
(xi) GAR has not filed any consent agreement under Section
341(f) of the Code or agreed to have Section 341(f)(2) of the Code apply to any
disposition of a subsection (f) asset (as defined in Section 341(f)(4) of the
Code) owned by GAR.
(xii) GAR is not a party to a tax sharing or allocation
agreement nor does GAR owe any amount under any such agreement.
(xiii) GAR is not, and has not been at any time, a "United
States real property holding corporation" within the meaning of Section
897(c)(2) of the Code.
(xiv) GAR's tax basis in its assets for purposes of
determining its future amortization, depreciation and other federal income tax
deductions is accurately reflected on GAR's tax books and records.
2.9 RESTRICTIONS ON BUSINESS ACTIVITIES. Except as disclosed in
Schedule 2.9 hereto, there is no agreement (noncompete or otherwise),
commitment, judgment, injunction, order or decree to which GAR is a party or
otherwise binding upon GAR which has or reasonably could be expected to have the
effect of prohibiting or impairing its ability to operate the Business after the
Closing Date, any acquisition of property (tangible or intangible) by GAR or the
conduct of the Business. Without limiting the foregoing, GAR has not entered
into any agreement under which GAR is restricted from selling, licensing or
otherwise distributing any of its products to any class of customers, in any
geographic area, during any period of time or in any segment of the market that
would be applicable to the Business after the Closing Date.
2.10 TITLE TO PROPERTIES; ABSENCE OF LIENS AND ENCUMBRANCES.
(a) GAR owns no real property, nor has it ever owned any real
property. Schedule 2.10(a) sets forth a list of all real property currently, or
at any time in the past, leased by GAR, the name of the lessor, the date of the
lease and each amendment thereto and, with
9
<PAGE> 10
respect to any current lease, the aggregate annual rental and/or other fees
payable under any such lease and any security interest in GAR's assets created
by such lease. All such current leases are in full force and effect, are valid
and effective in accordance with their respective terms, and there is not, under
any of such leases, any existing default or event of default (or event which
with notice or lapse of time, or both, would constitute a default). All such
current leases will remain in full force and effect following the Closing Date.
(b) GAR has good and valid title to, or, in the case of leased
properties and assets, valid leasehold interests in, all of its assets, real,
personal and mixed, used or held for use in the Business, free and clear of any
Liens (as defined in Section 2.8(b)(vii)), except as reflected in GAR Financial
Statements or in Schedule 2.10(b) and except for liens for taxes not yet due and
payable and such imperfections of title and encumbrances, if any, which are not
material in character, amount or extent, and which do not materially detract
from the value, or materially interfere with the present use, of the property
subject thereto or affected thereby.
2.11 INTELLECTUAL PROPERTY.
(a) To the best of its knowledge and the knowledge of Tivin, GAR
owns, or is licensed or otherwise possesses legally enforceable rights to use,
all patents, trademarks, trade names, service marks, copyrights, and any
applications therefor, maskworks, net lists, schematics, technology, know-how,
computer software programs or applications (in both source code and object code
form), and tangible or intangible proprietary information or material that are
used in the Business as currently conducted and as proposed to be conducted by
GAR (the "GAR INTELLECTUAL PROPERTY RIGHTS"). Neither GAR or Tivin have any
knowledge, nor have they received any written notice, of any violation of any of
the GAR Intellectual Property Rights upon the rights of any other party.
Schedule 2.11(a) sets forth a complete list of all patents, registered and
material unregistered trademarks and service marks, registered copyrights and
trade names, and any applications therefor, included in GAR Intellectual
Property Rights, and specifies, where applicable, the jurisdictions in which
each such GAR Intellectual Property Right has been issued or registered or in
which an application for such issuance and registration has been filed,
including the respective registration or application numbers and the names of
all registered owners.
(b) Schedule 2.11(b) sets forth a complete list of all licenses,
sublicenses and other agreements as to which GAR is a party and pursuant to
which GAR or any other person is authorized to use any GAR Intellectual Property
or trade secrets of GAR, and includes the identity of all parties thereto, a
description of the nature and subject agreement substantially in GAR's standard
forms.
2.12 AGREEMENTS, CONTRACTS AND COMMITMENTS. Except as set forth on
Schedule 2.12, GAR does not have, is not a party to, nor is it bound by, and
Neoforma will not be bound, by virtue of the transactions contemplated hereby,
by:
(a) any consulting or sales agreement, contract or commitment
under which any firm or other organization provides services to GAR,
10
<PAGE> 11
(b) any operating agreement or other agreement relating to the
operations of any business organization, including GAR,
(c) any fidelity or surety bond or completion bond,
(d) any lease of personal property having a value individually in
excess of $15,000,
(e) any agreement of indemnification or guaranty,
(f) any agreement, contract or commitment containing any covenant
limiting the freedom of GAR to engage in any line of business or to compete with
any person,
(g) any agreement, contract or commitment relating to capital
expenditures and involving future payments in excess of $15,000,
(h) any agreement, contract or commitment relating to the
disposition or acquisition of assets or any interest in any business enterprise
outside the ordinary course of GAR's business,
(i) any mortgages, indentures, loans or credit agreements,
security agreements or other agreements or instruments relating to the borrowing
of money or extension of credit, including guaranties referred to in clause (i)
hereof,
(j) any purchase order or contract for the purchase of raw
materials involving $15,000 or more,
(k) any construction contracts,
(l) any distribution, joint marketing or development agreement,
(m) any agreement pursuant to which GAR has granted or may grant
in the future, to any party, a source-code license or option or other right to
use or acquire source-code, or
(n) any other agreement, contract or commitment that involves
$15,000 or more or is not cancelable without penalty within thirty (30) days.
Except for such alleged breaches, violations and defaults, and events
that would constitute a breach, violation or default with the lapse of time,
giving of notice, or both, as are all noted in Schedule 2.11(b) or Schedule
2.12, as appropriate, GAR has not breached, violated or defaulted under, or
received notice that it has breached, violated or defaulted under, any of the
terms or conditions of any agreement, contract or commitment required to be set
forth on Schedule 2.11(b) or Schedule 2.12 (any such agreement, contract or
commitment, a "GAR CONTRACT"). Each GAR Contract is in full force and effect
and, except as otherwise disclosed in
11
<PAGE> 12
Schedule 2.11(b) or Schedule 2.12, is not subject to any default thereunder of
which Tivin or GAR has knowledge by any party obligated to GAR pursuant thereto.
2.13 INTERESTED PARTY TRANSACTIONS. Except as set forth on Schedule
2.13, no officer, director or Member of GAR (nor any ancestor, sibling,
descendant or spouse of any of such persons, or any trust, partnership or
corporation in which any of such persons has or has had an interest), has or has
had, directly or indirectly, (i) an economic interest in any entity which
furnished or sold, or furnishes or sells, services or products that GAR
furnishes or sells, or proposes to furnish or sell, (ii) an economic interest in
any entity that purchases from or sells or furnishes to GAR any goods or
services or (iii) a beneficial interest in any contract or agreement set forth
in Schedule 2.11(b) or Schedule 2.12; provided, that ownership of no more than
one percent (1%) of the outstanding voting stock of a publicly traded
corporation shall not be deemed an "economic interest in any entity" for
purposes of this Section 2.13. Except as disclosed on Schedule 2.13, all
interested party transactions were made on terms no more favorable to such
interested party than could have been obtained on an arm's-length basis.
2.14 COMPLIANCE WITH LAWS. To Tivin's or GAR's knowledge, GAR has
complied in all material respects with, is not in material violation of, and has
not received any notices of violation with respect to, any foreign, federal,
state or local statute, law or regulation. GAR holds all permits, licenses,
variances, exemptions, authorizations, orders and approvals of all Governmental
Agencies (as hereinafter defined, with each being a "PERMIT") that are required
for it to own, lease or operate its properties and assets and to carry on its
business as presently conducted, which Permits are listed on Schedule 2.14
hereto. There is presently no default under any such Permit. GAR is in
compliance in all material respects with (a) all applicable statutes, laws,
ordinances, rules, orders and regulations of any Governmental Agency, and (b)
their own respective internal policies and procedures. Tivin holds all Permits
required for the conduct of auctions in each jurisdiction in which the failure
to hold any such Permit would result in a GAR Material Adverse Effect.
Neither Tivin nor GAR has received any notification or communication
from any Governmental Agency which has not been fully and finally resolved (a)
asserting that either Tivin or GAR is not in substantial compliance with any of
the statutes, regulations, ordinances or guidelines which such Governmental
Agency enforces or administers, or with the internal policies and procedures of
GAR, (b) threatening to revoke any material Permit, (c) requiring or threatening
to require Tivin or GAR, or indicating that it may be required, to enter into a
cease and desist order, agreement or memorandum of understanding or any other
agreement, or (d) directing, restricting or limiting, or purporting to direct,
restrict or limit, in any manner the operations of Tivin or GAR. Neither Tivin
nor GAR has received, consented to or entered into, or is subject to, any
agreement with a Governmental Agency, nor has it been advised by any
Governmental Agency that such Governmental Agency is contemplating issuing or
requesting (or is considering the appropriateness of issuing or requesting) any
such agreement. The term "Governmental Agency" shall mean shall mean any court,
administrative agency or commission, or other governmental authority or
instrumentality, domestic or foreign, including, but not limited to, the United
States Food and Drug Administration.
12
<PAGE> 13
2.15 LITIGATION. Except as set forth in Schedule 2.15, there is no
action, suit or proceeding of any nature pending or threatened against GAR, its
properties or any of its officers or directors, in their respective capacities
as such. Except as set forth in Schedule 2.15, there is no investigation pending
or threatened against GAR, its properties or any of its officers or directors
(in their respective capacities as such) by or before any governmental entity.
Schedule 2.15 sets forth, with respect to any pending or threatened action,
suit, proceeding or investigation, the forum, the parties thereto, the subject
matter thereof and the amount of damages claimed or other remedy requested. No
Governmental Agency has at any time challenged or questioned the legal right of
GAR to manufacture, offer or sell any of its products in the present manner or
style thereof.
2.16 INSURANCE. Set forth on Schedule 2.16 is a list of all of GAR's
insurance policies and fidelity bonds. With respect to the insurance policies
and fidelity bonds covering the assets, business, equipment, properties,
operations, employees, officers and directors of GAR, there is no claim by GAR
pending under any of such policies or bonds as to which coverage has been
questioned, denied or disputed by the underwriters of such policies or bonds.
All premiums due and payable under all such policies and bonds have been paid
and GAR is otherwise in material compliance with the terms of such policies and
bonds (or other policies and bonds providing substantially similar insurance
coverage). Tivin or GAR has no knowledge of any threatened termination of, or
material premium increase with respect to, any of such policies.
2.17 MINUTE BOOKS. The minute books of GAR, if any, have been made
available to counsel for Neoforma, are the only minute books of GAR and, to the
extent they exist, contain a reasonably accurate summary of all meetings of
directors (or committees thereof) and Members or actions by written consent
since the time of organization of GAR.
2.18 ENVIRONMENTAL MATTERS.
(a) Hazardous Material. GAR has not operated any underground
storage tanks, and has no knowledge of the existence, at any time, of any
underground storage tank (or related piping or pumps), at any property that GAR
has at any time owned, operated, occupied or leased. GAR has not released any
amount of any substance that has been designated by any Governmental Entity or
by applicable federal, state or local law to be radioactive, toxic, hazardous or
otherwise a danger to health or the environment, including, without limitation,
PCBs, asbestos, oil and petroleum products, urea-formaldehyde and all substances
listed as a "hazardous substance," "hazardous waste," "hazardous material" or
"toxic substance" or words of similar import, under any law, including but not
limited to, the Comprehensive Environmental Response, Compensation, and
Liability Act of 1980, as amended; the Resource Conservation and Recovery Act of
1976, as amended; the Federal Water Pollution Control Act, as amended; the Clean
Air Act, as amended, and the regulations promulgated pursuant to said laws, (a
"HAZARDOUS MATERIAL"). No Hazardous Materials are present as a result of the
actions or omissions of GAR, or, to GAR's knowledge, as a result of any actions
of any third party or otherwise, in, on or under any property, including the
land and the improvements, ground water and surface water thereof, that GAR has
at any time owned, operated, occupied or leased.
13
<PAGE> 14
(b) Hazardous Materials Activities. GAR has not transported,
stored, used, manufactured, disposed of, released or exposed its employees or
others to Hazardous Materials in violation of any law in effect on or before the
Closing Date, nor has GAR disposed of, transported, sold, or manufactured any
product containing a Hazardous Material (any or all of the foregoing being
collectively referred to as "HAZARDOUS MATERIALS ACTIVITIES") in violation of
any rule, regulation, treaty or statute promulgated by any Governmental Entity
in effect prior to or as of the date hereof to prohibit, regulate or control
Hazardous Materials or any Hazardous Material Activity.
(c) Permits. To GAR's knowledge, it currently holds all
environmental approvals, permits, licenses, clearances and consents (the
"ENVIRONMENTAL PERMITS") necessary for the conduct of GAR's Hazardous Material
Activities and other businesses of GAR as such activities and businesses are
currently being conducted.
(d) Environmental Liabilities. No action, proceeding, revocation
proceeding, amendment, procedure, writ, injunction or claim is pending, or to
GAR's knowledge, threatened concerning any Environmental Permit, Hazardous
Material or any Hazardous Materials Activity of GAR. GAR is not aware of any
fact or circumstance which could involve GAR in any environmental litigation or
impose upon GAR any environmental liability.
(e) No Violation. The Business includes the temporary occupancy of
hospitals and other medical facilities by GAR and Tivin for the purpose of
auctioning or otherwise liquidating obsolete or excess medical equipment. Such
medical facilities may have had storage tanks, piping or pumps which contained
Hazardous or Toxic Materials located on them. This fact and/or knowledge of the
same by GAR or Tivin shall not constitute a breach of any representation,
warranty or other agreement contained herein.
2.19 BROKERS' AND FINDERS' FEES; THIRD PARTY EXPENSES. Except as set
forth on Schedule 2.19, GAR has not incurred, nor will it incur, directly or
indirectly, any liability for brokerage or finders' fees, investment banking
fees, consulting fees or agents' commissions or any similar charges in
connection with this Agreement or any transaction contemplated hereby. Schedule
2.19 sets forth the principal terms and conditions of any agreement, written or
oral, with respect to such fees. Schedule 2.19 also sets forth GAR's current
reasonable estimate of all outside expenses expected to be incurred by GAR in
connection with the negotiation and effectuation of the terms and conditions of
this Agreement and the transactions contemplated hereby.
2.20 EMPLOYEE MATTERS AND BENEFIT PLANS.
(a) Definitions. For purposes of this section, the following terms
shall have the meanings set forth below:
(i) "GAR AFFILIATE" shall mean any other person or entity
under common control with GAR within the meaning of Section 414(b), (c), (m) or
(o) of the Code and the regulations thereunder;
14
<PAGE> 15
(ii) "ERISA" shall mean the Employee Retirement Income
Security Act of 1974, as amended;
(iii) "GAR EMPLOYEE PLAN" shall refer to any collective
bargaining agreement or any plan, program, policy, practice, contract, agreement
or other arrangement providing for compensation, performance awards, bonus,
profit sharing, stock options, stock appreciation rights, unit or unit related
awards, severance, termination pay, retirement benefits, pension, fringe
benefits or other employee benefits or remuneration of any kind, whether formal
or informal, funded or unfunded and whether or not legally binding, including
without limitation, each "employee benefit plan", within the meaning of Section
3(3) of ERISA which is or has been maintained, contributed to, or required to be
contributed to, by GAR or any GAR Affiliate for the benefit of any "GAR
Employee" (as defined below), and pursuant to which GAR or any GAR Affiliate has
or may have any material liability contingent or otherwise;
(iv) "GAR EMPLOYEE" shall mean any current, former, or retired
employee, officer, or director of GAR or any GAR Affiliate;
(v) "GAR EMPLOYEE AGREEMENT" shall refer to each contract,
agreement or commitment concerning management, employment, severance,
post-employment liabilities or obligations, consulting, relocation,
repatriation, expatriation, visas, work permit or any similar agreement or
contract between GAR or any Affiliate and any Employee or consultant;
(vi) "IRS" shall mean the Internal Revenue Service;
(vii) "MULTIEMPLOYER PLAN" shall mean any "PENSION PLAN" (as
defined below) which is a "multiemployer plan", as defined in Section 3(37) of
ERISA; and
(viii) "GAR PENSION PLAN" shall refer to each GAR Employee
Plan which is an "employee pension benefit plan", within the meaning of Section
3(2) of ERISA.
(b) Schedule. Schedule 2.20 contains an accurate and complete list
of each GAR Employee Plan and each GAR Employee Agreement, if any, together with
a schedule of all liabilities, whether or not accrued, under each such GAR
Employee Plan or GAR Employee Agreement. GAR does not have any plan or
commitment, whether legally binding or not, to establish any new GAR Employee
Plan or GAR Employee Agreement, to modify any GAR Employee Plan or GAR Employee
Agreement (except to the extent required by law or to conform any such GAR
Employee Plan or GAR Employee Agreement to the requirements of any applicable
law, or as required by this Agreement), or to enter into any GAR Employee Plan
or GAR Employee Agreement, nor does it have any intention or commitment to do
any of the foregoing. Except for such alleged breaches, violations and defaults,
and events that would constitute a breach, violation or default with the lapse
of time, giving of notice, or both, as are all noted in Schedule 2.20, GAR has
not breached, violated or defaulted under, or received notice that it has
breached, violated or defaulted under, any of the terms or conditions of any GAR
Employee Agreement. Each GAR Employee Agreement is in full force and effect and,
except as
15
<PAGE> 16
otherwise disclosed in Schedule 2.20, is not subject to any default thereunder
of which Tivin or GAR has knowledge by any party obligated to GAR pursuant
thereto.
(c) Documents. GAR has made available to Neoforma (i) correct and
complete copies of all documents embodying or relating to each GAR Employee Plan
and each GAR Employee Agreement including all amendments thereto and written
interpretations thereof; (ii) the most recent annual actuarial valuations, if
any, prepared for each GAR Employee Plan; (iii) the most recent annual report
(Series 5500 and all schedules thereto), if any, required under ERISA or the
Code in connection with each GAR Employee Plan or related trust; (iv) if GAR
Employee Plan is funded, the most recent annual and periodic accounting of GAR
Employee Plan assets; (v) the most recent summary plan description together with
the most recent summary of material modifications, if any, required under ERISA
with respect to each GAR Employee Plan; (vi) all IRS determination letters and
rulings relating to GAR Employee Plans and copies of all applications and
correspondence to or from the IRS or the Department of Labor ("DOL") with
respect to any GAR Employee Plan; (vii) all communications material to any GAR
Employee or GAR Employees relating to any GAR Employee Plan and any proposed GAR
Employee Plans, in each case, relating to any amendments, terminations,
establishments, increases or decreases in benefits, acceleration of payments or
vesting schedules or other events which would result in any material liability
to GAR; and (viii) all registration statements and prospectuses prepared in
connection with each GAR Employee Plan.
(d) Employee Plan Compliance. Except as set forth on Schedule 2.20,
(i) GAR has performed in all material respects all obligations required to be
performed by it under each GAR Employee Plan, and each GAR Employee Plan has
been established and maintained in all material respects in accordance with its
terms and in compliance with all applicable laws, statutes, orders, rules and
regulations, including but not limited to ERISA or the Code; (ii) no "prohibited
transaction", within the meaning of Section 4975 of the Code or Section 406 of
ERISA, has occurred with respect to any GAR Employee Plan; (iii) there are no
actions, suits or claims pending, or, to the knowledge of GAR, threatened or
anticipated (other than routine claims for benefits) against any GAR Employee
Plan or against the assets of any GAR Employee Plan; and (iv) each GAR Employee
Plan can be amended, terminated or otherwise discontinued after the Closing in
accordance with its terms, without liability to GAR, Neoforma or any of its
Affiliates (other than ordinary administration expenses typically incurred in a
termination event); (v) there are no inquiries or proceedings pending or, to the
knowledge of GAR or any affiliates, threatened by the IRS or DOL with respect to
any GAR Employee Plan; and (vi) neither GAR nor any Affiliate is subject to any
penalty or tax with respect to any GAR Employee Plan under Section 402(i) of
ERISA or Section 4975 through 4980 of the Code.
(e) Pension Plans. GAR does not now, nor has it ever, maintained,
established, sponsored, participated in, or contributed to, any Pension Plan
which is subject to Part 3 of Subtitle B of Title I of ERISA, Title IV of ERISA
or Section 412 of the Code.
(f) Multiemployer Plans. At no time has GAR contributed to or been
requested to contribute to any Multiemployer Plan.
16
<PAGE> 17
(g) No Post-Employment Obligations. Except as set forth in Schedule
2.20, no GAR Employee Plan provides, or has any liability to provide, life
insurance, medical or other employee benefits to any GAR Employee upon his or
her retirement or termination of employment for any reason, except as may be
required by statute, and GAR has never represented, promised or contracted
(whether in oral or written form) to any GAR Employee (either individually or to
GAR Employees as a group) that such GAR Employee(s) would be provided with life
insurance, medical or other employee welfare benefits upon their retirement or
termination of employment, except to the extent required by statute.
(h) Effect of Transaction.
(i) Except as set forth on Schedule 2.20, the execution of
this Agreement and the consummation of the transactions contemplated hereby will
not (either alone or upon the occurrence of any additional or subsequent events)
constitute an event under any GAR Employee Plan, GAR Employee Agreement, trust
or loan that will or may result in any payment (whether of severance pay or
otherwise), acceleration, forgiveness of indebtedness, vesting, distribution,
increase in benefits or obligation to fund benefits with respect to any GAR
Employee.
(ii) Except as set forth on Schedule 2.20, no payment or
benefit which will or may be made by GAR or Neoforma or any of their respective
affiliates with respect to any Employee will be characterized as an "excess
parachute payment" within the meaning of Section 280G(b)(1) of the Code.
(i) Employment Matters. GAR (i) to its knowledge, is in compliance
in all material respects with all applicable foreign, federal, state and local
laws, rules and regulations respecting employment, employment practices, terms
and conditions of employment and wages and hours, in each case, with respect to
GAR Employees; (ii) has withheld all amounts required by law or by agreement to
be withheld from the wages, salaries and other payments to GAR Employees; (iii)
is not liable for any arrears of wages or any taxes or any penalty for failure
to comply with any of the foregoing; and (iv) is not liable for any payment to
any trust or other fund or to any governmental or administrative authority, with
respect to unemployment compensation benefits, social security or other benefits
or obligations for GAR Employees (other than routine payments to be made in the
normal course of business and consistent with past practice).
(j) Labor. No work stoppage or labor strike against GAR is pending
or, to the best knowledge of GAR, threatened. Except as set forth in Schedule
2.20, GAR is not involved in or, to the knowledge of GAR, threatened with, any
labor dispute, grievance, or litigation relating to labor, safety or
discrimination matters involving any GAR Employee, including, without
limitation, charges of unfair labor practices or discrimination complaints,
which, if adversely determined, would, individually or in the aggregate, result
in liability to GAR. Neither GAR nor any of its subsidiaries has engaged in any
unfair labor practices within the meaning of the National Labor Relations Act
which would, individually or in the aggregate, directly or indirectly result in
a liability to GAR. Except as set forth in Schedule 2.20, GAR is not presently,
nor has it been in the past, a party to, or bound by, any collective bargaining
17
<PAGE> 18
agreement or union contract with respect to GAR Employees and no collective
bargaining agreement is being negotiated by GAR.
2.21 REPRESENTATIONS COMPLETE. None of the representations or
warranties made by GAR or Tivin (as modified by Schedules), nor any statement
made in any schedule or certificate furnished by GAR or Tivin pursuant to this
Agreement, or furnished in or in connection with documents mailed or delivered
to the Members in connection with soliciting their consent to this Agreement and
the Securities Purchase, contains or will contain at the Closing, any untrue
statement of a material fact, or omits or will omit at the Closing to state any
material fact necessary in order to make the statements contained herein or
therein, in the light of the circumstances under which made, not misleading.
ARTICLE III
REPRESENTATIONS AND WARRANTIES OF NEOFORMA
Neoforma hereby represents and warrants to GAR and Tivin, subject to
such exceptions as are specifically disclosed in any Schedule to this Agreement
supplied by Neoforma to GAR or Tivin (the "NEOFORMA SCHEDULES") and dated as of
the date hereof, as follows:
3.1 ORGANIZATION OF NEOFORMA. Neoforma is a corporation duly organized,
validly existing and in good standing under the laws of the State of Delaware.
Neoforma has the corporate power to own its properties and to carry on their
business as now being conducted. Neoforma is duly qualified to do business and
in good standing as a foreign corporation in each jurisdiction in which the
failure to be so qualified would have a material adverse effect on the business,
assets (including intangible assets), financial condition or results of
operations of Neoforma (hereinafter referred to as a "NEOFORMA MATERIAL ADVERSE
EFFECT"). Neoforma has delivered a true and correct copy of its Certificate of
Incorporation and Bylaws, each as amended to date, to GAR.
3.2 NEOFORMA CAPITAL STRUCTURE. The authorized capital stock of
Neoforma consists of 40,000,000 shares of authorized Common Stock, $0.001 par
value (the "Common Stock"), of which 1,259,961 shares are issued and
outstanding, and 27,420,022 shares of preferred stock, $0.001 par value (the
"Preferred Stock"), of which 27,121,298 shares are issued and outstanding. All
shares of the Preferred Stock are convertible into shares of Common Stock on a
one for one basis. All outstanding shares of the Common Stock and Preferred
Stock are duly authorized, validly issued, fully paid and non-assessable and not
subject to preemptive rights created by statute, the Certificate of
Incorporation or Bylaws of Neoforma or any agreement to which Neoforma is a
party or by which it is bound. The Acquisition Sub, as of the Closing Date,
shall have delivered a true and correct copy of its organizational documents,
amended to date, to GAR. All issued and outstanding shares of the common stock
of the Acquisition Sub are, and shall until such time as the Note is repaid in
full continue to be, owned by Neoforma.
3.3 AUTHORITY. Neoforma has, and as of the Closing Date the Acquisition
Sub shall have, all requisite corporate power and authority to enter into this
Agreement and to consummate the transactions contemplated hereby. The execution
and delivery of this
18
<PAGE> 19
Agreement and the consummation of the transactions contemplated hereby have been
duly authorized by all necessary corporate action on the part of Neoforma.
Neoforma's Board of Directors have approved the Securities Purchase and this
Agreement. This Agreement has been duly executed and delivered by Neoforma and
constitutes the valid and binding obligation of Neoforma, enforceable in
accordance with its terms. Except as set forth on Schedule 3.3, the execution
and delivery of this Agreement by Neoforma does not, and, as of the Closing, the
consummation of the transactions contemplated hereby will not, conflict with, or
result in any violation of, or default under (with or without notice or lapse of
time, or both), or give rise to a right of termination, cancellation or
acceleration of any obligation or loss of any benefit under (any such event, a
"NEOFORMA CONFLICT") (i) any provision of the Certificate of Incorporation or
Bylaws of Neoforma, or (ii) any mortgage, indenture, lease, contract, or other
agreement or instrument, permit, concession, franchise, license, judgment,
order, decree, statute, law, ordinance, rule or regulation applicable to
Neoforma or its properties or assets. No consent, waiver, approval, order or
authorization of, or registration, declaration or filing with, any Governmental
Entity or any third party (so as not to trigger any Neoforma Conflict) is
required by or with respect to Neoforma in connection with the execution and
delivery of this Agreement or the consummation of the transactions contemplated
hereby, except for (i) such consents, waivers, approvals, orders,
authorizations, registrations, declarations and filings as may be required under
applicable federal and state securities laws and (ii) such other consents,
waivers, authorizations, filings, approvals and registrations which are set
forth on Schedule 3.3 of this Agreement.
3.4 REPRESENTATIONS COMPLETE. None of the representations or warranties
made by Neoforma, nor any statement made in any schedule or certificate
furnished by Neoforma pursuant to this Agreement contains or will contain at the
Closing, any untrue statement of a material fact, or omits or will omit at the
Closing to state any material fact necessary in order to make the statements
contained herein or therein, in the light of the circumstances under which made,
not misleading.
ARTICLE IV
CONDUCT PRIOR TO THE CLOSING
4.1 CONDUCT OF BUSINESS OF GAR. During the period from the date of this
Agreement and continuing until the earlier of the termination of this Agreement
or the Closing, GAR agrees (except to the extent that Neoforma shall otherwise
consent in writing) to carry on its business in the usual, regular and ordinary
course in substantially the same manner as heretofore conducted, to pay its
debts and Taxes when due, to pay or perform other obligations when due, and, to
the extent consistent with such business, to use all reasonable efforts
consistent with past practice and policies to preserve intact its present
business organization, keep available the services of its present officers and
key employees and preserve their relationships with customers, suppliers,
distributors, licensors, licensees, and others having business dealings with it,
all with the goal of preserving unimpaired its goodwill and ongoing businesses
at the Closing. GAR shall promptly notify Neoforma of any event or occurrence or
emergency not in the ordinary course of its business, and any material event
involving or adversely affecting GAR or its business. Except as set forth on
Schedule 4.1 hereto or as expressly contemplated by this Agreement, GAR shall
not, without the prior written consent of Neoforma:
19
<PAGE> 20
(a) Enter into any commitment, activity or transaction not in the
ordinary course of business;
(b) Transfer to any person or entity any rights to any GAR
Intellectual Property Rights;
(c) Enter into or amend any agreements pursuant to which any other
party is granted manufacturing, marketing, distribution or similar rights of any
type or scope with respect to any products of GAR;
(d) Amend or otherwise modify (or agree to do so), except in the
ordinary course of business, or violate the terms of, any of the agreements set
forth or described in GAR Schedules;
(e) Commence any litigation;
(f) Declare, set aside or pay any dividends on or make any other
distributions (whether in cash, equity interests or property) in respect of any
of its units or other evidences of ownership, or split, combine or reclassify
any of its units or issue or authorize the issuance of any other securities in
respect of, in lieu of or in substitution for units or other evidences of
ownership of GAR, or repurchase, redeem or otherwise acquire, directly or
indirectly, any GAR Member Interests (or GAR Member Interest Equivalents);
(g) Issue, grant, deliver or sell or authorize or propose the
issuance, grant, delivery or sale of, or purchase or propose the purchase of,
any units or securities convertible into, or subscriptions, rights, warrants or
options to acquire, or other agreements or commitments of any character
obligating it to issue any such units or other convertible securities;
(h) Cause or permit any amendments to its Organizational Documents;
(i) Acquire or agree to acquire by merging or consolidating with,
or by purchasing any assets or equity securities of, or by any other manner, any
business or any corporation, partnership, limited liability company, association
or other business organization or division thereof, or otherwise acquire or
agree to acquire any assets which are material, individually or in the
aggregate, to the business of GAR;
(j) Sell, lease, license or otherwise dispose of any of its
properties or assets, except in the ordinary course of business and consistent
with past practice;
(k) Incur any indebtedness for borrowed money or guarantee any such
indebtedness or issue or sell any debt securities of GAR or guarantee any debt
securities of others;
20
<PAGE> 21
(l) Grant any severance or termination pay to any director,
officer, employee or consultant, except payments made pursuant to standard
written agreements outstanding on the date hereof (which agreements are
disclosed on Schedule 2.20;
(m) Adopt or amend any employee benefit plan, program, policy or
arrangement, or enter into any employment contract, extend any employment offer,
pay or agree to pay any special bonus or special remuneration to any director,
employee or consultant, or increase the salaries or wage rates of its employees
(other than the two employees of GAR currently under review);
(n) Revalue any of its assets, including without limitation writing
down the value of inventory or writing off notes or accounts receivable in
excess of $10,000 in the aggregate;
(o) Pay, discharge or satisfy, in an amount in excess of $10,000,
in any one case, or $25,000, in the aggregate, any claim, liability or
obligation (absolute, accrued, asserted or unasserted, contingent or otherwise),
other than the payment, discharge or satisfaction in the ordinary course of
business of liabilities reflected or reserved against in GAR Financial
Statements;
(p) Make or change any material election in respect of Taxes, adopt
or change any accounting method in respect of Taxes, enter into any closing
agreement, settle any claim or assessment in respect of Taxes, or consent to any
extension or waiver of the limitation period applicable to any claim or
assessment in respect of Taxes;
(q) Enter into any strategic alliance, joint development or joint
marketing arrangement or agreement;
(r) Fail to pay or otherwise satisfy its monetary obligations as
they become due, except such as are being contested in good faith;
(s) Waive or commit to waive any rights with a value in excess of
$10,000, in any one case, or $25,000, in the aggregate;
(t) Cancel, materially amend or renew any insurance policy other
than in the ordinary course of business;
(u) Alter, or enter into any commitment to alter, its interest in
any corporation, association, joint venture, partnership, limited liability
company or other business entity in which GAR directly or indirectly holds any
interest on the date hereof; or
(v) Take, or agree in writing or otherwise to take, any of the
actions described in Sections 4.1(a) through 4.1(u) above, or any other action
that would prevent GAR from performing or cause GAR not to perform its covenants
hereunder.
21
<PAGE> 22
4.2 NO GAR SOLICITATION. Until the earlier of the Closing and the date
of termination of this Agreement pursuant to the provisions of Section 8.1
hereof, GAR will not (nor will GAR permit any of GAR's officers, directors,
Members, agents, representatives or affiliates to) directly or indirectly, take
any of the following actions with any party other than Neoforma and its
designees: (a) solicit, initiate, entertain, or encourage any proposals or
offers from, or conduct discussions with or engage in negotiations with, any
person relating to any possible acquisition of GAR or any of its subsidiaries
(whether by way of merger, purchase of equity securities, purchase of assets or
otherwise), any material portion of its or their capital stock or assets or any
equity interest in GAR or any of its subsidiaries, (b) provide information with
respect to it to any person, other than Neoforma, relating to, or otherwise
cooperate with, facilitate or encourage any effort or attempt by any such person
with regard to, any possible acquisition of GAR (whether by way of merger,
purchase of equity securities, purchase of assets or otherwise), any material
portion of its or their capital stock or assets or any equity interest in GAR or
any of its subsidiaries, (c) enter into an agreement with any person, other than
Neoforma, providing for the acquisition of GAR (whether by way of merger,
purchase of equity securities, purchase of assets or otherwise), any material
portion of its or their capital stock or assets or any equity interest in GAR or
any of its subsidiaries, or (d) make or authorize any statement, recommendation
or solicitation in support of any possible acquisition of GAR or any of its
subsidiaries (whether by way of merger, purchase of equity securities, purchase
of assets or otherwise), any material portion of its or their capital stock or
assets or any equity interest in GAR or any of its subsidiaries by any person,
other than by Neoforma. GAR shall immediately cease and cause to be terminated
any such contacts or negotiations with third parties relating to any such
transaction or proposed transaction. In addition to the foregoing, if GAR
receives prior to the Closing or the termination of this Agreement any offer or
proposal relating to any of the above, GAR shall immediately notify Neoforma
thereof, including information as to the identity of the offeror or the party
making any such offer or proposal and the specific terms of such offer or
proposal, as the case may be, and such other information related thereto as
Neoforma may reasonably request. Except as contemplated by this Agreement,
disclosure by GAR of the terms hereof (other than the prohibition of this
section) shall be deemed to be a violation of this Section 4.2.
ARTICLE V
ADDITIONAL AGREEMENTS
5.1 ACCESS TO INFORMATION. GAR shall afford Neoforma and its
accountants, counsel and other representatives, reasonable access during normal
business hours during the period prior to the Closing to (a) all of its
properties, books, contracts, commitments and records, and (b) all other
information concerning the business, properties and personnel (subject to
restrictions imposed by applicable law) of it as Neoforma may reasonably
request. Neoforma shall afford GAR and its accountants, counsel and other
representatives, reasonable access during normal business hours during the
period prior to the Closing to all materials necessary to reasonably permit it
to carry out the due diligence provided for in Section 6.2 (d) of this Agreement
as GAR may reasonably request. No information or knowledge obtained in any
investigation pursuant to this Section 5.1 shall affect or be deemed to modify
any representation or warranty contained herein.
22
<PAGE> 23
5.2 CONFIDENTIALITY. Each of the parties hereto hereby agrees to keep
the terms of this Agreement (except to the extent contemplated hereby) and such
information or knowledge obtained in any investigation pursuant to Section 5.1,
or pursuant to the negotiation and execution of this Agreement or the
effectuation of the transactions contemplated hereby, confidential; PROVIDED,
HOWEVER, that the foregoing shall not apply to information or knowledge which
(a) a party can demonstrate was already lawfully in its possession prior to the
disclosure thereof by the other party, (b) is generally known to the public and
did not become so known through any violation of law, (c) became known to the
public through no fault of such party, (d) is later lawfully acquired by such
party without confidentiality restrictions from other sources, (e) is required
to be disclosed by order of court or government agency with subpoena powers
(provided that such party shall have provided the other party with prior notice
of such order or subpoena and an opportunity to object or take other available
action) or (f) which is disclosed in the course of any litigation between any of
the parties hereto.
5.3 EXPENSES. Whether or not the Securities Purchase is consummated,
all fees and expenses incurred in connection with the Securities Purchase
including, without limitation, all legal, accounting, financial advisory,
consulting and all other fees and expenses of third parties ("THIRD PARTY
EXPENSES") incurred by a party in connection with the negotiation and
effectuation of the terms and conditions of this Agreement and the transactions
contemplated hereby, shall be the obligation of the respective party incurring
such fees and expenses.
5.4 PUBLIC DISCLOSURE. Neoforma shall have the right to issue such
press releases or other disclosures regarding the transactions contemplated
hereby in its sole discretion following the execution of this Agreement.
Neoforma shall obtain the prior consent of Tivin in the event he is named or
quoted in any such press release or disclosures.
5.5 CONSENTS. Neoforma, GAR and Tivin shall use their reasonable best
efforts to obtain the consents, waivers, assignments and approvals under any of
the GAR Contracts as may be required in connection with the Securities Purchase
(all of such consents, waivers and approvals are set forth in GAR Schedules) so
as to preserve and transfer all rights of and benefits to Neoforma thereunder
(or retain such rights and benefits with GAR).
5.6 REASONABLE EFFORTS. Subject to the terms and conditions provided in
this Agreement, each of the parties hereto shall use its reasonable efforts to
ensure that its representations and warranties remain true and correct in all
material respects, and to take promptly, or cause to be taken, all actions, and
to do promptly, or cause to be done, all things necessary, proper or advisable
under applicable laws and regulations to consummate and make effective the
transactions contemplated hereby, to obtain all necessary waivers, consents,
assignments and approvals, to effect all necessary registrations and filings,
and to remove any injunctions or other impediments or delays, legal or
otherwise, to consummate and make effective the transactions contemplated by
this Agreement for the purpose of securing to the parties hereto the benefits
contemplated by this Agreement; PROVIDED, that Neoforma shall not be required to
agree to any divestiture of any business, assets or property of Neoforma or its
subsidiaries or, or the imposition of any material limitation on the ability of
any of them to conduct their businesses or to own or exercise control of such
assets, properties and stock.
23
<PAGE> 24
5.7 EMPLOYMENT OF TIVIN. On the Closing Date, the Acquisition Sub,
Neoforma and Tivin agree to enter into an employment agreement in substantially
the same form as Exhibit C hereto (the "EMPLOYMENT AGREEMENT") which provides
for Tivin's being employed by the Acquisition Sub for a period of four (4)
years. The Employment Agreement shall provide for a base salary of One Hundred
Thousand Dollars ($100,000) per year, a bonus based upon the Acquisition Sub's
attaining certain sales thresholds to be agreed upon by the parties following
the Closing Date in a minimum amount of Fifty Thousand Dollars ($50,000) per
year, and shall provide for an automobile allowance of Fourteen Hundred Dollars
($1,400) per month.
5.8 CONSULTING AGREEMENT WITH FTIVIN. On the Closing Date, the
Acquisition Sub and FTivin agree to enter into a consulting agreement in
substantially the same form as Exhibit D hereto, which provides for FTivin's
acting as a consultant to the Acquisition Sub for a period of two years in
consideration for a consulting fee in the amount of $150,000 per year, which
consulting agreement shall be guaranteed by Neoforma pursuant to a guaranty in
substantially the same form as Exhibit E hereto.
5.9 TRANSFER OF INDUSTRIAL EQUIPMENT AUCTION ASSETS TO FTIVIN. Neoforma
agrees that ownership of those assets listed on Schedule 5.9 hereto, (the
"EXCLUDED ASSETS") which relate solely to the industrial equipment business
currently being conducted by GAR are being transferred to FTivin or his nominee,
on or before the Closing Date without there being any payment of consideration
to GAR by FTivin. Neoforma shall not consider such transfer to be in breach of
this Agreement. The parties expressly agree that the Excluded Assets shall not
include any assets owned by GAR and used in any manner in the medical equipment
auction business operated by GAR prior to the Closing Date.
5.10 NOTIFICATION OF CERTAIN MATTERS. GAR shall give prompt notice to
Neoforma, and Neoforma shall give prompt notice to GAR, of (a) the occurrence or
non-occurrence of any event, the occurrence or non-occurrence of which is likely
to cause any representation or warranty of GAR, Neoforma, respectively,
contained in this Agreement to be untrue or inaccurate at or prior to the
Closing and (b) any failure of GAR or Neoforma, as the case may be, to comply
with or satisfy any covenant, condition or agreement to be complied with or
satisfied by it hereunder; provided, however, that the delivery of any notice
pursuant to this Section 5.10 shall not limit or otherwise affect any remedies
available to the party receiving such notice.
5.11 ADDITIONAL DOCUMENTS AND FURTHER ASSURANCES. Each party hereto, at
the request of the other party hereto, shall execute and deliver such other
instruments and do and perform such other acts and things as may be necessary or
desirable for effecting completely the consummation of this Agreement and the
transactions contemplated hereby.
ARTICLE VI
CONDITIONS TO THE SECURITIES PURCHASE
6.1 CONDITIONS TO OBLIGATIONS OF EACH PARTY TO EFFECT THE SECURITIES
PURCHASE. The respective obligations of each party to this Agreement to effect
24
<PAGE> 25
the Securities Purchase shall be subject to the satisfaction at or prior to the
Closing of the following conditions:
(a) GAR Member Approval. This Agreement and the Securities Purchase
shall have been approved and adopted by the Members of GAR by the requisite vote
under applicable law and GAR's Organizational Documents.
(b) Neoforma Board Approval. This Agreement and the Securities
Purchase shall have been approved and adopted by the Board of Directors of
Neoforma by the requisite vote under applicable law and Neoforma's
organizational documents.
(c) No Injunctions or Restraints; Illegality. No temporary
restraining order, preliminary or permanent injunction or other order issued by
any court of competent jurisdiction or other legal or regulatory restraint or
prohibition preventing the consummation of the Securities Purchase shall be in
effect.
(d) Permits. All approvals from government authorities, including
any requisite Blue Sky approvals, which are appropriate or necessary for the
consummation of the Securities Purchase, shall have been obtained.
(e) Litigation. There shall be no BONA FIDE action, suit, claim or
proceeding of any nature pending, or overtly threatened, against Neoforma, GAR
or Tivin, their respective properties or any of their officers or directors,
arising out of, or in any way connected with, the Securities Purchase or other
transactions contemplated by the terms of this Agreement.
(f) Schedules. All Schedules and Exhibits to this Agreement and the
Employment Agreement shall have been prepared, agreed to by the parties and
attached to such agreements.
6.2 ADDITIONAL CONDITIONS TO OBLIGATIONS OF GAR. The obligations of GAR
and Tivin to consummate the Securities Purchase and the transactions
contemplated by this Agreement shall be subject to the satisfaction at or prior
to the Closing of each of the following conditions, any of which may be waived,
in writing, exclusively by GAR and Tivin:
(a) Representations and Warranties. The representations and
warranties of Neoforma contained in this Agreement shall be true and correct in
all material respects on and as of the Closing Date, except for changes
contemplated by this Agreement and except for those representations and
warranties which address matters only as of a particular date (which shall
remain true and correct as of such date), with the same force and effect as if
made on and as of the Closing Date, except, in all such cases, for such
breaches, inaccuracies or omissions of such representations and warranties which
have neither had nor reasonably would be expected to have a Material Adverse
Effect on Neoforma; and GAR and Tivin shall have received a certificate to such
effect signed on behalf of Neoforma by a duly authorized officer of Neoforma.
(b) Agreements and Covenants. Neoforma shall have performed or
complied in all material respects with all agreements and covenants required by
this Agreement to be
25
<PAGE> 26
performed or complied with by them on or prior to the Closing, and GAR and Tivin
shall have received a certificate to such effect signed by a duly authorized
officer of Neoforma.
(c) Legal Opinion; Tax Advice. GAR and Tivin shall have received a
legal opinion from Pepe & Hazard, LLP, counsel to Neoforma, in form reasonably
satisfactory to their legal counsel.
(d) Financial Due Diligence. GAR shall be satisfied that the
financial statements of Neoforma provided to it are complete and accurately
reflect the financial condition of Neoforma as represented by Neoforma and with
the results of its due diligence investigation of Neoforma.
6.3 ADDITIONAL CONDITIONS TO THE OBLIGATIONS OF NEOFORMA. The
obligations of Neoforma to consummate the Securities Purchase and the
transactions contemplated by this Agreement shall be subject to the satisfaction
at or prior to the Closing of each of the following conditions, any of which may
be waived, in writing, exclusively by Neoforma:
(a) Representations and Warranties. The representations and
warranties of GAR contained in this Agreement shall be true and correct in all
material respects on and as of the Closing Date, except for changes contemplated
by this Agreement and except for those representations and warranties which
address matters only as of a particular date (which shall remain true and
correct as of such date), with the same force and effect as if made on and as of
the Closing Date, except, in all such cases, for such breaches, inaccuracies or
omissions of such representations and warranties which have neither had nor
reasonably would be expected to have a Material Adverse Effect on GAR or
Neoforma; and Neoforma shall have received a certificate to such effect signed
on behalf of GAR by the chief executive officer and chief financial officer of
GAR.
(b) Agreements and Covenants. GAR and Tivin shall have performed or
complied in all material respects with all agreements and covenants required by
this Agreement to be performed or complied with by it on or prior to the
Closing, and Neoforma shall have received a certificate to such effect signed by
a duly authorized officer of GAR and Tivin.
(c) Third Party Consents. Neoforma shall have been furnished with
evidence satisfactory to it that GAR has obtained the consents, approvals and
waivers, if any, required to carry out the transactions set forth in this
Agreement.
(d) Legal Opinion. Neoforma shall have received a legal opinion from
Marks, Marks and Kaplan, Ltd., legal counsel to GAR and Tivin, in form
reasonably satisfactory to its legal counsel.
(e) Material Adverse Change. There shall not have occurred any
material adverse change in the business, assets (including intangible assets)
financial condition or results of operations of GAR since the date of GAR
Balance Sheet.
26
<PAGE> 27
(f) Noncompetition Agreements. Each of the persons listed on
Schedule 6.3(f) (which may be provided or supplemented on or before the Closing
Date) shall have executed and delivered to Neoforma on or before the Closing
Date a Noncompetition Agreement in form satisfactory to its legal counsel, and
all of the Noncompetition Agreements shall be in full force and effect.
(g) Employment Agreement. Erik Tivin shall have entered into the
Employment Agreement.
(h) Consulting Agreement. Fred Tivin shall have entered into the
Consulting Agreement.
(i) GAR Indebtedness. The total amount of indebtedness owing by GAR
(including accounts payable) shall not exceed One Hundred Thousand Dollars
($100,000).
(j) Due Diligence. Neoforma and its advisors shall be satisfied with
the results of its due diligence investigation of GAR and the Business. Neoforma
agrees to notify GAR of any additional due diligence requested by its investment
bankers, to the extent such due diligence is above or beyond that being
conducted by Neoforma's other advisors, and Neoforma's investment bankers shall
only be permitted to conduct such due diligence upon the consent of Tiven, which
consent shall not be unreasonably withheld.
ARTICLE VII
SURVIVAL OF REPRESENTATIONS AND WARRANTIES; INDEMNIFICATION
7.1 SURVIVAL OF REPRESENTATIONS AND WARRANTIES. All of the
representations and warranties of GAR, Tivin and Neoforma contained in this
Agreement or in any instrument delivered pursuant to this Agreement (each as
modified by the corresponding Schedules thereto) shall survive the Securities
Purchase and continue until 5:00 p.m., California time, on the two (2) year
anniversary of the Closing Date (the "EXPIRATION DATE").
7.2 INDEMNIFICATION.
(a) Indemnification by GAR and Tivin. GAR and Tivin jointly and
severally agree to indemnify and hold harmless Neoforma, the Acquisition Sub and
their officers, directors, and shareholders, against any and all loss, cost,
liability, claim, damage, deficiency, and expense whatsoever, including without
limitation legal fees and disbursements ("DAMAGE"), provided that Neoforma or
the Acquisition Sub may not make any claim for any Damage until such time as the
aggregated amount of any such Damage is equal to or exceeds $50,000, and
provided further that such indemnification shall be limited to an amount equal
to the unpaid portion of the Purchase Price (except to the extent otherwise
specifically stated herein), arising out of or resulting from:
(i) any misrepresentation, omission, breach of a
representation or warranty or other breach or non-fulfillment of any covenant on
the part of GAR or Tivin under this Agreement or any schedule, certificate or
other instrument furnished to Neoforma or the
27
<PAGE> 28
Acquisition Sub hereunder, or under any other agreement entered into in
connection with GAR's or Tivin's consummating the transactions contemplated by
and carrying out the purposes of this Agreement;
(ii) any liabilities arising from events occurring prior to
the Closing which have not been disclosed to Neoforma or the Acquisition Sub and
which have not arisen as the result of any act or omission attributable to
Neoforma or the Acquisition Sub, including but not limited to any tax
assessments (including but not limited to any tax liability related to General
Industrial Tool or Worldwide Auction Services), uninsured liabilities or breach
of contract;
(iii) any brokers' or finders' fees; and
(iv) all demands, assessments, judgments, costs and legal and
other fees and expenses arising from or in connection with any action, suit,
proceeding or claim incident to any of the foregoing.
(b) Neoforma's Procedure. Should any claim be made against Neoforma
or the Acquisition Sub for which indemnification is provided for in Section 7.2
(a) by a person not a party to this Agreement, Neoforma or the Acquisition Sub
shall promptly give GAR (if such claim is brought prior to the Closing) and
Tivin written notice of any such claim, and GAR (if such claim is brought prior
to the Closing) and Tivin shall thereafter defend or settle any such claim, at
their sole expense, on their own behalf and with counsel of their own choosing.
In such defense or settlement, Neoforma shall cooperate with and assist GAR (if
such claim is brought prior to the Closing) and Tivin to the maximum extent
reasonably possible and may participate therein with its own counsel. Any
payment resulting from such defense or settlement, together with the total
expense thereof, shall be binding on GAR (if such claim is brought prior to the
Closing) and Tivin. Failure to give notice within a reasonable period of time
shall not constitute a defense, in whole or in part, to any claim for
indemnification by Neoforma or the Acquisition Sub except and only to the extent
that such failure by Neoforma shall result in material prejudice to Tivin.
Notwithstanding the foregoing, Neoforma may, after not less than sixty
(60) days written notice to Tivin, make settlement of such claim, and such
settlement shall be binding on all such parties for purposes of this Section 7.2
(b); however, if within said sixty (60) day period Tivin shall have requested
Neoforma not to settle such claim and to deny such claim at the expense of
Tivin, Neoforma shall comply with such request provided that (i) Tivin shall
diligently defend such claim as provided above, and (ii) in Neoforma's
reasonable judgment failure to settle the same will not have a material or
adverse affect on the conduct of the business of Neoforma in the normal course.
Any payment resulting from such defense or settlement, together with the total
expense thereof, shall be binding on all parties, for the purposes of this
Section 7.2 (b).
Failure to give notice within a reasonable period of time shall not
constitute a defense, in whole or in part, to any claim for indemnification by
Neoforma, except and only to the extent that such failure by Neoforma shall
result in a material prejudice to GAR (if such claim is brought prior to the
Closing) and Tivin. In the event Neoforma or the Acquisition Sub incur, or a
28
<PAGE> 29
claim is made seeking, any Damages for which indemnification is allowed pursuant
to Section 7.2 (a) (i), (ii), (iii) or (iv), Neoforma or the Acquisition Sub
shall, in addition to any other remedies, have the right to offset the amount of
any such Damages against any amount which may be owing to Tivin under this
Agreement, the Note, or any agreement entered into between Tivin and/or GAR, on
the one hand, and the Acquisition Sub and/or Neoforma, on the other hand,
pursuant to this Agreement or otherwise and, to the extent such amount exceeds
any amounts still owing at such time from Neoforma to GAR. Anything herein to
the contrary notwithstanding, in no event shall Neoforma be required to consent
to a non-monetary term or condition to such settlement as a condition to
indemnification hereunder.
(c) Indemnification by Neoforma. Neoforma shall indemnify Tivin and
hold Tivin harmless at all times after the Closing against and in respect of any
of the following:
(i) any and all liabilities and obligations of Neoforma or GAR
arising after the Closing except to the extent that the same may have been
caused by circumstances existing prior to the Closing;
(ii) any and all Damages resulting from any misrepresentation,
omission, breach of representation or warranty, or non-fulfillment of any
covenant on the part of Neoforma under this Agreement or any schedule to this
Agreement or in any certificate or other instrument furnished to Tivin hereunder
or any other agreement entered into in connection with Neoforma consummating the
transactions contemplated by this Agreement;
(iii) any increased tax liability, including without
limitation all penalties and interest, incurred by Tivin due to the payments
under the Note being construed as ordinary income as opposed to capital gains;
and
(iv) all demands, assessments, judgments, costs and legal and
other fees and expenses arising from or in connection with any action, suit,
proceeding or claim incident to any of the foregoing.
(d) Tivin's Procedure. Should any claim be made against Tivin for
which indemnification is provided for in Section 7.2 (c) by a person not a party
to this Agreement, Tivin shall promptly give Neoforma written notice of any such
claim, and Neoforma shall thereafter defend or settle any such claim, at its
sole expense, on its own behalf and with counsel of its own choosing. In such
defense or settlement, Tivin shall cooperate with and assist Neoforma and Tivin
may participate therein to the maximum extent reasonably possible with his own
counsel. Any payment resulting from such defense or settlement, together with
the total expense thereof, shall be binding on Neoforma. Failure to give notice
within a reasonable period of time shall not constitute a defense, in whole or
in part, to any claim for indemnification by Tivin except and only to the extent
that such failure by Tivin shall result in material prejudice to Neoforma.
Notwithstanding the foregoing, Tivin may, after not less than sixty
(60) days written notice to Neoforma, make settlement of such claim, and such
settlement shall be binding on all such parties for purposes of this Section 7.2
(d); however, if within said sixty (60) day period
29
<PAGE> 30
Neoforma shall have requested Tivin not to settle such claim and to deny such
claim at the expense of Neoforma, Tivin shall comply with such request provided
that (i) Neoforma shall diligently defend such claim as provided above, and (ii)
in Tivin's reasonable judgment failure to settle the same will not have a
material or adverse affect on the conduct of the business of Tivin in the normal
course. Any payment resulting from such defense or settlement, together with the
total expense thereof, shall be binding on all parties, for the purposes of this
Section 7.2 (d).
Failure to give notice within a reasonable period of time shall not
constitute a defense, in whole or in part, to any claim for indemnification by
Tivin, except and only to the extent that such failure by Tivin shall result in
a material prejudice to Neoforma or the Acquisition Sub. In the event a claim is
made seeking any Damages for which indemnification is allowed pursuant to
Section 7.2 (c), Tivin shall, in addition to any other remedies, have the right
to offset the amount of any such Damages against any amount which may be owing
to Neoforma under this Agreement, any agreement entered into pursuant to this
Agreement or otherwise. Anything herein to the contrary notwithstanding, in no
event shall Tivin be required to consent to a non-monetary term or condition to
such settlement as a condition to indemnification hereunder.
(e) Remedies Cumulative. Except as herein expressly provided, the
remedies provided herein shall be cumulative and shall not preclude the
assertion by one Party of any other rights or the seeking of any other remedies
against the other Party.
ARTICLE VIII
TERMINATION, AMENDMENT AND WAIVER
8.1 TERMINATION. Except as provided in Section 8.2 below, this
Agreement may be terminated and the Securities Purchase abandoned at any time
prior to the Closing:
(a) by mutual consent of GAR, Tivin and Neoforma;
(b) by Neoforma, GAR or Tivin if: (i) the Closing has not occurred
before 5:00 p.m. (Pacific time) on September 17, 1999 (provided that the right
to terminate this Agreement under this clause 8.1(b)(i) shall not be available
to any party whose willful failure to fulfill any obligation hereunder has been
the cause of, or resulted in, the failure of the Closing to occur on or before
such date); (ii) there shall be a final nonappealable order of a federal or
state court in effect preventing consummation of the Securities Purchase; or
(iii) there shall be any statute, rule, regulation or order enacted, promulgated
or issued or deemed applicable to the Securities Purchase by any governmental
entity that would make consummation of the Securities Purchase illegal;
(c) by Neoforma if there shall be any action taken, or any statute,
rule, regulation or order enacted, promulgated or issued or deemed applicable to
the Securities Purchase, by any Governmental Entity, which would: (i) prohibit
Neoforma's ownership of GAR or ownership or operation of all or any portion of
the Business or the Acquisition Sub's ownership or operation of all or any
portion of the Business or (ii) compel Neoforma or the Acquisition Sub to
dispose of or hold separate all or a portion of the business or assets of GAR or
Neoforma as a result of the Securities Purchase;
30
<PAGE> 31
(d) by Neoforma if it is not in material breach of its obligations
under this Agreement and there has been a breach of any representation,
warranty, covenant or agreement contained in this Agreement on the part of GAR
and (i) such breach has not been cured within five (5) business days after
written notice to GAR (provided that, no cure period shall be required for a
breach which by its nature cannot be cured), and (ii) as a result of such breach
the conditions set forth in Section 6.3(a) or 6.3(b), as the case may be, would
not then be satisfied; or
(e) by GAR if it is not in material breach of its obligations under
this Agreement and there has been a breach of any representation, warranty,
covenant or agreement contained in this Agreement on the part of Neoforma and
(i) such breach has not been cured within five (5) business days after written
notice to Neoforma (provided that, no cure period shall be required for a breach
which by its nature cannot be cured), and (ii) as a result of such breach the
conditions set forth in Section 6.2(a) or 6.2(b), as the case may be, would not
then be satisfied.
Where action is taken to terminate this Agreement pursuant to this
Section 8.1, it shall be sufficient for such action to be authorized, in the
case of Neoforma, by the Board of Directors of Neoforma, and in the case of GAR,
by Tivin (if prior to the Closing Date).
8.2 EFFECT OF TERMINATION. In the event of termination of this
Agreement as provided in Section 8.1, this Agreement shall forthwith become void
and there shall be no liability or obligation on the part of Neoforma, or GAR,
or their respective officers, directors, shareholders or Members, or Tivin;
PROVIDED, that each party shall remain liable for any breaches of this Agreement
prior to its termination; and PROVIDED FURTHER, that, the provisions of Sections
5.2 and 5.3 of this Agreement shall remain in full force and effect and survive
any termination of this Agreement.
8.3 AMENDMENT. Except as is otherwise required by applicable law after
the Members of GAR approve this Agreement, this Agreement may be amended by the
parties hereto at any time by execution of an instrument in writing signed on
behalf of each of the parties hereto.
8.4 EXTENSION; WAIVER. At any time prior to the Closing, Neoforma, on
the one hand, and GAR and Tivin, on the other, may, to the extent legally
allowed, (a) extend the time for the performance of any of the obligations of
the other party hereto, (b) waive any inaccuracies in the representations and
warranties made to such party contained herein or in any document delivered
pursuant hereto, and (c) waive compliance with any of the agreements or
conditions for the benefit of such party contained herein. Any agreement on the
part of a party hereto to any such extension or waiver shall be valid only if
set forth in an instrument in writing signed on behalf of such party.
31
<PAGE> 32
ARTICLE IX
GENERAL PROVISIONS
9.1 NOTICES. All notices and other communications hereunder shall be in
writing and shall be deemed given if delivered personally or by commercial
delivery service, or mailed by registered or certified mail (return receipt
requested) or sent via facsimile (with acknowledgment of complete transmission)
to the parties at the following addresses (or at such other address for a party
as shall be specified by like notice):
If to Neoforma, to:
Neoforma, Inc.
3255-7 Scott Boulevard
Santa Clara, California 95054
Attention: Wm. Samuel Veazey, Controller
Telephone No.: (408) 654-5700
Facsimile No.: (408) 549-6299
With a copy to:
Pepe & Hazard, LLP
150 Federal Street, 28th Floor
Boston, Massachusetts 02110
Attn: John A. Kostrubanic, Esq.
Telephone No.: (617) 695-9090
Facsimile No.: (617) 695-9255
If to GAR or Tivin, to:
General Asset Recovery
3190 Kennicott Avenue
Arlington Heights, Illinois 60004
Attention: Erik Tivin
Telephone No.: (847) 222-1000
Facsimile No.: (847) 255-2922
With a copy to:
Marks, Marks and Kaplan Ltd.
120 North La Salle Street, Suite 3200
Chicago, Illinois 60602
Attn: Spencer J. Marks, Esq.
Telephone No.: (312) 332-5200
Facsimile No.: (312) 332-2952
32
<PAGE> 33
9.2 INTERPRETATION. The words "include," "includes" and "including"
when used herein shall be deemed in each case to be followed by the words
"without limitation." The table of contents and headings contained in this
Agreement are for reference purposes only and shall not affect in any way the
meaning or interpretation of this Agreement.
9.3 COUNTERPARTS. This Agreement may be executed in one or more
counterparts, all of which shall be considered one and the same agreement and
shall become effective when one or more counterparts have been signed by each of
the parties and delivered to the other party, it being understood that all
parties need not sign the same counterpart.
9.4 TRANSFER TAXES. GAR shall pay all real property transfer Taxes,
sales Taxes, stock transfer Taxes, documentary stamp Taxes, recording charges
and other similar Taxes resulting from, arising under or in connection with the
transfer of the Member Interests or any other related transaction under the
Agreement.
9.5 ENTIRE AGREEMENT; ASSIGNMENT. This Agreement, the Schedules and
Exhibits hereto, and the documents and instruments and other agreements among
the parties hereto referenced herein: (a) constitute the entire agreement among
the parties with respect to the subject matter hereof and supersede all prior
agreements and understandings, both written and oral, among the parties with
respect to the subject matter hereof; (b) are not intended to confer upon any
other person any rights or remedies hereunder; and (c) shall not be assigned by
operation of law or otherwise except as otherwise specifically provided, except
that Neoforma may assign its respective rights and delegate its obligations
hereunder to its affiliates; PROVIDED, that such affiliates agree to be bound by
the terms hereof.
9.6 SEVERABILITY. In the event that any provision of this Agreement or
the application thereof, becomes or is declared by a court of competent
jurisdiction to be illegal, void or unenforceable, the remainder of this
Agreement will continue in full force and effect and the application of such
provision to other persons or circumstances will be interpreted so as reasonably
to effect the intent of the parties hereto. The parties further agree to replace
such void or unenforceable provision of this Agreement with a valid and
enforceable provision that will achieve, to the extent possible, the economic,
business and other purposes of such void or unenforceable provision.
9.7 OTHER REMEDIES. Except as otherwise provided herein, any and all
remedies herein expressly conferred upon a party will be deemed cumulative with
and not exclusive of any other remedy conferred hereby, or by law or equity upon
such party, and the exercise by a party of any one remedy will not preclude the
exercise of any other remedy.
9.8 GOVERNING LAW; JURISDICTION AND VENUE. This Agreement shall be
governed by and construed in accordance with the laws of the State of Delaware,
regardless of the laws that might otherwise govern under applicable principles
of conflicts of laws thereof. Each of the parties hereto agrees that process may
be served upon them in any manner authorized by the laws of the State of
Delaware for such persons and waives and covenants not to assert or plead any
objection which they might otherwise have to such jurisdiction and such process.
Any
33
<PAGE> 34
dispute arising under this Agreement shall be resolved in a court of competent
jurisdiction within the State of California and the parties hereby consent to
the jurisdiction of such court.
9.9 RULES OF CONSTRUCTION. The parties hereto agree that they have been
represented by counsel during the negotiation and execution of this Agreement
and, therefore, waive the application of any law, regulation, holding or rule of
construction providing that ambiguities in an agreement or other document will
be construed against the party drafting such agreement or document. All
Schedules and Exhibits hereto shall be considered incorporated herein by
reference and are made a part hereof.
9.10 SPECIFIC PERFORMANCE. The parties hereto agree that irreparable
damage would occur in the event that any of the provisions of this Agreement
were not performed in accordance with their specific terms or were otherwise
breached. It is accordingly agreed that the parties shall be entitled to an
injunction or injunctions to prevent breaches of this Agreement and to enforce
specifically the terms and provisions hereof in any court of the United States
or any state having jurisdiction, this being in addition to any other remedy to
which they are entitled at law or in equity.
IN WITNESS WHEREOF, Neoforma, GAR, and Tivin, have caused this
Agreement to be signed by their duly authorized respective officers and
representatives, all as of the date first written above.
GENERAL ASSET RECOVERY, LLC NEOFORMA, INC.
By: _______________________________ By: _______________________________
Name: Name:
Title: Title:
NEOFORMA GAR, INC.
By: _______________________________
Name:
Title:
GAR MEMBER INTEREST HOLDERS
__________________________________ __________________________________
Erik Tivin, Individually Fred Tivin, Individually
34
<PAGE> 35
EXHIBIT A TO
EXHIBIT 2.01
PROMISSORY NOTE
$7,800,000 August _______, 1999
FOR VALUE RECEIVED, the undersigned, Neoforma GAR, Inc., a Delaware
corporation, with an address c/o Neoforma, Inc., 3255-7 Scott Boulevard, Santa
Clara, California 95054 (the "MAKER"), promises to pay Erik Tivin of 430 Newtown
Drive, Buffalo Grove, Illinois 60089 ("TIVIN") the principal sum of Seven
Million Eight Hundred Thousand Dollars ($7,800,000) with interest on the unpaid
balance from the date hereof at the rate of Seven Percent (7%) per annum. This
Note is entered into pursuant to the terms of a Securities Purchase Agreement
dated July 16th, 1999 by and among Neoforma, Inc. (the maker's parent company),
Tivin and General Asset Management, LLC pursuant to which the maker has acquired
all of the issued and outstanding securities of General Asset Management, LLC
(the "SECURITIES PURCHASE") and shall be subject to the terms and conditions
thereof, including without limitation, (i) the right of the maker to set off
against any amounts of principal and interest due hereunder the amount of any
indemnification which is determined to be payable by Tivin under Section 7 of
said Securities Purchase Agreement, and (ii) the partial acceleration of this
Note pursuant to Section 1.2 of said Securities Purchase Agreement as set forth
in Section 4 below.
This Note shall have the following additional terms and provisions:
1. Payment. Principal and interest shall be due and payable as follows:
(a) During the first twelve months following the closing date of the
Securities Purchase (the "CLOSING DATE"), the maker shall make payments
beginning on the first day of the month following the Closing Date and on the
first day of each month thereafter in an amount equal to the amount of interest
accrued on the outstanding balance under this Note during the preceding month
plus a principal payment of One Hundred Eighty Three Thousand Three Hundred
Thirty Three Dollars ($183,333);
(b) During the thirteenth through the forty-eighth month following
the Closing Date, the maker shall make payments on the first day of each month
in an amount equal to the amount of interest accrued on the outstanding balance
under this Note during the preceding month plus a principal payment of One
Hundred Thirty Seven Thousand Five Hundred Dollars ($137,500);
-35-
<PAGE> 36
(c) During the forty-ninth through the sixtieth month following the
Closing Date, the maker shall make payments on the first day of each month in an
amount equal to the amount of interest accrued on the outstanding balance under
this Note during the preceding month plus a principal payment of Fifty Four
Thousand One Hundred Sixty Seven Dollars ($54,167).
2. Prepayment/Conversion. This Note may be prepaid in whole or in part
at any time and from time to time without premium or penalty and without prior
notice to Tivin, and any such prepayments may not be directed to be applied to
any subsequent installments of principal. This Note shall not be convertible
into shares of the maker or of any endorser hereon or guarantor hereof.
3. Full Acceleration. This Note shall, at the option of Tivin, become
immediately due and payable without notice or demand by Tivin to the maker upon
the occurrence of any of the following events (each being an "EVENT OF
DEFAULT"):
(a) Failure of the maker to pay within ten (10) days after notice
thereof by Tivin to the maker that any payment of principal or interest herein
required shall have become due and not paid in a timely manner;
(b) Dissolution or termination of existence of the maker or of any
endorser hereon or guarantor hereof; or
(c) The making of an assignment for the benefit of creditors,
insolvency, appointment of a receiver (not discharged within sixty (60) days) of
any part of the property of, or the filing of a petition in bankruptcy, or the
commencement of any proceedings under any bankruptcy or insolvency law or any
law relating to the relief of debtors, readjustment or indebtedness,
reorganization, composition or extension, by or (if not discharged within sixty
(60) days) against, the maker or any endorser hereon or guarantor hereof.
4. Partial Acceleration. In the event of the termination of the
Employment Agreement dated August _____, 1999 between the maker of this Note and
Tivin without "cause" as defined in said Employment Agreement, an amount equal
to fifty percent (50%) of the unpaid portion of this Note shall become
immediately payable, with the balance of this Note continuing to be payable in
the same manner and over the same time period over the balance of the term of
this Note, except that each monthly principal payment shall be reduced to an
amount equal to fifty percent (50%) of the payments set forth in Section 1.
5. Notices. Any notice, request or instruction to be given hereunder
shall be in writing and shall be delivered in person or transmitted by facsimile
(with confirmation in writing to be made available upon request) or mailed by
certified mail, return receipt
-36-
<PAGE> 37
requested, postage prepaid, and delivered to the appropriate party and address
as shown above. Either of the addresses specified above may be changed by notice
given as herein provided. All communications will be deemed effective upon
receipt.
6. No Assignment. This Note shall inure solely to the benefit of Tivin
and shall not be assignable.
7. Waiver.
(a) The maker and all endorsers and guarantors of this Note hereby
waive presentment, demand, protest and all other demands in connection with the
delivery and enforcement of this Note.
(b) Tivin shall not, by any act, delay, omission or otherwise, be
deemed to have waived any of its rights or remedies hereunder, unless such
waiver be in writing and signed by Tivin, and then only to the extent expressly
set forth therein. A waiver on any one occasion shall not constitute or be
construed as a bar to or a waiver of any such right or remedy on any future
occasion.
8. Choice of Law. The execution, delivery and performance of this Note
shall be governed by and construed in accordance with the laws of the State of
Delaware.
9. Legal Fees. Maker shall be liable for any and all fees and expenses
incurred by Tivin, including legal fees, in connection with his enforcing this
Note.
This Note has been executed under seal on the day and year first above
written.
NEOFORMA GAR, INC.
_____________________________ By:_____________________________
Witness
-37-
<PAGE> 38
EXHIBIT B TO
EXHIBIT 2.01
GUARANTY
THIS GUARANTY ("GUARANTY"), executed as of the ____ day of August, 1999
is by Neoforma, Inc., a Delaware corporation, having a mailing address of 3255-7
Scott Boulevard, Santa Clara, California 95054 ("GUARANTOR") for the benefit of
Erik Tivin having an address of 430 Newtown Drive, Buffalo Grove, Illinois 60089
( the "SELLER").
RECITALS
This Guaranty is given in connection with a promissory note (the "NOTE")
of even date herewith executed by Neoforma GAR, Inc., a Delaware corporation
(the "BUYER") in favor of the Seller in the original principal amount of Seven
Million Eight Hundred Thousand Dollars ($7,800,000) issued pursuant to and as an
inducement to Seller to enter into that certain Securities Purchase Agreement
dated July 16th, 1999, by and among Guarantor, Buyer and Seller (the
"AGREEMENT") which provided for the purchase by the Buyer of the issued and
outstanding securities of General Asset Recovery, LLC, an Illinois limited
liability company.
NOW THEREFORE, in consideration of the transactions contemplated in the
Agreement and for other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, Guarantor hereby makes the
following representations and warranties to Seller and hereby covenants and
agrees with Seller as follows:
1. GUARANTY. Guarantor hereby absolutely, unconditionally and
irrevocably guaranties to Seller the performance and payment when due, whether
at maturity, by acceleration or otherwise, of all liabilities and obligations
now or hereafter owing by, or chargeable to Buyer under the Note, including
without limitation, principal and interest, and all other liabilities and
obligations of Buyer to Seller, which become due, if ever, under the Note (the
foregoing being hereinafter collectively referred to as the "OBLIGATIONS"). Upon
the occurrence of an Event of Default (as defined in the Note), Guarantor shall,
on demand by Seller, immediately pay and perform all Obligations as are then or
may thereafter from time to time become due and owing, without further notice
from Seller.
2. MISCELLANEOUS.
(a) Notices. Any notice, request or instruction to be given
hereunder shall be in writing and shall be delivered in person or
transmitted by facsimile (with confirmation in writing to be made
available upon request) or mailed by certified mail, return receipt
requested, postage prepaid, and delivered to the appropriate party and
address as shown above. Either of the addresses specified above may be
changed by notice given as herein provided. All communications will be
deemed effective upon receipt.
38
<PAGE> 39
(b) No Assignment. This Guaranty shall be binding upon Guarantor
and inure solely to the benefit of Seller and shall not be assignable.
(c) Termination. If all sums and indebtedness owing under the
Note shall be fully and indefeasibly paid in cash, this Guaranty shall
terminate and be of no further force or any effect.
(d) Governing Law. The execution, delivery and performance of
this Guaranty shall be governed by the laws of the State of Delaware.
(e) Legal Fees. Guarantor shall be liable for any and all fees
and expenses incurred by Seller, including legal fees, in connection
with its enforcing this Guaranty.
GUARANTOR
Neoforma, Inc.
By:
-------------------------------------
Robert J. Zollars, President and
Chief Executive Officer
39
<PAGE> 40
EXHIBIT C TO
EXHIBIT 2.01
EMPLOYMENT AGREEMENT
This Employment Agreement (the "EMPLOYMENT AGREEMENT") is made this
_____ day of August, 1999, by and between Neoforma GAR, Inc., a Delaware
corporation, (the "COMPANY"), Neoforma, Inc., a Delaware corporation,
("NEOFORMA"), and Erik Tivin of Buffalo Grove, Illinois (the "EMPLOYEE").
RECITALS
The Company has acquired all of the issued and outstanding securities
(the "SECURITIES PURCHASE") of General Asset Recovery, LLC, ("GAR") pursuant to
the terms of a certain Securities Purchase Agreement dated July 16th, 1999,
which provided for the employment of the Employee by the Company.
The Company and the Employee acknowledge that the Employee's abilities
and services are essential to the prospects of the Company, the Company desires
to hire the Employee as its President, and the Employee desires to accept such
employment.
The parties hereto desire to enter into a comprehensive agreement to
set forth the terms and conditions pursuant to which the Employee shall be
employed by the Company.
NOW, THEREFORE, in consideration of Employee's employment by the
Company, the mutual covenants and agreements hereinafter set forth, and for
other good and valuable consideration, the receipt and sufficiency of which are
hereby acknowledged, the Company and the Employee, intending to be legally
bound, agree as follows:
1. Employment. The Company hereby agrees to employ the Employee, and
the Employee hereby accepts employment, all upon the terms, conditions and
covenants set forth in this Employment Agreement which the Company and Employee
agree are reasonable.
2. Duties. The Employee shall serve on a full-time basis as the
Company's President, with all powers and duties customarily associated with such
title and as are otherwise set forth herein, and shall:
(a) faithfully and diligently perform the duties of President of the
Company, and Vice President of Neoforma, the Company's parent company;
(b) comply with the overall reasonable business policies established
by the Chief Executive Officer (the "CHIEF EXECUTIVE OFFICER") of Neoforma, or
by the Board of Directors (the "BOARD OF DIRECTORS") of Neoforma; and
(c) do all things reasonably within his power to promote, develop,
operate and expand the "business of the Company" in a manner designed to meet
with the projections set forth on Schedule A hereto. For the purposes of setting
forth the duties of the Employee in
40
<PAGE> 41
this Section 2, the "business of the Company" shall include, (i) the business
operated as GAR prior to its acquisition by the Company, which the Employee
agrees to operate in substantially the same manner as it was operated by him
prior to such acquisition; (ii) a medical equipment auction business, which may
include Neoforma Trade, over which the Employee is given oversight, whether such
business is operated directly through the Company or otherwise; and (iii) the
asset management business operated by Neoforma prior to the acquisition of GAR
by the Company, whether operated through the Company or otherwise.
The Employee agrees to perform such other related duties as may be
delegated to the Employee from time to time by the Chief Executive Officer or by
the Board of Directors. The Employee shall devote his full time and reasonable
business efforts in the performance of his duties and shall not have any outside
employment while employed on a full-time basis by the Company. The Employee
shall report directly to the Chief Executive Officer or a similar level
executive officer of Neoforma appointed by the Board of Directors, and shall be
required to submit a monthly operations report to such Chief Executive Officer
or such other officer on or before the fifteenth day of each month with respect
to the Company's operations for the prior month. The Employee shall not be
required to relocate his base of employment outside of the State of Illinois.
3. Term. The term of this Employment Agreement shall begin on the date
hereof (the "EFFECTIVE DATE") and shall continue until the earlier of December
31, 2001 or the date of any termination hereunder (the "TERM").
4. Compensation. All compensation paid or payable hereunder shall be
deemed to be paid or payable by the Company in accordance with the Company's
general policy, as set forth in the Company's written manuals, unless this
Employment Agreement specifically states otherwise.
(a) Salary. During the Term of this Employment Agreement, the
Company shall pay to the Employee, in consideration for the services provided by
him hereunder, an annual base salary in the minimum of One Hundred Thousand
Dollars ($100,000) per year (the "ANNUAL SALARY"), which amount shall be payable
in accordance with Neoforma's customary payroll practices and shall be prorated
for any partial years of employment hereunder. The Board of Directors shall have
the right but not the obligation to increase the amount of the Annual Salary
based upon the performance of the Company and the Employee.
(b) Bonus. As further compensation, provided Employee remains
employed by the Company, Employee shall be entitled to receive an annual bonus
payable following the completion of each year during the Term, based on the
level of sales attained by the Company, which bonus shall be calculated in the
manner set forth on Schedule B attached hereto but which shall not be less than
Fifty Thousand Dollars ($50,000) per year.
(c) Stock Options. In consideration of his continued employment
hereunder, the Employee shall be granted options to purchase up to Five Hundred
Fifty
41
<PAGE> 42
Thousand (550,000) shares of the common stock, $0.001 par value, of Neoforma,
which options shall be exercisable at a price of $0.10 per share. The options
shall vest (i) at a rate of Thirty Three Thousand Three Hundred Thirty Three
(33,333) shares per month during each of months one through twelve following the
closing date of the Securities Purchase (the "CLOSING Date") (on the same date
of each month as the Closing Date), and (ii) at the rate of Four Thousand One
Hundred Sixty Seven (4,167) shares per month during each of months thirteen
through forty-seven, with the balance of the remaining options to vest in month
forty-eight, following the Closing Date (on the same day of each month as the
Closing Date). Notwithstanding the foregoing, in the event Employee ceases to be
employed by the Company during the term of this Employment Agreement, other than
if Employee is terminated by the Company without cause as defined in Section 9,
Employee shall forfeit the right to exercise any options which have not yet
vested. The options being issued hereunder shall be exercisable for a period of
seven years and shall be issued pursuant to Neoforma's 19__ Employee Stock
Option Plan.
5. Benefits. All benefits paid or payable hereunder shall be deemed to
be paid or payable by the Company in accordance with the Company's general
policy, as set forth in the Company's written manuals, unless this Employment
Agreement specifically states otherwise.
(a) Vacation, Paid Holidays. During the Term, the Employee shall be
entitled to take twenty-two (22) days of paid time off, unless otherwise agreed
upon by the Employee and the Company. The Employee shall also be entitled to
paid absence for all holidays provided by the Company to its other employees
plus any other holiday upon which the Company is closed for business. Nothing
herein shall prohibit the Company from changing the holidays which it observes
hereafter.
(b) Other Benefits. During the Term, the Employee shall be entitled
to participate (to the extent that he is eligible) in all other employee
benefits, if any, provided by the Company under the same terms and conditions as
provided for its other executive officers including but not limited to: (i)
health and disability insurance under such policies or plans as the Company may
adopt; (ii) participation in such 401(k) plan as the Company may establish; and
(iii) term life insurance coverage in such amounts and under such policies or
plans as the Company may adopt.
(c) Automobile Allowance. The Employee shall be entitled each month
to an automobile allowance in the amount of One Thousand Four Hundred Dollars
($1,400) which shall be used for automobile related expenses incurred by the
Employee in the performance of his duties hereunder.
6. Reimbursement for Expenses. Upon the submission of appropriate
invoices or vouchers, the Employee shall be entitled to reimbursement for all
reasonable expenses that he incurs in the performance of his duties under this
Employment Agreement in furthering the
42
<PAGE> 43
business and policies of the Company, such reimbursement to be paid in
accordance with Neoforma's customary expense reimbursement practices.
7. Key Person Life Insurance. The Company shall have the right but not
the obligation to maintain and pay for a key person life insurance policy on the
life of the Employee, as to which the Company shall be the sole beneficiary and
owner. The Employee agrees upon the execution of this Employment Agreement to
cooperate fully with the Company and to provide the Company with all necessary
documents in order for the Company to obtain such policy.
8. Withholding. The Company shall withhold or deduct from the
Employee's cash compensation any amounts required by law to be so withheld or
deducted.
9. Termination by The Company.
(a) This Employment Agreement may be terminated by the Company upon
the occurrence of any of the following:
(i) the Employee's death. If the Employee dies during the Term,
the Company's obligations under this Employment Agreement shall terminate
immediately and the Employee's estate shall be entitled to all arrearages of
salary and expenses but shall not be entitled to further compensation unless
otherwise specifically provided for under this Employment Agreement.
(ii) the action by the Board of Directors following the
Employee's "disability". For this purpose, "disability" means a physical or
mental illness or other incapacity which renders the Employee unable to perform
substantially all of his duties for a period of six (6) months. For purposes of
this Employment Agreement, disability shall be deemed a continuation of any
prior disability if the disability is related to the prior disability and
commences within twelve (12) months of the termination of the prior disability.
Disability, and any relation to any prior disability, shall be determined by a
physician acceptable to the Company and the Employee provided that if the
Company and the Employee fail to agree on a mutually acceptable physician, a
third physician shall be chosen by each party's physician and any determination
by such third physician shall be binding. If the Employee becomes disabled
during the Term, the Employee may pursue his rights under any disability plan
maintained by the Company.
(iii) the action of Neoforma's Board of Directors for Cause.
"Cause" is defined as the occurrence of any of the following events: (A) fraud,
misappropriation, embezzlement or intentional misconduct on the part of the
Employee, (B) the Employee's willful failure to substantially perform his duties
for the Company when, and to the extent, requested by the Board of Directors, or
its lawfully designated representative, to do so and failure to correct same
within five (5) business days after notice from the Board of Directors or its
lawfully designated representative requesting the Employee to do so, which has a
materially
43
<PAGE> 44
adverse effect upon the Company, or (C) the Employee's willful breach of any
material provision of this Employment Agreement and such breach continues for a
period of five (5) business days after notice from the Board of Directors or its
lawfully designated representative of such breach. Termination by the Company
for cause will be effective immediately upon receipt by the Employee of notice
of such termination.
(b) Termination of Benefits. In the event of any termination by the
Company for "cause" pursuant to Section 9 (a) hereof, or any voluntary
termination by the Employee, in addition to the termination of the various
benefits and compensation payable to the Employee hereunder generally, the
benefits provided for pursuant to Section 4 of this Employment Agreement shall,
to the extent not yet accrued or vested, automatically cease and terminate, and
any and all unvested stock options held by Employee in Neoforma shall
automatically expire.
(c) Survival. Notwithstanding anything else in this Employment
Agreement, the provisions of Section 10 (Confidentiality), Section 11
(Non-Competition and Non-Solicitation), Section 12 (Developments), Section 13
(Representations and Warranties) and Section 23 (Equitable Remedies) shall
survive the termination of the Employee's employment with the Company, if by the
Company, for "cause" or by the Employee. In the event the Employee's employment
hereunder is terminated by the Company without cause, or due to the bankruptcy
or insolvency of the Company, or due to any material breach of this Employment
Agreement by the Company, the only provision of this Employment Agreement which
shall survive shall be Section 10 (Confidentiality) to the extent that it deals
with Confidential Information of the Company which existed prior to the date of
this Employment Agreement.
10. Confidentiality. During the Term of this Employment Agreement and
thereafter, the Employee hereby covenants and agrees that he shall not other
than for the benefit of the Company publish, disclose to any third party or in
any way use for his own benefit any confidential information ("Confidential
Information"), including without limitation, any balance sheet or income
statement information (including but not limited to the value, amount or
condition of capital assets and/or inventory, sales figures, profitability,
etc.), or any other financial data, banking information, credit information,
trade secrets, financial statements or related data, customer lists or
information pertaining to customers or any unique distribution, manufacturing,
marketing and research methods of the Company or its parent or affiliates (or
formerly of General Asset Recovery, LLC), and any other Confidential Information
concerning the Company's or its parent or affiliate's, business, structure or
affairs, (or the business, structure or affairs formerly of General Asset
Recovery, LLC). All Confidential Information and copies thereof are the sole
property of the Company and Employee shall deliver promptly to the Company at
the termination of his employment or at any time as the Board of Directors may
request, without retaining copies, any Confidential Information made, compiled,
delivered, made available or otherwise obtained by Employee. Employee shall also
use his best efforts and exercise utmost diligence to protect and safeguard the
Confidential Information of the Company's customers, contractors and others with
whom
44
<PAGE> 45
the Company has a business relationship, whether learned or acquired by Employee
during the course of his employment by the Company.
The nondisclosure obligations of this Section 10 shall not apply to:
(a) information that may be disclosed generally or is in the public domain
through no fault of the Employee; (b) information received from a third party
outside the Company that was disclosed without a breach of any confidentiality
obligation; (c) information approved for release by written authorization of the
Company; or (d) information that may be required by law or an order of any
court, agency or proceeding to be disclosed. This Section 10 shall remain in
effect notwithstanding any termination of this Employment Agreement.
11. Non-Competition and Non-Solicitation.
(a) During the time Employee is employed by the Company, Employee
shall devote his full time and efforts to the business of the Company and shall
not participate, directly or indirectly, in any capacity, in any business or
activity that is in competition with the Company. For a period of eighteen (18)
months after the termination of employment with the Company for any reason: (i)
Employee shall not hire or attempt to hire any employee of the Company, or
assist in such hiring by anyone else, or encourage any employee to terminate his
or her employment with the Company; (ii) Employee shall not participate,
directly or indirectly, in any capacity, in any business or activity that is in
competition with the Company in the medical equipment re-sale industry, medical
facility planning industry or in any other business in which the Company is
engaged, in any state in which the Company does business; and (iii) Employee
shall not cause or assist to cause any of the customers of the Company with whom
Employee communicated, dealt with or became acquainted during his term of
employment with the Company to enter into contractual arrangements with himself
or any other person, firm, partnership, corporation or other company in any
business or activity that is in competition with the Company.
(b) "Blue Pencil" Rule. The Employee and the Company desire that
the provisions of this Section 11 be enforced to the fullest extent permissible
under the laws and public policies applied in each jurisdiction in which
enforcement is sought. If a court of competent jurisdiction, however, determines
that any restrictions imposed on the Employee in this Section are unreasonable
or unenforceable because of duration, area of restriction, or otherwise, the
Employee and the Company agree and intend that the court shall enforce this
Section 11 to whatever extent the court deems reasonable to effect the intent of
this Section 11.
(c) Legitimate Purpose. The Employee has read carefully all of the
terms and conditions of this Section 11 and agrees that the restraints set forth
herein (i) are reasonable and necessary to support the legitimate business
interests and goodwill of the Company, and (ii) will not preclude the Employee
from earning a livelihood during the life of this Section 11.
45
<PAGE> 46
12. Developments. All Confidential Information and all other
discoveries, inventions, processes, methods, and improvements conceived,
developed, or otherwise made by Employee at any time, alone or with others, and
in any way relating to the Company's present or future business or products,
whether or not patentable or subject to copyright protection and whether or not
reduced to tangible form or reduced to practice, during the Term of employment
("DEVELOPMENTS"), shall be the sole property of the Company. Employee agrees to
and hereby does assign to the Company all right, title, and interest throughout
the world in and to all Developments and agrees to promptly disclose such
Developments to the Company and take all such actions reasonably requested by
the Company to establish and confirm the Company's ownership of such
Developments. Employee agrees that all such Developments shall constitute works
made for hire under the copyright laws of the United States and hereby assigns
to the Company all copyrights, patents, trademarks and other proprietary rights
the Employee may have in such Developments.
13. Representations and Warranties. Prior to the execution and delivery
of this Employment Agreement, the Employee represents and warrants that he has
terminated all of his obligations under any other employment agreement or other
similar agreement, whether written or oral, with any other party. The Employee
has delivered copies of all such employment or other agreements and evidence
satisfactory to the Company of the termination of such agreements. The Employee
represents and warrants that the execution of this Employment Agreement will not
result in a breach of any written agreement to which the Employee is a party or
by which the Employee is bound. The Employee covenants and agrees to defend,
indemnify and hold harmless the Company, its affiliates and its successors and
assigns against any and all claims, damages, liabilities, suits, actions, costs,
charges and expenses, including, without limitation, attorneys' fees, resulting
from a breach of this Section 13.
14. Notice. All necessary notices, payments, demands and requests shall
be in writing and shall be deemed duly given three (3) days after being mailed
by certified mail, postage prepaid, return receipt requested, or when actually
received if sent by facsimile, overnight delivery or other means, and addressed
as follows:
Company: c/o Neoforma, Inc.
3255-7 Scott Boulevard
Santa Clara, California 95054
Attn: Wm. Samuel Veazey, Controller
Facsimile: (408) 549-6299
With a Copy to: John A. Kostrubanic, Esq.
Pepe & Hazard, LLP
150 Federal Street, 28th Floor
Boston, Massachusetts 02110
Facsimile: (617) 695-9255
46
<PAGE> 47
Employee: Erik Tivin
430 Newtown Drive
Buffalo Grove, Illinois 60089
Facsimile: (847) 255-2922
With a copy to: Spencer J. Marks, Esq.
Marks, Marks and Kaplan, Ltd.
120 North La Salle Street, Suite 3200
Chicago, Illinois 60602
Facsimile: (312) 332-2952
Each addressee may change its address or facsimile number for notice by
giving notice of change of address or facsimile number in the manner set forth
above.
15. Assignment. This Employment Agreement shall be freely assignable by
the Company to, and shall inure to the benefit of and be binding upon, any other
entity which shall succeed to the business presently being operated by the
Company, but, being a contract for personal services, neither this Employment
Agreement nor any rights hereunder shall be assignable by the Employee.
16. Further Execution. The parties agree to execute all documents
necessary to further effectuate the terms of this Employment Agreement.
17. Litigation. In the event of any dispute respecting this agreement,
such dispute shall be resolved in a court of competent jurisdiction in the State
of Illinois, and the parties hereto consent to such venue and jurisdiction. Each
party shall bear the cost of its own fees and expenses.
18. Authority. Each party represents that its undersigned
representative or corporate officer has all requisite power and authority to
enter into this Employment Agreement and to execute any and all instruments and
documents on its behalf necessary to and in performance of their respective
obligations hereunder.
19. Counterparts. This Employment Agreement may be executed in separate
counterparts, each of which shall be deemed original and all of which together
shall constitute one and the same instrument.
20. Waivers. No waiver, permit, consent or approval of any kind or
character on the part of any party of any breach or default under this
Employment Agreement, nor any waiver on the part of any party of any provisions
or conditions of this Employment Agreement, shall be valid unless made in
writing and signed by the party to be charged therewith, and shall be effective
only to the extent specifically set forth in such writing. No delay or omission
to exercise any right,
47
<PAGE> 48
power or remedy inuring to any party, upon any breach or default of any party
under this Employment Agreement, shall impair any such right, power or remedy of
such party nor shall it be construed to be a waiver of any such breach or
default, or an acquiescence therein, or of any similar breach or default
thereafter occurring; nor shall any waiver of any single breach or default be
deemed a waiver of any other breach or default theretofore or thereafter
occurring. All remedies either under this Employment Agreement or by law or
otherwise afforded to any party, shall be cumulative and not alternative.
21. Severability. If any provisions of this Employment Agreement shall
be held to be invalid or unenforceable to any extent or in any application, then
the remainder of this Employment Agreement and such terms and conditions, except
to such extent or in such application, shall not be affected thereby, and each
and every term and condition of this Employment Agreement shall be valid and
enforced to the fullest extent and in the broadest application permitted by law.
22. Headings. The paragraph headings contained herein are for
convenience and reference only, and shall be given no effect in the
interpretation of any term or condition of this Employment Agreement.
23. Equitable Remedies. Each party hereto hereby confirms that damages
at law may be an inadequate remedy for the breach or threatened breach of this
Employment Agreement and agrees that, in the event of a breach or threatened
breach by a party of any provision hereof, the other party's rights and
obligations hereunder shall be enforceable by specific performance, injunction,
or other equitable remedy, in addition to and not in lieu of any rights to
damages at law or other rights provided by statute or otherwise for a breach or
threatened breach of any provision hereof. Accordingly, each party hereto hereby
waives and agrees not to assert any objection to such equitable relief based
upon the purported existence of an adequate remedy at law, notwithstanding that
another party may also assert claims for damages at law or other claims as an
alternative to, or in addition to, such equitable relief.
24. Miscellaneous. This Employment Agreement is entered into and shall
be construed under the laws of the State of Illinois applicable to contracts
made and to be entirely performed within that State. This Employment Agreement
shall be amended, modified or terminated only by an instrument in writing,
signed by the party or parties to be charged. This Employment Agreement is the
entire agreement of the parties relating to the employment of the Employee by
the Company and supersedes all previous written or oral agreements.
48
<PAGE> 49
IN WITNESS WHEREOF the parties have executed or caused to be executed
this Employment Agreement under seal as of the day and year first above written.
NEOFORMA GAR, INC. NEOFORMA, INC.
By:_______________________________ By:_______________________________
Wayne McVicker, President Robert J. Zollars, President and
Chief Executive Officer
EMPLOYEE:
__________________________________
Erik Tivin
49
<PAGE> 50
EXHIBIT D TO
EXHIBIT 2.01
CONSULTING AGREEMENT
This Consulting Agreement (the "Agreement") is made this ____ day of
August, 1999, by and between Neoforma GAR, Inc., a Delaware corporation (the
"COMPANY"), and Fred Tivin of Highland Park, Illinois (the "CONSULTANT").
RECITALS
The Company is a wholly-owned subsidiary of Neoforma, Inc.
("NEOFORMA"), a Delaware corporation, and has acquired all of the issued and
outstanding securities (the "SECURITIES PURCHASE") of General Asset Recovery,
LLC, ("GAR") pursuant to the terms of a certain Securities Purchase Agreement
dated July 16th, 1999, which provided for the Consultant's acting as a
consultant to the Company.
The Company wishes to hire the Consultant as an independent contractor
to perform the services set forth herein, for the period of time, and upon the
terms and subject to the conditions, which are more particularly set forth
below; and
The Consultant desires to perform such services, for such period of
time and upon such terms and subject to such conditions;
NOW, THEREFORE, in consideration of the mutual covenants and agreements
hereinafter set forth, and for other good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged, the parties hereto
agree as follows:
1. Consulting Period. The Consultant is hereby retained by the Company
to perform, and the Consultant hereby agrees to perform, the services provided
for herein, as an independent contractor, for a period commencing on the date
hereof and ending on the two (2) year anniversary of the date hereof unless
terminated earlier as provided for herein (the "CONSULTING PERIOD").
2. Services and Duties. The Consultant agrees that during the
Consulting Period, he will provide certain services to the Company, consisting
of support and assistance in connection with the operation of the business
previously operated by General Asset Recovery, LLC, as well as such other tasks
and responsibilities which may be delegated to the Consultant by or under the
authority of the President of the Company and/or the Chief Executive Officer of
Neoforma, from time to time (the "CONSULTING SERVICES"). The Consultant shall
report directly to the President of the Company and to the Chief Executive
Officer of Neoforma or to any officer of Neoforma designated by the Board of
Directors of Neoforma.
50
<PAGE> 51
The Consultant agrees that he will conduct himself in a professional
and ethical manner at all times during the term of this Agreement and will take
no action that might cause injury to the business or goodwill of the Company.
The Consultant shall not perform consulting or other services for any
entity or person which is directly competitive with Neoforma or the Company
during the Consulting Period without the prior written consent of the Board of
Directors of Neoforma, which shall not be unreasonably withheld. However,
Consultant shall be permitted to perform consulting services for and be employed
by other non-competing businesses. It is the intention of the parties that
Consultant shall not be required to devote his full time and efforts to his
duties under this Consulting Agreement.
3. Compensation/Reimbursement for Expenses. All compensation paid or
payable hereunder shall be deemed to be paid or payable by the Company unless
this Agreement specifically states otherwise.
(a) Consulting Fees. In consideration for the Consulting Services
and subject to the due performance thereof, the Company shall pay to the
Consultant during the Consulting Period a fee of One Hundred Fifty Thousand
Dollars ($150,000) per year (the "CONSULTING FEE") which Consulting Fee shall be
payable during the term of this Agreement in equal semi-monthly installments in
accordance with the Company's customary practices. The Consulting Fee shall be
pro-rated for any partial year during which the Consultant provides Consulting
Services.
(b) Reimbursement for Expenses. At the end of each month during the
Consulting Period, the Company shall reimburse the Consultant for reasonable
items of miscellaneous and travel expenses incurred in furtherance of the
business of the Company, but payment shall be made only against a signed
itemized list of such expenditures.
(c) Automobile Allowance. The Consultant shall be entitled each
month to an automobile allowance in an amount equal to his actual automobile
related expenses, up to the amount of One Thousand Four Hundred Dollars ($1,400)
which shall be used for automobile related expenses incurred by the Consultant
in the performance of his duties hereunder.
4. Key Person Life Insurance. The Company shall have the right but not
the obligation to maintain and pay for a key person life insurance policy on the
life of the Consultant throughout the duration of this Agreement, as to which
the Company shall be the sole beneficiary and owner. The Consultant agrees upon
the execution of this Agreement to
51
<PAGE> 52
cooperate fully with the Company and to provide the Company with all necessary
documents in order for the Company to obtain such policy.
5. Status as Independent Consultant. It is the intent and purpose of
this Agreement to create a legal relationship of independent contractor, and not
employment, as between the Company and the Consultant. The Consultant will not
be treated as an employee of the Company for purposes of the Federal Insurance
Contributions Act, the Social Security Act, the Federal Unemployment Tax Act,
income tax withholding at source, or workmen's compensation laws, and will not
be eligible for any employee benefits whatsoever, other than those set forth
herein. The Consultant shall be responsible for the payment of self-employment
and federal income taxes due on all payments hereunder. In the event that any
governmental or administrative agency, whether federal, state or local, shall
subsequently determine that for their purposes, the relationship is one of
employment as between said parties, then in such event Consultant shall bear any
and all loss, costs and expenses of the Company in connection with or arising
out of such determination, whether in the nature of past or future FICA
contributions, Social Security taxes, unemployment taxes or income taxes. The
Consultant shall indemnify the Company and hold it harmless from any liability
to any former Company or to any other party in connection with or arising out of
any such governmental or administrative determination, or otherwise as a
consequence of Consultant's status as an independent contractor rather than an
employee of the Company.
6. Termination.
(a) This Agreement may be terminated upon any of the following:
(i) the Consultant's death;
(ii) the action by the Board of Directors of Neoforma
following the Consultant's "disability". For this purpose, "disability" means a
physical or mental illness or other incapacity which renders the Consultant
unable to perform substantially all of his duties for a period of two (2)
months. For purposes of this Agreement, disability shall be deemed a
continuation of any prior disability if the disability is related to the prior
disability and commences within eight (8) months of the termination of the prior
disability. Disability, and any relation to any prior disability, shall be
determined by a physician acceptable to the Company; or
(iii) the action of the Board of Directors or Chief Executive
Officer of Neoforma or the President of the Company for Cause. "Cause" is
defined as the occurrence of any of the following events: (A) fraud,
misappropriation, embezzlement or intentional misconduct on the part of the
Consultant, (B) the Consultant's willful failure to substantially
52
<PAGE> 53
perform his duties for the Company when, and to the extent, requested by the
Board of Directors, or its lawfully designated representative, to do so and
failure to correct same within five (5) business days after notice from the
Board of Directors or its lawfully designated representative requesting the
Consultant to do so, which has a materially adverse effect upon the Company, or
(C) the Consultant's willful breach of any material provision of this Agreement
and such breach continues for a period of five (5) business days after notice
from the Board of Directors or its lawfully designated representative of such
breach. Termination by the Company for cause will be effective immediately upon
receipt by the Consultant of notice of such termination.
(b) Termination of Benefits. In the event of any termination
pursuant to this Section during the term of this Agreement, in addition to the
termination of the various benefits and compensation payable to the Consultant
hereunder generally, the benefits provided for pursuant to Section 3 of this
Agreement shall, to the extent not yet accrued, automatically cease and
terminate.
(c) Survival. Notwithstanding anything else in this Agreement, the
provisions of Section 7 (Confidentiality), Section 8 (Non-Competition and
Non-Solicitation), Section 9 (Developments), and Section 20 (Equitable Remedies)
shall survive the termination of this Agreement, if by the Company, for "cause"
or by the Consultant. In the event this Agreement is terminated by the Company
without cause, or due to the bankruptcy or insolvency of the Company, or due to
any material breach of this Agreement by the Company, the only provision of this
Agreement which shall survive shall be Section 7 (Confidentiality) to the extent
that it deals with Confidential Information of the Company which existed prior
to the date of this Agreement.
7. Confidentiality. During the Consulting Period and thereafter, the
Consultant hereby covenants and agrees that he shall not other than for the
benefit of the Company publish, disclose to any third party or in any way use
for his own benefit any confidential information ("Confidential Information"),
including without limitation, any balance sheet or income statement information
(including but not limited to the value, amount or condition of capital assets
and/or inventory, sales figures, profitability, etc.), or any other financial
data, banking information, credit information, trade secrets, financial
statements or related data, customer lists or information pertaining to
customers or any unique distribution, manufacturing, marketing and research
methods of the Company or its parent or affiliates (or formerly of General Asset
Recovery, LLC), and any other Confidential Information concerning the Company's
or its parent or affiliate's, business, structure or affairs, (or the business,
structure or affairs formerly of General Asset Recovery, LLC). All Confidential
Information and copies thereof are the sole property of the Company and
Consultant shall deliver promptly to the Company at the termination of his
Consulting Period or at any time as
53
<PAGE> 54
Neoforma's Board of Directors may request, without retaining copies, any
Confidential Information made, compiled, delivered, made available or otherwise
obtained by Consultant. Consultant shall also use his best efforts and exercise
utmost diligence to protect and safeguard the Confidential Information of the
Company's customers, contractors and others with whom the Company has a business
relationship, whether learned or acquired by Consultant during the course of his
Consulting Period.
The nondisclosure obligations of this Section 7 shall not apply to: (a)
information that may be disclosed generally or is in the public domain through
no fault of the Consultant; (b) information received from a third party outside
the Company that was disclosed without a breach of any confidentiality
obligation; (c) information approved for release by written authorization of the
Company; or (d) information that may be required by law or an order of any
court, agency or proceeding to be disclosed. This Section 7 shall remain in
effect notwithstanding any termination of this Agreement.
8. Non-Competition and Non-Solicitation.
(a) During the time the Consultant is consulting for the Company,
Consultant shall devote his full time and efforts to the business of the Company
and shall not participate, directly or indirectly, in any capacity, in any
business or activity that is in competition with the Company. For a period of
eighteen (18) months after the termination of the Consulting Period with the
Company for any reason: (i) Consultant shall not hire or attempt to hire any
employee of the Company, or assist in such hiring by anyone else, or encourage
any employee to terminate his or her employment with the Company; (ii)
Consultant shall not participate, directly or indirectly, in any capacity, in
any business or activity that is in competition with the Company in the medical
equipment re-sale industry, medical facility planning industry or in any other
business in which the Company is engaged, in any state in which the Company does
business; and (iii) Consultant shall not cause or assist to cause any of the
customers of the Company with whom Consultant communicated, dealt with or became
acquainted during his term of consulting for the Company to enter into
contractual arrangements with himself or any other person, firm, partnership,
corporation or other company in any business or activity that is in competition
with the Company.
(b) "Blue Pencil" Rule. The Consultant and the Company desire that
the provisions of this Section 8 be enforced to the fullest extent permissible
under the laws and public policies applied in each jurisdiction in which
enforcement is sought. If a court of competent jurisdiction, however, determines
that any restrictions imposed on the Consultant in this Section are unreasonable
or unenforceable because of duration, area of restriction, or otherwise, the
Consultant and the Company agree and intend that the court shall enforce this
Section 8 to whatever extent the court deems reasonable to effect the intent of
this Section 8.
-54-
<PAGE> 55
(c) Legitimate Purpose. The Consultant has read carefully all of
the terms and conditions of this Section 8 and agrees that the restraints set
forth herein (i) are reasonable and necessary to support the legitimate business
interests and goodwill of the Company, and (ii) will not preclude the Consultant
from earning a livelihood during the life of this Section 8.
9. Developments. All Confidential Information and all other
discoveries, inventions, processes, methods, and improvements conceived,
developed, or otherwise made by Consultant at any time, alone or with others,
and in any way relating to the Company's present or future business or products,
whether or not patentable or subject to copyright protection and whether or not
reduced to tangible form or reduced to practice, during the term of this
agreement and for six months thereafter ("Developments"), shall be the sole
property of the Company. Consultant agrees to and hereby does assign to the
Company all right, title, and interest throughout the world in and to all
Developments and agrees to promptly disclose such Developments to the Company
and take all such actions reasonably requested by the Company to establish and
confirm the Company's ownership of such Developments. Consultant agrees that all
such Developments shall constitute works made for hire under the copyright laws
of the United States and hereby assigns to the Company all copyrights, patents,
trademarks and other proprietary rights the Consultant may have in such
Developments.
10. Notices. All necessary notices, payments, demands and requests
shall be in writing and shall be deemed duly given three (3) days after being
mailed by certified mail, postage prepaid, return receipt requested, or when
actually received if sent by facsimile, overnight delivery or other means, and
addressed as follows:
Company: c/o Neoforma, Inc.
3255-7 Scott Boulevard
Santa Clara, California 95054
Attn: Wm. Samuel Veazey, Controller
Facsimile: (408) 549-6299
With a Copy to: John A. Kostrubanic, Esq.
Pepe & Hazard, LLP
150 Federal Street, 28th Floor
Boston, Massachusetts 02110
Facsimile: (617) 695-9255
Consultant: Fred Tivin
747 Sumac Drive
Highland Park, Illinois 60035
-55-
<PAGE> 56
With a Copy to: Marks, Marks and Kaplan Ltd.
120 North La Salle Street, Suite 3200
Chicago, Illinois 60602
Attn: Spencer J. Marks, Esq.
Facsimile No.: (312) 332-2952
Each addressee may change its address or facsimile number for notice by
giving notice of change of address or facsimile number in the manner set forth
above.
11. Assignment. This Agreement shall be freely assignable by the
Company to, and shall inure to the benefit of and be binding upon, any other
entity which shall succeed to the business presently being operated by the
Company, but, being a contract for personal services, neither this Agreement nor
any rights hereunder shall be assignable by the Consultant.
12. Further Execution. The parties agree to execute all documents
necessary to further effectuate the terms of this Agreement.
13. Litigation. In the event of any dispute respecting this agreement,
such dispute shall be resolved in a court of competent jurisdiction in the State
of Illinois, and the parties hereto consent to such venue and jurisdiction. Each
party shall bear the cost of its own fees and expenses.
14. Authority. Each party represents that its undersigned
representative or corporate officer has all requisite power and authority to
enter into this Agreement and to execute any and all instruments and documents
on its behalf necessary to and in performance of their respective obligations
hereunder.
15. Counterparts. This Agreement may be executed in separate
counterparts, each of which shall be deemed an original and all of which
together shall constitute one and the same instrument.
16. Waivers. No waiver, permit, consent or approval of any kind or
character on the part of any party of any breach or default under this
Agreement, nor any waiver on the part of any party of any provisions or
conditions of this Agreement, shall be valid unless made in writing and signed
by the party to be charged therewith, and shall be effective only to the extent
specifically set forth in such writing. No delay or omission to exercise any
right, power or remedy inuring to any party, upon any breach or default of any
party under this Agreement, shall impair any such right, power or remedy of such
party nor shall it be construed to be a waiver of any such breach or default, or
an acquiescence therein, or of any similar breach or
-56-
<PAGE> 57
default thereafter occurring; nor shall any waiver of any single breach or
default be deemed a waiver of any other breach or default theretofore or
thereafter occurring. All remedies either under this Agreement or by law or
otherwise afforded to any party, shall be cumulative and not alternative.
17. Severability. In case any provision of this Agreement shall be
invalid, illegal or unenforceable, such provision shall be reformed to the
extent necessary to permit enforcement thereof, and the validity, legality and
enforceability of the remaining provisions shall not in any way be affected or
impaired thereby.
18. Titles and Subtitles. The titles of the sections and subsections of
this Agreement are for convenience of reference only and are not to be
considered in construing this Agreement.
19. Equitable Remedies. Each party hereto hereby confirms that damages
at law may be an inadequate remedy for the breach or threatened breach of this
Agreement and agrees that, in the event of a breach or threatened breach by a
party of any provision hereof, the other party's rights and obligations
hereunder shall be enforceable by specific performance, injunction, or other
equitable remedy, in addition to and not in lieu of any rights to damages at law
or other rights provided by statute or otherwise for a breach or threatened
breach of any provision hereof. Accordingly, each party hereto hereby waives and
agrees not to assert any objection to such equitable relief based upon the
purported existence of an adequate remedy at law, notwithstanding that another
party may also assert claims for damages at law or other claims as an
alternative to, or in addition to, such equitable relief.
20. Miscellaneous. This Agreement is entered into and shall be
construed under the laws of the State of Illinois applicable to contracts made
and to be entirely performed within that state. This Agreement shall be amended,
modified or terminated only by an instrument in writing, signed by the party or
parties to be charged. This Agreement constitutes the full and entire
understanding and agreement between the parties with regard to the subject
matter hereof, and supersedes all previous oral or written agreements,
correspondence and understandings with regard to such subject matter.
-57-
<PAGE> 58
IN WITNESS WHEREOF the parties have executed or caused to be executed
this Agreement under seal as of the day and year first above written.
CONSULTANT: NEOFORMA GAR, INC.
__________________________________ By:________________________________
Fred Tivin
58
<PAGE> 59
EXHIBIT E TO
EXHIBIT 2.01
GUARANTY
THIS GUARANTY ("GUARANTY"), executed as of the ____ day of August, 1999 is
by Neoforma, Inc., a Delaware corporation, having a mailing address of 3255-7
Scott Boulevard, Santa Clara, California 95054 ("GUARANTOR") for the benefit of
Fred Tivin having an address of 430 Newtown Drive, Buffalo Grove, Illinois 60089
( the "CONSULTANT").
RECITALS
This Guaranty is given as an inducement for the Consultant to enter into a
consulting agreement (the "CONSULTING AGREEMENT") of even date herewith with the
Guarantor's wholly-owned subsidiary, Neoforma GAR, Inc., a Delaware corporation
(the "BUYER"), pursuant to that certain Securities Purchase Agreement dated July
16th, 1999, by and among Guarantor, Buyer and Consultant which provided for the
purchase by the Buyer of the issued and outstanding securities of General Asset
Recovery, LLC, an Illinois limited liability company.
NOW THEREFORE, in consideration of the Consulting Services (as defined in
the Consulting Agreement) contemplated in the Consulting Agreement and for other
good and valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, Guarantor hereby covenants and agrees with Consultant as follows:
1. GUARANTY. Guarantor hereby absolutely, unconditionally and irrevocably
guaranties to Consultant the payment when due of the Consulting Fee (as defined
in the Consulting Agreement). Upon the failure of the Buyer to pay within ten
(10) days after the notice thereof by the Consultant to the Buyer that any
payment of the Consulting Fee shall have become due and not paid in a timely
manner, Guarantor shall, on demand by Consultant, immediately pay such portion
of the Consulting Fee as is then or may thereafter from time to time become due
and owing, without further notice from Consultant.
2. MISCELLANEOUS.
(a) Notices. Any notice, request or instruction to be given
hereunder shall be in writing and shall be delivered in person or
transmitted by facsimile (with confirmation in writing to be made
available upon request) or mailed by certified mail, return receipt
requested, postage prepaid, and delivered to the appropriate party and
address as shown above. Either of the addresses specified above may be
changed by notice given as herein provided. All communications will be
deemed effective upon receipt.
(b) No Assignment. This Guaranty shall be binding upon Guarantor and
inure solely to the benefit of Consultant and shall not be assignable.
59
<PAGE> 60
(c) Termination. If all sums and indebtedness owing under the
Consulting Agreement shall be fully and indefeasibly paid in cash, this
Guaranty shall terminate and be of no further force or any effect.
(d) Governing Law. The execution, delivery and performance of this
Guaranty shall be governed by the laws of the State of Delaware.
(e) Legal Fees. Guarantor shall be liable for any and all fees and
expenses incurred by Consultant, including legal fees, in connection with
its enforcing this Guaranty.
GUARANTOR
Neoforma, Inc.
By:
-------------------------------------
Robert J. Zollars, President and
Chief Executive Officer
60
<PAGE> 1
EXHIBIT 3.01
AMENDED AND RESTATED CERTIFICATE OF
INCORPORATION OF NEOFORMA.COM, INC.
Neoforma.com, Inc., a corporation organized and existing under the laws of
the State of Delaware, hereby certifies as follows:
A. The name of the corporation is Neoforma.com, Inc. The original
Certificate of Incorporation was filed with the Secretary of State of Delaware
on August 18, 1998.
B. Pursuant to Section 228, 242, and 245 of the General Corporation Law of
the State of Delaware, this Amended and Restated Certificate of Incorporation
restates and integrates and further amends the Certificate of Incorporation of
this corporation.
C. The text of the Certificate of Incorporation is hereby amended and
restated in its entirety to read as follows:
ONE The name of this corporation is Neoforma.com, Inc.
TWO The address of the registered office of the corporation in the State of
Delaware is 15 East North Street, City of Dover, County of Kent, DE 19901. The
name of its registered agent at that address is Incorporating Services, Ltd.
THREE The purpose of the corporation is to engage in any lawful act or
activity for which a corporation may be organized under the General Corporation
Law of Delaware.
FOUR This corporation is authorized to issue two classes of stock to be
designated, respectively, "Common Stock" and "Preferred Stock." The total number
of shares which the corporation is authorized to issue is 240,747,048 shares.
200,000,000 shares shall be Common Stock with a par value of $.001. 40,747,048
shares shall be Preferred Stock with a par value of $.001, 9,000,000 of which
shall be designated as Series A Preferred Stock, 2,860,000 of which shall be
designated as Series B Preferred Stock, 5,109,937 of which shall be designated
as Series C Preferred Stock, 10,572,886 of which shall be designated as Series D
Preferred Stock, 11,168,662 of which are designated Series E Preferred Stock and
2,035,563 of which are designated Series E-1 Preferred Stock.
FIVE The rights, preferences, privileges and restrictions granted to or
imposed upon the Common Stock and Preferred Stock are as follows:
1 Dividend Provisions.
a. Series E Preferred Stock and Series E-1 Preferred Stock. The
holders of shares of Series E Preferred Stock and Series E-1 Preferred Stock
shall be entitled to receive
<PAGE> 2
dividends, out of any assets legally available therefor, prior and in preference
to any declaration, payment or setting aside of any dividend (payable other than
in Common Stock or other securities and rights convertible into or entitling the
holder thereof to receive, directly or indirectly, additional shares of Common
Stock of this corporation) on the Series A Preferred Stock, Series B Preferred
Stock, Series C Preferred Stock, Series D Preferred Stock or Common Stock of
this corporation, at the rate of $0.4544 per share per annum for the Series E
Preferred Stock and Series E-1 Preferred Stock, or, if greater (as determined on
a per annum basis and on an as converted basis for such Preferred Stock), an
amount equal to that paid on any outstanding shares of Common Stock of this
corporation.
b. Remaining Preferred Stock. Subject to the prior dividend rights of
the Series E Preferred Stock and the Series E-1 Preferred Stock as set forth in
Section 1(a), the holders of the Series A Preferred Stock, Series B Preferred
Stock, Series C Preferred Stock and Series D Preferred Stock shall be entitled
to receive dividends, out of any assets legally available therefor, prior and in
preference to any declaration or payment of any dividend (payable other than in
Common Stock or other securities and rights convertible into or entitling the
holder thereof to receive, directly or indirectly, additional shares of Common
Stock of this corporation) on the Common Stock, at the rate of $.02 per share
per annum for the Series A Preferred Stock, $.04 per share per annum for the
Series B Preferred Stock, $.062 per share per annum for the Series C Preferred
Stock, and $.0944 per share per annum for the Series D Preferred Stock, or, if
greater (as determined on a per annum basis and on an as converted basis for the
Preferred Stock), an amount equal to that paid on any outstanding shares of
Common Stock of this corporation.
c. Dividends Non-Cumulative. The dividends payable under Section 1(a)
and 1(b) shall be payable when, as and if declared by the Board of Directors,
and shall not be cumulative, and no right shall accrue to holders of Common
Stock or Preferred Stock by reason of the fact that dividends on said shares are
not declared in any period.
2 Liquidation Preference.
(a) Series E and Series E-1 Preferred Preference. In the event of any
liquidation, dissolution or winding up of this corporation, either voluntary or
involuntary, the holders of the Series E Preferred Stock and the holders of the
Series E-1 Preferred Stock shall be entitled to receive, prior and in preference
to any distribution of any of the assets or funds of this corporation to the
holders of Series A Preferred Stock, Series B Preferred Stock, Series C
Preferred Stock, Series D Preferred Stock and Common Stock by reason of their
ownership thereof, an amount per share equal to $5.68, for each outstanding
share of such Series E Preferred Stock and Series E-1 Preferred Stock held, plus
an amount equal to any declared but unpaid dividends on such share of Series E
Preferred Stock or Series E-1 Preferred Stock up to the date fixed for
distribution. If upon the occurrence of such event, the assets and funds of this
corporation legally available for distribution to the stockholders shall be
insufficient to permit the payment to holders of Series E Preferred Stock and
Series E-1 Preferred Stock of the full aforesaid preferential amounts, then the
entire assets and funds of this corporation legally
-2-
<PAGE> 3
available for distribution to the stockholders shall be distributed ratably
among the holders of the Series E Preferred Stock and Series E-1 Preferred Stock
in accordance with the aggregate preference payment to which they are entitled.
(b) Remaining Preferred Stock. Subject to the prior payment of the
liquidation preference for the Series E Preferred Stock and Series E-1 Preferred
Stock as described in Section 2(a) above, the holders of the Series A Preferred
Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred
Stock shall be entitled to receive, prior and in preference to any distribution
of any of the assets or funds of this corporation to the holders of Common Stock
by reason of their ownership thereof, an amount per share equal to $.25, $.50,
$.77 and $1.18, respectively, for each outstanding share of such Preferred Stock
held, plus an amount equal to any declared but unpaid dividends on such share of
Preferred Stock up to the date fixed for distribution. If upon the occurrence of
such event, the assets and funds of this corporation legally available for
distribution under this Section 2(b) to the holders of Series A Preferred Sock,
Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock
shall be insufficient to permit the payment to holders of such Preferred Stock
of the full aforesaid preferential amounts, then, the entire assets and funds of
this corporation then legally available for distribution to such stockholders
shall be distributed ratably among the holders of such Preferred Stock in
accordance with the aggregate preference payment to which they are entitled.
(c) Participation. After the payment or setting aside of payment set
forth in Sections 2(a) and 2(b) above, the remaining assets and funds of the
corporation legally available for distribution to the stockholders shall be
distributed on a pro-rata basis to the holders of the Preferred Stock, on an as
converted basis, and the holders of the Common Stock until the holders of the
Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock,
Series D Preferred Stock, Series E Preferred Stock and Series E-1 Preferred
Stock have received an additional $.25, $.50, $.77, $1.18, $5.68 and $5.68 per
share, respectively.
After the distributions to the stockholders pursuant to Sections 2(a), 2(b)
and 2(c) above have been made, the remaining assets and funds of the corporation
legally available for distribution to stockholders shall be distributed pro-rata
solely among the holders of Common Stock.
(d) Mergers. A merger, reorganization, or sale of all or substantially
all of the assets of this corporation, or other transaction or series of related
transactions in which either (i) the stockholders of this corporation
immediately prior to the transaction or series of related transactions possess
less than 50% of the voting power of the surviving or acquiring entity (or its
parent) immediately after the transaction or (ii) one or a group of affiliated
stockholders acquires more than 50% of the voting power of this corporation (a
"CHANGE OF CONTROL") shall be deemed to be a liquidation, dissolution or winding
up within the meaning of this Section 2; provided that the holders of Preferred
Stock and Common Stock shall be paid in cash or in securities received or in a
combination thereof (which combination shall be in the same proportions as the
consideration received in the transaction). Any securities to be delivered to
the holders of the Preferred Stock and Common Stock upon merger, reorganization,
sale of substantially all the
-3-
<PAGE> 4
assets of the corporation or transaction or related series of transactions
resulting in a Change of Control shall be valued as follows:
(i) if traded on a securities exchange or the Nasdaq National
Market, the value shall be deemed to be the average of the closing sale prices
of the securities on such exchange over the 30-day period ending three (3)
business days prior to the closing;
(ii) if actively traded over-the-counter, the value shall be
deemed to be the average of the closing bid prices (or closing sales prices,
whichever is applicable) over the 30-day period ending three (3) business days
prior to the closing; or
(iii) if there is no active public market, the value shall be the
fair market value thereof as determined in good faith by the Board of Directors
of the corporation, but if challenged by the holders of more than 50% of the
outstanding shares of Preferred Stock, then as determined by an independent
appraiser selected by the Board of Directors of the corporation, the cost of
such appraisal to be borne by the corporation.
(e) This corporation will give written notice of any liquidation,
dissolution or winding up (or any transaction which might reasonably be deemed
to be a liquidation, dissolution or winding up pursuant to part (d) above) to
each record holder of Preferred Stock not less than 20 days prior to the date
stated therein for the distribution and payment of the amounts provided in this
Section 2. Each holder of Preferred Stock may convert all or any portion of the
Preferred Stock into Common Stock at any time on or prior to the date fixed in
such notice for distribution and payment or the date of a merger, consolidation
or sale of assets deemed to be a liquidation, dissolution or winding up of the
Company.
3 Conversion. The holders of the Preferred Stock shall have conversion
rights as follows (the "CONVERSION RIGHTS"):
(a) Right to Convert. Each share of Preferred Stock shall be
convertible into share(s) of Common Stock without the payment of any additional
consideration by the holder thereof and at the option of the holder thereof, at
any time after the date of issuance of such share, at the office of the
corporation or any transfer agent for the Preferred Stock. Each share of
Preferred Stock shall be convertible into the number of fully paid and
nonassessable shares of Common Stock which results from dividing the Conversion
Price (as hereinafter defined) per share in effect for the Preferred Stock at
the time of conversion into the per share Conversion Value (as hereinafter
defined) of such series. On the date of the filing of this document with the
Delaware Secretary of State: the initial Conversion Price per share of the
Series A Preferred Stock shall be $.25; and the Conversion Value per share of
the Series A Preferred Stock shall be $.25; the initial Conversion Price per
share of the Series B Preferred Stock shall be $.50; and the Conversion Value
per share of the Series B Preferred Stock shall be $.50; the initial Conversion
Price per share of the Series C Preferred Stock shall be $.77; the Conversion
Value per share of the Series C Preferred Stock shall be $.77; the initial
Conversion Price per share of the Series D Preferred Stock shall be $1.18; and
the Conversion Value per share of the Series D Preferred
-4-
<PAGE> 5
Stock shall be $1.18; the initial Conversion Price per share of the Series E
Preferred Stock and of the Series E-1 Preferred Stock shall be $5.68; and the
Conversion Value per share of the Series E Preferred Stock and of the Series E-1
Preferred Stock shall be $5.68. The initial Conversion Price of the Preferred
Stock shall be subject to adjustment from time to time as provided below. The
number of shares of Common Stock into which a single share of a particular
series of Preferred Stock is convertible is hereinafter referred to as the
"CONVERSION RATE" of such series of Preferred Stock.
(b) Automatic Conversion. Each share of Preferred Stock shall
automatically be converted into shares of Common Stock at its then effective
Conversion Rate immediately prior to the initial closing of an underwritten
initial public offering pursuant to an effective registration statement under
the Securities Act of 1933, as amended, covering the offer and sale of Common
Stock in which (a) the public offering price equals or exceeds $10.00 per share
(adjusted to reflect subsequent stock dividends, stock splits or
recapitalization) and (b) the aggregate proceeds of the offering to the Company
before deduction of underwriting discounts and expenses of the offering equals
or exceeds $60,000,000; provided, however, if the closing of such public
offering occurs on or before December 31, 2000, then the minimum price per share
for purposes of clause (a) of this paragraph shall be $7.00 per share (adjusted
to reflect subsequent stock dividends, stock splits or recapitalization), and
for the purposes of the automatic conversion described in this Section 3(b), the
Conversion Price per share of Series E Preferred Stock and the Conversion Price
per share of Series E-1 Preferred Stock shall be adjusted such that the
Conversion Price shall equal the Conversion Price in effect immediately prior to
the closing of such public offering multiplied by the ratio of (z) the public
offering price divided by (q) $10.00. "QUALIFIED IPO" shall mean any public
offering in which the public offering price and the aggregate proceeds raised
equal or exceed the thresholds in this Section 3(b) for automatic conversion of
the Preferred Stock.
(c) Mechanics of Conversion. Before any holder of Preferred Stock
shall be entitled to convert the same into shares of Common Stock, such holder
shall surrender the certificate or certificates therefor, duly endorsed, at the
office of the corporation or of any transfer agent for the Preferred Stock (or
in the case of a lost certificate, shall present such evidence of loss and an
appropriate undertaking as the corporation may require) and shall give written
notice to the corporation at such office that such holder elects to convert the
same (except that no such written notice of election to convert shall be
necessary in the event of an automatic conversion pursuant to Section 3(b)
hereof). The corporation shall, as soon as practicable thereafter, issue and
deliver at such office to such holder of Preferred Stock a certificate or
certificates for the number of shares of Common Stock to which such holder shall
be entitled as aforesaid. Such conversion shall be deemed to have been made
immediately prior to the close of business on the date of such surrender of the
shares of Preferred Stock to be converted (except that in the case of an
automatic conversion pursuant to Section 3(b) hereof such conversion shall be
deemed to have been made immediately prior to the initial closing of the
offering referred to in Section 3(b) without regard to surrender of the
certificate) and the person or persons entitled to receive the shares of Common
Stock issuable upon such conversion shall be treated for all purposes as the
record holder or holders of such shares of Common Stock on such date.
-5-
<PAGE> 6
(d) Fractional Shares. In lieu of any fractional shares to which the
holder of Preferred Stock would otherwise be entitled, the corporation shall pay
cash equal to such fraction multiplied by the fair market value of one share of
such series of Preferred Stock as determined by the Board of Directors of the
corporation. Whether or not fractional shares are issuable upon such conversion
shall be determined on the basis of the total number of shares of Preferred
Stock of each holder to be converted at such time into Common Stock and the
number of shares of Common Stock issuable to such holder upon such aggregate
conversions.
(e) Adjustment of Conversion Price. The Conversion Price of each
series of Preferred Stock shall be subject to adjustment from time to time as
follows:
(i) If the corporation shall issue, after the date on which any
shares of Series E Preferred Stock or Series E-1 Preferred Stock were first
issued, any Common Stock or Common Stock equivalents other than "Excluded
Stock," as defined below, for a consideration per share less than the Conversion
Price for a series of Preferred Stock in effect immediately prior to the
issuance of such Common Stock (excluding stock dividends, subdivisions,
split-ups, combinations, dividends or recapitalizations which are covered by
Section 3(e)(iii), (iv), (v) and (vi)) (such issuance with such exclusions, a
"DILUTIVE ISSUANCE"), the Conversion Price for such series in effect immediately
after each such Dilutive Issuance shall forthwith (except as provided in this
Section 3(e)) be adjusted as set forth below for the respective series of
Preferred Stock:
(A) with regard to the Series E Preferred Stock and, subject
to the provisions of Section 3(e)(ix), the Series E-1 Preferred Stock, such
Conversion Price shall be adjusted to the Effective Price (as defined below) per
share of such share of Common Stock or Common Stock equivalent issued in such
Dilutive Issuance, provided, however, that if application of the foregoing
provision of this clause (A) would reduce the Conversion Price for the Series E
Preferred Stock or Series E-1 Preferred Stock, as applicable, below the then
effective Conversion Price for the Series D Preferred Stock, then the Conversion
Price of Series E Preferred Stock and/or Series E-1 Preferred Stock, as the case
may be, shall be reduced under this clause (A) only to the then effective
Conversion Price for the Series D Preferred Stock, and the Series E Preferred
Stock and/or Series E-1 Preferred Stock shall thereafter be deemed to be
included in, and any further adjustment with regard to, such Dilutive Issuance
or any subsequent Dilutive Issuance shall be calculated only with regard to, the
formula set forth in Section 3(e)(i)(B). As used in this paragraph, "EFFECTIVE
PRICE" shall mean the lowest price per share of Common Stock and Common Stock
equivalents issued or deemed to be issued under Section 3(e)(i)(C); and
(B) with regard to the Series A Preferred Stock, Series B
Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and, subject
to the foregoing paragraph, Series E Preferred Stock and Series E-1 Preferred
Stock, such Conversion Price shall be adjusted to a price equal to the quotient
obtained by dividing:
(1) an amount equal to the sum of
-6-
<PAGE> 7
(x) the total number of shares of Common Stock
outstanding (including any shares of Common Stock issuable upon conversion of
the Preferred Stock, or deemed to have been issued pursuant to Section
3(e)(i)(C)(3) or pursuant to Section 3(e)(ii)) immediately prior to such
Dilutive Issuance multiplied by the Conversion Price in effect immediately prior
to such Dilutive Issuance, plus
(y) the consideration received by the corporation
upon such Dilutive Issuance, by
(2) the total number of shares of Common Stock
outstanding (including any shares of Common Stock issuable upon conversion of
the Preferred Stock or deemed to have been issued pursuant to Section
3(e)(i)(C)(3) or pursuant to Section 3(e)(ii)) immediately prior to such
Dilutive Issuance plus the additional shares of Common Stock issued in such
Dilutive Issuance (but not including any additional shares of Common Stock
deemed to be issued as a result of any adjustment in the Conversion Price
resulting from such Dilutive Issuance).
(C) For purposes of any adjustment of the Conversion Price
pursuant to this Section 3(c)(i), the following provisions shall be applicable:
(1) In the case of the issuance of Common Stock for
cash, the consideration shall be deemed to be the amount of cash paid therefor
after deducting any discounts or commissions paid or incurred by the corporation
in connection with the issuance and sale thereof.
(2) In the case of the issuance of Common Stock for a
consideration in whole or in part other than cash, the consideration other than
cash shall be deemed to be the fair market value thereof as determined by the
Board of Directors of the corporation, in accordance with generally accepted
accounting principles; provided, however, that such fair market value as
determined by the Board of Directors of the corporation shall equal the
aggregate Current Market Price (as defined below) of the shares of Common Stock
being issued for consideration other than cash.
(3) In the case of the issuance of (i) options to
purchase or rights to subscribe for Common Stock (other than Excluded Stock),
(ii) securities by their terms convertible into or exchangeable for Common Stock
(other than Excluded Stock), or (iii) options to purchase or rights to subscribe
for such convertible or exchangeable securities (other than Excluded Stock)
("Common Stock equivalents"):
(A) the aggregate maximum number of shares of
Common Stock deliverable upon exercise of such options to purchase or rights to
subscribe for Common Stock shall be deemed to have been issued at the time such
options or rights were issued and for a consideration equal to the consideration
(determined in the manner provided in
-7-
<PAGE> 8
Sections 3(e)(i)(C)(1) and (2) above), if any, received by the corporation for
the issuance of such options or rights plus the minimum purchase price provided
in such options or rights for the Common Stock covered thereby;
(B) the aggregate maximum number of shares of
Common Stock deliverable upon conversion of or in exchange for any such
convertible or exchangeable securities or upon the exercise of options to
purchase or rights to subscribe for such convertible or exchangeable securities
and subsequent conversion or exchange thereof, shall be deemed to have been
issued at the time such securities were issued or such options or rights were
issued and for a consideration equal to the consideration received by the
corporation for any such securities and related options or rights (excluding any
cash received on account of accrued interest or accrued dividends), plus the
minimum additional consideration, if any, to be received by the corporation upon
the conversion or exchange of such securities or the exercise of any related
options or rights (the consideration in each case to be determined in the manner
provided in Sections 3(e)(i)(C)(1) and (2) above);
(C) on any change in the number of shares of
Common Stock deliverable upon exercise of any such options or rights or
conversion of or exchange for such convertible or exchangeable securities, or on
any change in the minimum purchase price of such options, rights or securities,
other than a change resulting from the antidilution provisions of such options,
rights or securities, the Conversion Price shall forthwith be readjusted to such
Conversion Price as would have obtained had the adjustment made upon (x) the
issuance of such options, rights or securities not exercised, converted or
exchanged prior to such change, as the case may be, been made upon the basis of
such change or (y) the options or rights related to such securities not
converted or exchanged prior to such change, as the case may be, been made upon
the basis of such change; and
(D) on the expiration of any such options or
rights, the termination of any such rights to convert or exchange or the
expiration of any options or rights related to such convertible or exchangeable
securities, the Conversion Price shall forthwith be readjusted to such
Conversion Price as would have obtained had the adjustment made upon the
issuance of such options, rights, convertible or exchangeable securities or
options or rights related to such convertible or exchangeable securities, as the
case may be, been made upon the basis of the issuance of only the number of
shares of Common Stock actually issued upon the exercise of such options or
rights, upon the conversion or exchange of such convertible or exchangeable
securities or upon the exercise of the options or rights related to such
convertible or exchangeable securities, as the case may be.
(ii) "EXCLUDED STOCK" shall mean:
(A) all shares of Common Stock and warrants or other
contract rights to purchase Common Stock issued and outstanding on the date this
document is filed with the Delaware Secretary of State, and the shares of Common
Stock issued upon exercise of such warrants;
-8-
<PAGE> 9
(B) all shares of Preferred Stock and warrants and other
rights to purchase Preferred Stock issued and outstanding on the date this
document is filed with the Delaware Secretary of State, the shares of Preferred
Stock issued upon exercise of such warrants, all additional shares of Series E
Preferred Stock and Series E-1 Preferred Stock issued or issuable pursuant to
that certain Preferred Stock Purchase Agreement between the Company and certain
purchasers of the Company's Series E Preferred Stock and Series E-1 Preferred
Stock (the "PURCHASE AGREEMENT"), as amended from time to time, and the Common
Stock into which all such outstanding or issuable shares of Preferred Stock are
convertible;
(C) all shares of Common Stock, warrants or options to
purchase Common Stock or other securities and all shares of Preferred or Common
Stock issuable upon exercise or conversion thereof issued to officers,
directors, consultants or employees of the corporation pursuant to any plan or
arrangement approved by the Board of Directors of the corporation, whether
issued before or after the date this document is filed with the Delaware
Secretary of State;
(D) up to 14,000 shares of Common Stock, warrants or options
to purchase Common Stock or Preferred Stock or other securities convertible into
or exchangeable for Common Stock issued after the date this document is filed
with the Delaware Secretary of State to lending or leasing institutions pursuant
to any plan or arrangement approved by the Board of Directors of the
corporation;
(E) up to 1,000,000 shares of Common Stock issued after the
date this document is filed with the Delaware Secretary of State in connection
with the acquisition of another corporation or entity by this corporation by
consolidation, merger, purchase of all or substantially all of the assets, or
fifty percent (50%) or more of the voting power of such other corporation or
entity or fifty percent (50%) or more of the equity ownership of such other
corporation or entity; and
(F) all shares of Common Stock, warrants or options to
purchase Common Stock or other securities and all shares of Preferred or Common
Stock issued upon exercise or exchange of such securities issued pursuant to or
in connection with the undertaking by the Corporation of each Commercial
Agreement (as defined in the Purchase Agreement).
All outstanding shares of Excluded Stock (including any
shares issuable upon conversion of the Preferred Stock) shall be deemed to be
outstanding after issuance of such Excluded Stock or issuance or options or
warrants constituting Excluded Stock for all purposes of the computations of
Section 3(e)(i)(B) above.
(iii) If the number of shares of Common Stock outstanding at any
time after the date hereof is increased by a stock dividend payable in shares of
Common Stock or Common Stock equivalent or by a subdivision or split-up of
shares of Common Stock, then, on
-9-
<PAGE> 10
the date such payment is made or such change is effective, the Conversion Price
of each series of Preferred Stock shall be appropriately decreased so that the
number of shares of Common Stock issuable on conversion of any shares of such
series of Preferred Stock shall be increased in proportion to such increase of
outstanding shares.
(iv) If the number of shares of Common Stock outstanding at any
time after the date hereof is decreased by a combination of the outstanding
shares of Common Stock, then, on the effective date of such combination, the
Conversion Price of each series of Preferred Stock shall be appropriately
increased so that the number of shares of Common Stock issuable on conversion of
any shares of a series of Preferred Stock shall be decreased in proportion to
such decrease in outstanding shares.
(v) In case the corporation shall declare a cash dividend upon
its Common Stock payable otherwise than out of retained earnings or shall
distribute to holders of its Common Stock shares of its capital stock (other
than Common Stock), stock or other securities of other persons, evidences of
indebtedness issued by the corporation or other persons, assets (excluding cash
dividends) or options or rights (excluding options to purchase and rights to
subscribe for Common Stock or other securities of the corporation convertible
into or exchangeable for Common Stock), then, in each such case, the holders of
shares of Preferred Stock shall, concurrent with the distribution to holders of
Common Stock, receive a like distribution based upon the number of shares of
Common Stock into which such shares of Preferred Stock are convertible.
(vi) In case, at any time after the date hereof, of any capital
reorganization, or any reclassification of the stock of the corporation (other
than as a result of a stock dividend or subdivision, split-up or combination of
shares), or the consolidation or merger of the corporation with or into another
person (other than a consolidation or merger in which the corporation is the
continuing entity and which does not result in any change in the Common Stock),
or of the sale or other disposition of all or substantially all the properties
and assets of the corporation, the shares of Preferred Stock shall, after such
reorganization, reclassification, consolidation, merger, sale or other
disposition, be convertible into the kind and number of shares of stock or other
securities or property of the corporation or otherwise to which such holder
would have been entitled if immediately prior to such reorganization,
reclassification, consolidation, merger, sale or other disposition he had
converted his shares of Preferred Stock into Common Stock. The provisions of
this clause (vi) shall similarly apply to successive reorganizations,
reclassifications, consolidations, mergers, sales or other dispositions.
(vii) All calculations under this Section 3 shall be made to the
nearest cent or to the nearest one hundredth (1/100) of a share, as the case may
be.
(viii) For the purpose of any computation pursuant to this
Section 3(e), the "CURRENT MARKET PRICE" at any date of one share of Common
Stock, shall be deemed to be the average of the highest reported bid and the
lowest reported offer prices on the preceding business day as furnished by the
National Quotation Bureau, Incorporated (or equivalent recognized source
-10-
<PAGE> 11
of quotations); provided, however, that if the Common Stock is not traded in
such manner that the quotations referred to in this clause (viii) are available
for the period required hereunder, Current Market Price shall be determined in
good faith by the Board of Directors of the corporation, but if challenged by
the holders of more than 50% of the outstanding shares of Preferred Stock, then
as determined by an independent appraiser selected by the Board of Directors of
the corporation, the cost of such appraisal to be borne by the challenging
parties.
(ix) (A) In addition to the adjustments to the Conversion Rate
for Dilutive Issuances effecting the Series E-1 Preferred Stock provided in
Section 3(e)(i): if the Company shall have exceeded the Revenue Targets (as
defined in the Purchase Agreement), then the Conversion Ratio of the Series E-1
Preferred Stock shall be adjusted as of the Revenue Adjustment Date (as defined
in the Purchase Agreement), so that each share of Series E-1 Preferred Stock
shall be convertible into 0.7143 shares of Common Stock; and if the Company
shall have failed to achieve its Revenue Threshold (as defined in the Purchase
Agreement), then the Conversion Ratio of the Series E-1 Preferred Stock shall be
adjusted as of the Revenue Adjustment Date so that each share of Series E-1
Preferred Stock shall be convertible into 1.6667 shares of Common Stock; (B) The
Conversion Rates in the immediately preceding clause (A) will be proportionally
adjusted for events described in Section 3(e)(iii) and Section 3(e)(iv) before
the Revenue Adjustment Date; and (C) notwithstanding any other provision of this
Section 3(e)(ix) if, (x) before the Revenue Adjustment Date, the corporation
effects a Dilutive Issuance which results in an adjustment to the Conversion
Price of the Series E-1 Preferred Stock, and (y) the corporation thereafter
shall have failed to exceed the Revenue Threshold, then the combined effect on
the Conversion Rate of the Series E-1 Preferred Stock after all adjustments to
the Conversion Price under Section 3(e)(i) for Dilutive Issuances before the
Revenue Adjustment Date and of the adjustment to the Conversion Rate under the
immediately clause (A) of this paragraph shall not result in a Conversion Rate
which causes one share of Series E-1 Preferred Stock to convert into a larger
number of shares of Common Stock than the greater of that determined by (q)
adjustments under Section 3(e)(i) for all Dilutive Issuances before the Revenue
Adjustment Date or (z) the application of the provisions of clause (A) of this
paragraph.
(f) Minimal Adjustments. No adjustment in the Conversion Price of
a series of Preferred Stock need be made if such adjustment would result in a
change in the Conversion Price of such series of Preferred Stock of less than
$0.01. Any adjustment of less than $0.01 which is not made shall be carried
forward and shall be made at the time of and together with any subsequent
adjustment which, on a cumulative basis, amounts to an adjustment of $0.01 or
more in the Conversion Price of such series of Preferred Stock.
(g) No Impairment. Without the consent of the majority of the
outstanding shares of Preferred Stock and a majority of the outstanding Series E
and Series E-1, voting together as a class, the corporation will not through any
reorganization, recapitalization, transfer of assets, consolidation, merger,
dissolution, issue or sale of securities or any other voluntary action, avoid or
seek to avoid the observance or performance of any of the terms to be observed
or performed hereunder by the corporation, but will at all times in good faith
assist in the carrying out of all the provisions of this Section 3 and in the
taking of all such action as may be
-11-
<PAGE> 12
necessary or appropriate in order to protect the Conversion Rights of the
holders of Preferred Stock against impairment.
(h) Certificate as to Adjustments. Upon the occurrence of each
adjustment or readjustment of the Conversion Rate pursuant to this Section 3,
the corporation at its expense shall promptly compute such adjustment or
readjustment in accordance with the terms hereof and prepare and furnish to each
holder of Preferred Stock a certificate setting forth such adjustment or
readjustment and showing in detail the facts upon which such adjustment or
readjustment is based. The corporation shall, upon written request at any time
of any holder of Preferred Stock, furnish or cause to be furnished to such
holder a like certificate setting forth (i) such adjustments and readjustments,
(ii) the Conversion Rate of such series at the time in effect, and (iii) the
number of shares of Common Stock and the amount, if any, of other property which
at the time would be received upon the conversions of such holder's shares of
Preferred Stock.
(i) Notices of Record Date. In the event of any taking by the
corporation of a record of the holders of any class of securities for the
purpose of determining the holders thereof who are entitled to receive any
dividend (other than a cash dividend) or other distribution, any right to
subscribe for, purchase or otherwise acquire any shares of stock of any class or
any other securities or property or to receive any other right, the corporation
shall mail to each holder of Preferred Stock at least ten (10) days prior to
such record date, a notice specifying the date on which any such record is to be
taken for the purpose of such dividend or distribution or right, and the amount
and character of such dividend, distribution or right.
(j) Reservation of Stock Issuable Upon Conversion. The
corporation shall at all times reserve and keep available out of its authorized
but unissued shares of Common Stock solely for the purpose of effecting the
conversion of the shares of Preferred Stock such number of its shares of Common
Stock as shall from time to time be sufficient to effect the conversion of all
outstanding shares of Preferred Stock; and if at any time the number of
authorized but unissued shares of Common Stock shall not be sufficient to effect
the conversion of all then outstanding shares of Preferred Stock, the
corporation will take such corporate action as may, in the opinion of its
counsel, be necessary to increase its authorized but unissued shares of Common
Stock to such number of shares as shall be sufficient for such purpose.
(k) Notices. Any notice required by the provisions of this
Section 3 to be given to the holder of shares of Preferred Stock shall be deemed
given if deposited in the United States mail, postage prepaid, and addressed to
each holder of record at his address appearing on the books of the corporation.
(l) Reissuance of Converted Shares. No shares of Preferred Stock
which have been converted into Common Stock after the original issuance thereof
shall ever again be reissued and all such shares so converted shall upon such
conversion cease to be a part of the authorized shares of the corporation.
-12-
<PAGE> 13
4. Voting Rights.
(a) Preferred Stock. The holder of each share of Preferred Stock shall
be entitled to the number of votes equal to the number of shares of Common Stock
into which each share of Preferred Stock could be converted on the record date
for the vote or consent of stockholders by written consent and, except as
otherwise required by law, shall have voting rights and powers equal to the
voting rights and powers of the Common Stock. The holder of each share of
Preferred Stock shall be entitled to notice of any stockholders' meeting in
accordance with the Bylaws of the corporation and shall vote with holders of the
Common Stock upon the election of directors and upon any other matter submitted
to a vote of stockholders, except those matters required by law or by the
provisions of this Certificate to be submitted to a class vote. Fractional votes
shall not, however, be permitted and any fractional voting rights resulting from
the above formula (after aggregating as to each holder of Preferred Stock all
shares of Common Stock into which such holder's shares of Preferred Stock could
be converted) shall be rounded to the nearest whole number (with one-half
rounded upward to one).
(b) Common Stock. Each holder of shares of Common Stock shall be
entitled to one vote for each share held.
(c) Board of Directors. (i) The Board of Directors of the corporation
shall consist of seven (7) members. (ii) For so long as an aggregate of
1,000,000 shares of the Series C Preferred Stock and 1,500,000 shares of the
Series D Preferred Stock (as adjusted for stock splits, stock dividends,
recapitalizations and the like) are outstanding: the holders of the Series D
Preferred Stock, voting as a separate series, shall be entitled to elect one (1)
director of the corporation; the holders of the Series C Preferred Stock, voting
as a separate series, shall be entitled to elect one (1) director of the
corporation; the holders of the Series A Preferred Stock, voting as a separate
series, shall be entitled to elect one (1) director of the corporation and the
holders of the Common Stock, voting together as a separate class, shall be
entitled to elect one (1) director of the corporation. (iii) For so long as an
aggregate of 2,000,000 shares of Series E Preferred and Series E-1 Preferred
Stock (as adjusted for stock splits, stock dividends, recapitalizations and the
like) are outstanding, the holders of the Series E Preferred Stock and Series
E-1 Preferred Stock, voting together on an as converted basis, shall be entitled
to elect (1) director. (iv) All remaining directors of the corporation shall be
elected by the holders of the Common Stock and Preferred Stock voting together
as a single class in accordance with the provision set forth in Section 4(a)
above. (v) Vacancies on the Board of Directors may be filled by a majority of
series, class or classes of shares whose holders could elect an individual to
fill such vacancy on the Board of Directors, except that a vacancy created by
the removal of a director or directors by the vote or written consent of the
stockholders, such stockholders being those who hold a majority of the
outstanding shares of the series, class or classes entitled to elect such
director or directors, or by court order may be filled by only the vote of a
majority of the outstanding shares entitled to vote thereon. In addition, the
stockholders entitled to vote thereon may elect a director or directors at any
time to fill any vacancy or vacancies not filled by the directors.
-13-
<PAGE> 14
5. Redemption Rights of the Certain Preferred Stock.
(a) Redemption on Demand by Series E and Series E-1 Preferred. Subject
to applicable law, at any time following the sixth anniversary of the initial
closing of the purchase and sale of Series E Preferred Stock and/or Series E-1
Preferred Stock under the Purchase Agreement and upon the affirmative vote of
the holders of the majority of the Series E Preferred Stock and Series E-1
Preferred Stock, voting as a separate class on an as-converted basis, the
corporation shall redeem, in accordance with this Section 5, all shares of
Series E Preferred Stock and Series E-1 Preferred Stock outstanding as of the
date of such demand, prior to and in preference to any other redemption of the
corporation's capital stock. In addition, and subject to applicable law,
following the sixth anniversary of the initial closing of the purchase and sale
of Series E Preferred Stock and/or Series E-1 Preferred Stock under the Purchase
Agreement, upon the request of any holder of shares of Series E Preferred Stock
and/or Series E-1 Preferred Stock with an aggregate value of $1,000,000 (at a
deemed per share price, for this purpose, equal to the initial Conversion Price
for the Series E Preferred Stock and Series E-1 Preferred Stock), the
corporation shall redeem, in accordance with this Section 5, such shares of
Series E Preferred Stock and Series E-1 Preferred Stock for which such holder
shall request redemption.
(b) Redemption on Demand for other Preferred Stock. Subject to
applicable law and the satisfaction of the prior redemption rights of the Series
E Preferred Stock and Series E-1 Preferred Stock in Section 5(a), at any time
following the seventh anniversary of the initial closing of the purchase and
sale of Series D Preferred Stock and upon the affirmative vote of the holders of
the majority of the Series C Preferred Stock and Series D Preferred Stock,
voting together as a single class on an as converted basis, the corporation
shall redeem, in accordance with this Section 5, all shares of Series C
Preferred Stock and Series D Preferred Stock outstanding as of the date of such
demand.
(c) As used in this Section 5:
(i) The term "REDEMPTION TRIGGER DATE" shall mean, (x) with
regard to the Series E Preferred Stock and/or Series E-1 Preferred Stock, the
date after the sixth anniversary of the initial closing of the purchase and sale
of Series E Preferred Stock and/or Series E-1 Preferred Stock under the Purchase
Agreement on which the requisite holder or holders of Series E Preferred Stock
and/or Series E-1 Preferred Stock as set forth in Section 5(a) demand redemption
thereof, or (y) with regard to the holders of the Series C Preferred Stock and
Series D Preferred Stock, the date after the seventh anniversary of the initial
closing of the purchase and sale of Series D Preferred Stock on which the
requisite holders of Series C Preferred Stock and Series D Preferred stock as
set forth in Section 5(b) demand redemption thereof.
(ii) The term "REDEMPTION NOTICE" means a written notice to the
holders of the particular series of Preferred Stock or shares of Preferred Stock
notifying each holder of the redemption to be effected, specifying the amount
and series of Preferred Stock to be redeemed from such holder, the date on which
such redemption shall be effected, the
-14-
<PAGE> 15
Redemption Price, the place at which payment may be obtained and the date on
which such holder's right to convert such series of Preferred Stock into Common
Stock, as to such shares, terminates and calling upon such holder to surrender
to the corporation, in the manner and at the place designated, its certificate
or certificates representing the shares to be redeemed.
(iii) The term "REDEMPTION DATE" means, with regard to a
particular series of Preferred Stock or shares of Preferred Stock, each date on
which redemption of outstanding shares of such series of Preferred Stock is to
take place pursuant to a Redemption Notice directed to the holders of such
shares of Preferred Stock as provided below.
(iv) The term "REDEMPTION PRICE" means (in each case
appropriately adjusted for stock splits, stock dividends, recapitalizations and
similar events): for Series C Preferred Stock, $0.77 per share; for the Series D
Preferred Stock, $1.18 per share; and for the Series E Preferred Stock and
Series E-1 Preferred Stock, $5.68 per share, plus all declared but unpaid
dividends.
(d) Redemption Notification for Series E and Series E-1 Preferred
Stock. Within 90 days of the applicable Redemption Trigger Date for the Series E
Preferred Stock and Series E-1 Preferred Stock, the corporation shall redeem all
outstanding shares of Series E Preferred Stock and Series E-1 Preferred Stock
outstanding as of the applicable Redemption Trigger Date or in the case of
holders of such Preferred Stock permitted individually to redeem their shares of
such Preferred Stock, the number of shares of Series E Preferred Stock and/or
Series E-1 Preferred Stock for which redemption has been demanded. At least 20
days prior to the Redemption Date, the corporation shall send the Redemption
Notice by first class mail, postage prepaid, to each affected holder of record
(at the close of business on the business day next preceding the day on which
notice is given) of the Series E Preferred Stock and Series E-1 Preferred Stock,
at the address last shown on the records of the corporation for such holder or
given by the holder to the corporation for the purpose of notice or if no such
address appears or is given, at the place where the principal executive office
of the corporation is located.
(e) Redemption Notification for other Preferred Stock. Beginning with
the first year anniversary of the Redemption Trigger Date for the Series C
Preferred Stock and Series D Preferred Stock, and subject in each case to the
prior satisfaction of all redemption rights for the Series E Preferred Stock and
Series E-1 Preferred Stock, the corporation shall be required to redeem annually
no more than that number of shares of Series C Preferred Stock and Series D
Preferred Stock equal to twenty-five (25) percent of the shares of Series C
Preferred Stock and Series D Preferred Stock outstanding as of the applicable
Redemption Trigger Date. Annually thereafter, each holder of Series C Preferred
Stock and Series D Preferred Stock shall surrender to the corporation for
redemption no more than that number of shares equal to twenty-five (25) percent
of the shares held by such holder on the applicable Redemption Trigger Date
(with one-half being rounded upwards). At least 20 days prior to each
anniversary of the applicable Redemption Trigger Date until all such shares have
been redeemed or converted into Common Stock, the Redemption Notice shall be
mailed first class, postage prepaid, to each holder of record (at the close of
business on the business day next preceding the day on which
-15-
<PAGE> 16
notice is given) of the Series C Preferred Stock and Series D Preferred Stock,
at the address last shown on the records of the corporation for such holder or
given by the holder to the corporation for the purpose of notice or if no such
address appears or is given, at the place where the principal executive office
of the corporation is located.
(f) Effect of Redemption Notice. Except as provided in Section 5(g),
from and after an applicable Redemption Date, (i) each holder of Series C
Preferred Stock, Series D Preferred Stock, Series E Preferred Stock or Series
E-1 Preferred Stock to be redeemed on such Redemption Date shall surrender to
the corporation the certificate or certificates representing such shares (or in
the case of a lost certificate, shall present such evidence of loss and an
appropriate undertaking as the corporation may require), in the manner and at
the place designated in the Redemption Notice, and thereupon, the aggregate
Redemption Price of such shares shall be payable in cash to the order of the
person whose name appears on such certificate or certificates as the owner
thereof and each surrendered certificate shall be canceled, and (ii) unless
there shall have been a default in payment of the Redemption Price for shares of
Preferred Stock to be redeemed on such Redemption Date, all rights of the
holders of such shares designated for redemption on such Redemption Date (as
holders of the Series C Preferred Stock, Series D Preferred Stock, Series E
Preferred Stock or Series E-1 Preferred Stock, as the case may be, except the
right to receive their respective Redemption Price without interest upon
surrender of their certificate (or in the case of a lost certificate such
evidence of loss and an appropriate undertaking as the corporation may require))
shall cease with respect to such shares, and such shares shall not thereafter be
transferred on the books of the corporation or be deemed to be outstanding for
any purpose whatsoever.
(g) Incomplete Redemption. If the funds of the corporation legally
available for redemption of shares of the Series C Preferred Stock and Series D
Preferred Stock or Series E Preferred Stock and Series E-1 Preferred Stock on
any Redemption Date are insufficient to redeem the total number of shares of the
Series C Preferred Stock and Series D Preferred Stock or Series E Preferred
Stock and Series E-1 Preferred Stock to be redeemed on such date, those funds
which are legally available will be used to redeem the maximum possible number
of such shares on a pro rata basis among the holders of the Series C Preferred
Stock and Series D Preferred Stock or Series E Preferred Stock and Series E-1
Preferred Stock based upon each holder's share of the total redemption price,
provided that the corporation shall not redeem any shares of Series C Preferred
Stock or Series D Preferred Stock regardless of the passage of any Redemption
Date therefor until the corporation has satisfied its obligations under Section
5(a) to redeem all shares of Series E Preferred Stock and Series E-1 Preferred
Stock covered by any applicable Redemption Notice (and not otherwise converted
into Common Stock within the time provided in Section 5(h)). The shares of
Series C Preferred Stock and Series D Preferred Stock or Series E Preferred
Stock and Series E-1 Preferred Stock covered by the Redemption Notice but not
redeemed shall remain outstanding and be entitled to all the rights and
preferences provided herein. At any time thereafter when additional funds of the
corporation are legally available for the redemption of shares of Preferred
Stock covered by a prior Redemption Notice and not redeemed, such funds will
immediately be set aside for the redemption of the balance of the shares which
the corporation was obligated to redeem on any Redemption Date but which it
-16-
<PAGE> 17
has not redeemed and if it is economically reasonable to do so given the expense
of payment and the amounts of additional funds which have become legally
available for redemption of such shares, the corporation shall send a Redemption
Notice with regard to such shares in the manner provided in Section 5(d) or
5(e); provided that the holders of such Series C Preferred Stock, Series D
Preferred Stocks, Series E Preferred Stock and Series E-1 Preferred Stock, as
applicable, shall receive at least 10 days notice of such redemption, and
provided further, that the corporation shall not redeem any shares of Series C
Preferred Stock or Series D Preferred Stock regardless of the passage of any
Redemption Date therefor until the corporation has satisfied its obligations
under Section 5(a) to redeem all shares of Series E Preferred Stock and Series
E-1 Preferred Stock covered by an applicable Redemption Notice (and not
otherwise converted into Common Stock within the time provided in Section 5(h)).
(h) Redemption Funding. On or prior to a Redemption Date, the
corporation shall deposit the Redemption Price of all shares of Series C
Preferred Stock and Series D Preferred Stock or Series E Preferred Stock and
Series E-1 Preferred Stock, as the case may be, designated for redemption in the
Redemption Notice (or if the amount of funds which are legally available for the
redemption of shares of Series C Preferred Stock and Series D Preferred Stock or
Series E Preferred Stock and Series E-1 Preferred Stock is insufficient for such
redemption, then as provide in Section 5(h), such lesser amount as is available
for such redemption), with a bank or trust company located in the State of
California having aggregate capital and surplus in excess of $50,000,000 as a
trust fund for the benefit of the respective holders of the shares designated
for redemption and not yet redeemed. Simultaneously, the corporation shall
deposit irrevocable instructions and authority to such bank or trust company to
pay, on and after the date fixed for redemption or prior thereto, the Redemption
Price of the shares of Series C Preferred Stock, Series D Preferred Stock,
Series E Preferred Stock and/or Series E-1 Preferred Stock to the holders
thereof, respectively, to be redeemed in accordance with the Redemption Notice
upon surrender of their certificates. Any money deposited by the corporation
pursuant to this Section 5(h) for the redemption of shares of Preferred Stock on
a particular Redemption Date which shares are thereafter converted into shares
of Common Stock no later than the close of business on the last business day
prior to such Redemption Date shall be returned to the corporation forthwith
upon such conversion. The balance of any money deposited by the corporation
pursuant to this Section 5(h) remaining unclaimed at the expiration of six
months following a Redemption Date shall thereafter be returned to the
corporation (unless they shall have been set aside as provided in Section 5(g)
with regard to a prior partial redemption), provided that each stockholder to
which such money would have been payable from such deposit, had the stockholder
timely complied with the redemption procedures in Section 5(h) and the
Redemption Notice, shall be entitled, upon proof of ownership of the Preferred
Stock, to receive the redemption price for such stockholder's redeemed shares of
Preferred Stock but without interest from the relevant Redemption Date.
6. Protective Provisions. In addition to any other class vote that may be
required by law, (a) so long as at least an aggregate of 3,000,000 shares of
Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and
Series D Preferred Stock are outstanding, without first obtaining the approval
therefor (by vote or written consent, as provided by law) of the
-17-
<PAGE> 18
holders of at least a two-thirds of such then outstanding shares of such
Preferred Stock (voting as a single class on an as converted basis), and (b) so
long as at least an aggregate of 1,000,000 shares of Series E Preferred Stock
and Series E-1 Preferred Stock are outstanding, without first obtaining the
approval (by vote or written consent, as provided by law) of the holders of at
least fifty-one percent of such then outstanding shares of such Preferred Stock
(voting as a single class on an as converted basis), this corporation shall not
undertake any of the actions:
(i) effect a Change of Control in the corporation or sell all or
substantially all of its assets,
(ii) change the rights, preferences or privileges of any series
of Preferred Stock,
(iii) increase or decrease the authorized shares of Preferred
Stock or the designated shares of any series of Preferred Stock,
(iv) create a new series or class of shares having rights on a
parity with or superior to any outstanding class or series of
shares,
(v) except as set forth in this certificate, do any act which
would result in taxation under Section 305 of the Internal
Revenue Code,
(vi) divide the securities of any class into series having
different rights,
(vii) effect an exchange, reclassification or cancellation of all
or any part of a class of securities, including a reverse stock
split,
(viii) effect an exchange or create a right of exchange of all or
part of the shares of a class,
(ix) dissolve, liquidate or windup the corporation,
(x) declare or pay any dividends on the Common Stock,
(xi) increase the number of members of the corporation's Board of
Directors to more than seven (7) members,
(xii) except as set forth in this certificate or with regard to
repurchases of such stock from employees, directors, or
consultants, redeem or repurchase any shares of Common Stock,
Series A Preferred Stock, Series B Preferred Stock, Series C
Preferred Stock or Series D Preferred Stock or establish a
sinking fund to effect any such redemption or refund; or
-18-
<PAGE> 19
(xiii) incur any additional indebtedness in the aggregate in
excess of $20 million or convertible into equity with rights
senior to or on parity with the Series E Preferred Stock and
Series E-1 Preferred Stock.
7. Residual Rights. All rights accruing to the outstanding shares of
capital stock not expressly provided for to the contrary herein shall be vested
in the Common Stock.
SIX The following is applicable to the Common Stock:
1. Dividend Rights. Subject to the prior rights of holders of all classes
of stock at the time outstanding having prior rights as to dividends, the
holders of the Common Stock shall be entitled to receive, when and as declared
by the Board of Directors, out of any assets of the corporation legally
available therefor, such dividends as may be declared from time to time by the
Board of Directors.
2. Liquidation Rights. Upon the liquidation, dissolution or winding up of
the corporation, the assets of the corporation shall be distributed as provided
in Section 2 of Article Five hereof.
3. Redemption. The Common Stock is not redeemable.
4. Voting Rights. The holder of each share of Common Stock shall have the
right to one vote, and shall be entitled to notice of any stockholders' meeting
in accordance with the Bylaws of the corporation, and shall be entitled to vote
upon such matters and in such manner as may be provided by law.
SEVEN The corporation is to have perpetual existence.
EIGHT In furtherance and not in limitation of the powers conferred by
statute, the Board of Directors is expressly authorized to make, alter, amend or
repeal the Bylaws of the Corporation.
NINE For the management of the business and for the conduct of the affairs
of the corporation, and in further definition, limitation and regulation of the
powers of the corporation, of its directors and of its stockholders or any class
thereof, as the case may be, it is further provided that:
1. The conduct of the affairs of the corporation shall be managed
under the direction of the Board of Directors.
2. Each director shall hold office until such director's successor is
elected and qualified, or until such director's earlier death, resignation or
removal. No decrease in the authorized number of directors constituting the
Board of Directors shall shorten the term of any incumbent director.
-19-
<PAGE> 20
3. Subject to the rights of the holders of any series of Preferred
Stock and the Common Stock as provided in Section 4(c) of Article Five, any
vacancy occurring in the Board of Directors for any cause, and any newly created
directorship resulting from any increase in the authorized number of directors,
shall, unless (i) the Board of Directors determines by resolution that any such
vacancies or newly created directorships shall be filled by the stockholders, or
(ii) as otherwise provided by law, be filled only by the affirmative vote of a
majority of the directors then in office, although less than a quorum, or by a
sole remaining director, and not by the stockholders. Any director elected in
accordance with the preceding sentence shall hold office for the remainder of
the full term of the director for which the vacancy was created or occurred.
4. Subject to the rights of the holders of any series of Preferred
Stock and Common Stock set forth in Section 4(c) of Article Five, any director
or the entire Board of Directors may be removed by the holders of at least
sixty-six and two-thirds percent (66-2/3%) of the shares then entitled to vote
at an election of directors.
5. Subject to the rights of the holders of any series of Preferred
Stock to elect additional directors under specified circumstances, following the
closing of the corporation's initial public offering pursuant to an effective
registration statement under the Securities Act of 1933, as amended, covering
the offer and sale of Common Stock to the public (the "INITIAL PUBLIC
OFFERING"), the directors shall be divided, with respect to the time for which
they severally hold office, into three classes designated as Class I, Class II
and Class III, respectively. Directors shall be assigned to each class in
accordance with a resolution or resolutions adopted by the Board of Directors,
with the number of directors in each class to be divided as equally as
reasonably possible. The term of office of the Class I directors shall expire at
the corporation's first annual meeting of stockholders following the closing of
the Initial Public Offering, the term of office of the Class II directors shall
expire at the corporation's second annual meeting of stockholders following the
closing of the Initial Public Offering, and the term of office of the Class III
directors shall expire at the corporation's third annual meeting of stockholders
following the closing of the Initial Public Offering. At each annual meeting of
stockholders commencing with the first annual meeting of stockholders following
the closing of the Initial Public Offering, directors elected to succeed those
directors of the class whose terms then expire shall be elected for a term of
office to expire at the third succeeding annual meeting of stockholders after
their election. Prior to the closing of the Initial Public Offering, or in the
event the corporation is prohibited from dividing its board of directors through
the operation of Section 2115 of the California General Corporation Law
following the record date of the corporation's first annual meeting of
stockholders following the closing of the Initial Public Offering, each director
shall hold office until the next annual meeting of stockholders and until such
director's successor is elected and qualified, or until such director's earlier
death, resignation or removal.
5. Election of directors need not be by written ballot unless the
Bylaws of the corporation shall so provide.
6. Following the closing of the Initial Public Offering, no action
shall be taken by the stockholders of the corporation except at an annual or
special meeting of
-20-
<PAGE> 21
stockholders called in accordance with the Bylaws of the corporation, and no
action shall be taken by the stockholders by written consent.
7. Advance notice of stockholder nominations for the election of
directors of the corporation and of business to be brought by stockholders
before any meeting of stockholders of the corporation shall be given in the
manner provided in the Bylaws of the corporation. Business transacted at special
meetings of stockholders shall be confined to the purpose or purposes stated in
the notice of meeting.
8. Subject to Article IX of the Bylaws of the corporation, following
the closing of the Initial Public Offering, stockholders of the corporation
holding at least sixty-six and two-thirds percent (66-2/3%) of the corporation's
outstanding voting stock then entitled to vote at an election of directors shall
have the power to adopt, amend or repeal Bylaws of the corporation.
9. Following the closing of the Initial Public Offering, the
affirmative vote of the holders of at least sixty-six and two-thirds percent
(66-2/3%) of the corporation's outstanding voting stock then entitled to vote at
an election of directors, voting together as a single class, shall be required
to alter, change, amend, repeal or adopt any provision inconsistent with this
Article Nine.
TEN To the fullest extent permitted by the Delaware General Corporation Law
as the same exists or as may hereafter be amended, a director of the corporation
shall not be personally liable to the corporation or its stockholders for
monetary damages for breach of fiduciary duty as a director. The corporation
shall indemnify to the fullest extent permitted by law, any person made or
threatened to be made a party, to any action or proceeding, whether criminal,
civil, administrative or investigative, by reason of the fact the he or she, or
his or her testator or intestate, is or was a director or officer of the
corporation or any predecessor of the corporation, or serves or served at any
other enterprise as a director or officer at the request of the corporation or
any predecessor to the corporation. Neither any amendment nor repeal of this
Article, nor the adoption of any provision of this Certificate of Incorporation
inconsistent with this Article, shall eliminate or reduce the effect of this
Article in respect of any matter occurring, or any cause of action, suit or
claim accruing or arising or that, but for this Article, would accrue or arise,
prior to such amendment, repeal or adoption of an inconsistent provision.
ELEVEN The corporation reserves the right to amend, alter, change or repeal
any provision contained in this Certificate of Incorporation, in the manner now
or hereafter prescribed by statute, and all rights conferred upon stockholders
herein are granted subject to this reservation.
-21-
<PAGE> 22
IN WITNESS WHEREOF, the corporation has caused this Amended and Restated
Certificate to be signed by its Chief Financial Officer and Secretary, this ___
day of October, 1999.
---------------------------------------
Frederick J. Ruegsegger,
Chief Financial Officer and Secretary
<PAGE> 1
EXHIBIT 3.03
BYLAWS
OF
NEOFORMA.COM, INC.
<PAGE> 2
TABLE OF CONTENTS
<TABLE>
<CAPTION>
Page
----
<S> <C> <C>
ARTICLE I CORPORATE OFFICES.............................................................1
1.1 REGISTERED OFFICE.............................................................1
1.2 OTHER OFFICES.................................................................1
ARTICLE II MEETINGS OF STOCKHOLDERS......................................................1
2.1 PLACE OF MEETINGS.............................................................1
2.2 ANNUAL MEETING................................................................1
2.3 SPECIAL MEETING...............................................................2
2.4 NOTICE OF STOCKHOLDERS' MEETINGS..............................................2
2.5 MANNER OF GIVING NOTICE AFFIDAVIT OF NOTICE...................................2
2.6 ADVANCE NOTICE OF STOCKHOLDER NOMINEES AND STOCKHOLDER BUSINESS...............2
2.7 QUORUM........................................................................3
2.8 ADJOURNED MEETING; NOTICE.....................................................4
2.9 CONDUCT OF BUSINESS...........................................................4
2.10 VOTING........................................................................4
2.11 WAIVER OF NOTICE..............................................................5
2.12 STOCKHOLDER ACTION BY WRITTEN CONSENT WITHOUT A MEETING.......................5
2.13 RECORD DATE FOR STOCKHOLDER NOTICE; VOTING; GIVING CONSENTS...................5
2.14 PROXIES.......................................................................6
2.15 LIST OF STOCKHOLDERS ENTITLED TO VOTE.........................................6
ARTICLE III DIRECTORS.....................................................................7
3.1 POWERS........................................................................7
3.2 NUMBER OF DIRECTORS...........................................................7
3.3 ELECTION, QUALIFICATION AND TERM OF OFFICE OF DIRECTORS.......................7
3.4 RESIGNATION AND VACANCIES.....................................................8
3.5 PLACE OF MEETINGS: MEETINGS BY TELEPHONE......................................8
3.6 REGULAR MEETINGS..............................................................9
3.7 SPECIAL MEETINGS; NOTICE......................................................9
3.8 QUORUM........................................................................9
3.9 WAIVER OF NOTICE..............................................................9
3.10 BOARD ACTION BY WRITTEN CONSENT WITHOUT AM A MEETING.........................10
3.11 FEES AND COMPENSATION OF DIRECTORS...........................................10
3.12 APPROVAL OF LOANS TO OFFICERS................................................10
3.13 REMOVAL OF DIRECTORS.........................................................10
</TABLE>
<PAGE> 3
TABLE OF CONTENTS
(continued)
<TABLE>
<CAPTION>
Page
----
<S> <C> <C>
ARTICLE IV COMMITTEES...................................................................11
4.1 COMMITTEES OF DIRECTORS......................................................11
4.2 COMMITTEE MINUTES............................................................11
4.3 MEETINGS AND ACTION OF COMMITTEES............................................11
ARTICLE V OFFICERS.....................................................................12
5.1 OFFICERS.....................................................................12
5.2 APPOINTMENT OF OFFICERS......................................................12
5.3 SUBORDINATE OFFICERS.........................................................12
5.4 REMOVAL AND RESIGNATION OF OFFICERS: FILLING VACANCIES.......................12
5.5 CHAIRMAN OF THE BOARD........................................................13
5.6 CHIEF EXECUTIVE OFFICE.......................................................13
5.7 PRESIDENT....................................................................13
5.8 VICE PRESIDENTS..............................................................13
5.9 SECRETARY....................................................................14
5.10 CHIEF FINANCIAL OFFICER......................................................14
5.11 ASSISTANT SECRETARY..........................................................15
5.12 ASSISTANT TREASURER..........................................................15
5.13 REPRESENTATION OF SHARES OF OTHER CORPORATIONS...............................15
5.14 AUTHORITY AND DUTIES OF OFFICERS.............................................15
ARTICLE VI INDEMNITY....................................................................15
6.1 THIRD PARTY ACTIONS..........................................................15
6.2 ACTIONS BY OR IN THE RIGHT OF THE CORPORATION................................16
6.3 SUCCESSFUL DEFENSE...........................................................16
6.4 DETERMINATION OF CONDUCT.....................................................17
6.5 PAYMENT OF EXPENSES IN ADVANCE...............................................17
6.6 INDEMNITY NOT EXCLUSIVE......................................................17
6.7 INSURANCE INDEMNIFICATION....................................................17
6.8 THE CORPORATION..............................................................18
6.9 EMPLOYEE BENEFIT PLANS.......................................................18
6.10 CONTINUATION OF INDEMNIFICATION AND ADVANCEMENT OF EXPENSES..................19
ARTICLE VII RECORDS AND REPORTS..........................................................19
7.1 MAINTENANCE AND INSPECTION OF RECORDS........................................19
7.2 INSPECTION BY DIRECTORS......................................................19
7.3 ANNUAL STATEMENT TO STOCKHOLDERS.............................................20
ARTICLE VIII GENERAL MATTERS..............................................................20
8.1 CHECKS.......................................................................20
8.2 EXECUTION OF CORPORATE CONTRACTS AND INSTRUMENTS.............................20
8.3 STOCK CERTIFICATES: PARTLY PAID SHARES.......................................20
8.4 SPECIAL DESIGNATION ON CERTIFICATES..........................................21
</TABLE>
- ii -
<PAGE> 4
TABLE OF CONTENTS
(continued)
<TABLE>
<CAPTION>
Page
----
<S> <C> <C>
8.5 LOST CERTIFICATES............................................................21
8.6 CONSTRUCTION: DEFINITIONS....................................................22
8.7 DIVIDENDS....................................................................22
8.8 FISCAL YEAR..................................................................22
8.9 SEAL.........................................................................22
8.10 TRANSFER OF STOCK............................................................22
8.11 STOCK TRANSFER AGREEMENTS....................................................22
8.12 REGISTERED STOCKHOLDERS......................................................23
ARTICLE IX AMENDMENTS......................................................................23
</TABLE>
- iii -
<PAGE> 5
BYLAWS
OF
NEOFORMA.COM, INC.
ARTICLE I
CORPORATE OFFICES
1.1 REGISTERED OFFICE
The registered office of the corporation shall be in the City of
Wilmington, County of New Castle, State of Delaware. The name of the registered
agent of the corporation at such location is The Corporation Trust Company.
1.2 OTHER OFFICES
The board of directors may at any time establish other offices at any
place or places where the corporation is qualified to do business.
ARTICLE II
MEETINGS OF STOCKHOLDERS
2.1 PLACE OF MEETINGS
Meetings of stockholders shall be held at any place, either within or
without the State of Delaware, as may be designated by the board of directors or
in the manner provided in these bylaws. In the absence of any such designation,
stockholders' meetings shall be held at the registered office of the corporation
in the State of Delaware.
2.2 ANNUAL MEETING
The annual meeting of stockholders shall be held each year on a date and
at a time designated by the board of directors. In the absence of such
designation, the annual meeting of stockholders shall be held on the second
Tuesday of May of each year at 10:00 a.m. However, if such day falls on a legal
holiday, then the meeting shall be held at the same time and place on the next
succeeding business day. At the meeting, directors shall be elected and any
other proper business may be transacted.
<PAGE> 6
2.3 SPECIAL MEETING
A special meeting of the stockholders may be called at any time by the
board of directors, or by the chairman of the board, or by the president, or by
one or more stockholders holding shares in the aggregate entitled to cast not
less than ten percent of the votes at that meeting.
If a special meeting is called by any person or persons other than the
board of directors, the request shall be in writing, specifying the time of such
meeting and the general nature of the business proposed to be transacted, and
shall be delivered personally or sent by registered mail or by telegraphic or
other facsimile transmission to the chairman of the board, the president or the
secretary of the corporation. No business may be transacted at such special
meeting otherwise than specified in such notice. The officer receiving the
request shall cause notice to be promptly given to the stockholders entitled to
vote, in accordance with the provisions of Sections 2.4 and 2.5 of this Article
II, that a meeting will be held at the time requested by the person or persons
calling the meeting, not less than ten (10) nor more than sixty (60) days after
the receipt of the request. Nothing contained in this paragraph of this Section
2.3 shall be construed as limiting, fixing, or affecting the time when a meeting
of stockholders called by action of the board of directors may be held.
2.4 NOTICE OF STOCKHOLDERS' MEETINGS
All notices of meetings with stockholders shall be in writing and shall
be sent or otherwise given in accordance with Section 2.5 of these bylaws not
less than ten (10) nor more than sixty (60) days before the date of the meeting
to each stockholder entitled to vote at such meeting. The notice shall specify
the place, date, and hour of the meeting, and, in the case of a special meeting,
the purpose or purposes for which the meeting is called.
2.5 MANNER OF GIVING NOTICE AFFIDAVIT OF NOTICE
Written notice of any meeting of stockholders, if mailed, is given when
deposited in the United States mail, postage prepaid, directed to the
stockholder at his address as it appears on the records of the corporation. An
affidavit of the secretary or an assistant secretary or of the transfer agent of
the corporation that the notice has been given shall, in the absence of fraud,
be prima facie evidence of the facts stated therein.
2.6 ADVANCE NOTICE OF STOCKHOLDER NOMINEES AND STOCKHOLDER BUSINESS
Subject to the rights of holders of any class or series of stock having
a preference over the Common Stock as to dividends or upon liquidation,
(i) nominations for the election of directors, and
(ii) business proposed to be brought before any stockholder meeting
2
<PAGE> 7
may be made by the board of directors or proxy committee appointed by the board
of directors or by any stockholder entitled to vote in the election of directors
generally if such nomination or business proposed is otherwise proper business
before such meeting. However, any such stockholder may nominate one or more
persons for election as directors at a meeting or propose business to be brought
before a meeting, or both, only if such stockholder has given timely notice in
proper written form of their intent to make such nomination or nominations or to
propose such business. To be timely, such stockholder's notice must be delivered
to or mailed and received at the principal executive offices of the corporation
not less than one hundred twenty (120) calendar days in advance of (i) the date
specified in the corporation's proxy statement released to stockholders in
connection with the previous year's annual meeting of stockholders, if
applicable, or (ii) the date of such annual meeting; provided, however, that in
the event that no annual meeting was held in the previous year or the date of
the annual meeting has been changed by more than thirty (30) days from the date
contemplated at the time of the previous year's proxy statement, notice by the
stockholder to be timely must be so received a reasonable time before the
solicitation is made. To be in proper form, a stockholder's notice to the
secretary shall set forth:
(a) the name and address of the stockholder who intends to make the
nominations or propose the business and, as the case may be, of the
person or persons to be nominated or of the business to be proposed;
(b) a representation that the stockholder is a holder of record of stock
of the corporation entitled to vote at such meeting and, if applicable,
intends to appear in person or by proxy at the meeting to nominate the
person or persons specified in the notice;
(c) if applicable, a description of all arrangements or understandings
between the stockholder and each nominee and any other person or persons
(naming such person or persons) pursuant to which the nomination or
nominations are to be made by the stockholder;
(d) such other information regarding each nominee or each matter of
business to be proposed by such stockholder as would be required to be
included in a proxy statement filed pursuant to the proxy rules of the
Securities and Exchange Commission had the nominee been nominated, or
intended to be nominated, or the matter been proposed, or intended to be
proposed by the board of directors; and
(e) if applicable, the consent of each nominee to serve as director of
the corporation if so elected.
The chairman of the meeting shall refuse to acknowledge the nomination
of any person or the proposal of any business not made in compliance with the
foregoing procedure.
2.7 QUORUM
The holders of a majority of the stock issued and outstanding and
entitled to vote thereat, present in person or represented by proxy, shall
constitute a quorum at all meetings of the
3
<PAGE> 8
stockholders for the transaction of business except as otherwise provided by
statute or by the certificate of incorporation. If, however, such quorum is not
present or represented at any meeting of the stockholders, then either (i) the
Chairman of the meeting or (ii) the stockholders entitled to vote thereat,
present in person or represented by proxy, shall have power to adjourn the
meeting from time to time, without notice other than announcement at the
meeting, until a quorum is present or represented. At such adjourned meeting at
which a quorum is present or represented, any business may be transacted that
might have been transacted at the meeting as originally noticed.
2.8 ADJOURNED MEETING; NOTICE
When a meeting is adjourned to another time or place, unless these
bylaws otherwise require, notice need not be given of the adjourned meeting if
the time and place thereof are announced at the meeting at which the adjournment
is taken. At the adjourned meeting the corporation may transact any business
that might have been transacted at the original meeting. If the adjournment is
for more than thirty (30) days, or if after the adjournment a new record date is
fixed for the adjourned meeting, a notice of the adjourned meeting shall be
given to each stockholder of record entitled to vote at the meeting.
2.9 CONDUCT OF BUSINESS
The chairman of any meeting of stockholders shall determine the order of
business and the procedure at the meeting, including such regulation of the
manner of voting and the conduct of business.
2.10 VOTING
The stockholders entitled to vote at any meeting of stockholders shall
be determined in accordance with the provisions of Section 2.12 of these bylaws,
subject to the provisions of Sections 217 and 218 of the Delaware General
Corporation Law (relating to voting rights of fiduciaries, pledgors and joint
owners of stock and to voting trusts and other voting agreements).
Except as provided in the last paragraph of this Section 2.9, or as may
be otherwise provided in the certificate of incorporation, each stockholder
shall be entitled to one vote for each share of capital stock held by such
stockholder.
At a stockholders' meeting at which directors are to be elected, each
stockholder shall be entitled to cumulate votes (i.e., cast for any candidate a
number of votes greater than the number of votes which such stockholder normally
is entitled to cast) if the candidates' names have been properly placed in
nomination (in accordance with these bylaws) prior to commencement of the voting
and the stockholder requesting cumulative voting or any other stockholder voting
at the meeting in person or by proxy has given notice prior to commencement of
the voting of the stockholder's intention to cumulate votes. If cumulative
voting is properly requested, each holder of stock, or of any class or classes
or of a series or series thereof, who elects to cumulate votes shall be entitled
to as many votes as equals the number of votes which (absent this provision as
to cumulative voting) such person would be entitled to cast for the election of
directors with
4
<PAGE> 9
respect to his shares of stock multiplied by the number of directors to be
elected by such person, and that such person may cast all of such votes for a
single director or may distribute them among the number to be voted for, or for
any two or more of them, as such person may see fit.
2.11 WAIVER OF NOTICE
Whenever notice is required to be given under any provision of the
Delaware General Corporation Law or of the certificate of incorporation or these
bylaws, a written waiver, signed by the person entitled to notice, whether
before or after the time stated therein, shall be deemed equivalent to notice.
Attendance of a person at a meeting shall constitute a waiver of notice of such
meeting, except when the person attends a meeting for the express purpose of
objecting, at the beginning of the meeting, to the transaction of any business
because the meeting is not lawfully called or convened. Neither the business to
be transacted at, nor the purpose of, any regular or special meeting of the
stockholders, directors, or members of a committee of directors need be
specified in any written waiver of notice unless so required by the certificate
of incorporation or these bylaws.
2.12 STOCKHOLDER ACTION BY WRITTEN CONSENT WITHOUT A MEETING
Unless otherwise provided in the certificate of incorporation, any
action required to be taken at any annual or special meeting of stockholders of
a corporation, or any action that may be taken at any annual or special meeting
of such stockholders, may be taken without a meeting, without prior notice and
without a vote, if a consent or consents in writing, setting forth the action so
taken, shall be signed by the holders of outstanding stock having not less than
the minimum number of votes that would be necessary to authorize or take such
action at a meeting at which all shares entitled to vote thereon were present
and voted.
Prompt notice of the taking of the corporate action without a meeting by
less than unanimous written consent shall be given to those stockholders who
have not consented in writing. If the action which is consented to is such as
would have required the filing of a certificate under any section of the
Delaware General Corporation Law if such action had been voted on by
stockholders at a meeting thereof, then the certificate filed under such section
shall state, in lieu of any statement required by such section concerning any
vote of stockholders, that written notice and written consent have been given as
provided in Section 228 of the Delaware General Corporation Law.
2.13 RECORD DATE FOR STOCKHOLDER NOTICE; VOTING; GIVING CONSENTS
In order that the corporation may determine the stockholders entitled to
notice of or to vote at any meeting of stockholders or any adjournment thereof,
or entitled to express consent to corporate action in writing without a meeting,
or entitled to receive payment of any dividend or other distribution or
allotment of any rights, or entitled to exercise any rights in respect of any
change, conversion or exchange of stock or for the purpose of any other lawful
action, the board of directors may fix, in advance, a record date, which shall
not be more than sixty (60) nor less
5
<PAGE> 10
than ten (10) days before the date of such meeting, nor more than sixty (60)
days prior to any other action.
If the board of directors does not so fix a record date:
(i) The record date for determining stockholders entitled to notice of
or to vote at a meeting of stockholders shall be at the close of business on the
day next preceding the day on which notice is given, or, if notice is waived, at
the close of business on the day next preceding the day on which the meeting is
held.
(ii) The record date for determining stockholders entitled to express
consent to corporate action in writing without a meeting, when no prior action
by the board of directors is necessary, shall be the first date on which a
signed written consent is delivered to the corporation.
(iii) The record date for determining stockholders for any other purpose
shall be at the close of business on the day on which the board of directors
adopts the resolution relating thereto.
A determination of stockholders of record entitled to notice of or to
vote at a meeting of stockholders shall apply to any adjournment of the meeting;
provided, however, that the board of directors may fix a new record date for the
adjourned meeting.
2.14 PROXIES
Each stockholder entitled to vote at a meeting of stockholders or to
express consent or dissent to corporate action in writing without a meeting may
authorize another person or persons to act for such stockholder by a written
proxy, signed by such stockholder and filed with the secretary of the
corporation, but no such proxy shall be voted or acted upon after three (3)
years from its date, unless the proxy provides for a longer period. A proxy
shall be deemed signed if such stockholder's name is placed on the proxy by any
reasonable means including, but not limited to, by facsimile signature, manual
signature, typewriting, telegraphic transmission or otherwise, by such
stockholder or such stockholder's attorney-in-fact. The revocability of a proxy
that states on its face that it is irrevocable shall be governed by the
provisions of Section 212(e) of the Delaware General Corporation Law.
2.15 LIST OF STOCKHOLDERS ENTITLED TO VOTE
The officer who has charge of the stock ledger of a corporation shall
prepare and make, at least ten (10) days before every meeting of stockholders, a
complete list of the stockholders entitled to vote at the meeting, arranged in
alphabetical order, and showing the address of each stockholder and the number
of shares registered in the name of each stockholder. Such list shall be open to
the examination of any stockholder, for any purpose germane to the meeting,
during ordinary business hours, for a period of at least ten (10) days prior to
the meeting, either at a place within the city where the meeting is to be held,
which place shall be specified in the notice of the meeting, or, if not so
specified, at the place where the meeting is to be held. The list shall
6
<PAGE> 11
also be produced and kept at the time and place of the meeting during the whole
time thereof, and may be inspected by any stockholder who is present. Such list
shall presumptively determine the identity of the stockholders entitled to vote
at the meeting and the number of shares held by each of them.
ARTICLE III
DIRECTORS
3.1 POWERS
Subject to the provisions of the Delaware General Corporation Law and
any limitations in the certificate of incorporation or these bylaws relating to
action required to be approved by the stockholders or by the outstanding shares,
the business and affairs of the corporation shall be managed and all corporate
powers shall be exercised by or under the direction of the board of directors.
3.2 NUMBER OF DIRECTORS
The number of directors of the corporation shall be seven (7) until
changed by a bylaw amending this Section 3.2, duly adopted by the board of
directors or by the stockholders.
No reduction of the authorized number of directors shall have the effect
of removing any director before that director's term of office expires.
3.3 ELECTION, QUALIFICATION AND TERM OF OFFICE OF DIRECTORS
Except as provided in Section 3.4 of these bylaws, directors shall be
elected at each annual meeting of stockholders to hold office until the next
annual meeting. Directors need not be stockholders unless so required by the
certificate of incorporation or these bylaws, wherein other qualifications for
directors may be prescribed. Each director, including a director elected to fill
a vacancy, shall hold office until his successor is elected and qualified or
until his earlier resignation or removal.
Elections of directors need not be by written ballot.
3.4 RESIGNATION AND VACANCIES
Any director may resign at any time upon written notice to the attention
of the Secretary of the corporation. When one or more directors shall resign
from the board of directors, effective at a future date, a majority of the
directors then in office, including those who have so resigned, shall have power
to fill such vacancy or vacancies, the vote thereon to take effect when such
resignation or resignations shall become effective, and each director so chosen
shall hold office as provided in this section in the filling of other vacancies.
Unless otherwise provided in the certificate of incorporation or these
bylaws:
7
<PAGE> 12
(i) Vacancies and newly created directorships resulting from any
increase in the authorized number of directors elected by all of the
stockholders having the right to vote as a single class may be filled by a
majority of the directors then in office, although less than a quorum, or by a
sole remaining director.
(ii) Whenever the holders of any class or classes of stock or
series thereof are entitled to elect one or more directors by the certificate of
incorporation, vacancies and newly created directorships of such class or
classes or series may be filled by a majority of the directors elected by such
class or classes or series thereof then in office, or by a sole remaining
director so elected.
If at any time, by reason of death or resignation or other cause, the
corporation should have no directors in office, then any officer or any
stockholder or an executor, administrator, trustee or guardian of a stockholder,
or other fiduciary entrusted with like responsibility for the person or estate
of a stockholder, may call a special meeting of stockholders in accordance with
the provisions of the certificate of incorporation or these bylaws, or may apply
to the Court of Chancery for a decree summarily ordering an election as provided
in Section 211 of the Delaware General Corporation Law.
If, at the time of filling any vacancy or any newly created
directorship, the directors then in office constitute less than a majority of
the whole board (as constituted immediately prior to any such increase), then
the Court of Chancery may, upon application of any stockholder or stockholders
holding at least ten (10) percent of the total number of the shares at the time
outstanding having the right to vote for such directors, summarily order an
election to be held to fill any such vacancies or newly created directorships,
or to replace the directors chosen by the directors then in office as aforesaid,
which election shall be governed by the provisions of Section 211 of the
Delaware General Corporation Law as far as applicable.
3.5 PLACE OF MEETINGS: MEETINGS BY TELEPHONE
The board of directors of the corporation may hold meetings, both
regular and special, either within or outside the State of Delaware.
Unless otherwise restricted by the certificate of incorporation or these
bylaws, members of the board of directors, or any committee designated by the
board of directors, may participate in a meeting of such board of directors, or
committee by means of conference telephone or similar communications equipment
by means of which all persons participating in the meeting can hear each other,
and such participation in a meeting pursuant to this section shall constitute
presence in person at the meeting.
3.6 REGULAR MEETINGS
Regular meetings of the board of directors may be held without notice at
such time and at such place as shall from time to time be determined by the
board.
8
<PAGE> 13
3.7 SPECIAL MEETINGS; NOTICE
Special meetings of the board of directors for any purpose or purposes
may be called at any time by the chairman of the board, the president, any vice
president, the secretary or any two (2) directors.
Notice of the time and place of special meetings shall be delivered
personally or by telephone to each director or sent by first-class mail or
telegram, charges prepaid, addressed to each director at that director's address
as it is shown on the records of the corporation. If the notice is mailed, it
shall be deposited in the United States mail at least four (4) days before the
time of the holding of the meeting. If the notice is delivered personally or by
telephone or by telegram, it shall be delivered personally or by telephone or to
the telegraph company at least forty-eight (48) hours before the time of the
holding of the meeting. Any oral notice given personally or by telephone may be
communicated either to the director or to a person at the office of the director
who the person giving the notice has reason to believe will promptly communicate
it to the director. The notice need not specify the purpose or the place of the
meeting, if the meeting is to be held at the principal executive office of the
corporation.
3.8 QUORUM
At all meetings of the board of directors, a majority of the authorized
number of directors shall constitute a quorum for the transaction of business
and the act of a majority of the directors present at any meeting at which there
is a quorum shall be the act of the board of directors, except as may be
otherwise specifically provided by statute, the certificate of incorporation, or
these bylaws. If a quorum is not present at any meeting of the board of
directors, then the directors present thereat may adjourn the meeting from time
to time, without notice other than announcement at the meeting, until a quorum
is present.
A meeting at which a quorum is initially present may continue to
transact business notwithstanding the withdrawal of directors, if any action
taken is approved by at least a majority of the required quorum for that
meeting.
3.9 WAIVER OF NOTICE
Whenever notice is required to be given under any provision of the
Delaware General Corporation Law, the certificate of incorporation, or these
bylaws, a written waiver thereof, signed by the person entitled to notice,
whether before or after the time stated therein, shall be deemed equivalent to
notice. Attendance of a person at a meeting shall constitute a waiver of notice
of such meeting, except when such person attends a meeting for the express
purpose of objecting, at the beginning of the meeting, to the transaction of any
business because the meeting is not lawfully called or convened. Neither the
business to be transacted at, nor the purpose of, any regular or special meeting
of the directors, or members of a committee of directors, need be specified in
any written waiver of notice unless so required by the certificate of
incorporation or these bylaws.
9
<PAGE> 14
3.10 BOARD ACTION BY WRITTEN CONSENT WITHOUT AM A MEETING
Unless otherwise restricted by the certificate of incorporation or these
bylaws, any action required or permitted to be taken at any meeting of the board
of directors, or of any committee thereof may be taken without a meeting if all
members of the board or committee, as the case may be, consent thereto in
writing and the writing or writings are filed with the minutes of proceedings of
the board or committee.
3.11 FEES AND COMPENSATION OF DIRECTORS
Unless otherwise restricted by the certificate of incorporation or these
bylaws, the board of directors shall have the authority to fix the compensation
of directors.
3.12 APPROVAL OF LOANS TO OFFICERS
The corporation may lend money to, or guarantee any obligation of, or
otherwise assist any officer or other employee of the corporation or of its
subsidiary, including any officer or employee who is a director of the
corporation or its subsidiary, whenever, in the judgment of the directors, such
loan, guaranty or assistance may reasonably be expected to benefit the
corporation. The loan, guaranty or other assistance may be with or without
interest and may be unsecured, or secured in such manner as the board of
directors shall approve, including, without limitation, a pledge of shares of
stock of the corporation. Nothing in this section contained shall be deemed to
deny, limit or restrict the powers of guaranty or warranty of the corporation at
common law or under any statute.
3.13 REMOVAL OF DIRECTORS
Unless otherwise restricted by statute, by the certificate of
incorporation or by these bylaws, any director or the entire board of directors
may be removed, with or without cause, by the holders of a majority of the
shares then entitled to vote at an election of directors; provided, however,
that, so long as stockholders of the corporation are entitled to cumulative
voting, if less than the entire board is to be removed, no director may be
removed without cause if the votes cast against his removal would be sufficient
to elect such director if then cumulatively voted at an election of the entire
board of directors or, if there be classes of directors, at an election of the
class of directors of which such director is a part.
No reduction of the authorized number of directors shall have the effect
of removing any director prior to the expiration of such director's term of
office.
ARTICLE IV
COMMITTEES
4.1 COMMITTEES OF DIRECTORS
The board of directors may, by resolution passed by a majority of the
whole board, designate one or more committees, with each committee to consist of
one or more of the
10
<PAGE> 15
directors of the corporation. The board may designate one or more directors as
alternate members of any committee, who may replace any absent or disqualified
member at any meeting of the committee. In the absence or disqualification of a
member of a committee, the member or members thereof present at any meeting and
not disqualified from voting, whether or not such member or members constitute a
quorum, may unanimously appoint another member of the board of directors to act
at the meeting in the place of any such absent or disqualified member. Any such
committee, to the extent provided in the resolution of the board of directors,
or in the bylaws of the corporation, shall have and may exercise all the powers
and authority of the board of directors in the management of the business and
affairs of the corporation, and may authorize the seal of the corporation to be
affixed to all papers that may require it; but no such committee shall have the
power or authority (i) approving or adopting or recommending to the
stockholders, any action or matter expressly required by the Delaware General
Corporation Law to be submitted to stockholders for approval or (ii) adopting,
amending, or repealing any bylaws of the corporation; and, unless the board
resolution establishing the committee, the bylaws or the certificate of
incorporation expressly so provide, no such committee shall have the power or
authority to declare a dividend, to authorize the issuance of stock, or to adopt
a certificate of ownership and merger pursuant to Section 253 of the Delaware
General Corporation Law.
4.2 COMMITTEE MINUTES
Each committee shall keep regular minutes of its meetings and report the
same to the board of directors when required.
4.3 MEETINGS AND ACTION OF COMMITTEES
Meetings and actions of committees shall be governed by, and held and
taken in accordance with, the provisions of Article III of these bylaws, Section
3.5 (place of meetings and meetings by telephone), Section 3.6 (regular
meetings), Section 3.7 (special meetings and notice), Section 3.8 (quorum),
Section 3.9 (waiver of notice), and Section 3.10 (action without a meeting),
with such changes in the context of those bylaws as are necessary to substitute
the committee and its members for the board of directors and its members;
provided, however, that the time of regular meetings of committees may be
determined either by resolution of the board of directors or by resolution of
the committee, that special meetings of committees may also be called by
resolution of the board of directors and that notice of special meetings of
committees shall also be given to all alternate members, who shall have the
right to attend all meetings of the committee. The board of directors may adopt
rules for the government of any committee not inconsistent with the provisions
of these bylaws.
ARTICLE V
OFFICERS
5.1 OFFICERS
The officers of the corporation shall be a president, a secretary, and a
chief financial officer. The corporation may also have, at the discretion of the
board of directors, a chairman of
11
<PAGE> 16
the board, one or more vice presidents, one or more assistant vice presidents,
one or more assistant secretaries, one or more assistant treasurers, and any
such other officers as may be appointed in accordance with the provisions of
Section 5.3 of these bylaws. Any number of offices may be held by the same
person.
5.2 APPOINTMENT OF OFFICERS
The officers of the corporation, except such officers as may be
appointed in accordance with the provisions of Sections 5.3 or 5.5 of these
bylaws, shall be appointed by the board of directors, subject to the rights, if
any, of an officer under any contract of employment.
5.3 SUBORDINATE OFFICERS
The board of directors may appoint, or empower the president to appoint,
such other officers and agents as the business of the corporation may require,
each of whom shall hold office for such period, have such authority, and perform
such duties as are provided in these bylaws or as the board of directors may
from time to time determine.
5.4 REMOVAL AND RESIGNATION OF OFFICERS: FILLING VACANCIES
Subject to the rights, if any, of an officer under any contract of
employment, any officer may be removed, either with or without cause, by an
affirmative vote of the majority of the board of directors at any regular or
special meeting of the board or, except in the case of an officer chosen by the
board of directors, by any officer upon whom such power of removal may be
conferred by the board of directors.
Any officer may resign at any time by giving written notice to the
corporation. Any resignation shall take effect at the date of the receipt of
that notice or at any later time specified in that notice; and, unless otherwise
specified in that notice, the acceptance of the resignation shall not be
necessary to make it effective. Any resignation is without prejudice to the
rights, if any, of the corporation under any contract to which the officer is a
party.
Any vacancy occurring in any office of the corporation shall be filled
by the board of directors.
5.5 CHAIRMAN OF THE BOARD
The chairman of the board, if such an officer be elected, shall, if
present, preside at meetings of the board of directors and exercise and perform
such other powers and duties as may from time to time be assigned to the
chairman of the board by the board of directors or as may be prescribed by these
bylaws. If there is no president and no one has been appointed chief executive
officer, then the chairman of the board shall also be the chief executive
officer of the corporation and shall have the powers and duties prescribed in
Section 5.6 of these bylaws.
12
<PAGE> 17
5.6 CHIEF EXECUTIVE OFFICE
The board of directors shall select a chief executive officer of the
corporation who shall be subject to the control of the board of directors and
have general supervision, direction and control of the business and the officers
of the corporation. The chief executive officer shall preside at all meetings of
the stockholders and, in the absence or nonexistence of a chairman of the board,
at all meetings of the board of directors.
5.7 PRESIDENT
The president shall have the general powers and duties of management
usually vested in the office of president of a corporation and shall have such
other powers and duties as may be prescribed by the board of directors or these
bylaws. In addition and subject to such supervisory powers, if any, as may be
given by the board of directors to the chairman of the board, if no one has been
appointed chief executive officer, the president shall be the chief executive
officer of the corporation and shall, subject to the control of the board of
directors, have the powers and duties described in Section 5.6.
5.8 VICE PRESIDENTS
In the absence or disability of the president, the vice presidents, if
any, in order of their rank as fixed by the board of directors or, if not
ranked, a vice president designated by the board of directors, shall perform all
the duties of the president and when so acting shall have all the powers of, and
be subject to all the restrictions upon, the president. The vice presidents
shall have such other powers and perform such other duties as from time to time
may be prescribed for them respectively by the board of directors, these bylaws,
the president or the chairman of the board.
5.9 SECRETARY
The secretary shall keep or cause to be kept, at the principal executive
office of the corporation or such other place as the board of directors may
direct, a book of minutes of all meetings and actions of directors, committees
of directors, and stockholders. The minutes shall show the time and place of
each meeting, whether regular or special (and, if special, how authorized and
the notice given), the names of those present at directors' meetings or
committee meetings, the number of shares present or represented at stockholders'
meetings, and the proceedings thereof.
The secretary shall keep, or cause to be kept, at the principal
executive office of the corporation or at the office of the corporation's
transfer agent or registrar, as determined by resolution of the board of
directors, a share register, or a duplicate share register, showing the names of
all stockholders and their addresses, the number and classes of shares held by
each, the number and date of certificates evidencing such shares, and the number
and date of cancellation of every certificate surrendered for cancellation.
13
<PAGE> 18
The secretary shall give, or cause to be given, notice of all meetings
of the stockholders and of the board of directors required to be given by law or
by these bylaws. The secretary shall keep the seal of the corporation, if one be
adopted, in safe custody and shall have such other powers and perform such other
duties as may be prescribed by the board of directors or by these bylaws.
5.10 CHIEF FINANCIAL OFFICER
The chief financial officer shall keep and maintain, or cause to be kept
and maintained, adequate and correct books and records of accounts of the
properties and business transactions of the corporation, including accounts of
its assets, liabilities, receipts, disbursements, gains, losses, capital
retained earnings, and shares. The books of account shall at all reasonable
times be open to inspection by any director.
The chief financial officer shall deposit all moneys and other valuables
in the name and to the credit of the corporation with such depositories as may
be designated by the board of directors. The chief financial officer shall
disburse the funds of the corporation as may be ordered by the board of
directors, shall render to the president and directors, whenever they request
it, an account of all his transactions as chief financial officer and of the
financial condition of the corporation, and shall have other powers and perform
such other duties as may be prescribed by the board of directors or these
bylaws.
The chief financial officer shall be the treasurer of the corporation.
5.11 ASSISTANT SECRETARY
The assistant secretary, or, if there is more than one, the assistant
secretaries in the order determined by the stockholders or board of directors
(or if there be no such determination, then in the order of their election)
shall, in the absence of the secretary or in the event of his or her inability
or refusal to act, perform the duties and exercise the powers of the secretary
and shall perform such other duties and have such other powers as may be
prescribed by the board of directors or these bylaws.
5.12 ASSISTANT TREASURER
The assistant treasurer, or, if there is more than one, the assistant
treasurers, in the order determined by the stockholders or board of directors
(or if there be no such determination, then in the order of their election),
shall, in the absence of the chief financial officer or in the event of his or
her inability or refusal to act, perform the duties and exercise the powers of
the chief financial officer and shall perform such other duties and have such
other powers as may be prescribed by the board of directors or these bylaws.
5.13 REPRESENTATION OF SHARES OF OTHER CORPORATIONS
The chairman of the board, the president, any vice president, the chief
financial officer, the secretary or assistant secretary of this corporation, or
any other person authorized by the
14
<PAGE> 19
board of directors or the president or a vice president, is authorized to vote,
represent, and exercise on behalf of this corporation all rights incident to any
and all shares of any other corporation or corporations standing in the name of
this corporation. The authority granted herein may be exercised either by such
person directly or by any other person authorized to do so by proxy or power of
attorney duly executed by such person having the authority.
5.14 AUTHORITY AND DUTIES OF OFFICERS
In addition to the foregoing authority and duties, all officers of the
corporation shall respectively have such authority and perform such duties in
the management of the business of the corporation as may be designated from time
to time by the board of directors or the stockholders.
ARTICLE VI
INDEMNITY
6.1 THIRD PARTY ACTIONS
The corporation shall indemnify any person who was or is a party or is
threatened to be made a party to any threatened, pending, or completed action,
suit or proceeding, whether civil, criminal, administrative or investigative
(other than an action by or in the right of the corporation) by reason of the
fact that such person is or was a director, officer, employee or agent of the
corporation, or is or was serving at the request of the corporation as a
director, officer, employee or agent of another corporation, partnership, joint
venture trust or other enterprise, against expenses (including attorneys' fees),
judgments, fines and amounts paid in settlement (if such settlement is approved
in advance by the corporation, which approval shall not be unreasonably
withheld) actually and reasonably incurred by such person in connection with
such action, suit or proceeding if such person acted in good faith and in a
manner such person reasonably believed to be in or not opposed to the best
interests of the corporation, and, with respect to any criminal action or
proceeding, had no reasonable cause to believe such person's conduct was
unlawful. The termination of any action, suit or proceeding by judgment, order,
settlement, conviction, or upon a plea of nolo contendere or its equivalent,
shall not, of itself, create a presumption that the person did not act in good
faith and in a manner which the person reasonably believed to be in or not
opposed to the best interest of the corporation, and, with respect to any
criminal action or proceeding, had reasonable cause to believe that the person's
conduct was unlawful.
6.2 ACTIONS BY OR IN THE RIGHT OF THE CORPORATION
The corporation shall indemnify any person who was or is a party or is
threatened to be made a party to any threatened, pending or completed action or
suit by or in the right of the corporation to procure a judgment in its favor by
reason of the fact that such person is or was a director, officer, employee or
agent of corporation, or is or was serving at the request of the corporation as
a director, officer, employee or agent of another corporation, partnership,
joint venture, trust or other enterprise against expenses (including attorneys'
fees) and amounts paid in
15
<PAGE> 20
settlement (if such settlement is approved in advance by the corporation, which
approval shall not be unreasonably withheld) actually and reasonably incurred by
such person in connection with the defense or settlement of such action or suit
if such person acted in good faith and in manner such person reasonably believed
to be in or not opposed to the best interests of the corporation, except that no
indemnification shall be made in respect of any claim, issue or matter as to
which such person shall have been adjudged to be liable to the corporation
unless and only to the extent that the Delaware Court of Chancery or the court
in which such action or suit was brought shall determine upon application that,
despite the adjudication of liability but in view of all the circumstances of
the case, such person is fairly and reasonably entitled to indemnity for such
expenses which the Delaware Court of Chancery or such other court shall deem
proper. Notwithstanding any other provision of this Article VI, no person shall
be indemnified hereunder for any expenses or amounts paid in settlement with
respect to any action to recover short-swing profits under Section 16(b) of the
Securities Exchange Act of 1934, as amended.
6.3 SUCCESSFUL DEFENSE
To the extent that a director, officer, employee or agent of the
corporation has been successful on the merits or otherwise in defense of any
action, suit or proceeding referred to in Sections 6.1 and 6.2, or in defense of
any claim, issue or matter therein, such person shall be indemnified against
expenses (including attorneys' fees) actually and reasonably incurred by such
person in connection therewith.
6.4 DETERMINATION OF CONDUCT
Any indemnification under Sections 6.1 and 6.2 (unless ordered by a
court) shall be made by the corporation only as authorized in the specific case
upon a determination that the indemnification of the director, officer, employee
or agent is proper in the circumstances because such person has met the
applicable standard of conduct set forth in Sections 6.1 and 6.2. Such
determination shall be made (1) by the Board of Directors or the Executive
Committee by a majority vote of a quorum consisting of directors who were not
parties to such action, suit or proceeding or (2) or if such quorum is not
obtainable or, even if obtainable, a quorum of disinterested directors so
directs, by independent legal counsel in a written opinion, or (3) by the
stockholders. Notwithstanding the foregoing, a director, officer, employee or
agent of the Corporation shall be entitled to contest any determination that the
director, officer, employee or agent has not met the applicable standard of
conduct set forth in Sections 6.1 and 6.2 by petitioning a court of competent
jurisdiction.
6.5 PAYMENT OF EXPENSES IN ADVANCE
Expenses incurred in defending a civil or criminal action, suit or
proceeding, by an individual who may be entitled to indemnification pursuant to
Section 6.1 or 6.2, shall be paid by the corporation in advance of the final
disposition of such action, suit or proceeding upon receipt of an undertaking by
or on behalf of the director, officer, employee or agent to repay such amount if
it shall ultimately be determined that such person is not entitled to be
indemnified by the corporation as authorized in this Article VI.
16
<PAGE> 21
6.6 INDEMNITY NOT EXCLUSIVE
The indemnification and advancement of expenses provided by or granted
pursuant to the other sections of this Article VI shall not be deemed exclusive
of any other rights to which those seeking indemnification or advancement of
expenses may be entitled under any by-law, agreement, vote of stockholders or
disinterested directors or otherwise, both as to action in such person's
official capacity and as to action in another capacity while holding such
office.
6.7 INSURANCE INDEMNIFICATION
The corporation shall have the power to purchase and maintain insurance
on behalf of any person who is or was a director, officer, employee or agent of
the corporation, or is or was serving at the request of the corporation as a
director, officer, employee or agent of another corporation, partnership, joint
venture, trust or other enterprise, against any liability asserted against such
person and incurred by such person in any such capacity or arising out of such
person's status as such, whether or not the corporation would have the power to
indemnify such person against such liability under the provisions of this
Article VI.
6.8 THE CORPORATION
For purposes of this Article VI, references to "the corporation" shall
include, in addition to the resulting corporation, any constituent corporation
(including any constituent of a constituent) absorbed in a consolidation or
merger which, if its separate existence had continued, would have had power and
authority to indemnify its directors, officers, and employees or agents, so that
any person who is or was a director, officer, employee or agent of such
constituent corporation, or is or was serving at the request of such constituent
corporation as a director, officer, employee or agent of another corporation,
partnership, joint venture, trust or other enterprise, shall stand in the same
position under and subject to the provisions of this Article VI (including,
without limitation the provisions of Section 6.4) with respect to the resulting
or surviving corporation as such person would have with respect to such
constituent corporation if its separate existence had continued.
6.9 EMPLOYEE BENEFIT PLANS
For purposes of this Article VI, references to "other enterprises" shall
include employee benefit plans; references to "fines" shall include any excise
taxes assessed on a person with respect to an employee benefit plan; and
references to "serving at the request of the corporation" shall include any
service as a director, officer, employee or agent of the corporation which
imposes duties on, or involves services by, such director, officer, employee, or
agent with respect to an employee benefit plan, its participants, or
beneficiaries; and a person who acted in good faith and in a manner such person
reasonably believed to be in the interest of the participants and beneficiaries
of an employee benefit plan shall be deemed to have acted in a manner "not
opposed to the best interests of the corporation" as referred to in this Article
VI.
17
<PAGE> 22
6.10 CONTINUATION OF INDEMNIFICATION AND ADVANCEMENT OF EXPENSES
The indemnification and advancement of expenses provided by, or granted
pursuant to, this Article VI shall, unless otherwise provided when authorized or
ratified, continue as to a person who has ceased to be a director, officer,
employee or agent and shall inure to the benefit of the heirs, executors and
administrators of such a person.
ARTICLE VII
RECORDS AND REPORTS
7.1 MAINTENANCE AND INSPECTION OF RECORDS
The corporation shall, either at its principal executive officer or at
such place or places as designated by the board of directors, keep a record of
its stockholders listing their names and addresses and the number and class of
shares held by each stockholder, a copy of these bylaws as amended to date,
accounting books, and other records.
Any stockholder of record, in person or by attorney or other agent,
shall, upon written demand under oath stating the purpose thereof, have the
right during the usual hours for business to inspect for any proper purpose the
corporation's stock ledger, a list of its stockholders, and its other books and
records and to make copies or extracts therefrom. A proper purpose shall mean a
purpose reasonably related to such person's interest as a stockholder. In every
instance where an attorney or other agent is the person who seeks the right to
inspection, the demand under oath shall be accompanied by a power of attorney or
such other writing that authorizes the attorney or other agent so to act on
behalf of the stockholder. The demand under oath shall be directed to the
corporation at its registered office in Delaware or at its principal place of
business.
The officer who has charge of the stock ledger of the corporation shall
prepare and make, at least ten (10) days before every meeting of stockholders, a
complete list of the stockholders entitled to vote at the meeting, arranged in
alphabetical order, showing the address of each stockholder and the number of
shares registered in the name of each stockholder. Such list shall be open to
the examination of any stockholder, for any purpose germane to the meeting,
during ordinary business hours, for a period of at least ten (10) days prior to
the meeting, either at a place within the city where the meeting is to be held,
which place shall be specified in the notice of the meeting, or, if not so
specified, at the place where the meeting is to be held. The list shall also be
produced and kept at the time and place of the meeting during the whole time
thereof, and may be inspected by any stockholder who is present.
7.2 INSPECTION BY DIRECTORS
Any director shall have the right to examine the corporation's stock
ledger, a list of its stockholders, and its other books and records for a
purpose reasonably related to his position as a director. The Court of Chancery
is hereby vested with the exclusive jurisdiction to determine whether a director
is entitled to the inspection sought. The Court may summarily order the
18
<PAGE> 23
corporation to permit the director to inspect any and all books and records, the
stock ledger, and the stock list and to make copies or extracts therefrom. The
Court may, in its discretion, prescribe any limitations or conditions with
reference to the inspection, or award such other and further relief as the Court
may deem just and proper.
7.3 ANNUAL STATEMENT TO STOCKHOLDERS
The board of directors shall present at each annual meeting, and at any
special meeting of the stockholders when called for by vote of the stockholders,
a full and clear statement of the business and condition of the corporation.
ARTICLE VIII
GENERAL MATTERS
8.1 CHECKS
From time to time, the board of directors shall determine by resolution
which person or persons may sign or endorse all checks, drafts, other orders for
payment of money, notes or other evidences of indebtedness that are issued in
the name of or payable to the corporation, and only the persons so authorized
shall sign or endorse those instruments.
8.2 EXECUTION OF CORPORATE CONTRACTS AND INSTRUMENTS
The board of directors, except as otherwise provided in these bylaws,
may authorize any officer or officers, or agent or agents, to enter into any
contract or execute any instrument in the name of and on behalf of the
corporation; such authority may be general or confined to specific instances.
Unless so authorized or ratified by the board of directors or within the agency
power of an officer, no officer, agent or employee shall have any power or
authority to bind the corporation by any contract or engagement or to pledge its
credit or to render it liable for any purpose or for any amount.
8.3 STOCK CERTIFICATES; PARTLY PAID SHARES
The shares of the corporation shall be represented by certificates,
provided that the board of directors of the corporation may provide by
resolution or resolutions that some or all of any or all classes or series of
its stock shall be uncertificated shares. Any such resolution shall not apply to
shares represented by a certificate until such certificate is surrendered to the
corporation. Notwithstanding the adoption of such a resolution by the board of
directors, every holder of stock represented by certificates and upon request
every holder of uncertificated shares shall be entitled to have a certificate
signed by, or in the name of the corporation by the chairman or vice-chairman of
the board of directors, or the president or vice-president, and by the chief
financial officer or an assistant treasurer, or the secretary or an assistant
secretary of such corporation representing the number of shares registered in
certificate form. Any or all of the signatures on the certificate may be a
facsimile. In case any officer, transfer agent or registrar who has signed or
whose facsimile signature has been placed upon a certificate has ceased to be
19
<PAGE> 24
such officer, transfer agent or registrar before such certificate is issued, it
may be issued by the corporation with the same effect as if such person were
such officer, transfer agent or registrar at the date of issue.
The corporation may issue the whole or any part of its shares as partly
paid and subject to call for the remainder of the consideration to be paid
therefor. Upon the face or back of each stock certificate issued to represent
any such partly paid shares, upon the books and records of the corporation in
the case of uncertificated partly paid shares, the total amount of the
consideration to be paid therefor and the amount paid thereon shall be stated.
Upon the declaration of any dividend on fully paid shares, the corporation shall
declare a dividend upon partly paid shares of the same class, but only upon the
basis of the percentage of the consideration actually paid thereon.
8.4 SPECIAL DESIGNATION ON CERTIFICATES
If the corporation is authorized to issue more than one class of stock
or more than one series of any class, then the powers, the designations, the
preferences, and the relative, participating, optional or other special rights
of each class of stock or series thereof and the qualifications, limitations or
restrictions of such preferences and/or rights shall be set forth in full or
summarized on the face or back of the certificate that the corporation shall
issue to represent such class or series of stock; provided, however, that,
except as otherwise provided in Section 202 of the General Corporation Law of
Delaware, in lieu of the foregoing requirements there may be set forth on the
face or back of the certificate that the corporation shall issue to represent
such class or series of stock a statement that the corporation will furnish
without charge to each stockholder who so requests the powers, the designations,
the preferences, and the relative, participating, optional or other special
rights of each class of stock or series thereof and the qualifications,
limitations or restrictions of such preferences and/or rights.
8.5 LOST CERTIFICATES
Except as provided in this Section 8.5, no new certificates for shares
shall be issued to replace a previously issued certificate unless the latter is
surrendered to the corporation and canceled at the same time. The corporation
may issue a new certificate of stock or uncertificated shares in the place of
any certificate theretofore issued by it, alleged to have been lost, stolen or
destroyed, and the corporation may require the owner of the lost, stolen or
destroyed certificate, or his legal representative, to give the corporation a
bond sufficient to indemnify it against any claim that may be made against it on
account of the alleged loss, theft or destruction of any such certificate or the
issuance of such new certificate or uncertificated shares.
8.6 CONSTRUCTION: DEFINITIONS
Unless the context requires otherwise, the general provisions, rules of
construction, and definitions in the Delaware General Corporation Law shall
govern the construction of these bylaws. Without limiting the generality of this
provision, the singular number includes the plural, the plural number includes
the singular, and the term "person" includes both a corporation and a natural
person.
20
<PAGE> 25
8.7 DIVIDENDS
The directors of the corporation, subject to any restrictions contained
in (i) the Delaware General Corporation Law or (ii) the certificate of
incorporation, may declare and pay dividends upon the shares of its capital
stock. Dividends may be paid in cash, in property, or in shares of the
corporation's capital stock.
The directors of the corporation may set apart out of any of the funds
of the corporation available for dividends a reserve or reserves for any proper
purpose and may abolish any such reserve. Such purposes shall include but not be
limited to equalizing dividends, repairing or maintaining any property of the
corporation, and meeting contingencies.
8.8 FISCAL YEAR
The fiscal year of the corporation shall be fixed by resolution of the
board of directors and may be changed by the board of directors.
8.9 SEAL
The corporation may adopt a corporate seal, which shall be adopted and
which may be altered by the board of directors, and may use the same by causing
it or a facsimile thereof to be impressed or affixed or in any other manner
reproduced.
8.10 TRANSFER OF STOCK
Upon surrender to the corporation or the transfer agent of the
corporation of a certificate for shares duly endorsed or accompanied by proper
evidence of succession, assignation or authority to transfer, it shall be the
duty of the corporation to issue a new certificate to the person entitled
thereto, cancel the old certificate, and record the transaction in its books.
8.11 STOCK TRANSFER AGREEMENTS
The corporation shall have power to enter into and perform any agreement
with any number of stockholders of any one or more classes of stock of the
corporation to restrict the transfer of shares of stock of the corporation of
any one or more classes owned by such stockholders in any manner not prohibited
by the Delaware General Corporation Law.
8.12 REGISTERED STOCKHOLDERS
The corporation shall be entitled to recognize the exclusive right of a
person registered on its books as the owner of shares to receive dividends and
to vote as such owner, shall be entitled to hold liable for calls and
assessments the person registered on its books as the owner of shares, and shall
not be bound to recognize any equitable or other claim to or interest in such
share or shares on the part of another person, whether or not it shall have
express or other notice thereof, except as otherwise provided by the laws of
Delaware.
21
<PAGE> 26
ARTICLE IX
AMENDMENTS
The bylaws of the corporation may be adopted, amended or repealed by the
stockholders entitled to vote; provided, however, that the corporation may, in
its certificate of incorporation, confer the power to adopt, amend or repeal
bylaws upon the directors. The fact that such power has been so conferred upon
the directors shall not divest the stockholders of the power, nor limit their
power to adopt, amend or repeal bylaws.
22
<PAGE> 1
EXHIBIT 4.04
THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER
THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE SOLD, PLEDGED, OR
OTHERWISE TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION THEREOF UNDER SUCH ACT
OR PURSUANT TO RULE 144 OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE
CORPORATION AND ITS COUNSEL, THAT SUCH REGISTRATION IS NOT REQUIRED.
QUICKSTART
WARRANT TO PURCHASE STOCK
Corporation: Neoforma, Inc., a California corporation
Number of Shares: 45,000
Class of Stock: Series C Preferred / Other:
[strike descriptions that do not apply]
Initial Exercise Price: $.77 per share
Issue Date: 6/25/1998
Expiration Date: 6/25/2003
THIS WARRANT CERTIFIES THAT, for the agreed upon value of $1.00 and for
other good and valuable consideration, SILICON VALLEY BANK ("Holder") is
entitled to purchase the number of fully paid and nonassessable shares of the
class of securities (the "Shares") of the corporation (the "Company") at the
initial exercise price per Share (the "Warrant Price") all as set forth above
and as adjusted pursuant to Article 2 of this Warrant, subject to the provisions
and upon the terms and conditions set forth in this Warrant.
ARTICLE 1. EXERCISE.
1.1 Method of Exercise. Holder may exercise this Warrant by delivering a
duly executed Notice of Exercise in substantially the form attached as
Appendix I to the principal office of the Company. Unless Holder is exercising
the conversion right set forth in Section 1.2, Holder shall also deliver to the
Company a check for the aggregate Warrant Price for the Shares being purchased.
1.2 Conversion Right. In lieu of exercising this Warrant as specified in
Section 1.1, Holder may from time to time convert this Warrant, in whole or in
part, into a number of Shares determined by dividing (a) the aggregate fair
market value of the Shares or other securities otherwise issuable upon exercise
of this Warrant minus the aggregate Warrant Price of such Shares by (b) the fair
market value of one Share. The fair market value of the Shares shall be
determined pursuant to Section 1.4.
1.3 Intentionally Omitted
1
<PAGE> 2
1.4 Fair Market Value. If the Shares are traded in a public market, the
fair market value of the Shares shall be the closing price of the Shares (or the
closing price of the Company's stock into which the Shares are convertible)
reported for the business day immediately before Holder delivers its Notice of
Exercise to the Company. If the Shares are not traded in a public market, the
Board of Directors of the Company shall determine fair market value in its
reasonable good faith judgment.
1.5 Delivery of Certificate and New Warrant. Promptly after Holder
exercises or converts this Warrant, the Company shall deliver to Holder
certificates for the Shares acquired and, if this Warrant has not been fully
exercised or converted and has not expired, a new Warrant representing the
Shares not so acquired.
1.6 Replacement of Warrants. On receipt of evidence reasonably satisfactory
to the Company of the loss, theft, destruction or mutilation of this Warrant
and, in the case of loss, theft or destruction, on delivery of an indemnity
agreement reasonably satisfactory in form and amount to the Company or, in the
case of mutilation, on surrender and cancellation of this Warrant, the Company
at its expense shall execute and deliver, in lieu of this Warrant, a new warrant
of like tenor.
1.7 Repurchase on Sale, Merger, or Consolidation of the Company.
1.7.1. "Acquisition". For the purpose of this Warrant, "Acquisition"
means any sale, license, or other disposition of all or substantially all of the
assets of the Company, or any reorganization, consolidation, or merger of the
Company where the holders of the Company's securities before the transaction
beneficially own less than 50% of the outstanding voting securities of the
surviving entity after the transaction.
1.7.2. Assumption of Warrant. Upon the closing of any Acquisition the
successor entity may, at its option, assume the obligations of this Warrant, and
this Warrant shall be exercisable for the same securities, cash, and property as
would be payable for the Shares issuable upon exercise of the unexercised
portion of this Warrant as if such Shares were outstanding on the record date
for the Acquisition and subsequent closing. The Warrant Price shall be adjusted
accordingly. If the successor entity does not assume the obligations of the
Company under this Warrant, then this Warrant shall be deemed to have been
automatically converted pursuant to Section 1.2 and thereafter Holder shall
participate in the Acquisition as a holder of the Shares (or other securities
issuable upon exercise of this Warrant) on the same terms as other holders of
the same class of securities of the Company.
ARTICLE 2. ADJUSTMENTS TO THE SHARES.
2.1 Stock Dividends, Splits, Etc. If the Company declares or pays a
dividend on its common stock (or the Shares if the Shares are securities other
than common stock) payable in common stock, or other securities, subdivides the
outstanding common stock into a greater amount of common stock, or, if the
Shares are securities other than common stock, subdivides the Shares in a
transaction that increases the amount of common stock into which the Shares are
2
<PAGE> 3
convertible, then upon exercise of this Warrant, for each Share acquired, Holder
shall receive, without cost to Holder, the total number and kind of securities
to which Holder would have been entitled had Holder owned the Shares of record
as of the date the dividend or subdivision occurred.
2.2 Reclassification, Exchange or Substitution. Upon any reclassification,
exchange, substitution, or other event that results in a change of the number
and/or class of the securities issuable upon exercise or conversion of this
Warrant, Holder shall be entitled to receive, upon exercise or conversion of
this Warrant, the number and kind of securities and property that Holder would
have received for the Shares if this Warrant had been exercised immediately
before such reclassification, exchange, substitution, or other event. Such an
event shall include any automatic conversion of the outstanding or issuable
securities of the Company of the same class or series as the Shares to common
stock pursuant to the terms of the Company's Articles of Incorporation upon the
closing of a registered public offering of the Company's common stock. The
Company or its successor shall promptly issue to Holder a new Warrant for such
new securities or other property. The new Warrant shall provide for adjustments
which shall be as nearly equivalent as may be practicable to the adjustments
provided for in this Article 2 including, without limitation, adjustments to the
Warrant Price and to the number of securities or property issuable upon exercise
of the new Warrant. The provisions of this Section 2.2 shall similarly apply to
successive reclassifications, exchanges, substitutions, or other events.
2.3 Adjustments for Combinations, Etc. If the outstanding Shares are
combined or consolidated, by reclassification or otherwise, into a lesser number
of shares, the Warrant Price shall be proportionately increased.
2.4 Adjustments for Diluting Issuances. The Shares shall be afforded the
protections (if any) against diluting issuances of stock as are prescribed for
the class of stock of the Shares under the Company's Articles of Incorporation,
as amended from time to time.
2.5 No Impairment. The Company shall not, by amendment of its Articles of
Incorporation or through a reorganization, transfer of assets, consolidation,
merger, dissolution, issue, or sale of securities or any other voluntary action,
avoid or seek to avoid the observance or performance of any of the terms to be
observed or performed under this Warrant by the Company, but shall at all times
in good faith assist in carrying out of all the provisions of this Article 2 and
in taking all such action as may be necessary or appropriate to protect Holder's
rights under this Article against impairment. If the Company takes any action
affecting the Shares or its common stock other than as described above that
adversely affects Holder's rights under this Warrant, the Warrant Price shall be
adjusted downward and the number of Shares issuable upon exercise of this
Warrant shall be adjusted upward in such a manner that the aggregate Warrant
Price of this Warrant is unchanged.
2.6 Fractional Shares. No fractional Shares shall be issuable upon exercise
or conversion of the Warrant and the number of Shares to be issued shall be
rounded down to the nearest whole Share. If a fractional share interest arises
upon any exercise or conversion of the
3
<PAGE> 4
Warrant, the Company shall eliminate such fractional share interest by paying
Holder amount computed by multiplying the fractional interest by the fair market
value of a full Share.
2.7 Certificate as to Adjustments. Upon each adjustment of the Warrant
Price, the Company at its expense shall promptly compute such adjustment, and
furnish Holder with a certificate of its Chief Financial Officer setting forth
such adjustment and the facts upon which such adjustment is based. The Company
shall, upon written request, furnish Holder a certificate setting forth the
Warrant Price in effect upon the date thereof and the series of adjustments
leading to such Warrant Price.
ARTICLE 3. REPRESENTATIONS AND COVENANTS OF THE COMPANY.
3.1 Representations and Warranties. The Company hereby represents and
warrants to the Holder as follows:
(a) The initial Warrant Price referenced on the first page of this
Warrant is not greater than the fair market value of the Shares as of the date
of this Warrant.
(b) All Shares which may be issued upon the exercise of the purchase
right represented by this Warrant, and all securities, if any, issuable upon
conversion of the Shares, shall, upon issuance, be duly authorized, validly
issued, fully paid and nonassessable, and free of any liens and encumbrances
except for restrictions on transfer provided for herein or under applicable
federal and state securities laws.
3.2 Notice of Certain Events. If the Company proposes at any time (a) to
declare any dividend or distribution upon its common stock, whether in cash,
property, stock, or other securities and whether or not a regular cash dividend;
(b) to offer for subscription pro rata to the holders of any class or series of
its stock any additional shares of stock of any class or series or other rights;
(c) to effect any reclassification or recapitalization of common stock; (d) to
merge or consolidate with or into any other corporation, or sell, lease,
license, or convey all or substantially all of its assets, or to liquidate,
dissolve or wind up; or (e) offer holders of registration rights the opportunity
to participate in an underwritten public offering of the company's securities
for cash, then, in connection with each such event, the Company shall give
Holder (1) at least 10 days prior written notice of the date on which a record
will be taken for such dividend, distribution, or subscription rights (and
specifying the date on which the holders of common stock will be entitled
thereto) or for determining rights to vote, if any, in respect of the matters
referred to in (c) and (d) above; (2) in the case of the matters referred to in
(c) and (d) above at least 10 days prior written notice of the date when the
same will take place (and specifying the date on which the holders of common
stock will be entitled to exchange their common stock for securities or other
property deliverable upon the occurrence of such event); and (3) in the case of
the matter referred to in (e) above, the same notice as is given to the holders
of such registration rights.
3.3 Information Rights. So long as the Holder holds this Warrant and/or any
of the Shares, the Company shall deliver to the Holder promptly upon Holder's
reasonable
4
<PAGE> 5
request, copies of all notices or other written communications to the
shareholders of the Company, the annual audited financial statements of the
Company certified by independent public accountants of recognized standing and
the Company's quarterly, unaudited financial statements.
ARTICLE 4. MISCELLANEOUS.
4.1 Term; Notice of Expiration. This Warrant is exercisable, in whole or in
part, at any tine and from time to time on or before the Expiration Date set
forth above.
4.2 Legends. This Warrant and the Shares (and the securities issuable,
directly or indirectly, upon conversion of the Shares, if any) shall be
imprinted with a legend in substantially the following form:
THIS SECURITY HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS
AMENDED, AND MAY NOT BE SOLD, PLEDGED OR OTHERWISE TRANSFERRED WITHOUT AN
EFFECTIVE REGISTRATION THEREOF UNDER SUCH ACT OR PURSUANT TO RULE 144 OR AN
OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE CORPORATION AND ITS
COUNSEL THAT SUCH REGISTRATION IS NOT REQUIRED.
4.3 Compliance with Securities Laws on Transfer. This Warrant and the
Shares issuable upon exercise this Warrant (and the securities issuable,
directly or indirectly, upon conversion of the Shares, if any) may not be
transferred or assigned in whole or in part without compliance with applicable
federal and state securities laws by the transferor and the transferee
(including, without limitation, the delivery of investment representation
letters and legal opinions reasonably satisfactory to the Company, as reasonably
requested by the Company). The Company shall not require Holder to provide an
opinion of counsel if the transfer is to an affiliate of Holder or if there is
no material question as to the availability of current information as referenced
in Rule 144(c), Holder represents that it has complied with Rule 144(d) and (e)
in reasonable detail, the selling broker represents that it has complied with
Rule 144(f), and the Company is provided with a copy of Holder s notice of
proposed sale.
4.4 Transfer Procedure. Subject to the provisions of Section 4.3 Holder may
transfer all or part of this Warrant or the Shares issuable upon exercise of
this Warrant (or the securities issuable, directly or indirectly, upon
conversion of the Shares, if any) by giving the Company notice of the portion of
the Warrant being transferred setting forth the name, address and taxpayer
identification number of the transferee and surrendering this Warrant to the
Company for reissuance to the transferee(s) (and Holder if applicable);
provided, however, that Holder may transfer all or part of this Warrant to
Silicon Valley Bancshares and The Silicon Valley Bank Foundation, at any time
without notice to the Company. The terms and conditions of this Warrant shall
inure to the benefit of, and be binding upon, the Company and the holders hereof
and their respective permitted successors and assigns. Unless the Company is
filing financial information with the SEC pursuant to the Securities Exchange
Act of 1934, the
5
<PAGE> 6
Company shall have the right to refuse to transfer any portion of this
Warrant to any party who directly competes with the Company.
4.5 Notices. All notices and other communications from the Company to the
Holder, or vice versa, shall be deemed delivered and effective when given
personally or mailed by first-class registered or certified mail, postage
prepaid, at such address as may have been furnished to the Company or the
Holder, as the case may be, in writing by the Company or the Holder from time to
time.
4.6 Waiver. This Warrant and any term hereof may be changed, waived,
discharged or terminated only by an instrument in writing signed by the party
against which enforcement of such change, waiver, discharge or termination is
sought.
4.7 Attorneys' Fees. In the event of any dispute between the parties
concerning the terms and provisions of this Warrant, the party prevailing in
such dispute shall be entitled to collect from the other party all costs
incurred in such dispute, including reasonable attorneys' fees.
4.8 Governing Law. This Warrant shall be governed by and construed in
accordance with the laws of the State of California, without giving effect to
its principles regarding conflicts of law.
"COMPANY"
Neoforma, Inc.
By: /s/ JEFF KLECK
-----------------------------------------
Name: Jeff Kleck
---------------------------------------
(Print)
Title: Chairman of the Board, President or
Vice President
By:
-----------------------------------------
Name:
---------------------------------------
(Print)
Title: Chief Financial Officer, Secretary,
Assistant Treasurer or Assistant
Secretary
6
<PAGE> 7
APPENDIX I
NOTICE OF EXERCISE
1. The undersigned hereby elects; to purchase __________ shares of the
Common/Series __________ Preferred [strike one] Stock of ______________________
________________________ pursuant to the terms of the attached Warrant, and
tenders herewith payment of the purchase price of such shares in full.
1. The undersigned hereby elects to convert the attached Warrant into
Shares/cash [strike one] in the manner specified in the Warrant. This conversion
is exercised with respect to _______________________ of the Shares covered by
the Warrant.
[Strike paragraph that does not apply.]
2. Please issue a certificate or certificates representing said shares
in the name of the undersigned or in such other name as is specified below:
------------------------------------
(Name)
------------------------------------
------------------------------------
(Address)
3. The undersigned represents it is acquiring the shares solely for
its own account and not as nominee for any other party and not with a view
toward the resale or distribution thereof except in compliance with applicable
securities laws.
------------------------------------
(Signature)
- ----------------------
(Date)
7
<PAGE> 8
AMENDMENT TO WARRANT AGREEMENT
This Amendment to Warrant Agreement (the "Agreement") is made as of March
5, 1999 by and between Silicon Valley Bank ("Holder) and Neoforma, Inc.
("Company")
RECITALS
A. Company and Holder are parties to, among other documents, a QuickStart
Warrant to Purchase Stock, dated June 25, 1998, each together with all schedules
and exhibits thereto (the "Warrant Agreement").
B. Company has agreed to amend the Class of Stock to reflect the Series C
Preferred Shares.
NOW, THEREFORE, the parties agree as follows:
1. The Class of Stock as provided in the Warrant Agreement is hereby
amended to mean Series C Preferred Shares.
2. LEGAL EFFECT; INTERPRETATION. This Agreement amends certain terms of the
Warrant Agreement. Company confirms that, except as amended by this Agreement,
the Warrant Agreement remain in full force and effect. Unless otherwise defined,
all terms capitalized in this Agreement shall have the meanings assigned in the
Warrant Agreement. This Agreement, together with the Warrant Agreement,
constitutes the entire agreement of the parties with respect to the subject
matter hereof, and supersedes all prior agreements and negotiations.
3. COUNTERPARTS. This Agreement may be executed in two or more
counterparts, each of which shall be deemed an original, and all of which shall
constitute one and the same instrument.
4. TIME OF ESSENCE. Time is of the essence for the performance of all
obligations set forth in this Agreement.
IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the date
first written above.
COMPANY: HOLDER:
NEOFORMA, INC. SILICON VALLEY BANK
By: __________________________ By: ________________________________
Name: ________________________ Name: ______________________________
Title: _______________________ Title: _____________________________
8
<PAGE> 1
EXHIBIT 4.05
THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 AS
AMENDED, OR ANY STATE SECURITIES LAWS. THEY MAY NOT BE SOLD, OFFERED FOR SALE,
PLEDGED, OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT
RELATED THERETO OR AN OPINION OF COUNSEL (WHICH MAY BE COMPANY COUNSEL)
REASONABLY SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY APPLICABLE STATE SECURITIES
LAWS.
WARRANT AGREEMENT
TO PURCHASE SHARES OF THE SERIES D PREFERRED STOCK OF
NEOFORMA, INC.
DATED AS OF MAY 12, 1999 (THE "EFFECTIVE DATE")
WHEREAS, Neoforma, Inc., a Delaware corporation (the "Company") has
entered into a Subordinated Loan and Security Agreement dated as of May 12,
1999, and related Subordinated Promissory Note(s) (collectively, the "Loans")
with Comdisco, Inc., a Delaware corporation (the "Warrantholder"); and
WHEREAS, the Company desires to grant to Warrantholder, in
consideration for such Loans, the right to purchase shares of its Series D
Preferred Stock;
NOW, THEREFORE, in consideration of the Warrantholder executing and
delivering such Loans and in consideration of mutual covenants and agreements
contained herein, the Company and Warrantholder agree as follows:
1. GRANT OF THE RIGHT TO PURCHASE PREFERRED STOCK.
The Company hereby grants to the Warrantholder, and the Warrantholder
is entitled, upon the terms and subject to the conditions hereinafter set forth,
to subscribe to and purchase, from the Company, 228,813 fully paid and
non-assessable shares of the Company's Series D Preferred Stock ("Preferred
Stock") at a purchase price of $1.18 per share (the "Exercise Price"). The
number and purchase price of such shares are subject to adjustment as provided
in Section 8 hereof.
2. TERM OF THE WARRANT AGREEMENT.
Except as otherwise provided for herein, the term of this Warrant
Agreement and the right to purchase Preferred Stock as granted herein shall
commence on the Effective Date and shall be exercisable for a period of (i)
seven (7) years or (ii) three (3) years from the effective date of the Company's
initial public offering, whichever is longer.
Notwithstanding the term of this Warrant Agreement as set forth above,
the right to purchase Preferred Stock as granted shall expire, if not previously
exercised, immediately upon the closing of the issuance and sale of shares of
Common Stock of the Company in the Company's first public offering of securities
for its own account pursuant to an effective registration statement under the
Securities Act of 1933, as amended (the "Initial Public Offering"), provided
that the underwriters so request that the Warrantholder exercise at that time.
The Company shall notify the Warrantholder if the Initial Public Offering is
proposed within a reasonable period of time prior to the filing of a
registration statement and if the Company fails to deliver such written notice
within a reasonable period of time, anything to the contrary in this Warrant
Agreement notwithstanding, the rights to purchase will not expire until ten (10)
business days after the Company delivers such notice to the Warrantholder. Such
notice shall also contain such details of the proposed Initial Public Offering
as are reasonable in the circumstances and notice that this Warrant Agreement is
expected to expire upon closing thereof. If such closing does not take place,
the Company shall promptly notify the Warrantholder that such proposed
transaction has been terminated. Anything to the contrary in this Warrant
Agreement notwithstanding, the Warrantholder may rescind any exercise of its
purchase rights promptly after such notice of termination of the proposed
transaction if the exercise of warrants occurred after the Company notified the
Warrantholder that the Initial Public Offering was
-1-
<PAGE> 2
proposed or if the exercise were otherwise precipitated by such proposed Initial
Public Offering. In the event of such rescission, the Warrants will continue to
be exercisable on the same terms and conditions.
3. EXERCISE OF THE PURCHASE RIGHTS.
The purchase rights set forth in this Warrant Agreement are exercisable
by the Warrantholder, in whole or in part, at any time, or from time to time,
prior to the expiration of the term set forth in Section 2 above, by tendering
to the Company at its principal office a notice of exercise in the form attached
hereto as Exhibit I (the "Notice of Exercise"), duly completed and executed.
Promptly upon receipt of the Notice of Exercise and the payment of the purchase
price in accordance with the terms set forth below, and in no event later than
twenty-one (21) business days thereafter, the Company shall issue to the
Warrantholder a certificate for the number of shares of Preferred Stock
purchased and shall execute the acknowledgment of exercise in the form attached
hereto as Exhibit II (the "Acknowledgment of Exercise") indicating the number of
shares which remain subject to future purchases, if any.
The Exercise Price may be paid at the Warrantholder's election either
(i) by cash or check, or (ii) by surrender of Warrants ("Net Issuance") as
determined below. If the Warrantholder elects the Net Issuance method, the
Company will issue Preferred Stock in accordance with the following formula:
X = Y(A-B)
------
A
Where: X = the number of shares of Preferred Stock to be
issued to the Warrantholder.
Y = the number of shares of Preferred Stock requested to
be exercised for payment under this Warrant Agreement.
A = the fair market value of one (1) share of Preferred
Stock.
B = the Exercise Price.
For purposes of the above calculation, current fair market value of
Preferred Stock shall mean with respect to each share of Preferred Stock:
(i) if the exercise is in connection with an initial public
offering of the Company's Common Stock, and if the Company's
Registration Statement relating to such public offering has been
declared effective by the SEC, then the fair market value per share
shall be the product of (x) the initial "Price to Public" specified in
the final prospectus with respect to the offering and (y) the number of
shares of Common Stock into which each share of Preferred Stock is
convertible at the time of such exercise;
(ii) if this Warrant is exercised after, and not in connection
with the Company's initial public offering, and:
(a) if traded on a securities exchange, the fair
market value shall be deemed to be the product of (x) the
average of the closing prices over a five (5) day period
ending three days before the day the current fair market value
of the securities is being determined and (y) the number of
shares of Common Stock into which each share of Preferred
Stock is convertible at the time of such exercise; or
(b) if actively traded over-the-counter, the fair
market value shall be deemed to be the product of (x) the
average of the closing bid and asked prices quoted on the
NASDAQ system (or similar system) over the five (5) day period
ending three days before the day the current fair market value
of the securities is being determined and (y) the number of
shares of Common Stock into which each share of Preferred
Stock is convertible at the time of such exercise;
(iii) if at any time the Common Stock is not listed on any
securities exchange or quoted in the NASDAQ System or the
over-the-counter market, the current fair market value of Preferred
Stock shall be the product of (x) the highest price per share which the
Company could obtain from a willing buyer (not a current employee or
director) for shares of Common Stock sold by the Company, from
authorized but unissued shares, as determined in good faith by its
Board of Directors and (y) the number of shares of Common Stock into
which each share of Preferred Stock is convertible at the time of such
exercise, unless
-2-
<PAGE> 3
the Company shall become subject to a merger, acquisition or other
consolidation pursuant to which the Company is not the surviving party,
in which case the fair market value of Preferred Stock shall be deemed
to be the value received by the holders of the Company's Preferred
Stock on a common equivalent basis pursuant to such merger or
acquisition.
Upon partial exercise by either cash or Net Issuance, the Company shall
promptly issue an amended Warrant Agreement representing the remaining number of
shares purchasable hereunder. All other terms and conditions of such amended
Warrant Agreement shall be identical to those contained herein, including, but
not limited to the Effective Date hereof.
4. RESERVATION OF SHARES.
(a) Authorization and Reservation of Shares. During the term of this
Warrant Agreement, the Company will at all times have authorized and reserved a
sufficient number of shares of its Preferred Stock to provide for the exercise
of the rights to purchase Preferred Stock as provided for herein.
(b) Registration or Listing. If any shares of Preferred Stock required
to be reserved hereunder require registration with or approval of any
governmental authority under any Federal or State law (other than any
registration under the Securities Act of 1933, as amended ("1933 Act"), as then
in effect, or any similar Federal statute then enforced, or any state securities
law, required by reason of any transfer involved in such conversion), or listing
on any domestic securities exchange, before such shares may be issued upon
conversion, the Company will, at its expense and as expeditiously as possible,
use its best efforts to cause such shares to be duly registered, listed or
approved for listing on such domestic securities exchange, as the case may be.
5. NO FRACTIONAL SHARES OR SCRIP.
No fractional shares or scrip representing fractional shares shall be
issued upon the exercise of the Warrant, but in lieu of such fractional shares
the Company shall make a cash payment therefor upon the basis of the Exercise
Price then in effect.
6. NO RIGHTS AS STOCKHOLDER.
This Warrant Agreement does not entitle the Warrantholder to any voting
rights or other rights as a stockholder of the Company prior to the exercise of
the Warrant.
7. WARRANTHOLDER REGISTRY.
The Company shall maintain a registry showing the name and address of
the registered holder of this Warrant Agreement.
8. ADJUSTMENT RIGHTS.
The purchase price per share and the number of shares of Preferred
Stock purchasable hereunder are subject to adjustment, as follows:
(a) Merger and Sale of Assets. If at any time there shall be a capital
reorganization of the shares of the Company's stock (other than a combination,
reclassification, exchange or subdivision of shares otherwise provided for
herein), or a merger or consolidation of the Company with or into another
corporation whether or not the Company is the surviving corporation, or the sale
of all or substantially all of the Company's properties and assets to any other
person (hereinafter referred to as a "Merger Event"), then, as a part of such
Merger Event, lawful provision shall be made so that the Warrantholder shall
thereafter be entitled to receive, upon exercise of the Warrant, the number of
shares of Preferred S-stock or other securities of the successor corporation
resulting from such Merger Event, equivalent in value to that which would have
been issuable if Warrantholder had exercised this Warrant immediately prior to
the Merger Event. In any such case, appropriate adjustment (as determined in
good faith by the Company's Board of Directors) shall be made in the application
of the provisions of this Warrant Agreement with respect to the rights and
interest of the Warrantholder after the Merger Event to the end that the
provisions of this Warrant Agreement (including adjustments of the Exercise
Price and number of shares of Preferred Stock purchasable) shall be applicable
to the greatest extent possible.
(b) Reclassification of Shares. If the Company at any time shall, by
combination, reclassification, exchange or subdivision of securities or
otherwise, change any of the securities as to which purchase rights under
-3-
<PAGE> 4
this Warrant Agreement exist into the same or a different number of securities
of any other class or classes, this Warrant Agreement shall thereafter represent
the right to acquire such number and kind of securities as would have been
issuable as the result of such change with respect to the securities which were
subject to the purchase rights under this Warrant Agreement immediately prior to
such combination, reclassification, exchange, subdivision or other change.
(c) Subdivision or Combination of Shares. If the Company at any time
shall combine or subdivide its Preferred Stock, the Exercise Price shall be
proportionately decreased in the case of a subdivision, or proportionately
increased in the case of a combination.
(d) Stock Dividends. If the Company at any time shall pay a dividend
payable in, or make any other distribution (except any distribution specifically
provided for in the foregoing subsections (a) or (b)) of the Company's stock,
then the Exercise Price shall be adjusted, from and after the record date of
such dividend or distribution, to that price determined by multiplying the
Exercise Price in effect immediately prior to such record date by a fraction (i)
the numerator of which shall be the total number of all shares of the Company's
stock deemed outstanding pursuant to its Certificate of Incorporation in effect
immediately prior to such issuance immediately prior to such dividend or
distribution, and (ii) the denominator of which shall be the total number of all
shares of the Company's stock deemed outstanding immediately after such dividend
or distribution. The Warrantholder shall thereafter be entitled to purchase, at
the Exercise Price resulting from such adjustment, the number of shares of
Preferred Stock (calculated to the nearest whole share with one half being
rounded down) obtained by multiplying the Exercise Price in effect immediately
prior to such adjustment by the number of shares of Preferred Stock issuable
upon the exercise hereof immediately prior to such adjustment and dividing the
product thereof by the Exercise Price resulting from such adjustment.
(e) Right to Purchase Additional Stock. If the Company has not paid any
Subordinated Promissory Note(s) entered into pursuant to the Loan(s) in its
entirety by the Maturity Date (as defined in the applicable Subordinated
Promissory Note(s)), then for each additional month, or portion thereof,
thereafter that the outstanding principal is not paid, Warrantholder shall have
the right to purchase from the Company, at the Exercise Price (adjusted as set
forth herein), an additional number of shares of Preferred Stock which number
shall be determined by (i) multiplying the outstanding principal amount which
due but unpaid by 1% and (ii) dividing the product thereof by the Exercise
Price.
(f) Antidilution Rights. Additional antidilution rights applicable to
the Preferred Stock purchasable hereunder are as set forth in the Company's
Certificate of Incorporation, as amended through the Effective Date, a true and
complete copy of which is attached hereto as Exhibit ___ (the "Charter"). The
Company shall promptly provide the Warrantholder with any restatement,
amendment, modification or waiver of the Charter. The Company shall provide
Warrantholder with prior written notice of any issuance of its stock or other
equity security to occur after the Effective Date of this Warrant, which notice
shall include (a) the price at which such stock or security is to be sold, (b)
the number of shares to be issued, and (c) such other information as necessary
for Warrantholder to determine if a dilutive event has occurred.
(g) Notice of Adjustments. If: (i) the Company shall declare any
dividend or distribution upon its stock, whether in cash, property, stock or
other securities; (ii) the Company shall offer for subscription prorata to the
holders of any class of its Preferred or other convertible stock any additional
shares of stock of any class or other rights; (iii) there shall be any Merger
Event; (iv) there shall be an initial public offering; or (v) there shall be any
voluntary dissolution, liquidation or winding up of the Company; then, in
connection with each such event, the Company shall send to the Warrantholder:
(A) at least twenty (20) days' prior written notice of the date on which the
books of the Company shall close or a record shall be taken for such dividend,
distribution, subscription rights (specifying the date on which the holders of
Preferred Stock shall be entitled thereto) or for determining rights to vote in
respect of such Merger Event, dissolution, liquidation or winding up; (B) in the
case of any such Merger Event, dissolution, liquidation or winding up, at least
twenty (20) days' prior written notice of the date when the same shall take
place (and specifying the date on which the holders of Preferred Stock shall be
entitled to exchange their Preferred Stock for securities or other property
deliverable upon such Merger Event, dissolution, liquidation or winding up); and
(C) in the case of a public offering, the Company shall give the Warrantholder
at least twenty (20) days written notice prior to the effective date thereof.
Each such written notice shall set forth, in reasonable detail, (i) the
event requiring the adjustment, (ii) the amount of the adjustment, (iii) the
method by which such adjustment was calculated, (iv) the Exercise Price, and (v)
the number of shares subject to purchase hereunder after giving effect to such
adjustment, and shall be given by first class mail, postage prepaid, addressed
to the Warrantholder, at the address as shown on the books of the Company.
-4-
<PAGE> 5
(h) Timely Notice. Failure to timely provide such notice required by
subsection (g) above shall entitle Warrantholder to retain the benefit of the
applicable notice period notwithstanding anything to the contrary contained in
any insufficient notice received by Warrantholder. The notice period shall begin
on the date Warrantholder actually receives a written notice containing all the
information specified above.
9. REPRESENTATIONS, WARRANTIES AND COVENANTS OF THE COMPANY.
(a) Reservation of Preferred Stock. The Preferred Stock issuable upon
exercise of the Warrantholder's rights has been duly and validly reserved and,
when issued in accordance with the provisions of this Warrant Agreement, will be
validly issued, fully paid and non-assessable, and will be free of any taxes,
liens, charges or encumbrances of any nature whatsoever; provided, however, that
the Preferred Stock issuable pursuant to this Warrant Agreement may be subject
to restrictions on transfer under state and/or Federal securities laws. The
Company has made available to the Warrantholder true, correct and complete
copies of its Charter and Bylaws, as amended. The issuance of certificates for
shares of Preferred Stock upon exercise of the Warrant Agreement shall be made
without charge to the Warrantholder for any issuance tax in respect thereof, or
other cost incurred by the Company in connection with such exercise and the
related issuance of shares of Preferred Stock. The Company shall not be required
to pay any tax which may be payable in respect of any transfer involved and the
issuance and delivery of any certificate in a name other than that of the
Warrantholder.
(b) Due Authority. The execution and delivery by the Company of this
Warrant Agreement and the performance of all obligations of the Company
hereunder, including the issuance to Warrantholder of the right to acquire the
shares of Preferred Stock, have been duly authorized by all necessary corporate
action on the part of the Company, and the Loans and this Warrant Agreement are
not inconsistent with the Company's Charter or Bylaws, do not contravene any law
or governmental rule, regulation or order applicable to it, do not and will not
contravene any provision of, or constitute a default under, any indenture,
mortgage, contract or other instrument to which it is a party or by which it is
bound, and the Loans and this Warrant Agreement constitute legal, valid and
binding agreements of the Company, enforceable in accordance with their
respective terms.
(c) Consents and Approvals. No consent or approval of, giving of notice
to, registration with, or taking of any other action in respect of any state,
Federal or other governmental authority or agency is required with respect to
the execution, delivery and performance by the Company of its obligations under
this Warrant Agreement, except for the filing of notices pursuant to Regulation
D under the 1933 Act and any filing required by applicable state securities law,
which filings will be effective by the time required thereby.
(d) Issued Securities. All issued and outstanding shares of Common
Stock, Preferred Stock or any other securities of the Company have been duly
authorized and validly issued and are fully paid and nonassessable. All
outstanding shares of Common Stock, Preferred Stock and any other securities
were issued in full compliance with all Federal and state securities laws. In
addition:
(i) The authorized capital of the Company consists of (A)
40,000,000 shares of Common Stock, of which 1,216,000 shares are issued
and outstanding, and (B) 9,000,000 shares of Series A Preferred Stock,
of which 9,000,000 shares are issued and outstanding and are
convertible into 9,000,000 shares of Common Stock; (C) 2,860,000 shares
of Series B Preferred Stock, of which 2,860,000 shares are issued and
outstanding and are convertible into 2,860,000 shares of Common Stock;
(D) 5,109,937 shares of Series C Preferred Stock, of which 5,064,937
shares are issued and outstanding and are convertible into 5,064,937
shares of Common Stock; (D) 10,455,085 shares of Series D Preferred
Stock, of which 10,162,381 shares are issued and outstanding and are
convertible into 10,162,381 shares of Common Stock.
(ii) The Company has reserved (A) 7,156,078 shares of Common
Stock for issuance under its 1997 Stock Option Plan and (B) one warrant
to purchase 45,000 shares of Series C Preferred Stock. There are no
other options, warrants, conversion privileges or other rights
presently outstanding to purchase or otherwise acquire any authorized
but unissued shares of the Company's capital stock or other securities
of the Company.
(iii) In accordance with the Company's Certificate of
Incorporation, no stockholder of the Company has preemptive rights to
purchase new issuances of the Company's capital stock.
(e) Insurance. The Company has in full force and effect insurance
policies, with extended coverage, insuring the Company and its property and
business against such losses and risks, and in such amounts, as are
-5-
<PAGE> 6
customary for corporations engaged in a similar business and similarly situated
and as otherwise may be required pursuant to the terms of any other contract or
agreement.
(f) Other Commitments to Register Securities. Except as set forth in
the Investors Rights Agreement the Company is not, pursuant to the terms of any
other agreement currently in existence, under any obligation to register under
the 1933 Act any of its presently outstanding securities or any of its
securities which may hereafter be issued.
(g) Exempt Transaction. Subject to the accuracy of the Warrantholder's
representations in Section 10 hereof, the issuance of the Preferred Stock upon
exercise of this Warrant will constitute a transaction exempt from (i) the
registration requirements of Section 5 of the 1933 Act, in reliance upon Section
4(2) thereof, and (ii) the qualification requirements of the applicable state
securities laws.
(h) Compliance with Rule 144. At the written request of the
Warrantholder, who proposes to sell Preferred Stock issuable upon the exercise
of the Warrant in compliance with Rule 144 promulgated by the Securities and
Exchange Commission, the Company shall furnish to the Warrantholder, within ten
days after receipt of such request, a written statement confirming the Company's
compliance with the filing requirements of the Securities and Exchange
Commission as set forth in such Rule, as such Rule may be amended from time to
time.
10. REPRESENTATIONS AND COVENANTS OF THE WARRANTHOLDER.
This Warrant Agreement has been entered into by the Company in reliance
upon the following representations and covenants of the Warrantholder:
(a) Investment Purpose. The right to acquire Preferred Stock or the
Preferred Stock issuable upon exercise of the Warrantholder's rights contained
herein will be acquired for investment and not with a view to the sale or
distribution of any part thereof, and the Warrantholder has no present intention
of selling or engaging in any public distribution of the same except pursuant to
a registration or exemption.
(b) Private Issue. The Warrantholder understands (i) that the Preferred
Stock issuable upon exercise of this Warrant is not registered under the 1933
Act or qualified under applicable state securities laws on the ground that the
issuance contemplated by this Warrant Agreement will be exempt from the
registration and qualifications requirements thereof, and (ii) that the
Company's reliance on such exemption is predicated on the representations set
forth in this Section 10.
(c) Disposition of Warrantholder's Rights. In no event will the
Warrantholder make a disposition of any of its rights to acquire Preferred Stock
or Preferred Stock issuable upon exercise of such rights unless and until (i) it
shall have notified the Company of the proposed disposition, and (ii) if
requested by the Company, it shall have furnished the Company with an opinion of
counsel (which counsel may either be inside or outside counsel to the
Warrantholder) satisfactory to the Company and its counsel to the effect that
(A) appropriate action necessary for compliance with the 1933 Act has been
taken, or (B) an exemption from the registration requirements of the 1933 Act is
available. Notwithstanding the foregoing, the restrictions imposed upon the
transferability of any of its rights to acquire Preferred Stock or Preferred
Stock issuable on the exercise of such rights do not apply to transfers from the
beneficial owner of any of the aforementioned securities to its nominee or from
such nominee to its beneficial owner, and shall terminate as to any particular
share of Preferred Stock when (1) such security shall have been effectively
registered under the 1933 Act and sold by the holder thereof in accordance with
such registration or (2) such security shall have been sold without registration
in compliance with Rule 144 under the 1933 Act, or (3) a letter shall have been
issued to the Warrantholder at its request by the staff of the Securities and
Exchange Commission or a ruling shall have been issued to the Warrantholder at
its request by such Commission stating that no action shall be recommended by
such staff or taken by such Commission, as the case may be, if such security is
transferred without registration under the 1933 Act in accordance with the
conditions set forth in such letter or ruling and such letter or ruling
specifies that no subsequent restrictions on transfer are required. Whenever the
restrictions imposed hereunder shall terminate, as hereinabove provided, the
Warrantholder or holder of a share of Preferred Stock then outstanding as to
which such restrictions have terminated shall be entitled to receive from the
Company, without expense to such holder, one or more new certificates for the
Warrant or for such shares of Preferred Stock not bearing any restrictive
legend.
(d) Financial Risk. The Warrantholder has such knowledge and experience
in financial and business matters as to be capable of evaluating the merits and
risks of its investment, and has the ability to bear the economic risks of its
investment.
-6-
<PAGE> 7
(e) Risk of No Registration. The Warrantholder understands that if the
Company does not register with the Securities and Exchange Commission pursuant
to Section 12 of the 1934 Act (the "1934 Act"), or file reports pursuant to
Section 15(d), of the 1934 Act, or if a registration statement covering the
securities under the 1933 Act is not in effect when it desires to sell (i) the
rights to purchase Preferred Stock pursuant to this Warrant Agreement, or (ii)
the Preferred Stock issuable upon exercise of the right to purchase, it may be
required to hold such securities for an indefinite period. The Warrantholder
also understands that any sale of its rights of the Warrantholder to purchase
Preferred Stock or Preferred Stock which might be made by it in reliance upon
Rule 144 under the 1933 Act may be made only in accordance with the terms and
conditions of that Rule.
(f) Accredited Investor. Warrantholder is an "accredited investor"
within the meaning of the Securities and Exchange Rule 501 of Regulation D, as
presently in effect.
11. TRANSFERS.
Subject to the terms and conditions contained in Section 10 hereof,
this Warrant Agreement and all rights hereunder are transferable in whole or in
part by the Warrantholder and any successor transferee, provided, however, in no
event shall the number of transfers of the rights and interests in all of the
Warrants exceed three (3) transfers. The transfer shall be recorded on the books
of the Company upon receipt by the Company of a notice of transfer in the form
attached hereto as Exhibit III (the "Transfer Notice"), at its principal offices
and the payment to the Company of all transfer taxes and other governmental
charges imposed on such transfer.
12. MISCELLANEOUS.
(a) Effective Date. The provisions of this Warrant Agreement shall be
construed and shall be given effect in all respects as if it had been executed
and delivered by the Company on the date hereof. This Warrant Agreement shall be
binding upon any successors or assigns of the Company.
(b) Attorney's Fees. In any litigation, arbitration or court proceeding
between the Company and the Warrantholder relating hereto, the prevailing party
shall be entitled to attorneys' fees and expenses and all costs of proceedings
incurred in enforcing this Warrant Agreement.
(c) Governing Law. This Warrant Agreement shall be governed by and
construed for all purposes under and in accordance with the laws of the State of
Illinois.
(d) Counterparts. This Warrant Agreement may be executed in two or more
counterparts, each of which shall be deemed an original, but all of which
together shall constitute one and the same instrument.
(e) Notices. Any notice required or permitted hereunder shall be given
in writing and shall be deemed effectively given upon personal delivery,
facsimile transmission (provided that the original is sent by personal delivery
or mail as hereinafter set forth) or seven (7) days after deposit in the United
States mail, by registered or certified mail, addressed (i) to the Warrantholder
at 6111 North River Road, Rosemont, Illinois 60018, attention: Venture Lease
Administration, cc: Legal Department, attn.: General Counsel, (and/or, if by
facsimile, (847) 518-5465 and (847)518-5088 and (ii) to the Company at 3255
Scott Blvd., Bldg. 6, Santa Clara, CA 95050, Attention: Chief Financial Officer
(and/or if by facsimile, (408) 549-6299) or at such other address as any such
party may subsequently designate by written notice to the other party.
(f) Remedies. In the event of any default hereunder, the non-defaulting
party may proceed to protect and enforce its rights either by suit in equity
and/or by action at law, including but not limited to an action for damages as a
result of any such default, and/or an action for specific performance for any
default where Warrantholder will not have an adequate remedy at law and where
damages will not be readily ascertainable. The Company expressly agrees that it
shall not oppose an application by the Warrantholder or any other person
entitled to the benefit of this Agreement requiring specific performance of any
or all provisions hereof or enjoining the Company from continuing to commit any
such breach of this Agreement.
(g) No Impairment of Rights. The Company will not, by amendment of its
Charter or through any other means, avoid or seek to avoid the observance or
performance of any of the terms of this Warrant, but will at all times in good
faith assist in the carrying out of all such terms and in the taking of all such
actions as may be necessary or appropriate in order to protect the rights of the
Warrantholder against impairment.
-7-
<PAGE> 8
(h) Survival. The representations, warranties, covenants and conditions
of the respective parties contained herein or made pursuant to this Warrant
Agreement shall survive the execution and delivery of this Warrant Agreement.
(i) Severability. In the event any one or more of the provisions of this
Warrant Agreement shall for any reason be held invalid, illegal or
unenforceable, the remaining provisions of this Warrant Agreement shall be
unimpaired, and the invalid, illegal or unenforceable provision shall be
replaced by a mutually acceptable valid, legal and enforceable provision, which
comes closest to the intention of the parties underlying the invalid, illegal or
unenforceable provision.
(j) Amendments. Any provision of this Warrant Agreement may be amended
by a written instrument signed by the Company and by the Warrantholder.
(k) Additional Documents. The Company, upon execution of this Warrant
Agreement, shall provide the Warrantholder with certified resolutions with
respect to the representations, warranties and covenants set forth in
subparagraphs (a) through (d), (f) and (g) of Section 9 above. If the purchase
price for the Loans referenced in the preamble of this Warrant Agreement exceeds
$1,000,000, the Company will also provide Warrantholder with an opinion from the
Company's counsel with respect to those same representations, warranties and
covenants. The Company shall also supply such other documents as the
Warrantholder may from time to time reasonably request.
IN WITNESS WHEREOF, the parties hereto have caused this Warrant
Agreement to be executed by its officers thereunto duly authorized as of the
Effective Date.
COMPANY: NEOFORMA, INC.
By: /s/ JEFFREY KLECK
--------------------------------
Title: CEO
-----------------------------
WARRANTHOLDER: COMDISCO, INC.
By: /s/ JAMES LABE
---------------------------------
Title: President,
Comdisco Ventures Division
------------------------------
-8-
<PAGE> 9
EXHIBIT I TO
EXHIBIT 4.05
EXHIBIT I
NOTICE OF EXERCISE
TO: ____________________________
(1) The undersigned Warrantholder hereby elects to purchase _______ shares
of the Series ____ Preferred Stock of _________________, pursuant to
the terms of the Warrant Agreement dated the ______ day of
________________________, 19__ (the "Warrant Agreement") between
_____________________________________ and the Warrantholder, and
tenders herewith payment of the purchase price for such shares in full,
together with all applicable transfer taxes, if any.
(2) In exercising its rights to purchase the Series ____ Preferred Stock of
________________________________________, the undersigned hereby
confirms and acknowledges the investment representations and warranties
made in Section 10 of the Warrant Agreement.
(3) Please issue a certificate or certificates representing said shares of
Series ____ Preferred Stock in the name of the undersigned or in such
other name as is specified below.
_________________________________
(Name)
_________________________________
(Address)
WARRANTHOLDER: COMDISCO, INC.
By: _________________________
Title: _________________________
Date: _________________________
-9-
<PAGE> 10
EXHIBIT II TO
EXHIBIT 4.05
EXHIBIT II
ACKNOWLEDGMENT OF EXERCISE
The undersigned ____________________________________, hereby
acknowledge receipt of the "Notice of Exercise" from Comdisco, Inc., to purchase
____ shares of the Series ____ Preferred Stock of _________________, pursuant to
the terms of the Warrant Agreement, and further acknowledges that ______ shares
remain subject to purchase under the terms of the Warrant Agreement.
COMPANY:
By: _________________________
Title: _________________________
Date: _________________________
-10-
<PAGE> 11
EXHIBIT III TO
EXHIBIT 4.05
EXHIBIT III
TRANSFER NOTICE
(TO TRANSFER OR ASSIGN THE FOREGOING WARRANT AGREEMENT EXECUTE THIS FORM AND
SUPPLY REQUIRED INFORMATION. DO NOT USE THIS FORM TO PURCHASE SHARES.)
FOR VALUE RECEIVED, the foregoing Warrant Agreement and all rights
evidenced thereby are hereby transferred and assigned to
___________________________________________________________
(Please Print)
whose address is___________________________________________
___________________________________________________________
Dated: ______________________________
Holder's Signature: _________________
Holder's Address: ___________________
_____________________________________
Signature Guaranteed: _____________________________________
NOTE: The signature to this Transfer Notice must correspond with the name as
it appears on the face of the Warrant Agreement, without alteration or
enlargement or any change whatever. Officers of corporations and those
acting in a fiduciary or other representative capacity should file
proper evidence of authority to assign the foregoing Warrant Agreement.
-11-
<PAGE> 12
EXHIBIT TO
EXHIBIT 4.05
AMENDED AND RESTATED CERTIFICATE OF
INCORPORATION OF NEOFORMA, INC.
Neoforma, Inc., a corporation organized and existing under the laws of
the State of Delaware, hereby certifies as follows:
A. The name of the corporation is Neoforma, Inc. The original
Certificate of Incorporation was filed with the Secretary of State of Delaware
on August 18, 1998.
B. Pursuant to Section 228, 242, and 245 of the General Corporation Law
of the State of Delaware, this Amended and Restated Certificate of Incorporation
restates and integrates and further amends the Certificate of Incorporation of
this corporation.
C. The text of the Certificate of Incorporation is hereby amended and
restated in its entirety to read as follows:
ONE The name of this corporation is Neoforma, Inc.
TWO The address of the corporation's registered office in the State of
Delaware is Corporation Trust Center, 1209 Orange Street, in the City of
Wilmington, County of New Castle, Zip Code 19801. The name of its registered
agent at such address is The Corporation Trust Company.
THREE The purpose of the corporation is to engage in any lawful act or
activity for which a corporation may be organized under the General Corporation
Law of Delaware.
FOUR This corporation is authorized to issue two classes of stock to be
designated, respectively, "Common Stock" and "Preferred Stock." The total number
of shares which the corporation is authorized to issue is 67,425,022 shares.
40,000,000 shares shall be Common Stock with a par value of $.001. 27,425,022
shares shall be Preferred Stock with a par value of $.001, 9,000,000 of which
shall be designated as Series A Preferred Stock, 2,860,000 of which shall be
designated as Series B Preferred Stock, 5,109,937 of which shall be designated
as Series C Preferred Stock and 10,455,085 of which shall be designated as
Series D Preferred Stock.
FIVE The rights, preferences, privileges and restrictions granted to or
imposed upon the Common Stock and Preferred Stock are as follows:
1. Dividend Provisions. The holders of shares of Preferred Stock shall
be entitled to receive dividends, out of any assets legally available therefor,
prior and in preference to any declaration or payment of any dividend (payable
other than in Common Stock or other securities and
12
<PAGE> 13
rights convertible into or entitling the holder thereof to receive, directly or
indirectly, additional shares of Common Stock of this corporation) on the Common
Stock of this corporation, at the rate of $.02 per share per annum for the
Series A Preferred Stock, $.04 per share per annum for the Series B Preferred
Stock, $.062 per share per annum for the Series C Preferred Stock and $.0944 per
share per annum for the Series D Preferred Stock, or, if greater (as determined
on a per annum basis and on an as converted basis for the Preferred Stock), an
amount equal to that paid on any other outstanding shares of this corporation,
except that the shares of a given series of Preferred Stock shall not receive
any greater dividend as a result of the corporation's payment of a dividend on
any such series of Preferred Stock. Such dividends shall be payable when, as and
if declared by the Board of Directors, and shall not be cumulative, and no right
shall accrue to holders of Common Stock or Preferred Stock by reason of the fact
that dividends on said shares are not declared in any prior period.
2. Liquidation Preference.
(a) Preferred Preference. In the event of any liquidation,
dissolution or winding up of this corporation, either voluntary or involuntary,
the holders of the Series A Preferred Stock, Series B Preferred Stock, Series C
Preferred Stock and Series D Preferred Stock shall be entitled to receive, prior
and in preference to any distribution of any of the assets of this corporation
to the holders of Common Stock by reason of their ownership thereof, an amount
per share equal to $.25, $.50, $.77, and $1.18, respectively, for each
outstanding share of such Preferred Stock held, plus an amount equal to any
declared but unpaid dividends on such share of Preferred Stock up to the date
fixed for distribution. If upon the occurrence of such event, the assets and
funds thus distributed among the holders of the Preferred Stock shall be
insufficient to permit the payment to such holders of the full aforesaid
preferential amounts, then, the entire assets and funds of this corporation
legally available for distribution shall be distributed ratably among the
holders of the Preferred Stock in accordance with the aggregate preference
payment to which they are entitled.
(b) After the payment or setting aside of payment set forth in (a)
above, the remaining assets of the corporation shall be distributed on a
pro-rata basis to the holders of the Preferred Stock, on an as converted basis,
and the holders of the Common Stock until the holders of the Series A Preferred
Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred
Stock have received an additional $.25, $.50, $.77 and $1.18 per share,
respectively.
After the distributions to the stockholders pursuant to Sections 2(a) and
(b) above have been made, the remaining assets of the corporation available for
distribution to stockholders shall be distributed pro-rata among the holders of
Common Stock.
(c) Mergers. A merger, reorganization, or sale of all or
substantially all of the assets of this corporation, or other transactions or
series of related transactions in which the stockholders of this corporation
immediately prior to the transaction or series of related transactions possess
less than 50% of the voting power of the surviving entity (or its parent)
immediately after the transaction (a "Change of Control") shall be deemed to be
a liquidation, dissolution or winding up within the meaning of this Section 2;
provided that the holders of Preferred Stock and Common
13
<PAGE> 14
Stock shall be paid in cash or in securities received or in a combination
thereof (which combination shall be in the same proportions as the consideration
received in the transaction). Any securities to be delivered to the holders of
the Preferred Stock and Common Stock upon merger, reorganization, sale of
substantially all the assets of the corporation, or transaction or related
series of transactions resulting in a Change of Control shall be valued as
follows:
(i) if traded on a securities exchange or the Nasdaq
National Market, the value shall be deemed to be the average of the closing sale
prices of the securities on such exchange over the 30-day period ending three
(3) business days prior to the closing;
(ii) if actively traded over-the-counter, the value shall be
deemed to be the average of the closing bid prices (or closing sales prices,
whichever is applicable) over the 30-day period ending three (3) business days
prior to the closing; and
(iii) if there is no active public market, the value shall
be the fair market value thereof as determined in good faith by the board of
directors of the corporation, but if challenged by the holders of more than 50%
of the outstanding shares of Preferred Stock, then as determined by an
independent appraiser selected by the board of directors of the corporation, the
cost of such appraisal to be borne by the challenging parties.
3. Conversion. The holders of the Preferred Stock shall have conversion
rights as follows (the "Conversion Rights"):
(a) Right to Convert. Each share of Preferred Stock shall be
convertible into share(s) of Common Stock without the payment of any additional
consideration by the holder thereof and, at the option of the holder thereof, at
any time after the date of issuance of such share, at the office of the
corporation or any transfer agent for the Preferred Stock. Each share of
Preferred Stock shall be convertible into the number of fully paid and
nonassessable shares of Common Stock which results from dividing the Conversion
Price (as hereinafter defined) per share in effect for the Preferred Stock at
the time of conversion into the per share Conversion Value (as hereinafter
defined) of such series. The initial Conversion Price per share of the Series A
Preferred Stock shall be $.25; and the Conversion Value per share of the Series
A Preferred Stock shall be $.25; the initial Conversion Price per share of the
Series B Preferred Stock shall be $.50; and the Conversion Value per share of
the Series B Preferred Stock shall be $.50; the initial Conversion Price per
share of the Series C Preferred Stock shall be $.77; the Conversion Value per
share of the Series C Preferred Stock shall be $.77; the initial Conversion
Price per share of the Series D Preferred Stock shall be $1.18; and the
Conversion Value per share of the Series D Preferred Stock shall be $1.18. The
initial Conversion Price of the Preferred Stock shall be subject to adjustment
from time to time as provided below. The number of shares of Common Stock into
which a share of Preferred Stock is convertible is hereinafter referred to as
the "Conversion Rate" of such series.
(b) Automatic Conversion. Each share of Preferred Stock shall
automatically be converted into shares of Common Stock at its then effective
Conversion Rate immediately prior to
14
<PAGE> 15
the closing of an initial public offering pursuant to an effective registration
statement under the Securities Act of 1933, as amended, covering the offer and
sale of Common Stock in which (a) the public offering price equals or exceeds
$4.72 per share (adjusted to reflect subsequent stock dividends, stock splits or
recapitalization) and (b) the aggregate proceeds raised equals or exceeds
$20,000,000.
(c) Mechanics of Conversion. Before any holder of Preferred Stock
shall be entitled to convert the same into shares of Common Stock, such holder
shall surrender the certificate or certificates therefor, duly endorsed, at the
office of the corporation or of any transfer agent for the Preferred Stock and
shall give written notice to the corporation at such office that such holder
elects to convert the same (except that no such written notice of election to
convert shall be necessary in the event of an automatic conversion pursuant to
Section 3(b) hereof). The corporation shall, as soon as practicable thereafter,
issue and deliver at such office to such holder of Preferred Stock a certificate
or certificates for the number of shares of Common Stock to which such holder
shall be entitled as aforesaid. Such conversion shall be deemed to have been
made immediately prior to the close of business on the date of such surrender of
the shares of Preferred Stock to be converted (except that in the case of an
automatic conversion pursuant to Section 3(b) hereof such conversion shall be
deemed to have been made immediately prior to the closing of the offering
referred to in Section 3(b)) and the person or persons entitled to receive the
shares of Common Stock issuable upon such conversion shall be treated for all
purposes as the record holder or holders of such shares of Common Stock on such
date.
(d) Fractional Shares. In lieu of any fractional shares to which
the holder of Preferred Stock would otherwise be entitled, the corporation shall
pay cash equal to such fraction multiplied by the fair market value of one share
of such series of Preferred Stock as determined by the board of directors of the
corporation. Whether or not fractional shares are issuable upon such conversion
shall be determined on the basis of the total number of shares of Preferred
Stock of each holder to be converted at such time into Common Stock and the
number of shares of Common Stock issuable upon such aggregate conversion.
(e) Adjustment of Conversion Price. The Conversion Price of each
series of Preferred Stock shall be subject to adjustment from time to time as
follows:
(i) If the corporation shall issue, after the date on which
any shares of Series D Preferred Stock were first issued, any Common Stock other
than "Excluded Stock," as defined below, for a consideration per share less than
the Conversion Price for a series of Preferred Stock in effect immediately prior
to the issuance of such Common Stock (excluding stock dividends, subdivisions,
split-ups, combinations, dividends or recapitalizations which are covered by
Section 3(e)(iii), (iv), (v) and (vi)), the Conversion Price for such series in
effect immediately after each such issuance shall forthwith (except as provided
in this Section 3(e)) be adjusted to a price equal to the quotient obtained by
dividing:
(A) an amount equal to the sum of
15
<PAGE> 16
(x) the total number of shares of Common Stock
outstanding (including any shares of Common Stock issuable upon conversion of
the Preferred Stock, or deemed to have been issued pursuant to subdivision
(B)(3) of this clause (i) and to clause (ii) below) immediately prior to such
issuance multiplied by the Conversion Price in effect immediately prior to such
issuance, plus
(y) the consideration received by the
corporation upon such issuance, by
(B) the total number of shares of Common Stock
outstanding (including any shares of Common Stock issuable upon conversion of
the Preferred Stock or deemed to have been issued pursuant to subdivision (B)(3)
of this clause (i) and to clause (ii) below) immediately prior to such issuance
plus the additional shares of Common Stock issued in such issuance (but not
including any additional shares of Common Stock deemed to be issued as a result
of any adjustment in the Conversion Price resulting from such issuance).
For purposes of any adjustment of the Conversion Price
pursuant to this clause (i), the following provisions shall be applicable:
(1) In the case of the issuance of Common Stock
for cash, the consideration shall be deemed to be the amount of cash paid
therefor after deducting any discounts or commissions paid or incurred by the
corporation in connection with the issuance and sale thereof.
(2) In the case of the issuance of Common Stock
for a consideration in whole or in part other than cash, the consideration other
than cash shall be deemed to be the fair market value thereof as determined by
the board of directors of the corporation, in accordance with generally accepted
accounting treatment; provided, however, that if, at the time of such
determination, the corporation's Common Stock is traded in the over-the-counter
market or on a national or regional securities exchange, such fair market value
as determined by the board of directors of the corporation shall not exceed the
aggregate "Current Market Price" (as defined below) of the shares of Common
Stock being issued.
(3) In the case of the issuance of (i) options
to purchase or rights to subscribe for Common Stock (other than Excluded Stock),
(ii) securities by their terms convertible into or exchangeable for Common
Stock (other than Excluded Stock), or (iii) options to purchase or rights to
subscribe for such convertible or exchangeable securities:
(A) the aggregate maximum number of
shares of Common Stock deliverable upon exercise of such options to purchase or
rights to subscribe for Common Stock shall be deemed to have been issued at the
time such options or rights were issued and for a consideration equal to the
consideration (determined in the manner provided in
16
<PAGE> 17
subdivisions (1) and (2) above), if any, received by the corporation upon the
issuance of such options or rights plus the minimum purchase price provided in
such options or rights for the Common Stock covered thereby;
(B) the aggregate maximum number of
shares of Common Stock deliverable upon conversion of or in exchange for any
such convertible or exchangeable securities or upon the exercise of options to
purchase or rights to subscribe for such convertible or exchangeable securities
and subsequent conversion or exchange thereof, shall be deemed to have been
issued at the time such securities were issued or such options or rights were
issued and for a consideration equal to the consideration received by the
corporation for any such securities and related options or rights (excluding any
cash received on account of accrued interest or accrued dividends), plus the
minimum additional consideration, if any, to be received by the corporation upon
the conversion or exchange of such securities or the exercise of any related
options or rights (the consideration in each case to be determined in the manner
provided in subdivisions (1) and (2) above);
(C) on any change in the number of shares
of Common Stock deliverable upon exercise of any such options or rights or
conversion of or exchange for such convertible or exchangeable securities, or on
any change in the minimum purchase price of such options, rights or securities,
other than a change resulting from the antidilution provisions of such options,
rights or securities, the Conversion Price shall forthwith be readjusted to such
Conversion Price as would have obtained had the adjustment made upon (x) the
issuance of such options, rights or securities not exercised, converted or
exchanged prior to such change, as the case may be, been made upon the basis of
such change or (y) the options or rights related to such securities not
converted or exchanged prior to such change, as the case may be, been made upon
the basis of such change; and
(D) on the expiration of any such options
or rights, the termination of any such rights to convert or exchange or the
expiration of any options or rights related to such convertible or exchangeable
securities, the Conversion Price shall forthwith be readjusted to such
Conversion Price as would have obtained had the adjustment made upon the
issuance of such options, rights, convertible or exchangeable securities or
options or rights related to such convertible or exchangeable securities, as the
case may be, been made upon the basis of the issuance of only the number of
shares of Common Stock actually issued upon the exercise of such options or
rights, upon the conversion or exchange of such convertible or exchangeable
securities or upon the exercise of the options or rights related to such
convertible or exchangeable securities, as the case may be.
(ii) "Excluded Stock" shall mean:
(1) all shares of Common Stock issued and outstanding
on the date this document is filed with the Delaware Secretary of State;
17
<PAGE> 18
(2) all shares of Preferred Stock issued and
outstanding on the date this document is filed with the Delaware Secretary of
State and the Common Stock into which such shares of Preferred Stock are
convertible;
(3) all shares of Common Stock, warrants or options to
purchase Common Stock or other securities issued to officers, directors,
consultants or employees of the corporation pursuant to any plan or arrangement
approved by the board of directors of the corporation; and
(4) all shares of Common Stock, warrants or options to
purchase Common Stock or other securities issued to lending or leasing
institutions pursuant to any plan or arrangement approved by the board of
directors of the corporation.
All outstanding shares of Excluded Stock (including
any shares issuable upon conversion of the Preferred Stock) shall be deemed to
be outstanding for all purposes of the computations of Section 3(e)(i) above.
(iii) If the number of shares of Common Stock outstanding at
any time after the date hereof is increased by a stock dividend payable in
shares of Common Stock or by a subdivision or split-up of shares of Common
Stock, then, on the date such payment is made or such change is effective, the
Conversion Price of each series of Preferred Stock shall be appropriately
decreased so that the number of shares of Common Stock issuable on conversion of
any shares of such series of Preferred Stock shall be increased in proportion to
such increase of outstanding shares.
(iv) If the number of shares of Common Stock outstanding at
any time after the date hereof is decreased by a combination of the outstanding
shares of Common Stock, then, on the effective date of such combination, the
Conversion Price of each series of Preferred Stock shall be appropriately
increased so that the number of shares of Common Stock issuable on conversion of
any shares of a series of Preferred Stock shall be decreased in proportion to
such decrease in outstanding shares.
(v) In case the corporation shall declare a cash dividend
upon its Common Stock payable otherwise than out of retained earnings or shall
distribute to holders of its Common Stock shares of its capital stock (other
than Common Stock), stock or other securities of other persons, evidences of
indebtedness issued by the corporation or other persons, assets (excluding cash
dividends) or options or rights (excluding options to purchase and rights to
subscribe for Common Stock or other securities of the corporation convertible
into or exchangeable for Common Stock), then, in each such case, the holders of
shares of Preferred Stock shall, concurrent with the distribution to holders of
Common Stock, receive a like distribution based upon the number of shares of
Common Stock into which such shares of Preferred Stock are convertible.
(vi) In case, at any time after the date hereof, of any
capital reorganization, or any reclassification of the stock of the corporation
(other than as a result of a stock dividend or
18
<PAGE> 19
subdivision, split-up or combination of shares), or the consolidation or merger
of the corporation with or into another person (other than a consolidation or
merger in which the corporation is the continuing entity and which does not
result in any change in the Common Stock), or of the sale or other disposition
of all or substantially all the properties and assets of the corporation, the
shares of Preferred Stock shall, after such reorganization, reclassification,
consolidation, merger, sale or other disposition, be convertible into the kind
and number of shares of stock or other securities or property of the corporation
or otherwise to which such holder would have been entitled if immediately prior
to such reorganization, reclassification, consolidation, merger, sale or other
disposition he had converted his shares of Preferred Stock into Common Stock.
The provisions of this clause (vi) shall similarly apply to successive
reorganizations, reclassifications, consolidations, mergers, sales or other
dispositions.
(vii) All calculations under this Section 3 shall be made to
the nearest cent or to the nearest one hundredth (1/100) of a share, as the case
may be.
(viii) For the purpose of any computation pursuant to this
Section 3(e), the "Current Market Price" at any date of one share of Common
Stock, shall be deemed to be the average of the highest reported bid and the
lowest reported offer prices on the preceding business day as furnished by the
National Quotation Bureau, Incorporated (or equivalent recognized source of
quotations); provided, however, that if the Common Stock is not traded in such
manner that the quotations referred to in this clause (viii) are available for
the period required hereunder, Current Market Price shall be determined in good
faith by the board of directors of the corporation, but if challenged by the
holders of more than 50% of the outstanding shares of Preferred Stock, then as
determined by an independent appraiser selected by the board of directors of the
corporation, the cost of such appraisal to be borne by the challenging parties.
(f) Minimal Adjustments. No adjustment in the Conversion Price need
be made if such adjustment would result in a change in the Conversion Price of
less than $0.01. Any adjustment of less than $0.01 which is not made shall be
carried forward and shall be made at the time of and together with any
subsequent adjustment which, on a cumulative basis, amounts to an adjustment of
$0.01 or more in the Conversion Price.
(g) No Impairment. Without the consent of the majority of the
outstanding shares of Preferred Stock, the corporation will not through any
reorganization, recapitalization, transfer of assets, consolidation, merger,
dissolution, issue or sale of securities or any other voluntary action, avoid or
seek to avoid the observance or performance of any of the terms to be observed
or performed hereunder by the corporation, but will at all times in good faith
assist in the carrying out of all the provisions of this Section 3 and in the
taking of all such action as may be necessary or appropriate in order to protect
the Conversion Rights of the holders of Preferred Stock against impairment.
(h) Certificate as to Adjustments. Upon the occurrence of each
adjustment or readjustment of the Conversion Rate pursuant to this Section 3,
the corporation at its expense shall
19
<PAGE> 20
promptly compute such adjustment or readjustment in accordance with the terms
hereof and prepare and furnish to each holder of Preferred Stock a certificate
setting forth such adjustment or readjustment and showing in detail the facts
upon which such adjustment or readjustment is based. The corporation shall, upon
written request at any time of any holder of Preferred Stock, furnish or cause
to be furnished to such holder a like certificate setting forth (i) such
adjustments and readjustments, (ii) the Conversion Rate of such series at the
time in effect, and (iii) the number of shares of Common Stock and the amount,
if any, of other property which at the time would be received upon the
conversions of such holder's shares of Preferred Stock.
(i) Notices of Record Date. In the event of any taking by the
corporation of a record of the holders of any class of securities for the
purpose of determining the holders thereof who are entitled to receive any
dividend (other than a cash dividend) or other distribution, any right to
subscribe for, purchase or otherwise acquire any shares of stock of any class or
any other securities or property or to receive any other right, the corporation
shall mail to each holder of Preferred Stock at least ten (10) days prior to
such record date, a notice specifying the date on which any such record is to be
taken for the purpose of such dividend or distribution or right, and the amount
and character of such dividend, distribution or right.
(j) Reservation of Stock Issuable Upon Conversion. The corporation
shall at all times reserve and keep available out of its authorized but unissued
shares of Common Stock solely for the purpose of effecting the conversion of the
shares of Preferred Stock such number of its shares of Common Stock as shall
from time to time be sufficient to effect the conversion of all outstanding
shares of Preferred Stock; and if at any time the number of authorized but
unissued shares of Common Stock shall not be sufficient to effect the conversion
of all then outstanding shares of Preferred Stock, the corporation will take
such corporate action as may, in the opinion of its counsel, be necessary to
increase its authorized but unissued shares of Common Stock to such number of
shares as shall be sufficient for such purpose.
(k) Notices. Any notice required by the provisions of this Section
3 to be given to the holder of shares of Preferred Stock shall be deemed given
if deposited in the United States mail, postage prepaid, and addressed to each
holder of record at his address appearing on the books of the corporation.
(l) Reissuance of Converted Shares. No shares of Preferred Stock
which have been converted into Common Stock after the original issuance thereof
shall ever again be reissued and all such shares so converted shall upon such
conversion cease to be a part of the authorized shares of the corporation.
4. Voting Rights.
(a) Preferred Stock. The holder of each share of Preferred Stock
shall be entitled to the number of votes equal to the number of shares of Common
Stock into which each share of Preferred Stock could be converted on the record
date for the vote or consent of shareholders written
20
<PAGE> 21
consent and, except as otherwise required by law, shall have voting rights and
powers equal to the voting rights and powers of the Common Stock. The holder of
each share of Preferred Stock shall be entitled to notice of any shareholders'
meeting in accordance with the bylaws of the corporation and shall vote with
holders of the Common Stock upon the election of directors and upon any other
matter submitted to a vote of shareholders, except those matters required by law
to be submitted to a class vote. Fractional votes shall not, however, be
permitted and any fractional voting rights resulting from the above formula
(after aggregating all shares of Common Stock into which shares of Preferred
Stock held by each holder could be converted) shall be rounded to the nearest
whole number (with one-half rounded upward to one).
(b) Common Stock. Each holder of shares of Common Stock shall be
entitled to one vote for each share held.
(c) Board of Directors. The Board of Directors of the corporation
shall consist of six (6) members. The holders of the Series D Preferred Stock,
voting as a separate series, shall be entitled to elect one (1) director of the
corporation. The holders of the Series C Preferred Stock, voting as a separate
series, shall be entitled to elect one (1) director of the corporation. The
holders of the Series A Preferred Stock, voting as a separate series, shall be
entitled to elect one (1) director of the corporation. The holders of the Common
Stock, voting together as a separate class, shall be entitled to elect one (1)
director of the corporation. All remaining directors of the corporation shall be
elected by the holders of the Common Stock and Preferred Stock voting together
as a single class in accordance with the provision set forth in Section 4(a)
above. Vacancies on the board of directors may be filled by a majority of the
remaining directors originally elected by the same series, class or classes of
shares who could elect an individual to fill such vacancy on the board of
directors, though less than a quorum, except that a vacancy created by the
removal of a director or directors by the vote or written consent of the
shareholders, such shareholders being those who hold a majority of the
outstanding shares of the series, class or classes entitled to elect such
director or directors, or by court order may be filled by only the vote of a
majority of the outstanding shares entitled to vote thereon. The shareholders
entitled to vote thereon may elect a director or directors at any time to fill
any vacancy or vacancies not filled by the directors. This Section 4(c) shall
not apply unless 1,000,000 shares of the Series C Preferred Stock and 1,500,000
shares of the Series D Preferred Stock (as adjusted for stock splits, stock
dividends, recapitalizations and the like) are outstanding.
5. Redemption Rights of the Series C and Series D Preferred Stock.
(a) Redemption on Demand. Subject to applicable law, at any time
following the seventh anniversary of the closing of the purchase and sale of
Series D Preferred Stock and upon the affirmative vote of the holders of the
majority of the Series C Preferred Stock and Series D Preferred Stock, voting
together as a single class on an as converted basis, the corporation shall
redeem, in accordance with this Section 5, all shares of Series C Preferred
Stock and Series D Preferred Stock outstanding as of the date of such demand,
which date shall hereinafter be referred to as the "Redemption Date."
21
<PAGE> 22
(b) Redemption Price. The Redemption Price for Series C Preferred
Stock shall be $.77 per share (appropriately adjusted for stock splits, stock
dividends, recapitalizations and similar events). The Redemption Price for the
Series D Preferred Stock shall be $1.18 per share (appropriately adjusted for
stock splits, stock dividends, recapitalizations and similar events).
(c) Redemption Procedure. Beginning with the first year anniversary
of the Redemption Date, the corporation shall be required to redeem annually no
more than that number of shares of Series C Preferred Stock and Series D
Preferred Stock equal to twenty-five (25) percent of the shares of Series C
Preferred Stock and Series D Preferred Stock outstanding as of the Redemption
Date. Annually thereafter, each holder of Series C Preferred Stock and Series D
Preferred Stock shall surrender to the corporation for redemption no more than
that number of shares equal to twenty-five (25) percent of the shares held by
such holder on the Redemption Date (with one-half being rounded upwards). At
least 20 days prior to the yearly anniversary of the Redemption Date, written
notice (the "Redemption Notice") shall be mailed first class, postage prepaid,
to each holder of record (at the close of business on the business day next
preceding the day on which notice is given) of the Series C Preferred Stock and
Series D Preferred Stock, at the address last shown on the records of the
corporation for such holder or given by the holder to the corporation for the
purpose of notice or if no such address appears or is given, at the place where
the principal executive office of the corporation is located, notifying such
holder of the redemption to be effected, specifying the amount to be redeemed by
such holder, the Redemption Date, the Redemption Price, the place at which
payment may be obtained and the date on which such holder's right to convert
Series C Preferred Stock or Series D Preferred Stock into Common Stock, as to
such shares, terminates and calling upon such holder to surrender to the
corporation, in the manner and at the place designated, its certificate or
certificates representing the shares to be redeemed. Except as provided in
paragraph 5(d), on or after the Redemption Date, each holder of Series C
Preferred Stock or Series D Preferred Stock to be redeemed shall surrender to
the corporation the certificate or certificates representing such shares, in the
manner and at the place designated in the Redemption Notice, and thereupon, the
aggregate Redemption Price of such shares shall be payable in cash to the order
of the person whose name appears on such certificate or certificates as the
owner thereof and each surrendered certificate shall be canceled.
(d) Effect of Redemption. From and after the Redemption Date,
unless there shall have been a default in payment of the Redemption Price, all
rights of the holders of such shares designated for redemption (as holders of
the Series C Preferred Stock or Series D Preferred Stock, as the case may be,
except the right to receive their respective Redemption Price without interest
upon surrender of their certificate of certificates) shall cease with respect to
such shares, and such shares shall not thereafter be transferred on the books of
the corporation or be deemed to be outstanding for any purpose whatsoever. If
the funds of the corporation legally available for redemption of shares of the
Series C Preferred Stock and Series D Preferred Stock on any Redemption Date are
insufficient to redeem the total number of shares of the Series C Preferred
Stock and Series D Preferred Stock to be redeemed on such date, those funds
which are legally available will be used to redeem the maximum possible number
of such shares on a pro rata basis
22
<PAGE> 23
among the holders of the Series C Preferred Stock and Series D Preferred Stock
based upon each holder's share of the total redemption price. The shares of
Series C Preferred Stock and Series D Preferred Stock not redeemed shall remain
outstanding and be entitled to all the rights and preferences provided herein.
At any time thereafter when additional funds of the corporation are legally
available for the redemption of shares of Series C Preferred Stock and Series D
Preferred Stock, such finds will immediately be set aside for the redemption of
the balance of the shares which the corporation was obligated to redeem on any
Redemption Date but which it has not redeemed; provided that the holders of such
Series C Preferred Stock and Series D Preferred Stock shall receive at least 10
days notice of such redemption.
(e) Redemption Funding. On or prior to the Redemption Date, the
corporation shall deposit the Redemption Price of all shares of Series C
Preferred Stock and Series D Preferred Stock designated for redemption in the
Redemption Notice, with a bank or trust company located in the State of
California having aggregate capital and surplus in excess of $50,000,000 as a
trust fund for the benefit of the respective holders of the shares designated
for redemption and not yet redeemed. Simultaneously, the corporation shall
deposit irrevocable instructions and authority to such bank or trust company to
pay, on and after the date fixed for redemption or prior thereto, the Redemption
Price of the Series C Preferred Stock and Series D Preferred Stock to the
holders thereof, respectively, upon surrender of their certificates. Any money
or notes deposited by the corporation pursuant to this paragraph 5(e) for the
redemption of shares which are thereafter converted into shares of Common Stock
pursuant to paragraph 5(c) hereof no later than the close of business on the
last business day prior to the Redemption Date shall be returned to the
corporation forthwith upon such conversion. The balance of any money or notes
deposited by the corporation pursuant to this subsection remaining unclaimed at
the expiration of six months following the Redemption Date shall thereafter be
returned to the corporation, provided that the shareholder to which such money
would be payable hereunder shall be entitled, upon proof of its ownership of the
Preferred Stock and payment of any bond requested by the corporation, to receive
such monies but without interest from the Redemption Date.
6. Protective Provisions. In addition to any other class vote that may be
required by law, so long as at least 4,000,000 shares of Preferred Stock are
outstanding, this corporation shall not without first obtaining the approval (by
vote or written consent, as provided by law) of the holders of at least a
two-thirds of the then outstanding shares of Preferred Stock (voting as a class
on an as converted basis) undertake any of the following:
(i) effect a Change of Control in the corporation or sell all or
substantially all of its assets,
(ii) change the rights, preferences or privileges of any series of
Preferred Stock,
(iii) increase or decrease the authorized shares of Preferred Stock
or the designated shares of any series of Preferred Stock,
23
<PAGE> 24
(iv) create a new series or class of shares having rights on a
parity with or superior to any outstanding class or series of
shares,
(v) except as set forth in this certificate, do any act which would
result in taxation under Section 305 of the Internal Revenue Code,
(vi) divide the securities of any class into series having
different rights,
(vii) effect an exchange, reclassification or cancellation of all
or any part of a class of securities, including a reverse stock
split,
(viii) effect an exchange or create a right of exchange of all or
part of the shares of a class,
(ix) dissolve, liquidate or windup the corporation,
(x) declare or pay any dividends on the Common Stock,
(xi) increase the number of members of the corporation's Board of
Directors to more than six (6) members, or
(xii) redeem or repurchase any shares of Series A or Series B
Preferred Stock.
7. Residual Rights. All rights accruing to the outstanding shares of
capital stock not expressly provided for to the contrary herein shall be vested
in the Common Stock.
SIX The following is applicable to the Common Stock:
1. Dividend Rights. Subject to the prior rights of holders of all classes
of stock at the time outstanding having prior rights as to dividends, the
holders of the Common Stock shall be entitled to receive, when and as declared
by the Board of Directors, out of any assets of the corporation legally
available therefor, such dividends as may be declared from time to time by the
Board of Directors.
2. Liquidation Rights. Upon the liquidation, dissolution or winding up of
the corporation, the assets of the corporation shall be distributed as provided
in Section 2 of Article Five hereof.
3. Redemption. The Common Stock is not redeemable.
4. Voting Rights. The holder of each share of Common Stock shall have the
right to one vote, and shall be entitled to notice of any stockholders' meeting
in accordance with the Bylaws
24
<PAGE> 25
of the corporation, and shall be entitled to vote upon such matters and in such
manner as may be provided by law.
SEVEN The corporation is to have perpetual existence.
EIGHT In furtherance and not in limitation of the powers conferred by
statute, the Board of Directors is expressly authorized to make, alter, amend or
repeal the Bylaws of the Corporation.
NINE The election of directors need not be by written ballot unless the
Bylaws of the corporation shall so provide.
TEN To the fullest extent permitted by the Delaware General Corporation
Law as the same exists or as may hereafter be amended, a director of the
corporation shall not be personally liable to the corporation or its
stockholders for monetary damages for breach of fiduciary duty as a director.
The corporation shall indemnify to the fullest extent permitted by the law, any
person made or threatened to be made a party, to any action or proceeding,
whether criminal, civil, administrative or investigative, by reason of the fact
the he or she, or his or her testator or intestate, is or was a director or
officer of the corporation or any predecessor of the corporation, or serves or
served at any other enterprise as a director or officer at the request of the
corporation or any predecessor to the corporation. Neither any amendment nor
repeal of this Article, nor the adoption of any provision of this Certificate of
Incorporation inconsistent with this Article, shall eliminate or reduce the
effect of this Article in respect of any matter occurring, or any cause of
action, suit or claim accruing or arising or that, but for this Article, would
accrue or arise, prior to such amendment, repeal or adoption of an inconsistent
provision.
ELEVEN The corporation reserves the right to amend, alter, change or
repeal any provision contained in this Certificate of Incorporation, in the
manner now or hereafter prescribed by statute, and all rights conferred upon
stockholders herein are granted subject to this reservation.
25
<PAGE> 26
IN WITNESS WHEREOF, the corporation has caused this Amended and Restated
Certificate to be signed by its Chief Executive Officer and attested by its
Secretary, this 18th day of February, 1999.
/s/ JEFFREY KLECK, Chief Executive Officer
/s/ J. CASEY MCGLYNN, Secretary
26
<PAGE> 1
EXHIBIT 4.06
THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER
THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE SOLD, PLEDGED, OR
OTHERWISE TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION THEREOF UNDER SUCH ACT
OR PURSUANT TO RULE 144 OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE
CORPORATION AND ITS COUNSEL, THAT SUCH REGISTRATION IS NOT REQUIRED.
QUICKSTART
WARRANT TO PURCHASE STOCK
Corporation: Neoforma, Inc., a Delaware corporation
Number of Shares: 10,000
Class of Stock: Series D Preferred
Initial Exercise Price: $1.18 per share
Issue Date: July 20, 1999
Expiration Date: July 20, 2004
THIS WARRANT CERTIFIES THAT, for the agreed upon value of $1.00 and for
other good and valuable consideration, SILICON VALLEY BANK ("Holder") is
entitled to purchase the number of fully paid and nonassessable shares of the
class of securities (the "Shares") of the corporation (the "Company") at the
initial exercise price per Share (the "Warrant Price") all as set forth above
and as adjusted pursuant to Article 2 of this Warrant, subject to the provisions
and upon the terms and conditions set forth in this Warrant.
ARTICLE 1. EXERCISE.
1.1 Method of Exercise. Holder may exercise this Warrant by
delivering a duly executed Notice of Exercise in substantially the form attached
as Appendix 1 to the principal office of the Company. Unless Holder is
exercising the conversion right set forth in Section 1.2, Holder shall also
deliver to the Company a check for the aggregate Warrant Price for the Shares
being purchased.
1.2 Conversion Right. In lieu of exercising this Warrant as
specified in Section 1.1, Holder may from time to time convert this Warrant, in
whole or in part, into a number of Shares determined by dividing (a) the
aggregate fair market value of the Shares or other securities otherwise issuable
upon exercise of this Warrant minus the aggregate Warrant Price of such Shares
by (b) the fair market value of one Share. The fair market value of the Shares
shall be determined pursuant to Section 1.4.
1.3 Intentionally Omitted
1.4 Fair Market Value. If the Shares are traded in a public
market, the fair market value of the Shares shall be the closing price of the
Shares (or the closing price of the Company's stock into which the Shares are
convertible) reported for the business day immediately before Holder delivers
its Notice of Exercise to the Company. If the Shares are not traded in a public
market, the Board of Directors of the Company shall determine fair market value
in its reasonable good faith judgment.
1.5 Delivery of Certificate and New Warrant. Promptly after
Holder exercises or converts this Warrant, the Company shall deliver to Holder
certificates for the Shares acquired and, if this Warrant has not been fully
exercised or converted and has not expired, a new Warrant representing the
Shares not so acquired.
1
<PAGE> 2
1.6 Replacement of Warrants. On receipt of evidence reasonably
satisfactory to the Company of the loss, theft, destruction or mutilation of
this Warrant and, in the case of loss, theft or destruction, on delivery of an
indemnity agreement reasonably satisfactory in form and amount to the Company
or, in the case of mutilation, on surrender and cancellation of this Warrant,
the Company at its expense shall execute and deliver, in lieu of this Warrant, a
new warrant of like tenor.
1.7 Repurchase on Sale, Merger, or Consolidation of the Company.
1.7.1. "Acquisition". For the purpose of this Warrant,
"Acquisition" means any sale, license, or other disposition of all or
substantially all of the assets of the Company, or any reorganization,
consolidation, or merger of the Company where the holders of the Company's
securities before the transaction beneficially own less than 50% of the
outstanding voting securities of the surviving entity after the transaction.
1.7.2. Assumption of Warrant. Upon the closing of any
Acquisition the successor entity may, at its option, assume the obligations of
this Warrant, and this Warrant shall be exercisable for the same securities,
cash, and property as would be payable for the Shares issuable upon exercise of
the unexercised portion of this Warrant as if such Shares were outstanding on
the record date for the Acquisition and subsequent closing. The Warrant Price
shall be adjusted accordingly. If the successor entity does not assume the
obligations of the Company under this Warrant, then this Warrant shall be deemed
to have been automatically converted pursuant to Section 1.2 and thereafter
Holder shall participate in the Acquisition as a holder of the Shares (or other
securities issuable upon exercise of this Warrant) on the same terms as other
holders of the same class of securities of the Company.
ARTICLE 2. ADJUSTMENTS TO THE SHARES.
2.1 Stock Dividends, Splits, Etc. If the Company declares or pays
a dividend on its common stock (or the Shares if the Shares are securities other
than common stock) payable in common stock, or other securities, subdivides the
outstanding common stock into a greater amount of common stock, or, if the
Shares are securities other than common stock, subdivides the Shares in a
transaction that increases the amount of common stock into which the Shares are
convertible, then upon exercise of this Warrant, for each Share acquired, Holder
shall receive, without cost to Holder, the total number and kind of securities
to which Holder would have been entitled had Holder owned the Shares of record
as of the date the dividend or subdivision occurred.
2.2 Reclassification, Exchange or Substitution. Upon any
reclassification, exchange, substitution, or other event that results in a
change of the number and/or class of the securities issuable upon exercise or
conversion of this Warrant, Holder shall be entitled to receive, upon exercise
or conversion of this Warrant, the number and kind of securities and property
that Holder would have received for the Shares if this Warrant had been
exercised immediately before such reclassification, exchange, substitution, or
other event. Such an event shall include any automatic conversion of the
outstanding or issuable securities of the Company of the same class or series as
the Shares to common stock pursuant to the terms of the Company's Certificate of
Incorporation upon the closing of a registered public offering of the Company's
common stock. The Company or its successor shall promptly issue to Holder a new
Warrant for such new securities or other property. The new Warrant shall provide
for adjustments which shall be as nearly equivalent as may be practicable to the
adjustments provided for in this Article 2 including, without limitation,
adjustments to the Warrant Price and to the number of securities or property
issuable upon exercise of the new Warrant. The provisions of this Section 2.2
shall similarly apply to successive reclassifications, exchanges, substitutions,
or other events.
2.3 Adjustments for Combinations, Etc. If the outstanding Shares
are combined or consolidated, by reclassification or otherwise, into a lesser
number of shares, the Warrant Price shall be proportionately increased.
2
<PAGE> 3
2.4 Adjustments for Diluting Issuances. The Shares shall be
afforded the protections (if any) against diluting issuances of stock as are
prescribed for the class of stock of the Shares under the Company's Certificate
of Incorporation, as amended from time to time.
2.5 No Impairment. The Company shall not, by amendment of its
Certificate of Incorporation or through a reorganization, transfer of assets,
consolidation, merger, dissolution, issue, or sale of securities or any other
voluntary action, avoid or seek to avoid the observance or performance of any of
the terms to be observed or performed under this Warrant by the Company, but
shall at all times in good faith assist in carrying out of all the provisions of
this Article 2 and in taking all such action as may be necessary or appropriate
to protect Holder's rights under this Article against impairment. Provided,
however, that this Section 2.5 shall not prevent the Company from amending its
Certificate of Incorporation upon the consent of its stockholders.
2.6 Fractional Shares. No fractional Shares shall be issuable
upon exercise or conversion of the Warrant and the number of Shares to be issued
shall be rounded down to the nearest whole Share. If a fractional share interest
arises upon any exercise or conversion of the Warrant, the Company shall
eliminate such fractional share interest by paying Holder amount computed by
multiplying the fractional interest by the fair market value of a full Share.
2.7 Certificate as to Adjustments. Upon each adjustment of the
Warrant Price, the Company at its expense shall promptly compute such
adjustment, and furnish Holder with a certificate of its Chief Financial Officer
setting forth such adjustment and the facts upon which such adjustment is based.
The Company shall, upon written request, famish Holder a certificate setting
forth the Warrant Price in effect upon the date thereof and the series of
adjustments leading to such Warrant Price.
ARTICLE 3. REPRESENTATIONS AND COVENANTS OF THE COMPANY.
3.1 Representations and Warranties. The Company hereby represents
and warrants to the Holder as follows:
(a) The initial Warrant Price referenced on the first page
of this Warrant is not greater than the fair market value of the Shares as of
the date of this Warrant.
(b) All Shares which may be issued upon the exercise of the
purchase right represented by this Warrant, and all securities, if any, issuable
upon conversion of the Shares, shall, upon issuance, be duly authorized, validly
issued, fully paid and nonassessable, and free of any liens and encumbrances
except for restrictions on transfer provided for herein or under applicable
federal and state securities laws.
3.2 Notice of Certain Events. If the Company proposes at any time
(a) to declare any dividend or distribution upon its common stock, whether in
cash, property, stock, or other securities and whether or not a regular cash
dividend; (b) to offer for subscription pro rata to the holders of any class or
series of its stock any additional shares of stock of any class or series or
other rights; (c) to effect any reclassification or recapitalization of common
stock; (d) to merge or consolidate with or into any other corporation, or sell,
lease, license, or convey all or substantially all of its assets, or to
liquidate, dissolve or wind up; or (e) offer holders of registration rights the
opportunity to participate in an underwritten public offering of the company's
securities for cash, then, in connection with each such event, the Company shall
give Holder (1) at least 10 days prior written notice of the date on which a
record will be taken for such dividend, distribution, or subscription rights
(and specifying the date on which the holders of common stock will be entitled
thereto) or for determining rights to vote, if any, in respect of the matters
referred to in (c) and (d) above; (2) in the case of the matters referred to in
(c) and (d) above at least 10 days prior written notice of the date when the
same will take place (and specifying the date on which the holders of
3
<PAGE> 4
common stock will be entitled to exchange their common stock for securities or
other property deliverable upon the occurrence of such event); and (3) in the
case of the matter referred to in (e) above, the same notice as is given to the
holders of such registration rights.
3.3 Information Rights. So long as the Holder holds this Warrant
and/or any of the Shares, the Company shall deliver to the Holder promptly upon
Holder's reasonable request, copies of all notices or other written
communications to the shareholders of the Company, the annual audited financial
statements of the Company certified by independent public accountants of
recognized standing and the Company's quarterly, unaudited financial statements.
3.4 Registration Under Securities Act of 1933, as amended. The
Company agrees that the Shares or, if the Shares are convertible into common
stock of the Company, such common stock, shall be subject to the registration
rights set forth on Exhibit B, if attached.
ARTICLE 4. REPRESENTATIONS, WARRANTIES OF THE HOLDER. The Holder hereby
represents and warrants to the Company as follows:
4.1 Purchase for Own Account. Except for transfers to Holder's
affiliates, this Warrant and the securities to be acquired upon exercise of this
Warrant by the Holder hereunder will be acquired for investment for the Holder's
own account, not as a nominee or agent, and not with a view to the public resale
or distribution thereof within the meaning of the 1933 Act, and the Holder has
no present intention of selling, granting any participation in, or otherwise
distributing the same. If not an individual, the Holder also represents that the
Holder has not been formed for the specific purpose of acquiring this Warrant or
the Shares.
4.2 Disclosure of Information. The Holder has received or has had
full access to all the information it considers necessary or appropriate to make
an informed investment decision with respect to the acquisition of this Warrant
and its underlying securities. The Holder further has had an opportunity to ask
questions and receive answers from, the Company regarding the terms and
conditions of the offering of this Warrant and its underlying securities and to
obtain additional information (to the extent the Company possessed such
information or could acquire it without unreasonable effort or expense)
necessary to verify any information furnished to the Holder or to which the
Holder has access.
4.3 Investment Experience. The Holder understands that the
purchase of this Warrant and its underlying securities involves substantial
risk. The Holder: (i) has experience as an investor in securities of companies
in the development stage and acknowledges that the Holder is able to fend for
itself, can bear the economic risk of such Holder's investment in this Warrant
and its underlying securities and has such knowledge and experience in financial
or business matters that the Holder is capable of evaluating the merits and
risks of its investment in this Warrant and its underlying securities and/or
(ii) has a preexisting personal or business relationship with the Company and
certain of its officers, directors or controlling persons of a nature and
duration that enables the Holder to be aware of the character, business acumen
and financial circumstances of such persons.
4.4 Accredited Investor Status. The Holder is an "accredited
investor" within the meaning of Regulation D promulgated under the 1933 Act.
4.5 "Market Stand-Off" Agreement. Holder agrees not to sell, make
any short sale of, loan, grant any option for the purchase of, or otherwise
transfer or dispose of any common stock (or other securities) of the Company
held by such Holder during a period of time determined by the Company and its
underwriters (not to exceed 180 days in the event of the Company's initial
public offering and 90 days in the event of any other public offering) following
the effective date of a registration statement of the Company filed under the
Securities act of 1933, as amended, provided that all officers and directors of
the Company who then hold common stock (or other securities) of the Company
enter into similar
4
<PAGE> 5
agreements. Holder further agrees, if so requested by the Company or its
underwriters, to enter into an agreement in a form satisfactory to the Company
and such underwriter. The Company may impose stop-transfer instructions with
respect to the common stock (or securities) subject to the foregoing restriction
until the end of said period.
ARTICLE 5. MISCELLANEOUS.
5.1 Term: Notice of Expiration. This Warrant is exercisable, in
whole or in part, at any time and from time to time on or before the Expiration
Date set forth above.
5.2 Legends. This Warrant and the Shares (and the securities
issuable, directly or indirectly, upon conversion of the Shares, if any) shall
be imprinted with a legend in substantially the following form:
THIS SECURITY HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933,
AS AMENDED, AND MAY NOT BE SOLD, PLEDGED OR OTHERWISE TRANSFERRED
WITHOUT AN EFFECTIVE REGISTRATION THEREOF UNDER SUCH ACT OR PURSUANT TO
RULE 144 OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE
CORPORATION AND ITS COUNSEL THAT SUCH REGISTRATION IS NOT REQUIRED.
5.3 Compliance with Securities Laws on Transfer. This Warrant and
the Shares issuable upon exercise this Warrant (and the securities issuable,
directly or indirectly, upon conversion of the Shares, if any) may not be
transferred or assigned in whole or in part without compliance with applicable
federal and state securities laws by the transferor and the transferee
(including, without limitation, the delivery of investment representation
letters and legal opinions reasonably satisfactory to the Company, as reasonably
requested by the Company). The Company shall not require Holder to provide an
opinion of counsel if the transfer is to an affiliate of Holder or if there is
no material question as to the availability of current information as referenced
in Rule 144(c), Holder represents that it has complied with, Rule 144(d) and (e)
in reasonable detail, the selling broker represents that it has complied with
Rule 144(f), and the Company is provided with a copy of Holder s notice of
proposed sale.
5.4 Transfer Procedure. Subject to the provisions of Section 4.3
Holder may transfer all or part of this Warrant or the Shares issuable upon
exercise of this Warrant (or the securities issuable, directly or indirectly,
upon conversion of the Shares, if any) by giving the Company notice of the
portion of the Warrant being transferred setting forth the name, address and
taxpayer identification number of the transferee and surrendering this Warrant
to the Company for reissuance to the transferee(s) (and Holder if applicable);
provided, however, that Holder may transfer all or part of this Warrant to
Silicon Valley Bancshares and The Silicon Valley Bank Foundation, at any time
without notice to the Company. The terms and conditions of this Warrant shall
inure to the benefit of, and be binding upon, the Company and the holders hereof
and their respective permitted successors and assigns. Unless the Company is
filing financial information with the SEC pursuant to the Securities Exchange
Act of 1934, the Company shall have the right to refuse to transfer any portion
of this Warrant to any party who directly competes with the Company.
5.5 Notices. All notices and other communications from the
Company to the Holder, or vice versa, shall be deemed delivered and effective
when given personally or mailed by first-class registered or certified mail,
postage prepaid, at such address as may have been furnished to the Company or
the Holder, as the case may be, in writing by the Company or the Holder from
time to time.
5.6 Waiver. This Warrant and any term hereof may be changed,
waived, discharged or terminated only by an instrument in writing signed by the
party against which enforcement of such change, waiver, discharge or termination
is sought.
5
<PAGE> 6
5.7 Attorneys' Fees. In the event of any dispute between the
parties concerning the terms and provisions of this Warrant, the party
prevailing in such dispute shall be entitled to collect from the other party all
costs incurred in such dispute, including reasonable attorneys' fees.
5.8 Governing Law. This Warrant shall be governed by and construed
in accordance with the laws of the State of California, without giving effect to
its principles regarding conflicts of law.
"COMPANY"
NEOFORMA, INC.
By: /s/ ROBERT ZOLLARS
---------------------------------------------
Name: Robert Zollars
---------------------------------------------
(Print)
Title: Chairman of the Board, President or
Vice President
By: /s/ FREDRICK RUEGSEGGER
---------------------------------------------
Name: Fredrick Ruegsegger
---------------------------------------------
(Print)
Title: Chief Financial Officer, Secretary,
Assistant Treasurer or Assistant Secretary
6
<PAGE> 7
APPENDIX I
NOTICE OF EXERCISE
1. The undersigned hereby elects; to purchase __________ shares of the
Common/Series __________ Preferred [strike one] Stock of ______________________
________________________ pursuant to the terms of the attached Warrant, and
tenders herewith payment of the purchase price of such shares in full.
1. The undersigned hereby elects to convert the attached Warrant into
Shares/cash [strike one] in the manner specified in the Warrant. This conversion
is exercised with respect to _______________________ of the Shares covered by
the Warrant.
[Strike paragraph that does not apply.]
2. Please issue a certificate or certificates representing said shares
in the name of the undersigned or in such other name as is specified below:
------------------------------------
(Name)
------------------------------------
------------------------------------
(Address)
3. The undersigned represents it is acquiring the shares solely for
its own account and not as nominee for any other party and not with a view
toward the resale or distribution thereof except in compliance with applicable
securities laws.
------------------------------------
(Signature)
- ----------------------
(Date)
7
<PAGE> 1
EXHIBIT 4.07
THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 AS
AMENDED, OR ANY STATE SECURITIES LAWS. THEY MAY NOT BE SOLD, OFFERED FOR SALE,
PLEDGED, OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT
RELATED THERETO OR AN OPINION OF COUNSEL (WHICH MAY BE COMPANY COUNSEL)
REASONABLY SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY APPLICABLE STATE
SECURITIES LAWS.
WARRANT AGREEMENT
TO PURCHASE SHARES OF THE SERIES D PREFERRED STOCK OF
NEOFORMA, INC.
DATED AS OF JULY 7, 1999 (THE "EFFECTIVE DATE")
WHEREAS, Neoforma, Inc., a Delaware corporation (the "Company") has
entered into a Loan and Security Agreement and Master Lease Agreement dated as
of July 7, 1999, Equipment Schedules VL-1 and VL-2 and related Promissory Notes
and Summary Equipment Schedules (collectively, the "Loans and Leases") with
Comdisco, Inc., a Delaware corporation (the "Warrantholder"); and
WHEREAS, the Company desires to grant to Warrantholder, in consideration
for such Loans and Leases, the right to purchase shares of its Series D
Preferred Stock;
NOW THEREFORE, in consideration of the Warrantholder executing and
delivering such Loans and Leases and in consideration of mutual covenants and
agreements contained herein, the Company and Warrantholder agree as follows:
1. GRANT OF THE RIGHT TO PURCHASE PREFERRED STOCK.
The Company hereby grants to the Warrantholder, and the Warrantholder is
entitled, upon the terms and subject to the conditions hereinafter set forth, to
subscribe to and purchase, from the Company, 137,711 fully paid and
non-assessable shares of the Company's Series D Preferred Stock ("Preferred
Stock") at a purchase price of $1.18 per share (the "Exercise Price"). The
number and purchase price of such shares are subject to adjustment as provided
in Section 8 hereof.
2. TERM OF THE WARRANT AGREEMENT.
Except as otherwise provided for herein, the term of this Warrant
Agreement and the right to purchase Preferred Stock as granted herein shall
commence on the Effective Date and shall be exercisable for a period of (i)
seven (7) years or (ii) three (3) years from the effective date of the
Company's initial public offering, whichever is longer.
Notwithstanding the term of this Warrant Agreement as set forth above,
the right to purchase Preferred Stock as granted shall expire, if not
previously exercised, immediately upon the closing of the issuance and sale of
shares of Common Stock of the Company in the Company's first public offering of
securities for its own account pursuant to an effective registration statement
under the Securities Act of 1933, as amended (the "Initial Public Offering"),
provided that the underwriters so request that the Warrantholder exercise at
that time.
The Company shall notify the Warrantholder if the Initial Public Offering is
proposed within a reasonable period of time prior to the filing of a
registration statement and if the Company fails to deliver such written notice
within a reasonable period of time, anything to the contrary in this Warrant
Agreement notwithstanding, the rights to purchase will not expire until ten
(10) business days after the Company delivers such notice to the Warrantholder.
Such notice shall also contain such details of the proposed Initial Public
Offering as are reasonable in the circumstances and notice that this Warrant
Agreement is expected to expire upon closing thereof. If such closing does not
take place, the Company shall promptly notify the Warrantholder that such
proposed transaction has been terminated. Anything to the contrary in this
Warrant Agreement notwithstanding, the Warrantholder may rescind any exercise
of its purchase rights promptly after such notice of termination of the
proposed transaction if the exercise of warrants occurred after the Company
notified the Warrantholder that the Initial Public Offering was proposed or if
the exercise were otherwise precipitated by such
-1-
<PAGE> 2
proposed Initial Public Offering. In the event of such rescission, the Warrants
will continue to be exercisable on the same terms and conditions.
3. EXERCISE OF THE PURCHASE RIGHTS.
The purchase rights set forth in this Warrant Agreement are exercisable by
the Warrantholder, in whole or in part, at any time, or from time to time,
prior to the expiration of the term set forth in Section 2 above, by tendering
to the Company at its principal office a notice of exercise in the form
attached hereto as Exhibit I (the "Notice of Exercise"), duly completed and
executed. Promptly upon receipt of the Notice of Exercise and the payment of
the purchase price in accordance with the terms set forth below, and in no
event later than twenty-one (21) business days thereafter, the Company shall
issue to the Warrantholder a certificate for the number of shares of Preferred
Stock purchased and shall execute the acknowledgment of exercise in the form
attached hereto as Exhibit II (the "Acknowledgment of Exercise") indicating the
number of shares which remain subject to future purchases, if any.
The Exercise Price may be paid at the Warrantholder's election either (i)
by cash or check, or (ii) by surrender of Warrants ("Net Issuance") as
determined below. If the Warrantholder elects the Net Issuance method, the
Company will issue Preferred Stock in accordance with the following formula:
X = Y(A - B)
--------
A
Where: X = the number of shares of Preferred Stock to be issued to the
Warrantholder.
Y = the number of shares of Preferred Stock requested to be
exercised for payment under this Warrant Agreement.
A = the fair market value of one (1) share of Preferred Stock.
B = the Exercise Price.
For purposes of the above calculation, current fair market value of
Preferred Stock shall mean with respect to each share of Preferred Stock:
(i) if the exercise is in connection with an initial public offering
of the Company's Common Stock, and if the Company's Registration Statement
relating to such public offering has been declared effective by the SEC,
then the fair market value per share shall be the product of (x) the
initial "Price to Public" specified in the final prospectus with respect
to the offering and (y) the number of shares of Common Stock into which
each share of Preferred Stock is convertible at the time of such exercise;
(ii) if this Warrant is exercised after, and not in connection with
the Company's initial public offering, and:
(a) if traded on a securities exchange, the fair market value
shall be deemed to be the product of (x) the average of the closing
prices over a five (5) day period ending three days before the day
the current fair market value of the securities is being determined
and (y) the number of shares of Common Stock into which each share of
Preferred stock is convertible at the time of such exercise; or
(b) if actively traded over-the-counter, the fair market value
shall be deemed to be the product of (x) the average of the closing
bid and asked prices quoted on the NASDAQ system (or similar system)
over the five (5) day period ending three days before the day the
current fair market value of the securities is being determined and
(y) the number of shares of Common Stock into which each share of
Preferred Stock is convertible at the time of such exercise;
(iii) if at any time the Common Stock is not listed on any
securities exchange or quoted in the NASDAQ System or the over-the-counter
market, the current fair market value of Preferred Stock shall be the
product of (x) the highest price per share which the Company could obtain
from a willing buyer (not a current employee or director) for shares of
Common Stock sold by the Company, from authorized but unissued shares, as
determined in good faith by its Board of Directors and (y) the number of
shares of Common Stock into which each share of Preferred Stock is
convertible at the time of such exercise, unless the Company shall become
subject to a merger, acquisition or other consolidation pursuant to which
the
-2-
<PAGE> 3
Company is not the surviving party, in which case the fair market value of
Preferred Stock shall be deemed to be the value received by the holders of
the Company's Preferred Stock on a common equivalent basis pursuant to
such merger or acquisition.
Upon partial exercise by either cash or Net Issuance, the Company shall
promptly issue an amended Warrant Agreement representing the remaining number
of shares purchasable hereunder. All other terms and conditions of such amended
Warrant Agreement shall be identical to those contained herein, including, but
not limited to the Effective Date hereof.
4. RESERVATION OF SHARES.
(a) Authorization and Reservation of Shares. During the term of this
Warrant Agreement, the Company will at all times have authorized and reserved a
sufficient number of shares of its Preferred Stock to provide for the exercise
of the rights to purchase Preferred Stock as provided for herein.
(b) Registration or Listing. If any shares of Preferred Stock required to
be reserved hereunder require registration with or approval of any governmental
authority under any Federal or State law (other than any registration under the
Securities Act of 1933, as amended ("1933 Act"), as then in effect, or any
similar Federal statute then enforced, or any state securities law, required by
reason of any transfer involved in such conversion), or listing on any domestic
securities exchange, before such shares may be issued upon conversion, the
Company will, at its expense and as expeditiously as possible, use its best
efforts to cause such shares to be duly registered, listed or approved for
listing on such domestic securities exchange, as the case may be.
5. NO FRACTIONAL SHARES OR SCRIP.
No fractional shares or scrip representing fractional shares shall be
issued upon the exercise of the Warrant, but in lieu of such fractional shares
the Company shall make a cash payment therefor upon the basis of the Exercise
Price then in effect.
6. NO RIGHTS AS STOCKHOLDER.
This Warrant Agreement does not entitle the Warrantholder to any voting
rights or other rights as a stockholder of the Company prior to the exercise of
the Warrant.
7. WARRANTHOLDER REGISTRY.
The Company shall maintain a registry showing the name and address of the
registered holder of this Warrant Agreement.
8. ADJUSTMENT RIGHTS.
The purchase price per share and the number of shares of Preferred Stock
purchasable hereunder are subject to adjustment, as follows:
(a) Merger and Sale of Assets. If any time there shall be a capital
reorganization of the shares of the Company's stock (other than a combination,
reclassification, exchange or subdivision of shares otherwise provided for
herein), or a merger or consolidation of the Company with or into another
corporation whether or not the Company is the surviving corporation, or the
sale of all or substantially all of the Company's properties and assets to any
other person (hereinafter referred to as a "Merger Event"), then, as a part of
such Merger Event, lawful provision shall be made so that the Warrantholder
shall thereafter be entitled to receive, upon exercise of the Warrant, the
number of shares of Preferred Stock or other securities of the successor
corporation resulting from such Merger Event, equivalent in value to that which
would have been issuable if Warrantholder had exercised this Warrant
immediately prior to the Merger Event. In any such case, appropriate adjustment
(as determined in good faith by the Company's Board of Directors) shall be made
in the application of the provisions of this Warrant Agreement with respect to
the rights and interest of the Warrantholder after the Merger Event to the end
that the provisions of this Warrant Agreement (including adjustments of the
Exercise Price and number of shares of Preferred Stock purchasable) shall be
applicable to the greatest extent possible.
(b) Reclassification of Shares. If the Company at any time shall, by
combination, reclassification, exchange or subdivision of securities or
otherwise, change any of the securities as to which purchase rights under this
Warrant Agreement exist into the same or a different number of securities of
any other class or classes, this Warrant Agreement shall thereafter represent
the right to acquire such number and kind of securities as would have
-3-
<PAGE> 4
been issuable as the result of such change with respect to the securities which
were subject to the purchase rights under this Warrant Agreement immediately
prior to such combination, reclassification, exchange, subdivision or other
change.
(c) Subdivision or Combination of Shares. If the Company at any time
shall combine or subdivide its Preferred Stock, the Exercise Price shall be
proportionately decreased in the case of a subdivision, or proportionately
increased in the case of a combination.
(d) Stock Dividends. If the Company at any time shall pay a dividend
payable in, or make any other distribution (except any distribution specifically
provided for in the foregoing subsections (a) or (b)) of the Company's stock,
then the Exercise Price shall be adjusted, from and after the record date of
such dividend or distribution, to that price determined by multiplying the
Exercise Price in effect immediately prior to such record date by a fraction (i)
the numerator of which shall be the total number of all shares of the Company's
stock deemed outstanding pursuant to its Certificate of Incorporation in effect
immediately prior to such issuance immediately prior to such dividend or
distribution, and (ii) the denominator of which shall be the total number of all
shares of the Company's stock deemed outstanding immediately after such dividend
or distribution. The Warrantholder shall thereafter be entitled to purchase, at
the Exercise Price resulting from such adjustment, the number of shares of
Preferred Stock (calculated to the nearest whole share with one half being
rounded down) obtained by multiplying the Exercise Price in effect immediately
prior to such adjustment by the number of shares of Preferred Stock issuable
upon the exercise hereof immediately prior to such adjustment and dividing the
product thereof by the Exercise Price resulting from such adjustment.
(e) Right of Purchase Additional Stock. If, the Warrantholder's total cost
of equipment pursuant to the Loans and Leases exceeds $2,500,000, Warrantholder
shall have the right to purchase from the Company, at the Exercise Price
(adjusted as set forth herein), an additional number of shares, which number
shall be determined by (i) multiplying the amount by which the Warrantholder's
total equipment cost exceeds $2,500,000 by 6.5%, and (ii) dividing the product
thereof by the Exercise Price per share referenced above.
(f) Antidilution Rights. Additional antidilution rights applicable to the
Preferred Stock purchasable hereunder are as set forth in the Company's
Certificate of Incorporation, as amended through the Effective Date, a true and
complete copy of which is attached hereto as Exhibit (the "Charter"). The
Company shall promptly provide the Warrantholder with any restatement,
amendment, modification or waiver of the Charter. The Company shall provide
Warrantholder with prior written notice of any issuance of its stock or other
equity to occur after the Effective Date of this Warrant, which notice shall
include (a) the price at which such stock or security is to be sold, (b) the
number of shares to be issued, and (c) such other information as necessary for
Warrantholder to determine if a dilutive event has occurred.
(g) Notice of Adjustments. If: (i) the Company shall declare any dividend
or distribution upon its stock, whether in cash, property, stock or other
securities; (ii) the Company shall offer for subscription prorata to the
holders of any class of its Preferred or other convertible stock any additional
shares of stock of any class or other rights; (iii) there shall be any Merger
Event; (iv) there shall be an initial public offering; or (v) there shall be
any voluntary dissolution, liquidation or winding up of the Company; then, in
connection with each such event, the Company shall send to the Warrantholder:
(A) at least twenty (20) days' prior written notice of the date on which the
books of the Company shall close or a record shall be taken for such dividend,
distribution, subscription rights (specifying the date on which the holders of
Preferred Stock shall be entitled thereto) or for determining rights to vote in
respect of such Merger Event, dissolution, liquidation or winding up; (B) in
the case of any such Merger Event, dissolution, liquidation or winding up, at
least twenty (20) days' prior written notice of the date when the same shall
take place (and specifying the date on which the holders of Preferred Stock
shall be entitled to exchange their Preferred Stock for securities or other
property deliverable upon such Merger Event, dissolution, liquidation or
winding up); and (C) in the case of a public offering, the Company shall give
the Warrantholder at least twenty (20) days written notice prior to the
effective date thereof.
Each such written notice shall set forth, in reasonable detail, (i) the
event requiring the adjustment, (ii) the amount of the adjustment, (iii) the
method by which such adjustment was calculated, (iv) the Exercise Price, and
(v) the number of shares subject to purchase hereunder after giving effect to
such adjustment, and shall be given by first class mail, postage prepaid,
addressed to the Warrantholder, at the address as shown on the books of the
Company.
(h) Timely Notice. Failure to timely provide such notice required by
subsection (g) above shall entitle Warrantholder to retain the benefit of the
applicable notice period notwithstanding anything to the contrary contained in
any insufficient notice received by Warrantholder. The notice period shall
begin on the date Warrantholder actually receives a written notice containing
all the information specified above.
-4-
<PAGE> 5
9. REPRESENTATIONS, WARRANTIES AND COVENANTS OF THE COMPANY.
(a) Reservation of Preferred Stock. The Preferred Stock issuable upon
exercise of the Warrantholder's rights has been duly and validly reserved and,
when issued in accordance with the provisions of this Warrant Agreement, will
be validly issued, fully paid and non-assessable, and will be free of any
taxes, liens, charges or encumbrances of any nature whatsoever, provided,
however, that the Preferred Stock issuable pursuant to this Warrant Agreement
may be subject to restrictions on transfer under state and/or Federal securities
laws. The Company has made available to the Warrantholder true, correct and
complete copies of its Charter and Bylaws, as amended. The issuance of
certificates for shares of Preferred Stock upon exercise of the Warrant
Agreement shall be made without charge to the Warrantholder for any issuance
tax in respect thereof, or other cost incurred by the Company in connection with
such exercise and the related issuance of shares of Preferred Stock. The
Company shall not be required to pay any tax which may be payable in respect to
any transfer involved and the issuance and delivery of any certificate in a
name other than that of the Warrantholder.
(b) Due Authority. The execution and delivery by the Company of this
Warrant Agreement and the performance of all obligations of the Company
hereunder, including the issuance to Warrantholder of the right to acquire the
shares of Preferred Stock, have been duly authorized by all necessary corporate
action on the part of the Company, and the Loans and Leases and this Warrant
Agreement are not inconsistent with the Company's Charter or Bylaws, do not
contravene any law or governmental rule, regulation or order applicable to it,
do not and will not contravene any provision of, or constitute a default under,
any indenture, mortgage, contract or other instrument to which it is a party or
by which it is bound, and the Loans and Leases and this Warrant Agreement
constitute legal, valid and binding agreements to the Company, enforceable in
accordance with their respective terms.
(c) Consents and Approvals. No consent or approval of, giving of notice
to, registration with, or taking of any other action in respect of any state,
Federal or other governmental authority or agency is required with respect to
the execution, delivery and performance by the Company of its obligations under
this Warrant Agreement, except for the filing of notices pursuant to Regulation
D under the 1933 Act and any filing required by applicable state securities
law, which filings will be effective by the time required thereby.
(d) Issued Securities. All issued and outstanding shares of Common
Stock, Preferred Stock or any other securities of the Company have been duly
authorized and validly issued and are fully paid and nonassessable. All
outstanding shares of Common Stock, Preferred Stock and any other securities
were issued in full compliance with all Federal and state securities laws. In
addition:
(i) The authorized capital of the Company consists of (A)
75,000,000 shares of Common Stock, of which 1,216,000 shares are issued and
outstanding, and (B) 9,000,000 shares of Series A Preferred Stock, of which
9,000,000 shares are issued and outstanding and are convertible into
9,000,000 shares of Common Stock; (C) 2,860,000 shares of Series B
Preferred Stock, of which 2,860,000 shares are issued and outstanding and
are convertible into 2,860,000 shares of Common Stock; (D) 5,109,937 shares
of Series C Preferred Stock, of which 5,064,937 shares are issued and
outstanding and are convertible into 5,064,937 shares of Common Stock; (D)
10,455,085 shares of Series D Preferred Stock, of which 10,198,361 shares
are issued and outstanding and are convertible into 10,198,361 shares of
Common Stock.
(ii) The Company has reserved (A) 14,656,078 shares of Common stock
for issuance under its 1997 Stock Option Plan (B) one warrant to purchase
45,000 shares of Series C Preferred Stock and (c) one warrant to purchase
228,813 shares of Series D Preferred Stock. There are no other options,
warrants, conversion privileges or other rights presently outstanding to
purchase or otherwise acquire any authorized but unissued shares of the
Company's capital stock or other securities of the Company.
(iii) In accordance with the Company's Certificate of Incorporation,
no stockholder of the Company has preemptive rights to purchase new
issuance of the Company's capital stock.
(e) Insurance. The Company has in full force and effect insurance
policies, with extended coverage, insuring the Company and its property and
business against such losses and risks, and in such amounts, as are customary
for corporations engaged in a similar business and similarly situated and as
otherwise may be required pursuant to the terms of any other contract or
agreement.
(f) Other Commitments to Register Securities. Except as set forth in the
Investors Rights Agreement the Company is not, pursuant to the terms of any
other agreement currently in existence, under any obligation to
-5-
<PAGE> 6
register under the 1933 Act any of its presently outstanding securities or any
of its securities which may hereafter be issued.
(g) Exempt Transaction. Subject to the accuracy of the Warrantholder's
representations in Section 10 hereof, the issuance of the Preferred Stock upon
exercise of this Warrant will constitute a transaction exempt from (i) the
registration requirements of Section 5 of the 1933 Act, in reliance upon
Section 4(2) thereof, and (ii) the qualification requirements of the applicable
state securities laws.
(h) Compliance with Rule 144. At the written request of the
Warrantholder, who proposed to sell Preferred Stock issuable upon the exercise
of the Warrant in compliance with Rule 144 promulgated by the Securities and
Exchange Commission, the Company shall furnish to the Warrantholder, within ten
days after receipt of such request, a written statement confirming the
Company's compliance with the filing requirements of the Securities and
Exchange Commission as set forth in such Rule, as such Rule may be amended from
time to time.
10. REPRESENTATIONS AND COVENANTS OF THE WARRANTHOLDER.
This Warrant Agreement has been entered into by the Company in reliance
upon the following representations and covenants of the Warrantholder:
(a) Investment Purpose. The right to acquire Preferred Stock or the
Preferred Stock issuable upon exercise of the Warrantholder's rights contained
herein will be acquired for investment and not with a view to the sale or
distribution of any part thereof, and the Warrantholder has no present
intention of selling or engaging in any public distribution of the same except
pursuant to a registration or exemption.
(b) Private Issue. The Warrantholder understands (i) that the Preferred
Stock issuable upon exercise of this Warrant is not registered under the 1933
Act or qualified under applicable state securities laws on the ground that the
issuance contemplated by this Warrant Agreement will be exempt from the
registration and qualifications requirements thereof, and (ii) that the
Company's reliance on such exemption is predicated on the representations set
forth in this Section 10.
(c) Disposition of Warrantholder's Rights. In no event will the
Warrantholder make a disposition of any of its rights to acquire Preferred Stock
or Preferred Stock issuable upon exercise of such rights unless and until (i) it
shall have notified the Company of the proposed disposition, and (ii) if
requested by the Company, ti shall have furnished the Company with an opinion of
counsel (which counsel may either be inside or outside counsel to the
Warrantholder) satisfactory to the Company and its counsel to the effect that
(A) appropriate action necessary for compliance with the 1933 Act has been
taken, or (B) an exemption from the registration requirements of the 1933 Act is
available. Notwithstanding the foregoing, the restrictions imposed upon the
transferability of any of its rights to acquire Preferred Stock or Preferred
Stock issuable on the exercise of such rights do not apply to transfers from the
beneficial owner of any of the aforementioned securities to its nominee or from
such nominee to its beneficial owner, and shall terminate as to any particular
share of Preferred Stock when (1) such security shall have been effectively
registered under the 1933 Act and sold by the holder thereof in accordance with
such registration or (2) such security shall have been sold without registration
in compliance with Rule 144 under the 1933 Act, or (3) a letter shall have been
issued to the Warrantholder at its request by the staff of the Securities and
Exchange Commission or a ruling shall have been issued to the Warrantholder at
its request by such Commission stating that no action shall be recommended by
such staff or taken by such Commission, as the case may be, if such security is
transferred without registration under the 1933 Act in accordance with the
conditions set forth in such letter or ruling and such letter or ruling
specifies that no subsequent restrictions on transfer are required. Whenever the
restrictions imposed hereunder shall terminate, as hereinabove provided, the
Warrantholder or holder of a share of Preferred Stock then outstanding as to
which such restrictions have terminated shall be entitled to receive from the
Company, without expense to such holder, one or more new certificates for the
Warrant or for such shares of Preferred Stock not bearing any restrictive
legend.
(d) Financial Risk. The Warrantholder has such knowledge and experience
in financial and business matters as to be capable of evaluating the merits and
risks of its investment, and has the ability to bear the economic risks of its
investment.
(e) Risk of No Registration. The Warrantholder understands that if the
Company does not register with the Securities and Exchange Commission pursuant
to Section 12 of the 1934 Act (the "1934 Act"), or file reports pursuant to
Section 15(d), of the 1934 Act, or if a registration statement covering the
securities under the 1933 Act is not in effect when it desires to sell (i) the
rights to purchase Preferred Stock pursuant to this Warrant Agreement, or (ii)
the Preferred Stock issuable under exercise of the right to purchase, it may be
required to hold such securities for an indefinite period. The Warrantholder
also understands that any sale of its rights of the Warrantholder to purchase
-6-
<PAGE> 7
Preferred Stock or Preferred Stock which might be made by it in reliance upon
Rule 144 under the 1933 Act may be made only in accordance with the terms and
conditions of that Rule.
(f) Accredited Investor. Warrantholder is an "accredited investor"
within the meaning of the Securities and Exchange Rule 501 of Regulation D, as
presently in effect.
11. TRANSFERS.
Subject to the terms and conditions contained in Section 10 hereof, this
Warrant Agreement and all rights hereunder are transferable in whole or in part
by the Warrantholder and any successor transferee, provided, however, in no
event shall the number of transfers of the rights and interests in all of the
Warrants exceed three (3) transfers. The transfers shall be recorded on the
books of the Company upon receipt by the Company of a notice of transfer in the
form attached hereto as Exhibit III (the "Transfer Notice"), at its principal
offices and the payment to the Company of all transfer taxes and other
governmental charges imposed on such transfer.
12. LOCKUP.
Warrantholder agrees in connection with the Company's Initial Public
Offering (1) not to sell, make short of, loan, grant any options for the
purchase of, or otherwise dispose of any shares of Common Stock of the Company
held by Holder (other than those shares included in the registration) without
the prior written consent of the Company or the underwriters managing such
Initial Public Offering of the Company's securities for one hundred eighty
(180) days from the effective date of such registration, and (2) Warrantholder
further agrees to execute any agreement reflecting (1) above as may be
requested by the underwriters at the time of the public offering.
13. MISCELLANEOUS.
(a) Effective Date. The provisions of this Warrant Agreement shall be
construed and shall be given effect in all respects as if it had been executed
and delivered by the Company on the date hereof. This Warrant Agreement shall
be binding upon any successors or assigns of the Company.
(b) Attorney's Fees. In any litigation, arbitration or court proceeding
between the Company and the Warrantholder relating hereto, the prevailing party
shall be entitled to attorneys' fees and expenses and all costs of proceedings
incurred in enforcing this Warrant Agreement.
(c) Governing Law. This Warrant Agreement shall be governed by and
construed for all purposes under and in accordance with the laws of the State
of Illinois.
(d) Counterparts. This Warrant Agreement may be executed in two or more
counterparts, each of which shall be deemed an original, but all of which
together shall constitute one and the same instrument.
(e) Notices. Any notice required or permitted hereunder shall be given
in writing and shall be deemed effectively given upon personal delivery,
facsimile transmission (provided that the original is sent by personal delivery
or mail as hereinafter set forth) or seven (7) days after deposit in the United
States mail, by registered or certified mail, addressed (i) to the
Warrantholder at 6111 North River Road, Rosemont, Illinois 60018, attention:
Venture Lease Administration, cc: Legal Department, attn.: General Counsel,
(and/or, if by facsimile, (847) 518-5465 and (847) 518-5088 and (ii) to the
Company at 3255 Scott Blvd., Bldg. 6, Santa Clara, CA 95050, Attention: Chief
Financial Officer (and/or if by facsimile, (408) 549-6299) or at such other
address as any such party may subsequently designate by written notice to the
other party.
(f) Remedies. In the event of any default hereunder, the non-defaulting
party may proceed to protect and enforce its rights either by suit in equity
and/or by action at law, including but not limited to an action for damages as
a result of any such default, and/or an action for specific performance for any
default where Warrantholder will not have an adequate remedy at law and where
damages will not be readily ascertainable. The Company expressly agrees that
it shall not oppose an application by the Warrantholder or any other person
entitled to the benefit of this Agreement requiring specific performance of any
or all provisions hereof or enjoining the Company from continuing to commit any
such breach of this Agreement.
(g) No Impairment of Rights. The Company will not, by amendment of its
Charter or through any other means, avoid or seek to avoid the observance or
performance of any of the terms of this Warrant, but will at all times
-7-
<PAGE> 8
in good faith assist in the carrying out of all such terms and in the taking of
all such actions as may be necessary or appropriate in order to protect the
rights of the Warrantholder against impairment.
(h) Survival. The representations, warranties, covenants and conditions of
the respective parties contained herein or made pursuant to this Warrant
Agreement shall survive the execution and delivery of this Warrant Agreement.
(i) Severability. In the event any one or more of the provisions of this
Warrant Agreement shall for any reason be held invalid, illegal or
unenforceable, the remaining provisions of this Warrant Agreement shall be
unimpaired, and the invalid, illegal or unenforceable provision shall be
replaced by a mutually acceptable valid, legal and enforceable provision, which
comes closest to the intention of the parties underlying the invalid, illegal
or unenforceable provision.
(j) Amendments. Any provision of this Warrant Agreement may be amended by
a written instrument signed by the Company and by the Warrantholder.
(k) Additional Documents. The Company, upon execution of this Warrant
Agreement, shall provide the Warrantholder with certified resolutions with
respect to the representations, warranties and covenants set forth in
subparagraphs (a) through (d), (f) and (g) of Section 9 above. If the purchase
price for the Loans and Leases referenced in the preamble of this Warrant
Agreement exceeds $1,000,000, the Company will also provide Warrantholder with
an opinion from the Company's counsel with respect to those same
representations, warranties and covenants. The Company shall also supply such
other documents as the Warrantholder may from time to time reasonably request.
IN WITNESS WHEREOF, the parties hereto have caused this Warrant Agreement
to be executed by its officers thereunto duly authorized as of the Effective
Date.
COMPANY: NEOFORMA, INC.
By: /s/ ROBERT ZOLLARS
------------------------------------
Title: CEO
---------------------------------
WARRANTHOLDER: COMDISCO, INC.
By: /s/ JAMES LABE
------------------------------------
Title: James Labe, President
Comdisco Ventures Division
---------------------------------
-8-
<PAGE> 9
EXHIBIT I TO
EXHIBIT 4.07
EXHIBIT I
NOTICE OF EXERCISE
TO: __________________
(1) The undersigned Warrantholder hereby elects to purchase ______ shares of
the Series __ Preferred Stock of ______________, pursuant to the terms of
the Warrant Agreement dated the ____________ day of _____________, 19__
(the "Warrant Agreement") between _______________________________ and the
Warrantholder, and tenders herewith payment of the purchase price for
such shares in full, together with all applicable transfer taxes, if any.
(2) In exercising its rights to purchase the Series __ Preferred Stock of
_____________________, the undersigned hereby confirms and acknowledges
the investment representations and warranties made in Section 10 of the
Warrant Agreement.
(3) Please issue a certificate or certificates representing said shares of
Series __ Preferred Stock in the name of the undersigned or in such other
name as specified below.
______________________________
(Name)
______________________________
(Address)
WARRANTHOLDER; COMDISCO, INC.
By: _______________________
Title: _______________________
Date: ________________________
-9-
<PAGE> 10
EXHIBIT II TO
EXHIBIT 4.07
EXHIBIT II
ACKNOWLEDGMENT OF EXERCISE
The undersigned ______________________ hereby acknowledge receipt of the
"Notice of Exercise" from Comdisco, Inc., to purchase _______ shares of the
Series __ Preferred Stock of _____________, pursuant to the terms of the Warrant
Agreement, and further acknowledges that _______ shares remain subject to
purchase under the terms of the Warrant Agreement.
Company:
By: _____________________________
Title: __________________________
Date: ___________________________
-10-
<PAGE> 11
EXHIBIT III TO
EXHIBIT 4.07
EXHIBIT III
TRANSFER NOTICE
(TO TRANSFER OR ASSIGN THE FOREGOING WARRANT AGREEMENT EXECUTE THIS FORM AND
SUPPLY REQUIRED INFORMATION. DO NOT USE THIS FORM TO PURCHASE SHARES.)
FOR VALUE RECEIVED, the foregoing Warrant Agreement and all rights
evidenced thereby are hereby transferred and assigned to
______________________________________________________
(Please Print)
whose address is ______________________________________
_______________________________________________________
Dated: ____________________________________
Holder's Signature: _______________________
Holder's Address: _________________________
___________________________________________
Signature Guaranteed: _________________________________
NOTE: The signature to this Transfer Notice must correspond with the name as it
appears on the face of the Warrant Agreement, without alteration or
enlargement or any change whatever. Officers of corporations and those
acting in a fiduciary or other representative capacity should file proper
evidence of authority to assign the foregoing Warrant Agreement.
-11-
<PAGE> 12
EXHIBIT TO
EXHIBIT 4.07
AMENDED AND RESTATED CERTIFICATE OF
INCORPORATION OF NEOFORMA, INC.
Neoforma, Inc., a corporation organized and existing under the laws of
the State of Delaware, hereby certifies as follows:
A. The name of the corporation is Neoforma, Inc. The original
Certificate of Incorporation was filed with the Secretary of State of Delaware
on August 18, 1998.
B. Pursuant to Section 228, 242, and 245 of the General Corporation Law
of the State of Delaware, this Amended and Restated Certificate of Incorporation
restates and integrates and further amends the Certificate of Incorporation of
this corporation.
C. The text of the Certificate of Incorporation is hereby amended and
restated in its entirety to read as follows:
ONE The name of this corporation is Neoforma, Inc.
TWO The address of the corporation's registered office in the State of
Delaware is Corporation Trust Center, 1209 Orange Street, in the City of
Wilmington, County of New Castle, Zip Code 19801. The name of its registered
agent at such address is The Corporation Trust Company.
THREE The purpose of the corporation is to engage in any lawful act or
activity for which a corporation may be organized under the General Corporation
Law of Delaware.
FOUR This corporation is authorized to issue two classes of stock to be
designated, respectively, "Common Stock" and "Preferred Stock." The total number
of shares which the corporation is authorized to issue is 67,425,022 shares.
40,000,000 shares shall be Common Stock with a par value of $.001. 27,425,022
shares shall be Preferred Stock with a par value of $.001, 9,000,000 of which
shall be designated as Series A Preferred Stock, 2,860,000 of which shall be
designated as Series B Preferred Stock, 5,109,937 of which shall be designated
as Series C Preferred Stock and 10,455,085 of which shall be designated as
Series D Preferred Stock.
FIVE The rights, preferences, privileges and restrictions granted to or
imposed upon the Common Stock and Preferred Stock are as follows:
1. Dividend Provisions. The holders of shares of Preferred Stock shall
be entitled to receive dividends, out of any assets legally available therefor,
prior and in preference to any declaration or payment of any dividend (payable
other than in Common Stock or other securities and
12
<PAGE> 13
rights convertible into or entitling the holder thereof to receive, directly or
indirectly, additional shares of Common Stock of this corporation) on the Common
Stock of this corporation, at the rate of $.02 per share per annum for the
Series A Preferred Stock, $.04 per share per annum for the Series B Preferred
Stock, $.062 per share per annum for the Series C Preferred Stock and $.0944 per
share per annum for the Series D Preferred Stock, or, if greater (as determined
on a per annum basis and on an as converted basis for the Preferred Stock), an
amount equal to that paid on any other outstanding shares of this corporation,
except that the shares of a given series of Preferred Stock shall not receive
any greater dividend as a result of the corporation's payment of a dividend on
any such series of Preferred Stock. Such dividends shall be payable when, as and
if declared by the Board of Directors, and shall not be cumulative, and no right
shall accrue to holders of Common Stock or Preferred Stock by reason of the fact
that dividends on said shares are not declared in any prior period.
2. Liquidation Preference.
(a) Preferred Preference. In the event of any liquidation,
dissolution or winding up of this corporation, either voluntary or involuntary,
the holders of the Series A Preferred Stock, Series B Preferred Stock, Series C
Preferred Stock and Series D Preferred Stock shall be entitled to receive, prior
and in preference to any distribution of any of the assets of this corporation
to the holders of Common Stock by reason of their ownership thereof, an amount
per share equal to $.25, $.50, $.77, and $1.18, respectively, for each
outstanding share of such Preferred Stock held, plus an amount equal to any
declared but unpaid dividends on such share of Preferred Stock up to the date
fixed for distribution. If upon the occurrence of such event, the assets and
funds thus distributed among the holders of the Preferred Stock shall be
insufficient to permit the payment to such holders of the full aforesaid
preferential amounts, then, the entire assets and funds of this corporation
legally available for distribution shall be distributed ratably among the
holders of the Preferred Stock in accordance with the aggregate preference
payment to which they are entitled.
(b) After the payment or setting aside of payment set forth in (a)
above, the remaining assets of the corporation shall be distributed on a
pro-rata basis to the holders of the Preferred Stock, on an as converted basis,
and the holders of the Common Stock until the holders of the Series A Preferred
Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred
Stock have received an additional $.25, $.50, $.77 and $1.18 per share,
respectively.
After the distributions to the stockholders pursuant to Sections 2(a) and
(b) above have been made, the remaining assets of the corporation available for
distribution to stockholders shall be distributed pro-rata among the holders of
Common Stock.
(c) Mergers. A merger, reorganization, or sale of all or
substantially all of the assets of this corporation, or other transactions or
series of related transactions in which the stockholders of this corporation
immediately prior to the transaction or series of related transactions possess
less than 50% of the voting power of the surviving entity (or its parent)
immediately after the transaction (a "Change of Control") shall be deemed to be
a liquidation, dissolution or winding up within the meaning of this Section 2;
provided that the holders of Preferred Stock and Common
13
<PAGE> 14
Stock shall be paid in cash or in securities received or in a combination
thereof (which combination shall be in the same proportions as the consideration
received in the transaction). Any securities to be delivered to the holders of
the Preferred Stock and Common Stock upon merger, reorganization, sale of
substantially all the assets of the corporation, or transaction or related
series of transactions resulting in a Change of Control shall be valued as
follows:
(i) if traded on a securities exchange or the Nasdaq
National Market, the value shall be deemed to be the average of the closing sale
prices of the securities on such exchange over the 30-day period ending three
(3) business days prior to the closing;
(ii) if actively traded over-the-counter, the value shall be
deemed to be the average of the closing bid prices (or closing sales prices,
whichever is applicable) over the 30-day period ending three (3) business days
prior to the closing; and
(iii) if there is no active public market, the value shall
be the fair market value thereof as determined in good faith by the board of
directors of the corporation, but if challenged by the holders of more than 50%
of the outstanding shares of Preferred Stock, then as determined by an
independent appraiser selected by the board of directors of the corporation, the
cost of such appraisal to be borne by the challenging parties.
3. Conversion. The holders of the Preferred Stock shall have conversion
rights as follows (the "Conversion Rights"):
(a) Right to Convert. Each share of Preferred Stock shall be
convertible into share(s) of Common Stock without the payment of any additional
consideration by the holder thereof and, at the option of the holder thereof, at
any time after the date of issuance of such share, at the office of the
corporation or any transfer agent for the Preferred Stock. Each share of
Preferred Stock shall be convertible into the number of fully paid and
nonassessable shares of Common Stock which results from dividing the Conversion
Price (as hereinafter defined) per share in effect for the Preferred Stock at
the time of conversion into the per share Conversion Value (as hereinafter
defined) of such series. The initial Conversion Price per share of the Series A
Preferred Stock shall be $.25; and the Conversion Value per share of the Series
A Preferred Stock shall be $.25; the initial Conversion Price per share of the
Series B Preferred Stock shall be $.50; and the Conversion Value per share of
the Series B Preferred Stock shall be $.50; the initial Conversion Price per
share of the Series C Preferred Stock shall be $.77; the Conversion Value per
share of the Series C Preferred Stock shall be $.77; the initial Conversion
Price per share of the Series D Preferred Stock shall be $1.18; and the
Conversion Value per share of the Series D Preferred Stock shall be $1.18. The
initial Conversion Price of the Preferred Stock shall be subject to adjustment
from time to time as provided below. The number of shares of Common Stock into
which a share of Preferred Stock is convertible is hereinafter referred to as
the "Conversion Rate" of such series.
(b) Automatic Conversion. Each share of Preferred Stock shall
automatically be converted into shares of Common Stock at its then effective
Conversion Rate immediately prior to
14
<PAGE> 15
the closing of an initial public offering pursuant to an effective registration
statement under the Securities Act of 1933, as amended, covering the offer and
sale of Common Stock in which (a) the public offering price equals or exceeds
$4.72 per share (adjusted to reflect subsequent stock dividends, stock splits or
recapitalization) and (b) the aggregate proceeds raised equals or exceeds
$20,000,000.
(c) Mechanics of Conversion. Before any holder of Preferred Stock
shall be entitled to convert the same into shares of Common Stock, such holder
shall surrender the certificate or certificates therefor, duly endorsed, at the
office of the corporation or of any transfer agent for the Preferred Stock and
shall give written notice to the corporation at such office that such holder
elects to convert the same (except that no such written notice of election to
convert shall be necessary in the event of an automatic conversion pursuant to
Section 3(b) hereof). The corporation shall, as soon as practicable thereafter,
issue and deliver at such office to such holder of Preferred Stock a certificate
or certificates for the number of shares of Common Stock to which such holder
shall be entitled as aforesaid. Such conversion shall be deemed to have been
made immediately prior to the close of business on the date of such surrender of
the shares of Preferred Stock to be converted (except that in the case of an
automatic conversion pursuant to Section 3(b) hereof such conversion shall be
deemed to have been made immediately prior to the closing of the offering
referred to in Section 3(b)) and the person or persons entitled to receive the
shares of Common Stock issuable upon such conversion shall be treated for all
purposes as the record holder or holders of such shares of Common Stock on such
date.
(d) Fractional Shares. In lieu of any fractional shares to which
the holder of Preferred Stock would otherwise be entitled, the corporation shall
pay cash equal to such fraction multiplied by the fair market value of one share
of such series of Preferred Stock as determined by the board of directors of the
corporation. Whether or not fractional shares are issuable upon such conversion
shall be determined on the basis of the total number of shares of Preferred
Stock of each holder to be converted at such time into Common Stock and the
number of shares of Common Stock issuable upon such aggregate conversion.
(e) Adjustment of Conversion Price. The Conversion Price of each
series of Preferred Stock shall be subject to adjustment from time to time as
follows:
(i) If the corporation shall issue, after the date on which
any shares of Series D Preferred Stock were first issued, any Common Stock other
than "Excluded Stock," as defined below, for a consideration per share less than
the Conversion Price for a series of Preferred Stock in effect immediately prior
to the issuance of such Common Stock (excluding stock dividends, subdivisions,
split-ups, combinations, dividends or recapitalizations which are covered by
Section 3(e)(iii), (iv), (v) and (vi)), the Conversion Price for such series in
effect immediately after each such issuance shall forthwith (except as provided
in this Section 3(e)) be adjusted to a price equal to the quotient obtained by
dividing:
(A) an amount equal to the sum of
15
<PAGE> 16
(x) the total number of shares of Common Stock
outstanding (including any shares of Common Stock issuable upon conversion of
the Preferred Stock, or deemed to have been issued pursuant to subdivision
(B)(3) of this clause (i) and to clause (ii) below) immediately prior to such
issuance multiplied by the Conversion Price in effect immediately prior to such
issuance, plus
(y) the consideration received by the
corporation upon such issuance, by
(B) the total number of shares of Common Stock
outstanding (including any shares of Common Stock issuable upon conversion of
the Preferred Stock or deemed to have been issued pursuant to subdivision (B)(3)
of this clause (i) and to clause (ii) below) immediately prior to such issuance
plus the additional shares of Common Stock issued in such issuance (but not
including any additional shares of Common Stock deemed to be issued as a result
of any adjustment in the Conversion Price resulting from such issuance).
For purposes of any adjustment of the Conversion Price
pursuant to this clause (i), the following provisions shall be applicable:
(1) In the case of the issuance of Common Stock
for cash, the consideration shall be deemed to be the amount of cash paid
therefor after deducting any discounts or commissions paid or incurred by the
corporation in connection with the issuance and sale thereof.
(2) In the case of the issuance of Common Stock
for a consideration in whole or in part other than cash, the consideration other
than cash shall be deemed to be the fair market value thereof as determined by
the board of directors of the corporation, in accordance with generally accepted
accounting treatment; provided, however, that if, at the time of such
determination, the corporation's Common Stock is traded in the over-the-counter
market or on a national or regional securities exchange, such fair market value
as determined by the board of directors of the corporation shall not exceed the
aggregate "Current Market Price" (as defined below) of the shares of Common
Stock being issued.
(3) In the case of the issuance of (i) options
to purchase or rights to subscribe for Common Stock (other than Excluded Stock),
(ii) securities by their terms convertible into or exchangeable for Common
Stock (other than Excluded Stock), or (iii) options to purchase or rights to
subscribe for such convertible or exchangeable securities:
(A) the aggregate maximum number of
shares of Common Stock deliverable upon exercise of such options to purchase or
rights to subscribe for Common Stock shall be deemed to have been issued at the
time such options or rights were issued and for a consideration equal to the
consideration (determined in the manner provided in
16
<PAGE> 17
subdivisions (1) and (2) above), if any, received by the corporation upon the
issuance of such options or rights plus the minimum purchase price provided in
such options or rights for the Common Stock covered thereby;
(B) the aggregate maximum number of
shares of Common Stock deliverable upon conversion of or in exchange for any
such convertible or exchangeable securities or upon the exercise of options to
purchase or rights to subscribe for such convertible or exchangeable securities
and subsequent conversion or exchange thereof, shall be deemed to have been
issued at the time such securities were issued or such options or rights were
issued and for a consideration equal to the consideration received by the
corporation for any such securities and related options or rights (excluding any
cash received on account of accrued interest or accrued dividends), plus the
minimum additional consideration, if any, to be received by the corporation upon
the conversion or exchange of such securities or the exercise of any related
options or rights (the consideration in each case to be determined in the manner
provided in subdivisions (1) and (2) above);
(C) on any change in the number of shares
of Common Stock deliverable upon exercise of any such options or rights or
conversion of or exchange for such convertible or exchangeable securities, or on
any change in the minimum purchase price of such options, rights or securities,
other than a change resulting from the antidilution provisions of such options,
rights or securities, the Conversion Price shall forthwith be readjusted to such
Conversion Price as would have obtained had the adjustment made upon (x) the
issuance of such options, rights or securities not exercised, converted or
exchanged prior to such change, as the case may be, been made upon the basis of
such change or (y) the options or rights related to such securities not
converted or exchanged prior to such change, as the case may be, been made upon
the basis of such change; and
(D) on the expiration of any such options
or rights, the termination of any such rights to convert or exchange or the
expiration of any options or rights related to such convertible or exchangeable
securities, the Conversion Price shall forthwith be readjusted to such
Conversion Price as would have obtained had the adjustment made upon the
issuance of such options, rights, convertible or exchangeable securities or
options or rights related to such convertible or exchangeable securities, as the
case may be, been made upon the basis of the issuance of only the number of
shares of Common Stock actually issued upon the exercise of such options or
rights, upon the conversion or exchange of such convertible or exchangeable
securities or upon the exercise of the options or rights related to such
convertible or exchangeable securities, as the case may be.
(ii) "Excluded Stock" shall mean:
(1) all shares of Common Stock issued and outstanding
on the date this document is filed with the Delaware Secretary of State;
17
<PAGE> 18
(2) all shares of Preferred Stock issued and
outstanding on the date this document is filed with the Delaware Secretary of
State and the Common Stock into which such shares of Preferred Stock are
convertible;
(3) all shares of Common Stock, warrants or options to
purchase Common Stock or other securities issued to officers, directors,
consultants or employees of the corporation pursuant to any plan or arrangement
approved by the board of directors of the corporation; and
(4) all shares of Common Stock, warrants or options to
purchase Common Stock or other securities issued to lending or leasing
institutions pursuant to any plan or arrangement approved by the board of
directors of the corporation.
All outstanding shares of Excluded Stock (including
any shares issuable upon conversion of the Preferred Stock) shall be deemed to
be outstanding for all purposes of the computations of Section 3(e)(i) above.
(iii) If the number of shares of Common Stock outstanding at
any time after the date hereof is increased by a stock dividend payable in
shares of Common Stock or by a subdivision or split-up of shares of Common
Stock, then, on the date such payment is made or such change is effective, the
Conversion Price of each series of Preferred Stock shall be appropriately
decreased so that the number of shares of Common Stock issuable on conversion of
any shares of such series of Preferred Stock shall be increased in proportion to
such increase of outstanding shares.
(iv) If the number of shares of Common Stock outstanding at
any time after the date hereof is decreased by a combination of the outstanding
shares of Common Stock, then, on the effective date of such combination, the
Conversion Price of each series of Preferred Stock shall be appropriately
increased so that the number of shares of Common Stock issuable on conversion of
any shares of a series of Preferred Stock shall be decreased in proportion to
such decrease in outstanding shares.
(v) In case the corporation shall declare a cash dividend
upon its Common Stock payable otherwise than out of retained earnings or shall
distribute to holders of its Common Stock shares of its capital stock (other
than Common Stock), stock or other securities of other persons, evidences of
indebtedness issued by the corporation or other persons, assets (excluding cash
dividends) or options or rights (excluding options to purchase and rights to
subscribe for Common Stock or other securities of the corporation convertible
into or exchangeable for Common Stock), then, in each such case, the holders of
shares of Preferred Stock shall, concurrent with the distribution to holders of
Common Stock, receive a like distribution based upon the number of shares of
Common Stock into which such shares of Preferred Stock are convertible.
(vi) In case, at any time after the date hereof, of any
capital reorganization, or any reclassification of the stock of the corporation
(other than as a result of a stock dividend or
18
<PAGE> 19
subdivision, split-up or combination of shares), or the consolidation or merger
of the corporation with or into another person (other than a consolidation or
merger in which the corporation is the continuing entity and which does not
result in any change in the Common Stock), or of the sale or other disposition
of all or substantially all the properties and assets of the corporation, the
shares of Preferred Stock shall, after such reorganization, reclassification,
consolidation, merger, sale or other disposition, be convertible into the kind
and number of shares of stock or other securities or property of the corporation
or otherwise to which such holder would have been entitled if immediately prior
to such reorganization, reclassification, consolidation, merger, sale or other
disposition he had converted his shares of Preferred Stock into Common Stock.
The provisions of this clause (vi) shall similarly apply to successive
reorganizations, reclassifications, consolidations, mergers, sales or other
dispositions.
(vii) All calculations under this Section 3 shall be made to
the nearest cent or to the nearest one hundredth (1/100) of a share, as the case
may be.
(viii) For the purpose of any computation pursuant to this
Section 3(e), the "Current Market Price" at any date of one share of Common
Stock, shall be deemed to be the average of the highest reported bid and the
lowest reported offer prices on the preceding business day as furnished by the
National Quotation Bureau, Incorporated (or equivalent recognized source of
quotations); provided, however, that if the Common Stock is not traded in such
manner that the quotations referred to in this clause (viii) are available for
the period required hereunder, Current Market Price shall be determined in good
faith by the board of directors of the corporation, but if challenged by the
holders of more than 50% of the outstanding shares of Preferred Stock, then as
determined by an independent appraiser selected by the board of directors of the
corporation, the cost of such appraisal to be borne by the challenging parties.
(f) Minimal Adjustments. No adjustment in the Conversion Price need
be made if such adjustment would result in a change in the Conversion Price of
less than $0.01. Any adjustment of less than $0.01 which is not made shall be
carried forward and shall be made at the time of and together with any
subsequent adjustment which, on a cumulative basis, amounts to an adjustment of
$0.01 or more in the Conversion Price.
(g) No Impairment. Without the consent of the majority of the
outstanding shares of Preferred Stock, the corporation will not through any
reorganization, recapitalization, transfer of assets, consolidation, merger,
dissolution, issue or sale of securities or any other voluntary action, avoid or
seek to avoid the observance or performance of any of the terms to be observed
or performed hereunder by the corporation, but will at all times in good faith
assist in the carrying out of all the provisions of this Section 3 and in the
taking of all such action as may be necessary or appropriate in order to protect
the Conversion Rights of the holders of Preferred Stock against impairment.
(h) Certificate as to Adjustments. Upon the occurrence of each
adjustment or readjustment of the Conversion Rate pursuant to this Section 3,
the corporation at its expense shall
19
<PAGE> 20
promptly compute such adjustment or readjustment in accordance with the terms
hereof and prepare and furnish to each holder of Preferred Stock a certificate
setting forth such adjustment or readjustment and showing in detail the facts
upon which such adjustment or readjustment is based. The corporation shall, upon
written request at any time of any holder of Preferred Stock, furnish or cause
to be furnished to such holder a like certificate setting forth (i) such
adjustments and readjustments, (ii) the Conversion Rate of such series at the
time in effect, and (iii) the number of shares of Common Stock and the amount,
if any, of other property which at the time would be received upon the
conversions of such holder's shares of Preferred Stock.
(i) Notices of Record Date. In the event of any taking by the
corporation of a record of the holders of any class of securities for the
purpose of determining the holders thereof who are entitled to receive any
dividend (other than a cash dividend) or other distribution, any right to
subscribe for, purchase or otherwise acquire any shares of stock of any class or
any other securities or property or to receive any other right, the corporation
shall mail to each holder of Preferred Stock at least ten (10) days prior to
such record date, a notice specifying the date on which any such record is to be
taken for the purpose of such dividend or distribution or right, and the amount
and character of such dividend, distribution or right.
(j) Reservation of Stock Issuable Upon Conversion. The corporation
shall at all times reserve and keep available out of its authorized but unissued
shares of Common Stock solely for the purpose of effecting the conversion of the
shares of Preferred Stock such number of its shares of Common Stock as shall
from time to time be sufficient to effect the conversion of all outstanding
shares of Preferred Stock; and if at any time the number of authorized but
unissued shares of Common Stock shall not be sufficient to effect the conversion
of all then outstanding shares of Preferred Stock, the corporation will take
such corporate action as may, in the opinion of its counsel, be necessary to
increase its authorized but unissued shares of Common Stock to such number of
shares as shall be sufficient for such purpose.
(k) Notices. Any notice required by the provisions of this Section
3 to be given to the holder of shares of Preferred Stock shall be deemed given
if deposited in the United States mail, postage prepaid, and addressed to each
holder of record at his address appearing on the books of the corporation.
(l) Reissuance of Converted Shares. No shares of Preferred Stock
which have been converted into Common Stock after the original issuance thereof
shall ever again be reissued and all such shares so converted shall upon such
conversion cease to be a part of the authorized shares of the corporation.
4. Voting Rights.
(a) Preferred Stock. The holder of each share of Preferred Stock
shall be entitled to the number of votes equal to the number of shares of Common
Stock into which each share of Preferred Stock could be converted on the record
date for the vote or consent of shareholders written
20
<PAGE> 21
consent and, except as otherwise required by law, shall have voting rights and
powers equal to the voting rights and powers of the Common Stock. The holder of
each share of Preferred Stock shall be entitled to notice of any shareholders'
meeting in accordance with the bylaws of the corporation and shall vote with
holders of the Common Stock upon the election of directors and upon any other
matter submitted to a vote of shareholders, except those matters required by law
to be submitted to a class vote. Fractional votes shall not, however, be
permitted and any fractional voting rights resulting from the above formula
(after aggregating all shares of Common Stock into which shares of Preferred
Stock held by each holder could be converted) shall be rounded to the nearest
whole number (with one-half rounded upward to one).
(b) Common Stock. Each holder of shares of Common Stock shall be
entitled to one vote for each share held.
(c) Board of Directors. The Board of Directors of the corporation
shall consist of six (6) members. The holders of the Series D Preferred Stock,
voting as a separate series, shall be entitled to elect one (1) director of the
corporation. The holders of the Series C Preferred Stock, voting as a separate
series, shall be entitled to elect one (1) director of the corporation. The
holders of the Series A Preferred Stock, voting as a separate series, shall be
entitled to elect one (1) director of the corporation. The holders of the Common
Stock, voting together as a separate class, shall be entitled to elect one (1)
director of the corporation. All remaining directors of the corporation shall be
elected by the holders of the Common Stock and Preferred Stock voting together
as a single class in accordance with the provision set forth in Section 4(a)
above. Vacancies on the board of directors may be filled by a majority of the
remaining directors originally elected by the same series, class or classes of
shares who could elect an individual to fill such vacancy on the board of
directors, though less than a quorum, except that a vacancy created by the
removal of a director or directors by the vote or written consent of the
shareholders, such shareholders being those who hold a majority of the
outstanding shares of the series, class or classes entitled to elect such
director or directors, or by court order may be filled by only the vote of a
majority of the outstanding shares entitled to vote thereon. The shareholders
entitled to vote thereon may elect a director or directors at any time to fill
any vacancy or vacancies not filled by the directors. This Section 4(c) shall
not apply unless 1,000,000 shares of the Series C Preferred Stock and 1,500,000
shares of the Series D Preferred Stock (as adjusted for stock splits, stock
dividends, recapitalizations and the like) are outstanding.
5. Redemption Rights of the Series C and Series D Preferred Stock.
(a) Redemption on Demand. Subject to applicable law, at any time
following the seventh anniversary of the closing of the purchase and sale of
Series D Preferred Stock and upon the affirmative vote of the holders of the
majority of the Series C Preferred Stock and Series D Preferred Stock, voting
together as a single class on an as converted basis, the corporation shall
redeem, in accordance with this Section 5, all shares of Series C Preferred
Stock and Series D Preferred Stock outstanding as of the date of such demand,
which date shall hereinafter be referred to as the "Redemption Date."
21
<PAGE> 22
(b) Redemption Price. The Redemption Price for Series C Preferred
Stock shall be $.77 per share (appropriately adjusted for stock splits, stock
dividends, recapitalizations and similar events). The Redemption Price for the
Series D Preferred Stock shall be $1.18 per share (appropriately adjusted for
stock splits, stock dividends, recapitalizations and similar events).
(c) Redemption Procedure. Beginning with the first year anniversary
of the Redemption Date, the corporation shall be required to redeem annually no
more than that number of shares of Series C Preferred Stock and Series D
Preferred Stock equal to twenty-five (25) percent of the shares of Series C
Preferred Stock and Series D Preferred Stock outstanding as of the Redemption
Date. Annually thereafter, each holder of Series C Preferred Stock and Series D
Preferred Stock shall surrender to the corporation for redemption no more than
that number of shares equal to twenty-five (25) percent of the shares held by
such holder on the Redemption Date (with one-half being rounded upwards). At
least 20 days prior to the yearly anniversary of the Redemption Date, written
notice (the "Redemption Notice") shall be mailed first class, postage prepaid,
to each holder of record (at the close of business on the business day next
preceding the day on which notice is given) of the Series C Preferred Stock and
Series D Preferred Stock, at the address last shown on the records of the
corporation for such holder or given by the holder to the corporation for the
purpose of notice or if no such address appears or is given, at the place where
the principal executive office of the corporation is located, notifying such
holder of the redemption to be effected, specifying the amount to be redeemed by
such holder, the Redemption Date, the Redemption Price, the place at which
payment may be obtained and the date on which such holder's right to convert
Series C Preferred Stock or Series D Preferred Stock into Common Stock, as to
such shares, terminates and calling upon such holder to surrender to the
corporation, in the manner and at the place designated, its certificate or
certificates representing the shares to be redeemed. Except as provided in
paragraph 5(d), on or after the Redemption Date, each holder of Series C
Preferred Stock or Series D Preferred Stock to be redeemed shall surrender to
the corporation the certificate or certificates representing such shares, in the
manner and at the place designated in the Redemption Notice, and thereupon, the
aggregate Redemption Price of such shares shall be payable in cash to the order
of the person whose name appears on such certificate or certificates as the
owner thereof and each surrendered certificate shall be canceled.
(d) Effect of Redemption. From and after the Redemption Date,
unless there shall have been a default in payment of the Redemption Price, all
rights of the holders of such shares designated for redemption (as holders of
the Series C Preferred Stock or Series D Preferred Stock, as the case may be,
except the right to receive their respective Redemption Price without interest
upon surrender of their certificate of certificates) shall cease with respect to
such shares, and such shares shall not thereafter be transferred on the books of
the corporation or be deemed to be outstanding for any purpose whatsoever. If
the funds of the corporation legally available for redemption of shares of the
Series C Preferred Stock and Series D Preferred Stock on any Redemption Date are
insufficient to redeem the total number of shares of the Series C Preferred
Stock and Series D Preferred Stock to be redeemed on such date, those funds
which are legally available will be used to redeem the maximum possible number
of such shares on a pro rata basis
22
<PAGE> 23
among the holders of the Series C Preferred Stock and Series D Preferred Stock
based upon each holder's share of the total redemption price. The shares of
Series C Preferred Stock and Series D Preferred Stock not redeemed shall remain
outstanding and be entitled to all the rights and preferences provided herein.
At any time thereafter when additional funds of the corporation are legally
available for the redemption of shares of Series C Preferred Stock and Series D
Preferred Stock, such finds will immediately be set aside for the redemption of
the balance of the shares which the corporation was obligated to redeem on any
Redemption Date but which it has not redeemed; provided that the holders of such
Series C Preferred Stock and Series D Preferred Stock shall receive at least 10
days notice of such redemption.
(e) Redemption Funding. On or prior to the Redemption Date, the
corporation shall deposit the Redemption Price of all shares of Series C
Preferred Stock and Series D Preferred Stock designated for redemption in the
Redemption Notice, with a bank or trust company located in the State of
California having aggregate capital and surplus in excess of $50,000,000 as a
trust fund for the benefit of the respective holders of the shares designated
for redemption and not yet redeemed. Simultaneously, the corporation shall
deposit irrevocable instructions and authority to such bank or trust company to
pay, on and after the date fixed for redemption or prior thereto, the Redemption
Price of the Series C Preferred Stock and Series D Preferred Stock to the
holders thereof, respectively, upon surrender of their certificates. Any money
or notes deposited by the corporation pursuant to this paragraph 5(e) for the
redemption of shares which are thereafter converted into shares of Common Stock
pursuant to paragraph 5(c) hereof no later than the close of business on the
last business day prior to the Redemption Date shall be returned to the
corporation forthwith upon such conversion. The balance of any money or notes
deposited by the corporation pursuant to this subsection remaining unclaimed at
the expiration of six months following the Redemption Date shall thereafter be
returned to the corporation, provided that the shareholder to which such money
would be payable hereunder shall be entitled, upon proof of its ownership of the
Preferred Stock and payment of any bond requested by the corporation, to receive
such monies but without interest from the Redemption Date.
6. Protective Provisions. In addition to any other class vote that may be
required by law, so long as at least 4,000,000 shares of Preferred Stock are
outstanding, this corporation shall not without first obtaining the approval (by
vote or written consent, as provided by law) of the holders of at least a
two-thirds of the then outstanding shares of Preferred Stock (voting as a class
on an as converted basis) undertake any of the following:
(i) effect a Change of Control in the corporation or sell all or
substantially all of its assets,
(ii) change the rights, preferences or privileges of any series of
Preferred Stock,
(iii) increase or decrease the authorized shares of Preferred Stock
or the designated shares of any series of Preferred Stock,
23
<PAGE> 24
(iv) create a new series or class of shares having rights on a
parity with or superior to any outstanding class or series of
shares,
(v) except as set forth in this certificate, do any act which would
result in taxation under Section 305 of the Internal Revenue Code,
(vi) divide the securities of any class into series having
different rights,
(vii) effect an exchange, reclassification or cancellation of all
or any part of a class of securities, including a reverse stock
split,
(viii) effect an exchange or create a right of exchange of all or
part of the shares of a class,
(ix) dissolve, liquidate or windup the corporation,
(x) declare or pay any dividends on the Common Stock,
(xi) increase the number of members of the corporation's Board of
Directors to more than six (6) members, or
(xii) redeem or repurchase any shares of Series A or Series B
Preferred Stock.
7. Residual Rights. All rights accruing to the outstanding shares of
capital stock not expressly provided for to the contrary herein shall be vested
in the Common Stock.
SIX The following is applicable to the Common Stock:
1. Dividend Rights. Subject to the prior rights of holders of all classes
of stock at the time outstanding having prior rights as to dividends, the
holders of the Common Stock shall be entitled to receive, when and as declared
by the Board of Directors, out of any assets of the corporation legally
available therefor, such dividends as may be declared from time to time by the
Board of Directors.
2. Liquidation Rights. Upon the liquidation, dissolution or winding up of
the corporation, the assets of the corporation shall be distributed as provided
in Section 2 of Article Five hereof.
3. Redemption. The Common Stock is not redeemable.
4. Voting Rights. The holder of each share of Common Stock shall have the
right to one vote, and shall be entitled to notice of any stockholders' meeting
in accordance with the Bylaws
24
<PAGE> 25
of the corporation, and shall be entitled to vote upon such matters and in such
manner as may be provided by law.
SEVEN The corporation is to have perpetual existence.
EIGHT In furtherance and not in limitation of the powers conferred by
statute, the Board of Directors is expressly authorized to make, alter, amend or
repeal the Bylaws of the Corporation.
NINE The election of directors need not be by written ballot unless the
Bylaws of the corporation shall so provide.
TEN To the fullest extent permitted by the Delaware General Corporation
Law as the same exists or as may hereafter be amended, a director of the
corporation shall not be personally liable to the corporation or its
stockholders for monetary damages for breach of fiduciary duty as a director.
The corporation shall indemnify to the fullest extent permitted by the law, any
person made or threatened to be made a party, to any action or proceeding,
whether criminal, civil, administrative or investigative, by reason of the fact
the he or she, or his or her testator or intestate, is or was a director or
officer of the corporation or any predecessor of the corporation, or serves or
served at any other enterprise as a director or officer at the request of the
corporation or any predecessor to the corporation. Neither any amendment nor
repeal of this Article, nor the adoption of any provision of this Certificate of
Incorporation inconsistent with this Article, shall eliminate or reduce the
effect of this Article in respect of any matter occurring, or any cause of
action, suit or claim accruing or arising or that, but for this Article, would
accrue or arise, prior to such amendment, repeal or adoption of an inconsistent
provision.
ELEVEN The corporation reserves the right to amend, alter, change or
repeal any provision contained in this Certificate of Incorporation, in the
manner now or hereafter prescribed by statute, and all rights conferred upon
stockholders herein are granted subject to this reservation.
25
<PAGE> 26
IN WITNESS WHEREOF, the corporation has caused this Amended and Restated
Certificate to be signed by its Chief Executive Officer and attested by its
Secretary, this 18th day of February, 1999.
/s/ JEFFREY KLECK, Chief Executive Officer
/s/ J. CASEY MCGLYNN, Secretary
26
<PAGE> 1
EXHIBIT 10.01
INDEMNITY AGREEMENT
This Indemnity Agreement (this "AGREEMENT"), is entered into as of
_________, ____ by and between Neoforma.com, Inc., a Delaware corporation
(the "COMPANY"), and [the undersigned] [INSERT NAME], a director and/or officer
of the Company (the "INDEMNITEE").
RECITALS
A. The Company is aware that competent and experienced persons are
increasingly reluctant to serve as directors or officers of corporations unless
they are protected by comprehensive liability insurance and/or indemnification,
due to increased exposure to litigation costs and risks resulting from their
service to such corporations, and due to the fact that the exposure frequently
bears no reasonable relationship to the compensation of such directors and
officers;
B. Based upon their experience as business managers, the Board of
Directors of the Company (the "BOARD") has concluded that, to retain and attract
talented and experienced individuals to serve as officers and directors of the
Company, and to encourage such individuals to take the business risks necessary
for the success of the Company, it is necessary for the Company contractually to
indemnify officers and directors and to assume for itself maximum liability for
expenses and damages in connection with claims against such officers and
directors in connection with their service to the Company;
C. Section 145 of the General Corporation Law of Delaware, under which
the Company is organized (the "LAW"), empowers the Company to indemnify by
agreement its officers, directors, employees and agents, and persons who serve,
at the request of the Company, as directors, officers, employees or agents of
other corporations or enterprises, and expressly provides that the
indemnification provided by the Law is not exclusive; and
D. The Company desires and has requested the Indemnitee to serve or
continue to serve as a director or officer of the Company free from undue
concern for claims for damages arising out of or related to such services to the
Company.
NOW, THEREFORE, the parties hereto, intending to be legally bound,
hereby agree as follows:
1. DEFINITIONS.
1.1 Agent. For the purposes of this Agreement, "AGENT" of the
Company means any person who is or was a director or officer of the Company or a
subsidiary of the Company; or is or was serving at the request of, for the
convenience of, or to represent the interest of the Company or a subsidiary of
the Company as a director or officer of another foreign or domestic corporation,
partnership, joint venture, trust or other enterprise or an affiliate of the
Company;
1
<PAGE> 2
or was a director or officer of another enterprise or affiliate of the Company
at the request of, for the convenience of, or to represent the interests of such
predecessor corporation. The term "ENTERPRISE" includes any employee benefit
plan of the Company, its subsidiaries, affiliates and predecessor corporations.
1.2 Expenses. For purposes of this Agreement, "EXPENSES" includes
all direct and indirect costs of any type or nature whatsoever (including,
without limitation, all attorneys' fees and related disbursements and other
out-of-pocket costs) actually and reasonably incurred by the Indemnitee in
connection with the investigation, defense or appeal of a proceeding or
establishing or enforcing a right to indemnification or advancement of expenses
under this Agreement, Section 145 or otherwise; provided, however, that expenses
shall not include any judgments, fines, ERISA excise taxes or penalties or
amounts paid in settlement of a proceeding.
1.3 Proceeding. For the purposes of this Agreement, "PROCEEDING"
means any threatened, pending or completed action, suit or other proceeding,
whether civil, criminal, administrative, investigative or any other type
whatsoever.
1.4 Subsidiary. For purposes of this Agreement, "SUBSIDIARY"
means any corporation of which more than fifty percent (50%) of the outstanding
voting securities is owned directly or indirectly by the Company, by the Company
and one or more of its subsidiaries or by one or more of the Company's
subsidiaries.
2. AGREEMENT TO SERVE. The Indemnitee agrees to serve and/or continue to
serve as an agent of the Company, at the will of the Company (or under separate
agreement, if such agreement exists), in the capacity the Indemnitee currently
serves as an agent of the Company, faithfully and to the best of his ability, so
long as he is duly appointed or elected and qualified in accordance with the
applicable provisions of the charter documents of the Company or any subsidiary
of the Company; provided, however, that the Indemnitee may at any time and for
any reason resign from such position (subject to any contractual obligation that
the Indemnitee may have assumed apart from this Agreement), and the Company or
any subsidiary shall have no obligation under this Agreement to continue the
Indemnitee in any such position.
3. DIRECTORS' AND OFFICERS' INSURANCE. The Company shall, to the extent
that the Board determines it to be economically reasonable, maintain a policy of
directors' and officers' liability insurance ("D&O INSURANCE"), on such terms
and conditions as may be approved by the Board.
4. MANDATORY INDEMNIFICATION. Subject to Section 9 below, the Company
shall indemnify the Indemnitee:
4.1 Third Party Actions. If the Indemnitee is a person who was or
is a party or is threatened to be made a party to any proceeding (other than an
action by or in the right of the Company) by reason of the fact that he is or
was an agent of the Company, or by reason of anything done or not done by him in
any such capacity, against any and all expenses and
2
<PAGE> 3
liabilities of any type whatsoever (including, but not limited to, judgments,
fines, ERISA excise taxes or penalties and amounts paid in settlement) actually
and reasonably incurred by him in connection with the investigation, defense,
settlement or appeal of such proceeding if he acted in good faith and in a
manner he reasonably believed to be in, or not opposed to, the best interests of
the Company and, with respect to any criminal action or proceeding, had no
reasonable cause to believe his conduct was unlawful; and
4.2 Derivative Actions. If the Indemnitee is a person who was or
is a party or is threatened to be made a party to any proceeding by or in the
right of the Company to procure a judgment in its favor by reason of the fact
that he is or was an agent of the Company, or by reason of anything done or not
done by him in any such capacity, against any amounts paid in settlement of any
such proceeding and all expenses actually and reasonably incurred by him in
connection with the investigation, defense, settlement or appeal of such
proceeding if he acted in good faith and in a manner he reasonably believed to
be in, or not opposed to, the best interests of the Company; except that no
indemnification under this subsection shall be made in respect of any claim,
issue or matter as to which such person shall have been finally adjudged to be
liable to the Company by a court of competent jurisdiction due to willful
misconduct of a culpable nature in the performance of his duty to the Company,
unless and only to the extent that the Court of Chancery or the court in which
such proceeding was brought shall determine upon application that, despite the
adjudication of liability but in view of all the circumstances of the case, such
person is fairly and reasonably entitled to indemnity for such amounts which the
Court of Chancery or such other court shall deem proper; and
4.3 Exception for Amounts Covered by Insurance. Notwithstanding
the foregoing, the Company shall not be obligated to indemnify the Indemnitee
for expenses or liabilities of any type whatsoever (including, but not limited
to, judgments, fines, ERISA excise taxes or penalties and amounts paid in
settlement) to the extent such have been paid directly to the Indemnitee by D&O
Insurance.
5. PARTIAL INDEMNIFICATION AND CONTRIBUTION.
5.1 Partial Indemnification. If the Indemnitee is entitled under
any provision of this Agreement to indemnification by the Company for some or a
portion of any expenses or liabilities of any type whatsoever (including, but
not limited to, judgments, fines, ERISA excise taxes or penalties and amounts
paid in settlement) incurred by him in the investigation, defense, settlement or
appeal of a proceeding but is not entitled, however, to indemnification for all
of the total amount thereof, then the Company shall nevertheless indemnify the
Indemnitee for such total amount except as to the portion thereof to which the
Indemnitee is not entitled to indemnification.
5.2 Contribution. If the Indemnitee is not entitled to the
indemnification provided in Section 4 for any reason other than the statutory
limitations set forth in the Law, then in respect of any threatened, pending or
completed proceeding in which the Company is jointly liable with the Indemnitee
(or would be if joined in such proceeding), the Company shall
3
<PAGE> 4
contribute to the amount of expenses (including attorneys' fees), judgments,
fines and amounts paid in settlement actually and reasonably incurred and paid
or payable by the Indemnitee in such proportion as is appropriate to reflect (i)
the relative benefits received by the Company on the one hand and the Indemnitee
on the other hand from the transaction from which such proceeding arose and (ii)
the relative fault of the Company on the one hand and of the Indemnitee on the
other hand in connection with the events which resulted in such expenses,
judgments, fines or settlement amounts, as well as any other relevant equitable
considerations. The relative fault of the Company on the one hand and of the
Indemnitee on the other hand shall be determined by reference to, among other
things, the parties' relative intent, knowledge, access to information and
opportunity to correct or prevent the circumstances resulting in such expenses,
judgments, fines or settlement amounts. The Company agrees that it would not be
just and equitable if contribution pursuant to this Section 5 were determined by
pro rata allocation or any other method of allocation which does not take
account of the foregoing equitable considerations.
6. MANDATORY ADVANCEMENT OF EXPENSES.
6.1 Advancement. Subject to Section 9 below, the Company shall
advance all expenses incurred by the Indemnitee in connection with the
investigation, defense, settlement or appeal of any proceeding to which the
Indemnitee is a party or is threatened to be made a party by reason of the fact
that the Indemnitee is or was an agent of the Company or by reason of anything
done or not done by him in any such capacity. The Indemnitee hereby undertakes
to promptly repay such amounts advanced only if, and to the extent that, it
shall ultimately be determined that the Indemnitee is not entitled to be
indemnified by the Company under the provisions of this Agreement, the
Certificate of Incorporation or Bylaws of the Company, the Law or otherwise. The
advances to be made hereunder shall be paid by the Company to the Indemnitee
within thirty (30) days following delivery of a written request therefor by the
Indemnitee to the Company.
6.2 Exception. Notwithstanding the foregoing provisions of this
Section 6, the Company shall not be obligated to advance any expenses to the
Indemnitee arising from a lawsuit filed directly by the Company against the
Indemnitee if an absolute majority of the members of the Board reasonably
determines in good faith, within thirty (30) days of the Indemnitee's request to
be advanced expenses, that the facts known to them at the time such
determination is made demonstrate clearly and convincingly that the Indemnitee
acted in bad faith. If such a determination is made, the Indemnitee may have
such decision reviewed by another forum, in the manner set forth in Sections
8.3, 8.4 and 8.5 hereof, with all references therein to "indemnification" being
deemed to refer to "advancement of expenses," and the burden of proof shall be
on the Company to demonstrate clearly and convincingly that, based on the facts
known at the time, the Indemnitee acted in bad faith. The Company may not avail
itself of this Section 6.2 as to a given lawsuit if, at any time after the
occurrence of the activities or omissions that are the primary focus of the
lawsuit, the Company has undergone a change in control. For this purpose, a
change in control shall mean a given person or group of affiliated persons or
groups increasing their beneficial ownership interest in the Company by at least
twenty (20) percentage points without advance Board approval.
4
<PAGE> 5
7. NOTICE AND OTHER INDEMNIFICATION PROCEDURES.
7.1 Promptly after receipt by the Indemnitee of notice of the
commencement of or the threat of commencement of any proceeding, the Indemnitee
shall, if the Indemnitee believes that indemnification with respect thereto may
be sought from the Company under this Agreement, notify the Company of the
commencement or threat of commencement thereof.
7.2 If, at the time of the receipt of a notice of the
commencement of a proceeding pursuant to Section 7.1 hereof, the Company has D&O
Insurance in effect, the Company shall give prompt notice of the commencement of
such proceeding to the insurers in accordance with the procedures set forth in
the respective policies. The Company shall thereafter take all necessary or
desirable action to cause such insurers to pay, on behalf of the Indemnitee, all
amounts payable as a result of such proceeding in accordance with the terms of
such D&O Insurance policies.
7.3 In the event the Company shall be obligated to advance the
expenses for any proceeding against the Indemnitee, the Company, if appropriate,
shall be entitled to assume the defense of such proceeding, with counsel
approved by the Indemnitee (which approval shall not be unreasonably withheld),
upon the delivery to the Indemnitee of written notice of its election to do so.
After delivery of such notice, approval of such counsel by the Indemnitee and
the retention of such counsel by the Company, the Company will not be liable to
the Indemnitee under this Agreement for any fees of counsel subsequently
incurred by the Indemnitee with respect to the same proceeding, provided that:
(a) the Indemnitee shall have the right to employ his own counsel in any such
proceeding at the Indemnitee's expense; (b) the Indemnitee shall have the right
to employ his own counsel in connection with any such proceeding, at the expense
of the Company, if such counsel serves in a review, observer, advice and
counseling capacity and does not otherwise materially control or participate in
the defense of such proceeding; and (c) if (i) the employment of counsel by the
Indemnitee has been previously authorized by the Company, (ii) the Indemnitee
shall have reasonably concluded that there may be a conflict of interest between
the Company and the Indemnitee in the conduct of any such defense or (iii) the
Company shall not, in fact, have employed counsel to assume the defense of such
proceeding, then the fees and expenses of the Indemnitee's counsel shall be at
the expense of the Company.
8. DETERMINATION OF RIGHT TO INDEMNIFICATION.
8.1 To the extent the Indemnitee has been successful on the
merits or otherwise in defense of any proceeding referred to in Section 4.1 or
4.2 of this Agreement or in the defense of any claim, issue or matter described
therein, the Company shall indemnify the Indemnitee against expenses actually
and reasonably incurred by him in connection with the investigation, defense or
appeal of such proceeding, or such claim, issue or matter, as the case may be.
8.2 In the event that Section 8.1 is inapplicable, or does not
apply to the entire proceeding, the Company shall nonetheless indemnify the
Indemnitee unless the Company shall prove by clear and convincing evidence to a
forum listed in Section 8.3 below that the
5
<PAGE> 6
Indemnitee has not met the applicable standard of conduct required to entitle
the Indemnitee to such indemnification.
8.3 The Indemnitee shall be entitled to select the forum in which
the validity of the Company's claim under Section 8.2 hereof that the Indemnitee
is not entitled to indemnification will be heard from among the following,
except that the Indemnitee can select a forum consisting of the stockholders of
the Company only with the approval of the Company:
(a) A quorum of the Board consisting of directors who are
not parties to the proceeding for which indemnification is being sought;
(b) The stockholders of the Company;
(c) Legal counsel mutually agreed upon by the Indemnitee
and the Board, which counsel shall make such determination in a written opinion;
(d) A panel of three arbitrators, one of whom is selected
by the Company, another of whom is selected by the Indemnitee and the last of
whom is selected by the first two arbitrators so selected; or
(e) The Court of Chancery of Delaware or other court
having jurisdiction of subject matter and the parties.
8.4 As soon as practicable, and in no event later than thirty
(30) days after the forum has been selected pursuant to Section 8.3 above, the
Company shall, at its own expense, submit to the selected forum its claim that
the Indemnitee is not entitled to indemnification, and the Company shall act in
the utmost good faith to assure the Indemnitee a complete opportunity to defend
against such claim.
8.5 If the forum selected in accordance with Section 8.3 hereof
is not a court, then after the final decision of such forum is rendered, the
Company or the Indemnitee shall have the right to apply to the Court of Chancery
of Delaware, the court in which the proceeding giving rise to the Indemnitee's
claim for indemnification is or was pending or any other court of competent
jurisdiction, for the purpose of appealing the decision of such forum, provided
that such right is executed within sixty (60) days after the final decision of
such forum is rendered. If the forum selected in accordance with Section 8.3
hereof is a court, then the rights of the Company or the Indemnitee to appeal
any decision of such court shall be governed by the applicable laws and rules
governing appeals of the decision of such court.
8.6 Notwithstanding any other provision in this Agreement to the
contrary, the Company shall indemnify the Indemnitee against all expenses
incurred by the Indemnitee in connection with any hearing or proceeding under
this Section 8 involving the Indemnitee and against all expenses incurred by the
Indemnitee in connection with any other proceeding between the Company and the
Indemnitee involving the interpretation or enforcement of the rights of the
Indemnitee under this Agreement unless a court of competent jurisdiction finds
that each of the
6
<PAGE> 7
material claims and/or defenses of the Indemnitee in any such proceeding was
frivolous or not made in good faith.
9. EXCEPTIONS. Any other provision herein to the contrary
notwithstanding, the Company shall not be obligated pursuant to the terms of
this Agreement:
9.1 Claims Initiated by Indemnitee. To indemnify or advance
expenses to the Indemnitee with respect to proceedings or claims initiated or
brought voluntarily by the Indemnitee and not by way of defense, except with
respect to proceedings specifically authorized by the Board or brought to
establish or enforce a right to indemnification and/or advancement of expenses
arising under this Agreement, the charter documents of the Company or any
subsidiary or any statute or law or otherwise, but such indemnification or
advancement of expenses may be provided by the Company in specific cases if the
Board finds it to be appropriate; or
9.2 Unauthorized Settlements. To indemnify the Indemnitee
hereunder for any amounts paid in settlement of a proceeding unless the Company
consents in advance in writing to such settlement, which consent shall not be
unreasonably withheld; or
9.3 Securities Law Actions. To indemnify the Indemnitee on
account of any suit in which judgment is rendered against the Indemnitee for an
accounting of profits made from the purchase or sale by the Indemnitee of
securities of the Company pursuant to the provisions of Section l6(b) of the
Securities Exchange Act of 1934 and amendments thereto or similar provisions of
any federal, state or local statutory law; or
9.4 Unlawful Indemnification. To indemnify the Indemnitee if a
final decision by a court having jurisdiction in the matter shall determine that
such indemnification is not lawful. In this respect, the Company and the
Indemnitee have been advised that the Securities and Exchange Commission takes
the position that indemnification for liabilities arising under the federal
securities laws is against public policy and is, therefore, unenforceable and
that claims for indemnification should be submitted to appropriate courts for
adjudication.
10. NON-EXCLUSIVITY. The provisions for indemnification and advancement
of expenses set forth in this Agreement shall not be deemed exclusive of any
other rights which the Indemnitee may have under any provision of law, the
Company's Certificate of Incorporation or Bylaws, the vote of the Company's
stockholders or disinterested directors, other agreements or otherwise, both as
to action in the Indemnitee's official capacity and to action in another
capacity while occupying his position as an agent of the Company, and the
Indemnitee's rights hereunder shall continue after the Indemnitee has ceased
acting as an agent of the Company and shall inure to the benefit of the heirs,
executors and administrators of the Indemnitee.
11. GENERAL PROVISIONS.
11.1 Interpretation of Agreement. It is understood that the
parties hereto intend this Agreement to be interpreted and enforced so as to
provide indemnification and advancement of expenses to the Indemnitee to the
fullest extent now or hereafter permitted by law, except as
7
<PAGE> 8
expressly limited herein.
11.2 Severability. If any provision or provisions of this
Agreement shall be held to be invalid, illegal or unenforceable for any reason
whatsoever, then: (a) the validity, legality and enforceability of the remaining
provisions of this Agreement (including, without limitation, all portions of any
paragraphs of this Agreement containing any such provision held to be invalid,
illegal or unenforceable that are not themselves invalid, illegal or
unenforceable) shall not in any way be affected or impaired thereby; and (b) to
the fullest extent possible, the provisions of this Agreement (including,
without limitation, all portions of any paragraphs of this Agreement containing
any such provision held to be invalid, illegal or unenforceable, that are not
themselves invalid, illegal or unenforceable) shall be construed so as to give
effect to the intent manifested by the provision held invalid, illegal or
unenforceable and to give effect to Section 11.1 hereof.
11.3 Modification and Waiver. No supplement, modification or
amendment of this Agreement shall be binding unless executed in writing by both
of the parties hereto. No waiver of any of the provisions of this Agreement
shall be deemed or shall constitute a waiver of any other provision hereof
(whether or not similar), nor shall such waiver constitute a continuing waiver.
11.4 Subrogation. In the event of full payment under this
Agreement, the Company shall be subrogated to the extent of such payment to all
of the rights of recovery of the Indemnitee, who shall execute all documents
required and shall do all acts that may be necessary or desirable to secure such
rights and to enable the Company effectively to bring suit to enforce such
rights.
11.5 Counterparts. This Agreement may be executed in one or more
counter-parts, which shall together constitute one agreement.
11.6 Successors and Assigns. The terms of this Agreement shall
bind, and shall inure to the benefit of, the successors and assigns of the
parties hereto.
11.7 Notice. All notices, requests, demands and other
communications under this Agreement shall be in writing and shall be deemed duly
given: (a) if delivered by hand and signed for by the party addressee; or (b) if
mailed by certified or registered mail, with postage prepaid, on the third
business day after the mailing date. Addresses for notice to either party are as
shown on the signature page of this Agreement or as subsequently modified by
written notice.
11.8 Governing Law. This Agreement shall be governed exclusively
by and construed according to the laws of the State of California, as applied to
contracts between California residents entered into and to be performed entirely
within California.
11.9 Consent to Jurisdiction. The Company and the Indemnitee each
hereby irrevocably consent to the jurisdiction of the courts of the State of
California for all purposes in connection with any action or proceeding which
arises out of or relates to this Agreement.
8
<PAGE> 9
11.10 Attorneys' Fees. In the event Indemnitee is required to
bring any action to enforce rights under this Agreement (including, without
limitation, the expenses of any Proceeding described in Section 3), the
Indemnitee shall be entitled to all reasonable fees and expenses in bringing and
pursuing such action, unless a court of competent jurisdiction finds each of the
material claims of the Indemnitee in any such action was frivolous and not made
in good faith.
IN WITNESS WHEREOF, the parties hereto have entered into this Indemnity
Agreement effective as of the date first written above.
NEOFORMA.COM, INC.: INDEMNITEE:
By:
[Name]
Name:
Title:
Address:
Neoforma.com, Inc.
3255-7 Scott Blvd.
Santa Clara, CA 95054
Attn: President
9
<PAGE> 1
EXHIBIT 10.02
NEOFORMA, INC.
1997 STOCK PLAN
1. Purposes of the Plan. The purposes of this Stock Plan are to attract
and retain the best available personnel for positions of substantial
responsibility, to provide additional incentive to Employees and Consultants of
NEOFORMA, INC. and its Subsidiaries (collectively the "Company") and to promote
the success of the Company's business. Options granted under the Plan may be
Incentive Stock Options or Nonstatutory Stock Options as determined by the
Administrator at the time of grant of an Option and subject to applicable
provisions of Section 422 of the Code and the regulations promulgated
thereunder. Stock Purchase Rights may also be granted under the Plan.
2. Definitions. As used herein, the following definitions shall apply:
(a) "Administrator" means the Board or any of its Committees
appointed pursuant to Section 4 of the Plan.
(b) "Board" means the Board of Directors of the Company.
(c) "Code" means the Internal Revenue Code of 1986 as amended.
(d) "Committee" means a Committee appointed by the Board of
Directors in accordance with Section 4 of the Plan.
(e) "Common Stock" means the Common Stock of the Company.
(f) "Company" means Neoforma, Inc. Delaware corporation.
(g) "Consultant" means any person who is engaged by the Company or
any Parent or Subsidiary to render consulting or advisory services and is
compensated for such services, and any Director of the Company whether
compensated for such services or not. If the Company registers any class of any
equity security pursuant to the Exchange Act, the term Consultant shall
thereafter not include Directors who are not compensated for their services or
are paid only a Director's fee by the Company.
(h) "Continuous Status as an Employee or Consultant" means that the
employment or consulting relationship with the Company, any Parent or Subsidiary
is not interrupted or terminated. Continuous Status as an Employee or Consultant
shall not be considered interrupted in the case of (i) any leave of absence
approved by the Company or (ii) transfers between locations of the Company or
between the Company, its Parent, any Subsidiary, or any successor. Leaves of
absence approved by Company include sick, military, or other approved personal
leave approved by an authorized representative of the Company. For purposes of
Incentive Stock Options no such leave may exceed 90 days, unless reemployment
upon expiration of such leave is guaranteed by statute or contract, including
Company policies. If reemployment upon expiration of a leave of absence approved
by the Company is not so guaranteed, on the 91st day of such leave any Incentive
Stock Option held by the Optionee shall cease to be treated as an Incentive
Stock Option and shall be treated for tax purposes as a Nonstatutory Stock
Option.
1
<PAGE> 2
(i) "Director" means a member of the Board of Directors of the
Company.
(j) "Employee" means any person, including Officers and Directors,
employed by the Company or any Parent or Subsidiary of the Company. The payment
of a Director's fee by the Company shall not be sufficient to constitute
"employment" by the Company.
(k) "Exchange Act" means the Securities Exchange Act of 1934, as
amended.
(l) "Fair Market Value" means, as of any date, the value of Common
Stock determined as follows:
(i)If the Common Stock is listed on any established stock
exchange or a national market system, including without limitation the Nasdaq
National Market of the National Association of Securities Dealers, Inc.
Automated Quotation ("NASDAQ") System, its Fair Market Value shall be the
closing sales price for such stock (or the closing bid, if no sales were
reported) as quoted on such exchange or system for the last market trading day
prior to the time of determination and reported in the Wall Street Journal or
such other source as the Administrator deems reliable:
(ii) If the Common Stock is quoted on the NASDAQ System (but not
on the Nasdaq National Market thereof) or regularly quoted by a recognized
securities dealer but selling prices are not reported, its Fair Market Value
shall be the mean between the high bid and low asked prices for the Common Stock
on the last market trading day prior to the day of determination; or,
(iii) In the absence of an established market for the Common
Stock the Fair Market Value thereof shall be determined in good faith by the
Administrator.
(m) "Incentive Stock Option" means an Option intended to qualify as
an incentive stock option within the meaning of Section 422 of the Code.
(n) "Nonstatutory Stock Option" means an Option not intended to
qualify as an Incentive Stock Option.
(o) "Officer" means a person who is an officer of the Company within
the meaning of Section 16 of the Exchange Act and the rules and regulations
promulgated thereunder.
(p) "Option" means a stock option granted pursuant to the Plan.
(q) "Optioned Stock" means the Common Stock subject to an Option or
a Stock Purchase Right.
(r) "Optionee" means an Employee or Consultant who receives an
Option or Stock Purchase Right.
(s) "Parent" means a "parent corporation," whether now or hereafter
existing as defined in Section 424(e) of the Code.
(t) "Plan" means this Neoforma, Inc. 1997 Stock Plan.
-2-
<PAGE> 3
(u) "Restricted Stock" means shares of Common Stock acquired
pursuant to a grant of a Stock Purchase Right under Section 11 below.
(v) "Section 16(b)" means Section 16(b) of the Securities Exchange
Act of 1934, as amended.
(w) "Share" means a share of the Common Stock, as adjusted in
accordance with Section 12 below.
(x) "Stock Purchase Right" means a right to purchase Common Stock
pursuant to Section 12 below.
(y) "Subsidiary" means a "subsidiary corporation," whether now or
hereafter existing, as defined in Section 424(f) of the Code.
3. Stock Subject to the Plan. Subject to the provisions of Section 12
of the Plan, the maximum aggregate number of Shares which may be subject to
option and sold under the Plan is 14,656,078 Shares. The Shares may be
authorized but unissued, or reacquired Common Stock. If an Option or Stock
Purchase Right expires or becomes unexercisable without having been exercised in
full, or is surrendered pursuant to an option exchange program, the unpurchased
Shares which were subject thereto shall become available for future grant or
sale under the Plan (unless the Plan has terminated). However, Shares that have
actually been issued under the Plan, upon exercise of either an Option or Stock
Purchase Right, shall not be returned to the Plan and shall not become available
for future distribution under the Plan, except that if Shares of Restricted
Stock are repurchased by the Company at their original purchase price, and the
original purchaser of such Shares did not receive any benefits of ownership of
such Shares, such Shares shall become available for future grant under the Plan.
For purposes of the preceding sentence, voting rights shall not be considered a
benefit of Share ownership.
4. Administration of the Plan.
(a) Initial Plan Procedure. Prior to the date, if any, upon which
the Company becomes subject to the Exchange Act, the Plan shall be administered
by the Board or a Committee appointed by the Board.
(b) Plan Procedure After the Date. If any, upon which the Company
becomes Subject to the Exchange Act:
(i) Multiple Administrative Bodies. If permitted by Rule l6b-3,
the Plan may be administered by different bodies with respect to Directors,
Officers and Employees who are neither Directors nor Officers.
(ii) Administration With Respect to Directors and Officers. With
respect to grants of Options and Stock Purchase Rights to Employees who are also
Officers or Directors of the Company, the Plan shall be administered by (A) the
Board if the Board may administer the Plan in compliance with the rules under
Rule 16b-3 promulgated under the Exchange Act or any successor thereto ("Rule
16b-3") relating to the disinterested administration of employee benefit
-3-
<PAGE> 4
plans under which Section 16(b) exempt discretionary grants and awards of equity
securities are to be made, or (B) a Committee designated by the Board to
administer the Plan, which Committee shall be constituted to comply with the
rules under Rule 16b-3 relating to the disinterested administration of employee
benefit plans under which Section 16(b) exempt discretionary grants and awards
of equity securities are to be made. Once appointed, such Committee shall
continue to serve in its designated capacity until otherwise directed by the
Board. From time to time the Board may increase the size of the Committee and
appoint additional members thereof, remove members (with or without cause) and
appoint new members in substitution therefor, fill vacancies, however caused,
and remove all members of the Committee and thereafter directly administer the
Plan, all to the extent permitted by the rules under Rule l6b-3 relating to the
disinterested administration of employee benefit plans under which Section 16(b)
exempt discretionary grants and awards of equity securities are to be made.
(iii) Administration With Respect to Other Employees and
Consultants. With respect to grants of Options and Stock Purchase Rights to
Employees or Consultants who are neither Directors nor Officers of the Company,
the Plan shall be administered by (A) the Board or (B) a Committee designated by
the Board, which committee shall be constituted in such a manner as to satisfy
the legal requirements relating to the administration of incentive stock option
plans, if any, of California corporate and securities laws, of the Code, and of
any applicable stock exchange (the "Applicable Laws"). Once appointed, such
Committee shall continue to serve in its designated capacity until otherwise
directed by the Board. From time to time the Board may increase the size of the
Committee and appoint additional members thereof, remove members (with or
without cause) and appoint new members in substitution, therefor, fill
vacancies, however caused, and remove all members of the Committee and
thereafter directly administer the Plan, all to the extent permitted by the
Applicable Laws.
(c) Powers of the Administrator. Subject to the provisions of the
Plan and, in the case of a Committee, the specific duties delegated by the Board
to such Committee, and subject to the approval of any relevant authorities,
including the approval, if required, of any stock exchange upon which the Common
Stock is listed, the Administrator shall have the authority in its discretion:
(i) to determine the Fair Market Value of the Common Stock, in
accordance with Section 2(l) of the Plan;
(ii) to select the Consultants and Employees to whom Options and
Stock Purchase Rights may from time to time be granted hereunder;
(iii) to determine whether and to what extent Options and Stock
Purchase Rights or any combination thereof are granted hereunder;
(iv) to determine the number of Shares to be covered by each
such award granted hereunder;
(v) to approve forms of agreement for use under the Plan;
(vi) to determine the terms and conditions of any award granted
hereunder;
-4-
<PAGE> 5
(vii) to determine whether and under what circumstances an
Option may be settled in cash under subsections 9(f) instead of Common Stock;
(viii) to reduce the exercise price of any Option to the then
current Fair Market Value if the Fair Market Value of the Common Stock covered
by such Option has declined since the date the Option was granted; and
(ix) to construe and interpret the terms of the Plan and awards
granted pursuant to the Plan.
(d) Effect of Administrator's Decision. All decisions,
determinations and interpretations of the Administrator shall be final and
binding on all Optionees and any other holders of any Options or Stock Purchase
Rights.
5. Eligibility.
(a) Nonstatutory Stock Options and Stock Purchase Rights may be
granted to Employees and Consultants. Incentive Stock Options may be granted
only to Employees. An Employee or Consultant who has been granted an Option or
Stock Purchase Rights may, if otherwise eligible, be granted, additional Options
or Stock Purchase Rights.
(b) Each Option shall be designated in the written option agreement
as either an Incentive Stock Option or a Nonstatutory Stock Option. However,
notwithstanding such designation, to the extent that the aggregate Fair Market
Value of the Shares with respect to which Incentive Stock Options are
exercisable for the first time by the Optionee during any calendar year (under
all plans of the Company and any Parent or Subsidiary) exceeds $100,000, such
Options shall be treated as Nonstatutory Stock Options. For purposes of this
Section 5(b), Incentive Stock Options shall be taken into account in the order
in which they were granted. The Fair Market Value of the Shares shall be
determined of the time the Option with respect to such Shares is granted.
(c) Neither the Plan nor any Option or Stock Purchase Right shall
confer upon any Optionee any right with respect to continuation of his or her
employment or consulting relationship with the Company, nor shall it interfere
in any way with his or her right or the Company's right to terminate his or her
employment or consulting relationship at any time, with or without cause.
6. Term of Plan. The Plan shall become effective upon the earlier to
occur of its adoption by the Board of Directors or its approval by the
shareholders of the Company, as described in Section 18 of the Plan. It shall
continue in effect for a term often (10) years unless sooner terminated under
Section 14 of the Plan.
7. Term of Option. The term of each Option shall be the term stated in
the Option Agreement; provided, however, that the term shall be no more than ten
(10) years from the date of grant thereof. In the case of an Incentive Stock
Option granted to an Optionee who, at the time the Option is granted, owns stock
representing more than ten percent (10%) of the voting power of all classes of
stock of the Company or any Parent or Subsidiary, the term of the Option shall
be five (5)
-5-
<PAGE> 6
years from the date of grant thereof or such shorter term as may be provided in
the Option Agreement.
8. Option Exercise Price and Consideration.
(a) The per share exercise price for the Shares to be issued upon
exercise of an Option shall be such price as is determined by the Administrator,
but shall be subject to the following:
(i) In the case of an Incentive Stock Option:
(A) granted to an Employee who, at the time of grant of such
Option, owns stock representing more than ten percent (10%) of the voting power
of all classes of stock of the Company or any Parent or Subsidiary, the per
Share exercise price shall be no less than 110% of the Fair Market Value per
Share on the date of grant.
(B) granted to any other Employee, the per Share exercise
price shall be no less than 100% of the Fair Market Value per Share on the date
of grant.
(ii) In the case of a Nonstatutory Stock Option:
(A) granted to a person who, at the time of such Option,
owns stock representing more than ten percent (10%) of the voting power of all
classes of stock of the Company or any Parent or Subsidiary, the per Share
exercise price shall be no less than 110% of the Fair Market Value per Share on
the date of the grant.
(B) granted to any other person, the per Share exercise
price shall be no less than 85% of the Fair Market Value per Share on the date
of grant.
(b) The consideration to be paid for the Shares to be issued upon
exercise of an Option, including the method of payment, shall be determined by
the Administrator (and, in the case of an Incentive Stock Option, shall be
determined at the time of grant). Such consideration may consist of (1) cash,
(2) check, (3) promissory note, (4) other Shares which, in the case of Shares
acquired upon exercise of an Option, have been owned by the Optionee for more
than six months on the date of surrender, and have a Fair Market Value on the
date of surrender equal to the aggregate exercise price of the Shares as to
which such Option shall be exercised, (5) delivery of a properly executed
exercise notice together with such other documentation as the Administrator and
a broker, if applicable, shall require to effect an exercise of the Option and
delivery to the Company of the sale or loan proceeds required to pay the
exercise price, or (6) any combination of the foregoing methods of payment. In
making its determination as to the type of consideration to accept, the
Administrator shall consider if acceptance of such consideration may be
reasonably expected to benefit the Company.
9. Exercise of Option.
(a) Procedure for Exercise; Rights as a Shareholder. Any Option
granted hereunder shall be exercisable at such times and under such conditions
as determined by the
-6-
<PAGE> 7
Administrator, including performance criteria with respect to the Company and/or
the Optionee, and as shall be permissible under the terms of the Plan, but in no
case at a rate of less than 20% per year over five (5) years from the date the
Option is granted.
(i) An Option may not be exercised for a fraction of a Share.
(ii) An Option shall be deemed to be exercised when written
notice of such exercise has been given to the Company in accordance with the
terms of the Option by the person entitled to exercise the Option and full
payment for the Shares with respect to which the Option is exercised has been
received by the Company. Full payment may, as authorized by the Administrator,
consist of any consideration and method of payment allowable under Section 8(b)
hereof. Until the issuance (as evidenced by the appropriate entry on the books
of the Company or of a duly authorized transfer agent of the Company) of the
stock certificate evidencing such Shares, no right to vote, receive dividends or
any other rights as a shareholder shall exist with respect to the Optioned
Stock, notwithstanding the exercise of the Option. The Company shall issue (or
cause to be issued) such stock certificate promptly upon exercise of the Option.
No adjustment shall be made for a dividend or other right for which the record
date is prior to the date the stock certificate is issued, except as provided in
section 12 thereof.
(iii) Exercise of an Option in any manner shall result in a
decrease in the number of Shares which thereafter may be available, both for
purposes of the Plan and for sale under the Option, by the number of Shares as
to which the Option is exercised.
(b) Termination of Employment or Consulting Relationship. In the
event of termination of an Optionee's Continuous Status as an Employee or
Consultant (but not in the event of an Optionee's change of status from Employee
to Consultant (in which case an Employee's Incentive Stock Option shall
automatically convert to a Nonstatutory Stock Option on the date three (3)
months and one day following such change of status) or from Consultant to
Employee), such Optionee may, but only within such period of time as is
determined by the Administrator, of at least thirty (30) days, with such
determination in the case of an Incentive Stock Option not exceeding three (3)
months after the date of such termination (but in no event later than the
expiration date of the term of such Option as set forth in the Option
Agreement), exercise his or her Option to the extent that the Optionee was
entitled to exercise it at the date of such termination. To the extent that the
Optionee was not entitled to exercise the Option at the date of such
termination, or if the Optionee does not exercise such Option to the extent so
entitled within the time specified herein, the Option shall terminate.
(c) Disability of Optionee. In the event of termination of an
Optionee's Continuous Status as an Employee or Consultant as a result of his or
her disability, the Optionee may, but only within twelve (12) months from the
date of such termination (and in no event later than the expiration date of the
term of such Option as set forth in the Option Agreement), exercise the Option
to the extent otherwise entitled to exercise it at the date of such termination.
If such disability is not a "disability" as such term is defined in Section
22(e)(3) of the Code, in the case of an Incentive Stock Option such Incentive
Stock Option shall automatically cease to be treated as an Incentive Stock
Option and shall be treated for tax purposes as a Nonstatutory Stock Option on
the day three months and one day following such termination. To the extent the
Optionee was not
-7-
<PAGE> 8
entitled to exercise the Option at the date of termination, or if the Optionee
does not exercise such Option to the extent so entitled within the time
specified herein, the Option shall terminate, and the Shares covered by such
Option shall revert to the Plan.
(d) Death of Optionee. In the event of the death of an Optionee,
the Option may be exercised at any time within twelve (12) months following the
date of death (but in no event later than the expiration of the term of such
Option as set forth in the Notice of Grant) by the Optionee's estate or by a
person who acquired the right to exercise the Option by bequest or inheritance,
but only to the extent that the Optionee was entitled to exercise the Option on
the date of death. If, at the time of death, the Optionee was not entitled to
exercise his or her entire Option, the Shares covered by the unexercisable
portion of the Option shall immediately revert to the Plan. If, after the
Optionee's death, the Optionee's estate or a person who acquires the right to
exercise the Option by bequest or inheritance does not exercise the Option
within the time specified herein, the Option shall terminate, and the Shares
covered by such Option shall revert to the Plan.
(e) Rule 16b-3. Options granted to persons subject to Section 16(b)
of the Exchange Act must comply with Rule l6b-3 and shall contain such
additional conditions or restrictions as may be required thereunder to qualify
for the maximum exemption from Section 16 of the Exchange Act with respect to
Plan transactions.
(f) Buyout Provisions. The Administrator may at any time offer to
buy out, on terms reasonably acceptable to the Optionee and to the Company, for
a payment in cash or Shares, an Option previously granted, based on such terms
and conditions as the parties shall reasonably establish and the parties agree
that the dispute resolution procedures of Section 20 shall finally resolve any
disputes or disagreements arising the foregoing including without limitation
what constitutes a reasonable payment of cash or Shares or other reasonable
terms and conditions for any buyout requested by the Company.
10. Non-Transferability of Options and Stock Purchase Rights. Options
and Stock Purchase Rights may not be sold, pledged, assigned, hypothecated,
transferred, or disposed of in any manner other than by will or by the laws of
descent or distribution and may be exercised, during the lifetime of the
Optionee, only by the Optionee.
11. Stock Purchase Rights.
(a) Rights to Purchase. Stock Purchase Rights may be issued either
alone, in addition to, or in tandem with other awards under the Plan and/or cash
awards made outside of the Plan. After the Administrator determines that it will
offer Stock Purchase Rights under the Plan, it shall advise the offeree in
writing of the terms, conditions and restrictions related to the offer,
including the number of Shares that such person shall be entitled to purchase,
the price to be paid, and the time within which such person must accept such
offer, which shall in no event exceed thirty (30) days from the date upon which
the Administrator makes the determination to grant the Stock Purchase Right. The
offer shall be accepted by execution of a Restricted Stock purchase agreement in
the form determined by the Administrator. Shares purchased pursuant to the grant
of a Stock Purchase Right shall be referred to herein as "Restricted Stock."
-8-
<PAGE> 9
(b) Repurchase Option. Unless the Administrator determines
otherwise, the Restricted Stock purchase agreement shall grant the Company a
repurchase option exercisable upon the voluntary or involuntary termination of
the purchaser's employment with the Company for any reason (including death or
disability). The purchase price for Shares repurchased pursuant to the
Restricted Stock purchase agreement shall be the original price paid by the
purchaser and may be paid by cancellation of any indebtedness of the purchaser
to the Company. The repurchase option shall lapse at such rate as the
Administrator may determine, but in no case at a rate of less than 20% per year
over five years from the date of purchase.
(c) Other Provisions. The Restricted Stock purchase agreement shall
contain such other terms, provisions and conditions not inconsistent with the
Plan as may be determined by the Administrator in its sole discretion. In
addition, the provisions of Restricted Stock purchase agreements need not be the
same with respect to each Purchaser.
(d) Rights as a Shareholder. Once the Stock Purchase Right is
exercised, the purchaser shall have rights equivalent to those of a shareholder
and shall be a shareholder when his or her purchase is entered upon the records
of the duly authorized transfer agent of the Company. No adjustment shall be
made for a dividend or other right for which the record date is prior to the
date the Stock Purchase Right is exercised, except as provided in Section 12 of
the Plan.
12. Adjustments Upon Changes in Capitalization or Merger.
(a) Changes in Capitalization. Subject to any required action by
the shareholders of the Company, the number of shares of Common Stock covered by
each outstanding Option or Stock Purchase Right, and the number of shares of
Common Stock which have been authorized for issuance under the Plan but as to
which no Options or Stock Purchase Rights have yet been granted or which have
been returned to the Plan upon cancellation or expiration of an Option or Stock
Purchase Right, as well as the price per share of Common Stock covered by each
such outstanding Option or Stock Purchase Right, shall be proportionately
adjusted for any increase or decrease in the number of issued shares of Common
Stock resulting from a stock split, reverse stock split, stock dividend,
combination or reclassification of the Common Stock or any other increase or
decrease in the number of issued shares of Common Stock effected without receipt
of consideration by the Company. The conversion of any convertible securities of
the Company shall not be deemed to have been "effected without receipt of
consideration." Such adjustment shall be made by the Board, whose determination
in that respect shall be final, binding and conclusive. Except as expressly
provided herein, no issuance by the Company of shares of stock of any class, or
securities convertible into shares of stock of any class, shall affect, and no
adjustment by reason thereof shall be made with respect to, the number or price
of shares of Common Stock subject to an Option or Stock Purchase Right.
(b) Dissolution or Liquidation. In the event of the proposed
dissolution or liquidation of the Company, the Administrator shall notify the
Optionee at least fifteen (15) days prior to such proposed action. To the extent
it has not been previously exercised, the Option or Stock Purchase Right shall
terminate immediately prior to the consummation of such proposed action.
-9-
<PAGE> 10
(c) Merger. In the event of a merger of the Company with or into
another corporation, each outstanding Option or Stock Purchase Right may be
assumed or an equivalent option or right may be substituted by such successor
corporation or a parent or subsidiary of such successor corporation. If, in such
event, an Option or Stock Purchase Right is not assumed or substituted, the
Option or Stock Purchase Right shall terminate as of the date of the closing of
the merger. For the purposes of this paragraph, the Option or Stock Purchase
Right shall be considered assumed if, following the merger, the Option or Stock
Purchase Right confers the right to purchase or receive, for each Share of
Optioned Stock subject to the Option or Stock Purchase Right immediately prior
to the merger, the consideration (whether stock cash, or other securities or
property) received in the merger by holders of Common Stock for each Share held
on the effective date of the transaction (and if the holders are offered a
choice of consideration, the type of consideration chosen by the holders of a
majority of the outstanding Shares). If such consideration received in the
merger is not solely common stock of the successor corporation or its Parent,
the Administrator may, with the consent of the successor corporation, provide
for the consideration to be received upon the exercise of the Option or Stock
Purchase Right, for each Share of Optioned Stock subject to the Option or Stock
Purchase Rights to be solely common stock of the successor corporation or its
Parent equal in fair market value to the per share consideration received by
holders of Common Stock in the merger.
13. Time of Granting Options and Stock Purchase Rights. The date of
grant of an Option or Stock Purchase Right shall, for all purposes, be the date
on which the Administrator makes the determination granting such Option or Stock
Purchase Right, or such other date as is determined by the Administrator. Notice
of the determination shall be given to each Employee or Consultant to whom an
Option or Stock Purchase Right is so granted within a reasonable time after the
date of such grant.
14. Amendment and Termination of the Plan.
(a) Amendment and Termination. The Board may at any time amend,
alter, suspend or discontinue the Plan, but no amendment, alteration, suspension
or discontinuation shall be made which would impair the rights of any Optionee
under any grant theretofore made, without his or her consent. In addition, to
the extent necessary and desirable to comply with Rule 16b-3 under the Exchange
Act or with Section 422 of the Code (or any other applicable law or regulation,
including the requirements of the NASD or an established stock exchange), the
Company shall obtain shareholder approval of any Plan amendment in such a manner
and to such a degree as required.
(b) Effect of Amendment or Termination. Any such amendment or
termination of the Plan shall not affect Options or Stock Purchase Rights
already granted, and such Options and Stock Purchase Rights shall remain in full
force and effect as if this Plan had had not been amended or terminated, unless
mutually agreed otherwise between the Optionee and the Administrator, which
agreement must be in writing and signed by the Optionee and the Company.
15. Conditions Upon Issuance of Shares. Shares shall not be issued
pursuant to the exercise of an Option or Stock Purchase Right unless the
exercise of such Option or Stock Purchase Right and the issuance and delivery of
such Shares pursuant thereto shall comply with all relevant
-10-
<PAGE> 11
provisions of law, including, without limitation, the Securities Act of 1933, as
amended, the Exchange Act, the rules and regulations promulgated thereunder, and
the requirements of any stock exchange upon which the Shares may then be listed,
and shall be further subject to the approval of counsel for the Company with
respect to such compliance. As a condition to the exercise of an Option or Stock
Purchase Right, the Company may require the person exercising such Option or
Stock Purchase Right to represent and warrant at the time of any such exercise
that the Shares are being purchased only for investment and without any present
intention to sell or distribute such Shares if, in the opinion of counsel for
the Company, such a representation is required by any of the aforementioned
relevant provisions of law.
16. Reservation of Shares. The Company, during the term of this Plan,
shall at all times reserve and keep available such number of Shares as shall be
sufficient to satisfy the requirements of the Plan. The inability of the Company
to obtain authority from any regulatory body having jurisdiction, which
authority is deemed by the Company's counsel to be necessary to the lawful
issuance and sale of any Shares hereunder, shall relieve the Company of any
liability in respect of the failure to issue or sell such Shares as to which
such requisite authority shall not have been obtained.
17. Agreements. Options and Stock Purchase Rights shall be evidenced by
written agreements in such form as the Administrator shall approve from time to
time.
18. Shareholder Approval. Continuance of the Plan shall be subject to
approval by the shareholders of the Company within twelve (12) months before or
after the date the Plan is adopted. Such shareholder approval shall be obtained
in the degree and manner required under applicable state and federal law and the
rules of any stock exchange upon which the Common Stock is listed.
19. Information to Optionees and Purchasers. The Company shall provide
to each Optionee and to each individual who acquires Shares pursuant to the
Plan, not less frequently than annually during the period such Optionee or
purchaser has one or more Options or Stock Purchase Rights outstanding, and, in
the case of an individual who acquires Shares pursuant to the Plan, during the
period such individual owns such Shares, copies of annual financial statements.
The Company shall not be required to provide such statements to key employees
whose duties in connection with the Company assure their access to equivalent
information.
20. BINDING EXPEDITED ALTERNATIVE DISPUTE RESOLUTION. ANY CHALLENGE TO
THE GOOD FAITH OF THE FINAL DETERMINATION OF THE BOARD SHALL BE RESOLVED BY
FINAL, BINDING, CONFIDENTIAL, EXPEDITED ARBITRATION IN PALO ALTO, CALIFORNIA
BEFORE A NEUTRAL RETIRED JUDGE APPOINTED BY THE JUDICIAL ARBITRATION AND
MEDIATION SERVICE (JAMS) OF SAN JOSE, CALIFORNIA; THE ARBITRATION HEARING SHALL
BE EXPEDITED AND SHALL OCCUR WITHIN TEN (10) DAYS OF THE DEMAND THEREOF BY
EITHER PARTY AND SHALL BE LIMITED TO ONE EIGHT (8) HOUR HEARING IN WHICH EACH
PARTY IS ALLOTTED FOUR (4) HOURS TO PRESENT THAT PARTY'S POSITION, TESTIMONY,
EXHIBITS AND OTHER EVIDENCE. THE ARBITRATOR SHALL ISSUE A FINAL AND BINDING
WRITTEN AWARD WITHIN TEN (10) DAYS OF THE CLOSE OF THE HEARING AND EACH PARTY
SHALL HAVE TEN (10) DAYS FOLLOWING SUCH AWARD TO
-11-
<PAGE> 12
COMPLY THEREWITH. THE PARTIES AGREE THAT THEY ARE EACH WAIVING A RIGHT TO TRIAL
BY JURY, COURT TRIAL, APPEAL AND OTHER COURT PROCEDURES IN FAVOR OF AN EXPEDITED
RESOLUTION IN ACCORDANCE WITH THE TERMS AND CONDITIONS HEREOF.
-12-
<PAGE> 1
EXHIBIT 10.03
NEOFORMA, INC.
1999 EQUITY INCENTIVE PLAN
As Adopted _______________, 1999
1. PURPOSE. The purpose of this Plan is to provide incentives to
attract, retain and motivate eligible persons whose present and potential
contributions are important to the success of the Company, its Parent and
Subsidiaries, by offering them an opportunity to participate in the Company's
future performance through awards of Options, Restricted Stock and Stock
Bonuses. Capitalized terms not defined in the text are defined in Section 23.
2. SHARES SUBJECT TO THE PLAN.
2.1 Number of Shares Available. Subject to Sections 2.2 and 18,
the total number of Shares reserved and available for grant and issuance
pursuant to this Plan will be ______________ Shares plus Shares that are subject
to: (a) issuance upon exercise of an Option but cease to be subject to such
Option for any reason other than exercise of such Option; (b) an Award granted
hereunder but are forfeited or are repurchased by the Company at the original
issue price; and (c) an Award that otherwise terminates without Shares being
issued. In addition, any authorized shares not issued or subject to outstanding
grants under the Neoforma, Inc.'s _____________ Plan and the ______________ Plan
(the "PRIOR PLANS") on the Effective Date (as defined below) and any shares
issued under the Prior Plans that are forfeited or repurchased by the Company or
that are issuable upon exercise of options granted pursuant to the Prior Plans
that expire or become unexercisable for any reason without having been exercised
in full, will no longer be available for grant and issuance under the Prior
Plans, but will be available for grant and issuance under this Plan. In
addition, on each January 1, the aggregate number of Shares reserved and
available for grant and issuance pursuant to this Plan will be increased
automatically by a number of Shares equal to ___________% of the total
outstanding shares of the Company as of the immediately preceding December 31,
provided that no more than __________________ shares shall qualify as ISOs (as
defined in Section 5 below). At all times the Company shall reserve and keep
available a sufficient number of Shares as shall be required to satisfy the
requirements of all outstanding Options granted under this Plan and all other
outstanding but unvested Awards granted under this Plan.
2.2 Adjustment of Shares. In the event that the number of
outstanding shares is changed by a stock dividend, recapitalization, stock
split, reverse stock split, subdivision, combination, reclassification or
similar change in the capital structure of the Company without consideration,
then (a) the number of Shares reserved for issuance under this Plan, (b) the
Exercise Prices of and number of Shares subject to outstanding Options, and (c)
the number of Shares subject to other outstanding Awards will be proportionately
adjusted, subject to any required action by the Board or the stockholders of the
Company and compliance with applicable securities laws; provided, however, that
fractions of a Share will not be issued but will either be replaced by a cash
payment equal to the Fair Market Value of such fraction of a Share or will be
rounded up to the nearest whole Share, as determined by the Committee.
3. ELIGIBILITY. ISOs (as defined in Section 5 below) may be granted only
to employees (including officers and directors who are also employees) of the
Company or of a Parent or Subsidiary of the Company. All other Awards may be
granted to employees, officers, directors, consultants, independent contractors
and advisors of the Company or any Parent or Subsidiary of the Company; provided
such consultants, contractors and advisors render bona fide services not in
connection with the offer and sale of securities in a capital-raising
transaction. No person will be eligible to receive more than ____________ Shares
in any calendar year under this Plan pursuant to the grant of Awards hereunder,
other than new employees of the Company or of a Parent or Subsidiary of the
Company (including new employees who are also officers and directors of the
Company or any Parent or Subsidiary of the Company), who are eligible to receive
up to a maximum of ________________ Shares in the calendar year in which they
commence their employment. A person may be granted more than one Award under
this Plan.
1
<PAGE> 2
Neoforma, Inc.
1999 Equity Incentive Plan
4. ADMINISTRATION.
4.1 Committee Authority. This Plan will be administered by the
Committee or by the Board acting as the Committee. Except for automatic grants
to Outside Directors pursuant to Section 9 hereof, and subject to the general
purposes, terms and conditions of this Plan, and to the direction of the Board,
the Committee will have full power to implement and carry out this Plan. Except
for automatic grants to Outside Directors pursuant to Section 9 hereof, the
Committee will have the authority to:
(a) construe and interpret this Plan, any Award Agreement and
any other agreement or document executed pursuant to this
Plan;
(b) prescribe, amend and rescind rules and regulations
relating to this Plan or any Award;
(c) select persons to receive Awards;
(d) determine the form and terms of Awards;
(e) determine the number of Shares or other consideration
subject to Awards;
(f) determine whether Awards will be granted singly, in
combination with, in tandem with, in replacement of, or as
alternatives to, other Awards under this Plan or any other
incentive or compensation plan of the Company or any
Parent or Subsidiary of the Company;
(g) grant waivers of Plan or Award conditions;
(h) determine the vesting, exercisability and payment of
Awards;
(i) correct any defect, supply any omission or reconcile any
inconsistency in this Plan, any Award or any Award
Agreement;
(j) determine whether an Award has been earned; and
(k) make all other determinations necessary or advisable for
the administration of this Plan.
4.2 Committee Discretion. Except for automatic grants to Outside
Directors pursuant to Section 9 hereof, any determination made by the Committee
with respect to any Award will be made in its sole discretion at the time of
grant of the Award or, unless in contravention of any express term of this Plan
or Award, at any later time, and such determination will be final and binding on
the Company and on all persons having an interest in any Award under this Plan.
The Committee may delegate to one or more officers of the Company the authority
to grant an Award under this Plan to Participants who are not Insiders of the
Company.
5. OPTIONS. The Committee may grant Options to eligible persons and will
determine whether such Options will be Incentive Stock Options within the
meaning of the Code ("ISO") or Nonqualified Stock Options ("NQSOs"), the number
of Shares subject to the Option, the Exercise Price of the Option, the period
during which the Option may be exercised, and all other terms and conditions of
the Option, subject to the following:
5.1 Form of Option Grant. Each Option granted under this Plan
will be evidenced by an Award Agreement which will expressly identify the Option
as an ISO or an NQSO ("STOCK OPTION AGREEMENT"), and, except as otherwise
required by the terms of Section 9 hereof, will be in such form and contain such
provisions (which need not be the same for each Participant) as the Committee
may from time to time approve, and which will comply with and be subject to the
terms and conditions of this Plan.
2
<PAGE> 3
Neoforma, Inc.
1999 Equity Incentive Plan
5.2 Date of Grant. The date of grant of an Option will be the
date on which the Committee makes the determination to grant such Option, unless
otherwise specified by the Committee. The Stock Option Agreement and a copy of
this Plan will be delivered to the Participant within a reasonable time after
the granting of the Option.
5.3 Exercise Period. Options may be exercisable within the times
or upon the events determined by the Committee as set forth in the Stock Option
Agreement governing such Option; provided, however, that no Option will be
exercisable after the expiration of ten (10) years from the date the Option is
granted; and provided further that no ISO granted to a person who directly or by
attribution owns more than ten percent (10%) of the total combined voting power
of all classes of stock of the Company or of any Parent or Subsidiary of the
Company ("TEN PERCENT STOCKHOLDER") will be exercisable after the expiration of
five (5) years from the date the ISO is granted. The Committee also may provide
for Options to become exercisable at one time or from time to time, periodically
or otherwise, in such number of Shares or percentage of Shares as the Committee
determines.
5.4 Exercise Price. The Exercise Price of an Option will be
determined by the Committee when the Option is granted and may be not less than
85% of the Fair Market Value of the Shares on the date of grant; provided that:
(i) the Exercise Price of an ISO will be not less than 100% of the Fair Market
Value of the Shares on the date of grant; and (ii) the Exercise Price of any ISO
granted to a Ten Percent Stockholder will not be less than 110% of the Fair
Market Value of the Shares on the date of grant. Payment for the Shares
purchased may be made in accordance with Section 8 of this Plan.
5.5 Method of Exercise. Options may be exercised only by delivery
to the Company of a written stock option exercise agreement (the "EXERCISE
AGREEMENT") in a form approved by the Committee (which need not be the same for
each Participant), stating the number of Shares being purchased, the
restrictions imposed on the Shares purchased under such Exercise Agreement, if
any, and such representations and agreements regarding Participant's investment
intent and access to information and other matters, if any, as may be required
or desirable by the Company to comply with applicable securities laws, together
with payment in full of the Exercise Price for the number of Shares being
purchased.
5.6 Termination. Notwithstanding the exercise periods set forth
in the Stock Option Agreement, exercise of an Option will always be subject to
the following:
(a) If the Participant is Terminated for any reason except
death or Disability, then the Participant may exercise
such Participant's Options only to the extent that such
Options would have been exercisable upon the Termination
Date no later than three (3) months after the Termination
Date (or such shorter or longer time period not exceeding
five (5) years as may be determined by the Committee, with
any exercise beyond three (3) months after the Termination
Date deemed to be an NQSO), but in any event, no later
than the expiration date of the Options.
(b) If the Participant is Terminated because of Participant's
death or Disability (or the Participant dies within three
(3) months after a Termination other than for Cause or
because of Participant's Disability), then Participant's
Options may be exercised only to the extent that such
Options would have been exercisable by Participant on the
Termination Date and must be exercised by Participant (or
Participant's legal representative or authorized assignee)
no later than twelve (12) months after the Termination
Date (or such shorter or longer time period not exceeding
five (5) years as may be determined by the Committee, with
any such exercise beyond (a) three (3) months after the
Termination Date when the Termination is for any reason
other than the Participant's death or Disability, or (b)
twelve (12) months after the Termination Date when the
Termination is for Participant's death or Disability,
deemed to be an NQSO), but in any event no later than the
expiration date of the Options.
3
<PAGE> 4
Neoforma, Inc.
1999 Equity Incentive Plan
(c) Notwithstanding the provisions in paragraph 5.6(a) above,
if a Participant is terminated for Cause, neither the
Participant, the Participant's estate nor such other
person who may then hold the Option shall be entitled to
exercise any Option with respect to any Shares whatsoever,
after termination of service, whether or not after
termination of service the Participant may receive payment
from the Company or Subsidiary for vacation pay, for
services rendered prior to termination, for services
rendered for the day on which termination occurs, for
salary in lieu of notice, or for any other benefits. In
making such determination, the Board shall give the
Participant an opportunity to present to the Board
evidence on his behalf. For the purpose of this paragraph,
termination of service shall be deemed to occur on the
date when the Company dispatches notice or advice to the
Participant that his service is terminated.
5.7 Limitations on Exercise. The Committee may specify a
reasonable minimum number of Shares that may be purchased on any exercise of an
Option, provided that such minimum number will not prevent Participant from
exercising the Option for the full number of Shares for which it is then
exercisable.
5.8 Limitations on ISO. The aggregate Fair Market Value
(determined as of the date of grant) of Shares with respect to which ISO are
exercisable for the first time by a Participant during any calendar year (under
this Plan or under any other incentive stock option plan of the Company, Parent
or Subsidiary of the Company) will not exceed $100,000. If the Fair Market Value
of Shares on the date of grant with respect to which ISO are exercisable for the
first time by a Participant during any calendar year exceeds $100,000, then the
Options for the first $100,000 worth of Shares to become exercisable in such
calendar year will be ISO and the Options for the amount in excess of $100,000
that become exercisable in that calendar year will be NQSOs. In the event that
the Code or the regulations promulgated thereunder are amended after the
Effective Date of this Plan to provide for a different limit on the Fair Market
Value of Shares permitted to be subject to ISO, such different limit will be
automatically incorporated herein and will apply to any Options granted after
the effective date of such amendment.
5.9 Modification, Extension or Renewal. The Committee may modify,
extend or renew outstanding Options and authorize the grant of new Options in
substitution therefor, provided that any such action may not, without the
written consent of a Participant, impair any of such Participant's rights under
any Option previously granted. Any outstanding ISO that is modified, extended,
renewed or otherwise altered will be treated in accordance with Section 424(h)
of the Code. The Committee may reduce the Exercise Price of outstanding Options
without the consent of Participants affected by a written notice to them;
provided, however, that the Exercise Price may not be reduced below the minimum
Exercise Price that would be permitted under Section 5.4 of this Plan for
Options granted on the date the action is taken to reduce the Exercise Price.
5.10 No Disqualification. Notwithstanding any other provision in
this Plan, no term of this Plan relating to ISO will be interpreted, amended or
altered, nor will any discretion or authority granted under this Plan be
exercised, so as to disqualify this Plan under Section 422 of the Code or,
without the consent of the Participant affected, to disqualify any ISO under
Section 422 of the Code.
6. RESTRICTED STOCK. A Restricted Stock Award is an offer by the Company
to sell to an eligible person Shares that are subject to restrictions. The
Committee will determine to whom an offer will be made, the number of Shares the
person may purchase, the price to be paid (the "PURCHASE PRICE"), the
restrictions to which the Shares will be subject, and all other terms and
conditions of the Restricted Stock Award, subject to the following:
6.1 Form of Restricted Stock Award. All purchases under a
Restricted Stock Award made pursuant to this Plan will be evidenced by an Award
Agreement ("RESTRICTED STOCK PURCHASE AGREEMENT") that will be in such form
(which need not be the same for each Participant) as the Committee will from
time to time approve, and will comply with and be subject to the terms and
conditions of this Plan. The offer of Restricted Stock will be accepted by the
Participant's execution and delivery of the Restricted Stock Purchase Agreement
and full payment for the Shares to the Company within thirty (30) days from the
date the Restricted Stock Purchase Agreement is
4
<PAGE> 5
Neoforma, Inc.
1999 Equity Incentive Plan
delivered to the person. If such person does not execute and deliver the
Restricted Stock Purchase Agreement along with full payment for the Shares to
the Company within thirty (30) days, then the offer will terminate, unless
otherwise determined by the Committee.
6.2 Purchase Price. The Purchase Price of Shares sold pursuant to
a Restricted Stock Award will be determined by the Committee on the date the
Restricted Stock Award is granted, except in the case of a sale to a Ten Percent
Stockholder, in which case the Purchase Price will be 100% of the Fair Market
Value. Payment of the Purchase Price may be made in accordance with Section 8 of
this Plan.
6.3 Terms of Restricted Stock Awards. Restricted Stock Awards
shall be subject to such restrictions as the Committee may impose. These
restrictions may be based upon completion of a specified number of years of
service with the Company or upon completion of the performance goals as set out
in advance in the Participant's individual Restricted Stock Purchase Agreement.
Restricted Stock Awards may vary from Participant to Participant and between
groups of Participants. Prior to the grant of a Restricted Stock Award, the
Committee shall: (a) determine the nature, length and starting date of any
Performance Period for the Restricted Stock Award; (b) select from among the
Performance Factors to be used to measure performance goals, if any; and (c)
determine the number of Shares that may be awarded to the Participant. Prior to
the payment of any Restricted Stock Award, the Committee shall determine the
extent to which such Restricted Stock Award has been earned. Performance Periods
may overlap and Participants may participate simultaneously with respect to
Restricted Stock Awards that are subject to different Performance Periods and
having different performance goals and other criteria.
6.4 Termination During Performance Period. If a Participant is
Terminated during a Performance Period for any reason, then such Participant
will be entitled to payment (whether in Shares, cash or otherwise) with respect
to the Restricted Stock Award only to the extent earned as of the date of
Termination in accordance with the Restricted Stock Purchase Agreement, unless
the Committee will determine otherwise.
7. STOCK BONUSES.
7.1 Awards of Stock Bonuses. A Stock Bonus is an award of Shares
(which may consist of Restricted Stock) for services rendered to the Company or
any Parent or Subsidiary of the Company. A Stock Bonus may be awarded for past
services already rendered to the Company, or any Parent or Subsidiary of the
Company pursuant to an Award Agreement (the "STOCK BONUS AGREEMENT") that will
be in such form (which need not be the same for each Participant) as the
Committee will from time to time approve, and will comply with and be subject to
the terms and conditions of this Plan. A Stock Bonus may be awarded upon
satisfaction of such performance goals as are set out in advance in the
Participant's individual Award Agreement (the "PERFORMANCE STOCK BONUS
AGREEMENT") that will be in such form (which need not be the same for each
Participant) as the Committee will from time to time approve, and will comply
with and be subject to the terms and conditions of this Plan. Stock Bonuses may
vary from Participant to Participant and between groups of Participants, and may
be based upon the achievement of the Company, Parent or Subsidiary and/or
individual performance factors or upon such other criteria as the Committee may
determine.
7.2 Terms of Stock Bonuses. The Committee will determine the
number of Shares to be awarded to the Participant. If the Stock Bonus is being
earned upon the satisfaction of performance goals pursuant to a Performance
Stock Bonus Agreement, then the Committee will: (a) determine the nature, length
and starting date of any Performance Period for each Stock Bonus; (b) select
from among the Performance Factors to be used to measure the performance, if
any; and (c) determine the number of Shares that may be awarded to the
Participant. Prior to the payment of any Stock Bonus, the Committee shall
determine the extent to which such Stock Bonuses have been earned. Performance
Periods may overlap and Participants may participate simultaneously with respect
to Stock Bonuses that are subject to different Performance Periods and different
performance goals and other criteria. The number of Shares may be fixed or may
vary in accordance with such performance goals and criteria as may be determined
by the Committee. The Committee may adjust the performance goals applicable to
the Stock Bonuses to take into account changes in law and accounting or tax
rules and to make such adjustments as the
5
<PAGE> 6
Neoforma, Inc.
1999 Equity Incentive Plan
Committee deems necessary or appropriate to reflect the impact of extraordinary
or unusual items, events or circumstances to avoid windfalls or hardships.
7.3 Form of Payment. The earned portion of a Stock Bonus may be
paid currently or on a deferred basis with such interest or dividend equivalent,
if any, as the Committee may determine. Payment may be made in the form of cash
or whole Shares or a combination thereof, either in a lump sum payment or in
installments, all as the Committee will determine.
8. PAYMENT FOR SHARE PURCHASES.
8.1 Payment. Payment for Shares purchased pursuant to this Plan
may be made in cash (by check) or, where expressly approved for the Participant
by the Committee and where permitted by law:
(a) by cancellation of indebtedness of the Company to the
Participant;
(b) by surrender of shares that either: (1) have been owned by
Participant for more than six (6) months and have been
paid for within the meaning of SEC Rule 144 (and, if such
shares were purchased from the Company by use of a
promissory note, such note has been fully paid with
respect to such shares); or (2) were obtained by
Participant in the public market;
(c) by tender of a full recourse promissory note having such
terms as may be approved by the Committee and bearing
interest at a rate sufficient to avoid imputation of
income under Sections 483 and 1274 of the Code; provided,
however, that Participants who are not employees or
directors of the Company will not be entitled to purchase
Shares with a promissory note unless the note is
adequately secured by collateral other than the Shares;
(d) by waiver of compensation due or accrued to the
Participant for services rendered;
(e) with respect only to purchases upon exercise of an Option,
and provided that a public market for the Company's stock
exists:
(1) through a "same day sale" commitment from the
Participant and a broker-dealer that is a member of
the National Association of Securities Dealers (an
"NASD DEALER") whereby the Participant irrevocably
elects to exercise the Option and to sell a portion
of the Shares so purchased to pay for the Exercise
Price, and whereby the NASD Dealer irrevocably
commits upon receipt of such Shares to forward the
Exercise Price directly to the Company; or
(2) through a "margin" commitment from the Participant
and a NASD Dealer whereby the Participant
irrevocably elects to exercise the Option and to
pledge the Shares so purchased to the NASD Dealer
in a margin account as security for a loan from the
NASD Dealer in the amount of the Exercise Price,
and whereby the NASD Dealer irrevocably commits
upon receipt of such Shares to forward the Exercise
Price directly to the Company; or
(f) by any combination of the foregoing.
8.2 Loan Guarantees. The Committee may help the Participant pay
for Shares purchased under this Plan by authorizing a guarantee by the Company
of a third-party loan to the Participant.
9. AUTOMATIC GRANTS TO OUTSIDE DIRECTORS.
6
<PAGE> 7
Neoforma, Inc.
1999 Equity Incentive Plan
9.1 Types of Options and Shares. Options granted under this Plan
and subject to this Section 9 shall be NQSOs.
9.2 Eligibility. Options subject to this Section 9 shall be
granted only to Outside Directors.
9.3 Initial Grant. Each Outside Director who first becomes a
member of the Board on or after the Effective Date will automatically be granted
an Option for _____________ Shares (an "INITIAL GRANT") on the date such
Optionee first becomes a member of the Board, unless such Outside Director
received a grant of Options before the Effective Date. Each Optionee who became
a member of the Board prior to the Effective Date will receive an Initial Grant
immediately following the Effective Date.
9.4 Succeeding Grants. Immediately following each Annual Meeting
of stockholders, each Outside Director will automatically be granted an Option
for ___________ Shares (a "SUCCEEDING GRANT"), provided the Outside Director is
a member of the Board on such date and has served continuously as a member of
the Board for a period of at least one year since the date of such Outside
Director's Initial Grant.
9.5 Vesting. The date an Outside Director receives an Initial
Grant or a Succeeding Grant is referred to in this Plan as the "START DATE" for
such Option.
(a) Initial Grants. Each Initial Grant will vest as to
_______________% of the Shares on the first anniversary of
the Start Date for such Initial Grant, and as to
_________% of the Shares on each subsequent monthly
anniversary of the Start Date, so long as the Outside
Director continuously remains a director or a consultant
of the Company.
(b) Succeeding Grants. Each Succeeding Grant will vest as to
____________% of the Shares on the first anniversary of
the Start Date for such Succeeding Grant, and as to
____________% of the Shares on each subsequent monthly
anniversary of the Start Date, so long as the Outside
Director continuously remains a director or a consultant
of the Company.
Notwithstanding any provision to the contrary, in the event of a corporate
transaction described in Section 18.1, the vesting of all options granted to
Outside Directors pursuant to this Section 9 will accelerate and such options
will become exercisable in full prior to the consummation of such event at such
times and on such conditions as the Committee determines, and must be exercised,
if at all, within three months of the consummation of said event. Any options
not exercised within such three-month period shall expire.
9.6 Exercise Price. The exercise price of an Option pursuant to
an Initial Grant shall be the Fair Market Value of the Shares, at the time that
the Option is granted.
10. WITHHOLDING TAXES.
10.1 Withholding Generally. Whenever Shares are to be issued in
satisfaction of Awards granted under this Plan, the Company may require the
Participant to remit to the Company an amount sufficient to satisfy federal,
state and local withholding tax requirements prior to the delivery of any
certificate or certificates for such Shares. Whenever, under this Plan, payments
in satisfaction of Awards are to be made in cash, such payment will be net of an
amount sufficient to satisfy federal, state, and local withholding tax
requirements.
10.2 Stock Withholding. When, under applicable tax laws, a
Participant incurs tax liability in connection with the exercise or vesting of
any Award that is subject to tax withholding and the Participant is obligated to
pay the Company the amount required to be withheld, the Committee may in its
sole discretion allow the Participant to satisfy the minimum withholding tax
obligation by electing to have the Company withhold from the Shares to be issued
that number of Shares having a Fair Market Value equal to the minimum amount
required to be withheld, determined on the date that the amount of tax to be
withheld is to be determined. All elections by a
7
<PAGE> 8
Neoforma, Inc.
1999 Equity Incentive Plan
Participant to have Shares withheld for this purpose will be made in accordance
with the requirements established by the Committee and be in writing in a form
acceptable to the Committee.
11. TRANSFERABILITY.
11.1 Except as otherwise provided in this Section 11, Awards
granted under this Plan, and any interest therein, will not be transferable or
assignable by Participant, and may not be made subject to execution, attachment
or similar process, otherwise than by will or by the laws of descent and
distribution or as determined by the Committee and set forth in the Award
Agreement with respect to Awards that are not ISOs.
11.2 All Awards other than NQSO's. All Awards other than NQSO's
shall be exercisable: (i) during the Participant's lifetime, only by (A) the
Participant, or (B) the Participant's guardian or legal representative; and (ii)
after Participant's death, by the legal representative of the Participant's
heirs or legatees.
11.3 NQSOs. Unless otherwise restricted by the Committee, an NQSO
shall be exercisable: (i) during the Participant's lifetime only by (A) the
Participant, (B) the Participant's guardian or legal representative, (C) a
Family Member of the Participant who has acquired the NQSO by "permitted
transfer;" and (ii) after Participant's death, by the legal representative of
the Participant's heirs or legatees. "Permitted transfer" means, as authorized
by this Plan and the Committee in an NQSO, any transfer effected by the
Participant during the Participant's lifetime of an interest in such NQSO but
only such transfers which are by gift or domestic relations order. A permitted
transfer does not include any transfer for value and neither of the following
are transfers for value: (a) a transfer of under a domestic relations order in
settlement of marital property rights or (b) a transfer to an entity in which
more than fifty percent of the voting interests are owned by Family Members or
the Participant in exchange for an interest in that entity.
12. PRIVILEGES OF STOCK OWNERSHIP; RESTRICTIONS ON SHARES..
12.1 Voting and Dividends. No Participant will have any of the
rights of a stockholder with respect to any Shares until the Shares are issued
to the Participant. After Shares are issued to the Participant, the Participant
will be a stockholder and have all the rights of a stockholder with respect to
such Shares, including the right to vote and receive all dividends or other
distributions made or paid with respect to such Shares; provided, that if such
Shares are Restricted Stock, then any new, additional or different securities
the Participant may become entitled to receive with respect to such Shares by
virtue of a stock dividend, stock split or any other change in the corporate or
capital structure of the Company will be subject to the same restrictions as the
Restricted Stock; provided, further, that the Participant will have no right to
retain such stock dividends or stock distributions with respect to Shares that
are repurchased at the Participant's Purchase Price or Exercise Price pursuant
to Section 12.
12.2 Financial Statements. The Company will provide financial
statements to each Participant prior to such Participant's purchase of Shares
under this Plan, and to each Participant annually during the period such
Participant has Awards outstanding; provided, however, the Company will not be
required to provide such financial statements to Participants whose services in
connection with the Company assure them access to equivalent information.
12.3 Restrictions on Shares. At the discretion of the Committee,
the Company may reserve to itself and/or its assignee(s) in the Award Agreement
a right to repurchase a portion of or all Unvested Shares held by a Participant
following such Participant's Termination at any time within ninety (90) days
after the later of Participant's Termination Date and the date Participant
purchases Shares under this Plan, for cash and/or cancellation of purchase money
indebtedness, at the Participant's Exercise Price or Purchase Price, as the case
may be.
13. CERTIFICATES. All certificates for Shares or other securities
delivered under this Plan will be subject to such stock transfer orders, legends
and other restrictions as the Committee may deem necessary or advisable,
including restrictions under any applicable federal, state or foreign securities
law, or any rules, regula-
8
<PAGE> 9
Neoforma, Inc.
1999 Equity Incentive Plan
tions and other requirements of the SEC or any stock exchange or automated
quotation system upon which the Shares may be listed or quoted.
14. ESCROW; PLEDGE OF SHARES. To enforce any restrictions on a
Participant's Shares, the Committee may require the Participant to deposit all
certificates representing Shares, together with stock powers or other
instruments of transfer approved by the Committee, appropriately endorsed in
blank, with the Company or an agent designated by the Company to hold in escrow
until such restrictions have lapsed or terminated, and the Committee may cause a
legend or legends referencing such restrictions to be placed on the
certificates. Any Participant who is permitted to execute a promissory note as
partial or full consideration for the purchase of Shares under this Plan will be
required to pledge and deposit with the Company all or part of the Shares so
purchased as collateral to secure the payment of Participant's obligation to the
Company under the promissory note; provided, however, that the Committee may
require or accept other or additional forms of collateral to secure the payment
of such obligation and, in any event, the Company will have full recourse
against the Participant under the promissory note notwithstanding any pledge of
the Participant's Shares or other collateral. In connection with any pledge of
the Shares, Participant will be required to execute and deliver a written pledge
agreement in such form as the Committee will from time to time approve. The
Shares purchased with the promissory note may be released from the pledge on a
pro rata basis as the promissory note is paid.
15. EXCHANGE AND BUYOUT OF AWARDS. The Committee may, at any time or
from time to time, authorize the Company, with the consent of the respective
Participants, to issue new Awards in exchange for the surrender and cancellation
of any or all outstanding Awards. The Committee may at any time buy from a
Participant an Award previously granted with payment in cash, Shares (including
Restricted Stock) or other consideration, based on such terms and conditions as
the Committee and the Participant may agree.
16. SECURITIES LAW AND OTHER REGULATORY COMPLIANCE. An Award will not be
effective unless such Award is in compliance with all applicable federal and
state securities laws, rules and regulations of any governmental body, and the
requirements of any stock exchange or automated quotation system upon which the
Shares may then be listed or quoted, as they are in effect on the date of grant
of the Award and also on the date of exercise or other issuance. Notwithstanding
any other provision in this Plan, the Company will have no obligation to issue
or deliver certificates for Shares under this Plan prior to: (a) obtaining any
approvals from governmental agencies that the Company determines are necessary
or advisable; and/or (b) completion of any registration or other qualification
of such Shares under any state or federal law or ruling of any governmental body
that the Company determines to be necessary or advisable. The Company will be
under no obligation to register the Shares with the SEC or to effect compliance
with the registration, qualification or listing requirements of any state
securities laws, stock exchange or automated quotation system, and the Company
will have no liability for any inability or failure to do so.
17. NO OBLIGATION TO EMPLOY. Nothing in this Plan or any Award granted
under this Plan will confer or be deemed to confer on any Participant any right
to continue in the employ of, or to continue any other relationship with, the
Company or any Parent or Subsidiary of the Company or limit in any way the right
of the Company or any Parent or Subsidiary of the Company to terminate
Participant's employment or other relationship at any time, with or without
cause.
18. CORPORATE TRANSACTIONS.
18.1 Assumption or Replacement of Awards by Successor. Except for
automatic grants to Outside Directors pursuant to Section 9 hereof, in the event
of (a) a dissolution or liquidation of the Company, (b) a merger or
consolidation in which the Company is not the surviving corporation (other than
a merger or consolidation with a wholly-owned subsidiary, a reincorporation of
the Company in a different jurisdiction, or other transaction in which there is
no substantial change in the stockholders of the Company or their relative stock
holdings and the Awards granted under this Plan are assumed, converted or
replaced by the successor corporation, which assumption will be binding on all
Participants), (c) a merger in which the Company is the surviving corporation
but after which the stockholders of the Company immediately prior to such merger
(other than any
9
<PAGE> 10
Neoforma, Inc.
1999 Equity Incentive Plan
stockholder that merges, or which owns or controls another corporation that
merges, with the Company in such merger) cease to own their shares or other
equity interest in the Company, (d) the sale of substantially all of the assets
of the Company, or (e) the acquisition, sale, or transfer of more than 50% of
the outstanding shares of the Company by tender offer or similar transaction,
any or all outstanding Awards may be assumed, converted or replaced by the
successor corporation (if any), which assumption, conversion or replacement will
be binding on all Participants. In the alternative, the successor corporation
may substitute equivalent Awards or provide substantially similar consideration
to Participants as was provided to stockholders (after taking into account the
existing provisions of the Awards). The successor corporation may also issue, in
place of outstanding Shares of the Company held by the Participants,
substantially similar shares or other property subject to repurchase
restrictions no less favorable to the Participant. In the event such successor
corporation (if any) refuses to assume or substitute Awards, as provided above,
pursuant to a transaction described in this Subsection 18.1, such Awards will
expire on such transaction at such time and on such conditions as the Committee
will determine. Notwithstanding anything in this Plan to the contrary, the
Committee may, in its sole discretion, provide that the vesting of any or all
Awards granted pursuant to this Plan will accelerate upon a transaction
described in this Section 18. If the Committee exercises such discretion with
respect to Options, such Options will become exercisable in full prior to the
consummation of such event at such time and on such conditions as the Committee
determines, and if such Options are not exercised prior to the consummation of
the corporate transaction, they shall terminate at such time as determined by
the Committee.
18.2 Other Treatment of Awards. Subject to any greater rights
granted to Participants under the foregoing provisions of this Section 18, in
the event of the occurrence of any transaction described in Section 18.1, any
outstanding Awards will be treated as provided in the applicable agreement or
plan of merger, consolidation, dissolution, liquidation, or sale of assets.
18.3 Assumption of Awards by the Company. The Company, from time
to time, also may substitute or assume outstanding awards granted by another
company, whether in connection with an acquisition of such other company or
otherwise, by either; (a) granting an Award under this Plan in substitution of
such other company's award; or (b) assuming such award as if it had been granted
under this Plan if the terms of such assumed award could be applied to an Award
granted under this Plan. Such substitution or assumption will be permissible if
the holder of the substituted or assumed award would have been eligible to be
granted an Award under this Plan if the other company had applied the rules of
this Plan to such grant. In the event the Company assumes an award granted by
another company, the terms and conditions of such award will remain unchanged
(except that the exercise price and the number and nature of Shares issuable
upon exercise of any such option will be adjusted appropriately pursuant to
Section 424(a) of the Code). In the event the Company elects to grant a new
Option rather than assuming an existing option, such new Option may be granted
with a similarly adjusted Exercise Price.
19. ADOPTION AND STOCKHOLDER APPROVAL. This Plan will become effective
on the date on which the registration statement filed by the Company with the
SEC under the Securities Act registering the initial public offering of the
Company's Common Stock is declared effective by the SEC (the "EFFECTIVE DATE").
This Plan shall be approved by the stockholders of the Company (excluding Shares
issued pursuant to this Plan), consistent with applicable laws, within twelve
(12) months before or after the date this Plan is adopted by the Board. Upon the
Effective Date, the Committee may grant Awards pursuant to this Plan; provided,
however, that: (a) no Option may be exercised prior to initial stockholder
approval of this Plan; (b) no Option granted pursuant to an increase in the
number of Shares subject to this Plan approved by the Board will be exercised
prior to the time such increase has been approved by the stockholders of the
Company; (c) in the event that initial stockholder approval is not obtained
within the time period provided herein, all Awards granted hereunder shall be
cancelled, any Shares issued pursuant to any Awards shall be cancelled and any
purchase of Shares issued hereunder shall be rescinded; and (d) in the event
that stockholder approval of such increase is not obtained within the time
period provided herein, all Awards granted pursuant to such increase will be
cancelled, any Shares issued pursuant to any Award granted pursuant to such
increase will be cancelled, and any purchase of Shares pursuant to such increase
will be rescinded.
20. TERM OF PLAN/GOVERNING LAW. Unless earlier terminated as provided
herein, this Plan will terminate ten (10) years from the date this Plan is
adopted by the Board or, if earlier, the date of stockholder
10
<PAGE> 11
Neoforma, Inc.
1999 Equity Incentive Plan
approval. This Plan and all agreements thereunder shall be governed by and
construed in accordance with the laws of the State of California.
21. AMENDMENT OR TERMINATION OF PLAN. The Board may at any time
terminate or amend this Plan in any respect, including without limitation
amendment of any form of Award Agreement or instrument to be executed pursuant
to this Plan; provided, however, that the Board will not, without the approval
of the stockholders of the Company, amend this Plan in any manner that requires
such stockholder approval.
22. NONEXCLUSIVITY OF THE PLAN. Neither the adoption of this Plan by the
Board, the submission of this Plan to the stockholders of the Company for
approval, nor any provision of this Plan will be construed as creating any
limitations on the power of the Board to adopt such additional compensation
arrangements as it may deem desirable, including, without limitation, the
granting of stock options and bonuses otherwise than under this Plan, and such
arrangements may be either generally applicable or applicable only in specific
cases.
23. DEFINITIONS. As used in this Plan, the following terms will have the
following meanings:
"AWARD" means any award under this Plan, including any Option,
Restricted Stock or Stock Bonus.
"AWARD AGREEMENT" means, with respect to each Award, the signed
written agreement between the Company and the Participant setting forth the
terms and conditions of the Award.
"BOARD" means the Board of Directors of the Company.
"CAUSE" means the commission of an act of theft, embezzlement,
fraud, dishonesty or a breach of fiduciary duty to the Company or a Parent or
Subsidiary of the Company.
"CODE" means the Internal Revenue Code of 1986, as amended.
"COMMITTEE" means the Compensation Committee of the Board.
"COMPANY" means Neoforma, Inc. or any successor corporation.
"DISABILITY" means a disability, whether temporary or permanent,
partial or total, as determined by the Committee.
"EXCHANGE ACT" means the Securities Exchange Act of 1934, as
amended.
"EXERCISE PRICE" means the price at which a holder of an Option
may purchase the Shares issuable upon exercise of the Option.
"FAIR MARKET VALUE" means, as of any date, the value of a share
of the Company's Common Stock determined as follows:
(a) if such Common Stock is then quoted on the Nasdaq National
Market, its closing price on the Nasdaq National Market on
the date of determination as reported in The Wall Street
Journal;
(b) if such Common Stock is publicly traded and is then listed
on a national securities exchange, its closing price on
the date of determination on the principal national
securities exchange on which the Common Stock is listed or
admitted to trading as reported in The Wall Street
Journal;
11
<PAGE> 12
Neoforma, Inc.
1999 Equity Incentive Plan
(c) if such Common Stock is publicly traded but is not quoted
on the Nasdaq National Market nor listed or admitted to
trading on a national securities exchange, the average of
the closing bid and asked prices on the date of
determination as reported in The Wall Street Journal;
(d) in the case of an Award made on the Effective Date, the
price per share at which shares of the Company's Common
Stock are initially offered for sale to the public by the
Company's underwriters in the initial public offering of
the Company's Common Stock pursuant to a registration
statement filed with the SEC under the Securities Act; or
(e) if none of the foregoing is applicable, by the Committee
in good faith.
"FAMILY MEMBER" includes any of the following:
(a) child, stepchild, grandchild, parent, stepparent,
grandparent, spouse, former spouse, sibling, niece,
nephew, mother-in-law, father-in-law, son-in-law,
daughter-in-law, brother-in-law, or sister-in-law of the
Participant, including any such person with such
relationship to the Participant by adoption;
(b) any person (other than a tenant or employee) sharing the
Participant's household;
(c) a trust in which the persons in (a) and (b) have more than
fifty percent of the beneficial interest;
(d) a foundation in which the persons in (a) and (b) or the
Participant control the management of assets; or
(e) any other entity in which the persons in (a) and (b) or
the Participant own more than fifty percent of the voting
interest.
"INSIDER" means an officer or director of the Company or any
other person whose transactions in the Company's Common Stock are subject to
Section 16 of the Exchange Act.
"OPTION" means an award of an option to purchase Shares pursuant
to Section 5.
"OUTSIDE DIRECTOR" means a member of the Board who is not an
employee of the Company or any Parent, Subsidiary or Affiliate of the Company.
"PARENT" means any corporation (other than the Company) in an
unbroken chain of corporations ending with the Company if each of such
corporations other than the Company owns stock possessing 50% or more of the
total combined voting power of all classes of stock in one of the other
corporations in such chain.
"PARTICIPANT" means a person who receives an Award under this
Plan.
"PERFORMANCE FACTORS" means the factors selected by the Committee
from among the following measures to determine whether the performance goals
established by the Committee and applicable to Awards have been satisfied:
(a) Net revenue and/or net revenue growth;
(b) Earnings before income taxes and amortization and/or
earnings before income taxes and amortization growth;
12
<PAGE> 13
Neoforma, Inc.
1999 Equity Incentive Plan
(c) Operating income and/or operating income growth;
(d) Net income and/or net income growth;
(e) Earnings per share and/or earnings per share growth;
(f) Total stockholder return and/or total stockholder return
growth;
(g) Return on equity;
(h) Operating cash flow return on income;
(i) Adjusted operating cash flow return on income;
(j) Economic value added; and
(k) Individual confidential business objectives.
"PERFORMANCE PERIOD" means the period of service determined by
the Committee, not to exceed five years, during which years of service or
performance is to be measured for Restricted Stock Awards or Stock Bonuses.
"PLAN" means this Neoforma, Inc. 1999 Equity Incentive Plan, as
amended from time to time.
"RESTRICTED STOCK AWARD" means an award of Shares pursuant to
Section 6.
"SEC" means the Securities and Exchange Commission.
"SECURITIES ACT" means the Securities Act of 1933, as amended.
"SHARES" means shares of the Company's Common Stock reserved for
issuance under this Plan, as adjusted pursuant to Sections 2 and 18, and any
successor security.
"STOCK BONUS" means an award of Shares, or cash in lieu of
Shares, pursuant to Section 7.
"SUBSIDIARY" means any corporation (other than the Company) in an
unbroken chain of corporations beginning with the Company if each of the
corporations other than the last corporation in the unbroken chain owns stock
possessing 50% or more of the total combined voting power of all classes of
stock in one of the other corporations in such chain.
"TERMINATION" or "TERMINATED" means, for purposes of this Plan
with respect to a Participant, that the Participant has for any reason ceased to
provide services as an employee, officer, director, consultant, independent
contractor, or advisor to the Company or a Parent or Subsidiary of the Company.
An employee will not be deemed to have ceased to provide services in the case of
(i) sick leave, (ii) military leave, or (iii) any other leave of absence
approved by the Committee, provided, that such leave is for a period of not more
than 90 days, unless reemployment upon the expiration of such leave is
guaranteed by contract or statute or unless provided otherwise pursuant to
formal policy adopted from time to time by the Company and issued and
promulgated to employees in writing. In the case of any employee on an approved
leave of absence, the Committee may make such provisions respecting suspension
of vesting of the Award while on leave from the employ of the Company or a
Subsidiary as it may deem appropriate, except that in no event may an Option be
exercised after the expiration of the term set forth in the Option agreement.
The Committee will have sole discretion to determine whether a Participant has
ceased to provide services and the effective date on which the Participant
ceased to provide services (the "TERMINATION DATE").
13
<PAGE> 14
Neoforma, Inc.
1999 Equity Incentive Plan
"UNVESTED SHARES" means "Unvested Shares" as defined in the Award
Agreement.
"VESTED SHARES" means "Vested Shares" as defined in the Award
Agreement.
14
<PAGE> 1
EXHIBIT 10.04
NEOFORMA, INC.
1999 EMPLOYEE STOCK PURCHASE PLAN
As Adopted ___________________, 1999
1. ESTABLISHMENT OF PLAN. Neoforma, Inc. (the "COMPANY") proposes to
grant options for purchase of the Company's Common Stock to eligible employees
of the Company and its Participating Subsidiaries (as hereinafter defined)
pursuant to this Employee Stock Purchase Plan (this "PLAN"). For purposes of
this Plan, "PARENT CORPORATION" and "SUBSIDIARY" shall have the same meanings as
"parent corporation" and "subsidiary corporation" in Sections 424(e) and 424(f),
respectively, of the Internal Revenue Code of 1986, as amended (the "CODE").
"PARTICIPATING SUBSIDIARIES" are Parent Corporations or Subsidiaries that the
Board of Directors of the Company (the "BOARD") designates from time to time as
corporations that shall participate in this Plan. The Company intends this Plan
to qualify as an "employee stock purchase plan" under Section 423 of the Code
(including any amendments to or replacements of such Section), and this Plan
shall be so construed. Any term not expressly defined in this Plan but defined
for purposes of Section 423 of the Code shall have the same definition herein. A
total of ______________ shares of the Company's Common Stock is reserved for
issuance under this Plan. In addition, on each January 1, the aggregate number
of shares of the Company's Common Stock reserved for issuance under the Plan
shall be increased automatically by a number of shares equal to _________% of
the total number of outstanding shares of the Company Common Stock on the
immediately preceding December 31; provided, that the Board or the Committee may
in its sole discretion reduce the amount of the increase in any particular year;
and, provided further, that the aggregate number of shares issued over the term
of this Plan shall not exceed _______________ shares. Such number shall be
subject to adjustments effected in accordance with Section 14 of this Plan.
2. PURPOSE. The purpose of this Plan is to provide eligible employees of
the Company and Participating Subsidiaries with a convenient means of acquiring
an equity interest in the Company through payroll deductions, to enhance such
employees' sense of participation in the affairs of the Company and
Participating Subsidiaries, and to provide an incentive for continued
employment.
3. ADMINISTRATION. This Plan shall be administered by the Compensation
Committee of the Board (the "COMMITTEE"). Subject to the provisions of this Plan
and the limitations of Section 423 of the Code or any successor provision in the
Code, all questions of interpretation or application of this Plan shall be
determined by the Committee and its decisions shall be final and binding upon
all participants. Members of the Committee shall receive no compensation for
their services in connection with the administration of this Plan, other than
standard fees as established from time to time by the Board for services
rendered by Board members serving on Board committees. All expenses incurred in
connection with the administration of this Plan shall be paid by the Company.
4. ELIGIBILITY. Any employee of the Company or the Participating
Subsidiaries is eligible to participate in an Offering Period (as hereinafter
defined) under this Plan except the following:
(a) employees who are not employed by the Company or a
Participating Subsidiary (10) days before the beginning of such Offering Period,
except that employees who are employed on the Effective Date of the Registration
Statement filed by the Company with the Securities and Exchange Commission
("SEC") under the Securities Act of 1933, as amended (the "SECURITIES ACT")
registering the initial public offering of the Company's Common Stock shall be
eligible to participate in the first Offering Period under the Plan;
(b) employees who are customarily employed for twenty (20) hours
or less per week;
(c) employees who are customarily employed for five (5) months or
less in a calendar year;
(d) employees who, together with any other person whose stock
would be attributed to such employee pursuant to Section 424(d) of the Code, own
stock or hold options to purchase stock possessing five
1
<PAGE> 2
Neoforma, Inc.
1999 Employee Stock Purchase Plan
percent (5%) or more of the total combined voting power or value of all classes
of stock of the Company or any of its Participating Subsidiaries or who, as a
result of being granted an option under this Plan with respect to such Offering
Period, would own stock or hold options to purchase stock possessing five
percent (5%) or more of the total combined voting power or value of all classes
of stock of the Company or any of its Participating Subsidiaries; and
(e) individuals who provide services to the Company or any of its
Participating Subsidiaries as independent contractors who are reclassified as
common law employees for any reason except for federal income and employment tax
purposes.
5. OFFERING DATES. The offering periods of this Plan (each, an "OFFERING
PERIOD") shall be of twenty-four (24) months duration commencing on
________________ and _________________ of each year and ending on
___________________ and _________________ of each year; provided, however, that
notwithstanding the foregoing, the first such Offering Period shall commence on
the first business day on which price quotations for the Company's Common Stock
are available on the Nasdaq National Market (the "FIRST OFFERING DATE") and
shall end on ______________________. Except for the first Offering Period, each
Offering Period shall consist of four (4) six month purchase periods
(individually, a "PURCHASE PERIOD") during which payroll deductions of the
participants are accumulated under this Plan. The first Offering Period shall
consist of no more than five and no fewer than three Purchase Periods, any of
which may be greater or less than six months as determined by the Committee. The
first business day of each Offering Period is referred to as the "OFFERING
DATE". The last business day of each Purchase Period is referred to as the
"PURCHASE DATE". The Committee shall have the power to change the duration of
Offering Periods with respect to offerings without stockholder approval if such
change is announced at least fifteen (15) days prior to the scheduled beginning
of the first Offering Period to be affected.
6. PARTICIPATION IN THIS PLAN. Eligible employees may become
participants in an Offering Period under this Plan on the first Offering Date
after satisfying the eligibility requirements by delivering a subscription
agreement to the Company not later than five (5) days before such Offering Date.
Notwithstanding the foregoing, the Committee may set a later time for filing the
subscription agreement authorizing payroll deductions for all eligible employees
with respect to a given Offering Period. An eligible employee who does not
deliver a subscription agreement to the Company by such date after becoming
eligible to participate in such Offering Period shall not participate in that
Offering Period or any subsequent Offering Period unless such employee enrolls
in this Plan by filing a subscription agreement with the Company not later than
five (5) days preceding a subsequent Offering Date. Once an employee becomes a
participant in an Offering Period, such employee will automatically participate
in the Offering Period commencing immediately following the last day of the
prior Offering Period unless the employee withdraws or is deemed to withdraw
from this Plan or terminates further participation in the Offering Period as set
forth in Section 11 below. Such participant is not required to file any
additional subscription agreement in order to continue participation in this
Plan.
7. GRANT OF OPTION ON ENROLLMENT. Enrollment by an eligible employee in
this Plan with respect to an Offering Period will constitute the grant (as of
the Offering Date) by the Company to such employee of an option to purchase on
the Purchase Date up to that number of shares of Common Stock of the Company
determined by dividing (a) the amount accumulated in such employee's payroll
deduction account during such Purchase Period by (b) the lower of (i)
eighty-five percent (85%) of the fair market value of a share of the Company's
Common Stock on the Offering Date (but in no event less than the par value of a
share of the Company's Common Stock), or (ii) eighty-five percent (85%) of the
fair market value of a share of the Company's Common Stock on the Purchase Date
(but in no event less than the par value of a share of the Company's Common
Stock), provided, however, that the number of shares of the Company's Common
Stock subject to any option granted pursuant to this Plan shall not exceed the
lesser of (x) the maximum number of shares set by the Committee pursuant to
Section 10(c) below with respect to the applicable Purchase Date, or (y) the
maximum number of shares which may be purchased pursuant to Section 10(b) below
with respect to the applicable Purchase Date. The fair market value of a share
of the Company's Common Stock shall be determined as provided in Section 8
below.
8. PURCHASE PRICE. The purchase price per share at which a share of
Common Stock will be sold in any Offering Period shall be eighty-five percent
(85%) of the lesser of:
2
<PAGE> 3
Neoforma, Inc.
1999 Employee Stock Purchase Plan
(a) The fair market value on the Offering Date; or
(b) The fair market value on the Purchase Date.
For purposes of this Plan, the term "FAIR MARKET VALUE" means, as
of any date, the value of a share of the Company's Common Stock determined as
follows:
(a) if such Common Stock is then quoted on the Nasdaq National
Market, its closing price on the Nasdaq National Market on the date of
determination as reported in The Wall Street Journal;
(b) if such Common Stock is publicly traded and is then listed on
a national securities exchange, its closing price on the date of determination
on the principal national securities exchange on which the Common Stock is
listed or admitted to trading as reported in The Wall Street Journal;
(c) if such Common Stock is publicly traded but is not quoted on
the Nasdaq National Market nor listed or admitted to trading on a national
securities exchange, the average of the closing bid and asked prices on the date
of determination as reported in The Wall Street Journal; or
(d) if none of the foregoing is applicable, by the Board in good
faith, which in the case of the First Offering Date will be the price per share
at which shares of the Company's Common Stock are initially offered for sale to
the public by the Company's underwriters in the initial public offering of the
Company's Common Stock pursuant to a registration statement filed with the SEC
under the Securities Act.
9. PAYMENT OF PURCHASE PRICE; CHANGES IN PAYROLL DEDUCTIONS; ISSUANCE OF
SHARES.
(a) The purchase price of the shares is accumulated by regular
payroll deductions made during each Offering Period. The deductions are made as
a percentage of the participant's compensation in one percent (1%) increments
not less than ____________ percent (_________%), nor greater than ___________
percent (______%) or such lower limit set by the Committee. Compensation shall
mean all W-2 cash compensation, including, but not limited to, base salary,
wages, commissions, overtime, shift premiums and bonuses, plus draws against
commissions, provided, however, that for purposes of determining a participant's
compensation, any election by such participant to reduce his or her regular cash
remuneration under Sections 125 or 401(k) of the Code shall be treated as if the
participant did not make such election. Payroll deductions shall commence on the
first payday of the Offering Period and shall continue to the end of the
Offering Period unless sooner altered or terminated as provided in this Plan.
(b) A participant may increase or decrease the rate of payroll
deductions during an Offering Period by filing with the Company a new
authorization for payroll deductions, in which case the new rate shall become
effective for the next payroll period commencing more than fifteen (15) days
after the Company's receipt of the authorization and shall continue for the
remainder of the Offering Period unless changed as described below. Such change
in the rate of payroll deductions may be made at any time during an Offering
Period, but not more than one (1) change may be made effective during any
Purchase Period. A participant may increase or decrease the rate of payroll
deductions for any subsequent Offering Period by filing with the Company a new
authorization for payroll deductions not later than fifteen (15) days before the
beginning of such Offering Period.
(c) A participant may reduce his or her payroll deduction
percentage to zero during an Offering Period by filing with the Company a
request for cessation of payroll deductions. Such reduction shall be effective
beginning with the next payroll period commencing more than fifteen (15) days
after the Company's receipt of the request and no further payroll deductions
will be made for the duration of the Offering Period. Payroll deductions
credited to the participant's account prior to the effective date of the request
shall be used to purchase shares of Common Stock of the Company in accordance
with Section (e) below. A participant may not resume making payroll deductions
during the Offering Period in which he or she reduced his or her payroll
deductions to zero.
3
<PAGE> 4
Neoforma, Inc.
1999 Employee Stock Purchase Plan
(d) All payroll deductions made for a participant are credited to
his or her account under this Plan and are deposited with the general funds of
the Company. No interest accrues on the payroll deductions. All payroll
deductions received or held by the Company may be used by the Company for any
corporate purpose, and the Company shall not be obligated to segregate such
payroll deductions.
(e) On each Purchase Date, so long as this Plan remains in effect
and provided that the participant has not submitted a signed and completed
withdrawal form before that date which notifies the Company that the participant
wishes to withdraw from that Offering Period under this Plan and have all
payroll deductions accumulated in the account maintained on behalf of the
participant as of that date returned to the participant, the Company shall apply
the funds then in the participant's account to the purchase of whole shares of
Common Stock reserved under the option granted to such participant with respect
to the Offering Period to the extent that such option is exercisable on the
Purchase Date. The purchase price per share shall be as specified in Section 8
of this Plan. Any cash remaining in a participant's account after such purchase
of shares shall be refunded to such participant in cash, without interest;
provided, however that any amount remaining in such participant's account on a
Purchase Date which is less than the amount necessary to purchase a full share
of Common Stock of the Company shall be carried forward, without interest, into
the next Purchase Period or Offering Period, as the case may be. In the event
that this Plan has been oversubscribed, all funds not used to purchase shares on
the Purchase Date shall be returned to the participant, without interest. No
Common Stock shall be purchased on a Purchase Date on behalf of any employee
whose participation in this Plan has terminated prior to such Purchase Date.
(f) As promptly as practicable after the Purchase Date, the
Company shall issue shares for the participant's benefit representing the shares
purchased upon exercise of his or her option.
(g) During a participant's lifetime, his or her option to
purchase shares hereunder is exercisable only by him or her. The participant
will have no interest or voting right in shares covered by his or her option
until such option has been exercised.
10. LIMITATIONS ON SHARES TO BE PURCHASED.
(a) No participant shall be entitled to purchase stock under this
Plan at a rate which, when aggregated with his or her rights to purchase stock
under all other employee stock purchase plans of the Company or any Subsidiary,
exceeds $25,000 in fair market value, determined as of the Offering Date (or
such other limit as may be imposed by the Code) for each calendar year in which
the employee participates in this Plan. The Company shall automatically suspend
the payroll deductions of any participant as necessary to enforce such limit
provided that when the Company automatically resumes such payroll deductions,
the Company must apply the rate in effect immediately prior to such suspension.
(b) No more than two hundred percent (200%) of the number of
shares determined by using eighty-five percent (85%) of the fair market value of
a share of the Company's Common Stock on the Offering Date as the denominator
may be purchased by a participant on any single Purchase Date.
(c) No participant shall be entitled to purchase more than the
Maximum Share Amount (as defined below) on any single Purchase Date. Not less
than thirty (30) days prior to the commencement of any Offering Period, the
Committee may, in its sole discretion, set a maximum number of shares which may
be purchased by any employee at any single Purchase Date (hereinafter the
"MAXIMUM SHARE AMOUNT"). Until otherwise determined by the Committee, there
shall be no Maximum Share Amount. In no event shall the Maximum Share Amount
exceed the amounts permitted under Section 10(b) above. If a new Maximum Share
Amount is set, then all participants must be notified of such Maximum Share
Amount prior to the commencement of the next Offering Period. The Maximum Share
Amount shall continue to apply with respect to all succeeding Purchase Dates and
Offering Periods unless revised by the Committee as set forth above.
(d) If the number of shares to be purchased on a Purchase Date by
all employees participating in this Plan exceeds the number of shares then
available for issuance under this Plan, then the Company will make a pro rata
allocation of the remaining shares in as uniform a manner as shall be reasonably
practicable and as the
4
<PAGE> 5
Neoforma, Inc.
1999 Employee Stock Purchase Plan
Committee shall determine to be equitable. In such event, the Company shall give
written notice of such reduction of the number of shares to be purchased under a
participant's option to each participant affected.
(e) Any payroll deductions accumulated in a participant's account
which are not used to purchase stock due to the limitations in this Section 10
shall be returned to the participant as soon as practicable after the end of the
applicable Purchase Period, without interest.
11. WITHDRAWAL.
(a) Each participant may withdraw from an Offering Period under
this Plan by signing and delivering to the Company a written notice to that
effect on a form provided for such purpose. Such withdrawal may be elected at
any time at least fifteen (15) days prior to the end of an Offering Period.
(b) Upon withdrawal from this Plan, the accumulated payroll
deductions shall be returned to the withdrawn participant, without interest, and
his or her interest in this Plan shall terminate. In the event a participant
voluntarily elects to withdraw from this Plan, he or she may not resume his or
her participation in this Plan during the same Offering Period, but he or she
may participate in any Offering Period under this Plan which commences on a date
subsequent to such withdrawal by filing a new authorization for payroll
deductions in the same manner as set forth in Section 6 above for initial
participation in this Plan.
(c) If the Fair Market Value on the first day of the current
Offering Period in which a participant is enrolled is higher than the Fair
Market Value on the first day of any subsequent Offering Period, the Company
will automatically enroll such participant in the subsequent Offering Period.
Any funds accumulated in a participant's account prior to the first day of such
subsequent Offering Period will be applied to the purchase of shares on the
Purchase Date immediately prior to the first day of such subsequent Offering
Period, if any.
12. TERMINATION OF EMPLOYMENT. Termination of a participant's employment
for any reason, including retirement, death or the failure of a participant to
remain an eligible employee of the Company or of a Participating Subsidiary,
immediately terminates his or her participation in this Plan. In such event, the
payroll deductions credited to the participant's account will be returned to him
or her or, in the case of his or her death, to his or her legal representative,
without interest. For purposes of this Section 12, an employee will not be
deemed to have terminated employment or failed to remain in the continuous
employ of the Company or of a Participating Subsidiary in the case of sick
leave, military leave, or any other leave of absence approved by the Board;
provided that such leave is for a period of not more than ninety (90) days or
reemployment upon the expiration of such leave is guaranteed by contract or
statute.
13. RETURN OF PAYROLL DEDUCTIONS. In the event a participant's interest
in this Plan is terminated by withdrawal, termination of employment or
otherwise, or in the event this Plan is terminated by the Board, the Company
shall deliver to the participant all payroll deductions credited to such
participant's account. No interest shall accrue on the payroll deductions of a
participant in this Plan.
14. CAPITAL CHANGES. Subject to any required action by the stockholders
of the Company, the number of shares of Common Stock covered by each option
under this Plan which has not yet been exercised and the number of shares of
Common Stock which have been authorized for issuance under this Plan but have
not yet been placed under option (collectively, the "RESERVES"), as well as the
price per share of Common Stock covered by each option under this Plan which has
not yet been exercised, shall be proportionately adjusted for any increase or
decrease in the number of issued and outstanding shares of Common Stock of the
Company resulting from a stock split or the payment of a stock dividend (but
only on the Common Stock) or any other increase or decrease in the number of
issued and outstanding shares of Common Stock effected without receipt of any
consideration by the Company; provided, however, that conversion of any
convertible securities of the Company shall not be deemed to have been "effected
without receipt of consideration". Such adjustment shall be made by the
Committee, whose determination shall be final, binding and conclusive. Except as
expressly provided herein, no issue by the Company of shares of stock of any
class, or securities convertible into shares of stock of any class, shall
affect, and no
5
<PAGE> 6
Neoforma, Inc.
1999 Employee Stock Purchase Plan
adjustment by reason thereof shall be made with respect to, the number or price
of shares of Common Stock subject to an option.
In the event of the proposed dissolution or liquidation of the
Company, the Offering Period will terminate immediately prior to the
consummation of such proposed action, unless otherwise provided by the
Committee. The Committee may, in the exercise of its sole discretion in such
instances, declare that this Plan shall terminate as of a date fixed by the
Committee and give each participant the right to purchase shares under this Plan
prior to such termination. In the event of (i) a merger or consolidation in
which the Company is not the surviving corporation (other than a merger or
consolidation with a wholly-owned subsidiary, a reincorporation of the Company
in a different jurisdiction, or other transaction in which there is no
substantial change in the stockholders of the Company or their relative stock
holdings and the options under this Plan are assumed, converted or replaced by
the successor corporation, which assumption will be binding on all
participants), (ii) a merger in which the Company is the surviving corporation
but after which the stockholders of the Company immediately prior to such merger
(other than any stockholder that merges, or which owns or controls another
corporation that merges, with the Company in such merger) cease to own their
shares or other equity interest in the Company, (iii) the sale of all or
substantially all of the assets of the Company or (iv) the acquisition, sale, or
transfer of more than 50% of the outstanding shares of the Company by tender
offer or similar transaction, the Plan will continue with regard to Offering
Periods that commenced prior to the closing of the proposed transaction and
shares will be purchased based on the Fair Market Value of the surviving
corporation's stock on each Purchase Date, unless otherwise provided by the
Committee consistent with pooling of interests accounting treatment.
The Committee may, if it so determines in the exercise of its
sole discretion, also make provision for adjusting the Reserves, as well as the
price per share of Common Stock covered by each outstanding option, in the event
that the Company effects one or more reorganizations, recapitalizations, rights
offerings or other increases or reductions of shares of its outstanding Common
Stock, or in the event of the Company being consolidated with or merged into any
other corporation.
15. NONASSIGNABILITY. Neither payroll deductions credited to a
participant's account nor any rights with regard to the exercise of an option or
to receive shares under this Plan may be assigned, transferred, pledged or
otherwise disposed of in any way (other than by will, the laws of descent and
distribution or as provided in Section 22 below) by the participant. Any such
attempt at assignment, transfer, pledge or other disposition shall be void and
without effect.
16. REPORTS. Individual accounts will be maintained for each participant
in this Plan. Each participant shall receive promptly after the end of each
Purchase Period a report of his or her account setting forth the total payroll
deductions accumulated, the number of shares purchased, the per share price
thereof and the remaining cash balance, if any, carried forward to the next
Purchase Period or Offering Period, as the case may be.
17. NOTICE OF DISPOSITION. Each participant shall notify the Company in
writing if the participant disposes of any of the shares purchased in any
Offering Period pursuant to this Plan if such disposition occurs within two (2)
years from the Offering Date or within one (1) year from the Purchase Date on
which such shares were purchased (the "NOTICE PERIOD"). The Company may, at any
time during the Notice Period, place a legend or legends on any certificate
representing shares acquired pursuant to this Plan requesting the Company's
transfer agent to notify the Company of any transfer of the shares. The
obligation of the participant to provide such notice shall continue
notwithstanding the placement of any such legend on the certificates.
18. NO RIGHTS TO CONTINUED EMPLOYMENT. Neither this Plan nor the grant
of any option hereunder shall confer any right on any employee to remain in the
employ of the Company or any Participating Subsidiary, or restrict the right of
the Company or any Participating Subsidiary to terminate such employee's
employment.
19. EQUAL RIGHTS AND PRIVILEGES. All eligible employees shall have equal
rights and privileges with respect to this Plan so that this Plan qualifies as
an "employee stock purchase plan" within the meaning of Section 423 or any
successor provision of the Code and the related regulations. Any provision of
this Plan which is inconsistent with Section 423 or any successor provision of
the Code shall, without further act or amendment by the
6
<PAGE> 7
Neoforma, Inc.
1999 Employee Stock Purchase Plan
Company, the Committee or the Board, be reformed to comply with the requirements
of Section 423. This Section 19 shall take precedence over all other provisions
in this Plan.
20. NOTICES. All notices or other communications by a participant to the
Company under or in connection with this Plan shall be deemed to have been duly
given when received in the form specified by the Company at the location, or by
the person, designated by the Company for the receipt thereof.
21. TERM; STOCKHOLDER APPROVAL. After this Plan is adopted by the Board,
this Plan will become effective on the First Offering Date (as defined above).
This Plan shall be approved by the stockholders of the Company, in any manner
permitted by applicable corporate law, within twelve (12) months before or after
the date this Plan is adopted by the Board. No purchase of shares pursuant to
this Plan shall occur prior to such stockholder approval. This Plan shall
continue until the earlier to occur of (a) termination of this Plan by the Board
(which termination may be effected by the Board at any time), (b) issuance of
all of the shares of Common Stock reserved for issuance under this Plan, or (c)
ten (10) years from the adoption of this Plan by the Board.
22. DESIGNATION OF BENEFICIARY.
(a) A participant may file a written designation of a beneficiary
who is to receive any shares and cash, if any, from the participant's account
under this Plan in the event of such participant's death subsequent to the end
of an Purchase Period but prior to delivery to him of such shares and cash. In
addition, a participant may file a written designation of a beneficiary who is
to receive any cash from the participant's account under this Plan in the event
of such participant's death prior to a Purchase Date.
(b) Such designation of beneficiary may be changed by the
participant at any time by written notice. In the event of the death of a
participant and in the absence of a beneficiary validly designated under this
Plan who is living at the time of such participant's death, the Company shall
deliver such shares or cash to the executor or administrator of the estate of
the participant, or if no such executor or administrator has been appointed (to
the knowledge of the Company), the Company, in its discretion, may deliver such
shares or cash to the spouse or to any one or more dependents or relatives of
the participant, or if no spouse, dependent or relative is known to the Company,
then to such other person as the Company may designate.
23. CONDITIONS UPON ISSUANCE OF SHARES; LIMITATION ON SALE OF SHARES.
Shares shall not be issued with respect to an option unless the exercise of such
option and the issuance and delivery of such shares pursuant thereto shall
comply with all applicable provisions of law, domestic or foreign, including,
without limitation, the Securities Act, the Securities Exchange Act of 1934, as
amended, the rules and regulations promulgated thereunder, and the requirements
of any stock exchange or automated quotation system upon which the shares may
then be listed, and shall be further subject to the approval of counsel for the
Company with respect to such compliance.
24. APPLICABLE LAW. The Plan shall be governed by the substantive laws
(excluding the conflict of laws rules) of the State of California.
25. AMENDMENT OR TERMINATION OF THIS PLAN. The Board may at any time
amend, terminate or extend the term of this Plan, except that any such
termination cannot affect options previously granted under this Plan, nor may
any amendment make any change in an option previously granted which would
adversely affect the right of any participant, nor may any amendment be made
without approval of the stockholders of the Company obtained in accordance with
Section 21 above within twelve (12) months of the adoption of such amendment (or
earlier if required by Section 21) if such amendment would:
(a) increase the number of shares that may be issued under
this Plan; or
(b) change the designation of the employees (or class of
employees) eligible for participation in this Plan.
7
<PAGE> 8
Neoforma, Inc.
1999 Employee Stock Purchase Plan
Notwithstanding the foregoing, the Board may make such amendments
to the Plan as the Board determines to be advisable, if the continuation of the
Plan or any Offering Period would result in financial accounting treatment for
the Plan that is different from the financial accounting treatment in effect on
the date this Plan is adopted by the Board.
8
<PAGE> 1
EXHIBIT 10.08
CONSULTING AGREEMENT
This Agreement (the "Agreement") is made by and between Neoforma, Inc.,
a California corporation (the "Company") and Madhavan Rangaswami (the
"Consultant") as of July 1, 1999.
1. Services. The Consultant shall provide to the Company the
services set forth in paragraph 1 of Exhibit A in accordance with the terms and
conditions contained in this Agreement.
2. Term. Unless terminated in accordance with the provisions of
paragraph 7 hereof, the services provided by the Consultant to the Company shall
be performed during the period set forth in paragraph 2 of Exhibit A. The
Consultant shall coordinate his work efforts and report his progress regularly
to the individual set forth in paragraph 3 of Exhibit A.
3. Payment for Service Rendered. For providing the consulting
services as defined herein, the Company shall deliver to the Consultant the
consideration described in paragraph 4 of Exhibit A. The Company shall reimburse
the Consultant for all reasonable expenses provided the Company has approved
expenses above $500.00 per month in advance and in writing.
4. Nature of Relationship. The Consultant is an independent
contractor. The Consultant will not act as an agent nor shall he be deemed an
employee of the Company for the purposes of any employee benefit program,
income tax withholding, FICA taxes, unemployment benefits or otherwise. The
Consultant shall not enter into any agreement or incur any obligations on the
Company's behalf, or commit the Company in any manner without the Company's
prior written consent.
5. Confidentiality.
(a) The Consultant agrees that he shall not use (except for
the Company's benefit) or divulge to anyone either during the term of this
Agreement or thereafter any of the Company's trade secrets or other proprietary
data or information of any kind whatsoever acquired by the Consultant. The
Consultant further agrees that upon completion or termination of this
Agreement, he will turn over to the Company any notebook, data, information or
other material acquired or compiled by the Consultant in carrying out the terms
of the Agreement. However, the Consultant may keep one copy of such material
for archival purposes.
(b) The Consultant represents that his performance of the
terms of the Agreement does not and will not conflict with the terms of any
agreement to keep in confidence proprietary information and trade secrets
acquired in confidence or in trust prior to his consulting relationship with
the Company. The Consultant will not disclose to the Company, or induce the
Company to use, any confidential or proprietary information or material
belonging to any third party.
(c) The Consultant represents that he is not presently
retained by any entity that manufactures or sells products competitive with
those of the Company and he agrees that he will not
1
<PAGE> 2
accept such retention during the term of this Agreement without prior written
approval of the Company.
6. Inventions. The Consultant shall promptly and fully disclose to the
Company any and all inventions, improvements, discoveries, developments,
original works of authorship, software, trade secrets or other intellectual
property conceived, developed or reduced to practice by the Consultant during
the term of this Agreement and in any way relating to (a) the current research
and development of the Company, and (b) the services performed by the Consultant
under this Agreement (collectively, the "Information"). The Consultant shall
treat all of the Information as the proprietary property of the Company. The
Consultant agrees to assign, and does hereby assign, to the Company and its
successors and assigns, without further consideration, the Consultant's entire
right, title and interest in and to the Information whether or not patentable or
copyrightable. The Consultant further agrees to execute all applications for
patents and/or copyrights, domestic or foreign, assignments and other papers
necessary to secure and enforce rights related to the Information.
7. Indemnification. The Company will defend at its expense, any legal
proceeding brought against the Consultant, to the extent that it is based on a
claim that any services performed by the Consultant have resulted in a product
that is defectively designed or directly infringes a copyright or U.S. patent,
and will pay all settlements approved by the Company (which such approval shall
not be unreasonably withheld) and damages and court costs awarded by a court of
final appeal attributable to such a claim; provided that the Consultant: (a)
provides notice of the claim promptly to the Company; (b) gives to the Company
initial control of the defense of the same; (c) provides to the Company all
available information, assistance and authority to defend; and (d) has not
compromised or settled such proceeding without the prior written consent of the
Company.
8. Miscellaneous.
(a) This Agreement shall be governed by and construed in
accordance with the laws of the State of California. The federal and state
courts within the State of California shall have exclusive jurisdiction to
adjudicate any dispute arising out of this Agreement. The parties consent to
personal jurisdiction of the federal and state courts within California and
service of process being effected by registered mail sent to the address set
forth at the end of this Agreement.
(b) This Agreement may not be and shall not be deemed or
construed to have been modified, amended, rescinded, canceled or waived in whole
or in part, except by written instruments signed by the parties hereto. No
failure on the part of either party to exercise, and no delay in exercising, any
right or remedy hereunder shall operate as a waiver thereof; nor shall any
single or partial exercise of any right or remedy hereunder preclude any other
or further exercise thereof or the exercise of any other right or remedy granted
hereby or by any related document or by law.
-2-
<PAGE> 3
(c) This Agreement, including the exhibit attached hereto and made a
part hereof, constitutes and expresses the entire agreement and understanding
between the parties with respect to the services to be provided by the
Consultant. All previous discussions, promises, representations and
understandings between the parties relative to this Agreement, if any, have
been merged into this document. The provisions of paragraphs 5 and 6 shall
survive the termination of this Agreement. The terms and provisions of this
Agreement shall be binding on and inure to the benefit of the parties, their
heirs, legal representatives, successors and assigns.
(d) The Consultant may not subcontract all or any part of the
services to be provided hereunder without the prior written consent of the
Company.
IN WITNESS WHEREOF, the parties have executed this Agreement as of the
date first set forth above.
NEOFORMA, INC. CONSULTANT
a Delaware Corporation
By: ____________________ ____________________
Name: Robert Zollars Madhavan Rangaswami
Title: President and CEO
-3-
<PAGE> 4
EXHIBIT A TO
EXHIBIT 10.08
EXHIBIT A
NAME OF CONSULTANT: Madhavan Rangaswami
1. Description of consulting services:
Consultant shall perform the following functions, including but not
limited to:
o Consulting regarding marketing activities.
o Consulting regarding executive recruiting.
o Consulting regarding investment bankers.
2. Term of Agreement:
The initial term of this Agreement shall be three (3) months; provided
that at the end of such initial term the Company and Consultant may
extend the term of this Agreement for additional periods as determined
by the Company, upon the mutual agreement of the parties for additional
consideration.
3. The Consultant shall report to:
The Consultant shall report to the Company's Chief Executive Officer,
who is currently Robert J. Zollars.
4. Consideration for services:
As consideration for services, the Consultant shall receive the
following consideration:
(i) Subject to the discretion of the Board of Directors,
Consultant shall receive a stock option for 95,325 shares of the
Company's Common Stock which 50% vests immediately and the
remaining 50% is to vest monthly over the three months following
the date of this Agreement. The shares shall be subject to the
terms and conditions of such option agreement.
-4-
<PAGE> 1
EXHIBIT 10.10
EMPLOYMENT AGREEMENT
This Employment Agreement (the "EMPLOYMENT AGREEMENT") is made this
_____ day of August, 1999, by and between Neoforma GAR, Inc., a Delaware
corporation, (the "COMPANY"), Neoforma, Inc., a Delaware corporation,
("NEOFORMA"), and Erik Tivin of Buffalo Grove, Illinois (the "EMPLOYEE").
RECITALS
The Company has acquired all of the issued and outstanding securities
(the "SECURITIES PURCHASE") of General Asset Recovery, LLC, ("GAR") pursuant to
the terms of a certain Securities Purchase Agreement dated July 16th, 1999,
which provided for the employment of the Employee by the Company.
The Company and the Employee acknowledge that the Employee's abilities
and services are essential to the prospects of the Company, the Company desires
to hire the Employee as its President, and the Employee desires to accept such
employment.
The parties hereto desire to enter into a comprehensive agreement to
set forth the terms and conditions pursuant to which the Employee shall be
employed by the Company.
NOW, THEREFORE, in consideration of Employee's employment by the
Company, the mutual covenants and agreements hereinafter set forth, and for
other good and valuable consideration, the receipt and sufficiency of which are
hereby acknowledged, the Company and the Employee, intending to be legally
bound, agree as follows:
1. Employment. The Company hereby agrees to employ the Employee, and
the Employee hereby accepts employment, all upon the terms, conditions and
covenants set forth in this Employment Agreement which the Company and Employee
agree are reasonable.
2. Duties. The Employee shall serve on a full-time basis as the
Company's President, with all powers and duties customarily associated with such
title and as are otherwise set forth herein, and shall:
(a) faithfully and diligently perform the duties of President of the
Company, and Vice President of Neoforma, the Company's parent company;
(b) comply with the overall reasonable business policies established
by the Chief Executive Officer (the "CHIEF EXECUTIVE OFFICER") of Neoforma, or
by the Board of Directors (the "BOARD OF DIRECTORS") of Neoforma; and
(c) do all things reasonably within his power to promote, develop,
operate and expand the "business of the Company" in a manner designed to meet
with the projections set forth on Schedule A hereto. For the purposes of setting
forth the duties of the Employee in
1
<PAGE> 2
this Section 2, the "business of the Company" shall include, (i) the business
operated as GAR prior to its acquisition by the Company, which the Employee
agrees to operate in substantially the same manner as it was operated by him
prior to such acquisition; (ii) a medical equipment auction business, which may
include Neoforma Trade, over which the Employee is given oversight, whether such
business is operated directly through the Company or otherwise; and (iii) the
asset management business operated by Neoforma prior to the acquisition of GAR
by the Company, whether operated through the Company or otherwise.
The Employee agrees to perform such other related duties as may be
delegated to the Employee from time to time by the Chief Executive Officer or by
the Board of Directors. The Employee shall devote his full time and reasonable
business efforts in the performance of his duties and shall not have any outside
employment while employed on a full-time basis by the Company. The Employee
shall report directly to the Chief Executive Officer or a similar level
executive officer of Neoforma appointed by the Board of Directors, and shall be
required to submit a monthly operations report to such Chief Executive Officer
or such other officer on or before the fifteenth day of each month with respect
to the Company's operations for the prior month. The Employee shall not be
required to relocate his base of employment outside of the State of Illinois.
3. Term. The term of this Employment Agreement shall begin on the date
hereof (the "EFFECTIVE DATE") and shall continue until the earlier of December
31, 2001 or the date of any termination hereunder (the "TERM").
4. Compensation. All compensation paid or payable hereunder shall be
deemed to be paid or payable by the Company in accordance with the Company's
general policy, as set forth in the Company's written manuals, unless this
Employment Agreement specifically states otherwise.
(a) Salary. During the Term of this Employment Agreement, the
Company shall pay to the Employee, in consideration for the services provided by
him hereunder, an annual base salary in the minimum of One Hundred Thousand
Dollars ($100,000) per year (the "ANNUAL SALARY"), which amount shall be payable
in accordance with Neoforma's customary payroll practices and shall be prorated
for any partial years of employment hereunder. The Board of Directors shall have
the right but not the obligation to increase the amount of the Annual Salary
based upon the performance of the Company and the Employee.
(b) Bonus. As further compensation, provided Employee remains
employed by the Company, Employee shall be entitled to receive an annual bonus
payable following the completion of each year during the Term, based on the
level of sales attained by the Company, which bonus shall be calculated in the
manner set forth on Schedule B attached hereto but which shall not be less than
Fifty Thousand Dollars ($50,000) per year.
(c) Stock Options. In consideration of his continued employment
hereunder, the Employee shall be granted options to purchase up to Five Hundred
Fifty
2
<PAGE> 3
Thousand (550,000) shares of the common stock, $0.001 par value, of Neoforma,
which options shall be exercisable at a price of $0.10 per share. The options
shall vest (i) at a rate of Thirty Three Thousand Three Hundred Thirty Three
(33,333) shares per month during each of months one through twelve following the
closing date of the Securities Purchase (the "CLOSING Date") (on the same date
of each month as the Closing Date), and (ii) at the rate of Four Thousand One
Hundred Sixty Seven (4,167) shares per month during each of months thirteen
through forty-seven, with the balance of the remaining options to vest in month
forty-eight, following the Closing Date (on the same day of each month as the
Closing Date). Notwithstanding the foregoing, in the event Employee ceases to be
employed by the Company during the term of this Employment Agreement, other than
if Employee is terminated by the Company without cause as defined in Section 9,
Employee shall forfeit the right to exercise any options which have not yet
vested. The options being issued hereunder shall be exercisable for a period of
seven years and shall be issued pursuant to Neoforma's 19__ Employee Stock
Option Plan.
5. Benefits. All benefits paid or payable hereunder shall be deemed to
be paid or payable by the Company in accordance with the Company's general
policy, as set forth in the Company's written manuals, unless this Employment
Agreement specifically states otherwise.
(a) Vacation, Paid Holidays. During the Term, the Employee shall be
entitled to take twenty-two (22) days of paid time off, unless otherwise agreed
upon by the Employee and the Company. The Employee shall also be entitled to
paid absence for all holidays provided by the Company to its other employees
plus any other holiday upon which the Company is closed for business. Nothing
herein shall prohibit the Company from changing the holidays which it observes
hereafter.
(b) Other Benefits. During the Term, the Employee shall be entitled
to participate (to the extent that he is eligible) in all other employee
benefits, if any, provided by the Company under the same terms and conditions as
provided for its other executive officers including but not limited to: (i)
health and disability insurance under such policies or plans as the Company may
adopt; (ii) participation in such 401(k) plan as the Company may establish; and
(iii) term life insurance coverage in such amounts and under such policies or
plans as the Company may adopt.
(c) Automobile Allowance. The Employee shall be entitled each month
to an automobile allowance in the amount of One Thousand Four Hundred Dollars
($1,400) which shall be used for automobile related expenses incurred by the
Employee in the performance of his duties hereunder.
6. Reimbursement for Expenses. Upon the submission of appropriate
invoices or vouchers, the Employee shall be entitled to reimbursement for all
reasonable expenses that he incurs in the performance of his duties under this
Employment Agreement in furthering the
3
<PAGE> 4
business and policies of the Company, such reimbursement to be paid in
accordance with Neoforma's customary expense reimbursement practices.
7. Key Person Life Insurance. The Company shall have the right but not
the obligation to maintain and pay for a key person life insurance policy on the
life of the Employee, as to which the Company shall be the sole beneficiary and
owner. The Employee agrees upon the execution of this Employment Agreement to
cooperate fully with the Company and to provide the Company with all necessary
documents in order for the Company to obtain such policy.
8. Withholding. The Company shall withhold or deduct from the
Employee's cash compensation any amounts required by law to be so withheld or
deducted.
9. Termination by The Company.
(a) This Employment Agreement may be terminated by the Company upon
the occurrence of any of the following:
(i) the Employee's death. If the Employee dies during the Term,
the Company's obligations under this Employment Agreement shall terminate
immediately and the Employee's estate shall be entitled to all arrearages of
salary and expenses but shall not be entitled to further compensation unless
otherwise specifically provided for under this Employment Agreement.
(ii) the action by the Board of Directors following the
Employee's "disability". For this purpose, "disability" means a physical or
mental illness or other incapacity which renders the Employee unable to perform
substantially all of his duties for a period of six (6) months. For purposes of
this Employment Agreement, disability shall be deemed a continuation of any
prior disability if the disability is related to the prior disability and
commences within twelve (12) months of the termination of the prior disability.
Disability, and any relation to any prior disability, shall be determined by a
physician acceptable to the Company and the Employee provided that if the
Company and the Employee fail to agree on a mutually acceptable physician, a
third physician shall be chosen by each party's physician and any determination
by such third physician shall be binding. If the Employee becomes disabled
during the Term, the Employee may pursue his rights under any disability plan
maintained by the Company.
(iii) the action of Neoforma's Board of Directors for Cause.
"Cause" is defined as the occurrence of any of the following events: (A) fraud,
misappropriation, embezzlement or intentional misconduct on the part of the
Employee, (B) the Employee's willful failure to substantially perform his duties
for the Company when, and to the extent, requested by the Board of Directors, or
its lawfully designated representative, to do so and failure to correct same
within five (5) business days after notice from the Board of Directors or its
lawfully designated representative requesting the Employee to do so, which has a
materially
4
<PAGE> 5
adverse effect upon the Company, or (C) the Employee's willful breach of any
material provision of this Employment Agreement and such breach continues for a
period of five (5) business days after notice from the Board of Directors or its
lawfully designated representative of such breach. Termination by the Company
for cause will be effective immediately upon receipt by the Employee of notice
of such termination.
(b) Termination of Benefits. In the event of any termination by the
Company for "cause" pursuant to Section 9 (a) hereof, or any voluntary
termination by the Employee, in addition to the termination of the various
benefits and compensation payable to the Employee hereunder generally, the
benefits provided for pursuant to Section 4 of this Employment Agreement shall,
to the extent not yet accrued or vested, automatically cease and terminate, and
any and all unvested stock options held by Employee in Neoforma shall
automatically expire.
(c) Survival. Notwithstanding anything else in this Employment
Agreement, the provisions of Section 10 (Confidentiality), Section 11
(Non-Competition and Non-Solicitation), Section 12 (Developments), Section 13
(Representations and Warranties) and Section 23 (Equitable Remedies) shall
survive the termination of the Employee's employment with the Company, if by the
Company, for "cause" or by the Employee. In the event the Employee's employment
hereunder is terminated by the Company without cause, or due to the bankruptcy
or insolvency of the Company, or due to any material breach of this Employment
Agreement by the Company, the only provision of this Employment Agreement which
shall survive shall be Section 10 (Confidentiality) to the extent that it deals
with Confidential Information of the Company which existed prior to the date of
this Employment Agreement.
10. Confidentiality. During the Term of this Employment Agreement and
thereafter, the Employee hereby covenants and agrees that he shall not other
than for the benefit of the Company publish, disclose to any third party or in
any way use for his own benefit any confidential information ("Confidential
Information"), including without limitation, any balance sheet or income
statement information (including but not limited to the value, amount or
condition of capital assets and/or inventory, sales figures, profitability,
etc.), or any other financial data, banking information, credit information,
trade secrets, financial statements or related data, customer lists or
information pertaining to customers or any unique distribution, manufacturing,
marketing and research methods of the Company or its parent or affiliates (or
formerly of General Asset Recovery, LLC), and any other Confidential Information
concerning the Company's or its parent or affiliate's, business, structure or
affairs, (or the business, structure or affairs formerly of General Asset
Recovery, LLC). All Confidential Information and copies thereof are the sole
property of the Company and Employee shall deliver promptly to the Company at
the termination of his employment or at any time as the Board of Directors may
request, without retaining copies, any Confidential Information made, compiled,
delivered, made available or otherwise obtained by Employee. Employee shall also
use his best efforts and exercise utmost diligence to protect and safeguard the
Confidential Information of the Company's customers, contractors and others with
whom
5
<PAGE> 6
the Company has a business relationship, whether learned or acquired by Employee
during the course of his employment by the Company.
The nondisclosure obligations of this Section 10 shall not apply to:
(a) information that may be disclosed generally or is in the public domain
through no fault of the Employee; (b) information received from a third party
outside the Company that was disclosed without a breach of any confidentiality
obligation; (c) information approved for release by written authorization of the
Company; or (d) information that may be required by law or an order of any
court, agency or proceeding to be disclosed. This Section 10 shall remain in
effect notwithstanding any termination of this Employment Agreement.
11. Non-Competition and Non-Solicitation.
(a) During the time Employee is employed by the Company, Employee
shall devote his full time and efforts to the business of the Company and shall
not participate, directly or indirectly, in any capacity, in any business or
activity that is in competition with the Company. For a period of eighteen (18)
months after the termination of employment with the Company for any reason: (i)
Employee shall not hire or attempt to hire any employee of the Company, or
assist in such hiring by anyone else, or encourage any employee to terminate his
or her employment with the Company; (ii) Employee shall not participate,
directly or indirectly, in any capacity, in any business or activity that is in
competition with the Company in the medical equipment re-sale industry, medical
facility planning industry or in any other business in which the Company is
engaged, in any state in which the Company does business; and (iii) Employee
shall not cause or assist to cause any of the customers of the Company with whom
Employee communicated, dealt with or became acquainted during his term of
employment with the Company to enter into contractual arrangements with himself
or any other person, firm, partnership, corporation or other company in any
business or activity that is in competition with the Company.
(b) "Blue Pencil" Rule. The Employee and the Company desire that
the provisions of this Section 11 be enforced to the fullest extent permissible
under the laws and public policies applied in each jurisdiction in which
enforcement is sought. If a court of competent jurisdiction, however, determines
that any restrictions imposed on the Employee in this Section are unreasonable
or unenforceable because of duration, area of restriction, or otherwise, the
Employee and the Company agree and intend that the court shall enforce this
Section 11 to whatever extent the court deems reasonable to effect the intent of
this Section 11.
(c) Legitimate Purpose. The Employee has read carefully all of the
terms and conditions of this Section 11 and agrees that the restraints set forth
herein (i) are reasonable and necessary to support the legitimate business
interests and goodwill of the Company, and (ii) will not preclude the Employee
from earning a livelihood during the life of this Section 11.
6
<PAGE> 7
12. Developments. All Confidential Information and all other
discoveries, inventions, processes, methods, and improvements conceived,
developed, or otherwise made by Employee at any time, alone or with others, and
in any way relating to the Company's present or future business or products,
whether or not patentable or subject to copyright protection and whether or not
reduced to tangible form or reduced to practice, during the Term of employment
("DEVELOPMENTS"), shall be the sole property of the Company. Employee agrees to
and hereby does assign to the Company all right, title, and interest throughout
the world in and to all Developments and agrees to promptly disclose such
Developments to the Company and take all such actions reasonably requested by
the Company to establish and confirm the Company's ownership of such
Developments. Employee agrees that all such Developments shall constitute works
made for hire under the copyright laws of the United States and hereby assigns
to the Company all copyrights, patents, trademarks and other proprietary rights
the Employee may have in such Developments.
13. Representations and Warranties. Prior to the execution and delivery
of this Employment Agreement, the Employee represents and warrants that he has
terminated all of his obligations under any other employment agreement or other
similar agreement, whether written or oral, with any other party. The Employee
has delivered copies of all such employment or other agreements and evidence
satisfactory to the Company of the termination of such agreements. The Employee
represents and warrants that the execution of this Employment Agreement will not
result in a breach of any written agreement to which the Employee is a party or
by which the Employee is bound. The Employee covenants and agrees to defend,
indemnify and hold harmless the Company, its affiliates and its successors and
assigns against any and all claims, damages, liabilities, suits, actions, costs,
charges and expenses, including, without limitation, attorneys' fees, resulting
from a breach of this Section 13.
14. Notice. All necessary notices, payments, demands and requests shall
be in writing and shall be deemed duly given three (3) days after being mailed
by certified mail, postage prepaid, return receipt requested, or when actually
received if sent by facsimile, overnight delivery or other means, and addressed
as follows:
Company: c/o Neoforma, Inc.
3255-7 Scott Boulevard
Santa Clara, California 95054
Attn: Wm. Samuel Veazey, Controller
Facsimile: (408) 549-6299
With a Copy to: John A. Kostrubanic, Esq.
Pepe & Hazard, LLP
150 Federal Street, 28th Floor
Boston, Massachusetts 02110
Facsimile: (617) 695-9255
7
<PAGE> 8
Employee: Erik Tivin
430 Newtown Drive
Buffalo Grove, Illinois 60089
Facsimile: (847) 255-2922
With a copy to: Spencer J. Marks, Esq.
Marks, Marks and Kaplan, Ltd.
120 North La Salle Street, Suite 3200
Chicago, Illinois 60602
Facsimile: (312) 332-2952
Each addressee may change its address or facsimile number for notice by
giving notice of change of address or facsimile number in the manner set forth
above.
15. Assignment. This Employment Agreement shall be freely assignable by
the Company to, and shall inure to the benefit of and be binding upon, any other
entity which shall succeed to the business presently being operated by the
Company, but, being a contract for personal services, neither this Employment
Agreement nor any rights hereunder shall be assignable by the Employee.
16. Further Execution. The parties agree to execute all documents
necessary to further effectuate the terms of this Employment Agreement.
17. Litigation. In the event of any dispute respecting this agreement,
such dispute shall be resolved in a court of competent jurisdiction in the State
of Illinois, and the parties hereto consent to such venue and jurisdiction. Each
party shall bear the cost of its own fees and expenses.
18. Authority. Each party represents that its undersigned
representative or corporate officer has all requisite power and authority to
enter into this Employment Agreement and to execute any and all instruments and
documents on its behalf necessary to and in performance of their respective
obligations hereunder.
19. Counterparts. This Employment Agreement may be executed in separate
counterparts, each of which shall be deemed original and all of which together
shall constitute one and the same instrument.
20. Waivers. No waiver, permit, consent or approval of any kind or
character on the part of any party of any breach or default under this
Employment Agreement, nor any waiver on the part of any party of any provisions
or conditions of this Employment Agreement, shall be valid unless made in
writing and signed by the party to be charged therewith, and shall be effective
only to the extent specifically set forth in such writing. No delay or omission
to exercise any right,
8
<PAGE> 9
power or remedy inuring to any party, upon any breach or default of any party
under this Employment Agreement, shall impair any such right, power or remedy of
such party nor shall it be construed to be a waiver of any such breach or
default, or an acquiescence therein, or of any similar breach or default
thereafter occurring; nor shall any waiver of any single breach or default be
deemed a waiver of any other breach or default theretofore or thereafter
occurring. All remedies either under this Employment Agreement or by law or
otherwise afforded to any party, shall be cumulative and not alternative.
21. Severability. If any provisions of this Employment Agreement shall
be held to be invalid or unenforceable to any extent or in any application, then
the remainder of this Employment Agreement and such terms and conditions, except
to such extent or in such application, shall not be affected thereby, and each
and every term and condition of this Employment Agreement shall be valid and
enforced to the fullest extent and in the broadest application permitted by law.
22. Headings. The paragraph headings contained herein are for
convenience and reference only, and shall be given no effect in the
interpretation of any term or condition of this Employment Agreement.
23. Equitable Remedies. Each party hereto hereby confirms that damages
at law may be an inadequate remedy for the breach or threatened breach of this
Employment Agreement and agrees that, in the event of a breach or threatened
breach by a party of any provision hereof, the other party's rights and
obligations hereunder shall be enforceable by specific performance, injunction,
or other equitable remedy, in addition to and not in lieu of any rights to
damages at law or other rights provided by statute or otherwise for a breach or
threatened breach of any provision hereof. Accordingly, each party hereto hereby
waives and agrees not to assert any objection to such equitable relief based
upon the purported existence of an adequate remedy at law, notwithstanding that
another party may also assert claims for damages at law or other claims as an
alternative to, or in addition to, such equitable relief.
24. Miscellaneous. This Employment Agreement is entered into and shall
be construed under the laws of the State of Illinois applicable to contracts
made and to be entirely performed within that State. This Employment Agreement
shall be amended, modified or terminated only by an instrument in writing,
signed by the party or parties to be charged. This Employment Agreement is the
entire agreement of the parties relating to the employment of the Employee by
the Company and supersedes all previous written or oral agreements.
9
<PAGE> 10
IN WITNESS WHEREOF the parties have executed or caused to be executed
this Employment Agreement under seal as of the day and year first above written.
NEOFORMA GAR, INC. NEOFORMA, INC.
By:_______________________________ By:_______________________________
Wayne McVicker, President Robert J. Zollars, President and
Chief Executive Officer
EMPLOYEE:
__________________________________
Erik Tivin
10
<PAGE> 11
SCHEDULE A
TO
EMPLOYMENT AGREEMENT
BETWEEN NEOFORMA GAR, INC. AND ERIK TIVIN
PERFORMANCE STANDARDS
PURSUANT TO SECTION 2(C) OF THE EMPLOYMENT AGREEMENT
The measurement of Employee's performance of his duties as the President
of Neoforma GAR, Inc. ("the Company"), and Vice President of Neoforma, Inc., is
to do all things reasonably within his power to promote, develop, operate and
expand the business of the Company to meet, at a minimum, Net Sales of
$2,000,000 for the year ending December 31, 2000, and $2,500,000 for the year
ending December 31, 2001. Net Sales is defined as the total amount of sales
received by the Company including without limitation any Buyer's Premium, less
payments made to the Consignees.
Failure to achieve the aforestated minimums will constitute a wilful
failure to substantially perform Employee's duties for the Company pursuant to
Section 9(a)(iii)(B) of Employee's Employment Agreement to which this Schedule
A is attached and incorporated, and the Company will have the option, at its
sole discretion, to terminate Employee.
11
<PAGE> 12
SCHEDULE B
TO
EMPLOYMENT AGREEMENT
BETWEEN NEOFORMA GAR, INC. AND ERIK TIVIN
BONUS CALCULATIONS
PURSUANT TO SECTION 4(B) OF THE EMPLOYMENT AGREEMENT
Employee shall be paid a bonus based upon the total Net Sales achieved by
the Company. Net Sales is defined as the total amount of sales received by
Neoforma GAR, Inc. including without limitation any Buyer's Premium, less the
payments made to the Consignees.
Notwithstanding anything else contained in the Employment Agreement of Erik
Tivin to which this Schedule B is attached and incorporated, bonus to Employee
shall be paid at the end of each quarter during each calendar year based upon
the total Net Sales the Company has received by the end of the each said
quarter.
Employee's bonus shall be based upon the following schedule of achieved
total Net Sales:
Year 1999 Bonus - Employee shall be paid, at a minimum, his prorata
share of the guaranteed bonus of $50,000.
Year 2000 Bonus - 1.3% of $0.00 to $15,000,000 with a minimum bonus
paid of $50,000.
2% of $15,000,001 to $20,000,000
3% of Net Sales in excess of $20,000,000
Year 2001 Bonus - 1.33% of $0.00 to $18,000,000 with a minimum bonus
paid of $50,000
2% of $18,000,001 to $24,000,000
3% of Net Sales in excess of $24,000,000
12
<PAGE> 1
EXHIBIT 10.11
September 17,1999
Baghwan D. Goel
1155 Viscaino Avenue
Sunnyvale, CA 94086
Dear B.D.,
On behalf of Neoforma, Inc. (the "Company"), I am pleased to offer you a
position with the Company based upon the following terms:
1. Position. Upon acceptance of this offer, you will become an Executive
Vice President of Products and Services, reporting to Bob Zollars, our CEO. You
will be expected to devote at least forty (40) hours per week to the performance
of your duties and to give your best efforts to such duties. Your position may
require that you travel from time to time as the Company may reasonably request
and as shall be appropriate and necessary in the performance of your duties.
This offer is contingent upon your background clearing without incident.
2. Effective Date. The effective date of employment shall be October 1,
1999.
3. AT-WILL EMPLOYMENT. YOU SHOULD BE AWARE THAT YOUR EMPLOYMENT WITH THE
COMPANY IS FOR NO SPECIFIED PERIOD AND CONSTITUTES "AT-WILL" EMPLOYMENT. AS A
RESULT, YOU ARE FREE TO TERMINATE YOUR EMPLOYMENT AT ANY TIME, FOR ANY REASON OR
FOR NO REASON. SIMILARLY, THE COMPANY IS FREE TO TERMINATE YOUR EMPLOYMENT, AT
ANY TIME, FOR ANY REASON OR FOR NO REASON AND THAT THE TERMS OF YOUR EMPLOYMENT,
INCLUDING BUT NOT LIMITED TO PROMOTION, DEMOTION, TRANSFER, COMPENSATION,
BENEFITS, DUTIES AND LOCATION OF WORK MAY BE CHANGED AT ANY TIME, FOR ANY REASON
OR FOR NO REASON IN THE EVENT OF TERMINATION OF YOUR EMPLOYMENT, YOU WILL NOT BE
ENTITLED TO ANY PAYMENTS, BENEFITS, DAMAGES, AWARDS OR COMPENSATION OTHER THAN
AS MAY OTHERWISE BE AVAILABLE IN ACCORDANCE WITH THE COMPANY'S ESTABLISHED
EMPLOYEE PLANS AND POLICIES AT THE TIME OF TERMINATION.
1
<PAGE> 2
4. Compensation. The Company will pay you a salary of $225,000 per
annum, which is equivalent to $9375.00 semi-monthly, less applicable
withholdings, payable in accordance with the Company's standard payroll
policies. Your salary will begin as of the effective date of employment. The
first and last payment by the Company to you will be prorated, if necessary, to
reflect a commencement or termination date other than the first or last working
day of a pay period. Your salary and performance may be reviewed at least
annually by the President and or the Company's board of directors. You will
receive a bonus of $50,000.00 guaranteed payable in the first year.
Additionally, you will receive a sign-on bonus of $50,000.00 payable on the
first pay period following employment. However, should your employment with the
Company cease prior to the completion of one year, the sign-on bonus will be due
and payable in full.
5. Vacation and Benefits. Upon the Effective Date of your employment and
then for so long as you are employed by the Company you will accrue 1.67 days of
paid time off ("PTO") for each full month you are employed by the Company.
Vacation days and sick leave shall both be deducted from your accrued PTO. You
will also be entitled to standard fringe benefits in accordance with the
Company's practices covering employees, as such benefits may be in effect from
time to time. Please contact Human Resources if you would like additional
information regarding benefits.
6. Stock Option. Subject to action by the Company's board of directors
and compliance with applicable state and federal securities laws, the Company
will grant to you an option (the "Option") to purchase 550,000 shares of the
Company's Common Stock pursuant to the Company's 1997 Incentive Stock Plan (the
"Plan") adopted by the board of directors and stockholders of the Company. The
exercise price of the Option will be the fair market value of the Company's
Common Stock on the date of grant as determined by the Company's board of
directors. The Option will vest in equal monthly installments on the last day of
each month over the 48-month period beginning with October 1, 1999, provided
that the Executive remains an employee of the Company on each such vesting date.
In addition, in the event of a Change of Control (as defined as below), 50% of
the unvested portion of the Option shall immediately accelerate as to all shares
so that the Company's right to repurchase such shares shall lapse as of the
Change of Control (as defined below). At the Executive's election, the form of
payment for the Option Shares may be in a promissory note. Any such note and
associated security agreement shall be made in the form specified by the
Company, and shall bear interest at the then Applicable Federal Rate determined
under the Internal Revenue Code.
6a. Change of Control. For purposes of this Agreement, the term "Change
of Control," shall mean the occurrence of any of the following events subsequent
to the company's current series E financing:
2
<PAGE> 3
(i) Any "person" (as such term is used in Sections 13(d) and 14(d) of the
Securities Exchange Act of 1934, as amended (the "Exchange Act") is or
becomes the "beneficial owner" (as defined in Rule 13d-3 under the
Exchange Act), directly or indirectly, of securities of the Company
representing forty percent (40%) or more of the total voting power
represented by the Company's then outstanding voting securities;
provided, however, that a Change in Control shall be deemed to occur in
the event any one individual becomes the "beneficial owner" (as defined
in Rule 13d-3 under the Exchange Act), directly or indirectly, of
securities of the Company representing thirty percent (30%) or more of
the voting power represented by the Company's then outstanding voting
securities; or
(ii) A change in the composition of the Board of Directors of the Company
occurring within a two-year period, as a result of which fewer than a
majority of the directors are Incumbent Directors. "Incumbent Directors"
shall mean directors who either (A) are directors of the Company as of
the date hereof, or (B) are elected, or nominated for election, to the
Board of Directors of such election or nomination (but shall not include
an individual whose election or nomination is in connection with an
actual or threatened proxy contest relating to the election of directors
to the Company); or
(iii) A merger or consolidation of the Company with any other corporation,
other than a merger or consolidation which would result in the voting
securities of the Company outstanding immediately prior thereto
continuing to represent (either by remaining outstanding or by being
converted into voting securities of the surviving entity) at least
seventy percent (70%) of the total voting power represented by the
voting securities of the Company or such surviving entity outstanding
immediately after such merger or consolidation, or the stockholders of
the Company approve a plan of complete liquidation of the Company or an
agreement for the sale or disposition by the Company of all or
substantially all the Company's assets.
7. Employment, Confidential Information, Invention Assignment and
Arbitration Agreement. As a condition of accepting this offer of employment, you
will be required to complete, sign and return the Company's standard form of
Employment, Confidential Information, Invention Assignment and Arbitration
Agreement.
8. Immigration Laws. For purposes of federal immigration laws, you will
be required to provide to the Company documentary evidence of your identity and
eligibility for employment in the United States. Such documentation must be
provided within 3 business days of the effective date of your employment, or
your employment relationship with the Company may be terminated.
9. Conflicting Employment. During the period that you render services to
the Company, you will not engage in any employment, business or activity that is
in any way competitive with the business or proposed business of the Company.
You will disclose to the Company in writing any other gainful employment,
business or activity that you are
3
<PAGE> 4
currently associated with or participate in that competes with the Company. You
will not assist any other person or organization in competing with the Company
or in preparing to engage in competition with the business or proposed business
of the Company. You represent that your signing of this offer letter,
agreement(s) representing stock options granted to you, if any, under the Plan
and the Company's Employment, Confidential Information, Invention Assignment and
Arbitration Agreement and your commencement of employment with the Company will
not violate any agreement currently in place between yourself and current or
past employers.
10. Entire Agreement. This offer letter, the Employment, Confidential
Information, Invention Assignment and Arbitration Agreement and the agreement(s)
representing stock options granted to you, if any, under the Plan, when signed
by you, set forth the terms of your employment with the Company and supersede
any and all prior representations and agreements, whether written or oral.
11. Amendment. This agreement can only be amended in writing signed by
you and an officer of the Company. Any waiver of a right under this agreement
must be in writing.
12. Governing Law. This agreement will be governed under the laws of the
State of California applicable to such agreements made and to be performed
entirely within such State.
13. Severance. Notwithstanding Paragraph 3 above, if the Company
terminates your employment other than for justifiable cause (as defined below)
or there is a substantial change in your responsibilities, or you no longer
report to the President or CEO, the company shall pay to you a lump-sum amount
equal to twelve (12) months of your annual base salary at the time of
termination, less applicable withholdings. "Justifiable Cause" shall include the
commission of a felony, acts of moral turpitude, your refusal to obey a lawful
order of the board of directors, or the misuse of corporate funds or
opportunities.
We look forward to you joining the Company. If the foregoing terms are
agreeable, please indicate your acceptance by signing the enclosed copy of this
letter in the space provided below and returning it to me within three days.
Sincerely,
NEOFORMA, INC.
By:_______________________________
Fred Ruegsegger, CFO
AGREED AND ACCEPTED:
- -----------------------------
4
<PAGE> 1
EXHIBIT 10.12
[LETTERHEAD]
[NEOFORMA LOGO]
December 19, 1998
Bob Flury
545 Kearny Street
Alpharetta, GA
30022
Dear Bob,
On behalf of Neoforma, Inc. (the "Company"), I am pleased to offer you a
position with the Company based upon the following terms:
1. Position. Upon acceptance of this offer, you will become a Vice
President of Enterprise Sales for the Company reporting directly to Jeff Kleck,
CEO. You will be expected to devote at least forty (40) hours per week to the
performance of your duties and to give your best efforts to such duties. Your
position may require that you travel from time to time as the Company may
reasonably request and as shall be appropriate and necessary in the performance
of your duties.
2. Effective Date. The effective date of employment shall be January 18,
1998.
3. AT-WILL EMPLOYMENT. YOU SHOULD BE AWARE THAT YOUR EMPLOYMENT WITH THE
COMPANY IS FOR NO SPECIFIED PERIOD AND CONSTITUTES "AT-WILL" EMPLOYMENT. AS A
RESULT, YOU ARE FREE TO TERMINATE YOUR EMPLOYMENT AT ANY TIME, FOR ANY REASON OR
FOR NO REASON. SIMILARLY, THE COMPANY IS FREE TO TERMINATE YOUR EMPLOYMENT, AT
ANY TIME, FOR ANY REASON OR FOR NO REASON AND THAT THE TERMS OF YOUR EMPLOYMENT,
INCLUDING BUT NOT LIMITED TO PROMOTION, DEMOTION, TRANSFER, COMPENSATION,
BENEFITS, DUTIES AND LOCATION OF WORK MAY BE CHANGED AT ANY TIME, FOR ANY REASON
OR FOR NO REASON IN THE EVENT OF TERMINATION OF YOUR EMPLOYMENT, YOU WILL NOT BE
ENTITLED TO ANY PAYMENTS, BENEFITS, DAMAGES, AWARDS OR COMPENSATION OTHER THAN
AS MAY OTHERWISE BE AVAILABLE IN ACCORDANCE WITH THE COMPANY'S ESTABLISHED
EMPLOYEE PLANS AND POLICIES AT THE TM OF TERMINATION.
1
<PAGE> 2
4. Compensation. The Company will pay you a salary of $175,000.00 per
annum, less applicable withholdings, payable in accordance with the Company's
standard payroll policies. Your salary will begin as of the effective date of
employment. The first and last payment by the Company to you will be prorated,
if necessary, to reflect a commencement or termination date other than the first
or last working day of a pay period. In addition, your salary and performance
may be reviewed at least annually by the President and or the Company's board of
directors. In addition to the above stated salary, you will be able to earn a
bonus of up to $25,000 each quarter. The milestones for each such quarterly
bonus will be set by the President at least ten (10) days prior to the start of
each quarter, and, within thirty (30) days after the end of each quarter, the
Board of Directors, in its sole discretion, will assess the completion of such
milestones and determine the amount of such bonus.
5. Vacation and Benefits. Thirty (30) days after the Effective Date of
your employment and then for so long as you are employed by the Company you will
accrue 1.25 days of paid time off ("PTO") for each full month you are employed
by the Company. Vacation days and sick leave shall both be deducted from your
accrued PTO. You will also be entitled to standard fringe benefits in accordance
with the Company's practices covering employees, as such benefits may be in
effect from time to time. Please contact Human Resources if you would like
additional information regarding benefits.
6. Stock Option. Subject to action by the Company's board of directors
and compliance with applicable state and federal securities laws, the Company
will grant to you an option (the "Option") to purchase 340,000 sham of the
Company's Common Stock pursuant to the Company's 1997 Incentive Stock Plan (the
"Plan") adopted by the board of directors and stockholders of the Company. The
exercise price of the Option will be the fair market value of the Company's
Common Stock on the date of grant as determined by the Company's board of
directors. The Option will vest over four (4) years with one quarter (1/4) of
the shares vesting at the end of one full year following your effective date of
employment with the Company and an additional one forty-eighth (1/48) of the
shares will vest each full month thereafter until all of the shares are
exercisable, subject to all provisions of the Plan and your continued employment
with the Company.
7. Employment, Confidential Information, Invention Assignment and
Arbitration Agreement. As a condition of accepting this offer of employment, you
will be required to complete, sign and return the Company's standard form of
Employment, Confidential Information, Invention Assignment and Arbitration
Agreement.
8. Immigration Laws. For purposes of federal immigration laws, you will
be required to provide to the Company documentary evidence of your identity and
eligibility for employment in the United States. Such documentation must be
provided within 3 business days of the effective date of your employment, or
your employment relationship with the Company may be terminated.
9. Conflicting Employment. During the period that you render services to
the Company, you will not engage in any employment, business or activity that is
in any way competitive with the business or proposed business of the Company.
You will disclose to the Company in writing any other gainful employment,
business or activity that you are currently associated with or participate in
that competes with the Company. You will not assist any other person or
organization in competing
2
<PAGE> 3
with the Company or in preparing to engage in competition with the business or
proposed business of the Company. You represent that your signing of this offer
letter, agreement(s) representing stock options granted to you, if any, under
the Plan and the Company's Employment, Confidential Information, Invention
Assignment and Arbitration Agreement and your commencement of employment with
the Company will not violate any agreement currently in place between yourself
and current or past employers.
10. Entire Agreement. This offer letter, the Employment, Confidential
Information, Invention Assignment and Arbitration Agreement and the agreement(s)
representing stock options granted to you, if any, under the Plan, when signed
by you, set forth the terms of your employment with the Company and supersede
any and all prior representations and agreements, whether written or oral.
11. Amendment. This agreement can only be amended in writing signed by
you and an officer of the Company. Any waiver of a right under this agreement
must be in writing.
12. Governing Law. This agreement will be governed under the laws of the
State of California applicable to such agreements made and to be performed
entirely within such State.
We look forward to you joining the Company. If the foregoing terms are
agreeable, please indicate your acceptance by signing the enclosed copy of this
letter in the space provided below and returning it to me within three days.
Sincerely,
NEOFORMA, INC.
By: /s/ JEFFREY H. KLECK
--------------------------------------
Jeffrey H. Kleck, CEO
AGREED AND ACCEPTED:
/s/ BOB FLURY
- -----------------------------
3
<PAGE> 4
[NEOFORMA LETTERHEAD]
January 5, 1999
Dear Bob,
This letter is in response to our recent conversations regarding the terms
of the offer letter (the "Offer Letter"), dated December 19, 1998, offering you
the position of Vice President of Sales for Neoforma, Inc. (the "Company"). This
letter is intended to amend the Offer Letter as set forth below.
Paragraph 4 of the Offer Letter shall be amended and restated to read as
follows:
"Compensation/Severance.
(a) The Company will pay you a salary of $175,000.00 per annum,
less applicable withholdings, payable in accordance with the
Company's standard payroll policies. Your salary will begin as of
the effective date of employment. The first and last payment by
the Company to you will be prorated, if necessary, to reflect a
commencement or termination date other than the first or last
working day of a pay period. In addition, your salary and
performance may be reviewed at least annually by the President
and or the Company's board of directors. In addition to the above
stated salary, you will be able to earn a of up to $25,000 each
quarter. The milestones for each such quarterly bonus will be set
by the President at least ten (10) days prior to the start of
each quarter, and, within thirty (30) days after the end of each
quarter, the Board of Directors, in its sole discretion, will
assess the completion of such milestones and determine the amount
of such bonus. Notwithstanding the foregoing, during the first
calendar year of your employment with the Company, the Company
will pay to you the quarterly, $25,000.00 bonus set forth above,
or portion thereof to reflect a partial quarter of employment, if
you are employed by the Company in the position set forth above
in Paragraph 1 at the end of each quarter during such year,
regardless of milestone completion.
4
<PAGE> 5
(b) Notwithstanding Paragraph 3 above, if the Company terminates
your employment other than for justifiable cause (as defined
below), the Company shall pay to you a lump-sum amount equal to
three months of your annual base salary at the time of
termination, less applicable withholdings. "Justifiable Cause"
shall include the commission of a felony, acts of moral
turpitude, your refusal to obey a lawful order of the board of
directors, or the misuse of corporate funds or opportunities."
Except as expressly modified by this letter, the terms of the Offer Letter
shall remain in full force and effect. If the foregoing amendment is agreeable,
please indicate your acceptance by signing the enclosed copy of this letter in
the space provided below and returning it to me within three (3) days.
Sincerely,
NEOFORMA, INC.
By: /a/ JEFFREY H. KLECK
------------------------------------
Jeffrey H. Kleck, CEO
AGREED AND ACCEPTED:
/s/ ROBERT FLURY
- ----------------------------------
Robert Flury
5
<PAGE> 1
EXHIBIT 10.13
[LETTERHEAD]
[NEOFORMA LOGO]
June 29, 1999
Fred Ruegsegger
Dear Fred,
On behalf of NeoForma, Inc. (the "Company"), I am pleased to offer you a
position with the Company based upon the following terms:
1. Position. Upon acceptance of this offer, you will become the Chief
Financial Officer, reporting to Bob Zollars, President and CEO. You will be
expected to devote at least forty (40) hours per week to the performance of your
duties and to give your best efforts to such duties. Your position may require
that you travel from time to time as the Company may reasonably request and as
shall be appropriate and necessary in the performance of your duties.
2. Effective Date. The effective date of employment shall be July 12,
1999.(1)
3. AT WILL EMPLOYMENT. YOU SHOULD BE AWARE THAT YOUR EMPLOYMENT WITH THE
COMPANY IS FOR NO SPECIFIED PERIOD AND CONSTITUTES "AT WILL" EMPLOYMENT. AS A
RESULT, YOU ARE FREE TO TERMINATE YOUR EMPLOYMENT AT ANY TIME, FOR ANY REASON OR
FOR NO REASON. SIMILARLY, THE COMPANY IS FREE TO TERMINATE YOUR EMPLOYMENT, AT
ANY TIME, FOR ANY REASON OR FOR NO REASON AND THAT THE TERMS OF YOUR EMPLOYMENT,
INCLUDING BUT NOT LIMITED TO PROMOTION, DEMOTION, TRANSFER, COMPENSATION,
BENEFITS, DUTIES AND LOCATION OF WORK MAY BE CHANGED AT ANY TIME, FOR ANY REASON
FOR OR NO REASON IN THE EVENT OF TERMINATION OF YOUR EMPLOYMENT, YOU WILL NOT BE
ENTITLED TO ANY PAYMENTS, BENEFITS, DAMAGES, AWARDS OR COMPENSATION OTHER THAN
AS MAY OTHERWISE BE AVAILABLE IN ACCORDANCE WITH THE COMPANY'S ESTABLISHED
EMPLOYEE PLANS AND POLICIES AT THE TIME OF TERMINATION.
1
<PAGE> 2
4. Compensation. The Company will pay you a salary of $200,000 per
annum, less applicable withholdings, payable in accordance with the Company's
standard payroll policies. Your salary will begin as of the effective date of
employment. The first and last payment by the Company to you will be prorated,
if necessary, to reflect a commencement or termination date other than the first
or last working day of a pay period. Your salary and performance may be reviewed
at least annually by the President and or the Company's board of directors. In
addition to the above stated salary, you will be able to earn a bonus of up to
$12,500 each quarter. The milestones for each such quarterly bonus will be set
by the President at least ten (10) days prior to the start of each quarter, and,
within thirty (30) days after the end of each quarter, the Board of Directors,
in its sole discretion, will assess the completion of such milestones and
determine the amount of such bonus. The Company also agrees to repay the
outstanding relocation loan on your behalf in the amount of $25,000. The payment
of this loan shall be grossed up to encompass any tax obligations for you.
5. Vacation and Benefits. Upon the Effective Date of your employment and
then for so long as you are employed by the Company you will accrue 1.25 days of
paid time off ("PTO") for each full month you are employed by the Company.
Vacation days and sick leave shall both be deducted from your accrued PTO. You
will also be entitled to standard fringe benefits in accordance with the
Company's practices covering employees, as such benefits may be in effect from
time to time. Please contact Human Resources if you would like additional
information regarding benefits.
6. Stock Option. Subject to action by the Company's board of directors
and compliance with applicable state and federal securities laws, the Company
will grant to you an option (the "Option") to purchase 604,013 shares of the
Company Common Stock pursuant to the Company's 1998 Incentive Stock Plan (the
"Plan") adopted by the board of directors and stockholders of the Company. The
exercise price of the Option will be the fair market value of the Company's
Common Stock on the date of grant as determined by the Company's board of
directors. The Option will vest over four (4) years with one quarter (1/4) of
the shares vesting at the end of one full year following your effective date of
employment with the Company and an additional one forty-eighth (1/48) of the
shares will vest each full month thereafter until all of the shares are
exercisable, subject to all provisions of the Plan and your continued employment
with the Company. You will be allowed to purchase your shares against a secured
promissory note, to include a 4-year loan with the Company's standard terms of
repayment and a provision for the Company to buy back your options.
7. Employment, Confidential Information, Invention Assignment and
Arbitration Agreement. As a condition of accepting this offer of employment, you
will be required to complete, sign and return the Company's standard form of
Employment, Confidential Information, Invention Assignment and Arbitration
Agreement.
2
<PAGE> 3
8. Immigration Laws. For purposes of federal immigration laws, you will
be required to provide to the Company documentary evidence of your identity and
eligibility for employment in the United States. Such documentation must be
provided within 3 business days of the effective date of your employment, or
your employment relationship with the Company may be terminated.
9. Conflicting Employment. During the period that you render services to
the Company, you will not engage in any employment, business or activity that is
in any way competitive with the business or proposed business of the Company.
You will disclose to the Company in writing any other gainful employment,
business or activity that you are currently associated with or participate in
that competes with the Company. You will not assist any other person or
organization in competing with the Company or in preparing to engage in
competition with the business or proposed business of the Company. You represent
that your signing of this offer letter, agreement(s) representing stock options
granted to you, if any, under the Plan and the Company's Employment,
Confidential Information, Invention Assignment and Arbitration Agreement and
your commencement of employment with the Company will not violate any agreement
currently in place between yourself and current or past employers.
10. Entire Agreement. This offer letter, the Employment, Confidential
Information, Invention Assignment and Arbitration Agreement and the agreement(s)
representing stock options granted to you, if any, under the Plan, when signed
by you, set forth the terms of your employment with the Company and supersede
any and all prior representations and agreements, whether written or oral.
11. Amendment. This agreement can only be amended in writing signed by
you and an officer of the Company. Any waiver of a right under this agreement
must be in writing.
12. Governing Law. This agreement will be governed under the laws of the
State of California applicable to such agreement s made and to be performed
entirely within such State.
13. Severance. Notwithstanding Paragraph 3 above, if the Company
terminates your employment other than for justifiable cause (as defined below),
the Company shall pay to you a lump-sum amount equal to three (3) months of your
annual base salary at the time of termination, less applicable withholdings.
"Justifiable Cause" shall include the commission of a felony, acts of moral
turpitude, your refusal to obey a lawful order of the board of directors, or the
misuse of corporate funds or opportunities.
3
<PAGE> 4
We look forward to you joining the Company. If the foregoing terms are
agreeable, please indicate your acceptance by signing the enclosed copy of this
letter in the space provided below and returning it to me within three days.
Sincerely,
NEOFORMA, INC.
By: /s/ WAYNE MCVICKER
-----------------------------------------
Wayne McVicker, VP and Company-Founder
AGREED AND ACCEPTED:
/s/ FRED RUEGSEGGER
- ----------------------------
- --------
(1) With the condition that the effective date remains to be finally
determined, it being understood that Fred Ruegsegger will make a best
effort to ensure the earliest possible effective date.
4
<PAGE> 1
EXHIBIT 10.14
CONSULTING AGREEMENT
This Consulting Agreement (the "Agreement") is made this ____ day of
August, 1999, by and between Neoforma GAR, Inc., a Delaware corporation (the
"COMPANY"), and Fred Tivin of Highland Park, Illinois (the "CONSULTANT").
RECITALS
The Company is a wholly-owned subsidiary of Neoforma, Inc.
("NEOFORMA"), a Delaware corporation, and has acquired all of the issued and
outstanding securities (the "SECURITIES PURCHASE") of General Asset Recovery,
LLC, ("GAR") pursuant to the terms of a certain Securities Purchase Agreement
dated July 16th, 1999, which provided for the Consultant's acting as a
consultant to the Company.
The Company wishes to hire the Consultant as an independent contractor
to perform the services set forth herein, for the period of time, and upon the
terms and subject to the conditions, which are more particularly set forth
below; and
The Consultant desires to perform such services, for such period of
time and upon such terms and subject to such conditions;
NOW, THEREFORE, in consideration of the mutual covenants and agreements
hereinafter set forth, and for other good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged, the parties hereto
agree as follows:
1. Consulting Period. The Consultant is hereby retained by the Company
to perform, and the Consultant hereby agrees to perform, the services provided
for herein, as an independent contractor, for a period commencing on the date
hereof and ending on the two (2) year anniversary of the date hereof unless
terminated earlier as provided for herein (the "CONSULTING PERIOD").
2. Services and Duties. The Consultant agrees that during the
Consulting Period, he will provide certain services to the Company, consisting
of support and assistance in connection with the operation of the business
previously operated by General Asset Recovery, LLC, as well as such other tasks
and responsibilities which may be delegated to the Consultant by or under the
authority of the President of the Company and/or the Chief Executive Officer of
Neoforma, from time to time (the "CONSULTING SERVICES"). The Consultant shall
report directly to the President of the Company and to the Chief Executive
Officer of Neoforma or to any officer of Neoforma designated by the Board of
Directors of Neoforma.
-1-
<PAGE> 2
The Consultant agrees that he will conduct himself in a professional
and ethical manner at all times during the term of this Agreement and will take
no action that might cause injury to the business or goodwill of the Company.
The Consultant shall not perform consulting or other services for any
entity or person which is directly competitive with Neoforma or the Company
during the Consulting Period without the prior written consent of the Board of
Directors of Neoforma, which shall not be unreasonably withheld. However,
Consultant shall be permitted to perform consulting services for and be employed
by other non-competing businesses. It is the intention of the parties that
Consultant shall not be required to devote his full time and efforts to his
duties under this Consulting Agreement.
3. Compensation/Reimbursement for Expenses. All compensation paid or
payable hereunder shall be deemed to be paid or payable by the Company unless
this Agreement specifically states otherwise.
(a) Consulting Fees. In consideration for the Consulting Services
and subject to the due performance thereof, the Company shall pay to the
Consultant during the Consulting Period a fee of One Hundred Fifty Thousand
Dollars ($150,000) per year (the "CONSULTING FEE") which Consulting Fee shall be
payable during the term of this Agreement in equal semi-monthly installments in
accordance with the Company's customary practices. The Consulting Fee shall be
pro-rated for any partial year during which the Consultant provides Consulting
Services.
(b) Reimbursement for Expenses. At the end of each month during the
Consulting Period, the Company shall reimburse the Consultant for reasonable
items of miscellaneous and travel expenses incurred in furtherance of the
business of the Company, but payment shall be made only against a signed
itemized list of such expenditures.
(c) Automobile Allowance. The Consultant shall be entitled each
month to an automobile allowance in an amount equal to his actual automobile
related expenses, up to the amount of One Thousand Four Hundred Dollars ($1,400)
which shall be used for automobile related expenses incurred by the Consultant
in the performance of his duties hereunder.
4. Key Person Life Insurance. The Company shall have the right but not
the obligation to maintain and pay for a key person life insurance policy on the
life of the Consultant throughout the duration of this Agreement, as to which
the Company shall be the sole beneficiary and owner. The Consultant agrees upon
the execution of this Agreement to
-2-
<PAGE> 3
cooperate fully with the Company and to provide the Company with all necessary
documents in order for the Company to obtain such policy.
5. Status as Independent Consultant. It is the intent and purpose of
this Agreement to create a legal relationship of independent contractor, and not
employment, as between the Company and the Consultant. The Consultant will not
be treated as an employee of the Company for purposes of the Federal Insurance
Contributions Act, the Social Security Act, the Federal Unemployment Tax Act,
income tax withholding at source, or workmen's compensation laws, and will not
be eligible for any employee benefits whatsoever, other than those set forth
herein. The Consultant shall be responsible for the payment of self-employment
and federal income taxes due on all payments hereunder. In the event that any
governmental or administrative agency, whether federal, state or local, shall
subsequently determine that for their purposes, the relationship is one of
employment as between said parties, then in such event Consultant shall bear any
and all loss, costs and expenses of the Company in connection with or arising
out of such determination, whether in the nature of past or future FICA
contributions, Social Security taxes, unemployment taxes or income taxes. The
Consultant shall indemnify the Company and hold it harmless from any liability
to any former Company or to any other party in connection with or arising out of
any such governmental or administrative determination, or otherwise as a
consequence of Consultant's status as an independent contractor rather than an
employee of the Company.
6. Termination.
(a) This Agreement may be terminated upon any of the following:
(i) the Consultant's death;
(ii) the action by the Board of Directors of Neoforma
following the Consultant's "disability". For this purpose, "disability" means a
physical or mental illness or other incapacity which renders the Consultant
unable to perform substantially all of his duties for a period of two (2)
months. For purposes of this Agreement, disability shall be deemed a
continuation of any prior disability if the disability is related to the prior
disability and commences within eight (8) months of the termination of the prior
disability. Disability, and any relation to any prior disability, shall be
determined by a physician acceptable to the Company; or
(iii) the action of the Board of Directors or Chief Executive
Officer of Neoforma or the President of the Company for Cause. "Cause" is
defined as the occurrence of any of the following events: (A) fraud,
misappropriation, embezzlement or intentional misconduct on the part of the
Consultant, (B) the Consultant's willful failure to substantially
-3-
<PAGE> 4
perform his duties for the Company when, and to the extent, requested by the
Board of Directors, or its lawfully designated representative, to do so and
failure to correct same within five (5) business days after notice from the
Board of Directors or its lawfully designated representative requesting the
Consultant to do so, which has a materially adverse effect upon the Company, or
(C) the Consultant's willful breach of any material provision of this Agreement
and such breach continues for a period of five (5) business days after notice
from the Board of Directors or its lawfully designated representative of such
breach. Termination by the Company for cause will be effective immediately upon
receipt by the Consultant of notice of such termination.
(b) Termination of Benefits. In the event of any termination
pursuant to this Section during the term of this Agreement, in addition to the
termination of the various benefits and compensation payable to the Consultant
hereunder generally, the benefits provided for pursuant to Section 3 of this
Agreement shall, to the extent not yet accrued, automatically cease and
terminate.
(c) Survival. Notwithstanding anything else in this Agreement, the
provisions of Section 7 (Confidentiality), Section 8 (Non-Competition and
Non-Solicitation), Section 9 (Developments), and Section 20 (Equitable Remedies)
shall survive the termination of this Agreement, if by the Company, for "cause"
or by the Consultant. In the event this Agreement is terminated by the Company
without cause, or due to the bankruptcy or insolvency of the Company, or due to
any material breach of this Agreement by the Company, the only provision of this
Agreement which shall survive shall be Section 7 (Confidentiality) to the extent
that it deals with Confidential Information of the Company which existed prior
to the date of this Agreement.
7. Confidentiality. During the Consulting Period and thereafter, the
Consultant hereby covenants and agrees that he shall not other than for the
benefit of the Company publish, disclose to any third party or in any way use
for his own benefit any confidential information ("Confidential Information"),
including without limitation, any balance sheet or income statement information
(including but not limited to the value, amount or condition of capital assets
and/or inventory, sales figures, profitability, etc.), or any other financial
data, banking information, credit information, trade secrets, financial
statements or related data, customer lists or information pertaining to
customers or any unique distribution, manufacturing, marketing and research
methods of the Company or its parent or affiliates (or formerly of General Asset
Recovery, LLC), and any other Confidential Information concerning the Company's
or its parent or affiliate's, business, structure or affairs, (or the business,
structure or affairs formerly of General Asset Recovery, LLC). All Confidential
Information and copies thereof are the sole property of the Company and
Consultant shall deliver promptly to the Company at the termination of his
Consulting Period or at any time as
-4-
<PAGE> 5
Neoforma's Board of Directors may request, without retaining copies, any
Confidential Information made, compiled, delivered, made available or otherwise
obtained by Consultant. Consultant shall also use his best efforts and exercise
utmost diligence to protect and safeguard the Confidential Information of the
Company's customers, contractors and others with whom the Company has a business
relationship, whether learned or acquired by Consultant during the course of his
Consulting Period.
The nondisclosure obligations of this Section 7 shall not apply to: (a)
information that may be disclosed generally or is in the public domain through
no fault of the Consultant; (b) information received from a third party outside
the Company that was disclosed without a breach of any confidentiality
obligation; (c) information approved for release by written authorization of the
Company; or (d) information that may be required by law or an order of any
court, agency or proceeding to be disclosed. This Section 7 shall remain in
effect notwithstanding any termination of this Agreement.
8. Non-Competition and Non-Solicitation.
(a) During the time the Consultant is consulting for the Company,
Consultant shall devote his full time and efforts to the business of the Company
and shall not participate, directly or indirectly, in any capacity, in any
business or activity that is in competition with the Company. For a period of
eighteen (18) months after the termination of the Consulting Period with the
Company for any reason: (i) Consultant shall not hire or attempt to hire any
employee of the Company, or assist in such hiring by anyone else, or encourage
any employee to terminate his or her employment with the Company; (ii)
Consultant shall not participate, directly or indirectly, in any capacity, in
any business or activity that is in competition with the Company in the medical
equipment re-sale industry, medical facility planning industry or in any other
business in which the Company is engaged, in any state in which the Company does
business; and (iii) Consultant shall not cause or assist to cause any of the
customers of the Company with whom Consultant communicated, dealt with or became
acquainted during his term of consulting for the Company to enter into
contractual arrangements with himself or any other person, firm, partnership,
corporation or other company in any business or activity that is in competition
with the Company.
(b) "Blue Pencil" Rule. The Consultant and the Company desire that
the provisions of this Section 8 be enforced to the fullest extent permissible
under the laws and public policies applied in each jurisdiction in which
enforcement is sought. If a court of competent jurisdiction, however, determines
that any restrictions imposed on the Consultant in this Section are unreasonable
or unenforceable because of duration, area of restriction, or otherwise, the
Consultant and the Company agree and intend that the court shall enforce this
Section 8 to whatever extent the court deems reasonable to effect the intent of
this Section 8.
-5-
<PAGE> 6
(c) Legitimate Purpose. The Consultant has read carefully all of
the terms and conditions of this Section 8 and agrees that the restraints set
forth herein (i) are reasonable and necessary to support the legitimate business
interests and goodwill of the Company, and (ii) will not preclude the Consultant
from earning a livelihood during the life of this Section 8.
9. Developments. All Confidential Information and all other
discoveries, inventions, processes, methods, and improvements conceived,
developed, or otherwise made by Consultant at any time, alone or with others,
and in any way relating to the Company's present or future business or products,
whether or not patentable or subject to copyright protection and whether or not
reduced to tangible form or reduced to practice, during the term of this
agreement and for six months thereafter ("Developments"), shall be the sole
property of the Company. Consultant agrees to and hereby does assign to the
Company all right, title, and interest throughout the world in and to all
Developments and agrees to promptly disclose such Developments to the Company
and take all such actions reasonably requested by the Company to establish and
confirm the Company's ownership of such Developments. Consultant agrees that all
such Developments shall constitute works made for hire under the copyright laws
of the United States and hereby assigns to the Company all copyrights, patents,
trademarks and other proprietary rights the Consultant may have in such
Developments.
10. Notices. All necessary notices, payments, demands and requests
shall be in writing and shall be deemed duly given three (3) days after being
mailed by certified mail, postage prepaid, return receipt requested, or when
actually received if sent by facsimile, overnight delivery or other means, and
addressed as follows:
Company: c/o Neoforma, Inc.
3255-7 Scott Boulevard
Santa Clara, California 95054
Attn: Wm. Samuel Veazey, Controller
Facsimile: (408) 549-6299
With a Copy to: John A. Kostrubanic, Esq.
Pepe & Hazard, LLP
150 Federal Street, 28th Floor
Boston, Massachusetts 02110
Facsimile: (617) 695-9255
Consultant: Fred Tivin
747 Sumac Drive
Highland Park, Illinois 60035
-6-
<PAGE> 7
With a Copy to: Marks, Marks and Kaplan Ltd.
120 North La Salle Street, Suite 3200
Chicago, Illinois 60602
Attn: Spencer J. Marks, Esq.
Facsimile No.: (312) 332-2952
Each addressee may change its address or facsimile number for notice by
giving notice of change of address or facsimile number in the manner set forth
above.
11. Assignment. This Agreement shall be freely assignable by the
Company to, and shall inure to the benefit of and be binding upon, any other
entity which shall succeed to the business presently being operated by the
Company, but, being a contract for personal services, neither this Agreement nor
any rights hereunder shall be assignable by the Consultant.
12. Further Execution. The parties agree to execute all documents
necessary to further effectuate the terms of this Agreement.
13. Litigation. In the event of any dispute respecting this agreement,
such dispute shall be resolved in a court of competent jurisdiction in the State
of Illinois, and the parties hereto consent to such venue and jurisdiction. Each
party shall bear the cost of its own fees and expenses.
14. Authority. Each party represents that its undersigned
representative or corporate officer has all requisite power and authority to
enter into this Agreement and to execute any and all instruments and documents
on its behalf necessary to and in performance of their respective obligations
hereunder.
15. Counterparts. This Agreement may be executed in separate
counterparts, each of which shall be deemed an original and all of which
together shall constitute one and the same instrument.
16. Waivers. No waiver, permit, consent or approval of any kind or
character on the part of any party of any breach or default under this
Agreement, nor any waiver on the part of any party of any provisions or
conditions of this Agreement, shall be valid unless made in writing and signed
by the party to be charged therewith, and shall be effective only to the extent
specifically set forth in such writing. No delay or omission to exercise any
right, power or remedy inuring to any party, upon any breach or default of any
party under this Agreement, shall impair any such right, power or remedy of such
party nor shall it be construed to be a waiver of any such breach or default, or
an acquiescence therein, or of any similar breach or
-7-
<PAGE> 8
default thereafter occurring; nor shall any waiver of any single breach or
default be deemed a waiver of any other breach or default theretofore or
thereafter occurring. All remedies either under this Agreement or by law or
otherwise afforded to any party, shall be cumulative and not alternative.
17. Severability. In case any provision of this Agreement shall be
invalid, illegal or unenforceable, such provision shall be reformed to the
extent necessary to permit enforcement thereof, and the validity, legality and
enforceability of the remaining provisions shall not in any way be affected or
impaired thereby.
18. Titles and Subtitles. The titles of the sections and subsections of
this Agreement are for convenience of reference only and are not to be
considered in construing this Agreement.
19. Equitable Remedies. Each party hereto hereby confirms that damages
at law may be an inadequate remedy for the breach or threatened breach of this
Agreement and agrees that, in the event of a breach or threatened breach by a
party of any provision hereof, the other party's rights and obligations
hereunder shall be enforceable by specific performance, injunction, or other
equitable remedy, in addition to and not in lieu of any rights to damages at law
or other rights provided by statute or otherwise for a breach or threatened
breach of any provision hereof. Accordingly, each party hereto hereby waives and
agrees not to assert any objection to such equitable relief based upon the
purported existence of an adequate remedy at law, notwithstanding that another
party may also assert claims for damages at law or other claims as an
alternative to, or in addition to, such equitable relief.
20. Miscellaneous. This Agreement is entered into and shall be
construed under the laws of the State of Illinois applicable to contracts made
and to be entirely performed within that state. This Agreement shall be amended,
modified or terminated only by an instrument in writing, signed by the party or
parties to be charged. This Agreement constitutes the full and entire
understanding and agreement between the parties with regard to the subject
matter hereof, and supersedes all previous oral or written agreements,
correspondence and understandings with regard to such subject matter.
-8-
<PAGE> 9
IN WITNESS WHEREOF the parties have executed or caused to be executed
this Agreement under seal as of the day and year first above written.
CONSULTANT: NEOFORMA GAR, INC.
__________________________________ By:________________________________
Fred Tivin
-9-
<PAGE> 1
EXHIBIT 10.15
PROMISSORY NOTE
$7,800,000 August _______, 1999
FOR VALUE RECEIVED, the undersigned, Neoforma GAR, Inc., a Delaware
corporation, with an address c/o Neoforma, Inc., 3255-7 Scott Boulevard, Santa
Clara, California 95054 (the "MAKER"), promises to pay Erik Tivin of 430 Newtown
Drive, Buffalo Grove, Illinois 60089 ("TIVIN") the principal sum of Seven
Million Eight Hundred Thousand Dollars ($7,800,000) with interest on the unpaid
balance from the date hereof at the rate of Seven Percent (7%) per annum. This
Note is entered into pursuant to the terms of a Securities Purchase Agreement
dated July 16th, 1999 by and among Neoforma, Inc. (the maker's parent company),
Tivin and General Asset Management, LLC pursuant to which the maker has acquired
all of the issued and outstanding securities of General Asset Management, LLC
(the "SECURITIES PURCHASE") and shall be subject to the terms and conditions
thereof, including without limitation, (i) the right of the maker to set off
against any amounts of principal and interest due hereunder the amount of any
indemnification which is determined to be payable by Tivin under Section 7 of
said Securities Purchase Agreement, and (ii) the partial acceleration of this
Note pursuant to Section 1.2 of said Securities Purchase Agreement as set forth
in Section 4 below.
This Note shall have the following additional terms and provisions:
1. Payment. Principal and interest shall be due and payable as follows:
(a) During the first twelve months following the closing date of the
Securities Purchase (the "CLOSING DATE"), the maker shall make payments
beginning on the first day of the month following the Closing Date and on the
first day of each month thereafter in an amount equal to the amount of interest
accrued on the outstanding balance under this Note during the preceding month
plus a principal payment of One Hundred Eighty Three Thousand Three Hundred
Thirty Three Dollars ($183,333);
(b) During the thirteenth through the forty-eighth month following
the Closing Date, the maker shall make payments on the first day of each month
in an amount equal to the amount of interest accrued on the outstanding balance
under this Note during the preceding month plus a principal payment of One
Hundred Thirty Seven Thousand Five Hundred Dollars ($137,500);
-1-
<PAGE> 2
(c) During the forty-ninth through the sixtieth month following the
Closing Date, the maker shall make payments on the first day of each month in an
amount equal to the amount of interest accrued on the outstanding balance under
this Note during the preceding month plus a principal payment of Fifty Four
Thousand One Hundred Sixty Seven Dollars ($54,167).
2. Prepayment/Conversion. This Note may be prepaid in whole or in part
at any time and from time to time without premium or penalty and without prior
notice to Tivin, and any such prepayments may not be directed to be applied to
any subsequent installments of principal. This Note shall not be convertible
into shares of the maker or of any endorser hereon or guarantor hereof.
3. Full Acceleration. This Note shall, at the option of Tivin, become
immediately due and payable without notice or demand by Tivin to the maker upon
the occurrence of any of the following events (each being an "EVENT OF
DEFAULT"):
(a) Failure of the maker to pay within ten (10) days after notice
thereof by Tivin to the maker that any payment of principal or interest herein
required shall have become due and not paid in a timely manner;
(b) Dissolution or termination of existence of the maker or of any
endorser hereon or guarantor hereof; or
(c) The making of an assignment for the benefit of creditors,
insolvency, appointment of a receiver (not discharged within sixty (60) days) of
any part of the property of, or the filing of a petition in bankruptcy, or the
commencement of any proceedings under any bankruptcy or insolvency law or any
law relating to the relief of debtors, readjustment or indebtedness,
reorganization, composition or extension, by or (if not discharged within sixty
(60) days) against, the maker or any endorser hereon or guarantor hereof.
4. Partial Acceleration. In the event of the termination of the
Employment Agreement dated August _____, 1999 between the maker of this Note and
Tivin without "cause" as defined in said Employment Agreement, an amount equal
to fifty percent (50%) of the unpaid portion of this Note shall become
immediately payable, with the balance of this Note continuing to be payable in
the same manner and over the same time period over the balance of the term of
this Note, except that each monthly principal payment shall be reduced to an
amount equal to fifty percent (50%) of the payments set forth in Section 1.
5. Notices. Any notice, request or instruction to be given hereunder
shall be in writing and shall be delivered in person or transmitted by facsimile
(with confirmation in writing to be made available upon request) or mailed by
certified mail, return receipt
-2-
<PAGE> 3
requested, postage prepaid, and delivered to the appropriate party and address
as shown above. Either of the addresses specified above may be changed by notice
given as herein provided. All communications will be deemed effective upon
receipt.
6. No Assignment. This Note shall inure solely to the benefit of Tivin
and shall not be assignable.
7. Waiver.
(a) The maker and all endorsers and guarantors of this Note hereby
waive presentment, demand, protest and all other demands in connection with the
delivery and enforcement of this Note.
(b) Tivin shall not, by any act, delay, omission or otherwise, be
deemed to have waived any of its rights or remedies hereunder, unless such
waiver be in writing and signed by Tivin, and then only to the extent expressly
set forth therein. A waiver on any one occasion shall not constitute or be
construed as a bar to or a waiver of any such right or remedy on any future
occasion.
8. Choice of Law. The execution, delivery and performance of this Note
shall be governed by and construed in accordance with the laws of the State of
Delaware.
9. Legal Fees. Maker shall be liable for any and all fees and expenses
incurred by Tivin, including legal fees, in connection with his enforcing this
Note.
This Note has been executed under seal on the day and year first above
written.
NEOFORMA GAR, INC.
_____________________________ By:_____________________________
Witness
-3-
<PAGE> 1
EXHIBIT 10.16
SILICON VALLEY BANK
QUICKSTART LOAN AND SECURITY AGREEMENT
BORROWER: NEOFORMA, INC. ADDRESS: 800 EL CAMINO REAL WEST, SUITE 180
MOUNTAIN VIEW, CA 94040
DATE: 6/25/98
SILICON'S OFFER TO EXTEND FINANCING ON THE TERMS SET FORTH HEREIN SHALL EXPIRE
IF THIS AGREEMENT IS NOT EXECUTED BY BORROWER AND RETURNED TO SILICON WITHIN 30
DAYS OF THE ABOVE DATE.
THIS LOAN AND SECURITY AGREEMENT is entered into on the above date between
SILICON VALLEY BANK ("Silicon"), whose address is 3003 Tasman Drive, Santa
Clara, California 95054 and the borrower named above (jointly and severally, the
"Borrower"), whose chief executive office is located at the above address
("Borrower's Address").
1. LOANS. Silicon will make loans to Borrower (the "Loans") in amounts
determined by Silicon in its reasonable business judgment up to the amount (the
"Credit Limit") shown on the Schedule to this Agreement (the "Schedule"),
provided no Event of Default and no event which, with notice or passage of time
or both, would constitute an Event of Default has occurred. All Loans and other
monetary Obligations will bear interest at the rate shown on the Schedule.
Interest will be payable monthly, on the date shown on the monthly billing from
Silicon. Silicon may, in its discretion, charge interest to Borrower's deposit
accounts maintained with Silicon.
2. SECURITY INTEREST. As security for all present and future indebtedness,
guarantees, liabilities, and other obligations, of Borrower to Silicon
(collectively, the "Obligations"), Borrower hereby grants Silicon a continuing
security interest in all of Borrower's interest in the following types of
property, whether now owned or hereafter acquired, and wherever located
(collectively, the "Collateral"): All "accounts," "general intangibles,"
"contract rights," "chattel paper," "documents" "letters of credit,"
"instruments," "deposit accounts," "inventory," "farm products," investment
property," "fixtures" and "equipment," as such terms are defined in Division 9
of the California Uniform Commercial Code in effect on the date hereof, and all
products, proceeds and insurance proceeds of the foregoing.
3. REPRESENTATIONS AND AGREEMENTS OF BORROWER. Borrower represents to Silicon as
follows, and Borrower agrees that the following representations will continue to
be true, and that Borrower will comply with all of the following agreements
throughout the term of this Agreement:
3.1 CORPORATE EXISTENCE AND AUTHORITY. Borrower, if a corporation, is and
will continue to be, duly authorized, validly existing and in good standing
under the laws of the jurisdiction of its incorporation. The execution, delivery
and performance by Borrower of this Agreement, and all other documents
contemplated hereby have been duly and validly authorized, and do not violate
any law or any provision of, and are not grounds for acceleration under, any
agreement or instrument which is binding upon Borrower.
3.2 NAME; PLACES OF BUSINESS. The name of Borrower set forth in this
Agreement is its correct name. Borrower shall give Silicon 15 days' prior
written notice before changing its name. The address set forth in the heading to
this Agreement is Borrower's chief executive office. In addition, Borrower has
places of business and Collateral is located only at the locations set forth on
the Schedule. Borrower will give Silicon at least 15 days prior written notice
before changing its chief executive office or locating the Collateral at any
other location.
3.3 COLLATERAL. Silicon has and will at all times continue to have a
first-priority perfected security interest in all of the Collateral other than
specific equipment. Borrower will immediately advise Silicon in writing of any
material loss or damage to the Collateral.
3.4 FINANCIAL CONDITION AND STATEMENTS. All financial statements now or in
the future delivered to Silicon have been, and will be, prepared in conformity
with generally accepted accounting principles. Since the last date covered by
any such statement, there has been no material adverse change in the financial
condition or business of Borrower. Borrower will provide Silicon: (i) within 30
days after the end of each month, a monthly financial statement prepared by
Borrower, and such other information as Silicon shall reasonably request; (ii)
within 120 days following the end of Borrower's fiscal year, complete annual
financial statements, certified by independent certified public accountants
acceptable to Silicon and accompanied by the unqualified report
1
<PAGE> 2
thereon by said independent certified public accountants; and (iii) other
financial information reasonably requested by Silicon from time to time.
3.5 TAXES; COMPLIANCE WITH LAW. Borrower has filed, and will file, when due,
all tax returns and reports required by applicable law, and Borrower has paid,
and will pay, when due, all taxes, assessments, deposits and contributions now
or in the future owed by Borrower. Borrower has complied, and will comply, in
all material respects, with all applicable laws, rules and regulations.
3.6 INSURANCE. Borrower shall at all times insure all of the tangible
personal property Collateral and carry such other business insurance as is
customary in Borrower's industry.
3.7 ACCESS TO COLLATERAL AND BOOKS AND RECORDS. At reasonable times, on one
business day notice, Silicon, or its agents, shall have the right to inspect the
Collateral, and the right to audit and copy Borrower's books and records.
3.8 OPERATING ACCOUNTS. Borrower shall maintain its primary operating
accounts with Bank.
3.9 ADDITIONAL AGREEMENTS. Borrower shall not, without Silicon's prior
written consent, do any of the following: (i) enter into any transaction outside
the ordinary course of business except for the sale of capital stock to venture
investors, provided that Borrower promptly delivers written notification to
Silicon of any such sale; (ii) sell or transfer any Collateral, except in the
ordinary course of business; (iii) pay or declare any dividends on Borrower's
stock (except for dividends payable solely in stock of Borrower); or (iv)
redeem, retire, purchase or otherwise acquire, directly or indirectly, any of
Borrower's stock other than the repurchase of up to five percent (5%) of
Borrower's then issued stock in any fiscal year from Borrower's employees or
directors pursuant to written agreement with Borrower.
4. TERM. This Agreement shall continue in effect until the maturity date set
forth on the Schedule (the "Maturity Date"). This Agreement may be terminated,
without penalty, prior to the Maturity Date as follows: (i) by Borrower,
effective three business days after written notice of termination is given to
Silicon; or (ii) by Silicon at any time after the occurrence of an Event of
Default, without notice, effective immediately. On the Maturity Date or on any
earlier effective date of termination, Borrower shall pay all Obligations in
full, whether or not such Obligations are otherwise then due and payable. No
termination shall in any way affect or impair any security interest or other
right or remedy of Silicon, nor shall any such termination relieve Borrower of
any Obligation to Silicon, until all of the Obligations have been paid and
performed in full.
5. EVENTS OF DEFAULT AND REMEDIES. The occurrence of any of the following events
shall constitute an "Event of Default" under this Agreement: (a) Any
representation, statement, report or certificate given to Silicon by Borrower or
any of its officers, employees or agents, now or in the future, is untrue or
misleading in a material respect; or (b) Borrower fails to pay when due any Loan
or any interest thereon or any other monetary Obligation; or (c) the total
Obligations outstanding at any time exceed the Credit Limit; or (d) Borrower
fails to perform any other non-monetary Obligation, which failure is not cured
within 5 business days after the date due; or (e) Dissolution, termination of
existence, insolvency or business failure of Borrower; or appointment of a
receiver, trustee or custodian, for all or any part of the property of,
assignment for the benefit of creditors by, or the commencement of any
proceeding by or against Borrower under any reorganization, bankruptcy,
insolvency, arrangement, readjustment of debt, dissolution or liquidation law or
statute of any jurisdiction, now or in the future in effect; or (f) a material
adverse change in the business, operations, or financial or other condition of
Borrower. If an Event of Default occurs, Silicon, shall have the right to
accelerate and declare all of the Obligations to be immediately due and payable,
increase the interest rate by an additional four percent per annum, and exercise
all rights and remedies accorded it by applicable law.
6. GENERAL. If any provision of this Agreement is held to be unenforceable, the
remainder of this Agreement shall still continue in full force and effect. This
Agreement and any other written agreements, documents and instruments executed
in connection herewith are the complete agreement between Borrower and Silicon
and supersede all prior and contemporaneous negotiations and oral
representations and agreements, all of which are merged and integrated in this
Agreement. There are no oral understandings, representations or agreements
between the parties which are not in this Agreement or in other written
agreements signed by the parties in connection this Agreement. The failure of
Silicon at any time to require Borrower to comply strictly with any of the
provisions of this Agreement shall not waive Silicon's right later to demand and
receive strict compliance. Any waiver of a default shall not waive any other
default. None of the provisions of this Agreement may be waived except by a
specific written waiver signed by an officer of Silicon and delivered to
Borrower. The provisions of this Agreement may not be amended, except in a
writing signed by Borrower and Silicon. Borrower shall reimburse Silicon for all
reasonable attorneys' fees and all other reasonable costs incurred by Silicon,
in connection with this Agreement (whether or not a lawsuit is filed). If
Silicon or Borrower files any lawsuit against the other predicated on ' a breach
of this Agreement, the prevailing party shall be entitled to recover its
reasonable costs and attorneys' fees from the non-prevailing party. Borrower may
not assign any rights under this Agreement without Silicon's prior written
consent. This Agreement shall be governed by the laws of the State of
California.
2
<PAGE> 3
7. MUTUAL WAIVER OF JURY TRIAL. BORROWER AND SILICON EACH HEREBY WAIVE THE RIGHT
TO TRIAL BY JURY IN ANY ACTION OR PROCEEDING BASED UPON, ARISING OUT OF, OR IN
ANY WAY RELATING TO, THIS AGREEMENT OR ANY CONDUCT, ACT OR OMISSION OF SILICON
OR BORROWER OR ANY OF THEIR DIRECTORS, OFFICERS, EMPLOYEES, AGENTS, ATTORNEYS OR
AFFILIATES.
BORROWER: NEOFORMA, INC.
----------------------------------
By: /s/ JEFF KLECK
----------------------------------
PRESIDENT OR VICE PRESIDENT
CEO
SILICON:
----------------------------------
By:
----------------------------------
Title:
--------------------------------
3
<PAGE> 4
SILICON VALLEY BANK
SCHEDULE TO
QUICKSTART LOAN AND SECURITY AGREEMENT (EQUIPMENT ADVANCES)
BORROWER: Neoforma, Inc.
DATE: 6/25/98
This Schedule is an integral part of the Loan and Security Agreement
between Silicon Valley Bank ("Silicon") and the above-named borrower
("Borrower") of even date.
CREDIT LIMIT (EQUIPMENT) $ 750,000.00 (such amount to be funded under
(Section 1): the aggregate Credit Limit).Equipment
Advances will be made only on or prior to
12/25/98 (the "Last Advance Date")
and only for the purpose of purchasing
equipment reasonably acceptable to Silicon.
Borrower must provide invoices for the
equipment to Silicon on or before the Last
Advance Date.
INTEREST RATE (Section 1): A rate equal to the "Prime Rate" in effect
from time to time, plus 0% per annum.
Interest shall be calculated on the basis of
a 360-day year for the actual number of days
elapsed. "Prime Rate" means the rate
announced from time to time by Silicon as its
"prime rate;" it is a base rate upon which
other rates charged by Silicon are based, and
it is not necessarily the best rate available
at Silicon. The interest rate applicable to
the Obligations shall change on each date
there is a change in the Prime Rate.
MATURITY DATE (Section 4): After the Last Advance Date, the unpaid
principal balance of the Equipment Advances
shall be repaid in 36 equal monthly
installments of principal, plus interest,
commencing on 1/25/99 and continuing on the
same day of each month thereafter until the
entire unpaid principal balance of the
Equipment Advances and all accrued unpaid
interest have been paid (subject to Silicon's
right to accelerate the Equipment Advances on
an Event of Default).
BORROWER: SILICON:
Neoforma, Inc. SILICON VALLEY BANK
- ------------------------------------
By
---------------------------------- By
PRESIDENT OR VICE PRESIDENT ---------------------------
CEO Title
-------------------------
4
<PAGE> 5
SILICON VALLEY BANK
SCHEDULE TO
QUICKSTART LOAN AND SECURITY AGREEMENT (MASTER)
BORROWER: Neoforma, Inc.
DATE: 6/25/98
This Schedule is an integral part of the Loan and Security Agreement
between Silicon Valley Bank ("Silicon") and the above-named borrower
("Borrower") of even date.
CREDIT LIMIT (AGGREGATE) $ 750,000.00 includes, without limitation,
(Section 1): Equipment Advances and the Merchant
Services and Business Visa Reserve, if any)
INTEREST RATE (SECTION 1): A rate equal to the "Prime Rate" in effect
from time to time, plus 0% per annum.
Interest shall be calculated on the basis
of a 360-day year for the actual number
of days elapsed. "Prime Rate" means the
rate announced from time to time by
Silicon as its "prime rate;" it is a base
rate upon which other rates charged by
Silicon are based, and it is not
necessarily the best rate available at
Silicon. The interest rate applicable to
the Obligations shall change on each date
there is a change in the Prime Rate.
MATURITY DATE (Section 4): 12/25/99
OTHER LOCATIONS AND ADDRESSES
(Section 3.2): _____________________
OTHER AGREEMENTS: Borrower also agrees as follows:
1. LOAN FEE. Borrower shall concurrently
pay Silicon a non-refundable Loan Fee
in the amount of $ 2,000.00
2. BANKING RELATIONSHIP. Borrower shall at
all times maintain its primary banking
relationship with Silicon.
BORROWER: SILICON:
__________________________________
Neoforma, Inc. SILICON VALLEY BANK
By ______________________________ By __________________________
PRESIDENT OR VICE PRESIDENT
CEO Title _______________________
5
<PAGE> 6
LOAN MODIFICATION AGREEMENT
This Loan Modification Agreement is entered into as of July 20, 1999,
by and between Neoforma, Inc. ("Borrower") and Silicon Valley Bank ("Silicon").
1. DESCRIPTION OF EXISTING INDEBTEDNESS. Among other indebtedness which may be
owing by Borrower to Silicon, Borrower is indebted to Silicon pursuant to, among
other documents, a QuickStart Loan and Security Agreement (and Schedule
thereto), dated June 25, 1998, as may be amended from time to time, (the "Loan
Agreement"). The Loan Agreement provided for, among other things, a Credit Limit
in the original principal amount of Seven Hundred Fifty Thousand Dollars
($750,000). Defined terms used but not otherwise defined herein shall have the
same meanings as in the Loan Agreement. As of this date, the balance of
outstanding Equipment Advances is Four Hundred Thirty-Three Thousand Five
Dollars and 39/100 ($433,005.39).
Hereinafter, all indebtedness owing by Borrower to Silicon shall be referred to
as the "Indebtedness."
2. DESCRIPTION OF COLLATERAL AND GUARANTIES. Repayment of the Indebtedness is
secured by the Collateral as described in the Loan Agreement and that certain
Intellectual Property Security Agreement.
Hereinafter, the above-described security documents and guaranties, together
with all other documents securing repayment of the Indebtedness shall be
referred to as the "Security Documents." Hereinafter, the Security Documents,
together with all other documents evidencing or securing the Indebtedness shall
be referred to as the "Existing Loan Documents."
3. DESCRIPTION OF CHANGE IN TERMS.
A. Modification(s) to Loan Agreement (and Schedule thereto)
1. The paragraph entitled "Maturity Date" (Section 4) is
hereby amended, in its entirety, to read as follows:
Borrower will pay in one payment all outstanding
Equipment Advances plus all accrued unpaid interest
on July 20, 2000. In addition, Borrower will pay
regular monthly payments of all accrued unpaid
interest due as of each payment date beginning July
20, 1999, and all subsequent interest payments are
due on the same day of each month thereafter (subject
to Silicon's right to accelerate the Equipment
Advances on an Event of Default).
2. Section 3.10 entitled "Financial Covenants" is hereby
incorporated in to the Loan Agreement to read as
follows:
6
<PAGE> 7
Borrower shall comply with the following covenant, as
of the end of each month, except as otherwise
provided:
Liquidity: Borrower shall maintain a minimum
Liquidity ratio of 1.50 to 1.00. Liquidity shall be
defined as unrestricted cash and cash equivalents
plus accounts receivable divided by all Obligations
owing to Silicon. This covenant shall be monitored in
accordance with cash held by Silicon.
B. Modification(s) to Subordination Agreement.
1. The reference to the August 7, 1998 date of the
QuickStart Loan and Security Agreement between
Borrower and Bank is hereby deleted and replaced with
June 25, 1998.
4. CONSISTENT CHANGES. The Existing Loan Documents are hereby amended wherever
necessary to reflect the changes described above.
5. PAYMENT OF LOAN FEE. Borrower shall pay to Lender a fee in the amount of Two
Thousand Dollars ($2,000) (the "Loan Fee"), plus all out-of-pocket expenses.
6. NO DEFENSES OF BORROWER. Borrower (and each guarantor and pledgor signing
below) agrees that, as of the date hereof, it has no defenses against the
obligations to pay any amounts under the Indebtedness.
7. CONTINUING VALIDITY. Borrower (and each guarantor and pledgor signing below)
understands and agrees that in modifying the existing Indebtedness, Silicon is
relying upon Borrower's representations, warranties, and agreements, as set
forth in the Existing Loan Documents. Except as expressly modified pursuant to
this Loan Modification Agreement, the terms of the Existing Loan Documents
remain unchanged and in full force and effect. Silicon's agreement to
modifications to the existing Indebtedness pursuant to this Loan Modification
Agreement in no way shall obligate Silicon to make any future modifications to
the Indebtedness. Nothing in this Loan Modification Agreement shall constitute a
satisfaction of the Indebtedness. It is the intention of Silicon and Borrower to
retain as liable parties all makers and endorsers of Existing Loan Documents,
unless the party is expressly released by Silicon in writing. No maker,
endorser, or guarantor will be released by virtue of this Loan Modification
Agreement. The terms of this paragraph apply not only to this Loan Modification
Agreement, but also to all subsequent loan modification agreements.
8. CONDITION. The effectiveness of this Loan Modification Agreement is
conditioned upon payment of the Loan Fee and execution of the QuickStart Warrant
to Purchase Stock agreement.
7
<PAGE> 8
This Loan Modification Agreement is executed as of the date first
written above.
BORROWER: SILICON:
NEOFORMA, INC. SILICON VALLEY BANK
By: /s/ FREDERICK RUEGSEGGER By: /s/ PELE L. LOPEZ
------------------------------ -----------------------------
Name: Frederick Ruegsegger Name: Pele L. Lopez
------------------------------ -----------------------------
Title: CFO Title: AVP
------------------------------ -----------------------------
The undersigned hereby consent to (i) the modification to the Subordination
Agreement pursuant to this Loan Modification Agreement, and (ii) hereby ratifies
all the provisions of the Subordination Agreement and confirms that all
provisions of that document are in full force and effect.
CREDITOR:
COMDISCO, INC.
By: ------------------------- Date: -------------------------
Name: -------------------------
Title: -------------------------
8
<PAGE> 1
EXHIBIT 10.18
SUBORDINATED PROMISSORY NOTE
$2,000,000 Date: May 27, 1999
Due: June 1, 2002
FOR VALUE RECEIVED, Neoforma, Inc., a Delaware corporation (the "Borrower")
hereby promises to pay to the order of Comdisco, Inc., a Delaware corporation
(the "Lender") at P.O. Box 91744, Chicago, IL 60693 or such other place of
payment as the holder of this Secured Promissory Note (this "Note") may specify
from time to time in writing, in lawful money of the United States of America,
the principal amount of Two Million and 00/100 Dollars ($2,000,000.00) together
with interest at twelve and one half percent (12.5%) per annum from the date of
this Note to maturity of each installment on the principal hereof remaining
from time to time unpaid, such principal and interest to be paid in 36 equal
monthly installments of $66,999.22 each, commencing July 1, 1999 and on the
same day of each month thereafter to and including June 1, 2002, such
installments to be applied first to accrued and unpaid interest and the balance
to unpaid principal. Interest shall be computed on the basis of a year
consisting of twelve months of thirty days each.
This Note is the Note referred to in, and is executed and delivered in
connection with, that certain Subordinated Loan and Security Agreement dated
May 12, 1999 by and between Borrower and Lender (as the same may from time to
time be amended, modified or supplemented in accordance with its terms, the
"Loan Agreement"), and is entitled to the benefit and security of the Loan
Agreement and the other Loan Documents (as defined in the Loan Agreement), to
which reference is made for a statement of all of the terms and conditions
thereof. All terms defined in the Loan Agreement shall have the same
definitions when used herein, unless otherwise defined herein.
THIS NOTE IS EXPRESSLY SUBJECT TO THE TERMS OF THAT CERTAIN SUBORDINATION
AGREEMENT BY AND BETWEEN LENDER AND BORROWER FOR THE BENEFIT OF SENIOR
CREDITOR. IN THE EVENT OF ANY CONTRADICTION OR INCONSISTENCY BETWEEN THIS NOTE
AND THE SUBORDINATION AGREEMENT, THE TERMS OF THE SUBORDINATION AGREEMENT SHALL
CONTROL.
The Borrower waives presentment and demand for payment, notice of dishonor,
protest and notice of protest and any other notice as permitted under the UCC
or any applicable law.
-1-
<PAGE> 2
This Note has been negotiated and delivered to Lender and is payable in the
State of Illinois, and shall not become effective until accepted by Lender in
the State of Illinois. This Note shall be governed by and construed and
enforced in accordance with, the laws of the State of Illinois, excluding any
conflicts of law, rules or principles that would cause the application of the
laws of any other jurisdiction.
BORROWER: NEOFORMA, INC.
3255 Scott Blvd.
Santa Clara, CA 95054
Signature: /s/ Wayne McVicker
---------------------------
Print Name: Wayne McVicker
--------------------------
Title: Vice President
-------------------------------
-2-
<PAGE> 3
NEOFORMA, INC.
Prepared by V. Tonga
Loan Amount: 2,000,000.00
============
Interest Rate 12.500%
============
Payment 66,999.22
<TABLE>
<CAPTION>
Payment
Number Date Principal Interest Payment Balance
- -------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C>
05/27/99 2,000,000.00
1 07/01/99 43,338.11 23,611.11 66,999.22 1,956,611.89
2 08/01/99 46,617.85 20,381.37 66,999.22 1,909,994.05
3 09/01/99 47,103.45 19,895.77 66,999.22 1,862,890.60
4 10/01/99 47,594.11 19,405.11 66,999.22 1,815,296.49
5 11/01/99 48,089.88 18,909.34 66,999.22 1,767,206.61
6 12/01/99 48,590.82 18,408.40 66,999.22 1,718,615.79
7 01/01/00 49,096.97 17,902.25 66,999.22 1,669,518.82
8 02/01/00 49,608.40 17,390.82 66,999.22 1,619,910.42
9 03/01/00 50,125.15 16,874.07 66,999.22 1,569,785.26
10 04/01/00 50,647.29 16,351.93 66,999.22 1,519,137.97
11 05/01/00 51,174.87 15,824.35 66,999.22 1,467,963.11
12 06/01/00 51,707.94 15,291.28 66,999.22 1,416,255.17
13 07/01/00 52,246.56 14,752.66 66,999.22 1,364,008.61
14 08/01/00 52,790.80 14,208.42 66,999.22 1,311,217.81
15 09/01/00 53,340.70 13,658.52 66,999.22 1,257,877.11
16 10/01/00 53,896.33 13,102.89 66,999.22 1,203,980.78
17 11/01/00 54,457.75 12,541.47 66,999.22 1,149,523.02
18 12/01/00 55,025.02 11,974.20 66,999.22 1,094,498.00
19 01/01/01 55,598.20 11,401.02 66,999.22 1,038,899.80
20 02/01/01 56,177.35 10,821.87 66,999.22 982,722.46
21 03/01/01 56,762.53 10,236.69 66,999.22 925,959.93
22 04/01/01 57,353.80 9,645.42 66,999.22 868,606.12
23 05/01/01 57,951.24 9,047.98 66,999.22 810,654.89
24 06/01/01 58,554.90 8,444.32 66,999.22 752,099.99
25 07/01/01 59,164.85 7,834.37 66,999.22 692,935.14
26 08/01/01 59,781.15 7,218.07 66,999.22 633,154.00
27 09/01/01 60,403.87 6,595.35 66,999.22 572,750.13
28 10/01/01 61,033.07 5,966.15 66,999.22 511,717.06
29 11/01/01 61,668.83 5,330.39 66,999.22 450,048.22
30 12/01/01 62,311.22 4,688.00 66,999.22 387,737.01
31 01/01/02 62,960.29 4,038.93 66,999.22 324,776.71
32 02/01/02 63,616.13 3,383.09 66,999.22 261,160.58
33 03/01/02 64,278.80 2,720.42 66,999.22 196,881.79
34 04/01/02 64,948.37 2,050.85 66,999.22 131,933.42
35 05/01/02 65,624.91 1,374.31 66,999.22 66,308.51
36 06/01/02 66,308.51 690.71 66,999.22 0.00
</TABLE>
3
<PAGE> 1
EXHIBIT 10.19
LOAN AND SECURITY AGREEMENT
THIS AGREEMENT (the "Agreement"), dated as of July 7, 1999 is entered
into by and between Neoforma, Inc. a Delaware corporation having a principal
place of business at 3255 Scott Blvd., Santa Clara, CA 95054 (the "Borrower")
and Comdisco, Inc., a Delaware corporation having a principal place of business
at 6111 North River Road, Rosemont, Illinois 60018 (the "Lender" ). In
consideration of the mutual agreements contained herein, the parties hereto
agree as follows:
WHEREAS, Borrower desires to borrow from the Lender hereunder the
amount of Two Million Forty Two Thousand Seven Hundred Ninety Two
($2,042,792)and Lender is willing to lend said amount to Borrower on or before
August 7, 1999 (the "Funding Date") for the purchase of computers, workstations,
peripherals, instrumentation, electronic test, semiconductor, production,
manufacturing and test equipment ("Part I") and software and tenant improvements
(not to exceed Three Hundred Sixty Six Thousand Two Hundred Nine Dollars
($366,209)) ("Part II");
NOW, THEREFORE, it is agreed:
SECTION 1. THE LOAN
1. Subject to the terms and conditions set forth herein, Lender shall
lend to Borrower the aggregate original principal amount of Two Million Forty
Two Thousand Seven Hundred Ninety Two ($2,042,792) (the "Loan") with interest at
the rate of:
(a) Nine percent (9%) per annum for Part I payable in 48 monthly
installments of principal and interest, each payable in monthly payments as set
forth in the promissory note (the "Note A-1") in the form attached hereto and
made a part hereof as Exhibit A-1; and
(b) Eight percent (8%) per annum for Part II payable in 30 monthly
installments of principal and interest, each payable in monthly payments as set
forth in the promissory note (the "Note A-2") in the form attached hereto and
made a part hereof as Exhibit A-2. Hereinafter Note A-1 and Note A-2 shall be
referred to as "Note(s)"
1.2 Upon the occurrence of and during an Event of Default (as defined
herein), interest shall thereafter be calculated at a rate of five percent (5%)
in excess of the rate that would otherwise be applicable ("Default Rate"). All
such interest shall be due and payable in arrears, on the first day of the
following month.
1.3 Notwithstanding any provision in this Agreement, the Note(s), or
any other "Loan Document" (as defined herein), it is not the parties' intent to
contract for, charge or receive interest at a rate that is greater than the
maximum rate permissible by law which a court of competent jurisdiction shall
deem applicable hereto (which under the laws of the State of Illinois shall be
deemed to be the laws relating to permissible rates of interest on commercial
loans) (the "Maximum Rate"). If the Borrower actually pays Lender an amount of
interest, chargeable on the total aggregate principal Secured Obligations of
Borrower under this Agreement and the Note(s) (as said rate is calculated over a
period of time that is the longer of (i) the time from the date of this
Agreement through the maturity time as set forth on the Note(s), or (ii) the
entire period of time that any principal is outstanding on the Note(s)), which
-1-
<PAGE> 2
amount of interest exceeds interest calculated at the Maximum Rate on said
principal chargeable over said period of time, then such excess interest
actually paid by Borrower shall be applied first, to the payment of principal
outstanding on the Note(s); second, after all principal is repaid, to the
payment of Lender's out of pocket costs, expenses, and professional fees which
are owed by Borrower to Lender under this Agreement or the Loan Documents; and
third, after all principal, costs, expenses, and professional fees owed by
Borrower to Lender are repaid, the excess (if any) shall be refunded to
Borrower.
1.4 In the event any interest is not paid when due hereunder,
delinquent interest shall be added to principal and shall bear interest on
interest, compounded at the rate set forth in Section 1.1.
1.5 Upon and during the continuation of an Event of Default hereunder
(as defined herein), all Secured Obligations, including principal, interest,
compounded interest, and reasonable professional fees, shall bear interest at a
rate per annum equal to the Default Rate.
1.6 Borrower shall have the option to prepay the Note(s), in whole or
in part, at any time after the date hereof by paying the principal amount
together with all accrued and unpaid interest with respect to such principal
amount, as of the date of such prepayment [and the Balloon Payment as described
in the Note(s)] together with a prepayment premium equal to the difference, if
any, between (x) the amount being prepaid and (y) the present value, discounted
at the Treasury Rate, of each installment of principal and interest being
prepaid discounted to the date of prepayment. If the amount in (x) is greater
than the amount in (y), no prepayment premium shall be due. The "Treasury Rate"
shall mean the then prevailing yield on US Treasury Constant Maturities for the
most recent business day, as quoted in the Federal Reserve Statistical Release
H15, as of the date of prepayment for an obligation of comparable maturity to
the maturity date of the Note(s).
SECTION 2. SECURITY INTEREST
As security for the payment of all indebtedness ("Indebtedness") of the
Borrower to the Lender hereunder and under the Note(s), as the same may be
renewed, extended for any period or rearranged, and the performance by the
Borrower of its other obligations hereunder (the Indebtedness and such other
obligations being hereinafter sometimes collectively referred to as the "Secured
Obligations"), the Borrower hereby assigns to the Lender, and grants to the
Lender a first priority security interest in, all the Borrower's right, title,
and interest in and to the following property ("Collateral"): (i) the equipment
and other property (the "Equipment") described in Exhibit B attached hereto; and
(ii) all proceeds, products, replacements, additions to, substitutions for and
accessions to any and all Equipment including, without limitation, the proceeds
applicable to the insurance referred to in Section 4 hereof.
SECTION 3. REPRESENTATIONS AND WARRANTIES OF BORROWER
The Borrower represents, warrants and agrees that:
3.1 it has good title in and to the Equipment, free of all liens,
security interests, encumbrances and claims whatsoever, except for the interest
of the Lender therein;
-2-
<PAGE> 3
3.2 it has the full power and authority to, and does hereby grant and
convey to the Lender, a valid first priority perfected security interest in the
Collateral as security for the Secured Obligations, free of all liens, security
interests, encumbrances and claims, and shall execute such Uniform Commercial
Code ("UCC") financing statements in connection herewith as the Lender may
reasonably request. No other lien, security interest, adverse claim or
encumbrance has been created by Borrower or is known by Borrower to exist with
respect to any Collateral;
3.3 it is a corporation duly organized, legally existing and in good
standing under the laws of the State of Delaware, and is duly qualified as a
foreign corporation in all jurisdictions where the failure to so qualify would
have a material adverse effect on the Collateral or the business of the Borrower
taken as a whole;
3.4 the execution, delivery and performance of the Note(s), this
Agreement, the Warrant Agreement dated July 7, 1999 pursuant to which Borrower
granted to Lender the right to purchase the number of shares of preferred stock
as set forth therein ("Warrant Agreement"), and all financing statements,
certificates and other documents required to be delivered or executed in
connection herewith (collectively, the "Loan Documents") have been duly
authorized by all necessary corporate action of Borrower, the individual or
individuals executing the Loan Documents were duly authorized to do so, the
Equipment is personal property and as used by the Borrower will not be or become
fixtures under applicable law, and the Loan Documents constitute legal, valid
and binding obligations of the Borrower, enforceable in accordance with their
respective terms, subject to applicable bankruptcy, insolvency, reorganization
or other similar laws generally affecting the enforcement of the rights of
creditors;
3.5 the Loan Documents do not and will not violate any provisions of
its Certificate of Incorporation, bylaws or any material contract, agreement,
law, regulation, order, injunction, judgment, decree or writ to which the
Borrower is subject, or result in the creation or imposition of any lien,
security interest or other encumbrance upon the Collateral, other than those
created by this Agreement;
3.6 the execution, delivery and performance of the Loan Documents do
not require the consent or approval of any other person or entity including,
without limitation, any regulatory authority or governmental body of the United
States or any state thereof or any political subdivision of the United States or
any state thereof except the filing of state or federal securities filings
pursuant to relevant "Blue Sky" laws.
3.7 as of the date hereof no fact or condition exists that would (or
could, with the passage of time, the giving of notice, or both) constitute an
Event of Default under this Agreement or any of the Loan Documents and no event
which has had or could reasonably be expected to have a Material Adverse Effect
has occurred and is continuing. For purposes of this Agreement, "Material
Adverse Effect" means a material adverse effect upon (i) the business,
operations, properties, assets or financial condition of Borrower; or (ii)
except as otherwise disclosed herein, the ability of Borrower to perform the
Secured Obligations.
SECTION 4. INSURANCE AND RISK OF LOSS
4.1 Risk of loss of, damage to or destruction of the Collateral shall
be borne by the Borrower and effective from the date of this Agreement and until
the payment and
-3-
<PAGE> 4
performance in full of all Secured Obligations, Borrower shall at its own
expense cause to be carried and maintained all risk casualty insurance (covering
risk of fire, theft and other such risks as the Lender may require, including
standard and extended coverage) with respect to each item of Collateral in an
amount no less than the replacement costs applicable to such item of Collateral
during the term of this Agreement. All policies evidencing such casualty
insurance shall contain a standard mortgagee's endorsement and shall provide for
at least thirty days prior written notice by the underwriter or insurance
company to the Lender in the event of cancellation or expiration. Borrower shall
provide Lender with insurance certificates evidencing the foregoing at time of
closing.
4.2 If any item of Collateral is lost or rendered unusable as a result
of any physical damage to or destruction of such item of Equipment during the
period from the date hereof to and including the maturity date under the Note(s)
or the date all Secured Obligations hereunder have been fully satisfied,
whichever is earlier, Borrower shall give to Lender prompt notice thereof.
Borrower shall determine, within fifteen (15) days after the date of occurrence
of such loss, damage or destruction, whether such item of Equipment can be
repaired and restored to the condition in which such item of Collateral was
required to be maintained as of the date immediately preceding such damage. If
Borrower determines that such item of Collateral can be repaired, Borrower, at
its expense, shall cause such item of Collateral to be promptly repaired. If
Borrower determines that such item of Collateral is lost or cannot be repaired,
Borrower shall promptly notify the Lender and such item of Collateral shall be
deemed to have suffered a "Casualty Loss" for purposes of this Section as of the
date of the occurrence of such loss. Within fifteen (15) days following the
occurrence of any such loss, damage or destruction, Borrower shall notify the
Lender of the item(s) of Collateral which has suffered such Casualty Loss ("Loss
Item"), and within thirty (30) days thereafter (the "Settlement Date"), Borrower
shall either (a) replace such item(s) of Collateral with equipment of the
substantially similar model, type and feature configuration, in an operating
condition and repair no less than that required hereunder of the damaged or lost
equipment immediately prior to the date of such damage or loss, and having a
fair market value no less than the Casualty Value (as defined herein) applicable
to such item of Collateral as of the date immediately prior to such damage, in
which case such replacement equipment shall for all purposes hereunder become
part of the Collateral and (without limiting the preceding provisions) Borrower
shall grant to Lender a first lien and security interest in respect of such
replacement equipment pursuant to the terms of this Agreement, and Borrower
shall provide the Lender evidence satisfactory to the Lender of Borrower's good
and marketable title to such replacement equipment (free of any liens, security
interests or encumbrances other than those created by this Agreement) and
Borrower shall be entitled to receive the amount of any insurance or other
recovery received by Lender as the case may be up to cost of obtaining the
replacement equipment; or (b) so long as no Event of Default or event which with
the giving of notice or passage of time, or both, would constitute an Event of
Default, has occurred and is continuing, Borrower may provide substitute
equipment satisfactory to Lender to become part of the Collateral and Borrower
shall grant to Lender a first lien and security interest in respect of such
substitute equipment pursuant to the terms of this Agreement, and Borrower shall
provide the Lender evidence satisfactory to Lender of Borrower's good and
marketable title to such substitute equipment (free of any liens, security
interests or encumbrances other than created by this Agreement) and Lender shall
provide any required endorsements in connection with any insurance proceeds
received by Borrower pursuant to such insurance policies; or (c) Borrower shall
pay Lender the insurance proceeds payable pursuant to such insurance policies
("Insurance Proceeds") with respect to such Loss Item(s) and the principal
amount of the Note(s) (and interest accrued on the principal amount so
prepayable) shall become due and payable on the
-4-
<PAGE> 5
Settlement Date to the extent of the replacement cost for all such Loss Item(s).
For purposes of this Section 4.2, Casualty Value shall mean an amount equal to
the greater of the fair market value of the Equipment as of the date of the
Casualty Loss or the outstanding principal and accrued interest on the Loan.
Moneys so received shall be applied, on the date of such receipt, as follows:
first, to pay any accrued interest on the outstanding principal amount of the
Note(s) on such date; second, to prepay, the outstanding principal amount of the
Note(s) (to the extent of the fair market value attributable to such Loss
Item(s)); third, to pay any other Indebtedness of amounts then due and owing to
the Lender hereunder; and fourth, so long as there has occurred no Event of
Default under Section 8 hereof and no event which with the giving of notice or
passage of time or both would constitute an Event of Default, has occurred and
is continuing, Borrower and Lender hereby agree that the balance of any such
Insurance Proceeds shall be paid promptly to the Borrower.
4.3 Effective upon the date hereof under the Note(s) and while there
are any Secured Obligations outstanding, Borrower shall cause to be carried and
maintained comprehensive general liability insurance with regard to the
Collateral against risks customarily insured against in the Borrower's business.
Such risks shall include, without limitation, the risks of death, bodily injury
and property damage associated with the Collateral. All policies evidencing such
insurance shall provide for at least thirty (30) days prior written notice by
the underwriter or insurance company to the Lender in the event of cancellation
or expiration.
4.4 Borrower shall and does hereby indemnify and hold Lender, its
agents and shareholders harmless from and against any and all claims, costs,
expenses, damages and liabilities (including without limitation such claims,
costs, expenses, damages and liabilities based on liability in tort including
without limitation strict liability in tort) including reasonable attorneys'
fees, arising out of Borrower's ownership, possession, operation, control, use,
maintenance, delivery, or other disposition of the Collateral. Notwithstanding
the foregoing, Borrower shall not be responsible under the terms of this Section
4.4 to a party indemnified hereunder for any claims, costs, expenses, damages
and liabilities occasioned by the negligence or willful misconduct of such
indemnified party.
SECTION 5. COVENANTS OF BORROWER
Borrower covenants and agrees as follows at all times while any of the
Secured Obligations remain outstanding:
5.1 Borrower shall maintain the Equipment in good operating order,
repair, condition and appearance and protect the Equipment from deterioration,
other than normal wear and tear. Borrower shall not use the Equipment or permit
its use for any purpose other than for which it was designed. Borrower's
obligation regarding the maintenance of the Equipment shall include, without
limitation, all maintenance, repair, refurbishment and replacement recommended
or advised either by the manufacturer, or that commonly performed by prudent
business and/or professional practice. Any exceptions or qualifications
expressed in this Agreement relating to normal or ordinary wear and tear shall
not be deemed to limit Borrower's obligations pursuant to the preceding
sentence.
5.2 Borrower shall only relocate any item of the Collateral provided
that: (a) it shall have caused to be filed and/or delivered to the Lender all
UCC financing statements, certificates or other documents or instruments
necessary to continue in effect the first prior
-5-
<PAGE> 6
perfected security interest of the Lender in the Collateral, and (b) it shall
have given the Lender no less than fifteen (15) days prior written notice of
such relocation.
5.3 Upon the request of Lender, Borrower shall, during business hours,
make the Equipment available to Lender for inspection at the place where it is
normally located and shall make Borrower's log and maintenance records
pertaining to the Equipment available to Lender for inspection. Borrower shall
take all action necessary to maintain such logs and maintenance records in a
correct and complete fashion.
5.4 Upon the request of Lender, Borrower shall cause the Equipment to
be plainly, permanently and conspicuously marked, by stenciling or by metal tag
or plate affixed thereto, indicating Lender's security interest in the
Equipment. Borrower shall replace any such stenciling, tag or plate which may be
removed or destroyed or become illegible. Borrower shall keep all Equipment free
from any marking or labeling which might be interpreted as a claim of ownership
adverse to Borrower's.
5.5 Borrower covenants and agrees to pay when due, all taxes, fees or
other charges of any nature whatsoever (together with any related interest or
penalties) now or hereafter imposed or assessed against Borrower, Lender (except
taxes imposed on Lender's net income) or the Collateral or upon Borrower's
ownership, possession, use, operation or disposition thereof or upon Borrower's
rents, receipts or earnings arising therefrom. Borrower shall file on or before
the due date therefor all personal property tax returns in respect of the
Collateral.
5.6 Borrower shall furnish to Lender the financial statements listed
hereinafter, prepared in accordance with generally accepted accounting
principles consistently applied (the "Financial Statements"):
(a) as soon as practicable (and in any event within thirty
(30) days) after the end of each month: an internally prepared income
statement, balance sheet, and cash flow statement, (including the
commencement of any material litigation by or against Borrower), each
certified by Borrower's Chief Executive or Financial Officer to be true
and correct;
(b) as soon as practicable (and in any event within ninety
(90) days) after the end of each fiscal year, audited Financial
Statements, setting forth in comparative form the corresponding figures
for the preceding fiscal year, and accompanied by any audit report and
opinion of the independent certified public accountants selected by
Borrower; and
(c) promptly any additional information (including but not
limited to tax returns, income statements, balance sheets, and names of
principal creditors) as Lender reasonably believes necessary to
evaluate Borrower's continuing ability to meet financial obligations.
5.7 Notwithstanding the foregoing, after the effective date of the
initial registration statement covering a public offering of Borrower's
securities, the term "Financial Statements" shall be deemed to refer to only
those statements required by the Securities and Exchange Commission, to be
provided no less frequently than quarterly. Borrower will from time to time
execute, deliver and file, alone or with Lender, any financing statements,
security agreements or other documents; and take all further action that may be
necessary, or that Lender may
-6-
<PAGE> 7
reasonably request, to confirm, perfect, preserve and protect the security
interests intended to be granted hereby, and in addition, and for such purposes
only, Borrower hereby authorizes Lender to execute and deliver on behalf of
Borrower and to file such financing statements, security agreement and other
documents without the signature of Borrower either in Lender's name or in the
name of Borrower as agent and attorney-in-fact for Borrower.
5.8 Borrower shall protect and defend Borrower's title as well as the
interest of the Lender granted herein against all persons claiming any interest
adverse to Borrower or Lender and shall at all times keep the Collateral free
and clear from any attachment or levy, liens or encumbrances whatsoever (except
any placed thereon by Lender, or any liens arising by operation of law with
respect to any obligations not yet overdue or any other liens consented to in
writing by Lender) and shall give Lender immediate written notice thereof.
5.9 Borrower shall not sell, transfer, assign, hypothecate or otherwise
encumber its Intellectual Property without Lender's prior written consent.
SECTION 6. CONDITIONS PRECEDENT TO LOAN
On or prior to the Funding Date, Borrower will provide to Lender the
following, in form and substance satisfactory to Lender:
6.1 Such documentation, including without limitation, a Bill of Sale,
and other documents as shall reasonably evidence Borrower's right, title and
interest in and to the Equipment;
6.2 A certified resolution or other certificate of corporate authority
for the execution and the delivery of, and the performance of all Secured
Obligations under the Loan Documents and all related documentation;
6.3 Incumbency certificate evidencing the authority and facsimile
signatures of the individuals executing the Loan Documents;
6.4 UCC financing statements as deemed appropriate by Lender to perfect
its security interest in the Collateral;
6.5 Certified copies of the Certificate of Incorporation of Borrower;
6.6 Certificate of good standing for Borrower from its state of
incorporation and similar certificates from all jurisdictions in which it does
business and where the failure to be qualified would have a material adverse
effect on Borrower's business; and
6.7 Insurance certificates as required by Section 4 hereof.
SECTION 7. ASSIGNMENT BY LENDER
7.1 Borrower acknowledges and understands that Lender may sell and
assign all or a part of its interest hereunder and under the Note(s) and Loan
Documents to any person or entity (an "Assignee"). After such assignment the
term Lender shall mean such Assignee, and such Assignee shall be vested with all
rights, powers and remedies of Lender hereunder with respect to the interest so
assigned; but with respect to any such interest not so transferred, the
-7-
<PAGE> 8
Lender shall retain all rights, powers and remedies hereby given. No such
assignment by Lender shall relieve Borrower of any of its obligations hereunder.
Borrower shall acknowledge such assignment or assignments as shall be designated
by written notice given by Lender to Borrower. The Lender agrees that in the
event of any transfer by it of the Note(s), it will endorse thereon a notation
as to the portion of the principal of the Note(s) which shall have been paid at
the time of such transfer and as to the date to which interest shall have been
last paid thereon.
SECTION 8. DEFAULT
The occurrence of any one or more of the following events (herein
called "Events of Default") shall constitute a default hereunder and under the
Note(s):
8.1 The Borrower defaults in the payment of any principal or interest
payable under this Agreement, the Note(s) or any of the other Loan Documents and
such default continues for more than five (5) days after Lender provides written
notice to Borrower;
8.2 The Borrower defaults in the payment or performance of any other
covenant or obligation of the Borrower hereunder or under the Note(s) or any
other Loan Documents for more than ten (10) business days after the Lender has
given notice of such default to the Borrower;
8.3 As of the closing, any representation or warranty made herein by
the Borrower shall prove to have been false or misleading in any material
respect;
8.4 The making of an assignment by Borrower for the benefit of its
creditors or the admission by Borrower in writing of its inability to pay its
debts as they become due, or the insolvency of Borrower, or the filing by
Borrower of a voluntary petition in bankruptcy, or the adjudication of Borrower
as a bankrupt, or the filing by Borrower of any petition or answer seeking for
itself any reorganization, arrangement, composition, readjustment, liquidation,
dissolution, or similar relief under any present or future statute, law or
regulation, or the filing of any answer by Borrower admitting, or the failure by
Borrower to deny, the material allegations of a petition filed against it for
any such relief, or the seeking or consenting by Borrower to, or acquiescence by
Borrower in, the appointment of any trustee, receiver or liquidator of Borrower
or of all or any substantial part of the properties of Borrower, or the
inability of Borrower to pay its debts when due, or the commission by Borrower
of any act of bankruptcy as defined in the Federal Bankruptcy Act, as amended;
8.5 The failure by Borrower, within sixty (60) days after the
commencement of any proceeding against Borrower seeking any reorganization,
arrangement, composition, readjustment, liquidation, dissolution or similar
relief under any present or future statute, law or regulation, to obtain the
dismissal of such proceeding or, within sixty (60) days after the appointment,
without the written consent or acquiescence of Lender, of any trustee, receiver
or liquidator of Borrower or of all or any substantial part of the properties of
Borrower, to vacate such appointment; or
8.6 The default by Borrower under any other notes or other agreement
for borrowed money, lease or other agreement between Borrower and Lender.
-8-
<PAGE> 9
SECTION 9. REMEDIES
Upon the occurrence hereof of any one or more Events of Default,
Lender, at its option, may declare the Note(s) to be accelerated and immediately
due and payable, (provided, that upon the occurrence of an Event of Default of
the type described in 8.4 or 8.5, the Note(s) and all other Secured Obligations
shall automatically be accelerated and made due and payable without any further
act) whereupon the unpaid principal of and accrued interest on such Note(s)
shall become immediately due and payable, and shall thereafter bear interest at
the Default Rate and calculated in accordance with Section 1.2. Lender may
exercise all rights and remedies with respect to the Collateral granted pursuant
hereto for such Note(s), or otherwise available to it under applicable law,
including the right to release, hold or otherwise dispose of all or any part of
the Collateral and the right to utilize, process and commingle the Collateral.
Upon the happening and during the continuance of any Event of Default,
Lender may then, or at any time thereafter and from time to time, apply,
collect, sell in one or more sales, lease or otherwise dispose of, any or all of
the Collateral, in its then condition or following any commercially reasonably
preparation or processing, in such order as Lender may elect, and any such sale
may be made either at public or private sale at its place of business or
elsewhere. Borrower agrees that any such public or private sale may occur upon
five (5) business day's notice to Borrower. Lender may require Borrower to
assemble the Collateral and make it available to Lender at a place designated by
Lender which is reasonably convenient to Lender and Borrower. The proceeds of
any sale, disposition or other realization upon all or any part of the
collateral shall be distributed by Lender in the following order of priorities:
First, to Lender in an amount sufficient to pay in full Lender's
reasonable costs and professionals' and advisors' fees and expenses;
Second, to Lender in an amount equal to the then unpaid amount of the
Secured Obligations in such order and priority as Lender may choose in
its sole discretion; and
Finally, upon payment in full of all of the Secured Obligations, to
Borrower or its representatives or as a court of competent jurisdiction
may direct.
The Lender shall return to the Borrower any surplus Collateral remaining after
payment of all Secured Obligations.
SECTION 10. MISCELLANEOUS
10.1 Borrower shall remain liable to Lender for any unpaid Secured
Obligations, advances, costs, charges and expenses, together with interest
thereon and shall pay the same immediately to Lender at Lender's offices.
10.2 The powers conferred upon Lender by this Agreement are solely to
protect its interest in the Collateral and shall not impose any duty upon Lender
to exercise any such powers.
10.3 This is a continuing Agreement and the grant of a security
interest hereunder shall remain in full force and effect and all the rights,
powers and remedies of Lender hereunder shall continue to exist until the
Secured Obligations are paid in full as the same become due and payable. When
Borrower has paid in full all Secured Obligations, Lender will,
-9-
<PAGE> 10
promptly upon request of Borrower, execute a written termination statement,
reassigning to Borrower, without recourse, the Collateral and all rights
conveyed hereby and return possession (if Lender has possession) of the
Collateral to Borrower. The rights, powers and remedies of Lender hereunder
shall be in addition to all rights, powers and remedies given by statute or rule
of law and are cumulative. The exercise of any one or more of the rights, powers
and remedies provided herein shall not be construed as a waiver of any other
rights, powers and remedies of Lender. Furthermore, regardless of whether or not
the UCC is in effect in the jurisdiction where such rights, powers and remedies
are asserted, Lender shall have the rights, powers and remedies of a secured
party under the UCC.
10.4 Upon payment in full of all Secured Obligations, the Lender shall
cancel the Note(s), this Agreement and all UCC financing statements, if any, and
shall promptly deliver all such canceled documents to the Borrower.
10.5 GOVERNING LAW. This Agreement, the Note(s) and the other Loan
Documents have been negotiated and delivered to Lender in the State of Illinois
and shall not become effective until accepted by Lender in the State of
Illinois. Payment to Lender by Borrower of the Secured Obligations is due in the
State of Illinois. This Agreement shall be governed by, and construed and
enforced in accordance with the laws of the State of Illinois excluding conflict
of laws principles that would cause the application of laws of any other
jurisdiction.
10.6 CONSENT TO JURISDICTION AND VENUE. All judicial proceedings
arising in or under or related to this Agreement, the Note(s) or any of the
other Loan Documents may be brought in any state or federal court of competent
jurisdiction located in the State of Illinois. By execution and delivery of this
Agreement, each party hereto generally and unconditionally: (a) consents to
personal jurisdiction in Cook County, State of Illinois; (b) waives any
objection as to jurisdiction or venue in the aforesaid courts; and (d)
irrevocably agrees to be bound by any judgment rendered thereby in connection
with this Agreement, the Note(s) and the other Loan Documents. Service of
process on any party hereto in any action arising out of or relating to this
Agreement shall be effective if given in accordance with the requirements for
notice set forth in Section 10.8 below and shall be deemed effective and
received as set forth in Section 10.8 below. Nothing herein shall affect the
right to serve process in any other manner permitted by law or shall limit the
right of either party to bring proceedings in the courts of any other
jurisdiction.
10.7 Whenever possible, each provision of this Agreement shall be
interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Agreement shall be prohibited by or invalid under
such law, such provision shall be ineffective only to the extent and duration of
such prohibition or invalidity, without invalidating the remainder of such
provision or the remaining provisions of this Agreement.
10.8 Any notice required or given hereunder shall be deemed properly
given upon the earlier of: (i) the first business day after transmission by
facsimile or hand delivery or deposit with an overnight express service or
overnight mail delivery service; or (ii) or three (3) days after mailed, postage
prepaid, in each case, addressed to the designated recipient at its address set
forth herein or such other address as such party may advise the other party by
notice given in accordance with this provision.
-10-
<PAGE> 11
10.9 Lender and Borrower acknowledge that there are no agreements or
understandings, written or oral, between Lender and Borrower with respect to the
Loan, other than as set forth herein, in the Note(s) and the other Loan
Documents and that this Agreement, the Note(s) and the other Loan Documents
contain the entire agreement between Lender and Borrower with respect thereto.
None of the terms of this Agreement, the Note(s) and the other Loan Documents
may be amended except by an instrument executed by each of the parties hereto.
10.10 No omission, or delay, by Lender at any time to enforce any right
or remedy reserved to it, or to require performance of any of the terms,
covenants or provisions hereof by Borrower at any time designated, shall be a
waiver of any such right or remedy to which Lender is entitled, nor shall it in
any way affect the right of Lender to enforce such provisions thereafter.
10.11 All agreements, representations and warranties contained in this
Agreement or the Note(s), or in any Loan Documents delivered pursuant hereto or
in connection herewith shall be for the benefit of Lender and any Assignee and
shall survive the execution and delivery of this Agreement or the Note(s) and
the expiration or other termination of this Agreement or the Note(s).
10.12 This Agreement may be executed in any number of counterparts,
each of which shall be deemed an original, but all such counterparts together
shall constitute but one and the same instrument.
10.13 This Agreement shall be binding upon, and shall inure to the
benefit of, Borrower and its permitted assigns (if any). Borrower shall not
assign its obligations under this Agreement, the Note(s) or any of the other
Loan Documents without Lender's express written consent and any such attempted
assignment shall be void and of no effect. Any assignment by Borrower in
connection with a "Merger" (as defined below) shall be subject to Lender's prior
consent which shall not be unreasonably withheld. Any consent granted by Lender
shall be conditioned upon such surviving entity or transferee assuming
Borrower's Secured Obligations hereunder pursuant to assignment documents
reasonably acceptable to Lender. If Lender reasonably withholds its consent to
such assignment in connection with a Merger, the outstanding principal and
accrued and unpaid interest shall be prepaid in whole.
For purposes of this Agreement, a "Merger" shall mean any consolidation
or merger of the Borrower with or into any other corporation or entity, any sale
or conveyance of all or substantially all of the assets or stock of the Borrower
by or to any other person or entity in which Borrower is not the surviving
entity.
IN WITNESS WHEREOF, the Borrower and the Lender have duly executed and
delivered this Agreement as of the day and year first above written.
BORROWER: NEOFORMA , INC.
By: /s/ ROBERT ZOLLARS
----------------------------
Title: CEO
----------------------------
Date: 7/13/99
----------------------------
-11-
<PAGE> 12
ACCEPTED IN ROSEMONT, ILLINOIS:
LENDER: COMDISCO, INC.
By: /s/ JAMES LABE
-------------------------------------
Title: President, Comdisco Ventures Division
-------------------------------------
Date: 7/15/99
-------------------------------------
-12-
<PAGE> 13
EXHIBIT A-1 TO
EXHIBIT 10.19
HARDWARE
SECURED PROMISSORY NOTE
$1,032,001.98 DATE: SEPTEMBER 3, 1999
DUE: SEPTEMBER 1, 2003
FOR VALUE RECEIVED, Neoforma, Inc. a Delaware corporation (the "Borrower")
hereby promises to pay to the order of Comdisco, Inc., a Delaware corporation
(the "Lender") at P.O. Box 91744, Chicago, IL 60693 or such other place of
payment as the holder of this Secured Promissory Note (this "Note") may specify
from time to time in writing, in lawful money of the United States of America,
the principal amount of One Million Thirty Two Thousand One and 98/100 Dollars
($1,032,001.98) together with interest at Nine percent (9%) per annum from the
date of this Note to maturity of each installment on the principal hereof
remaining from time to time unpaid, such principal and interest to be paid 48
equal monthly installments consisting of 1 payment of $22,676.7 (.75%) each,
commencing October 1, 1999, followed by 8 payments of $7,712.67 each, commencing
November 1, 1999 and on the same day of each month hereafter, followed by 39
payments of $30,382.14 (2.945%) each, commencing July 1, 2000 and on the same
day of each month thereafter to and including September 1, 2003 and an
additional installment in the amount of $165,120.32 (16%) ("Balloon Payment") to
be paid on September 1, 2003, such installments to be applied first to accrued
and unpaid interest and the balance to unpaid principal. Interest shall be
computed on the basis of a year consisting of twelve months of thirty days each.
This Note is the Note referred to in, and is executed and delivered in
connection with, that certain Loan and Security Agreement dated July 7, 1999 by
and between Borrower and Lender (as the same may from time to time be amended,
modified or supplemented in accordance with its terms, the "Loan Agreement"),
and is entitled to the benefit and security of the Loan Agreement and the other
Loan Documents (as defined in the Loan Agreement), to which reference is made
for a statement of all of the terms and conditions thereof. All terms defined in
the Loan Agreement shall have the same definitions when used herein, unless
otherwise defined herein.
The Borrower waives presentment and demand for payment, notice of dishonor,
protest and notice of protest and any other notice as permitted under the UCC or
any applicable law.
This Note has been negotiated and delivered to Lender and is payable in the
State of Illinois, and shall not become effective until accepted by Lender in
the State of Illinois.
13
<PAGE> 14
This Note shall be governed by and construed and enforced in accordance with,
the laws of the State of Illinois, excluding any conflicts of law rules or
principles that would cause the application of the laws of any other
jurisdiction.
BORROWER: NEOFORMA, INC.
3255 Scott Blvd.
Santa Clara, CA 95054
Signature:
------------------------------
Print Name:
------------------------------
Title:
------------------------------
14
<PAGE> 15
EXHIBIT A-2 TO
EXHIBIT 10.19
SOFT COST SECURED PROMISSORY NOTE
240,363.61 Date:September 3, 1999
Due: March 1, 2002
FOR VALUE RECEIVED, Neoforma, Inc. a Delaware corporation (the "Borrower")
hereby promises to pay to the order of Comdisco, Inc., a Delaware corporation
(the "Lender") at P.O. Box 91744, Chicago, IL 60693 or such other place of
payment as the holder of this Secured Promissory Note (this "Note") may specify
from time to time in writing, in lawful money of the United States of America,
the principal amount of Two Hundred Forty Thousand Three Hundred Sixty Three and
61/100 Dollars ($240,363.61) together with interest at Nine percent (8%) per
annum from the date of this Note to maturity of each installment on the
principal hereof remaining from time to time unpaid, such principal and interest
to be paid 30 equal monthly installments consisting of 1 payments of $4,708.46
(.67%) each, commencing October 1, 1999, followed by 3 payments of $1,610.44
(.67%) each commencing November 1, 1999 and on the same day of each month
thereafter to and including January 1, 2000, followed by 26 payments of
$10,029.76 (4.17%) each, commencing February 1, 2000 and on the same day of each
month thereafter to and including March 1, 2002 and an additional installment in
the amount of $38,458.18 (16%) ("Balloon Payment") to be paid on March 1, 2002,
such installments to be applied first to accrued and unpaid interest and the
balance to unpaid principal. Interest shall be computed on the basis of a year
consisting of twelve months of thirty days each.
This Note is the Note referred to in, and is executed and delivered in
connection with, that certain Loan and Security Agreement dated July 7, 1999 by
and between Borrower and Lender (as the same may from time to time be amended,
modified or supplemented in accordance with its terms, the "Loan Agreement"),
and is entitled to the benefit and security of the Loan Agreement and the other
Loan Documents (as defined in the Loan Agreement), to which reference is made
for a statement of all of the terms and conditions thereof. All terms defined in
the Loan Agreement shall have the same definitions when used herein, unless
otherwise defined herein.
The Borrower waives presentment and demand for payment, notice of dishonor,
protest and notice of protest and any other notice as permitted under the UCC or
any applicable law.
This Note has been negotiated and delivered to Lender and is payable in the
State of Illinois, and shall not become effective until accepted by Lender in
the State of Illinois.
15
<PAGE> 16
This Note shall be governed by and construed and enforced in accordance with,
the laws of the State of Illinois, excluding any conflicts of law rules or
principles that would cause the application of the laws of any other
jurisdiction.
BORROWER: NEOFORMA, INC.
3255 Scott Blvd.
Santa Clara, CA 95054
Signature:
------------------------------
Print Name:
------------------------------
Title:
------------------------------
16
<PAGE> 17
EXHIBIT B TO
EXHIBIT 10.19
EQUIPMENT DESCRIPTION
17
<PAGE> 1
EXHIBIT 10.20
HARDWARE
SECURED PROMISSORY NOTE
$1,032,001.98 DATE: SEPTEMBER 3, 1999
DUE: SEPTEMBER 1, 2003
FOR VALUE RECEIVED, Neoforma, Inc. a Delaware corporation (the "Borrower")
hereby promises to pay to the order of Comdisco, Inc., a Delaware corporation
(the "Lender") at P.O. Box 91744, Chicago, IL 60693 or such other place of
payment as the holder of this Secured Promissory Note (this "Note") may specify
from time to time in writing, in lawful money of the United States of America,
the principal amount of One Million Thirty Two Thousand One and 98/100 Dollars
($1,032,001.98) together with interest at Nine percent (9%) per annum from the
date of this Note to maturity of each installment on the principal hereof
remaining from time to time unpaid, such principal and interest to be paid 48
equal monthly installments consisting of 1 payment of $22,676.7 (.75%) each,
commencing October 1, 1999, followed by 8 payments of $7,712.67 each, commencing
November 1, 1999 and on the same day of each month hereafter, followed by 39
payments of $30,382.14 (2.945%) each, commencing July 1, 2000 and on the same
day of each month thereafter to and including September 1, 2003 and an
additional installment in the amount of $165,120.32 (16%) ("Balloon Payment") to
be paid on September 1, 2003, such installments to be applied first to accrued
and unpaid interest and the balance to unpaid principal. Interest shall be
computed on the basis of a year consisting of twelve months of thirty days each.
This Note is the Note referred to in, and is executed and delivered in
connection with, that certain Loan and Security Agreement dated July 7, 1999 by
and between Borrower and Lender (as the same may from time to time be amended,
modified or supplemented in accordance with its terms, the "Loan Agreement"),
and is entitled to the benefit and security of the Loan Agreement and the other
Loan Documents (as defined in the Loan Agreement), to which reference is made
for a statement of all of the terms and conditions thereof. All terms defined in
the Loan Agreement shall have the same definitions when used herein, unless
otherwise defined herein.
The Borrower waives presentment and demand for payment, notice of dishonor,
protest and notice of protest and any other notice as permitted under the UCC or
any applicable law.
This Note has been negotiated and delivered to Lender and is payable in the
State of Illinois, and shall not become effective until accepted by Lender in
the State of Illinois.
-1-
<PAGE> 2
This Note shall be governed by and construed and enforced in accordance with,
the laws of the State of Illinois, excluding any conflicts of law rules or
principles that would cause the application of the laws of any other
jurisdiction.
BORROWER: NEOFORMA, INC.
3255 Scott Blvd.
Santa Clara, CA 95054
Signature: /s/ WAYNE MCVICKER
------------------------------
Print Name: Wayne McVicker
------------------------------
Title: VP and Founder
------------------------------
-2-
<PAGE> 1
EXHIBIT 10.21
SOFTCOST
SECURED PROMISSORY NOTE
240,363.61 Date:September 3, 1999
Due: March 1, 2002
FOR VALUE RECEIVED, Neoforma, Inc. a Delaware corporation (the "Borrower")
hereby promises to pay to the order of Comdisco, Inc., a Delaware corporation
(the "Lender") at P.O. Box 91744, Chicago, IL 60693 or such other place of
payment as the holder of this Secured Promissory Note (this "Note") may specify
from time to time in writing, in lawful money of the United States of America,
the principal amount of Two Hundred Forty Thousand Three Hundred Sixty Three and
61/100 Dollars ($240,363.61) together with interest at Nine percent (8%) per
annum from the date of this Note to maturity of each installment on the
principal hereof remaining from time to time unpaid, such principal and interest
to be paid 30 equal monthly installments consisting of 1 payments of $4,708.46
(.67%) each, commencing October 1, 1999, followed by 3 payments of $1,610.44
(.67%) each commencing November 1, 1999 and on the same day of each month
thereafter to and including January 1, 2000, followed by 26 payments of
$10,029.76 (4.17%) each, commencing February 1, 2000 and on the same day of each
month thereafter to and including March 1, 2002 and an additional installment in
the amount of $38,458.18 (16%) ("Balloon Payment") to be paid on March 1, 2002,
such installments to be applied first to accrued and unpaid interest and the
balance to unpaid principal. Interest shall be computed on the basis of a year
consisting of twelve months of thirty days each.
This Note is the Note referred to in, and is executed and delivered in
connection with, that certain Loan and Security Agreement dated July 7, 1999 by
and between Borrower and Lender (as the same may from time to time be amended,
modified or supplemented in accordance with its terms, the "Loan Agreement"),
and is entitled to the benefit and security of the Loan Agreement and the other
Loan Documents (as defined in the Loan Agreement), to which reference is made
for a statement of all of the terms and conditions thereof. All terms defined in
the Loan Agreement shall have the same definitions when used herein, unless
otherwise defined herein.
The Borrower waives presentment and demand for payment, notice of dishonor,
protest and notice of protest and any other notice as permitted under the UCC or
any applicable law.
This Note has been negotiated and delivered to Lender and is payable in the
State of Illinois, and shall not become effective until accepted by Lender in
the State of Illinois.
-1-
<PAGE> 2
This Note shall be governed by and construed and enforced in accordance with,
the laws of the State of Illinois, excluding any conflicts of law rules or
principles that would cause the application of the laws of any other
jurisdiction.
BORROWER: NEOFORMA, INC.
3255 Scott Blvd.
Santa Clara, CA 95054
Signature: /s/ WAYNE MCVICKER
------------------------------
Print Name: Wayne McVicker
------------------------------
Title: VP and Founder
------------------------------
-2-
<PAGE> 1
EXHIBIT 10.22
LEASE AGREEMENT
BLDG: Park Square I-6
OWNER: 500
PROP: 316
UNIT: 101
TENANT: 31609
THIS LEASE, made this 30th day of July, 1998 between JOHN ARRILLAGA,
Trustee, or his Successor Trustee, UTA dated 7/20/77 (JOHN ARRILLAGA SURVIVOR'S
TRUST) as amended, and RICHARD T. PEERY, Trustee, or his Successor Trustee, UTA
dated 7/20/77 (RICHARD T. PEERY SEPARATE PROPERTY TRUST) as amended,
hereinafter called Landlord, and NEOFORMA, INC., a California corporation,
hereinafter called Tenant.
WITNESSETH;
Landlord hereby leases to Tenant and Tenant hereby hires and takes from
Landlord those certain premises (the "Premises") outlined in red on Exhibit
"A", attached hereto and incorporated herein by this reference thereto more
particularly described as follows:
A portion of that certain 22,500 (plus or minus) square foot, one-story
building located at 3255-6 Scott Blvd., Suite 101, Santa Clara, California
95054, consisting of approximately 10,878 (plus or minus) square feet of space.
Said Premises is more particularly shown within the area outlined in Red on
Exhibit A attached hereto. The entire parcel, of which the Premises is a part,
is shown within the area outlined in Green on Exhibit A attached. The Premises
shall be improved by landlord as shown on Exhibit B attached hereto, and is
leased on an "as-is" basis, in its present condition, and in the configuration
as shown in Red on Exhibit B attached hereto.
As used herein the Complex shall mean and include all of the land outlined in
Green and described in Exhibit "A", attached hereto, and all of the buildings,
improvements, fixtures and equipment now or hereafter situated on said land.
Said letting and hiring is upon and subject to the terms, covenants and
conditions hereinafter set forth and Tenant covenants as a material part of the
consideration for this Lease to perform and observe each and all of said terms,
covenants and conditions. This Lease is made upon the conditions of such
performance and observance.
1. USE Tenant shall use the Premises only in conformance with applicable
governmental laws, regulations, rules and ordinances for the purpose of general
office, light manufacturing, research and development, and storage and other
uses necessary for Tenant to conduct Tenant's business, provided that such uses
shall be in accordance with all applicable governmental laws and ordinances and
for no other purpose. Tenant shall not do or permit to be done in or about the
Premises or the Complex nor bring or keep or permit to be brought or kept in or
about the Premises or the Complex anything which is prohibited by or will in any
way increase the existing rate of (or otherwise affect) fire or any insurance
covering the Complex or any part thereof, or any of its contents, or will cause
a cancellation of any insurance covering the Complex or any part thereof, or any
of its contents. Tenant shall not do or permit to be done anything in, on or
about the Premises or the Complex which will in any way obstruct or interfere
with the rights of other tenants or occupants of the Complex or injure or annoy
them, or use or allow the Premises to be used for any improper, immoral,
unlawful or objectionable purpose, nor shall Tenant cause, maintain or permit
any nuisance in, on or about the Premises or the Complex. No sale by auction
shall be permitted on the Premises. Tenant shall not place any loads upon the
floors, walls, or ceiling, which endanger the structure, or place any harmful
fluids or other materials in the drainage system of the building, or overload
existing electrical or other mechanical systems. No waste materials or refuse
shall be dumped upon or permitted to remain upon any part of the Premises or
outside of the building in which the Premises are a part, except in trash
containers placed inside exterior enclosures designated by Landlord for that
purpose or inside of the building proper where designated by Landlord. No
materials, supplies, equipment, finished products or semi-finished products, raw
materials or articles of any nature shall be stored upon or permitted to remain
outside the Premises or on any portion of common area of the Complex. No
loudspeaker or other device, system or apparatus which can be heard outside the
Premises shall be used in or at the Premises without the prior written consent
of Landlord. Tenant shall not commit or suffer to be committed any waste in or
upon the Premises. Tenant shall indemnify, defend and hold Landlord harmless
against any loss, expense, damage, attorneys' fees, or liability arising out of
failure of Tenant to comply with any applicable law. Tenant shall comply with
any covenant, condition, or restriction ("CC&R's") affecting the Premises. The
provisions of this paragraph are for the benefit of Landlord only and shall not
be construed to be for the benefit of any tenant or occupant of the Complex.
2. TERM*
A. The term of this Lease shall be for a period of FIVE (5) years (unless
sooner terminated as hereinafter provided) and, subject to Paragraphs 2(B) and
3, shall commence on the 1st day of September, 1998 and end on the 31st day
August of 2003.
B. Possession of the Premises shall be deemed tendered and the term of
this Lease shall commence when the first of the following occurs:
(a) One day after a Certificate of Occupancy is granted by the proper
governmental agency, or, if the governmental agency having jurisdiction over
the area in which the Premises are situated does not issue certificates of
occupancy, then the same number of days after certification by Landlord's
architect or contractor that Landlord's construction work has been completed; or
(b) Upon the occupancy of the Premises by any of Tenant's operating
personnel; or
(c) When the Tenant Improvements have been substantially completed for
Tenant's use and occupancy, in accordance and compliance with Exhibit B of this
Lease Agreement; or
(d) As otherwise agreed in writing.
3. POSSESSION If Landlord, for any reason whatsoever, cannot deliver possession
of said premises to Tenant at the commencement of the said term, as hereinbefore
specified, this Lease shall not be void or voidable; no obligation of Tenant
shall be affected thereby; nor shall Landlord or Landlord's agents be liable to
Tenant for any loss or damage resulting therefrom; but in that event the
commencement and termination dates of the Lease, and all other dates affected
thereby shall be revised to conform to the date of Landlord's delivery of
possession, as specified in Paragraph 2(b), above. The above is, however,
subject to the provision that the period of delay, of delivery of the premises
shall not exceed 30 days from the commencement date herein (except those delays
caused by Acts of God, strikes, war, utilities, governmental bodies, weather,
unavailable materials, and delays beyond Landlord's control shall be excluded
in calculating such period) in which instance Tenant, at its option, may, by
written notice to Landlord, terminate this Lease.
* It is agreed in the event said Lease commences on a date other than the first
day of the month the term of the Lease will be extended to account for the
number of days in the partial month. The Basic Rent during the resulting partial
month will be pro-rated (for the number of days in the partial month) at the
Basic Rent scheduled for the projected commencement date as shown in Paragraph
43.
1
<PAGE> 2
4. RENT
A. Basic Rent. Tenant agrees to pay to Landlord at such place as Landlord
may designate without deduction, offset, prior notice, or demand, and Landlord
agrees to accept as Basic Rent for the leased Premises the total sum of ONE
MILLION SEVEN HUNDRED SIXTY TWO THOUSAND TWO HUNDRED THIRTY SIX AND NO/100
($1,762,236.00) Dollars in lawful money of the United States of America, payable
as follows:
B. Time for Payment. In the event that the term of this Lease commences on
a date other than the first day of a calendar month, on the date of commencement
of the term hereof Tenant shall pay to Landlord as rent for the period from such
date of commencement to the first day of the next succeeding calendar month that
proportion of the monthly rent hereunder which the number of days between such
date of commencement and the first day of the next succeeding calendar month
bears to thirty (30). In the event that the term of this Lease for any reason
ends on a date other than the last day of a calendar month, on the first day of
the last calendar month of the term hereof Tenant shall pay to Landlord as rent
for the period from said first day of said last calendar month to and including
the last day of the term hereof that proportion of the monthly rent hereunder
which the number of days between said first day of said last calendar month and
the last day of the term hereof bears to thirty (30).
C. Late Charge. Notwithstanding any other provision of this Lease, if
Tenant is in default in the payment of rental as set forth in this Paragraph 4
when due, or any part thereof, Tenant agrees to pay Landlord, in addition to
the delinquent rental due, a late charge for each rental payment in default ten
(10) days. Said late charge shall equal ten (10%) percent of each rental
payment so in default.
D. Additional Rent. Beginning with the commencement date of the term of
this Lease, Tenant shall pay to Landlord in addition to the Basic Rent and as
Additional Rent the following:
(a) Tenant's proportionate share of all Taxes relating to the Complex as
set forth in Paragraph 12, and
(b) Tenant's proportionate share of all insurance premiums relating to the
Complex, as set forth in Paragraph 15, and
(c) Tenant's proportionate share of expenses for the operation, management,
maintenance and repair of the Building (including common areas of the
Building) and Common Areas of the Complex in which the Premises are
located as set forth in Paragraph 7, and
(d) All charges, costs and expenses, which Tenant is required to pay
hereunder, together with all interest and penalties, costs and expenses
including attorneys' fees and legal expenses, that may accrue thereto
in the event of Tenant's failure to pay such amounts, and all damages,
reasonable costs and expenses which Landlord may incur by reason of
default of Tenant or failure on Tenant's part to comply with the terms
of this Lease. In the event of nonpayment by Tenant of Additional Rent,
Landlord shall have all the rights and remedies with respect thereto as
Landlord has for nonpayment of rent.
The Additional Rent due hereunder shall be paid to Landlord or Landlord's agent
(i) within five days for taxes and insurance and within thirty days for all
other Additional Rent items after presentation of invoice from Landlord or
Landlord's agent setting forth such Additional Rent and/or (ii) at the option of
Landlord, Tenant shall pay to Landlord monthly, in advance, Tenant's prorata
share of an amount estimated by Landlord to be Landlord's approximate average
monthly expenditure for such Additional Rent items, which estimated amount shall
be reconciled within 120 days of the end of each calender year or more
frequently if Landlord so elects to do so at Landlord's sole and absolute
discretion, as compared to Landlord's actual expenditure for said Additional
Rent items, with Tenant paying to Landlord, upon demand, any amount of actual
expenses expended by Landlord in excess of said estimated amount, or Landlord
crediting to Tenant (providing Tenant is not in default in the performance of
any of the terms, covenants and conditions of this Lease) any amount of
estimated payments made by Tenant in excess of Landlord's actual expenditures
for said Additional Rent items. Within thirty (30) days after receipt of
Landlord's reconciliation, Tenant shall have the right, at Tenant's sole
expense, to audit, at a mutually convenient time at Landlord's office,
Landlord's records relating to the foregoing expenses. Such audit must be
conducted by Tenant or an independent nationally recognized accounting firm that
is not being compensated by Tenant or other third party on a contingency fee
basis. Landlord shall be provided a complete copy of said audit at no expense to
Landlord. If such audit reveals that Landlord has overcharged Tenant and the
audit is not challenged by Landlord, the amount overcharged shall be credited to
Tenant's account within thirty (30) days after the audit is concluded.
The respective obligations of Landlord and Tenant under this paragraph
shall survive the expiration or other termination of the term of this Lease, and
if the term hereof shall expire or shall otherwise terminate on a day other than
the last day of a calendar year, the actual Additional Rent incurred for the
calendar year in which the term hereof expires or otherwise terminates shall be
determined and settled on the basis of the statement of actual Additional Rent
incurred for the calendar year in which the term hereof expires or otherwise
terminates shall be determined and settled on the basis of the statement of
actual Additional Rent for such calendar year and shall be prorated in the
proportion which the number of days in such calendar preceding such expiration
or termination bears to 365.
E. Fixed Management Fee. Beginning with the Commencement Date of the Term
of this Lease, Tenant shall pay to Landlord, in addition to the Basic Rent and
Additional Rent, a fixed monthly management fee ("Management Fee") equal to 3%
of the Basic Rent due for each month during the Lease Term.
F. Place of Payment of Rent and Additional Rent. All Basic Rent hereunder
and all payments hereunder for Additional Rent shall be paid to Landlord at the
office of Landlord at Peery/Arrillaga, File 1504, Box 60000, San Francisco, CA
94160 or to such other person or to such other place as Landlord may from time
to time designate in writing.
G. Security Deposit. Concurrently with Tenant's execution of this Lease,
Tenant shall deposit with Landlord the sum of SIXTY THREE THOUSAND NINETY TWO
AND 40/100 ($63,092.40) Dollars. Said sum shall be held by Landlord as a
Security Deposit for the faithful performance by Tenant of all of the terms,
covenants, and conditions of this Lease to be kept and performed by Tenant
during the term hereof. If Tenant defaults with respect to any provision of this
Lease, including, but not limited to, the provisions relating to the payment of
rent and any of the monetary sums due herewith, Landlord may (but shall not be
required to) use, apply or retain all or any part of this Security Deposit for
the payment of any other amount which Landlord may spend by reason of Tenant's
default or to compensate Landlord for any other loss or damage with Landlord may
suffer by reason of Tenant's default. If any portion of said Deposit is so used
or applied, Tenant shall, within ten (10) days after written demand therefor,
deposit cash with Landlord in the amount sufficient to restore the Security
Deposit to its original amount. Tenant's failure to do so shall be a material
breach of this Lease. Landlord shall not be required to keep this Security
Deposit separate from its general funds, and Tenant shall not be entitled to
interest on such Deposit. If Tenant fully and faithfully performs every
provision of this Lease to be performed by it, the Security Deposit or any
balance thereof shall be returned to Tenant (or at Landlord's option, to the
last assignee of Tenant's interest hereunder) at the expiration of the Lease
term and after Tenant has vacated the Premises. In the event of termination of
Landlord's interest in this Lease, Landlord shall transfer said Deposit to
Landlord's successor in interest whereupon Tenant agrees to release Landlord
from liability for the return of such Deposit or the accounting therefor.
5. RULES AND REGULATIONS AND COMMON AREA Subject to the terms and
conditions of this Lease and such Rules and Regulations as Landlord may from
time to time prescribe, Tenant and Tenant's employees, invitees and customers
shall, in common with other occupants of the Complex in which the Premises are
located, and their respective employees, invitees and customers, and others
entitled to the use thereof, have the non-exclusive right to use the access
roads, parking areas, and facilities provided and designated by Landlord for the
general use and convenience of the occupants of the Complex in which the
Premises are located, which areas and facilities are referred to herein as
"Common Area". This right shall terminate upon the termination of this Lease.
Landlord reserves the right from time to time to make changes in the shape,
size, location, amount and extent of Common Area. Landlord further reserves the
right to promulgate such reasonable rules and regulations relating to the use of
the Common Area, and any part or parts thereof, as Landlord may deem appropriate
for the best interests of the occupants of the Complex. The Rules and
Regulations shall be binding upon Tenant upon delivery of a copy of them to
Tenant, and Tenant shall abide by them and cooperate in their observance. Such
Rules and Regulations may be amended by Landlord from time to time, with or
without advance notice, and all amendments shall be effective upon delivery of a
copy to Tenant. Landlord shall not be responsible to Tenant for the
non-performance by any other tenant or occupant of the Complex of any of said
Rules and Regulations.
Landlord shall operate, manage and maintain the Common Area. The manner in
which the Common Area shall be maintained and the expenditures for such
maintenance shall be at the discretion of Landlord.
2
<PAGE> 3
6. PARKING Tenant shall have the right to use with other tenants or
occupants of the Complex 32 parking spaces in the common parking areas of the
Complex. Tenant agrees, that Tenant, Tenant's employees, agents,
representatives and/or invitees shall not use parking spaces in excess of said
32 spaces allocated to Tenant hereunder. Landlord shall have the right, at
Landlord's sole discretion, to specifically designate the location of Tenant's
parking spaces within the common parking areas of the Complex in the event of a
dispute among the tenants occupying the building and/or Complex referred to
herein, in which event Tenant agrees that Tenant, Tenant's employees, agents,
representatives and/or invitees shall not use any parking spaces other than
those parking spaces specifically designated by Landlord for Tenant's use. Said
parking spaces, if specifically designated by Landlord to Tenant, may be
relocated by Landlord at any time, and from time to time. Landlord reserves the
right, at Landlord's sole discretion, to rescind any specific designation
of parking spaces, thereby returning Tenant's parking spaces to the common
parking area. Landlord shall give Tenant written notice of any change in
Tenant's parking spaces. Tenant shall not, at any time, park, or permit to be
parked, any trucks or vehicles adjacent to the loading areas so as to
interfere in any way with the use of such areas, nor shall Tenant at any time
park, or permit the parking of Tenant's trucks or other vehicles or the trucks
and vehicles of Tenant's suppliers or others, in any portion of the common area
not designated by Landlord for such use by Tenant. Tenant shall not park nor
permit to be parked, any inoperative vehicles or equipment on any portion of
the common parking area or other common areas of the Complex. Tenant agrees to
assume responsibility for compliance by its employees with the parking
provision contained herein. If Tenant or its employees park in other than such
designated parking areas, then Landlord may charge Tenant, as an additional
charge, and Tenant agrees to pay, ten ($10.00) Dollars per day for each day or
partial day each such vehicle is parked in any area other than that designated.
Tenant hereby authorizes Landlord at Tenant's sole expense to tow away from the
Complex any vehicle belonging to Tenant or Tenant's employees parked in
violation of these provisions, or to attach violation stickers or notices to
such vehicles. Tenant shall use the parking areas for the vehicle parking only,
and shall not use the parking areas for storage.
7. EXPENSES OF OPERATION, MANAGEMENT, AND MAINTENANCE OF THE COMMON AREAS OF
THE COMPLEX AND BUILDING IN WHICH THE PREMISES ARE LOCATED As Additional
Rent and in accordance with Paragraph 4D of this Lease, Tenant shall pay to
Landlord Tenant's proportionate share (calculated on a square footage or other
equitable basis as calculated by Landlord) of all expenses of operation,
management, maintenance and repair of the Common Areas of the Complex including,
but not limited to, license, permit, and inspection fees; security; utility
charges associated with exterior landscaping and lighting (including water and
sewer charges); all charges incurred in the maintenance and replacement of
landscaped areas, lakes, parking lots and paved areas (including repairs,
replacement, resealing and restriping), sidewalks, driveways; maintenance,
repair and replacement of all fixtures and electrical, mechanical, and plumbing
systems; structural elements and exterior surfaces of the buildings; salaries
and employee benefits of personnel and payroll taxes applicable thereto;
supplies, materials, equipment and tools; the cost of capital expenditures which
have the effect of reducing operating expenses, provided, however, that in the
event Landlord makes such capital improvements, Landlord may amortize its
investment in said improvements (together with interest at the rate of fifteen
(15%) percent per annum on the unamortized balance) as an operating expense in
accordance with standard accounting practices, provided, that such amortization
is not at a rate greater than the anticipated savings in the operating expenses.
"Additional Rent" as used herein shall not include Landlord's debt
repayments; interest on charges; expenses directly or indirectly incurred by
Landlord for the benefit of any other tenant; cost for the installation of
partitioning or any other tenant improvements; cost of attracting tenants;
depreciation; interest, or executive salaries.
As Additional Rent and in accordance with paragraph 4D of this Lease,
Tenant shall pay its proportionate share (calculated on a square footage or
other equitable basis as calculated by Landlord) of the cost of operation
(including common utilities), management, maintenance, and repair of the
building (including common areas such as lobbies, restrooms, janitor's closets,
hallways, elevators, mechanical and telephone rooms, stairwells, entrances,
spaces above the ceilings and janitorization of said common areas) in which the
Premises are located. The maintenance items herein referred to include, but are
not limited to, all windows, window frames, plate glass, glazing, truck doors,
main plumbing systems of the building (such as water and drain lines, sinks,
toilets, faucets, drains, showers and water fountains), main electrical systems
(such as panels and conduits), heating and airconditioning systems (such as
compressors, fans, air handlers, ducts, boilers, heaters), store fronts,
roofs, downspouts, building common area interiors (such as wall coverings,
window coverings, floor coverings and partitioning), ceilings, building
exterior doors, skylights (if any), automatic fire extinguishing systems, and
elevators; license, permit and inspection fees; security; salaries and
employee benefits of personnel and payroll taxes applicable thereto; supplies,
materials, equipment and tools; the cost of capital expenditures which have the
effect of reducing operating expenses, provided, however, that in the event
Landlord makes such capital improvements, Landlord may amortize its investment
in said improvements (together with interest at the rate of fifteen (15%)
percent per annum on the unamortized balance) as an operating expense in
accordance with standard accounting practices, provided, that such amortization
is not at a rate greater than the anticipated savings in the operating
expenses. Tenant hereby waives all rights under, and benefits of, subsection 1
of section 1932 and sections 1941 and 1942 of the California Civil Code and
under any similar law, statute or ordinance now or hereafter in effect.
8. ACCEPTANCE AND SURRENDER OF PREMISES By entry hereunder, Tenant accepts
the Premises as being in good and sanitary order, condition and repair and
accepts the building and improvements included in the Premises in their present
condition and without representation or warranty by Landlord as to the condition
of such building or as to the use or occupancy which may be made thereof. Any
exceptions to the foregoing must be by written agreement executed by Landlord
and Tenant. Tenant agrees on the last day of the Lease term, or on the sooner
termination of this Lease, to surrender the Premises promptly and peaceably to
Landlord in good condition and repair (damage by Acts of God, fire, normal wear
and tear excepted), with all interior walls painted, or cleaned so that they
appear freshly painted, and repaired and replaced, if damaged; all floors
cleaned and waxed; all carpets cleaned and shampooed; the airconditioning and
heating equipment serviced by a reputable and licensed service firm and in good
operating condition (provided the maintenance of such equipment has been
Tenant's responsibility during the term of this Lease) together with all
alterations, additions, and improvements which may have been made in, to, or on
the Premises (except movable trade fixtures installed at the expense of Tenant)
except that Tenant shall ascertain from Landlord within thirty (30) days before
the end of the term of this Lease whether Landlord desires to have the Premises
or any part or parts thereof restored to their condition and configuration as
when the Premises were delivered to Tenant and if Landlord shall so desire, then
Tenant shall restore said Premises or such part or parts thereof before the end
of this Lease at Tenant's sole cost and expense. Tenant, on or before the end of
the term or sooner termination of this Lease, shall remove all of Tenant's
personal property and trade fixtures from the Premises, and all property not so
removed on or before the end of the term or sooner termination of this Lease
shall be deemed abandoned by Tenant and title to same shall thereupon pass to
Landlord without compensation to Tenant. Landlord may, upon termination of this
Lease, remove all moveable furniture and equipment so abandoned by Tenant, at
Tenant's sole cost, and repair any damage caused by such removal at Tenant's
sole cost. If the Premises be not surrendered at the end of the term or sooner
termination of this Lease, Tenant shall indemnify Landlord against loss or
liability resulting from the delay by Tenant in so surrendering the Premises
including, without limitation, any claims made by any succeeding tenant founded
on such delay. Nothing contained herein shall be construed as an extension of
the term hereof or as a consent of Landlord to any holding over by Tenant. The
voluntary or other surrender of this Lease or the Premises by Tenant or a mutual
cancellation of this Lease shall not work as a merger and, at the option of
Landlord, shall either terminate all or any existing subleases or substenancies
or operate as an assignment to Landlord of all or any such subleases or
subtenancies.
9. ALTERATIONS AND ADDITIONS Tenant shall not make, or suffer to be made, any
alteration or addition to the Premises, or any part thereof, without the written
consent of Landlord first had and obtained by Tenant, but at the cost of Tenant,
and any addition to, or alteration of, the Premises, except moveable furniture
and trade fixtures, shall at once become a part of the Premises and belong to
Landlord. Landlord reserves the right to approve all contractors and mechanics
proposed by Tenant to make such alterations and additions. Tenant shall retain
title to all moveable furniture and trade fixtures placed in the Premises. All
heating, lighting, electrical, airconditioning, floor to ceiling partitioning,
drapery, carpeting, and floor installations made by Tenant, together with all
property that has become an integral part of the Premises, shall not be deemed
trade fixtures. Tenant agrees that it will not proceed to make such alteration
or additions, without having obtained consent from Landlord to do so, and until
five (5) days from the receipt of such consent, in order that Landlord may post
appropriate notices to avoid any liability to contractors or material suppliers
for payment for Tenant's improvements. Tenant will at all times permit such
notices to be posted and to remain posted until the completion of the work.
Tenant shall, if required by Landlord, secure at Tenant's own cost and expense,a
completion and lien indemnity bond, satisfactory to Landlord, for such work.
Tenant further covenants and agrees that any mechanic's lien filed against the
Premises or against the Complex for work claimed to have been done for, or
materials claimed to have been furnished to Tenant, will be discharged by
Tenant, by bond or otherwise, within ten (10) days after the filing thereof, at
the cost and expense of Tenant. Any exceptions to the foregoing must be made in
writing and executed by both Landlord and Tenant.
10. TENANT MAINTENANCE Tenant shall, at its sole cost and expense, keep and
maintain the Premises (including appurtenances) and every part thereof in a high
standard of maintenance and repair, and in good and sanitary condition. Tenant's
maintenance and repair responsibilities herein referred to include, but are not
limited to, janitorization, plumbing systems within the non-common areas of the
Premises (such as water and drain lines, sinks), electrical systems within the
non-common areas of the Premises (such as outlets, lighting fixtures, lamps,
bulbs, tubes, ballasts), heating and airconditioning controls within the
non-common areas of the Premises (such as mixing boxes, thermostats, time
clocks, supply and return grills), all interior improvements within the premises
including but not limited to: wall coverings, window coverings, acoustical
ceilings, vinyl tile, carpeting, partitioning, doors (both interior and
exterior, including closing mechanisms, latches, locks), and all other interior
improvements of any nature whatsoever. Tenant agrees to provide carpet shields
under all rolling chairs or to otherwise be responsible for wear and tear of the
carpet caused by such rolling chairs if such wear and tear exceeds that caused
by normal foot traffic in surrounding areas. Areas of excessive wear shall be
replaced at Tenant's sole expense upon Lease termination.
3
<PAGE> 4
11. UTILITIES OF THE BUILDING IN WHICH THE PREMISES ARE LOCATED As Additional
Rent and in accordance with paragraph 4 D of this Lease, Tenant shall pay its
proportionate share (calculated on a square footage or other equitable basis as
calculated by Landlord) of the cost of all utility charges such as water, gas,
electricity, telephone, telex and other electronic communications service, sewer
service, waste-pick-up and any other utilities, materials or services furnished
directly to the building in which the Premises are located, including, without
limitation, any temporary or permanent utility surcharge or other exactions
whether or not hereinafter imposed.
Landlord shall not be liable for and Tenant shall not be entitled to any
abatement or reduction of rent by reason of any interruption or failure of
utility services to the Premises when such interruption or failure is caused by
accident, breakage, repair, strikes, lockouts, or other labor disturbances or
labor disputes of any nature, or by any other cause, similar or dissimilar,
beyond the reasonable control of Landlord.
Provided that Tenant is not in default in the performance or observance of
any of the terms, covenants or conditions of this Lease to be performed or
observed by it, Landlord shall furnish to the Premises between the hours of
8:00AM and 6:00PM, Mondays through Fridays (holidays excepted) and subject to
the rules and regulations of the Complex hereinbefore referred to, reasonable
quantities of water, gas and electricity suitable for the intended use of the
Premises and heat and airconditioning required in Landlord's judgment for the
comfortable use and occupation of the Premises for such purposes. Tenant agrees
that at all times it will cooperate fully with Landlord and abide by all
regulations and requirements that Landlord may prescribe for the proper
functioning and protection of the building heating, ventilating and
airconditioning systems. Whenever heat generating machines, equipment, or any
other devices (including exhaust fans) are used in the Premises by Tenant which
affect the temperature or otherwise maintained by the airconditioning system,
Landlord shall have the right to install supplementary airconditioning units in
the Premises and the cost thereof, including the cost of installation and the
cost of operations and maintenance thereof, shall be paid by Tenant to Landlord
upon demand by Landlord. Tenant will not, without the written consent of
Landlord, use any apparatus or device in the Premises (including, without
limitation), electronic data processing machines or machines using current in
excess of 110 Volts which will in any way increase the amount of electricity,
gas, water or airconditioning usually furnished or supplied to premises being
used as general office space, or connect with electric current (except through
existing electrical outlets in the Premises), or with gas or water pipes any
apparatus or device for the purposes of using electric current, gas, or water.
If Tenant shall require water, gas, or electric current in excess of that
usually furnished or supplied to premises being used as general office space,
Tenant shall first obtain the written consent of Landlord, which consent shall
not be unreasonably withheld and Landlord may cause an electric current, gas, or
water meter to be installed in the Premises in order to measure the amount of
electric current, gas or water consumed for any such excess use. The cost of
any such meter and of the installation, maintenance and repair thereof, all
charges for such excess water, gas and electric current consumed (as shown by
such meters and at the rates then charged by the furnishing public utility); and
any additional expense incurred by Landlord in keeping account of electric
current, gas, or water so consumed shall be paid by Tenant, and Tenant agrees to
pay Landlord therefor promptly upon demand by Landlord.
12. TAXES A. As Additional Rent and in accordance with Paragraph 4 D of
this Lease, Tenant shall pay to Landlord Tenant's proportionate share of all
Real Property Taxes, which prorata share shall be allocated to the leased
Premises by square footage or other equitable basis, as calculated by Landlord.
The term "Real Property Taxes", as used herein, shall mean (i) all taxes,
assessments, levies and other charges of any kind or nature whatsoever, general
and special, foreseen and unforeseen (including all installments of principal
and interest required to pay any general or special assessments for public
improvements and any increases resulting from reassessments caused by any change
in ownership of the Complex) now or hereafter imposed by any governmental or
quasi-governmental authority or special district having the direct or indirect
power to tax or levy assessments, which are levied or assessed against, or with
respect to the value, occupancy or use of, all or any portion of the Complex (as
now constructed or as may at any time hereafter be constructed, altered, or
otherwise changed) or Landlord's interest therein; any improvements located
within the Complex regardless of ownership); the fixtures, equipment and other
property of Landlord, real or personal, that are an integral part of and located
in the Complex; or parking areas, public utilities, or energy within the
Complex; (ii) all charges, levies or fees imposed by reason of environmental
regulation or other governmental control of the Complex; and (iii) all costs and
fees (including attorneys' fees) incurred by Landlord in contesting any Real
Property Tax and in negotiating with public authorities as to any Real Property
Tax. If at any time during the term of this Lease the taxation or assessment of
the Complex prevailing as of the commencement date of this Lease shall be
altered so that in lieu of or in addition to any Real Property Tax described
above there shall be levied, assessed or imposed (whether by reason of a change
in the method of taxation or assessment, creation of a new tax or charge, or any
other cause) an alternate or additional tax or charge (i) on the value, use or
occupancy of the Complex or Landlord's interest therein or (ii) on or measured
by the gross receipts, income or rentals from the Complex, on Landlord's
business of leasing the Complex, or computed in any manner with respect to the
operation of the Complex, then any such tax or charge, however designated, shall
be included within the meaning of the term "Real Property Taxes" for purposes of
this Lease. If any Real Property Tax is based upon property or rents unrelated
to the Complex, then only that part of such Real Property Tax that is fairly
allocable to the Complex shall be included within the meaning of the term "Real
Property Taxes". Notwithstanding the foregoing, the term "Real Property Taxes"
shall not include estate, inheritance, gift or franchise taxes of Landlord or
the federal or state net income tax imposed on Landlord's income from all
sources.
B. Taxes on Tenant's Property
(a) Tenant shall be liable for and shall pay ten days before delinquency, taxes
levied against any personal property or trade fixtures place by Tenant in or
about the Premises. If any such taxes on Tenant's personal property or trade
fixtures are levied against Landlord or Landlord's property or if the assessed
value of the Premises is increased by the inclusion therein of a value placed
upon such personal property or trade fixtures of Tenant and if Landlord, after
written notice to Tenant, pays the taxes based on such increased assessment,
which Landlord shall have the right to do regardless of the validity thereof,
but only under proper protest if requested by Tenant, Tenant shall upon demand,
as the case may be, repay to Landlord the taxes so levied against Landlord, or
the proportion of such taxes resulting from such increase in the assessment;
provided that in any such event Tenant shall have the right, in the name of
Landlord and with Landlord's full cooperation, to bring suit in any court of
competent jurisdiction to recover the amount of any such taxes so paid under
protest, and any amount so recovered shall belong to Tenant.
(b) if the Tenant improvements in the Premises, whether installed, and/or
paid for by Landlord or Tenant and whether or not affixed to the real property
so as to become a part thereof, are assessed for real property tax purposes at
a valuation higher than the valuation at which standard office improvements in
other space in the Complex are assessed, then the real property taxes and
assessments levied against Landlord or the Complex by reason of such excess
assessed valuation shall be deemed to be taxes levied against personal property
of Tenant and shall be governed by the provisions of 12Ba, above. If the
records of the County Assessor are available and sufficiently detailed to serve
as a basis for determining whether said Tenant improvements are assessed at a
higher valuation than standard office improvements in other space in the
Complex, such records shall be binding on both the Landlord and the Tenant. If
the records of the County Assessor are not available or sufficiently detailed to
serve as a basis for making said determination, the actual cost of construction
shall be used.
13. LIABILITY INSURANCE Tenant at Tenant's expense, agrees to keep in force
during the term of this Lease a policy of commercial general liability
insurance with a combined single limit coverage of not less than Two Million
Dollars ($2,000,000) per occurrence for injuries to or death of persons
occurring in, on or about the Premises of the Complex, and property damage. The
policy or policies affecting such insurance, certificates of insurance of which
shall be furnished to Landlord, shall name Landlord as additional insureds, and
shall insure any liability of Landlord, contingent or otherwise, as respects
act or omissions of Tenant, its agents, employees or invitees or otherwise by
any conduct or transactions of any of said persons in or about or concerning
the Premises, including any failure of Tenant to observe or perform any of its
obligations hereunder; shall be issued by an insurance company admitted to
transact business in the State of California; and shall provide that the
insurance effected thereby shall not be canceled, except upon thirty (30) days'
prior written notice to Landlord. If, during the term of this Lease, in the
considered opinion of Landlord's Lender, insurance advisor, or counsel, the
amount of insurance described in this paragraph 13 is not adequate, Tenant
agrees to increase said coverage to such reasonable amount as Landlord's
Lender, insurance advisor, or counsel shall deem adequate.
14. TENANT'S PERSONAL PROPERTY INSURANCE AND WORKMAN'S COMPENSATION INSURANCE
Tenant shall maintain a policy or policies of fire and property damage
insurance in "all risk" form with a sprinkler leakage endorsement insuring the
personal property, inventory, trade fixtures, and leasehold improvements within
the leased Premises for the full replacement value thereof. The proceeds from
any of such policies shall be used for the repair or replacement of such items
so insured.
Tenant shall also maintain a policy of workman's compensation insurance
ant any other employee benefit insurance sufficient to comply with all laws.
15. PROPERTY INSURANCE Landlord shall purchase and keep in force and as
Additional Rent and in accordance with Paragraph 4D of this Lease, Tenant shall
pay to Landlord (or Landlord's agent if so directed by Landlord) Tenant's
proportionate share (calculated on a square footage or other equitable basis as
calculated by Landlord) of the deductibles on insurance claims and the cost of
policy or policies of insurance covering loss or damage to the Premises and
Complex in the amount of the full replacement value thereof, providing
protection against those perils included within the classification of "all
risks" insurance and flood and/or earthquake insurance, if available, plus a
policy of rental income insurance in the amount of one hundred (100%) percent of
twelve (12) months Basic Rent, plus sums paid as Additional Rent. If such
insurance cost is increased due to Tenant's use of the Premises or the Complex,
Tenant agrees to pay to Landlord the full cost of such increase. Tenant shall
have no interest in nor any right to the proceeds of any insurance procured by
Landlord for the Complex.
Landlord and Tenant do each hereby respectively release the other, to the
extent of insurance coverage of the releasing party, from any liability for loss
or damage caused by fire or any of the extended coverage casualties included in
the releasing party's insurance policies, irrespective of the cause of such fire
or casualty; provided, however, that if the insurance policy of either releasing
party prohibits such waiver, then this waiver shall not take effect until
consent to such waiver is obtained. If such waiver is so prohibited, the insured
party affected shall promptly notify the other party thereof.
4
<PAGE> 5
16. INDEMNIFICATION Landlord shall not be liable to Tenant and Tenant hereby
waives all claims against Landlord for any injury to or death of any person or
damage to or destruction of property in or about the Premises or the Complex by
or from any cause whatsoever, including, without limitation, gas, fire, oil,
electricity or leakage of any character from the roof, walls, basement or other
portion of the Premises or the Complex but excluding, however, the willful
misconduct or negligence of Landlord, its agents, servants, employees, invitees,
or contractors of which negligence Landlord has knowledge and reasonable time to
correct. Except as to injury to persons or damage to property to the extent
arising from the willful misconduct or the negligence of Landlord, its agents,
servants, employees, invitees, or contractors, Tenant shall hold Landlord
harmless from and defend Landlord against any and all expenses, including
reasonable attorneys' fees, in connection therewith, arising out of any injury
to or death of any person or damage to or destruction of property occurring in,
or for about the Premises, or any part thereof, from any cause whatsoever.
17. COMPLIANCE Tenant, at its sole cost and expense, shall promptly comply
with all laws, statutes, ordinances and governmental rules, regulations or
requirements now or hereafter in effect; with the requirements of any board of
fire underwriters or other similar body now or hereafter constituted; and with
any direction or occupancy certificate issued pursuant to law by any public
officer; provided, however, that no such failure shall be deemed a breach of the
provisions if Tenant, immediately upon notification, commences to remedy or
rectify said failure. The judgment of any court of competent jurisdiction or the
admission of Tenant in any action against Tenant, whether Landlord be a party
thereto or not, that Tenant has violated any such law, statute, ordinance or
governmental rule, regulation, requirement, direction or provision, shall be
conclusive of that fact as between Landlord and Tenant. This paragraph shall not
be interpreted as requiring Tenant to make structural changes or improvements,
except to the extent such changes or improvements are required as a result of
Tenant's use of the Premises. Tenant shall, at its sole cost and expense, comply
with any and all requirements pertaining to said Premises, of any insurance
organization or company, necessary for the maintenance of reasonable fire and
public liability insurance covering the Premises.
18. LIENS Tenant shall keep the Premises and the Complex free from any liens
arising out of any work performed, materials furnished or obligation incurred
by Tenant. In the event that Tenant shall not, within ten (10) days following
the imposition of such lien, cause the same to be released of record, Landlord
shall have, in addition to all other remedies provided herein and by law, the
right, but no obligation, to cause the same to be released by such means as it
shall deem proper, including payment of the claim giving rise to such lien. All
sums paid by Landlord for such purpose, and all expenses incurred by it in
connection therewith, shall be payable to Landlord by Tenant on demand with
interest at the prime rate of interest as quoted by the Bank of America.
19. ASSIGNMENT AND SUBLETTING Tenant shall not assign, transfer, or hypothecate
the leasehold estate under this Lease, or any interest therein, and shall not
sublet the Premises, or any part thereof, or any right or privilege appurtenant
thereto, or suffer any other person or entity to occupy or use the Premises, or
any portion thereof, without, in each case, the prior written consent of
Landlord which consent will not be unreasonably withheld. As a condition for
granting this consent to any assignment, transfer, or subletting, Landlord shall
require Tenant to pay to Landlord, as Additional Rent, all rents and/or
additional consideration due Tenant from its assignees, transferees, or
subtenants in excess of the Rent payable by Tenant to Landlord hereunder for the
assigned, transferred, and/or subleased space. Tenant shall, by thirty (30) days
written notice, advise Landlord of its intent to assign or transfer Tenant's
interest in the Lease or sublet the Premises or any portion thereof for any part
of the term hereof. Within thirty (30) days after receipt of said written
notice, Landlord may, in its sole discretion, elect to terminate this Lease as
to the portion of the Premises described in Tenant's notice on the date
specified in Tenant's notice by giving written notice of such election to
terminate; however, in the event Tenant's request to assign is related to a
merger and/or acquisition and Landlord elects to terminate, Tenant shall have
the right to rescind its request to assign, provided Tenant so notifies Landlord
in writing within five (5) days following Landlord's notice to terminate. If no
such notice to terminate is given to Tenant within said thirty (30) day period,
Tenant may proceed to locate an acceptance sublessee, assignee, or other
transferee for presentment to Landlord for Landlord's approval, all in
accordance with the terms, covenants, and conditions of this paragraph 19. If
Tenant intends to sublet the entire Premises and Landlord elects to terminate
this Lease, this Lease shall be terminated on the date specified in Tenant's
notice. If, however, this Lease shall terminate pursuant to the foregoing with
respect to less than all the Premises, the rent, as defined and reserved
hereinabove shall be adjusted on a pro rata basis to the number of square feet
retained by Tenant, and this Lease as so amended shall continue in full force
and effect. In the event Tenant is allowed to assign, transfer or sublet the
whole or any part of the Premises, with the prior written consent of Landlord,
no assignee, transferee or subtenant shall assign or transfer this Lease, either
in whole or in part, or sublet the whole or any part of the Premises, without
also having obtained the prior written consent of Landlord. A consent of
Landlord to one assignment, transfer, hypothecation, subletting, occupation or
use by other person shall not release Tenant from any of Tenant's obligations
hereunder or be deemed to be a consent to any subsequent similar or dissimilar
assignment, transfer, hypothecation, subletting, occupation or use by any other
person. Any such assignment, transfer, hypothecation, subletting, occupation or
use without such consent shall be void and shall constitute a breach of this
Lease by Tenant and shall, at the option of Landlord exercised by written notice
to Tenant, terminate this Lease. The leasehold estate under this Lease shall
not, nor shall any interest therein, be assignable for any purpose by operation
of law without the written consent of Landlord. As a condition to its consent,
Landlord shall require Tenant to apply all expenses in connection with the
assignment, and Landlord shall require Tenant's assignee or transferee (or other
assignees or transferees) to assume in writing all of the obligations under this
Lease and for Tenant to remain liable to Landlord under the Lease.
Notwithstanding the above, in no event will Landlord consent to a sub-sublease.
20. SUBORDINATION AND MORTGAGES In the event Landlord's title of leasehold
interest is now or hereafter encumbered by a deed of trust, upon the interest
of Landlord in the land and buildings in which the demised Premises are located,
to secure a loan from a lender (hereinafter referred to as "Lender" ) to
Landlord, Tenant shall, at the request of Landlord or Lender, execute in writing
an agreement subordinating its rights under this Lease to the lien of such
deed of trust, or, if so requested, agreeing that the lien of Lender's deed of
trust shall be or remain subject and subordinate to the rights of Tenant under
this Lease. Notwithstanding any such subordination, Tenant's possession under
this Lease shall not be disturbed if Tenant is not in default and so long as
Tenant shall pay all rent and observe and perform all of the provisions set
forth in this Lease.
21. ENTRY BY LANDLORD Landlord reserves, and shall at all reasonable times
after at least 24 hours notice (except in emergencies) have, the right to enter
the Premises to inspect them; to perform any services to be provided by Landlord
hereunder; to submit the Premises to prospective purchasers, mortgagees or
tenants; to post notices of nonresponsibility; and to alter, improve or repair
the Premises and any portion of the Complex, all without abatement of rent; and
may erect scaffolding and other necessary structures in or through the Premises
where reasonably required by the character of the work to be performed;
provided, however that the business of Tenant shall be interfered with to the
least extent that is reasonably practical. For each of the foregoing purposes,
any entry to the Premises obtained by Landlord by any of said means, or
otherwise, shall not under any circumstances be construed or deemed to be a
forcible or unlawful entry into or a detainer of the Premises or an eviction,
actual or constructive, of Tenant from the Premises or any portion thereof.
Landlord shall also have the right at any time to change the arrangement or
location of entrances or passageways, doors and doorways, and corridors,
elevators, stairs, toilets or other public parts of the Complex and to change
the name, number or designation by which the Complex is commonly known, and none
of the foregoing shall be deemed and actual or constructive eviction of Tenant,
or shall entitle Tenant to any reduction of rent hereunder.
22. BANKRUPTCY AND DEFAULT The commencement of a bankruptcy action or
liquidation action or reorganization action or insolvency action or an
assignment of or by Tenant for the benefit of creditors, or any similar action
undertaken by Tenant, or the insolvency of Tenant, shall, at Landlord's option,
constitute a breach of this Lease by Tenant. If the trustee or receiver
appointed to serve during a bankruptcy, liquidation, reorganization, insolvency
or similar action elects to reject Tenant's unexpired Lease, the trustee or
receiver shall notify Landlord in writing of its election within thirty (30)
days after an order for relief in a liquidation action or within thirty (30)
days after the commencement of any action.
Within thirty (30) days after court approval of the assumption of this
Lease, the trustee or receiver shall cure (or provide adequate assurance to the
reasonable satisfaction of Landlord that the trustee or receiver shall cure) any
and all previous defaults under the unexpired Lease and shall compensate
Landlord for all actual pecuniary loss and shall provide adequate assurance of
future performance under said Lease to the reasonable satisfaction of Landlord.
Adequate assurance of future performance, as used herein, includes, but shall
not be limited to: (i) assurance of source and payment of rent, and other
consideration due under this Lease; (ii) assurance that the assumption or
assignment of this Lease will not breach substantially any provision, such as
radius, location, use, or exclusivity provision, in any agreement relating to
the above described Premises.
Nothing contained in this section shall affect the existing right of
Landlord to refuse to accept an assignment upon commencement of or in connection
with a bankruptcy, liquidation, reorganization or insolvency action or an
assignment of Tenant for the benefit of creditors or other similar act. Nothing
contained in this Lease shall be construed as giving or granting or creating an
equity in the demised Premises to Tenant. In no event shall the leasehold
estate under this Lease, or any interest therein, be assigned by voluntary or
involuntary bankruptcy proceeding without the prior written consent of Landlord.
In no event shall this Lease or any rights or privileges hereunder be an asset
of Tenant under any bankruptcy, insolvency or reorganization proceedings.
The failure to perform or honor any covenant, condition or representation
make under this Lease shall constitute a default hereunder by Tenant upon
expiration of the appropriate grace period hereinafter provided. Tenant shall
have a period of five (5) days from the date of written notice from Landlord
within which to cure any default in the payment of rental or adjustment
thereto. Tenant shall have a period of thirty (30) days from the date of
written notice from Landlord within which to cure any other default under this
Lease. Upon an uncured default of this Lease by Tenant, Landlord shall have the
following rights and remedies in addition to any other rights or remedies
available to Landlord at law or in equity:
(a). The rights and remedies provided for by California Civil Code Section
1951.2, including but not limited to, recovery of the worth at the time of award
of the amount by which the unpaid rent for the balance of the term after the
time of award exceeds the amount of rental loss for the same period that Tenant
proves could be reasonably avoided, as computed pursuant to subsection (b) of
said Section 1951.2. Any proof by Tenant under subparagraphs (2) and (3) of
Section 1951.2 of the California Civil Code of the amount of rental loss that
could be reasonably avoided shall be made in the following manner: Landlord and
Tenant shall each select a licensed real estate broker in the business of
renting property of the same type and use as the Premises and in the same
geographic vicinity. Such two real estate brokers shall select a third licensed
real estate
5
<PAGE> 6
broker, and the three licensed real estate brokers so selected shall determine
the amount of the rental loss that could be reasonably avoided from the balance
of the term of the Lease after the time of award. The decision of the majority
of said licensed real estate brokers shall be final and binding upon the parties
hereto.
(b). The rights and remedies provided by California Civil Code Section
which allows Landlord to continue the Lease in effect and to enforce all of its
rights and remedies under this Lease, including the right to recover rent as it
becomes due, for so long as Landlord does not terminate Tenant's right to
possession; acts of maintenance or preservation, efforts to relet the Premises,
or the appointment of a receiver upon Landlord's initiative to protect its
interest under this Lease shall not constitute a termination of Tenant's right
to possession.
(c). The right to terminate this Lease by giving notice to Tenant in
accordance with applicable law.
(d). To the extent permitted by law the right and power, to enter the
Premises and remove therefrom all persons and property, and to store such
property in a public warehouse or elsewhere at the cost of and for the account
of Tenant, and to sell such property and apply such proceeds therefrom pursuant
to applicable California law. Landlord may from time to time sublet the Premises
or any part thereof for such term or terms (which may extend beyond the term of
this Lease) and at such rent and such other terms as Landlord in its sole
discretion may deem advisable, with the right to make alterations and repairs to
the Premises. Upon each subletting, (i) Tenant shall be immediately liable to
pay Landlord, in addition to indebtedness other than rent due hereunder, the
cost of such subletting, including, but not limited to reasonable attorneys'
fees, and any real estate commissions actually paid, and the cost of such
alterations and repairs incurred by Landlord and the amount, if any, by which
the rent hereunder for the period of such subletting (to the extent such period
does not exceed the term hereof) exceeds the amount to be paid as rent for the
Premises for such period or (ii) at the option of Landlord, rents received from
such subletting shall be applied first to payment of indebtedness other than
rent due hereunder from Tenant to Landlord; second, to the payment of any costs
of such subletting and of such alterations and repairs; third to payment of rent
due and unpaid hereunder; and the residue, if any, shall be held by Landlord and
applied in payment of future rent as the same becomes due hereunder. If Tenant
has been credited with any rent to be received by such subletting under option
(i) and such rent shall not be promptly paid to Landlord by the subtenant(s), or
if such rentals received from such subletting under option (ii) during any month
be less than that to be paid during that month by Tenant hereunder. Tenant shall
pay any such deficiency to Landlord. Such deficiency shall be calculated and
paid monthly. For all purposes set forth in this subparagraph (d). No taking
possession of the Premises by Landlord, shall be construed as an election on its
part to terminate this Lease unless a written notice of such intention be given
to Tenant. Notwithstanding any such subletting without termination, Landlord may
at any time hereafter elect to terminate this Lease for such previous breach.
(e). The right to have a receiver appointed for Tenant upon application by
Landlord, to take possession of the Premises and to apply any rental collected
from the Premises and to exercise all other rights and remedies granted to
Landlord pursuant to subparagraph d. above.
23. ABANDONMENT Tenant shall not vacate or abandon the Premises at any time
during the term of this Lease and if Tenant shall abandon, vacate or surrender
said Premises, or be dispossessed by the process of law, or otherwise, any
personal property belonging to Tenant and left on the Premises shall be deemed
to be abandoned, at the option of Landlord, except such property as may be
mortgaged to Landlord.
24. DESTRUCTION In the event the Premises are destroyed in whole or in part
from any cause, except for routine maintenance and repairs and incidental damage
and destruction caused from vandalism and accidents for which Tenant is
responsible for under Paragraph 10. Landlord may, at its option:
(a) Rebuild or restore the Premises to their condition prior to the
damage or destruction, or
(b) Terminate this Lease (providing that the Premises is damaged to the
extent of 33 1/3% of the replacement cost).
If Landlord does not give Tenant notice in writing within thirty (30) days
from the destruction of the Premises of its election to either rebuild and
restore them, or to terminate this Lease, Landlord shall be deemed to have
elected to rebuild or restore them, in which event Landlord agrees, at its
expense, promptly to rebuild or restore the Premises to their condition prior to
the damage or destruction. Tenant shall be entitled to a reduction in rent while
such repair is being made in the proportion that the area of the Premises
rendered untenantable by such damage bears to the total area of the Premises. If
Landlord initially estimates that the rebuilding or restoration will exceed 180
days or if Landlord does not complete the rebuilding or restoration within one
hundred eighty (180) days following the date of destruction (such period of time
to be extended for delays caused by the fault or neglect of Tenant or because of
Acts of God, acts of public agencies, labor disputes, strikes, fires, freight
embargoes, rainy or stormy weather, inability to obtain materials, supplies or
fuels, acts of contractors or subcontractors, or delay of the contractors due to
such causes or other contingencies beyond the control of Landlord), then Tenant
shall have the right to terminate this Lease by giving fifteen (15) days prior
written notice to Landlord. Notwithstanding anything herein to the contrary,
Landlord's obligation to rebuild or restore shall be limited to the building and
interior improvements constructed by Landlord as they existed as of the
commencement date of the Lease and shall not include restoration of Tenant's
trade fixtures, equipment, merchandise, or any improvements, alterations or
additions made by Tenant to the Premises, which Tenant shall forthwith replace
or fully repair at Tenant's sole cost and expense provided this Lease is not
cancelled according to the provisions above.
Unless this Lease is terminated pursuant to the foregoing provisions, this
Lease shall remain in full force and effect. Tenant hereby expressly waives the
provisions of Section 1932, Subdivision 2, in Section 1933, Subdivision 4 of the
California Civil Code.
In the event that the building in which the Premises are situated is
damaged or destroyed to the extent of not less than 33 1/3% of the replacement
cost thereof, Landlord may elect to terminate this Lease, whether the Premises
be injured or not. Notwithstanding anything to the contrary herein, Landlord
may terminate this Lease in the event of an uninsured event or if insurance
proceeds are insufficient to cover 100% of the rebuilding costs net of the
deductible.
25. EMINENT DOMAIN If all or any part of the Premises shall be taken by an
public or quasi-public authority under the power of eminent domain or conveyance
in lieu thereof, this Lease shall terminate as to any portion of the Premises so
taken or conveyed on the date when title vests in the condemnor, and Landlord
shall be entitled to any and all payment, income, rent, award, or any interest
therein whatsoever which may be paid or made in connection with such taking or
conveyance, and Tenant shall have no claim against Landlord or otherwise for the
value of any unexpired term of this Lease. Notwithstanding the foregoing
paragraph, any compensation specifically awarded Tenant for loss of business,
Tenant's personal property, moving cost or loss of goodwill, shall be and remain
the property of Tenant.
If (i) any action or proceeding is commenced for such taking of the
Premises or any part thereof, or if Landlord is advised in writing by any entity
or body having the right or power of condemnation of its intention to condemn
the premises or any portion thereof, or (ii) any of the foregoing events occur
with respect to the taking of any space in the Complex not leased hereby, or if
any such spaces so taken or conveyed in lieu of such taking and Landlord shall
decide to discontinue the use and operation of the Complex, or decide to
demolish, alter or rebuild the Complex, then, in any of such events Landlord
shall have the right to terminate this Lease by giving Tenant written notice
thereof with sixty (60) days of the date of receipt of said written advice, or
commencement of said action or proceeding, or taking conveyance, which
termination shall take place as of the first to occur of the last day of the
calendar month next following the month in which such notice is given or the
date on which title to the Premises shall vest in the condemnor.
In the event of such a partial taking or conveyance of the Premises, if the
portion of the Premises taken or conveyed is so substantial that the Tenant can
no longer reasonably conduct its business, Tenant shall have the privilege of
terminating this Lease within sixty (60) days from the date of such taking or
conveyance, upon written notice to Landlord of its intention so to do, and upon
giving of such notice this Lease shall terminate on the last day of the calendar
month next following the month in which such notice is given, upon payment of
Tenant of the rent from the date of such taking or conveyance to the date of
termination.
If a portion of the Premises be taken by condemnation or conveyance in lieu
thereof and neither Landlord nor Tenant shall terminate this Lease as provided
herein, this Lease shall continue in full force and effect as to the part of the
Premises not so taken or conveyed, and the rent herein shall be apportioned as
of the date of such taking or conveyance so that thereafter the rent to be paid
by Tenant shall be in the ratio that the area of the portion of the Premises not
so taken or conveyed bears to the total area of the Premises prior to such
taking.
26. SALE OR CONVEYANCE BY LANDLORD In the event of a sale or conveyance of the
Complex or any interest therein, by any owner of the reversion then constituting
Landlord, the transferor shall thereby be released from any further liability
upon any of the terms, covenants or conditions (express or implied) herein
contained in favor of Tenant, and in such event, insofar as such transfer is
concerned, Tenant agrees to look solely to the responsibility of the successor
in interest of such transferor in and to the Complex and this Lease. This Lease
shall not be affected by any such sale or conveyance, and Tenant agrees to
attorn to the successor in interest of such transferor.
27. ATTORNMENT TO LENDER OR THIRD PARTY In the event the interest of Landlord
in the land and buildings in which the leased Premises are located (whether such
interest of Landlord is a fee title interest or a leasehold interest) is
encumbered by deed of trust, and such interest is acquired by the lender or any
third party through judicial foreclosure or by exercise of a power of sale at
private trustee's foreclosure sale, Tenant hereby agrees to attorn to the
purchaser at any such foreclosure sale and to recognize such purchaser as the
Landlord under this Lease. In the event the lien of the deed of trust securing
the loan from a Lender to Landlord is prior and paramount to the Lease, this
Lease shall nonetheless continue in full force and effect for the remainder of
the unexpired term hereof, at the same rental herein reserved and upon all the
other items, conditions and covenants herein contained.
28. HOLDING OVER Any holding over by Tenant after expiration or other
termination of the term of this Lease with the written consent of Landlord
delivered to Tenant shall not constitute a renewal or extension of the Lease or
give Tenant any rights in or to the leased Premises except as expressly provided
in this Lease. Any holding over after the expiration or other termination of the
term of this Lease, with the consent of Landlord, shall be construed to be a
tenancy from month to month, on the same terms and conditions herein specified
insofar as applicable except that the monthly Basic Rent shall be increased to
an amount equal to one hundred fifty (150%) percent of the monthly Basic Rent
required during the last month of the Lease term.
6
<PAGE> 7
29. CERTIFICATE OF ESTOPPEL Tenant shall at any time upon not less than ten
(10) days' prior written notice from Landlord execute, acknowledge and deliver
to Landlord a statement in writing (i) certifying that this Lease is unmodified
and in full force and effect (or, if modified, stating the nature of such
modification and certifying that this Lease, as so modified, is in full force
and effect) and the date to which the rent and other charges are paid in
advance, if any, and (ii) acknowledging that there are not, to Tenant's
knowledge, any uncured defaults on the part of Landlord hereunder, or specifying
such defaults, if any, are claimed. Any such statement may be conclusively
relied upon by any prospective purchaser or encumbrancer of the Premises.
Tenant's failure to deliver such statement within such time shall be conclusive
upon Tenant that this Lease is in full force and effect, without modification
except as may be represented by Landlord: that there are no uncured defaults in
Landlord's performance, and that not more than one month's rent has been paid in
advance.
30. CONSTRUCTION CHANGES It is understood that the description of the Premises
and the location of ductwork, plumbing and other facilities therein are subject
to such minor changes as Landlord or Landlord's architect determines to be
desirable in the course of construction of the Premises, and no such changes, or
any changes in plans for any other portions of the Complex shall affect this
Lease or entitle Tenant to any reduction of rent hereunder or result in any
liability of Landlord to Tenant. Landlord does not guarantee the accuracy of any
drawings supplied to Tenant and verification of the accuracy of such drawings
rests with Tenant.
31. RIGHT OF LANDLORD TO PERFORM All terms, covenants and conditions of this
Lease to be performed or observed by Tenant shall be performed or observed by
Tenant at Tenant's sole cost and expense and without any reduction of rent. If
Tenant shall fail to pay any sum of money, or other rent, required to be paid by
it hereunder and such failure shall continue for five (5) days after written
notice by Landlord, or shall fail to perform any other term or covenant
hereunder on its part to be performed, and such failure shall continue for
thirty (30) days after written notice thereof by Landlord, Landlord, without
waiving or releasing Tenant from any obligation of Tenant hereunder, may, but
shall not be obligated to, make any such payment or perform any such other term
or covenant on Tenant's part to be performed. All sums so paid by Landlord and
all necessary costs of such performance by Landlord together with interest
thereon at the rate of the prime rate of interest per annum as quoted by the
Bank of America from the date of such payment or performance by Landlord, shall
be paid (and Tenant covenants to make such payment) to Landlord on demand by
Landlord, and Landlord shall have (in addition to any other right or remedy of
Landlord) the same rights and remedies in the event of nonpayment by Tenant as
in the case of failure by Tenant in the payment of rent hereunder.
32. ATTORNEYS' FEES.
(A) In the event that either Landlord or Tenant should bring suit for the
possession of the Premises, for the recovery of any sum due under this Lease, or
because of the breach of any provision of this Lease, or for any other relief
against the other party hereunder, then all costs and expenses, including
reasonable attorneys' fees, incurred by the prevailing party therein shall be
paid by the other party, which obligation on the part of the other party shall
be deemed to have accrued on the date of the commencement of such action and
shall be enforceable whether or not the action is prosecuted to judgement.
(B) Should Landlord be named as a defendant in any suit brought against
Tenant in connection with or arising out of Tenant's occupancy hereunder, Tenant
shall pay to Landlord its costs and expenses incurred in such suit, including a
reasonable attorney's fee.
33. WAIVER The waiver by either party of the other party's failure to
perform or observe any term, covenant or condition herein contained to be
performed or observed by such waiving party shall not be deemed to be a waiver
of such term, covenant or condition or of any subsequent failure of the party
failing to perform or observe the same or any other such term, covenant or
condition therein contained, and no custom or practice which may develop
between the parties hereto during the term hereof shall be deemed a waiver of,
or in any way affect, the right of either party to insist upon performance and
observance by the other party in strict accordance with the terms hereof.
34. NOTICES All notices, demands, requests, advices or designations which
may be or are required to be given by either party to the other hereunder shall
be in writing. All notices, demands, requests, advices or designation by
Landlord to Tenant shall be sufficiently given, made or delivered if personally
served on Tenant by leaving the same at the Premises or if sent by United States
certified or registered mail, postage prepaid, addressed to Tenant at the
Premises. All notices demands, requests, advices or designations by Tenant to
Landlord shall be sent by United States certified or registered mail, postage
prepaid, addressed to Landlord at its offices at Peery/Arrillaga, 2560 Mission
College Blvd., Suite 101, Santa Clara, CA 95054. Each notice, request, demand,
advice or designation referred to in this paragraph shall be deemed received on
the date of the personal service or mailing thereof in the manner herein
provided, as the case may be.
35. EXAMINATION OF LEASE Submission of this instrument for examination or
signature by Tenant does not constitute a reservation of or option for a lease,
and this instrument is not effective as a lease or otherwise until its
execution and delivery by both Landlord and Tenant.
36. DEFAULT BY LANDLORD Landlord shall not be in default unless Landlord
fails to perform obligations required of Landlord within a reasonable time, but
in no event earlier than thirty (30) days after written notice by Tenant to
Landlord and to the holder of any first mortgage or deed of trust covering the
Premises whose name and address shall have heretofore been furnished to Tenant
in writing, specifying wherein Landlord has failed to perform such obligations;
provided, however, that if the nature of Landlord's obligations is such that
more than thirty (30) days are required for performance, then Landlord shall not
be in default if Landlord commences performance within such thirty (30) day
period and thereafter diligently prosecutes the same to completion.
37. CORPORATE AUTHORITY If Tenant is a corporation, (or a partnership) each
individual executing this Lease on behalf of said corporation (or partnership)
represents and warrants that he is duly authorized to execute and deliver this
Lease on behalf of said corporation (or partnership) in accordance with the
by-laws of said corporation (or partnership in accordance with the partnership
agreement) and that this Lease is binding upon said corporation (or partnership)
in accordance with its terms. If Tenant is a corporation, Tenant shall, within
thirty (30) days after execution of this Lease, deliver to Landlord a certified
copy of the resolution of the Board of Directors of said corporation authorizing
or ratifying the execution of this Lease.
39. LIMITATION OF LIABILITY In consideration of the benefits accruing
hereunder, Tenant and all successors and assigns covenant and agree that, in
the event of any actual or alleged failure, breach or default hereunder by
Landlord:
(i) the sole and exclusive remedy shall be against Landlord's interest
in the Premises leased herein;
(ii) no partner of Landlord shall be sued or named as a party in any
suit or action (except as may be necessary to secure jurisdiction of the
partnership);
(iii) no service of process shall be made against any partner of Landlord
(except as may be necessary to secure jurisdiction of the partnership);
(iv) no partner of Landlord shall be required to answer or otherwise
plead to any service of process;
(v) no judgment will be taken against any partner of Landlord;
(vi) any judgment taken against any partner of Landlord may be vacated
and set aside at any time without hearing;
(vii) no writ of execution will ever be levied against the assets of any
partner of Landlord;
(viii) these covenants and agreements are enforceable both by Landlord and
also by any partner of Landlord.
Tenant agrees that each of the foregoing covenants and agreements shall be
applicable to any covenant or agreement either expressly contained in this Lease
or imposed by statute or at common law.
7
<PAGE> 8
40. MISCELLANEOUS AND GENERAL PROVISIONS
a. Tenant shall not, without the written consent of Landlord, use the name
of the building for any purpose other than as the address of the business
conducted by Tenant in the Premises.
b. This Lease shall in all respects be governed by and construed in
accordance with the laws of the State of California. If any provision of
this Lease shall be invalid, unenforceable or ineffective for any reason
whatsoever, all other provisions hereof shall be and remain in full force
and effect.
c. The term "Premises" includes the space leased hereby and any
improvements now or hereafter installed therein or attached thereto. The
term "Landlord" or any pronoun used in place thereof includes the plural
as well as the singular and the successors and assigns of Landlord. The
term "Tenant" or any pronoun used in place thereof includes the plural as
well as the singular and individuals, firms, associations, partnerships
and corporations, and their and each of their respective heirs, executors,
administrators, successors and permitted assigns, according to the context
hereof, and the provisions of this Lease shall inure to the benefit of and
bind such heirs, executors, administrators, successors and permitted
assigns.
The term "person" includes the plural as well as the singular and
individuals, firms, associations, partnerships and corporations. Words
used in any gender include other genders. If there be more than one Tenant
the obligations of Tenant hereunder are joint and several. The paragraph
headings of this Lease are for convenience of reference only and shall
have no effect upon the construction or interpretation of any provision
hereof.
d. Time is of the essence of this Lease and of each and all of its
provisions.
e. At the expiration or earlier termination of this Lease, Tenant shall
execute, acknowledge and deliver to Landlord, within ten (10) days after
written demand from Landlord to Tenant, any quitclaim deed or other
document required by any reputable title company, licensed to operate in
the State of California, to remove the cloud or encumbrance created by
this Lease from the real property of which Tenant's Premises are a part.
f. This instrument along with any exhibits and attachments hereto
constitutes the entire agreement between Landlord and Tenant relative to
the Premises and this agreement and the exhibits and attachments may be
altered, amended or revoked only by an instrument in writing signed by
both Landlord and Tenant. Landlord and Tenant agree hereby that all prior
or contemporaneous oral agreements between and among themselves and their
agents or representatives relative to the leasing of the Premises are
merged in or revoked by this agreement.
g. Neither Landlord nor Tenant shall record this Lease or a short form
memorandum hereof without the consent of the other.
h. Tenant further agrees to execute any amendments required by a lender to
enable Landlord to obtain financing, so long as Tenant's rights hereunder
are not substantially affected.
i. Paragraphs 43 through 56 are added hereto and are included as a part
of this lease.
j. Clauses, plats and riders, if any, signed by Landlord and Tenant and
endorsed on or affixed to this Lease are a part hereof.
k. Tenant covenants and agrees that no diminution or shutting off of
light, air or view by any structure which may be hereafter erected
(whether or not by Landlord) shall in any way affect his Lease, entitle
Tenant to any reduction of rent hereunder or result in any liability of
Landlord to Tenant.
41. BROKERS Tenant warrants that it had dealings with only the following real
estate brokers or agents in connection with the negotiation of this Lease:
none
- --------------------------------------------------------------------------------
and that it knows of no other real estate broker or agent who is entitled to a
commission in connection with this Lease.
42. SIGNS No sign, placard, picture, advertisement, name or notice shall be
inscribed, displayed or printed or affixed on or to any part of the outside of
the Premises or any exterior windows of the Premises without the written
consent of Landlord first had and obtained and Landlord shall have the right to
remove any such sign, placard, picture, advertisement, name or notice without
notice to and at the expense of Tenant. If Tenant is allowed to print or affix
or in any way place a sign in, on, or about the Premises, upon expiration or
other sooner termination of this Lease, Tenant at Tenant's sole cost and
expense shall both remove such sign and repair all damage in such a manner as to
restore all aspects of the appearance of the Premises to the condition prior to
the placement of said sign.
All approved signs or lettering on outside doors shall be printed,
painted, affixed or inscribed at the expense of Tenant by a person approved of
by Landlord.
Tenant shall not place anything or allow anything to be placed near the
glass of any window, door partition or wall which may appear unsightly from
outside the Premises.
IN WITNESS WHEREOF, Landlord and Tenant have executed and delivered this
Lease as of the day and year last written below.
LANDLORD: TENANT:
JOHN ARRILLAGA SURVIVOR'S TRUST NEOFORMA, INC.
a California corporation
By /s/ JOHN ARRILLAGA By /s/ JEFFREY H. KLECK
-------------------------------- --------------------------------------
John Arrillaga, Trustee
Date: 8/12/98 Title: CEO
----------------------------- ----------------------------------
RICHARD T. PEERY SEPARATE PROPERTY Type or Print Name Jeffrey H. Kleck
TRUST ----------------------
Date: August 7, 1998
-----------------------------------
By /s/ RICHARD T. PEERY
--------------------------------
Richard T. Peery, Trustee
Date: 8/11/98
-----------------------------
8
<PAGE> 9
Paragraphs 43 through 56 to Lease Agreement dated July 30, 1998, By and Between
the John Arrillaga Survivor's Trust and the Richard T. Peery Separate Property
Trust, as Landlord, and NEOFORMA, INC., a California corporation, as Tenant for
10,878 +/- Square Feet of Space Located at 3255-6 Scott Blvd., Suite 101, Santa
Clara, California.
43. BASIC RENT: In accordance with Paragraph 4A herein, the total aggregate
sum of ONE MILLION SEVEN HUNDRED SIXTY TWO THOUSAND TWO HUNDRED THIRTY SIX AND
NO/100 DOLLARS ($1,762,236.00), shall be payable as follows:
On September 1, 1998, the sum of TWENTY SEVEN THOUSAND ONE HUNDRED NINETY
FIVE AND NO/100 DOLLARS ($27,195.00), shall be due, and a like sum due on the
first day of each month thereafter, through and including August 1, 1999.
On September 1, 1999 the sum of TWENTY EIGHT THOUSAND TWO HUNDRED EIGHTY
TWO AND 80/100 DOLLARS ($28,282.80) shall be due, and a like sum due on the
first day of each month thereafter, through and including August 1, 2000.
On September 1, 2000, the sum of TWENTY NINE THOUSAND THREE HUNDRED
SEVENTY AND 60/100 DOLLARS ($29,370.60) shall be due, and a like sum due on the
first day of each month thereafter, through and including August 1, 2001.
On September 1, 2001, the sum of THIRTY THOUSAND FOUR HUNDRED FIFTY EIGHT
AND 40/100 DOLLARS ($30,458.40) shall be due, and a like sum due on the first
day of each month thereafter, through and including August 1, 2002.
On September 1, 2002, the sum of THIRTY ONE THOUSAND FIVE HUNDRED FORTY
SIX AND 20/100 DOLLARS ($31,546.20) shall be due, and a like sum due on the
first day of each month thereafter, through and including August 1, 2003; or
until the entire aggregate sum of ONE MILLION SEVEN HUNDRED SIXTY TWO THOUSAND
TWO HUNDRED THIRTY SIX AND NO/100 DOLLARS ($1,762,236.00) has been paid.
44. "AS-IS" BASIS: Landlord shall, at its sole cost and expense, prior to the
Lease Commencement Date, construct certain interior improvements in the
Premises as shown in Yellow and Blue on Exhibit B and as detailed on Exhibit
B-1 (the "Tenant Improvements"). Subject only to Paragraph 55 ("Compliance")
and to Landlord constructing the Tenant Improvements, it is hereby agreed that
the Premises leased hereunder is leased strictly on an "as-is" basis and in its
present condition, and in the configuration as shown on Exhibit B attached
hereto, and by reference made a part hereof. Except as noted herein, it is
specifically agreed between the parties that after Landlord constructs the
Tenant Improvements as shown on Exhibit B, Landlord shall not be required to
make, nor be responsible for any cost, in connection with any repair,
restoration, and/or improvement to the Premises in order for this Lease to
commence, or thereafter, throughout the Term of this Lease. Notwithstanding
anything to the contrary within this Lease, Landlord makes no warranty or
representation of any kind or nature whatsoever as to the condition or repair
of the Premises, nor as to the use or occupancy which may be made thereof.
In addition to and notwithstanding anything to the contrary in Paragraphs 8 and
this Paragraph 44 of this Lease, Tenant shall have thirty (30) days after the
Commencement Date to provide Landlord with a written "punch list" pertaining to
defects in the interior improvements constructed by Landlord for Tenant. As
soon as reasonably possible thereafter, Landlord, or one of Landlord's
representatives (if so approved by Landlord), and Tenant shall conduct a joint
walk-through of the Premises (if Landlord so requires), and inspect such Tenant
Improvements, using their best efforts to agree on the incomplete or defective
construction related to the Tenant Improvements installed for Tenant by
Landlord. After such inspection has been completed, Landlord shall prepare, and
both parties shall sign, a list of all "punch list" items which the parties
reasonably agree are (i) to be corrected by Landlord (but which shall exclude
any damage or defects caused by Tenant, its employees, agents or parties Tenant
has contracted with to work on the Premises) or (ii) if said defects and/or
damaged item(s) are not material, Landlord may elect, in its sole and absolute
discretion, not to repair such item(s), but to acknowledge in written form the
defect and/or damaged item(s); in which case, notwithstanding anything to the
contrary in said Lease Paragraph 8 ("Acceptance and Surrender"), Tenant shall
not be responsible upon Lease Termination to repair said item(s) so noted by
Landlord. Landlord shall have thirty (30) days thereafter (or longer if
necessary, provided Landlord is diligently pursuing the completion of the same)
to complete, at
9
<PAGE> 10
Landlord's expense, the "punch list" items without the Commencement Date of the
Lease and Tenant's obligation to pay Rental thereunder being affected.
Notwithstanding the foregoing, a crack in the foundation, or exterior walls or
any other defect in the structure or Building that does not endanger the
structural integrity of the building, or which is not life-threatening, shall
not be considered material, nor shall Landlord be responsible for repair of
same. This Paragraph shall be of no force and effect if Tenant shall fail to
give any such notice to Landlord within thirty (30) days after the Commencement
Date of this Lease.
45. CONSENT: Whatever the consent of one party to the other is required
hereunder, such consent shall not be unreasonably withheld.
46. CHOICE OF LAW; SEVERABILITY: This Lease shall in all respects be governed
by and construed in accordance with the laws of the State of California. If any
provisions of this Lease shall be invalid, unenforceable, or ineffective for
any reason whatsoever, all other provisions hereof shall be and remain in full
force and effect.
47. AUTHORITY TO EXECUTE: The parties executing this Lease Agreement hereby
warrant and represent that they are properly authorized to execute this Lease
Agreement and bind the parties on behalf of whom they execute this Lease
Agreement and to all of the terms, covenants and conditions of this Lease
Agreement as they relate to the respective parties hereto.
48. ASSESSMENT CREDITS: The demised property herein may be subject to a
special assessment levied by the City of Santa Clara as part of an Improvement
District. As part of said special assessment proceedings (if any), additional
bonds were or may be sold and assessments were or may be levied to provide for
construction contingencies and reserve funds. Interest shall be earned on such
funds created for contingencies and on reserve funds which will be credited for
the benefit of said assessment district. To the extent surpluses are created in
said district through unused contingency funds, interest earnings or reserve
funds, such surpluses shall be deemed the property of Landlord. Notwithstanding
that such surpluses may be credited on assessments otherwise due against the
Leased Premises, Tenant shall pay to Landlord, as additional rent if, and at
the time of any such credit of surpluses, an amount equal to all such surpluses
so credited. For example: if (i) the property is subject to an annual
assessment of $1,000.00, and (ii) a surplus of $200.00 is credited towards the
current year's assessment which reduces the assessment amount shown on the
property tax bill from $1,000.00 to $800.00, Tenant shall, upon receipt of
notice from Landlord, pay to Landlord said $200.00 credit as Additional Rent.
49. ASSIGNMENT AND SUBLETTING (CONTINUED):
A. Notwithstanding the foregoing, Landlord and Tenant agree that it
shall not be unreasonable for Landlord to refuse to consent to a proposed
assignment, sublease or other transfer ("Proposed Transfer") if the Premises or
any other portion of the Property would become subject to additional or
different Government Requirements as a direct or indirect consequence of the
Proposed Transfer and/or the Proposed Transferee's use and occupancy of the
Premises and the Property. However, Landlord may, in its sole discretion,
consent to such a Proposed Transfer where Landlord is indemnified by Tenant and
(i) Subtenant or (ii) Assignee, in form and substance satisfactory to
Landlord's counsel, by Tenant and/or the Proposed Transferee from and against
any and all costs, expenses, obligations and liability arising out of the
Proposed Transfer and/or the Proposed Transferee's use and occupancy of the
Premises and the Property.
B. Any and all sublease agreement(s) between Tenant and any and all
subtenant(s) (which agreements must be consented to by Landlord, pursuant to
the requirements of this Lease) shall contain the following language:
"If Landlord and Tenant jointly and voluntarily elect, for any reason
whatsoever, to terminate the Master Lease prior to the scheduled Master Lease
termination date, then this Sublease (if then still in effect) shall terminate
concurrently with the termination of the Master Lease. Subtenant expressly
acknowledges and agrees that (1) the voluntary termination of the Master Lease
by Landlord and Tenant and the resulting termination of this Sublease shall not
give Subtenant any right or power to make any legal or equitable claim against
Landlord, including without limitation any claim for interference with contract
or interference with prospective economic advantage, and
10
<PAGE> 11
(2) Subtenant hereby waives any all rights it may have under law or at
equity against Landlord to challenge such an early termination of the Sublease,
and unconditionally releases and relieves Landlord, and its officers, directors,
employees and agents, from any and all claims, demands, and/or causes of action
whatsoever (collectively, "Claims"), whether such matters are known or unknown,
latent or apparent, suspected or unsuspected, foreseeable or unforeseeable,
which Subtenant may have arising out of or in connection with any such early
termination of this Sublease. Subtenant knowingly and intentionally waives any
and all protection which is or may by given by Section 1542 of the California
Civil Code which provides as follows: "A general release does not extend to
claims which the creditor does not know or suspect to exist in his favor at the
time of executing the release, which if known by him must have materially
affected his settlement with debtor.
The term of this Sublease is therefore subject to early termination.
Subtenant's initials here below evidence (a) Subtenant's consideration of and
agreement to this early termination provision, (b) Subtenant's acknowledgment
that, in determining the net benefits to be derived by Subtenant under the
terms of this Sublease, Subtenant has anticipated the potential for early
termination, and (c) Subtenant's agreement to the general waiver and release of
Claims above.
Initials: __________ Initials: _________"
Subtenant Tenant
50. BANKRUPTCY AND DEFAULT: Paragraph 22 is modified to provide that with the
respect to non-monetary defaults not involving Tenant's failure to pay Basic
Rent or Additional Rent, Tenant shall not be in default of any non-monetary
obligation if (i) more than thirty (30) days is required to cure such
non-monetary default, and (ii) Tenant commence cure of such default as soon as
reasonably practicable after receiving written notice of such default from
Landlord and thereafter continuously and with due diligence prosecutes such
cure to completion.
51. ABANDONMENT: Paragraph 23 is modified to provide that Tenant shall not be
in default under the Lease if it leaves all or any part of Premises vacant so
long as (i) Tenant is performing all of its other obligations under the Lease
including the obligation to pay Basic Rent and Additional Rent, (ii) Tenant
provides on-site security during normal business hours for those parts of the
Premises left vacant, (iii) such vacancy does not materially and adversely
affect the validity or coverage of any policy of insurance carried by Landlord
with respect to the Premises, and (iv) the utilities and heating and
ventilation system are operated and maintained to the extent necessary to
prevent damage to the Premises or its systems.
52. HAZARDOUS MATERIALS: Landlord and Tenant agree as follows with respect to
the existence or use of "Hazardous Materials" (as defined herein) on, in, under
or about the Premises and real property located beneath said Premises and the
common areas of the Complex (hereinafter collectively referred to as the
"Property"):
A. As used herein, the term "Hazardous Materials" shall mean any
material, waste, chemical, mixture or byproduct which is or hereafter is
defined, listed or designated under Environmental Laws (defined below) as a
pollutant, or as a contaminant, or as a toxic or hazardous substance, waste or
material, or any other unwholesome, hazardous, toxic, biohazardous, or
radioactive material, waste, chemical, mixture or byproduct, or which is
listed, regulated, or restricted by any Environmental Law (including, without
limitation, petroleum hydrocarbons or any distillates or derivatives or
fractions thereof, polychlorinated biphenyls, or asbestos). As used herein, the
term "Environmental Laws" shall mean any applicable Federal, State of
California or local government law (including common law), statute, regulation,
rule, ordinance, permit, license, order, requirement, agreement, or approval,
or any determination, judgment, directive, or order of any executive or
judicial authority at any level of Federal, State of California or local
government (whether now existing or subsequently adopted or promulgated)
relating to pollution or the protection of the environment, ecology, natural
resources, or public health and safety.
B. Tenant shall obtain Landlord's written consent, which may be withheld
in Landlord's discretion, prior to the occurrence of any Tenant's Hazardous
Materials Activities (defined below); provided, however, that Landlord's
consent shall not be required for normal use in compliance with applicable
Environmental Laws of customary household and office supplies (Tenant shall
first provide Landlord with a list of said materials use), such as mild
cleaners, lubricants and copier toner. As used herein, the term "Tenant's
Hazardous Materials Activities" shall mean any and all
11
<PAGE> 12
use, handling, generation, storage, disposal, treatment, transportation,
release, discharge, or emission of any Hazardous Materials on, in, beneath, to
from, at or about the Property, in connection with Tenant's use of the
Property, or by Tenant or by any of Tenant's agents, employees, contractors,
vendors, invitees, visitors or its future subtenants or assignees. Tenant
agrees that any and all Tenant's Hazardous Materials Activities shall be
conducted in strict, full compliance with applicable Environmental Laws at
Tenant's expense, and shall not result in any contamination of the Property or
the environment. Tenant agrees to provide Landlord with prompt written notice of
any spill or release of Hazardous Materials at the Property during the term of
the Lease of which Tenant becomes aware, and further agrees to provide Landlord
with prompt written notice of any violation of Environmental Laws in connection
with Tenant's Hazardous Materials Activities of which Tenant becomes aware. If
Tenant's Hazardous Materials Activities involve Hazardous Materials other than
normal use of customary household and office supplies, Tenant also agrees at
Tenant's expense: (i) to install such Hazardous Materials monitoring, storage
and containment devices as Landlord reasonably deems necessary (Landlord shall
have no obligation to evaluate the need for any such installation or to require
any such installation); (ii) provide Landlord with a written inventory of such
Hazardous Materials, including an update of same each year upon the anniversary
date of the Commencement Date of the Lease ("Anniversary Date"); and (iii) on
each Anniversary Date, to retain a qualified environmental consultant,
acceptable to Landlord, to evaluate whether Tenant is in compliance with all
applicable Environmental Laws with respect to Tenant's Hazardous Materials
Activities. Tenant, at its expense, shall submit to Landlord a report from such
environmental consultant which discusses the environmental consultant's findings
within two (2) months of each Anniversary Date. Tenant, at its expense, shall
promptly undertake and complete any and all steps necessary, and in full
compliance with applicable Environmental Laws, to fully correct any and all
problems or deficiencies identified by the environmental consultant, and
promptly provide Landlord with documentation of all such corrections.
C. Prior to termination or expiration of the Lease, Tenant, at its
expense, shall (i) properly remove from the Property all Hazardous Materials
which come to be located at the Property in connection with Tenant's Hazardous
Materials Activities, and (ii) fully comply with and complete all facility
closure requirements of applicable Environmental Laws regarding Tenant's
Hazardous Materials Activities, including but not limited to (x) properly
restoring and repairing the Property to the extent damaged by such closure
activities, and (y) obtaining from the local Fire Department or other
appropriate governmental authority with jurisdiction a written concurrence that
closure has been completed in compliance with applicable Environmental Laws.
Tenant shall promptly provide Landlord with copies of any claims, notices, work
plans, data and reports prepared, received or submitted in connection with any
such closure activities.
D. If Landlord, in its sole discretion, believes that the Property has
become contaminated as a result of Tenant's Hazardous Materials Activities,
Landlord in addition to any other rights it may have under this Lease or under
Environmental Laws or other laws, may enter upon the Property and conduct
inspection, sampling and analysis, including but not limited to obtaining and
analyzing samples of soil and groundwater, for the purpose of determining the
nature and extent of such contamination. Tenant shall promptly reimburse
Landlord for the costs of such an investigation, including but not limited to
reasonable attorneys' fees Landlord incurs with respect to such investigation,
that discloses Hazardous Materials contamination for which Tenant is liable
under this Lease. Notwithstanding the above, Landlord may, at its option and in
its sole and absolute discretion, choose to perform remediation and obtain
reimbursement for cleanup costs as set forth herein from Tenant. Any cleanup
costs incurred by Landlord as the result of Tenant's Hazardous Materials
Activities shall be reimbursed by Tenant within thirty (30) days of
presentation of written documentation of the expense to Tenant by Landlord.
Such reimbursable costs shall include, but not be limited to, any reasonable
consultant and attorney fees incurred by Landlord. Tenant shall take all actions
necessary to preserve any claims it has against third parties, including, but
not limited to, its insurers, for claims related to its operation, management of
Hazardous Materials or contamination of the Property. Except as may be required
of Tenant by applicable Environmental Laws, Tenant shall not perform any
sampling, testing, or drilling to identify the presence of any Hazardous
Materials at the Property, without Landlord's prior written consent which may be
withheld in Landlord's discretion. Tenant shall promptly provide Landlord with
copies of any claims, notices, work plans, data and reports prepared, received
or submitted in connection with any sampling, testing or drilling performed
pursuant to the preceding sentence.
E. Tenant shall indemnify, defend (with legal counsel acceptable to
Landlord, whose consent shall not unreasonably be withheld) and hold harmless
Landlord, its employees, assigns, successors, successors-in-interest, agents
and representatives from and against any and all claims (including but not
limited to third party claims from a private party or a government authority),
liabilities, obligations, losses, causes of action, demands, governmental
proceedings or directives,
12
<PAGE> 13
fines, penalties, expenses, costs (including but not limited to reasonable
attorneys', consultants' and other experts' fees and costs), and damages, which
arise from or relate to: (i) Tenant's Hazardous Materials Activities; (ii) any
Hazardous Materials contamination caused by Tenant prior to the Commencement
Date of the Lease; or (iii) the breach of any obligation of Tenant under this
Paragraph 52 (collectively, "Tenant's Environmental Indemnification"). Tenant's
Environmental Indemnification shall include but is not limited to the
obligation to promptly and fully reimburse Landlord for loses in or reductions
to rental income, and diminution in fair market value of the Property. Tenant's
Environmental Indemnification shall further include but is not limited to the
obligation to diligently and properly implement to completion, at Tenant's
expense, any and all environmental investigation, removal, remediation,
monitoring, reporting, closure activities, or other environmental response
action (collectively, "Response Actions"). Tenant shall promptly provide
Landlord with copies of any claims, notices, work plans, data and reports
prepared, received or submitted in connection with any Response Actions.
It is agreed that the Tenant's responsibilities related to Hazardous Materials
will survive the expiration or termination of this Lease and that Landlord may
obtain specific performance of Tenant's responsibilities under this Paragraph
52.
53. ADDITIONAL RENT CONTINUED: The following items shall be excluded from
"Additional Rent":
A. Leasing commissions, attorney's fees, costs, disbursements, and other
expenses incurred in connection with negotiations with other tenants, or
disputes between Landlord and other third party tenant not related to Tenant
(herein after referred to as "Third Party Tenant"), or in connection with
marketing, leasing, renovating, or improving space for other current or
prospective tenants or other current or prospective occupants of the Complex;
notwithstanding anything to the contrary herein, any costs and expenses Landlord
is entitled to be reimbursed for as stated under Paragraph 22 ("Bankruptcy and
Default") are not excluded Additional Rent items as reflected in this Paragraph
53.
B. The cost of any service sold to any other Third Party Tenant or other
occupant whose leased premises are not part of the Premises leased herein and
for which Landlord is entitled to be reimbursed as an additional charge or
rental over and above the basic rent and additional rent payable under the
lease agreement with said other tenant (including, without limitation,
after-hours HVAC costs or over-standard electrical consumption costs incurred
by other tenants).
C. Any costs for which Landlord is entitled to be reimbursed by any
other Third Party Tenant or other occupant whose leased premises are not part
of the Premises leased herein.
D. Any costs, fines, or penalties incurred due to violations by Landlord
of any governmental rule or authority, provided Tenant is not responsible under
the Lease for such costs, fines and/or penalties, and/or provided Tenant's
actions or inactions did not cause, in whole or in part, such costs, fines
and/or penalties.
E. Wages, salaries, or other compensation paid to executive employees
above the grade of Property Manager.
F. Repairs or other work occasioned by fire, windstorm, or other insured
peril, to the extent that Landlord shall receive proceeds of such insurance or
would have received such proceeds had Landlord maintained the insurance
coverage required under this Lease providing said insurance coverage was
available and Tenant paid its share of the premium as required under the Lease
and any insurance deductible(s) which Tenant is responsible for paying and
provided Tenant is not responsible for the damage to the Premises.
G. Except as otherwise noted in this Lease, any mortgage debt, or ground
rents or any other amounts payable under any ground lease for the Property.
H. Any amounts paid to any person, firm, or corporation related or
otherwise affiliated with Landlord or any general partner, officer, or director
of Landlord or any general partners, to the extent same exceeds arms-length
competitive prices paid in the Santa Clara, California metropolitan area for
the services or goods provided.
54. TAXES CONTINUED: Notwithstanding anything within Paragraph 12, (i) the
amount of Real Property Taxes payable by Tenant hereunder shall be prorated to
reflect the dates of Lease Commencement
13
<PAGE> 14
and Lease Termination, and (ii) it is agreed that if any special assessments for
capital improvements are assessed, and if Landlord has the option to either pay
the entire assessment in cash or go to bond, and if Landlord elects to pay the
entire assessment in cash in lieu of going to bond, the entire portion of the
assessment assigned to Tenant's Leased Premises will be prorated over the same
period that the assessment would have been prorated had the assessment gone to
bond.
55. COMPLIANCE CONTINUED: Any non-conformance of the Tenant Improvements
installed and paid for by Landlord as set forth on Exhibit B, required to be
corrected by the governing agency, shall be corrected at the cost and expense of
Landlord if such non-conformance exists as of the Commencement Date of the Lease
and further provided that such governing agency's requirement and notice to
Landlord to correct the non-conformance is not initiated as a result of: (i)
Tenant's particular use of the Premises; (ii) any future improvements made by or
for Tenant; or (iii) any permit request made to a governing agency by or for
Tenant. Any non-conformance of the Premises occurring after the Commencement
Date of this Lease Agreement shall be the responsibility of Tenant to correct at
Tenant's cost and expense.
56. NOTICES: Any notice required under the Lease that is sent by mail shall be
deemed received, if properly addressed, no later than five (5) business days
after any such notice is stamped by the U.S. Post Office as deposited in the
United States mail certified, postage prepaid, return receipt requested.
14
<PAGE> 15
EXHIBIT A TO
EXHIBIT 10.22
[SITE PLAN]
PARK SQUARE - PHASE 1
3255 SCOTT BLVD. BUILDINGS 1-7
SANTA CLARA, CALIFORNIA 95054
PSI-6
15
<PAGE> 16
EXHIBIT B TO
EXHIBIT 10.22
[FIRST FLOOR PLAN]
PARK SQUARE - PHASE 1
3255-6 SCOTT BLVD. BUILDING 6
SANTA CLARA, CALIFORNIA 95054
PSI-6
16
<PAGE> 17
EXHIBIT B-1 TO
EXHIBIT 10.22
EXHIBIT B-1
TENANT IMPROVEMENTS TO BE PROVIDED BY LANDLORD
1) Demolition of (i) all interior walls and doors and (ii) the roll-up
exterior door as shown in Blue on Exhibit B.
2) Construction of (i) all interior walls and doors and (ii) exterior
glass as shown in Yellow on Exhibit B. All offices and conference rooms
within the Premises shall have full height glass facing the interior
with the exception of the server and storage rooms. Walls between
perimeter offices shall be centered on the window mullions.
3) The new office of the southwest corner of the building shall have fully
height glass facing the exterior similar to the southeast corner office
(shown in Yellow on Exhibit B).
4) The west exterior wall shall be of full height glass to the extent
allowed by existing utilities.
5) All paintable surfaces shall be freshly painted with Landlord's
standard white paint.
6) All discolored, damaged and/or non-conforming ceiling tiles shall be
replaced.
7) A floor to ceiling closet with a small access door shall be constructed
around the phone/trunk line embedded in the floor.
8) The electrical outlets and wiring shall be flush with the walls and
contained within the partition walls wherever possible. Existing
electrical outlets along the exterior windows shall be removed.
9) The outside of the building shall be cleaned.
10) The air-conditioning system shall be serviced prior to Lease
Commencement and maintained by Landlord as provided in Lease Paragraph
7 ("Expenses of Operation, Management and Maintenance of the Common
Areas of the Complex and Building in Which the Premises are Located).
11) The lighting fixtures in the ceiling shall be coordinated with Tenant's
cubicle layout.
17
<PAGE> 1
EXHIBIT 10.23
AMENDMENT NO. 1
TO LEASE
THIS AMENDMENT NO. 1 is made and entered into this 1st day of March, 1999,
by and between JOHN ARRILLAGA, Trustee, or his Successor Trustee UTA dated
7/20/77 (JOHN ARRILLAGA SURVIVOR'S TRUST) )(previously known as the "John
Arrillaga Separate Property Trust") as amended, and RICHARD T. PEERY, Trustee,
or his Successor Trustee UTA date 7/20/77 (RICHARD T. PEERY SEPARATE PROPERTY
TRUST) as amended, collectively as LANDLORD, and NEOFORMA, INC., a Delaware
corporation, as TENANT.
RECITALS
A. WHEREAS, by Lease Agreement dated July 30, 1998 Landlord leased to
Tenant approximately 10,878+ square feet of that certain 22,500+ square foot
building located at 3255-6 Scott Blvd., Suite 101, Santa Clara, California, the
details of which are more particularly set forth in said July 30, 1998 Lease
Agreement, and
B. WHEREAS, said Lease was amended by the Commencement Letter dated
September 15, 1998 which confirmed the September 1, 1998 Lease Commencement Date
and the August 31, 2003 Lease Termination Date, and,
C. WHEREAS, it is now the desire of the parties hereto to amend the Lease
by terminating said Lease effective April 30, 1999 and amending the Aggregate
Rent of said Lease Agreement as hereinafter set forth.
AGREEMENT
NOW THEREFORE, for valuable consideration, receipt of which is hereby
acknowledged, and in consideration of the hereinafter mutual promises, the
parties hereto do agree as follows:
1. TERMINATION OF LEASE: Subject to Paragraph 2 below, Landlord has
agreed to the early termination of said Lease Agreement effective April 30,
1999, subject to the terms and conditions stated herein. Tenant shall be
responsible for relinquishing the Premises in the condition required under Lease
Paragraph 8 ("Acceptance and Surrender of Premises") and Lease Paragraph 9
("Alterations and Additions") with the exception that Tenant shall not be
responsible for removing any alterations made to the Premises which were
officially consented to by Landlord. Prior to Lease Termination, Landlord and
Tenant shall conduct a joint inspection of the Premises to determine the extent
of the work required by Tenant to comply with the provisions of said Paragraphs
8 and 9 ("Restoration Work"). In lieu of Tenant completing the required
Restoration Work, Tenant agrees to pay to Landlord a fee equal to the total of
the estimates received from Landlord's contractors for the Restoration Work
("Restoration Fee"). Said Restoration Fee shall be paid by Tenant to Landlord
within ten days after Tenant receives Landlord's statement of said Restoration
Fee. Tenant shall be responsible for paying all Basic Rent and Additional Rent
and fulfilling all Lease obligations as contained in said Lease through the date
of termination. Notwithstanding the above, Tenant's obligations as stated in
Lease Paragraphs ("Compliance") and ("Hazardous Materials") shall survive the
Termination Date of this Lease.
2. EARLY TERMINATION OF LEASE CONTINGENT UPON LANDLORD OBTAINING AN AGREEMENT
WITH TENANT TO LEASE OTHER PREMISES: Landlord's agreement to allow the early
termination of Tenant's Lease is subject to and conditional upon Landlord
obtaining an executed agreement from Tenant to lease space located at 3255-7
Scott Blvd., Santa Clara, California (the "New Premises Lease") commencing the
day following the early Termination Date of Tenant's Lease. In the event
Landlord is unable to obtain the executed New Premises Lease with Tenant on or
before April 30, 1999 and/or in the event said New Premises Lease does not
commence on May 1, 1999, the Termination Date of this Lease shall be modified to
reflect the date Landlord so obtains the executed New Premises Lease and said
lease commences. In the event the Landlord does not obtain the executed New
Premises Lease from Tenant, this Lease shall continue in full force and effect
through the scheduled Lease Termination Date of August 31, 2003 and this
Amendment No. 1 shall be automatically rescinded. In no event, shall Tenant's
termination date exceed the original Termination Date of August 31, 2003
(provided Tenant fully
1
<PAGE> 2
complies with the terms and conditions in Paragraph 8, "Acceptance and
Surrender of Premises", of the Lease Agreement).
3. AGGREGATE RENT: The Aggregate Basic Rent for the Lease shall be decreased
by $1,544,676.00 or from $1,762,236.00 to $217,560.00.
EXCEPT AS MODIFIED HEREIN, all other terms, covenants, and conditions of
said July 30, 1998 Lease Agreement shall remain in full force and effect.
IN WITNESS WHEREOF, Landlord and Tenant have executed this Amendment No.
1 to Lease as of the day and year last written below.
LANDLORD: TENANT:
JOHN ARRILLAGA SURVIVOR'S TRUST NEOFORMA, INC.
a Delaware corporation
By /s/ JOHN ARRILLAGA By /s/ JEFFREY H. KLECK
-------------------------------- -----------------------------------
John Arrillaga, Trustee
Jeffrey H. Kleck
Date: 3/25/99 -------------------------------------
---------------------------- Print or Type Name
RICHARD T. PEERY SEPARATE Title: CEO
PROPERTY TRUST -------------------------------
By /s/ RICHARD T. PEERY Date: 4/14/99
-------------------------------- --------------------------------
Richard T. Peery, Trustee
Date: 3/26/99
-----------------------------
2
<PAGE> 1
EXHIBIT 10.24
LEASE AGREEMENT
BLDG: PSI-7
OWNER: EOC
PROP: 317
UNIT: 101
TENANT: 31709
THIS LEASE, made this 1st day of March, 1999 between JOHN ARRILLAGA,
Trustee, or his Successor Trustee, UTA dated 7/20/77 (JOHN ARRILLAGA SURVIVOR'S
TRUST) as amended, and RICHARD T. PEERY, Trustee, or his Successor Trustee, UTA
dated 7/20/77 (RICHARD T. PEERY SEPARATE PROPERTY TRUST) as amended,
hereinafter called Landlord, and NEOFORMA, INC., a Delaware corporation,
hereinafter called Tenant.
WITNESSETH:
Landlord hereby leases to Tenant and Tenant hereby hires and takes from
Landlord those certain premises (the "Premises") outlined in red on Exhibit "A"
attached hereto and incorporated herein by this reference thereto more
particularly described as follows:
All of that certain 22,500 (plus or minus) square foot, one-story building
located at 3255-7 Scott Blvd., Santa Clara, California 95054. Said Premises
is more particularly shown within the area outlined in Red on Exhibit A
attached hereto. The entire parcel, of which the Premises is a part, is
shown within the area outlined in Green on Exhibit A attached. The Premises
shall be improved by Landlord as shown on Exhibit B attached hereto, and is
leased on an "as-is" basis, in its present condition, and in the
configuration as shown in Red on Exhibit B attached hereto.
As used herein the Complex shall mean and include all of the land outlined in
Green and described in Exhibit "A", attached hereto, and all of the buildings,
improvements, fixtures and equipment now or hereafter situated on said land.
Said letting and hiring is upon and subject to the terms, covenants and
conditions hereinafter set forth and Tenant covenants as a material part of the
consideration for this Lease to perform and observe each and all of said terms,
covenants and conditions. This Lease is made upon the conditions of such
performance and observance.
1. USE Tenant shall use the Premises only in conformance with applicable
governmental laws, regulations, rules and ordinances for the purpose of
general office, light manufacturing, research and development, and storage and
other uses necessary for Tenant to conduct Tenant's business, provided that
such uses shall be in accordance with all applicable governmental laws and
ordinances and for no other purpose. Tenant shall not do or permit to be done
in or about the Premises or the Complex nor bring or keep or permit to be
brought or kept in or about the Premises or the Complex anything which is
prohibited by or will in any way increase the existing rate of (or otherwise
affect) fire or any insurance covering the Complex or any part thereof, or any
of its contents, or will cause a cancellation of any insurance covering any
insurance covering the Complex or any part thereof, or any of its contents.
Tenant shall not do or permit to be done anything in, on or about the Premises
or the Complex which will in any way obstruct or interfere with the rights of
other tenants or occupants of the Complex or injure or annoy them, or use or
allow the Premises to be used for any improper, immoral, unlawful or
objectionable purpose, nor shall Tenant cause, maintain or permit any nuisance
in, on or about the Premises or the Complex. No sale by auction shall be
permitted on the Premises. Tenant shall not place any loads upon the floors,
walls, or ceiling, which endanger the structure, or place any harmful fluids or
other materials in the drainage system of the building, or overload existing
electrical or other mechanical systems. No waste materials or refuse shall be
dumped upon or permitted to remain upon any part of the Premises or outside of
the building in which the Premises are a part, except in trash containers
placed inside exterior enclosures designated by Landlord for that purpose or
inside of the building proper where designated by Landlord. No materials,
supplies, equipment, finished products or semi-finished products, raw materials
or articles of any nature shall be stored upon or permitted to remain outside
the Premises or on any portion of common area of the Complex. No loudspeaker or
other device, system or apparatus which can be heard outside the Premises shall
be used in or at the Premises without the prior written consent of Landlord.
Tenant shall not commit or suffer to be committed any waste in or upon the
Premises. Tenant shall indemnify, defend and hold Landlord harmless against any
loss, expense, damage, attorneys' fees, or liability arising out of failure of
Tenant to comply with any applicable law. Tenant shall comply with any
covenant, condition, or restriction ("CC&R's") affecting the Premises. The
provisions of this paragraph are for the benefit of Landlord only and shall not
be construed to be for the benefit of any tenant or occupant of the Complex.
2. TERM *
A. The term of this Lease shall be for a period of FIVE (5) years (unless
sooner terminated as hereinafter provided) and, subject to Paragraphs 2(B) and
3, shall commence on the 1st day of May, 1999 and end on the 30th day April of
2004.
B. Possession of the Premises shall be deemed tendered and the term of
this Lease shall commence when the first of the following occurs:
(a) One day after a Certificate of Occupancy is granted by the
proper governmental agency, or, if the governmental agency having jurisdiction
over the area in which the Premises are situated does not issue certificates of
occupancy, then the same number of days after certification by Landlord's
architect or contractor that Landlord's construction work has been completed; or
(b) Upon the occupancy of the Premises by any of Tenant's operating
personnel; or
(c) When the Tenant Improvements have been substantially completed
for Tenant's use and occupancy, in accordance and compliance with Exhibit B of
this Lease Agreement; or
(d) As otherwise agreed in writing.
3. POSSESSION If Landlord, for any reason whatsoever, cannot deliver
possession of said premises to Tenant at the commencement of the said term, as
hereinbefore specified, this Lease shall not be void or voidable; no obligation
of Tenant shall be affected thereby, nor shall Landlord or Landlord's agents be
liable to Tenant for any loss or damage resulting therefrom; but in that event
the commencement and termination dates of the Lease, and all other dates
affected thereby shall be revised to conform to the date of Landlord's delivery
of possession, as specified in Paragraph 2(b), above. The above is, however,
subject to the provision that the period of delay of delivery of the premises
shall not exceed 30 days from the commencement date herein (except those delays
caused by Acts of God, strikes, war, utilities, governmental bodies, weather,
unavailable materials, and delays beyond Landlord's control shall be excluded
in calculating such period) in which instance Tenant, at its option, may, by
written notice to Landlord, terminate this Lease.
* It is agreed in the event said Lease commences on a date other than the first
day of the month the term of the Lease will be extended to account for the
number of days in the partial month. The Basic Rent during the resulting
partial month will be pro-rated (for the number of days in the partial month)
at the Basic Rent scheduled for the projected commencement date as shown in
Paragraph 43.
1
<PAGE> 2
4. RENT
A. Basic Rent. Tenant agrees to pay to Landlord at such place as
Landlord may designate without deduction, offset, prior notice, or demand, and
Landlord agrees to accept as Basic Rent for the leased Premises the total sum
of THREE MILLION SIX HUNDRED SEVENTY EIGHT THOUSAND SEVEN HUNDRED FIFTY AND
NO/100 ($3,678,750.00) Dollars in lawful money of the United States of America,
payable as follows:
B. Time for Payment. In the event that the term of this Lease commences
on a date other than the first day of a calendar month, on the date of
commencement of the term hereof Tenant shall pay to Landlord as rent for the
period from such date of commencement to the first day of the next succeeding
calendar month that proportion of the monthly rent hereunder which the number of
days between such date of commencement and the first day of the next succeeding
calendar month bears to thirty (30). In the event that the term of this Lease
for any reason ends on a date other than the last day of a calendar month, on
the first day of the last calendar month of the term hereof Tenant shall pay to
Landlord as rent for the period from said first day of said last calendar month
to and including the last day of the term hereof that proportion of the monthly
rent hereunder which the number of days between said first day of the said last
calendar month and the last day of the term hereof bears to thirty (30).
C. Late Charge. Notwithstanding any other provision of this Lease, if
Tenant is in default in the payment of rental as set forth in this Paragraph 4
when due, or any part thereof, Tenant agrees to pay Landlord, in addition to the
delinquent rental due, a late charge for each rental payment in default ten (10)
days. Said late charge shall equal ten (10%) percent of each rental payment so
in default.
D. Additional Rent. Beginning with the commencement date of the term of
this Lease, Tenant shall pay to Landlord in addition to the Basic Rent and as
Additional Rent the following:
(a) Tenant's proportionate share of all Taxes relating to the Complex
as set forth in Paragraph 12, and
(b) Tenant's proportionate share of all insurance premiums relating to
the Complex, as set forth in Paragraph 15, and
(c) Tenants proportionate share of expenses for the operation,
management, maintenance and repair of the Building (including
common areas of the Building) and Common Areas of the Complex in
which the Premises as located as set forth in Paragraph 7, and
(d) All charges, costs and expenses, which Tenant is required to pay
hereunder, together with all interest and penalties, costs and
expenses including attorney's fees and legal expenses, that may
accrue thereto in the event of Tenant's failure to pay such
amounts, and all damages, reasonable costs and expenses which
Landlord may incur by reason of default of Tenant or failure on
Tenant's part to comply with the terms of this Lease. In the event
of nonpayment by Tenant of Additional Rent, Landlord shall have all
the rights and remedies with respect thereto as Landlord has for
nonpayment of rent.
The Additional Rent due hereunder shall be paid to Landlord or Landlord's agent
(i) within five days for taxes and insurance and within thirty days for all
other Additional Rent items after presentation of invoice from Landlord or
Landlord's agent setting forth such Additional Rent and/or (ii) at the option of
Landlord, Tenant shall pay to Landlord monthly, in advance, Tenant's prorata
share of an amount estimated by Landlord to be Landlord's approximate average
monthly expenditure for such Additional Rent items, which estimated amount shall
be reconciled within 120 days of the end of each calendar year or more
frequently if Landlord so elects to do so at Landlord's sole and absolute
discretion, as compared to Landlord's actual expenditure for said Additional
Rent items, with Tenant paying to Landlord, upon demand, any amount of actual
expenses expended by Landlord in excess of said estimated amount, or Landlord
crediting to Tenant (providing Tenant is not in default in the performance of
any of the terms, covenants and conditions of this Lease) any amount of
estimated payments made by Tenant in excess of Landlord's actual expenditures
for said Additional Rent items. Within thirty (30) days after receipt of
Landlord's reconciliation, Tenant shall have the right, at Tenant's sole
expense, to audit, at a mutually convenient time at Landlord's office,
Landlord's records relating to the foregoing expenses. Such audit must be
conducted by Tenant or an independent nationally recognized accounting firm that
is not being compensated by Tenant or other third party on a contingency fee
basis. Landlord shall be provided a complete copy of said audit at no expense to
Landlord. If such audit reveals that Landlord has overcharged Tenant and the
audit is not challenged by Landlord, the amount overcharged shall be credited to
Tenant's account within thirty (30) days after the audit is concluded.
The respective obligations of Landlord and Tenant under this paragraph
shall survive the expiration or other termination of the term of this Lease, and
if the term hereof shall expire or shall otherwise terminate on a day other than
the last day of a calendar year, the actual Additional Rent incurred for the
calendar year in which the term hereof expires or otherwise terminates shall be
determined and settled on the basis of the statement of actual Additional Rent
for such calendar year and shall be prorated in the proportion which the number
of days in such calendar year preceding such expiration or termination bears to
365.
E. Fixed Management Fee. Beginning with the Commencement Date of the
Term of this Lease, Tenant shall pay to Landlord, in addition to the Basic Rent
and Additional Rent, a fixed monthly management fee equal to 2% of the Basic
Rent due for each month during the Lease Term ("Management Fee").
F. Place of Payment of Rent and Additional Rent. All Basic Rent
hereunder and all payments hereunder for Additional Rent shall be paid to
Landlord at the office of Landlord at Peery/Arrillaga, File 1504, Box 60000, San
Francisco, CA 94160 or to such other person or to such other place as Landlord
may from time to time designate in writing.
G. Security Deposit. Concurrently with Tenant's execution of this Lease,
Tenant shall deposit with Landlord the sum of ONE HUNDRED THIRTY FIVE THOUSAND
AND NO/100 ($135,000.00) Dollars. Said sum shall be held by Landlord as a
Security Deposit for the faithful performance by Tenant of all of the terms,
covenants, and conditions of this Lease to be kept and performed by Tenant
during the term hereof. If Tenant defaults with respect to any provision of this
Lease, including, but not limited to, the provisions relating to the payment of
rent and any of the monetary sums due herewith, Landlord may (but shall not be
required to) use, apply or retain all or any part of this Security Deposit for
the payment of any other amount which Landlord may spend by reason of Tenant's
default or to compensate Landlord for any other loss or damage which Landlord
may suffer by reason of Tenant's default. If any portion of said Deposit is so
used or applied, Tenant shall, within ten (10) days after written demand
therefor, deposit cash with Landlord in the amount sufficient to restore the
Security Deposit to its original amount. Tenant's failure to do so shall be a
material breach of this Lease. Landlord shall not be required to keep this
Security Deposit separate from its general funds, and Tenant shall not be
entitled to interest on such Deposit. If Tenant fully and faithfully performs
every provision of this Lease to be performed by it, the Security Deposit or any
balance thereof shall be returned to Tenant (or at Landlord's option, to the
last assignee of Tenant's interest hereunder) at the expiration of the Lease
term and after Tenant has vacated the Premises, in the event of termination of
Landlord's interest in this Lease, Landlord shall transfer said Deposit to
Landlord's successor in interest whereupon Tenant agrees to release Landlord
from liability for the return of such Deposit or the accounting therefor.
5. RULES AND REGULATIONS AND COMMON AREA. Subject to the terms and
conditions of this Lease and such Rules and Regulations as Landlord may from
time to time prescribe, Tenant and Tenant's employees, invitees and customers
shall, in common with other occupants of the Complex in which the Premises are
located, and their respective employees, invitees and customers, and others
entitled to the use thereof, have the non-exclusive right to use the access
roads, parking areas, and facilities provided and designated by Landlord for the
general use and convenience of the occupants of the Complex in which the
Premises are located, which areas and facilities are referred to herein as
"Common Area". This right shall terminate upon the termination of this Lease.
Landlord reserves the right from time to time to make changes in the shape,
size, location, amount and extent of Common Area. Landlord further reserves the
right to promulgate such reasonable rules and regulations relating to the use of
the Common Area, and any part or parts thereof, as Landlord may deem appropriate
for the best interests of the occupants of the Complex. The Rules and
Regulations shall be binding upon Tenant upon delivery of a copy of them to
Tenant, and Tenant shall abide by them and cooperate in their observance. Such
Rules and Regulations may be amended by Landlord from time to time, with or
without advance notice, and all amendments shall be effective upon delivery of a
copy to Tenant. Landlord shall not be responsible to Tenants for the
non-performance by any other tenant or occupant of the Complex of any of said
Rules and Regulations.
Landlord shall operate, manage and maintain the Common
Area. The manner in which the Common Area shall be maintained and the
expenditures for such maintenance shall be at the discretion of Landlord.
2
<PAGE> 3
6. PARKING. Tenant shall have the right to use with other tenants or occupants
of the Complex 67 parking spaces in the executive parking area of the
Complex. Tenant agrees, that Tenant, Tenant's employees, agents, representatives
and/or invitees shall not use parking spaces in excess of said 67 spaces
allocated to Tenant hereunder. Landlord shall have the right, at Landlord's sole
discretion, to specifically designate the location of Tenant's parking spaces
within the common parking areas of the Complex in the event of a dispute among
the tenants occupying the building and/or Complex referred to herein, in which
event Tenant agrees that Tenant, Tenant's employees, agents, representatives
and/or invitees shall not use any parking spaces other than those parking spaces
specifically designated by Landlord for Tenant's use. Said parking spaces, if
specifically designated by Landlord to Tenant, may be relocated by Landlord at
any time, and from time to time, Landlord reserves the right, at Landlord's sole
discretion, to rescind any specific designation of parking spaces, thereby
returning Tenant's parking spaces to the common parking area. Landlord shall
give Tenant written notice of any change in Tenant's parking spaces. Tenant
shall not, at any time, park, or permit to be parked, any trucks or vehicles
adjacent to the loading areas so as to interfere in any way with the use of such
areas, nor shall Tenant at any time park, or permit the parking of Tenant's
trucks or other vehicles or the trucks and vehicles of Tenant's suppliers or
others, in any portion of the common area not designated by Landlord for such
use by Tenant. Tenant shall not park nor permit to be parked, any inoperative
vehicles or equipment on any portion of the common parking area or other common
areas of the Complex. Tenant agrees to assume responsibility for compliance by
its employees with the parking provision contained herein. If Tenant or its
employees park in other than such designated parking areas, then Landlord may
charge Tenant, as an additional charge, and Tenant agrees to pay, ten ($10.00)
Dollars per day for each day or partial day each such vehicle is parked in any
area other than that designated. Tenant hereby authorizes Landlord at Tenant's
sole expense to tow away from the Complex any vehicle belonging to Tenant or
Tenant's employees parked in violation of these provisions, or to attach
violation stickers or notices to such vehicles. Tenant shall use the parking
areas for vehicle parking only, and shall not use the parking areas for storage.
7. EXPENSES OF OPERATION, MANAGEMENT, AND MAINTENANCE OF THE COMMON AREAS OF
THE COMPLEX. As Additional Rent and in accordance with Paragraph 4 D of this
Lease, Tenant shall pay to Landlord Tenant's proportionate share (calculated on
a square footage or other equitable basis as calculated by Landlord) of all
expenses of operation, management, maintenance and repair of the Common Areas
of the Complex including, but not limited to, license, permit, and inspection
fees; security; utility charges associated with exterior landscaping and
lighting (including water and sewer charges); all charges incurred in the
maintenance and replacement of landscaped areas, lakes, parking lots and paved
areas (including repairs, replacement, resealing and restriping), sidewalks,
driveways; maintenance, repair and replacement of all fixtures and electrical,
mechanical, and plumbing systems; structural elements and exterior surfaces of
the buildings; salaries and employee benefits of personnel and payroll taxes
applicable thereto; supplies, materials, equipment and tools; the cost of
capital expenditures which have the effect of reducing operating expenses,
provided, however, that in the event Landlord makes such capital improvements,
Landlord may amortize its investment in said improvements (together with
interest at the rate of fifteen (15%) percent per annum on the unamortized
balance) as an operating expense in accordance with standard accounting
practices, provided, that such amortization is not at a rate greater than the
anticipated savings in the operating expenses.
"Additional Rent" as used herein shall not include Landlord's debt
repayments; interest on charges; expenses directly or indirectly incurred by
Landlord for the benefit of any other tenant; cost for the installation of
partitioning or any other tenant improvements; cost of attracting tenants;
depreciation; interest, or executive salaries.
8. ACCEPTANCE AND SURRENDER OF PREMISES. By entry hereunder, Tenant accepts the
Premises as being in good and sanitary order, condition and repair and accepts
the building and improvements included in the Premises in their present
condition and without representation or warranty by Landlord as to the
condition of such building or as to the use or occupancy which may be made
thereof. Any exceptions to the foregoing must be by written agreement executed
by Landlord and Tenant. Tenant agrees on the last day of the Lease term, or on
the sooner termination of this Lease, to surrender the Premises promptly and
peaceably to Landlord in good condition and repair (damage by Acts of God, fire,
normal wear and tear excepted), with all interior walls painted, or cleaned so
that they appear freshly painted, and repaired and replaced, if damaged; all
floors cleaned and waxed; all carpets cleaned and shampooed; the
airconditioning and heating equipment serviced by a reputable and licensed
service firm and in good operating condition (provided the maintenance of such
equipment has been Tenant's responsibility during the term of this Lease)
together with all alterations, additions, and improvements which may have been
made in, to, or on the Premises (except movable trade fixtures installed at the
expense of Tenant) except that Tenant shall ascertain from Landlord within
thirty (30) days before the end of the term of this Lease whether Landlord
desires to have the Premises or any part or parts thereof restored to their
condition and configuration as when the Premises were delivered to Tenant and
if Landlord shall so desire, then Tenant shall restore said Premises or such
part or parts thereof before the end of this Lease at Tenant's sole cost and
expense. Tenant, on or before the end of the term or sooner termination of this
Lease, shall remove all of Tenant's personal property and trade fixtures from
the Premises, and all property not so removed on or before the end of the term
or sooner termination of this Lease shall be deemed abandoned by Tenant and
title to same shall thereupon pass to Landlord without compensation to Tenant.
Landlord may, upon termination of this Lease, remove all moveable furniture and
equipment so abandoned by Tenant, at Tenant's sole cost, and repair any damage
caused by such removal at Tenant's sole cost. If the Premises be not
surrendered at the end of the term or sooner termination of this Lease, Tenant
shall indemnify Landlord against loss or liability resulting from the delay by
Tenant in so surrendering the Premises including, without limitation, any
claims made by any succeeding tenant founded on such delay. Nothing contained
herein shall be construed as an extension of the term hereof or as a consent of
Landlord to any holding over by Tenant. The voluntary or other surrender of
this Lease or the Premises by Tenant or a mutual cancellation of this Lease
shall not work as a merger and, at the option of Landlord, shall either
terminate all or any existing subleases or subtenancies or operate as an
assignment to Landlord of all or any such subleases or subtenancies.
9. ALTERATIONS AND ADDITIONS. Tenant shall not make, or suffer to be made, any
alteration or addition to the Premises, or any part thereof, without the written
consent of Landlord first had and obtained by Tenant, but at the cost of Tenant,
and any addition to, or alteration of, the Premises, except moveable furniture
and trade fixtures, shall at once become a part of the Premises and belong to
Landlord. Landlord reserves the right to approve all contractors and mechanics
proposed by Tenant to make such alterations and additions. Tenant shall retain
title to all moveable furniture and trade fixtures placed in the Premises. All
heating, lighting, electrical, airconditioning, floor to ceiling partitioning,
drapery, carpeting, and floor installations made by Tenant, together with all
property that has become an integral part of the Premises, shall not be deemed
trade fixtures. Tenant agrees that it will not proceed to make such alteration
or additions, without having obtained consent from Landlord to do so, and until
five (5) days from the receipt of such consent, in order that Landlord may post
appropriate notices to avoid any liability to contractors or material suppliers
for payment for Tenant's improvements. Tenant will at all times permit such
notices to be posted and to remain posted until the completion of work. Tenant
shall, if required by Landlord, secure at Tenant's own cost and expense, a
completion and lien indemnity bond, satisfactory to Landlord, for such work.
Tenant further covenants and agrees that any mechanic's lien filed against the
Premises or against the Complex for work claimed to have been done for, or
materials claimed to have been furnished to Tenant, will be discharged by
Tenant, by bond or otherwise, within ten (10) days after the filing thereof, at
the cost and expense of Tenant. Any exceptions to the foregoing must be made in
writing and executed by both Landlord and Tenant.
10. TENANT MAINTENANCE. Tenant shall, at its sole cost and expense, keep and
maintain the Premises (including appurtenances) and every part thereof in a high
standard of maintenance and repair, and in good and sanitary condition. Tenant's
maintenance and repair responsibilities herein referred to include, but are not
limited to, all windows, window frames, plate glass, glazing, truck doors,
plumbing systems (such as water and drain lines, sinks, toilets, faucets,
drains, showers and water fountains), electrical systems (such as panels,
conduits, outlets, lighting fixtures, lamps, bulbs, tubes, ballasts), heating
and air-conditioning systems (such as compressors, fans, air handlers, ducts,
mixing boxes, thermostats, time clocks, boilers, heaters, supply and return
grills), store fronts, roofs, downspouts, all interior improvements within the
premises including but not limited to wall coverings, window coverings, carpet,
floor coverings, partitioning, ceilings, doors (both interior and exterior,
including closing mechanisms, latches, locks, skylights (if any), automatic fire
extinguishing systems, and elevators and all other interior improvements of any
nature whatsoever. Tenant agrees to provide carpet shields under all rolling
chairs or to otherwise be responsible for wear and tear of the carpet caused by
such rolling chairs if such wear and tear exceeds that caused by normal foot
traffic in surrounding areas. Areas of excessive wear shall be replaced at
Tenant's sole expense upon Lease termination. Tenant hereby waives all rights
under, and benefits of, subsection 1 of Section 1932 and Section 1941 and 1942
of the California Civil Code and under any similar law, statute or ordinance now
or hereafter in effect.
11. UTILITIES. Tenant shall pay promptly, as the same become due, all charges
for water, gas, electricity, telephone, telex and other electronic
communications service, sewer service, waste pick-up and any other utilities,
materials or services furnished directly to or used by Tenant on or about the
Premises during the term of this Lease, including, without limitation, any
temporary or permanent utility surcharge or other exactions whether or not
hereinafter imposed.
Landlord shall not be liable for and Tenant shall not be entitled to any
abatement or reduction of rent by reason of any interruption or failure of
utility services to the Premises when such interruption or failure is caused by
accident, breakage, repair, strikes, lockouts, or other labor disturbances or
labor disputes of any nature, or by any other cause, similar or dissimilar,
beyond the reasonable control of Landlord.
12. TAXES. A. As Additional Rent and in accordance with Paragraph 4 D of this
Lease, Tenant shall pay to Landlord Tenant's proportionate share of all Real
Property Taxes, which prorata share shall be allocated to the leased Premises by
square footage or other equitable basis, as calculated by Landlord. The term
"Real Property Taxes", as used herein, shall mean (i) all taxes, assessments,
levies and other charges of any kind or nature whatsoever, general and special,
foreseen and unforeseen (including in installments of principal and interest
required to pay any general or special assessments for public improvements and
any increases resulting from reassessments caused by
3
<PAGE> 4
any change in ownership of the Complex) now or hereafter imposed by any
governmental or quasi-governmental authority or special district having the ???
power to tax or levy assessments, which are levied or assessed against, or with
respect to the value, occupancy or use of, all or any portion of the Complex as
now constructed or as may at any time hereafter be constructed, altered, or
otherwise changed) or Landlord's interest therein, any improvements located
within the Complex (regardless of ownership); the fixtures, equipment and other
property of Landlord, real or personal, that are an integral part of and located
in the Complex; or parking areas, public utilities, or energy within the
Complex; (ii) all charges, levies or fees imposed by reason of environmental
regulation or other governmental control of the Complex, and (iii) all costs and
fees (including attorneys' fees) incurred by Landlord in contesting any Real
Property Tax and in negotiating with public authorities as to any Real Property
Tax. If at any time during the term of this Lease the taxation or assessment of
the Complex prevailing as of the commencement date of this Lease shall be
altered so that in lieu of or in addition to any Real Property Tax described
above there shall be levied, assessed or imposed (whether by reason of a change
in the method of taxation or assessment, creation of a new tax or charge, or any
other cause) an alternate or additional tax or charge (i) on the value, use or
occupancy of the Complex or Landlord's interest therein or (ii) on or measured
by the gross receipts, income or rentals from the Complex on Landlord's business
of leasing the Complex, or computed in any manner with respect to the operation
of the Complex, then any such tax or charge, however designated, shall be
included within the meaning of the term "Real Property Taxes" for purposes of
this Lease. If any Real Property Tax is based upon property or rents unrelated
to the Complex, then only that part of such real Property Tax that is fairly
allocable to the Complex shall be included within the meaning of the item "Real
Property Taxes". Notwithstanding the foregoing, the term "Real Property Taxes"
shall not include estate, inheritance, gift or franchise taxes of Landlord or
the federal or state net income tax imposed on Landlord's income from all
sources.
B. Taxation Tenant's Property
(a) Tenant shall be liable for and shall pay ten days before delinquency,
taxes levied against any personal property or trade fixtures placed by Tenant in
or about the Premises. If any such taxes on Tenant's personal property or trade
fixtures are levied against Landlord or Landlord's property or if the assessed
value of the Premises is increased by the inclusion therein of a value placed
upon such personal property or trade fixtures of Tenant and if Landlord, after
written notice to Tenant, pays the taxes based on such increased assessment,
which Landlord shall have the right to do regardless of the validity thereof,
but only under proper protest if requested by Tenant. Tenant shall upon demand,
as the case may be, repay to Landlord the taxes so levied against Landlord, or
the proportion of such taxes resulting from such increase in the assessment;
provided that in any such event Tenant shall have the right, in the name of
Landlord and with Landlord's full cooperation, to bring suit in any court of
competent jurisdiction to recover the amount of any such taxes so paid under
protest, and any amount so recovered shall belong to Tenant.
(b) if the Tenant improvements in the Premises, whether installed, and/or
paid for by Landlord or Tenant and whether or not affixed to the real property
so as to become a part thereof, are assessed for real property tax purposes at a
valuation higher than the valuation at which standard office improvements in
other space in the Complex are assessed, then the real property taxes and
assessments levied against Landlord or the Complex by reason of such excess
assessed valuation shall be deemed to be taxes levied against personal property
of Tenant and shall be governed by the provisions of 12Ba, above. If the
records of the County Assessor are available and sufficiently detailed to serve
as a basis for determining whether said Tenant improvements are assessed at a
higher valuation than standard office improvements in other space in the
Complex, such records shall be binding on both the Landlord and the Tenant. If
the records of the County Assessor are not available or sufficiently detailed to
serve as a basis for making said determination, the actual cost of construction
shall be used.
13. LIABILITY INSURANCE Tenant at Tenant's expense, agrees to keep in force
during the term of this Lease a policy of commercial general liability
insurance with a combined single limit coverage of not less than Two Million
Dollars ($2,000,000) per occurrence for injuries to or death of persons
occurring in, on or about the Premises or the Complex, and property damage
insurance with limits of $500,000. The policy or policies affecting such
insurance, certificates of insurance of which shall be furnished to Landlord,
shall name Landlord as additional insureds, and shall insure any liability of
Landlord, contingent or otherwise, as respects acts or omissions of Tenant, its
agents, employees or invitees or otherwise by any conduct or transactions of
any of said persons in or about or concerning the Premises, including any
failure of Tenant to observe or perform any of its obligations hereunder; shall
be issued by an insurance company admitted to transact business in the State of
California; and shall provide that the insurance effected thereby shall not be
canceled, except upon thirty (30) days' prior to written notice to Landlord. If
during the term of this Lease, in the considered opinion of Landlord's Lender,
insurance advisor, or counsel, the amount of insurance described in this
paragraph 13 is not adequate. Tenant agrees to increase said coverage to such
reasonable amount as Landlord's Lender, insurance advisor, or counsel shall deem
adequate.
14. TENANT'S PERSONAL PROPERTY INSURANCE AND WORKMAN'S COMPENSATION INSURANCE
Tenant shall maintain a policy or policies of fire and property damage insurance
in "all risk" form with a sprinkler leakage endorsement ensuring the personal
property, inventory, trade fixtures, and leasehold improvements within the
leased Premises for the full replacement value thereof. The proceeds from any of
such policies shall be used for the repair or replacement of such items so
insured.
Tenant shall also maintain a policy or policies of workman's compensation
insurance and any other employee benefit insurance sufficient to comply with
all laws.
15. PROPERTY INSURANCE Landlord shall purchase and keep in force and as
Additional Rent and in accordance with Paragraph 4D of this Lease. Tenant shall
pay to Landlord (or Landlord's agent if so directed by Landlord) Tenant's
proportionate share (calculated on a square footage or other equitable basis as
calculated by Landlord) of the deductibles on insurance claims and the cost of
policy or policies of insurance covering loss or damage to the Premises and
Complex in the amount of the full replacement value thereof, providing
protection against those perils included within the classification of "all
risks" insurance and flood and/or earthquake insurance, if available, plus a
policy of rental income insurance in the amount of one hundred (100%) percent of
twelve (12) months Basic Rent, plus sums paid as Additional Rent and any
deductibles related thereto. If such insurance cost is increased due to
Tenant's use of the Premises or the Complex. Tenant agrees to pay to Landlord
the full cost of such increase. Tenant shall have no interest in nor any right
to the proceeds of any insurance procured by Landlord for the Complex.
Landlord and Tenant do each hereby respectively release the other, to the
extent of insurance coverage of the releasing party, from any liability for loss
or damage caused by fire or any of the extended coverage casualties included in
the releasing party's insurance policies, irrespective of the cause of such
fire or casualty; provided, however, that the insurance policy of either
releasing party prohibits such waiver, then this waiver shall not take effect
until consent to such waiver is obtained. If such waiver is so prohibited, the
insured party affected shall promptly notify the other party thereof.
16. INDEMNIFICATION Landlord shall not be liable to Tenant and Tenant
hereby waives all claims against Landlord for any injury to or death of any
person or damage to or destruction of property in or about the Premises or the
Complex by or from any cause whatsoever, including, without limitation, gas,
fire, oil, electricity or leakage of any character from the roof, walls,
basement or other portion of the Premises or the Complex but excluding, however,
the willful misconduct or negligence of Landlord its agents, servants,
employees, invitees, or contractors of which negligence Landlord has knowledge
and reasonable time to correct. Except as to injury to persons or damage to
property to the extent arising from the willful misconduct or the negligence of
Landlord, its agents, servants, employees, invitees, or contractors. Tenant
shall hold Landlord harmless from and defend Landlord against any and all
expenses, including reasonable attorney's fees, in connection therewith,
arising out of any injury to or death of any person or damage to or destruction
of property occurring in, on or about the Premises, or any part thereof, from
any cause whatsoever.
17. COMPLIANCE Tenant, at its sole cost and expense shall promptly comply
with all laws, statutes, ordinances and governmental rules, regulations or
requirements now or hereafter in effect; with the requirements of any board of
fire underwriters or other similar body now or hereafter constituted; and with
any direction or occupancy certificate issued pursuant to law by any public
officer; provided, however, that no such failure shall be deemed a breach of
the provisions if Tenant, immediately upon notification, commences to remedy or
rectify said failure. The judgment of any court of competent jurisdiction or
the admission of Tenant in any action against Tenant, whether Landlord be a
party thereto or not, that Tenant has violated any such law, statute ordinance
or governmental rule, regulation, requirement, direction or provision, shall be
conclusive of that fact as between Landlord and Tenant. This paragraph shall
not be interpreted as requiring Tenant to make structural changes or
improvements, except to the extent such changes or improvements are required as
a result of Tenant's use of the Premises. Tenant shall at its sole cost and
expense, comply with any and all requirements pertaining to said Premises, of
any insurance organization or company, necessary for the maintenance of
reasonable fire and public liability insurance covering the Premises.
18. LIENS Tenant shall keep the Premises and the Complex free from any liens
arising out of any work performed, materials furnished or obligation incurred
by Tenant. In the event that Tenant shall not, within ten (10) days following
the imposition of such lien, cause the same to be released of record, Landlord
shall have, in addition to all other remedies provided herein and by law, the
right, but not obligation, to cause the same to be released by such means as it
shall deem proper, including payment of the claim giving rise to such lien. All
sums paid by Landlord for such purpose, and all expenses incurred by it in
connection therewith, shall be payable to Landlord by Tenant on demand with
interest at the prime rate of interest as quoted by the Bank of America.
4
<PAGE> 5
19. ASSIGNMENT AND SUBLETTING Tenant shall not assign, transfer, or
hypothecate the leasehold estate under this Lease, or any interest herein, and
shall not sublet the Premises, or any part thereof, or any right or privilege
appurtenant thereto, or allow any other person or entity to occupy or use the
Premises, or any portion thereof, without, in each case, the prior written
consent of Landlord which consent will not be unreasonably withheld. As a
condition for granting this consent to any assignment, transfer, or subletting,
Landlord shall require Tenant to pay Landlord, as Additional Rent, all rents
and/or additional consideration due Tenant from its assignees, transferees, or
subtenants in excess of the Rent payable by Tenant to Landlord hereunder for the
assigned, transferred and/or subleased space. Tenant shall, by thirty (30) days
written notice, advise Landlord of its intent to assign or transfer Tenant's
interest in the Lease or sublet the Premises or any portion thereof for any part
of the term hereof. Within thirty (30) days after receipt of said written
notice, Landlord may, in its sole discretion, elect to terminate this Lease as
to the portion of the Premises described in Tenant's notice on the date
specified in Tenant's notice by giving written notice of such election to
terminate. If no such notice to terminate is given to Tenant within said thirty
(30) day period, Tenant may proceed to locate an acceptable sublessee, assignee,
or other transferee for presentment to Landlord for Landlord's approval, all in
accordance with the terms, covenants, and conditions of this paragraph 19. If
Tenant intends to sublet the entire Premises and Landlord elects to terminate
this Lease, this Lease shall be terminated on the date specified in Tenant's
notice. If, however, this Lease shall terminate pursuant to the foregoing with
respect to less than all the Premises, the rent, as defined and reserved
hereinabove shall be adjusted on a pro rata basis to the number of square feet
retained by Tenant, and this Lease as so amended shall continue in full force
and effect. In the event Tenant is allowed to assign, transfer or sublet the
whole or any part of the Premises, with the prior written consent of Landlord,
no assignee, transferee or subtenant shall assign or transfer this Lease, either
in whole or in part, or sublet the whole or any part of the Premises, without
also having obtained the prior written consent of Landlord. A consent of
Landlord to one assignment, transfer, hypothecation, subletting, occupation or
use by any other person shall not release Tenant from any of Tenant's
obligations hereunder or be deemed to be a consent to any subsequent similar or
dissimilar assignment, transfer, hypothecation, subletting, occupation or use by
any other person. Any such assignment, transfer, hypothecation, subletting,
occupation or use without such consent shall be void and shall constitute a
breach of this Lease by Tenant and shall, at the option of Landlord exercised by
written notice to Tenant, terminate this Lease. The Leasehold estate under this
Lease shall not, nor shall any interest therein, be assignable for any purpose
by operation of law without the written consent of Landlord. As a condition to
its consent, Landlord shall require Tenant to pay all expenses in connection
with the assignment, and Landlord shall require Tenant's assignee or transferee
(or other assignees or transferees) to assume in writing all of the obligations
under this Lease and for Tenant to remain liable to Landlord under the Lease.
Notwithstanding the above, in no event will Landlord consent to a sub-sublease.
20. SUBORDINATION AND MORTGAGES In the event Landlord's title or leasehold
interest is now or hereafter encumbered by a deed of trust, upon the interest of
Landlord in the land and buildings in which the demised Premises are located, to
secure a loan from a lender (hereinafter referred to as "Lender") to Landlord,
Tenant shall, at the request of Landlord or Lender, execute in writing an
agreement subordinating its rights under this Lease to the lien of such deed of
trust, or, if so requested, agreeing that the lien of Lender's deed of trust
shall be or remain subject and subordinate to the rights of Tenant under this
Lease. Notwithstanding any such subordination, Tenant's possession under this
Lease shall not be disturbed if Tenant is not in default and so long as Tenant
shall pay all rent and observe and perform all of the provisions set forth in
this Lease.
21. ENTRY BY LANDLORD Landlord reserves, and shall at all reasonable times
after at least 24 hours notice (except in emergencies) have, the right to enter
the Premises to inspect them; to perform any services to be provided by Landlord
hereunder; to submit the Premises to prospective purchasers, mortgagers or
tenants; to post notices of nonresponsibility; and to alter, improve or repair
the Premises and any portion of the Complex, all without abatement of rent; and
may erect scaffolding and other necessary structures in or through the Premises
where reasonably required by the character of the work to be performed;
provided, however that the business of Tenant shall be interfered with to the
least extent that is reasonably practical. For each of the foregoing purposes,
Landlord shall at all times have and retain a key with which to unlock all of
the doors in an emergency in order to obtain entry to the Premises, and any
entry to the Premises obtained by Landlord by any of said means, or otherwise,
shall not under any circumstances be construed or deemed to be a forcible or
unlawful entry into or a detainer of the Premises or an eviction, actual or
constructive, of Tenant from the Premises or any portion thereof. Landlord shall
also have the right at any time to change the arrangement or location of
entrances or passageways, doors and doorways, and corridors, elevators, stairs,
toilets or other public parts of the Complex and to change the name, number or
designation by which the Complex is commonly known, and none of the foregoing
shall be deemed an actual or constructive eviction of Tenant, or shall entitle
Tenant to any reduction of rent hereunder.
22. BANKRUPTCY AND DEFAULT The commencement of a bankruptcy action or
liquidation action or reorganization action or insolvency action or an
assignment of or by Tenant for the benefit of creditors, or any similar action
undertaken by Tenant, or the insolvency of Tenant, shall, at Landlord's option,
constitute a breach of this Lease by Tenant. If the trustee or receiver
appointed to serve during a bankruptcy, liquidation, reorganization, insolvency
or similar action elects to reject Tenant's unexpired Lease, the trustee or
receiver shall notify Landlord in writing of its election within thirty (30)
days after an order for relief in a liquidation action or within thirty (30)
days after the commencement of any action.
Within thirty (30) days after court approval of the assumption of this
Lease, the trustee or receiver shall cure (or provide adequate assurance to the
reasonable satisfaction of Landlord that the trustee or receiver shall cure) any
and all previous defaults under the unexpired Lease and shall compensate
Landlord for all actual pecuniary loss and shall provide adequate assurance of
future performance under said Lease to the reasonable satisfaction of Landlord.
Adequate assurance of future performance, as used herein, includes, but shall
not be limited to: (i) assurance of source and payment of rent, and other
consideration due under this Lease; (ii) assurance that the assumption or
assignment of this Lease will not breach substantially any provision, such as
radius, location, use, or exclusivity provision, in any agreement relating to
the above described Premises.
Nothing contained in this section shall affect the existing right of
Landlord to refuse to accept an assignment upon commencement of or in connection
with a bankruptcy, liquidation, reorganization or insolvency action or an
assignment of Tenant for the benefit of creditors or other similar act. Nothing
contained in this Lease shall be construed as giving or granting or creating an
equity in the demised Premises to Tenant. In no event shall the leasehold estate
under this Lease, or any interest therein, be assigned by voluntary or
involuntary bankruptcy proceeding without the prior written consent of Landlord,
in no event shall this Lease or any rights or privileges hereunder be an asset
of Tenant under any bankruptcy, insolvency or reorganization proceedings.
The failure to perform or honor any covenant, condition or representation
made under this Lease shall constitute a default hereunder by Tenant upon
expiration of the appropriate grace period hereinafter provided. Tenant shall
have a period of five (5) days from the date of written notice from Landlord
within which to cure any default in the payment of rental or adjustment
thereto. Tenant shall have a period of thirty (30) days from the date of
written notice from Landlord within which to cure any other default under this
Lease; provided, however, that if the nature of Tenant's failure is such that
more than thirty (30) days is reasonably required to cure the same, Tenant
shall not be in default so long as Tenant commences performance within such
thirty (30) day period and thereafter prosecutes the same to completion. Upon
an uncured default of this Lease by Tenant, Landlord shall have the following
rights and remedies in addition to any other rights or remedies available to
Landlord at law or in equity:
(a). The rights and remedies provided for by California Civil Code Section
1951.2, including but not limited to, recovery of the worth at the time of award
of the amount by which the unpaid rent for the balance of the term after the
time of award exceeds the amount of rental loss for the same period that Tenant
proves could be reasonably avoided, as computed pursuant to subsection (b) of
said Section 1951.2. Any proof by Tenant under subparagraphs (2) and (3) of
Section 1951.2 of the California Civil Code of the amount of rental loss that
could be reasonably avoided shall be made in the following manner. Landlord and
Tenant shall each select a licensed real estate broker in the business of
renting property of the same type and use as the Premises and in the same
geographic vicinity. Such two real estate brokers shall select a third licensed
real estate broker, and the three licensed real estate brokers so selected shall
determine the amount of the rental loss that could be reasonably avoided from
the balance of the term of this Lease after the time of award. The decision of
the majority of said licensed real estate brokers shall be final and binding
upon the parties hereto.
(b). The rights and remedies provided by California Civil Code Section
which allows Landlord to continue the Lease in effect and to enforce all of its
rights and remedies under this Lease, including the right to recover rent as it
becomes due, for so long as Landlord does not terminate Tenant's right to
possession; acts of maintenance or preservation, efforts to relet the Premises,
or the appointment of a receiver upon Landlord's initiative to protect its
interest under this Lease shall not constitute a termination of Tenant's right
to possession.
(c). The right to terminate this Lease by giving notice to Tenant in
accordance with applicable law.
(d). To the extent permitted by law the right and power to enter the
Premises and remove therefrom all persons and property, to store such property
in a public warehouse or elsewhere at the cost of and for the account of Tenant,
and to sell such property and apply such proceeds therefrom pursuant to
applicable California law, Landlord may from time to time sublet the Premises or
any part thereof for such term or terms (which may extend beyond the term of
this Lease) and at such rent and such other terms as Landlord in its sole
discretion may deem advisable, with the right to make alterations, and repairs
to the Premises. Upon each subletting, (i) Tenant shall be immediately liable to
pay Landlord, in addition to indebtedness other than rent due hereunder, the
cost of such subletting, including, but not limited to, reasonable attorneys'
fees, and any real estate commissions actually paid, and the cost of such
alterations and repairs incurred by Landlord and the amount, if any, by which
the rent hereunder for the period of such subletting (to the extent such period
does not exceed the term hereof) exceeds the amount to be paid as rent for the
Premises for such period or (ii) at the option of Landlord, rents received from
such subletting shall be applied first to payment of indebtedness other than
rent due hereunder from Tenant to Landlord; second, to the payment of any costs
of such subletting and of such alterations and repairs; third to payment of rent
due and unpaid hereunder; and the residue, if any, shall be held by Landlord and
applied in payment of future rent as the same becomes due hereunder. If Tenant
has been credited with any rent to be received by such subletting under option
(i) and such rent shall not be promptly paid to Landlord by the subtenant(s) or
if such rentals received from such subletting under option (ii) during any month
be less than that to be paid during that month by Tenant hereunder, Tenant shall
pay any such deficiency to Landlord. Such deficiency shall be calculated and
paid monthly. No taking possession of the Premises by Landlord shall be
construed as an election on its part to terminate this Lease unless a written
notice of such
5
<PAGE> 6
intention be given to Tenant. Notwithstanding any such subletting without
termination, Landlord may at any time hereafter elect to terminate this Lease
for such previous breach.
(e) The right to have a receiver appointed for Tenant upon application by
Landlord, to take possession of the Premises and to apply any rental collected
from the Premises and to exercise all other rights and remedies granted to
Landlord (except that Tenant may vacate so long as it pays rent, provides an
on-site security guard during normal business hours from Monday through Friday,
and otherwise performs its obligations hereunder) pursuant to subparagraph d
above.
23. ABANDONMENT Tenant shall not vacate or abandon the Premises at any time
during the term of this Lease and if Tenant shall abandon, vacate or surrender
said Premises, or be dispossessed by the process of law, or otherwise, any
personal property belonging to Tenant and left on the Premises shall be deemed
to be abandoned, at the option of Landlord, except such property as may be
mortgaged to Landlord.
24. DESTRUCTION In the event the Premises are destroyed in whole or in part
from any cause, except for routine maintenance and repairs and incidental damage
and destruction caused from vandalism and accidents for which Tenant is
responsible for under Paragraph 10. Landlord may, at its option:
(a) Rebuild or restore the Premises to their condition prior to the
damage or destruction, or
(b) Terminate this Lease. (providing that the Premises is damaged to the
extent of 33 1/3% of the replacement cost)
If Landlord does not give Tenant notice in writing within thirty (30) days
from the destruction of the Premises of its election to either rebuild and
restore them, or to terminate this Lease, Landlord shall be deemed to have
elected to rebuild or restore them, in which event Landlord agrees, at its
expense, promptly to rebuild or restore the Premises to their condition prior to
the damage or destruction. Tenant shall be entitled to a reduction in rent while
such repair is being made in the proportion that the area of the Premises
rendered untenantable by such damage bears to the total area of the Premises. If
Landlord initially estimates that the rebuilding or restoration will exceed 180
days or if Landlord does not complete the rebuilding or restoration within one
hundred eighty (180) days following the date of destruction (such period of time
to be extended for delays caused by the fault or neglect of Tenant or because of
Acts of God, acts of public agencies, labor disputes, strikes, fires, freight
embargoes, rainy or stormy weather, inability to obtain materials, supplies or
fuels, acts of contractors or subcontractors, or delay of the contractors due to
such causes or other contingencies beyond the control of Landlord), then Tenant
shall have the right to terminate this Lease by giving fifteen (15) days prior
written notice to Landlord. Notwithstanding anything herein to the contrary,
Landlord's obligation to rebuild or restore shall be limited to the building and
interior improvements constructed by Landlord as they existed as of the
commencement date of the Lease and shall not include restoration of Tenant's
trade fixtures, equipment, merchandise, or any improvements, alterations or
additions made by Tenant to the Premises, which Tenant shall forthwith replace
or fully repair at Tenant's sole cost and expense provided this Lease is not
cancelled according to the provisions above.
Unless this Lease is terminated pursuant to the foregoing provisions, this
Lease shall remain in full force and effect. Tenant hereby expressly waives the
provisions of Section 1932, Subdivision 2, in Section 1933, Subdivision 4 of the
California Civil Code.
In the event that the building in which the premises are situated is
damaged or destroyed to the extent of not less than 33 1/3% of the replacement
cost thereof, Landlord may elect to terminate this Lease, whether the Premises
be injured or not. Notwithstanding anything to the contrary herein, Landlord may
terminate this Lease in the event of an uninsured event or if insurance proceeds
are insufficient to cover one hundred percent of the rebuilding costs net of the
deductible.
25. EMINENT DOMAIN If all or any part of the Premises shall be taken by an
public or quasi-public authority under the power of eminent domain or conveyance
in lieu thereof, this Lease shall terminate as to any portion of the Premises so
taken or conveyed on the date when title vests in the condemnor, and Landlord
shall be entitled to any and all payment, income, rent, award, or any interest
therein whatsoever which may be paid or made in connection with such taking or
conveyance, and Tenant shall have no claim against Landlord or otherwise for the
value of any unexpired term of this Lease. Notwithstanding the foregoing
paragraph, any compensation specifically awarded Tenant for loss of business,
Tenant's personal property, moving cost or loss of goodwill, shall be and remain
the property of Tenant.
If (i) any action or proceeding is commenced for such taking of the
Premises or any part thereof, or if Landlord is advised in writing by any entity
or body having the right or power of condemnation of its intention to condemn
the premises or any portion thereof, or (ii) any of the foregoing events occur
with respect to the taking of any space in the Complex not leased hereby, or if
any such spaces so taken or conveyed in lieu of such taking and Landlord shall
decide to discontinue the use and operation of the Complex, or decide to
demolish, alter or rebuild the Complex, then, in any of such events Landlord
shall have the right to terminate this Lease by giving Tenant written notice
thereof with sixty (60) days of the date of receipt of said written advice, or
commencement of said action or proceeding, or taking conveyance, which
termination shall take place as of the first to occur of the last day of the
calendar month next following the month in which such notice is given or the
date on which title to the Premises shall vest in the condemnor.
In the event of such a partial taking or conveyance of the Premises, if the
portion of the Premises taken or conveyed is so substantial that the Tenant can
no longer reasonably conduct its business, Tenant shall have the privilege of
terminating this Lease within sixty (60) days from the date of such taking or
conveyance, upon written notice to Landlord of its intention so to do, and upon
giving of such notice this Lease shall terminate on the last day of the calendar
month next following the month in which such notice is given, upon payment of
Tenant of the rent from the date of such taking or conveyance to the date of
termination.
If a portion of the Premises be taken by condemnation or conveyance in lieu
thereof and neither Landlord nor Tenant shall terminate this Lease as provided
herein, this Lease shall continue in full force and effect as to the part of the
Premises not so taken or conveyed, and the rent herein shall be apportioned as
of the date of such taking or conveyance so that thereafter the rent to be paid
by Tenant shall be in the ratio that the area of the portion of the Premises not
so taken or conveyed bears to the total area of the Premises prior to such
taking.
26. SALE OR CONVEYANCE BY LANDLORD In the event of a sale or conveyance of the
Complex or any interest therein, by any owner of the reversion then constituting
Landlord, the transferor shall thereby be released from any further liability
upon any of the terms, covenants or conditions (express or implied) herein
contained in favor of Tenant, and in such event, insofar as such transfer is
concerned, Tenant agrees to look solely to the responsibility of the successor
in interest of such transferor in and to the Complex and this Lease. This Lease
shall not be affected by any such sale or conveyance, and Tenant agrees to
attorn to the successor in interest of such transferor.
27. ATTORNMENT TO LENDER OR THIRD PARTY In the event the interest of Landlord
in the land and buildings in which the leased Premises are located (whether such
interest of Landlord is a fee title interest or a leasehold interest) is
encumbered by deed of trust, and such interest is acquired by the lender or any
third party through judicial foreclosure or by exercise of a power of sale at
private trustee's foreclosure sale. Tenant hereby agrees to attorn to the
purchaser at any such foreclosure sale and to recognize such purchaser as the
Landlord under this Lease. In the event the lien of the deed of trust securing
the loan from a Lender to Landlord is prior and paramount to the Lease, this
Lease shall nonetheless continue in full force and effect for the remainder of
the unexpired term hereof, at the same rental herein reserved and upon all the
other items, conditions and covenants herein contained.
28. HOLDING OVER Any holding over by Tenant after expiration or other
termination of the term of this Lease with the written consent of Landlord
delivered to Tenant shall not constitute a renewal or extension of the Lease or
give Tenant any rights in or to the leased Premises except as expressly provided
in this Lease. Any holding over after the expiration or other termination of the
term of this Lease, with the consent of Landlord, shall be construed to be a
tenancy from month to month, on the same terms and conditions herein specified
insofar as applicable except that the monthly Basic Rent shall be increased to
an amount equal to one hundred fifty (150%) percent of the monthly Basic Rent
required during the last month of the Lease term.
29. CERTIFICATE OF ESTOPPEL Tenant shall at any time upon not less than ten
(10) days' prior written notice to Landlord execute, acknowledge and deliver to
Landlord a statement in writing (i) certifying that this Lease is unmodified and
in full force and effect (or, if modified, stating the nature of such
modification and certifying that this Lease, as so modified, is in full force
and effect) and the date to which the rent and other charges are paid in
advance, if any, and (ii) acknowledging that there are not, to Tenant's
knowledge, any uncured defaults on the part of Landlord hereunder, or specifying
such defaults, if any, are claimed. Any such statement may be conclusively
relied upon by any prospective purchaser or encumbrancer of the Premises.
Tenant's failure to deliver such statement within such time shall be conclusive
upon Tenant that this Lease is in full force and effect, without modification
except as may be represented by Landlord; that there are no uncured defaults in
Landlord's performance, and that not more than one month's rent has been paid in
advance.
30. CONSTRUCTION CHANGES It is understood that the description of the Premises
and the location of ductwork, plumbing and other facilities therein are subject
to such minor changes as Landlord or Landlord's architect determines to be
desirable in the course of construction of the Premises, and no such changes, or
any changes in plans for any other portions of the Complex shall affect this
Lease or entitle Tenant to any reduction of rent hereunder or result in any
liability of Landlord to Tenant. Landlord does not guarantee the accuracy of any
drawings supplied to Tenant and verification of the accuracy of such drawings
rests with Tenant.
31. RIGHT OF LANDLORD TO PERFORM All terms, covenants and conditions of this
Lease to be performed or observed by Tenant shall be performed or observed by
Tenant at Tenant's sole cost and expense and without any reduction of rent. If
Tenant shall fail to pay any sum of money, or other rent, required to be paid
by it hereunder and such failure shall continue for five (5) days after written
notice thereof by Landlord, or shall fail to perform any other term or covenant
hereunder on its part to be performed, and such failure shall continue for
thirty (30) days after written notice thereof by Landlord. Landlord, without
waiving or releasing Tenant from any obligation of Tenant hereunder, may, but
shall not be obligated to, make any such payment or perform
6
<PAGE> 7
any such other term or covenant on Tenant's part to be performed. All sums so
paid by Landlord and all necessary costs of such performance by Landlord
together with interest thereon at the rate of the prime rate of interest per
annum as quoted by the Bank of America from the date of such payment or
performance by Landlord, shall be paid (and Tenant covenants to make such
payment) to Landlord on demand by Landlord, and Landlord shall have (in addition
to any other right or remedy of Landlord) the same rights and remedies in the
event of nonpayment by Tenant as in the case of failure by Tenant in the payment
of rent hereunder.
32. ATTORNEYS' FEES
(A) In the event that either Landlord or Tenant should bring suit for the
possession of the Premises, for the recovery of any sum due under this Lease, or
because of the breach of any provision of this Lease, or for any other relief
against the other party hereunder, then all costs and expenses, including
reasonable attorneys' fees, incurred by the prevailing party therein shall be
paid by the other party, which obligation on the part of the other party shall
be deemed to have accrued on the date of the commencement of such action and
shall be enforceable whether or not the action is prosecuted to judgement.
(B) Should Landlord be named as a defendant in any suit brought against
Tenant in connection with or arising out of Tenant's occupancy hereunder, Tenant
shall pay to Landlord its costs and expenses incurred in such suit, including a
reasonable attorney's fee.
33. WAIVER The waiver by either party of the other party's failure to perform
or observe any term, covenant or condition herein contained to be performed or
observed by such waiving party shall not be deemed to be a waiver of such term,
covenant or condition or of any subsequent failure of the party failing to
perform or observe the same or any other such term, covenant or condition
therein contained, and no custom or practice which may develop between the
parties hereto during the term hereof shall be deemed a waiver of, or in any way
affect, the right of either party to insist upon performance and observance by
the other party in strict accordance with the terms hereof.
34. NOTICES All notices, demands, requests, advices or designations which may
be or are required to be given by either party to the other hereunder shall be
in writing. All notices, demands, requests, advices or designations by Landlord
to Tenant shall be sufficiently given, made or delivered if personally served on
Tenant by leaving the same at the Premises or if sent by United States certified
or registered mail, postage prepaid, addressed to Tenant at the Premises. All
notices, demands, requests, advices or designations by Tenant to Landlord shall
be sent by United States certified or registered mail, postage prepaid,
addressed to Landlord at its offices at Peery/Arrillaga, 2560 Mission College
Blvd., #101, Santa Clara, CA 95054. Each notice, request, demand, advice or
designation referred to in this paragraph shall be deemed received on the date
of the personal service or mailing thereof in the manner herein provided, as the
case may be.
35. EXAMINATION OF LEASE Submission of this instrument for examination or
signature by Tenant does not constitute a reservation of or option for a lease,
and this instrument is not effective as a lease or otherwise until its execution
and delivery by both Landlord and Tenant.
36. DEFAULT BY LANDLORD Landlord shall not be in default unless Landlord fails
to perform obligations required of Landlord within a reasonable time, but in no
event earlier than thirty (30) days after written notice by Tenant to Landlord
and to the holder of any first mortgage or deed of trust covering the Premises
whose name and address shall have heretofore been furnished to Tenant in
writing, specifying wherein Landlord has failed to perform such obligations;
provided, however, that if the nature of Landlord's obligations is such that
more than thirty (30) days are required for performance, then Landlord shall not
be in default if Landlord commences performance within such thirty (30) day
period and thereafter diligently prosecutes the same to completion.
37. CORPORATE AUTHORITY If Tenant is a corporation, (or a partnership) each
individual executing this Lease on behalf of said corporation (or partnership)
represents and warrants that he is duly authorized to execute and deliver this
Lease on behalf of said corporation (or partnership) in accordance with the
by-laws of said corporation (or partnership in accordance with the partnership
agreement) and that this Lease is binding upon said corporation (or partnership)
in accordance with its terms. If Tenant is a corporation, Tenant shall, within
thirty (30) days after execution of this Lease, deliver to Landlord a certified
copy of the resolution of the Board of Directors of said corporation authorizing
or ratifying the execution of this Lease.
38.
39. LIMITATION OF LIABILITY In consideration of the benefits accruing
hereunder, Tenant and all successors and assigns covenant and agree that, in the
event of any actual or alleged failure, breach or default hereunder by Landlord:
(i) the sole and exclusive remedy shall be against Landlord's interest in
the Premises leased herein;
(ii) no partner of Landlord shall be sued or named as a party in any suit
or action (except as may be necessary to secure jurisdiction of the
partnership);
(iii) no service of process shall be made against any partner of Landlord
(except as may be necessary to secure jurisdiction of the partnership);
(iv) no partner of Landlord shall be required to answer or otherwise plead
to any service of process;
(v) no judgment will be taken against any partner of Landlord;
(vi) any judgment taken against any partner of Landlord may be vacated and
set aside at any time without hearing;
(vii) no writ of execution will ever be levied against the assets of any
partner of Landlord;
(viii) these covenants and agreements are enforceable both by Landlord and
also by any partner of Landlord.
Tenant agrees that each of the foregoing covenants and agreements shall be
applicable to any covenant or agreement either expressly contained in this Lease
or imposed by statute or at common law.
40. MISCELLANEOUS AND GENERAL PROVISIONS
a. Tenant shall not, without the written consent of Landlord, use the name
of the building for any purpose other than as the address of the business
conducted by Tenant in the Premises.
b. This Lease shall in all respects by governed by and construed in
accordance with the laws of the State of California. If any provision of
this Lease shall be invalid, unenforceable or ineffective for any reason
whatsoever, all other provisions hereof shall be and remain in full force
and effect.
c. The term "Premises" includes the space leased hereby and any
improvements now or hereafter installed therein or attached thereto. The
term "Landlord" or any pronoun used in place thereof includes the plural as
well as the singular and the successors and assigns of Landlord. The term
"Tenant" or any pronoun used in place thereof includes the plural as well
as the singular and individuals, firms, associations, partnerships and
corporations, and their and each of their respective heirs, executors,
administrators, successors and permitted assigns, according to the context
hereof, and the provisions of this Lease shall inure to the benefit of and
bind such heirs, executors, administrators, successors and permitted
assigns.
The term "person" includes the plural as well as the singular and
individuals, firms, associations, partnerships and corporations. Words used
in any gender include other genders. If there be more than one Tenant the
obligations of Tenant hereunder are joint and several. The paragraph
headings of this Lease are for convenience of reference only and shall have
no effect upon the construction or interpretation of any provision hereof.
d. Time is of the essence of this Lease and of each and all of its
provisions.
7
<PAGE> 8
e. At the expiration or earlier termination of this Lease, Tenant shall
execute, acknowledge and deliver to Landlord, within ten (10) days after
[illegible] Landlord to Tenant, any quitclaim deed or other document
required by any reputable title company, licensed to operate in the State
of California, to [illegible] or encumbrance created by this Lease from the
real property of which Tenant's Premises are a part.
f. This instrument along with any exhibits and attachments, hereto
constitutes the entire agreement between Landlord and Tenant relative to
the Premises and any agreement and the exhibits and attachments may be
altered, amended or revoked only by an instrument in writing signed by both
Landlord and Tenant. Landlord and Tenant agree hereby that all prior or
contemporaneous oral agreements between and among themselves and their
agents or representatives relative to the leasing of the Premises are
merged in or revoked by this agreement.
g. Neither Landlord nor Tenant shall record this Lease or a short form
memorandum hereof without the consent of the other.
h. Tenant further agrees to execute any amendments required by a lender
to enable Landlord to obtain financing, so long as Tenant's rights
hereunder are not substantially affected.
i. Paragraphs 43 through 57 are added hereto and are included as a part
of this lease.
j. Clauses, plats and riders, if any, signed by Landlord and Tenant and
endorsed on or affixed to this Lease are a part hereof.
k. Tenant covenants and agrees that no diminution or shutting off of
light, air or view by any structure which may be hereafter erected (whether
or not by Landlord) shall in any way affect his Lease, entitle Tenant to
any reduction of rent hereunder or result in any liability of Landlord to
Tenant.
41. BROKERS Tenant warrants that it had dealings with only the following real
estate brokers or agents in connection with the negotiation of this Lease: none
and that it knows of no other real estate broker or agent who is entitled to a
commission in connection with this Lease.
42. SIGNS No sign, placard, picture, advertisement, name or notice shall be
inscribed, displayed or printed or affixed on or to any part of the outside
of the Premises or any exterior windows of the Premises without the written
consent of Landlord first had and obtained and Landlord shall have the right to
remove any such sign, placard, picture, advertisement, name or notice without
notice to and at the expense of Tenant. If Tenant is allowed to print or affix
or in any way place a sign in, on, or about the Premises, upon expiration or
other sooner termination of this Lease. Tenant at Tenant's sole cost and
expense shall both remove such sign and repair all damage in such a manner as
to restore all aspects of the appearance of the Premises to the condition prior
to the placement of said sign.
All approved signs or lettering on outside doors shall be printed, painted,
affixed or inscribed at the expense of Tenant by a person approved of by
Landlord.
Tenant shall not place anything or allow anything to be placed near the
glass of any window, door partition or wall which may appear unsightly from
outside the Premises.
IN WITNESS WHEREOF. Landlord and Tenant have executed and delivered this
Lease as of the day and year last written below.
LANDLORD: TENANT
JOHN ARRILLAGA SURVIVOR'S TRUST NEOFORMA, INC.
a Delaware corporation
By /s/ JOHN ARRILLAGA By /s/ JEFFREY H. KLECK
------------------------------- ----------------------------
John Arrillaga, Trustee Jeffrey H. Kleck, CEO
Date: 3/20/99 Date: 3/19/99
---------------------------- -------------------------
RICHARD T. PEERY SEPARATE PROPERTY TRUST
By /s/ RICHARD T. PEERY
-------------------------------
Richard T. Peery, Trustee
Date: 3/26/99
----------------------------
8
<PAGE> 9
Paragraphs 43 through 57 to Lease Agreement dated March 1, 1999, By and Between
the John Arrillaga Survivor's Trust and the Richard T. Peery Separate Property
Trust, as Landlord, and NEOFORMA, INC., a Delaware corporation, as Tenant for
22,500 +/- Square Feet of Space Located at 3255-7 Scott Blvd., Santa Clara,
California.
43. BASIC RENT: In accordance with Paragraph 4A herein, the total aggregate
sum of THREE MILLION SIX HUNDRED SEVENTY EIGHT THOUSAND SEVEN HUNDRED FIFTY AND
NO/100 DOLLARS ($3,678,750.00), shall be payable as follows:
On May 1, 1999, the sum of FORTY TWO THOUSAND ONE HUNDRED EIGHTY SEVEN AND
50/100 DOLLARS ($42,187.50) shall be due, and a like sum due on the first day
of each month thereafter, through and including August 1, 1999.
On September 1, 1999, the sum of FIFTY EIGHT THOUSAND FIVE HUNDRED AND
NO/100 DOLLARS ($58,500.00) shall be due, and a like sum due on the first day
of each month thereafter, through and including August 1, 2000.
On September 1, 2000, the sum of SIXTY THOUSAND SEVEN HUNDRED FIFTY AND
NO/100 DOLLARS ($60,750.00) shall be due, and a like sum due on the first day
of each month thereafter, through and including August 1, 2001.
On September 1, 2001, the sum of SIXTY THREE THOUSAND AND NO/100 DOLLARS
($63,000.00) shall be due, and a like sum due on the first day of each month
thereafter, through and including August 1, 2002.
On September 1, 2002, the sum of SIXTY FIVE THOUSAND TWO HUNDRED FIFTY
AND NO/100 DOLLARS ($65,250.00) shall be due, and a like sum due on the first
day of each month thereafter, through and including August 1, 200?.
On September 1, 2003, the sum of SIXTY SEVEN THOUSAND FIVE HUNDRED AND
NO/100 DOLLARS ($67,500.00) shall be due, and a like sum due on the first day
of each month thereafter, through and including April 1, 2004; or until the
entire aggregate sum of THREE MILLION SIX HUNDRED SEVENTY EIGHT THOUSAND SEVEN
HUNDRED FIFTY AND NO/100 DOLLARS ($3,678,750.00) has been paid.
44. "AS-IS" BASIS: Subject only to Paragraph 55 ("Compliance") and to Landlord
constructing the improvements shown on Exhibit B attached hereto, it is hereby
agreed that the Premises leased hereunder is leased strictly on an "as-is"
basis and in its present condition, and in the configuration as shown on
Exhibit B attached hereto, and by reference made a part hereof. Except as
noted herein, it is specifically agreed between the parties that after Landlord
constructs the interior improvements as shown on Exhibit B, Landlord shall not
be required to make, nor be responsible for any cost, in connection with any
repair, restoration, and/or improvement to the Premises in order for this Lease
to commence, or thereafter, throughout the Term of this Lease. Notwithstanding
anything to the contrary within this Lease, Landlord makes no warranty or
representation of any kind or nature whatsoever as to the condition or repair
of the Premises, nor as to the use or occupancy which may be made thereof.
In addition to and notwithstanding anything to the contrary in Paragraphs
8 and this Paragraph 44 of this Lease, Tenant shall have thirty (30) days after
the Commencement Date to provide Landlord with a written "punch list"
pertaining to defects in the interior improvements constructed by Landlord for
Tenant. As soon as reasonably possible thereafter, Landlord, or one of
Landlord's representatives (if so approved by Landlord), and Tenant shall
conduct a joint walk-through of the Premises (if Landlord so requires), and
inspect such Tenant Improvements, using their best efforts to agree on the
incomplete or defective construction related to the Tenant Improvements
installed for Tenant by Landlord. After such inspection has been completed,
Landlord shall prepare, and both parties shall sign, a list of all "punch list"
items which the parties reasonably agree are (i) to be corrected by Landlord
(but which shall exclude any damage or defects caused by Tenant, its employees,
agents or parties Tenant has contracted with to work on the Premises) or (ii)
if said defects and/or damaged item(s) are not material, Landlord may elect, in
its sole and absolute discretion, not to repair such item(s), but to
acknowledge in written form the defect and/or damaged item(s); in which case,
notwithstanding anything to the contrary in said Lease Paragraph 8 ("Acceptance
and Surrender"), Tenant shall not be responsible upon Lease Termination to
repair said item(s) so noted by Landlord, Landlord shall have thirty (30) days
thereafter (or longer if necessary, provided Landlord is diligently pursuing
the completion of the same) to complete, at Landlord's expense, the "punch list"
items
9
<PAGE> 10
without the Commencement Date of the Lease and Tenant's obligation to pay Rental
thereunder being affected. Notwithstanding the foregoing, a crack in the
foundation, or exterior walls or any other defect in the structure or Building
that does not endanger the structural integrity of the building, or which is not
life-threatening, shall not be considered material, nor shall Landlord be
responsible for repair of same. This Paragraph shall be of no force and effect
if Tenant shall fail to give any such notice to Landlord within thirty (30)
days of the Commencement Date of this Lease.
45. CONSENT: Whenever the consent of one party to the other is required
hereunder, such consent shall not be unreasonably withheld.
46. CHOICE OF LAW; SEVERABILITY: This Lease shall in all respects be governed
by and construed in accordance with the laws of the State of California. If any
provisions of this Lease shall be invalid, unenforceable, or ineffective for
any reason whatsoever, all other provisions hereof shall be and remain in full
force and effect.
47. AUTHORITY TO EXECUTE: The parties executing this Lease Agreement hereby
warrant and represent that they are properly authorized to execute this Lease
Agreement and bind the parties on behalf of whom they execute this Lease
Agreement and to all of the terms, covenants and conditions of this Lease
Agreement as they relate to the respective parties hereto.
48. ASSESSMENT CREDITS: The demised property herein may be subject to a
special assessment levied by the City of as part of an Improvement District. As
a part of said special assessment proceedings (if any), additional bonds were
or may be sold and assessments were or may be levied to provide for construction
contingencies and reserve funds. Interest shall be earned on such funds created
for contingencies and on reserve funds which will be credited for the benefit
of said assessment district. To the extent surpluses are created in said
district through unused contingency funds, interest earnings or reserve funds,
such surpluses shall be deemed the property of Landlord. Notwithstanding that
such surpluses may be credited on assessments otherwise due against the Leased
Premises, Tenant shall pay to Landlord, as additional rent if, and at the time
of any such credit of surpluses, an amount equal to all such surpluses so
credited. For example: if (i) the property is subject to an annual assessment
of $1,000.00, and (ii) a surplus of $200.00 is credited towards the current
year's assessment which reduces the assessment amount shown on the property tax
bill from $1,000.00 to $800.00, Tenant shall, upon receipt of notice from
Landlord, pay to Landlord said $200.00 credit as Additional Rent.
49. ASSIGNMENT AND SUBLETTING (CONTINUED):
A. Notwithstanding the foregoing, Landlord and Tenant agree that it
shall not be unreasonable for Landlord to refuse to consent to a proposed
assignment, sublease or other transfer ("Proposed Transfer") if the Premises or
any other portion of the Property would become subject to additional or
different Government Requirements as a direct or indirect consequence of the
Proposed Transfer and/or the Proposed Transferee's use and occupancy of the
Premises and the Property. However, Landlord may, in its sole discretion,
consent to such a Proposed Transfer where Landlord is indemnified by Tenant and
(i) Subtenant or (ii) Assignee, in form and substance satisfactory to
Landlord's counsel, by Tenant and/or the Proposed Transferee from and against
any and all costs, expenses, obligations and liability arising out of the
Proposed Transfer and/or the Proposed Transferee's use and occupancy of the
Premises and the Property.
B. Any and all sublease agreement(s) between Tenant and any and all
subtenant(s) (which agreements must be consented to by Landlord, pursuant to
the requirements of this Lease) shall contain the following language:
"If Landlord and Tenant jointly and voluntarily elect, for any reason
whatsoever, to terminate the Master Lease prior to the scheduled Master Lease
termination date, then this Sublease (if then still in effect) shall terminate
concurrently with the termination of the Master Lease. Subtenant expressly
acknowledges and agrees that (1) the voluntary termination of the Master Lease
by Landlord and Tenant and the resulting termination of this Sublease shall not
give Subtenant any right or power to make any legal or equitable claim against
Landlord, including without limitation any claim for interference with contract
or interference with prospective economic advantage, and (2) Subtenant hereby
waives any and all rights it may have under law or at equity against Landlord
to challenge such an early termination of the Sublease, and unconditionally
releases and relieves Landlord, and its officers, directors, employees and
agents, from any and all claims, demands, and/or causes of action whatsoever
(collectively, "Claims"), whether such matters are known or unknown, latent or
apparent, suspected or unsuspected, foreseeable or unforeseeable, which
10
<PAGE> 11
Subtenant may have arising out of or in connection with any such early
termination of this Sublease. Subtenant knowingly and intentionally
waives any and all protection which is or may be given by Section 1542 of the
California Civil Code which provides as follows: "A general release does not
extend to claims which the creditor does not know or suspect to exist in his
favor at the time of executing the release, which if known by him must have
materially affected his settlement with debtor.
The term of this Sublease is therefore subject to early termination.
Subtenant's initials here below evidence (a) Subtenant's consideration of and
agreement to this early termination provision, (b) Subtenant's acknowledgment
that, in determining the net benefits to be derived by Subtenant under the
terms of this Sublease, Subtenant has anticipated the potential for early
termination, and (c) Subtenant's agreement to the general waiver and release of
Claims above.
Initials: __________ Initials: __________"
Subtenant Tenant
50. BANKRUPTCY AND DEFAULT: Paragraph 22 is modified to provide that with
respect to non-monetary defaults not involving Tenant's failure to pay Basic
Rent or Additional Rent, Tenant shall not be in default of any non-monetary
obligation if (i) more than thirty (30) days is required to cure such
non-monetary default, and (ii) Tenant commences cure of such default as soon as
reasonably practicable after receiving written notice of such default from
Landlord and thereafter continuously and with due diligence prosecutes such cure
to completion.
51. ABANDONMENT: Paragraph 23 is modified to provide that Tenant shall not be
in default under the Lease if it leaves all or any part of Premises vacant so
long as (i) Tenant is performing all of its other obligations under the Lease
including the obligation to pay Basic Rent and Additional Rent (ii) Tenant
provides on-site security during normal business hours for those parts of the
Premises left vacant, (iii) such vacancy does not materially and adversely
affect the validity or coverage of any policy of insurance carried by Landlord
with respect to the Premises, and (iv) the utilities and heating and
ventilation system are operated and maintained to the extent necessary to
prevent damage to the Premises or its systems.
52. HAZARDOUS MATERIALS: Landlord and Tenant agree as follows with respect to
the existence or use of "Hazardous Materials" (as defined herein) on, in, under
or about the Premises and real property located beneath said Premises and the
common areas of the Complex (hereinafter collectively referred to as the
"Property"):
A. As used herein, the term "Hazardous Materials" shall mean any
material, waste, chemical, mixture or byproduct which is or hereafter is
defined, listed or designated under Environmental Laws (defined below) as a
pollutant, or as a contaminant, or as a toxic or hazardous substance, waste or
material, or any other unwholesome, hazardous, toxic, biohazardous, or
radioactive material, waste, chemical, mixture or byproduct, or which is
listed, regulated or restricted by any Environmental Law (including, without
limitation, petroleum hydrocarbons or any distillates or derivatives or
fractions thereof, polychlorinated biphenyls, or asbestos). As used herein, the
term "Environmental Laws" shall mean any applicable Federal, State of California
or local government law (including common law), statute, regulation, rule,
ordinance, permit, license, order, requirement, agreement, or approval, or any
determination, judgment, directive, or order of any executive or judicial
authority at any level of Federal, State of California or local government
(whether now existing or subsequently adopted or promulgated) relating to
pollution or the protection of the environment, ecology, natural resources, or
public health and safety.
B. Tenant shall obtain Landlord's written consent, which may be withheld
in Landlord's discretion, prior to the occurrence of any Tenant's Hazardous
Materials Activities (defined below); provided, however, that Landlord's consent
shall not be required for normal use in compliance with applicable Environmental
Law of customary household and office supplies (Tenant shall first provide
Landlord with a list of said materials use), such as mild cleaners, lubricants
and copier toner. As used herein, the term "Tenant's Hazardous Materials
Activities" shall mean any and all use, handling, generation, storage, disposal,
treatment, transportation, release, discharge, or emission of any Hazardous
Materials on, in, beneath, to, from, at or about the Property, in connection
with Tenant's use of the Property, or by Tenant or by any of Tenant's agents,
employees, contractors, vendors, invitees, visitors or its future subtenants or
assignees. Tenant agrees that any and all Tenant's Hazardous Materials
Activities shall be conducted in strict, full compliance with applicable
Environmental Laws at Tenant's expense, and shall not result in any
11
<PAGE> 12
contamination of the Property or the environment. Tenant agrees to provide
Landlord with prompt written notice of any spill or release of Hazardous
Materials at the Property during the term of the Lease of which Tenant becomes
aware, and further agrees to provide Landlord with prompt written notice of any
violation of Environmental Laws in connection with Tenant's Hazardous Materials
Activities of which Tenant becomes aware. If Tenant's Hazardous Materials
Activities involve Hazardous Materials other than normal use of customary
household and office supplies, Tenant also agrees at Tenant's expense: (i) to
install such Hazardous Materials monitoring, storage and containment devices as
Landlord reasonably deems necessary (Landlord shall have no obligation to
evaluate the need for any such installation or to require any such
installation); (ii) provide Landlord with a written inventory of such Hazardous
Materials, including an update of same each year upon the anniversary date of
the Commencement Date of the Lease ("Anniversary Date"); and (iii) on each
Anniversary Date, to retain a qualified environmental consultant, acceptable to
Landlord, to evaluate whether Tenant is in compliance with all applicable
Environmental Laws with respect to Tenant's Hazardous Materials Activities.
Tenant, at its expense, shall submit to Landlord a report from such
environmental consultant which discusses the environmental consultant's findings
within two (2) months of each Anniversary Date. Tenant, at its expense, shall
promptly undertake and complete any and all steps necessary, and in full
compliance with applicable Environmental Laws, to fully correct any and all
problems or deficiencies identified by the environmental consultant, and
promptly provide Landlord with documentation of all such corrections.
C. Prior to termination or expiration of the Lease, Tenant, at its
expense, shall (i) properly remove from the Property all Hazardous Materials
which come to be located at the Property in connection with Tenant's Hazardous
Materials Activities, and (ii) fully comply with and complete all facility
closure requirements of applicable Environmental Laws regarding Tenant's
Hazardous Materials Activities, including but not limited to (x) properly
restoring and repairing the Property to the extent damaged by such closure
activities, and (y) obtaining from the local Fire Department or other
appropriate governmental authority with jurisdiction a written concurrence that
closure has been completed in compliance with applicable Environmental Laws.
Tenant shall promptly provide Landlord with copies of any claims, notices, work
plans, data and reports prepared, received or submitted in connection with any
such closure activities.
D. If Landlord, in its sole discretion, believes that the Property has
become contaminated as a result of Tenant's Hazardous Materials Activities,
Landlord in addition to any other rights it may have under this Lease or under
Environmental Laws or other laws, may enter upon the Property and conduct
inspection, sampling and analysis, including but not limited to obtaining and
analyzing samples of soil and groundwater, for the purpose of determining the
nature and extent of such contamination. Tenant shall promptly reimburse
Landlord for the costs of such an investigation, including but not limited to
reasonable attorneys' fees Landlord incurs with respect to such investigation,
that discloses Hazardous Materials contamination for which Tenant is liable
under this Lease. Notwithstanding the above, Landlord may, at its option and in
its sole and absolute discretion, choose to perform remediation and obtain
reimbursement for cleanup costs as set forth herein from Tenant. Any cleanup
costs incurred by Landlord as the result of Tenant's Hazardous Materials
Activities shall be reimbursed by Tenant within thirty (30) days of presentation
of written documentation of the expense to Tenant by Landlord. Such reimbursable
costs shall include, but not be limited to, any reasonable consultant and
attorney fees incurred by Landlord. Tenant shall take all actions necessary to
preserve any claims it has against third parties, including, but not limited
to, its insurers, for claims related to its operation, management of Hazardous
Materials or contamination of the Property. Except as may be required of Tenant
by applicable Environmental Laws, Tenant shall not perform any sampling,
testing, or drilling to identify the presence of any Hazardous Materials at the
Property, without Landlord's prior written consent which may be withheld in
Landlord's discretion. Tenant shall promptly provide Landlord with copies of
any claims, notices, work plans, data and reports prepared, received or
submitted in connection with any sampling, testing or drilling performed
pursuant to the preceding sentence.
E. Tenant shall indemnify, defend (with legal counsel acceptable to
Landlord, whose consent shall not unreasonably be withheld) and hold harmless
Landlord, its employees, assigns, successors, successors-in-interest, agents
and representatives from and against any and all claims (including but not
limited to third party claims from a private party or a government authority),
liabilities, obligations, losses, causes of action, demands, governmental
proceedings or directives, fines, penalties, expenses, costs (including but not
limited to reasonable attorneys', consultants' and other experts' fees and
costs), and damages, which arise from or relate to: (i) Tenant's Hazardous
Materials Activities; (ii) any Hazardous Materials contamination caused by
Tenant prior to the Commencement Date of the Lease; or (iii) the breach of any
obligation of Tenant under this Paragraph (collectively, "Tenant's
Environmental indemnification"). Tenant's Environmental Indemnification shall
include but is not limited to the obligation to promptly and fully reimburse
Landlord for losses in or reductions to rental income, and diminution in fair
market value of the Property. Tenant's Environmental Indemnification shall
further include but is not limited to the
12
<PAGE> 13
obligation to diligently and properly implement to completion, at Tenant's
expense, any and all environmental investigation, removal, remediation,
monitoring, reporting, closure activities, or other environmental response
action (collectively, "Response Actions"). Tenant shall promptly provide
Landlord with copies of any claims, notices, work plans, data and reports
prepared, received or submitted in connection with any Response Actions.
It is agreed that the Tenant's responsibilities related to Hazardous Materials
will survive the expiration or termination of this Lease and that Landlord may
obtain specific performance of Tenant's responsibilities under this Paragraph
52.
53. ADDITIONAL RENT CONTINUED: The following items shall be excluded from
"Additional Rent":
A. Leasing commissions, attorney's fees, costs, disbursements, and other
expenses incurred in connection with negotiations with other tenants, or
disputes between Landlord and other third party tenant not related to Tenant
(hereinafter referred to as "Third Party Tenant"), or in connection with
marketing, leasing, renovating, or improving space for other current or
prospective tenants or other current or prospective occupants of the Complex;
notwithstanding anything to the contrary herein, any costs and expenses Landlord
is entitled to be reimbursed for as stated under Paragraph 22 ("Bankruptcy and
Default") ARE NOT excluded Additional Rent items as reflected in this Paragraph
53.
B. The cost of any service sold to any other Third Party Tenant or other
occupant whose leased premises are not part of the Premises leased herein and
for which Landlord is entitled to be reimbursed as an additional charge or
rental over and above the basic rent and additional rent payable under the
lease agreement with said other tenant (including, without limitation,
after-hours HVAC costs or over-standard electrical consumption costs incurred
by other tenants).
C. Any costs for which Landlord is entitled to be reimbursed by any
other Third Party Tenant or other occupant whose leased premises are not part
of the Premises leased herein.
D. Any costs, fines, or penalties incurred due to violations by Landlord
of any governmental rule or authority, provided Tenant is not responsible under
the Lease for such costs, fines and/or penalties, and/or provided Tenant's
actions or inactions did not cause, in whole or in part, such costs, fines
and/or penalties.
E. Wages, salaries, or other compensation paid to executive employees
above the grade of Property Manager.
F. Repairs or other work occasioned by fire, windstorm, or other insured
peril, to the extent that Landlord shall receive proceeds of such insurance or
would have received such proceeds had Landlord maintained the insurance coverage
required under this Lease providing said insurance coverage was available and
Tenant paid its share of the premium as required under the Lease and any
insurance deductible(s) which Tenant is responsible for paying and provided
Tenant is not responsible for the damage to the Premises.
G. Except as otherwise noted in this Lease, any mortgage debt, or ground
rents or any other amounts payable under any ground lease for the Property.
H. Any amounts paid to any person, firm, or corporation related or
otherwise affiliated with Landlord or any general partner, officer, or director
of Landlord or any general partners, to the extent same exceeds arms-length
competitive prices paid in the Santa Clara, California metropolitan area for
the services or goods provided.
54. TAXES CONTINUED: Notwithstanding anything within Paragraph 12, (i) the
amount of Real Property Taxes payable by Tenant hereunder shall be prorated to
reflect the dates of Lease Commencement and Lease Termination, and (ii) it is
agreed that if any special assessments for capital improvements are assessed,
and if Landlord has the option to either pay the entire assessment in cash or go
to bond, and if Landlord elects to pay the entire assessment in cash in lieu of
going to bond, the entire portion of the assessment assigned to Tenant's Leased
Premises will be prorated over the same period that the assessment would have
been prorated had the assessment gone to bond.
55. COMPLIANCE CONTINUED: Any non-conformance of the Tenant Improvements
installed and paid for by Landlord as set forth on Exhibit B, required to be
corrected by the governing
13
<PAGE> 14
agency, shall be corrected at the cost and expense of Landlord if such non-
conformance exists as of the Commencement Date of the Lease and further provided
that such governing agency's requirement and notice to Landlord to correct the
non-conformance is not initiated as a result of: (i) Tenant's particular use of
the Premises; (ii) any future improvements made by or for Tenant; or (iii) any
permit request made to a governing agency by or for Tenant. Any non-conformance
of the Premises occurring after the Commencement Date of this Lease Agreement
shall be the responsibility of Tenant to correct at Tenant's cost and expense.
56. NOTICES: Any notice required under the Lease that is sent by mail shall be
deemed received, if properly addressed, no later than five (5) business days
after any such notice is stamped by the U.S. Post Office as deposited in the
United States mail certified, postage prepaid, return receipt requested.
57. TERMINATION OF PREVIOUS LEASE UPON COMMENCEMENT OF THIS LEASE:
A. It is understood that Tenant is currently occupying approximately 10,878
square feet of space located at 3255-6 Scott Blvd., Suite 101, Santa Clara,
California, leased under separate Lease Agreement dated July 30, 1998 between
Landlord and Tenant ("Existing Lease"). It is therefore agreed that upon
commencement of this Lease Agreement, said Lease Agreement shall terminate
subject to Paragraph 57(B) herein, and this Lease Agreement shall be considered
the only Lease Agreement between the parties for the Premises leased hereunder.
B. Tenant, as a material consideration for the termination of said Lease
dated July 30, 1998, agrees to indemnify Landlord and hold Landlord harmless
from and against any and all claims or liabilities of any nature whatsoever
incurred by Tenant during and arising out of (i) Tenant's tenancy, (ii) arising
out of the cancellation of the Lease and surrender of the Premises, and (iii)
from any and all claims or obligations owing to third parties.
C. Tenant also agrees that, upon termination of said 10,878 square feet of
space, Tenant shall comply with the provisions of Amendment No. 1 to the
Existing Lease.
14
<PAGE> 15
EXHIBIT A TO
EXHIBIT 10.24
[SITE PLAN]
3255 SCOTT BLVD., BUILDING 1-7
SANTA CLARA, CALIFORNIA 95054
PSI-7
15
<PAGE> 16
EXHIBIT B TO
EXHIBIT 10.24
Neoforma
3255 #7 Scott Blvd.
Santa Clara
[FACILITY LAYOUT DIAGRAM]
PSI-7
16
<PAGE> 1
EXHIBIT 10.25
BLDG: PSI-6
LEASE AGREEMENT OWNER: 500
PROP: 316
UNIT: 101
TENANT: 31610
THIS LEASE, made this 16th day of August, 1999 between JOHN ARRILLAGA, Trustee,
or his Successor Trustee, UTA dated 7/20/77 (JOHN ARRILLAGA SURVIVOR'S TRUST)
as amended, and RICHARD T. PEERY, Trustee, or his Successor Trustee, UTA dated
7/20/77 (RICHARD T. PEERY SEPARATE PROPERTY TRUST) as amended, hereinafter
called Landlord, and NEOFORMA, INC., a Delaware corporation, hereinafter called
Tenant.
WITNESSETH:
Landlord hereby leases to Tenant and Tenant hereby hires and takes from
Landlord those certain premises (the "Premises") outlined in red on Exhibit "A",
attached hereto and incorporated herein by this reference thereto more
particularly described as follows:
A portion of that certain 22,500(plus/minus sign) square foot, one-story
building located at 3255-6 Scott Blvd., Suite 101, Santa Clara, California
95054, consisting of approximately 10,878(plus/minus sign) square feet of space.
Said Premises is more particularly shown within the area outlined in Red on
Exhibit A attached hereto. The entire parcel, of which the Premises is a part,
is shown within the area outlined in Green on Exhibit A attached. The Premises
is leased on an "as-is" basis, in its present condition, and in the
configuration as shown in Red on Exhibit B attached hereto.
As used herein the Complex shall mean and include all of the land outlined in
Green and described in Exhibit "A", attached hereto, and all of the buildings,
improvements, fixtures and equipment now or hereafter situated on said land.
Said letting and hiring is upon and subject to the terms, covenants and
conditions hereinafter set forth and Tenant covenants as a material part of the
consideration for this Lease to perform and observe each and all of said terms,
covenants and conditions. This Lease is made upon the conditions of such
performance and observance.
1. USE. Tenant shall use the Premises only in conformance with applicable
governmental laws, regulations, rules and ordinances for the purpose of general
office, light manufacturing, research and development, and storage and other
uses necessary for Tenant to conduct Tenant's business, provided that such uses
shall be in accordance with all applicable governmental laws and ordinances and
for no other purpose. Tenant shall not do or permit to be done in or about the
Premises or the Complex nor bring or keep or permit to be brought or kept in or
about the Premises or the Complex anything which is prohibited by or will in any
way increase the existing rate of (or otherwise affect) fire or any insurance
covering the Complex or any part thereof, or any of its contents, or will cause
a cancellation of any insurance covering the Complex or any part thereof, or any
of its contents. Tenant shall not do or permit to be done anything in, on or
about the Premises or the Complex which will in any way obstruct of interfere
with the rights of other tenants or occupants of the Complex or injure or annoy
them, or use or allow the Premises to be used for any improper, immoral,
unlawful objectionable purpose, nor shall Tenant cause, maintain or permit any
nuisance in, on or about the Premises or the Complex. No sale by auction shall
be permitted on the Premises. Tenant shall not place any loads upon the floors,
walls, or ceiling, which endanger the structure or place any harmful fluids or
other materials in the drainage system of the building, or overload existing
electrical or other mechanical systems. No waste materials or refuse shall be
dumped upon or permitted to remain upon any part of the Premises or outside of
the building in which the Premises are a part, except in trash containers placed
inside exterior enclosures designated by Landlord for that purpose or inside of
the building proper where designated by Landlord. No materials, supplies,
equipment, finished products or semi-finished products, raw materials or
articles of any nature shall be stored upon or permitted to remain outside the
Premises or on any portion of common area of the Complex. No loudspeaker or
other device, system or apparatus which can be heard outside the Premises shall
be used in or at the Premises without the prior written consent of Landlord.
Tenant shall not commit or suffer to be committed any waste in or upon the
Premises. Tenant shall indemnify, defend and hold Landlord harmless against any
loss, expense, damage, attorneys' fees, or liability arising out of failure of
Tenant to comply with any applicable law. Tenant shall comply with any covenant,
condition, or restriction ("CC&R's") affecting the Premises. The provisions of
this paragraph are for the benefit of Landlord only and shall not be construed
to be for the benefit of any tenant or occupant of the Complex.
2. TERM *
A. The term of this Lease shall be for a period of SEVEN (7) years
(unless sooner terminated as hereinafter provided) and, subject to Paragraphs
2(B) and 3, shall commence on the 1st day of October, 1999 and end on the 30th
day of September of 2006.
B. Possession of the Premises shall be deemed tendered and the term of
this Lease shall commence on October 1, 1999, or
(d) As otherwise agreed to in writing.
3. POSSESSION. If Landlord, for any reason whatsoever, cannot deliver
possession of said premises to Tenant at the commencement of the said term, as
hereinbefore specified, this Lease shall not be void or voidable; no obligation
of Tenant shall be affected thereby; nor shall Landlord or Landlord's agents be
liable to Tenant for any loss or damage resulting therefrom; but in that event
the commencement and termination dates of the Lease, and all other dates
affected thereby shall be revised to conform to the date of Landlord's delivery
of possession, as specified in Paragraph 2(b), above. The above is, however,
subject to the provision that the period of delay, of delivery of the premises
shall not exceed 30 days from the commencement date herein (except those delays
caused by Acts of God, strikes, war, utilities, governmental bodies, weather,
unavailable materials, and delays beyond Landlord's control shall be excluded in
calculating such period) in which instance Tenant, at its option, may, by
written notice to Landlord, terminate this Lease.
* It is agreed in the event said Lease commences on a date other than the first
day of the month the term of the Lease will be extended to account for the
number of days in the partial month. The Basic Rent during the resulting
partial month will be pro-rated (for the number of days in the partial month)
at the Basic Rent scheduled for the projected commencement date as shown in
Paragraph 43.
1
<PAGE> 2
4. RENT
A. Basic Rent. Tenant agrees to pay to Landlord at such place as Landlord
may designate without deduction, offset, prior notice, or demand, and Landlord
agrees to accept as Basic Rent for the leased Premises the total sum of TWO
MILLION SIX HUNDRED FORTY NINE THOUSAND EIGHT HUNDRED EIGHTY AND 80/100
($2,649,880.80) Dollars in lawful money of the United States of America,
payable as follows:
SEE PARAGRAPH 43 FOR BASIC RENT SCHEDULE.
B. Time for Payment. In the event that the term of this Lease commences on a
date other than the first day of a calendar month, on the date of commencement
of the term hereof Tenant shall pay to Landlord as rent for the period from
such date of commencement to the first day of the next succeeding calendar
month that proportion of the monthly rent hereunder which the number of days
between such date of commencement and the first day of the next succeeding
calendar month bears to thirty (30). In the event that the term of this Lease
for any reason ends on a date other than the last day of a calendar month, on
the first day of the last calendar month of the term hereof Tenant shall pay to
Landlord as rent for the period from said first day of said last calendar month
to and including the last day of the term hereof that proportion of the monthly
rent hereunder which the number of days between said first day of said last
calendar month and the last day of the term hereof bears to thirty (30).
C. Late Charge. Notwithstanding any other provision of this Lease, if Tenant
is in default in the payment of rental as set forth in this Paragraph 4 when
due, or any part thereof, Tenant agrees to pay Landlord, in addition to the
delinquent rental due, a late charge for each rental payment in default ten
(10) days. Said late charge shall equal ten (10%) percent of each rental
payment so in default.
D. Additional Rent. Beginning with the commencement date of the term of this
Lease, Tenant shall pay to Landlord in addition to the Basic Rent and as
Additional Rent the following:
(a) Tenant's proportionate share of all Taxes relating to the Complex as set
forth in Paragraph 12, and
(b) Tenant's proportionate share of all insurance premiums and deductibles
relating to the Complex, as set forth in Paragraph 15, and
(c) Tenant's proportionate share of expenses for the operation, management,
maintenance and repair of the Building (including common areas of the
Building) and Common Areas of the Complex in which the Premises are
located as set forth in Paragraph 7, and
(d) All charges, costs and expenses, which Tenant is required to pay
hereunder, together with all interest and penalties, costs and expenses
including attorneys' fees and legal expenses, that may accrue thereto in
the event of Tenant's failure to pay such amounts, and all damages,
reasonable costs and expenses which Landlord may incur by reason of
default of Tenant or failure on Tenant's part to comply with the terms of
this Lease. In the event of nonpayment by Tenant of Additional Rent
Landlord shall have all the rights and remedies with respect thereto as
Landlord has for nonpayment of rent.
The Additional Rent due hereunder shall be paid to Landlord or Landlord's agent
(i) within five days for taxes and insurance and within thirty days for all
other Additional Rent items after presentation of invoice from Landlord or
Landlord's agent setting forth such Additional Rent and/or (ii) at the option of
Landlord, Tenant shall pay to Landlord monthly, in advance, Tenant's prorata
share of an amount estimated by Landlord to be Landlord's approximate average
monthly expenditure for such Additional Rent items, which estimated amount shall
be reconciled within 120 days of the end of each calendar year or more
frequently if Landlord so elects to do so at Landlord's sole and absolute
discretion, as compared to Landlord's actual expenditure for said Additional
Rent items, with Tenant paying to Landlord, upon demand, any amount of actual
expenses expended by Landlord in excess of said estimated amount, or Landlord
crediting to Tenant (providing Tenant is not in default in the performance of
any of the terms, covenants and conditions of this Lease) any amount of
estimated payments made by Tenant in excess of Landlord's actual expenditures
for said Additional Rent items. Within thirty (30) days after receipt of
Landlord's reconciliation, Tenant shall have the right, at Tenant's sole
expense, to audit, at a mutually convenient time at Landlord's office,
Landlord's records relating to the foregoing expenses. Such audit must be
conducted by Tenant or an independent nationally recognized accounting firm that
is not being compensated by Tenant or other third party on a contingency fee
basis. Landlord shall be provided a complete copy of said audit at no expense to
Landlord. If such audit reveals that Landlord has overcharged Tenant and the
audit is not challenged by Landlord, the amount overcharged shall be credited to
Tenant's account within thirty (30) days after the audit is concluded.
The respective obligations of Landlord and Tenant under this paragraph shall
survive the expiration or other termination of the term of this Lease, and if
the term hereof shall expire or shall otherwise terminate on a day other than
the last day of a calendar year, the actual Additional Rent incurred for the
calendar year in which the term hereof expires or otherwise terminates shall be
determined and settled on the basis of the statement of actual Additional Rent
for such calendar year and shall be prorated in the proportion which the number
of days in such calendar year preceding such expiration or termination bears to
365.
E. Fixed Management Fee. Beginning with the Commencement Date of the Term of
this Lease, Tenant shall pay to Landlord, in addition to the Basic Rent and
Additional Rent, a fixed monthly management fee ("Management Fee") equal to 3%
of the Basic Rent due for each month during the Lease Term.
F. Place of Payment of Rent and Additional Rent. All Basic Rent hereunder
and all payments hereunder for Additional Rent shall be paid to Landlord at the
office of Landlord at Peery/Arrillaga, File 1504, Box 60000, San Francisco, CA
94160 or to such other person or to such other place as Landlord may from time
to time designate in writing.
G. Security Deposit. Concurrently with Tenant's execution of this Lease,
Tenant shall deposit with Landlord the sum of SIXTY NINE THOUSAND SIX HUNDRED
NINETEEN AND 20/100 ($69,619.20) Dollars. Said sum shall be held by Landlord as
a Security Deposit for the faithful performance by Tenant of all of the terms,
covenants, and conditions of this Lease to be kept and performed by Tenant
during the term hereof. If Tenant defaults with respect to any provision of
this Lease, including, but not limited to, the provisions relating to the
payment of rent and any of the monetary sums due herewith, Landlord may (but
shall not be required to) use, apply or retain all or any part of this Security
Deposit for the payment of any other amount which Landlord may spend by reason
of Tenant's default or to compensate Landlord for any other loss or damage
which Landlord may suffer by reason of Tenant's default. If any portion of said
Deposit is so used or applied, Tenant shall, within ten (10) days after written
demand therefor, deposit cash with Landlord in the amount sufficient to restore
the Security Deposit to its original amount. Tenant's failure to do so shall be
a material breach of this Lease. Landlord shall not be required to keep this
Security Deposit separate from its general funds, and Tenant shall not be
entitled to interest on such Deposit. If Tenant fully and faithfully performs
every provision of this Lease to be performed by it, the Security Deposit or
any balance thereof shall be returned to Tenant (or at Landlord's option, to
the last assignee of Tenant's interest hereunder) at the expiration of the
Lease term and after Tenant has vacated the Premises. In the event of
termination of Landlord's interest in this Lease, Landlord shall transfer said
Deposit to Landlord's successor in interest whereupon Tenant agrees to release
Landlord from liability for the return of such Deposit or the accounting
therefor.
5. RULES AND REGULATIONS AND COMMON AREA Subject to the terms and conditions
of this Lease and such Rules and Regulations as Landlord may from time to time
prescribe, Tenant and Tenant's employees, invitees and customers shall, in
common with other occupants of the Complex in which the Premises are located,
and their respective employees, invitees and customers, and others entitled to
the use thereof, have the non-exclusive right to use the access roads, parking
areas, and facilities provided and designated by Landlord for the general use
and convenience of the occupants of the Complex in which the Premises are
located, which areas and facilities are referred to herein as "Common Area".
This right shall terminate upon the termination of this Lease. Landlord
reserves the right from time to time to make changes in the shape, size,
location, amount and extent of Common Area. Landlord further reserves the right
to promulgate such reasonable rules and regulations relating to the use of the
Common Area, and any part or parts thereof, as Landlord may deem appropriate
for the best interests of the occupants of the Complex. The Rules and
Regulations shall be binding upon Tenant upon delivery of a copy of them to
Tenant, and Tenant shall abide by them and cooperate in their observance. Such
Rules and Regulations may be amended by Landlord from time to time, with or
without advance notice, and all amendments shall be effective upon delivery of
a copy to Tenant. Landlord shall not be responsible to Tenant for the
non-performance by any other tenant or occupant of the Complex of any of said
Rules and Regulations.
Landlord shall operate, manage and maintain the Common Area. The manner in
which the Common Area shall be maintained and the expenditures for such
maintenance shall be at the discretion of Landlord.
2
<PAGE> 3
6. PARKING Tenant shall have the right to use with other tenants or
occupants of the Complex 32 parking spaces in the common parking areas of the
Complex. Tenant agrees, that Tenant, Tenant's employees, agents,
representatives and/or invitees shall not use parking spaces in excess of said
32 spaces allocated to Tenant hereunder. Landlord shall have the right, at
Landlord's sole discretion, to specifically designate the location of Tenant's
parking spaces within the common parking areas of the Complex in the event of a
dispute among the tenants occupying the building and/or Complex referred to
herein, in which event Tenant agrees that Tenant, Tenant's employees, agents,
representatives and/or invitees shall not use any parking spaces other than
those parking spaces specifically designated by Landlord for Tenant's use. Said
parking spaces, if specifically designated by Landlord to Tenant, may be
relocated by Landlord at any time, and from time to time. Landlord reserves the
right, at the Landlord's sole discretion, to rescind any specific designation
of parking spaces, thereby returning Tenant's parking spaces to the common
parking area. Landlord shall give Tenant written notice of any change in
Tenant's parking spaces. Tenant shall not, at any time, park, or permit to be
parked, any trucks or vehicles adjacent to the loading areas so as to
interfere in any way with the use of such areas, nor shall Tenant at any time
park, or permit the parking of Tenant's trucks or other vehicles or the trucks
and vehicles of Tenant's suppliers or others, in any portion of the common area
not designated by Landlord for such use by Tenant. Tenant shall not park nor
permit to be parked, any inoperative vehicles or equipment on any portion of
the common parking area or other common areas of the Complex. Tenant agrees to
assume responsibility for compliance by its employees with the parking
provision contained herein. If Tenant or its employees park in other than such
designated parking areas, then Landlord may charge Tenant, as an additional
charge, and Tenant agrees to pay, ten ($10.00) Dollars per day for each day or
partial day each such vehicle is parked in any area other than that designated.
Tenant hereby authorizes Landlord at Tenant's sole expense to tow away from the
Complex any vehicle belonging to Tenant or Tenant's employees parked in
violation of these provisions, or to attach violation stickers or notices to
such vehicles. Tenant shall use the parking areas for the vehicle parking only,
and shall not use the parking areas for storage.
7. EXPENSES OF OPERATION, MANAGEMENT, AND MAINTENANCE OF THE COMMON AREAS OF
THE COMPLEX AND BUILDINGS IN WHICH THE PREMISES ARE LOCATED. As Additional
Rent and in accordance with Paragraph 4D of this Lease, Tenant shall pay to
Landlord Tenant's proportionate share (calculated on a square footage or other
equitable basis as calculated by Landlord) of all expenses of operation,
management, maintenance and repair of the Common Areas of the Complex
including, but not limited to, license, permit, and inspection fees; security;
utility charges associated with exterior landscaping and lighting (including
water and sewer charges); all charges incurred in the maintenance and
replacement of landscaped areas, lakes, parking lots and paved areas (including
repairs, replacement, resealing and restriping), sidewalks; driveways;
maintenance, repair and replacement of all fixtures and electrical, mechanical,
and plumbing systems; structural elements and exterior surfaces of the
buildings; salaries and employee benefits of personnel and payroll taxes
applicable thereto; supplies, materials, equipment and tools; the cost of
capital expenditures which have the effect of reducing operating expenses,
provided, however, that in the event Landlord makes such capital improvements,
Landlord may amortize its investment in said improvements (together with
interest at the rate of fifteen (15%) percent per annum on the unamortized
balance) as an operating expense in accordance with standard accounting
practices, provided, that such amortization is not a rate greater than the
anticipated savings in the operating expenses.
"Additional Rent" as used herein shall not include Landlord's debt
repayments; interest on charges; expenses directly or indirectly incurred by
Landlord for the benefit of any other tenant; cost for the installation of
partitioning or any other tenant improvements; cost of attracting tenants;
depreciation; interest, or executive salaries.
As additional Rent and in accordance with paragraph 4D of this Lease,
Tenant shall pay its proportionate share (calculated on a square footage or
other equitable basis as calculated by Landlord) of the cost of operation
(including common utilities), management, maintenance, and repair of the
building (including common areas such as lobbies, restrooms, janitor's closets,
hallways, elevators, mechanical and telephone rooms, stairwells, entrances,
spaces above the ceilings and janitorization of said common areas) in which the
Premises are located. The maintenance items herein referred to include, but are
not limited to, all windows, window frames, plate glass, glazing, truck doors,
main plumbing systems of the building (such as water and drain lines, sinks,
toilets, faucets, drains, showers and water fountains), main electrical systems
(such as panels and conduits), heating and airconditioning systems (such as
compressors, fans, air handlers, ducts, boilers, heaters), store fronts,
roofs, downspouts, building common area interiors (such as wall coverings,
window coverings, floor coverings, and partitioning), ceilings, building
exterior doors, skylights (if any), automatic fire extinguishing systems, and
elevators; license, permit and inspection fees; security; salaries and
employee benefits of personnel and payroll taxes applicable thereto; supplies,
materials, equipment and tools; the cost of capital expenditures which have the
effect of reducing operating expenses, provided, however, that in the event
Landlord makes such capital improvements, Landlord may amortize its investment
in said improvements (together with interest at the rate of fifteen (15%)
percent per annum on the unamortized balance) as an operating expense in
accordance with standard accounting practices, provided, that such amortization
is not at a rate greater than the anticipated savings in the operating
expenses. Tenant hereby waives all rights under, and benefits of, subsection 1
of Section 1932 and Sections 1941 and 1942 of the California Civil Code and
under any similar law, statute or ordinance now or hereafter in effect.
8. ACCEPTANCE AND SURRENDER OF PREMISES By entry hereunder, Tenant accepts
the Premises as being in good and sanitary order, condition and repair and
accepts the building and improvements included in the Premises in their present
condition and without representation or warranty by Landlord as to the condition
os such building or as to the use or occupancy which may be made thereof. Any
exceptions to the foregoing must be by written agreement executed by Landlord
and Tenant. Tenant agrees on the last day of the Lease term, or on the sooner
termination of this Lease, to surrender the Premises promptly and peaceably to
Landlord in good condition and repair (damage by Acts of God, fire, normal wear
and tear excepted), with all interior walls painted, or cleaned so that they
appear freshly painted, and repaired and replaced, if damaged; all floors
cleaned and waxed; all carpets cleaned and shampooed; the airconditioning and
heating equipment serviced by a reputable and licensed service firm and in good
operating condition (provided the maintenance of such equipment has been
Tenant's responsibility during the term of this Lease) together with all
alterations, additions, and improvements which may have been made in, to or on
the Premises (except movable trade fixtures installed at the expense of Tenant)
except that Tenant shall ascertain from Landlord within thirty (30) days before
the end of the term of this Lease whether Landlord desires to have the Premises
or any part or parts thereof restored to their condition and configuration as
when the Premises were delivered to Tenant and if Landlord shall so desire, then
Tenant shall restore said Premises or such part or parts thereof before the end
of this Lease at Tenant's sole cost and expense. Tenant, on or before the end of
the term or sooner termination of this Lease, shall remove all of Tenant's
personal property and trade fixtures from the Premises, and all property not so
removed on or before the end of the term or sooner termination of this Lease
shall be deemed abandoned by Tenant and title to same shall thereupon pass to
Landlord without compensation to Tenant. Landlord may, upon termination of this
Lease, remove all moveable furniture and equipment so abandoned by Tenant, at
Tenant's sole cost, and repair any damage caused by such removal at Tenant's
sole cost. If the Premises be not surrendered at the end of the term or sooner
termination of this Lease, Tenant shall indemnify Landlord against loss or
liability resulting from the delay by Tenant in so surrendering the Premises
including, without limitation, any claims made by any succeeding tenant founded
on such delay. Nothing contained herein shall be construed as an extension of
the term hereof or as a consent of Landlord to any holding over by Tenant. The
voluntary or other surrender of this Lease or the Premises by Tenant or a mutual
cancellation of this Lease shall not work as a merger and, at the option of
Landlord, shall either terminate all or any existing subleases or subtenancies
or operate as an assignment to Landlord of all or any such subleases or
subtenancies.
9. ALTERATIONS AND ADDITIONS Tenant shall not make, or suffer to be made, any
alteration or addition to the Premises, or any part thereof, without the written
consent of Landlord first had and obtained by Tenant, but at the cost of Tenant,
and any addition to, or alteration of, the Premises, except moveable furniture
and trade fixtures, shall at once become a part of the Premises and belong to
Landlord. Landlord reserves the right to approve all contractors and mechanics
proposed by Tenant to make such alterations and additions. Tenant shall retain
title to all moveable furniture and trade fixtures placed in the Premises. All
heating, lighting, electrical, airconditioning, floor to ceiling partitioning,
drapery, carpeting, and floor installations made by Tenant, together with all
property that has become an integral part of the Premises, shall not be deemed
trade fixtures. Tenant agrees that it will not proceed to make such alteration
or additions, without having obtained consent from Landlord to do so, and until
five (5) days from the receipt of such consent, in order that Landlord may post
appropriate notices to avoid any liability to contractors or material suppliers
for payment for Tenant's improvements. Tenant will at all times permit such
notices to be posted and to remain posted until the completion of the work.
Tenant shall, if required by Landlord, secure at Tenant's own cost and expense,
a completion and lien indemnity bond, satisfactory to Landlord, for such work.
Tenant further covenants and agrees that any mechanic's lien filed against the
Premises or against the Complex for work claimed to have been done for, or
materials claimed to have been furnished to Tenant, will be discharged by
Tenant, by bond or otherwise, within ten (10) days after the filing thereof, at
the cost and expense of Tenant. Any exceptions to the foregoing must be made in
writing and executed by both Landlord and Tenant.
10. TENANT MAINTENANCE Tenant shall, at its sole cost and expense, keep and
maintain the Premises (including appurtenances) and every part thereof in a high
standard of maintenance and repair, and in good and sanitary condition. Tenant's
maintenance and repair responsibilities herein referred to include, but are not
limited to janitorization, plumbing systems within the non-common areas of the
Premises (such as water and drain lines, sinks), electrical systems within the
non-common areas of the Premises (such as outlets, lighting fixtures, lamps,
bulbs, tubes, ballasts), heating and airconditioning controls within the
non-common areas of the Premises (such as mixing boxes, thermostats, time
clocks, supply and return grills), all interior improvements within the Premises
including but not limited to: wall coverings, window coverings, acoustical
ceilings, vinyl tile, carpeting, partitioning, doors (both interior and
exterior, including closing mechanisms, latches, locks), and all other interior
improvements of any nature whatsoever. Tenant agrees to provide carper shields
under all rolling chain or to otherwise be responsible for wear and tear of the
carpet caused by such rolling chairs if such wear and tear exceeds that caused
by normal foot traffic in surrounding areas. Areas of excessive wear shall be
replaced at Tenant's sole expense upon Lease termination.
3
<PAGE> 4
11. UTILITIES OF THE BUILDING IN WHICH THE PREMISES ARE LOCATED. As Additional
Rent and in accordance with paragraph 4 D of this Lease, Tenant shall pay its
proportionate share (calculated on a square footage or other equitable basis as
calculated by Landlord) of the cost of all utility charges such as water, gas,
electricity, telephone, telex and other electronic communications service, sewer
service, waste-pick-up and any other utilities, materials or services furnished
directly to the building in which the Premises are located, including, without
limitation, any temporary or permanent utility surcharge or other exactions
whether or not hereinafter imposed.
Landlord shall not be liable for and Tenant shall not be entitled to any
abatement or reduction of rent by reason of any interruption or failure of
utility services to the Premises when such interruption or failure is caused by
accident, breakage, repair, strikes, lockouts, or other labor disturbances or
labor disputes of any nature, or by any other cause, similar or dissimilar,
beyond the reasonable control of Landlord.
Provided that Tenant is not in default in the performance or observance of
any of the terms, covenants or conditions of this Lease to be performed or
observed by it, Landlord shall furnish to the Premises between the hours of
8:00AM and 6:00PM, Mondays through Fridays (holidays excepted) and subject to
the rules and regulations of the Complex hereinbefore referred to, reasonable
quantities of water, gas and electricity suitable for the intended use of the
Premises and heat and airconditioning required in Landlord's judgment for the
comfortable use and occupation of the Premises for such purposes. Tenant agrees
that at all times it will cooperate fully with Landlord and abide by all
regulations and requirements that Landlord may prescribe for the proper
functioning and protection of the building heating, ventilating and
airconditioning systems. Whenever heat generating machines, equipment, or any
other devices (including exhaust fans) are used in the Premises by Tenant which
affect the temperature or otherwise maintained by the airconditioning system,
Landlord shall have the right to install supplementary airconditioning units in
the Premises and the cost thereof, including the cost of installation and the
cost of operation and maintenance thereof, shall be paid by Tenant to Landlord
upon demand by Landlord. Tenant will not, without the written consent of
Landlord, use any apparatus or device in the Premises (including, without
limitation), electronic data processing machines or machines using current in
excess of 110 Volts which will in any way increase the amount of electricity,
gas, water or airconditioning usually furnished or supplied to premises being
used as general office space, or connect with electric current (except through
existing electrical outlets in the Premises), or with gas or water pipes any
apparatus or device for the purposes of using electric current, gas, or water.
If Tenant shall require water, gas, or electric current in excess of that
usually furnished or supplied to premises being used as general office space,
Tenant shall first obtain the written consent of Landlord, which consent shall
not be unreasonably withheld and Landlord may cause an electric current, gas, or
water meter to be installed in the Premises in order to measure the amount of
electric current, gas or water consumed for any such excess use. The cost of
any such meter and of the installation, maintenance and repair thereof, all
charges for such excess water, gas and electric current consumed (as shown by
such meters and at the rates then charged by the furnishing public utility); and
any additional expense incurred by Landlord in keeping account of electric
current, gas, or water so consumed shall be paid by Tenant, and Tenant agrees to
pay Landlord therefor promptly upon demand by Landlord.
12. TAXES A. As Additional Rent and in accordance with Paragraph 4 D of
this Lease, Tenant shall pay to Landlord Tenant's proportionate share of all
Real Property Taxes, which prorata share shall be allocated to the leased
Premises by square footage or other equitable basis, as calculated by Landlord.
The term "Real Property Taxes", as used herein, shall mean (i) all taxes,
assessments, levies and other charges of any kind or nature whatsoever, general
and special, foreseen and unforeseen (including all installments of principal
and interest required to pay any general or special assessments for public
improvements and any increases resulting from reassessments caused by any change
in ownership of the Complex) now or hereafter imposed by any governmental or
quasi-governmental authority or special district having the direct or indirect
power to tax or levy assessments, which are levied or assessed against, or with
respect to the value, occupancy or use of, all or any portion of the Complex (as
now constructed or as may at any time hereafter be constructed, altered, or
otherwise changed) or Landlord's interest therein; any improvements located
within the Complex regardless of ownership); the fixtures, equipment and other
property of Landlord, real or personal, that are an integral part of and located
in the Complex; or parking areas, public utilities, or energy within the
Complex; (ii) all charges, levies or fees imposed by reason of environmental
regulation or other governmental control of the Complex; and (iii) all costs and
fees (including attorneys' fees) incurred by Landlord in contesting any Real
Property Tax and in negotiating with public authorities as to any Real Property
Tax. If at any time during the term of this Lease the taxation or assessment of
the Complex prevailing as of the commencement date of this Lease shall be
altered so that in lieu of or in addition to any Real Property Tax described
above there shall be levied, assessed or imposed (whether by reason of a change
in the method of taxation or assessment, creation of a new tax or charge, or any
other cause) an alternate or additional tax or charge (i) on the value, use or
occupancy of the Complex or Landlord's interest therein or (ii) on or measured
by the gross receipts, income or rentals from the Complex, on Landlord's
business of leasing the Complex, or computed in any manner with respect to the
operation of the Complex, then any such tax or charge, however designated, shall
be included within the meaning of the term "Real Property Taxes" for purposes of
this Lease. If any Real Property Tax is based upon property or rents unrelated
to the Complex, then only that part of such Real Property Tax that is fairly
allocable to the Complex shall be included within the meaning of the term "Real
Property Taxes". Notwithstanding the foregoing, the term "Real Property Taxes"
shall not include estate, inheritance, gift or franchise taxes of Landlord or
the federal or state net income tax imposed on Landlord's income from all
sources. The term "Real Estate Taxes: shall also include supplemental taxes
related to the period of Tenant's Lease Term whenever levied, including any such
taxes that may be levied after the Lease Term has expired.
B. Taxes on Tenant's Property
(a) Tenant shall be liable for and shall pay ten days before delinquency, taxes
levied against any personal property or trade fixtures placed by Tenant in or
about the Premises. If any such taxes on Tenant's personal property or trade
fixtures are levied against Landlord or Landlord's property or if the assessed
value of the Premises is increased by the inclusion therein of a value placed
upon such personal property or trade fixtures of Tenant and if Landlord, after
written notice to Tenant pays the taxes based on such increased assessment,
which Landlord shall have the right to do regardless of the validity thereof,
but only under proper protest if requested by Tenant. Tenant shall upon demand,
as the case may be, repay to Landlord the taxes so levied against Landlord, or
the proportion of such taxes resulting from such increase in the assessment;
provided that in any such event Tenant shall have the right, in the name of
Landlord and with Landlord's full cooperation, to bring suit in any court of
competent jurisdiction to recover the amount of any such taxes so paid under
protest, and any amount so recovered shall belong to Tenant.
(b) if the Tenant improvements in the Premises, whether installed, and/or
paid for by Landlord or Tenant and whether or not affixed to the real property
so as to become a part thereof, are assessed for real property tax purposes at
a valuation higher than the valuation at which standard office improvements in
other space in the Complex are assessed, then the real property taxes and
assessments levied against Landlord or the Complex by reason of such excess
assessed valuation shall be deemed to be taxes levied against personal property
of Tenant and shall be governed by the provisions of 12Ba, above. If the
records of the County Assessor are available and sufficiently detailed to serve
as a basis for determining whether said Tenant improvements are assessed at a
higher valuation than standard office improvements in other space in the
Complex, such records shall be binding on both the Landlord and the Tenant. If
the records of the County Assessor are not available or sufficiently detailed to
serve as a basis for making said determination, the actual cost of construction
shall be used.
13. LIABILITY INSURANCE Tenant at Tenant's expense, agrees to keep in force
during the term of this Lease a policy of commercial general liability
insurance with a combined single limit coverage of not less than Two Million
Dollars ($2,000,000) per occurrence for injuries to or death of persons
occurring in, on or about the Premises of the Complex, and property damage. The
policy or policies affecting such insurance, certificates of insurance of which
shall be furnished to Landlord, shall name Landlord as additional insureds, and
shall insure any liability of Landlord, contingent or otherwise, as respects
acts or omissions of Tenant, its agents, employees or invitees or otherwise by
any conduct or transactions of any of said persons in or about or concerning
the Premises, including any failure of Tenant to observe or perform any of its
obligations hereunder, shall be issued by an insurance company admitted to
transact business in the State of California; and shall provide that the
insurance effected thereby shall not be canceled, except upon thirty (30) days'
prior written notice to Landlord. If, during the terms of this Lease, in the
considered opinion of Landlord's Lender, insurance advisor, or counsel, the
amount of insurance described in this paragraph 13 is not adequate, Tenant
agrees to increase said coverage to such reasonable amount as Landlord's
Lender, insurance advisor, or counsel shall deem adequate.
14. TENANT'S PERSONAL PROPERTY INSURANCE AND WORKMAN'S COMPENSATION INSURANCE
Tenant shall maintain a policy or policies of fire and property damage
insurance in "all risk" form with a sprinkler leakage endorsement insuring the
personal property, inventory, trade fixtures, and leasehold improvements within
the leased Premises for the full replacement value thereof. The proceeds from
any of such policies shall be used for the repair or replacement of such items
so insured.
Tenant shall also maintain a policy of workman's compensation insurance
and any other employee benefit insurance sufficient to comply with all laws.
15. PROPERTY INSURANCE Landlord shall purchase and keep in force and as
Additional Rent and in accordance with Paragraph 4D of this Lease, Tenant shall
pay to Landlord Tenant's proportionate share (calculated on a square footage or
other equitable basis as calculated by Landlord) of the cost of policy or
policies of insurance covering loss or damage to the Premises and Complex in
the amount of the full replacement value thereof, providing protection against
those perils included within the classification of "all risks" insurance and
flood and/or earthquake insurance, if available, plus a policy of rental income
insurance in the amount of one hundred (100%) percent of twelve (12) months
Basic Rent, plus sums paid as Additional Rent. If such insurance cost is
increased due to Tenant's use of the Premises or the Complex, Tenant agrees to
pay to Landlord the full cost of such increase. Tenant shall have no interest
in nor any right to the proceeds of any insurance procured by Landlord for the
Complex.
Landlord and Tenant do each hereby respectively release the other, to the
extent of insurance coverage of the releasing party, from any liability for
loss or damage caused by fire or any of the extended coverage casualties
included in the releasing party's insurance policies irrespective of the cause
of such fire or casualty; provided, however, that if the insurance policy of
either releasing party prohibits such waiver, then this waiver shall not take
effect until consent is obtained. If such waiver is so prohibited, the insured
party affected shall promptly notify the other party thereof.
4
<PAGE> 5
16. INDEMNIFICATION Landlord shall not be liable to Tenant and Tenant hereby
waives all claims against Landlord for any injury to or death of any person or
damage to or destruction of property in or about the Premises or the Complex by
or from any cause whatsoever, including, without limitation, gas, fire, oil,
electricity or leakage of any character from the roof, walls, basement or other
portion of the Premises or the Complex but excluding, however, the willful
misconduct or negligence of Landlord, its agents, servants, employees, invitees,
or contractors of which negligence Landlord has knowledge and reasonable time to
correct. Except as to injury to persons or damage to property to the extent
arising from the willful misconduct or the negligence of Landlord, its agents,
servants, employees, invitees, or contractors, Tenant shall hold Landlord
harmless from and defend Landlord against any and all expenses, including
reasonable attorneys' fees, in connection therewith, arising out of any injury
to or death of any person or damage to or destruction of property occurring in,
on, or about the Premises, or any part thereof, from any cause whatsoever.
17. COMPLIANCE Tenant, at its sole cost and expense, shall promptly comply
with all laws, statutes, ordinances and governmental rules, regulations or
requirements now or hereafter in effect; with the requirements of any board of
fire underwriters or other similar body now or hereafter constituted; and with
any direction or occupancy certificate issued pursuant to law by any public
officer; provided, however, that no such failure shall be deemed a breach of the
provisions if Tenant, immediately upon notification, commences to remedy or
rectify said failure. The judgment of any court of competent jurisdiction or the
admission of Tenant in any action against Tenant, whether Landlord be a party
thereto or not, that Tenant has violated any such law, statute, ordinance or
governmental rule, regulation, requirement, direction or provision, shall be
conclusive of that fact as between Landlord and Tenant. This paragraph shall not
be interpreted as requiring Tenant to make structural changes or improvements,
except to the extent such changes or improvements are required as a result of
Tenant's use of the Premises. Tenant shall, at its sole cost and expense, comply
with any and all requirements pertaining to said Premises, of any insurance
organization or company, necessary for the maintenance of reasonable fire and
public liability insurance covering the Premises.
18. LIENS Tenants shall keep the Premises and the Complex free from any liens
arising out of any work performed, materials furnished or obligation incurred by
Tenant. In the event that Tenant shall not, within ten (10) days following the
imposition of such lien, cause the same to be released of record, Landlord shall
have, in addition to all other remedies provided herein and by law, the right,
but no obligation, to cause the same to be released by such means as it shall
deem proper, including payment of the claim giving rise to such lien. All sums
paid by Landlord for such purpose, and all expenses incurred by it in connection
therewith, shall be payable to Landlord by Tenant on demand with interest at the
prime rate of interest as quoted by the Bank of America.
19. ASSIGNMENT AND SUBLETTING Tenant shall not assign, transfer, or hypothecate
the leasehold estate under this Lease, or any interest therein, and shall not
sublet the Premises, or any part thereof, or any right or privilege appurtenant
thereto, or suffer any other person or entity to occupy or use the Premises, or
any portion thereof, without, in each case, the prior written consent of
Landlord which consent will not be unreasonably withheld. As a condition for
granting this consent to any assignment, transfer, or subletting, Landlord shall
require Tenant to pay to Landlord, as Additional Rent, all rents and/or
additional consideration due Tenant from its assignees, transferees, or
subtenants in excess of the Rent payable by Tenant to Landlord hereunder for the
assigned, transferred, and/or subleased space. Tenant shall, by thirty (30) days
written notice, advise Landlord of its intent to assign or transfer Tenant's
interest in the Lease or sublet the Premises or any portion thereof for any part
of the term hereof. Within thirty (30) days after receipt of said written
notice, Landlord may, in its sole discretion, elect to terminate this Lease as
to the portion of the Premises described in Tenant's notice on the date
specified in Tenant's notice by giving written notice of such election to
terminate. If no such notice to terminate is given to Tenant within said thirty
(30) day period, Tenant may proceed to locate an acceptance sublessee, assignee,
or other transferee for presentment to Landlord for Landlord's approval, all in
accordance with the terms, covenants, and conditions of this paragraph 19. If
Tenant intends to sublet the entire Premises and Landlord elects to terminate
this Lease, this Lease shall be terminated on the date specified in Tenant's
notice. If, however, this Lease shall terminate pursuant to the foregoing with
respect to less than all the Premises, the rent, as defined and reserved
hereinabove shall be adjusted on a pro rata basis to the number of square feet
retained by Tenant, and this Lease as so amended shall continue in full force
and effect. In the event Tenant is allowed to assign, transfer or sublet the
whole or any part of the Premises, with the prior written consent of Landlord,
no assignee, transferee or subtenant shall assign or transfer this Lease, either
in whole or in part, or sublet the whole or any part of the Premises, without
also having obtained the prior written consent of Landlord. A consent of
Landlord to one assignment, transfer, hypothecation, subletting, occupation or
use by any other person shall not release Tenant from any of Tenant's
obligations hereunder or be deemed to be a consent to any subsequent similar or
dissimilar assignment, transfer, hypothecation, subletting, occupation or use by
any other person. Any such assignment, transfer, hypothecation, subletting,
occupation or use without such consent shall be void and shall constitute a
breach of this Lease by Tenant and shall, at the option of Landlord exercised by
written notice to Tenant, terminate this Lease. The leasehold estate under this
Lease shall not, nor shall any interest therein, be assignable for any purpose
by operation of law without the written consent of Landlord. As a condition to
its consent, Landlord shall require Tenant to pay all expenses in connection
with the assignment, and Landlord shall require Tenant's assignee or transferee
(or other assignees or transferees) to assume in writing all of the obligations
under this Lease and for Tenant to remain liable to Landlord under the Lease.
Not withstanding the above, in no event will Landlord consent to a
sub-sublease.
20. SUBORDINATION AND MORTGAGES In the event Landlord's title or leasehold
interest is now or hereafter encumbered by a deed of trust, upon the interest of
Landlord in the land and buildings in which the demised Premises are located, to
secure a loan from a lender (hereinafter referred to as "Lender") to Landlord,
Tenant shall, at the request of Landlord or Lender, execute in writing an
agreement subordinating its rights under this Lease to the lien of such deed of
trust, or, if so requested, agreeing that the lien of Lender's deed of trust
shall be or remain subject and subordinate to the rights of Tenant under this
Lease. Notwithstanding any such subordination, Tenant's possession under this
Lease shall not be disturbed if Tenant is not in default and so long as Tenant
shall pay all rent and observe and perform all of the provisions set forth in
this Lease.
21. ENTRY BY LANDLORD Landlord reserves, and shall at all reasonable times
after at least 24 hours notice (except in emergencies) have, the right to enter
the Premises to inspect them; to perform any services to be provided by Landlord
hereunder; to submit the Premises to prospective purchasers, mortgagees or
tenants; to post notices of nonresponsibility; and to alter, improve or repair
the Premises and any portion of the Complex, all without abatement of rent; and
may erect scaffolding and other necessary structures in or through the Premises
where reasonably required by the character of the work to be performed,
provided, however that the business of Tenant shall be interfered with to the
least extent that is reasonably practical. For each of the foregoing purposes,
any entry to the Premises obtained by Landlord by any of said means, or
otherwise shall not under any circumstances be construed or deemed to be a
forcible or unlawful entry into or a detainer of the Premises or an eviction,
actual or constructive, of Tenant from the Premises or any portion thereof.
Landlord shall also have the right at any time to change the arrangement or
location of entrances or passageways, doors and doorways, and corridors,
elevators, stairs, toilets or other public parts of the Complex and to change
the name, number or designation by which the Complex is commonly known, and none
of the foregoing shall be deemed an actual or constructive eviction of Tenant,
or shall entitle Tenant to any reduction of rent hereunder.
22. BANKRUPTCY AND DEFAULT The commencement of a bankruptcy action or
liquidation action or reorganization action or insolvency action or an
assignment of or by Tenant for the benefit of creditors, or any similar action
undertaken by Tenant, or the insolvency of Tenant, shall, at Landlord's option,
constitute a breach of this Lease by Tenant. If the trustee or receiver
appointed to serve during a bankruptcy, liquidation, reorganization, insolvency
or similar action elects to reject Tenant's unexpired Lease, the trustee or
receiver shall notify Landlord in writing of its election within thirty (30)
days after an order for relief in a liquidation action or within thirty (30)
days after the commencement of any action.
Within thirty (30) days after court approval of the assumption of this
Lease, the trustee or receiver shall cure (or provide adequate assurance to the
reasonable satisfaction of Landlord that the trustee or receiver shall cure) any
and all previous defaults under the unexpired Lease and shall compensate
Landlord for all actual pecuniary loss and shall provide adequate assurance of
future performance under said Lease to the reasonable satisfaction of Landlord.
Adequate assurance of future performance, as used herein, includes, but shall
not be limited to: (i) assurance of source and payment of rent, and other
consideration due under this Lease; (ii) assurance that the assumption or
assignment of this Lease will not breach substantially any provision, such as
radius, location, use, or exclusivity provision, in any agreement relating to
the above described Premises.
Nothing contained in this section shall affect the existing right of
Landlord to refuse to accept an assignment upon commencement of or in connection
with a bankruptcy, liquidation, reorganization or insolvency action or an
assignment of Tenant for the benefit of creditors or other similar act. Nothing
contained in this Lease shall be construed as giving or granting or creating an
equity in the demised Premises to Tenant. In no event shall the leasehold estate
under this Lease, or any interest therein, be assigned by voluntary or
involuntary bankruptcy proceeding without the prior written consent of Landlord.
In no event shall this Lease or any rights or privileges hereunder be an asset
of Tenant under any bankruptcy, insolvency or reorganization proceedings.
The failure to perform or honor any covenant, condition or representation
made under this Lease shall constitute a default hereunder by Tenant upon
expiration of the appropriate grace period hereinafter provided. Tenant shall
have a period of five (5) days from the date of written notice from Landlord
within which to cure any default in the payment of rental or adjustment thereto.
Tenant shall have a period of thirty (30) days from the date of written notice
from Landlord within which to cure any other default under this Lease. Upon an
uncured default of this Lease by Tenant, Landlord shall have the following
rights and remedies in addition to any other rights or remedies available to
Landlord at law or in equity:
(a). The rights and remedies provided for by California Civil Code Section
1951.2, including but not limited to, recovery of the worth at the time of award
of the amount by which the unpaid rent for the balance of the term after the
time of award exceeds the amount of rental loss for the same period that Tenant
proves could be reasonably avoided, as computed pursuant to subsection (b) of
said Section 1951.2. Any proof by Tenant under subparagraphs (2) and (3) of
Section 1951.2 of the California Civil Code of the amount of rental loss that
could be reasonably avoided shall be made in the following manner: Landlord and
Tenant shall each select a licensed real estate broker in the business of
renting property of the same type and use as the Premises and in the same
geographic vicinity. Such two real estate brokers shall select a third licensed
real estate
5
<PAGE> 6
broker, and the three licensed real estate brokers so selected shall determine
the amount of the rental loss that could be reasonably avoided from the balance
of the term of this Lease after the time of award. The decision of the majority
of said licensed real estate brokers shall be final and binding upon the parties
hereto.
(b). The rights and remedies provided by California Civil Code Section
which allows Landlord to continue the Lease in effect and to enforce all of its
rights and remedies under this Lease, including the right to recover rent as it
becomes due, for so long as Landlord does not terminate Tenant's right to
possession, acts of maintenance or preservation, efforts to relet the Premises,
or the appointment of a receiver upon Landlord's initiative to protect its
interest under this Lease shall not constitute a termination of Tenant's right
to possession.
(c). The right to terminate this Lease by giving notice to Tenant in
accordance with applicable law.
(d). To the extent permitted by law the right power to enter the Premises
and remove therefrom all persons and property, to store such property in a
public warehouse or elsewhere at the cost of and for the account of Tenant, and
to sell such property and apply such proceeds therefrom pursuant to applicable
California law. Landlord may from time to time sublet the Premises or any part
thereof for such term or terms (which may extend beyond the term of this Lease)
and at such rent and such other terms as Landlord in its sole discretion may
deem advisable, with the right to make alterations and repairs to the Premises.
Upon each subletting, (i) Tenant shall be immediately liable to pay Landlord, in
addition to indebtedness other than rent due hereunder, the cost of such
subletting, including, but not limited to, reasonable attorneys' fees, and any
real estate commissions actually paid, and the cost of such alterations and
repairs incurred by Landlord and the amount, if any, by which the rent hereunder
for the period of such subletting (to the extent such period does not exceed the
term hereof) exceeds the amount to be paid as rent for the Premises for such
period or (ii) at the option of Landlord, rents received from such subletting
shall be applied first to payment of indebtedness other than rent due hereunder
from Tenant to Landlord; second, to the payment of any costs of such subletting
and of such alterations and repairs; third to payment of rent due and unpaid
hereunder; and the residue, if any, shall be held by Landlord and applied in
payment of future rent as the same becomes due hereunder. If Tenant has been
credited with any rent to be received by such subletting under option (i) and
such rent shall not be promptly paid to Landlord by the subtenant(s), or if such
rentals received from such subletting under option (ii) during any month be less
than that to be paid during that month by Tenant hereunder. Tenant shall pay any
such deficiency to Landlord. Such deficiency shall be calculated and paid
monthly. For all purposes set forth in this subparagraph d. No taking possession
of the Premises by Landlord shall be construed as an election on its part to
terminate this Lease unless a written notice of such intention be given to
Tenant. Notwithstanding any such subletting without termination, Landlord may at
any time hereafter elect to terminate this Lease for such previous breach.
(e). The right to have a receiver appointed for Tenant upon application by
Landlord, to take possession of the Premises and to apply any rental collected
from the Premises and to exercise all other rights and remedies granted to
Landlord pursuant to subparagraph d. above.
23. ABANDONMENT Tenant shall not vacate or abandon the Premises at any time
during the term of this Lease and if Tenant shall abandon, vacate or surrender
said Premises, or be dispossessed by the process of law, or otherwise, any
personal property belonging to Tenant and left on the Premises shall be deemed
to be abandoned, at the option of Landlord, except such property as may be
mortgaged to Landlord.
24. DESTRUCTION In the event the Premises are destroyed in whole or in part
from any cause, except for routine maintenance and repairs and incidental damage
and destruction caused from vandalism and accidents for which Tenant is
responsible for under Paragraph 10, Landlord may, at its option:
(a) Rebuild or restore the Premises to their condition prior to the
damage or destruction, or
(b) Terminate this Lease. (providing that the Premises is damaged to the
extent of 33 1/3% of the replacement cost)
If Landlord does not give Tenant notice in writing within thirty (30) days
from the destruction of the Premises of its election to either rebuild and
restore them, or to terminate this Lease, Landlord shall be deemed to have
elected to rebuild or restore them, in which event Landlord agrees, at its
expense, promptly to rebuild or restore the Premises to their condition prior to
the damage or destruction, Tenant shall be entitled to a reduction in rent while
such repair is being made in the proportion that the area of the Premises
rendered untenantable by such damage bears to the total area of the Premises. If
Landlord initially estimates that the rebuilding or restoration will exceed 180
days or if Landlord does not complete the rebuilding or restoration within one
hundred eighty (180) days following the date of destruction (such period of time
to be extended for delays caused by the fault or neglect of Tenant or because of
Acts of God, acts of public agencies, labor disputes, strikes, fires, freight
embargoes, rainy or stormy weather, inability to obtain materials, supplies or
fuels, acts of contractors or subcontractors, or delay of the contractors due to
such causes or other contingencies beyond the control of Landlord), then Tenant
shall have the right to terminate this Lease by giving fifteen (15) days prior
written notice to Landlord. Notwithstanding anything herein to the contrary,
Landlord's obligation to rebuild or restore shall be limited to the building and
interior improvements constructed by Landlord as they existed as of the
commencement date of the Lease and shall not include restoration of Tenant's
trade fixtures, equipment, merchandise, or any improvements, alterations or
additions made by Tenant to the Premises, which Tenant shall forthwith replace
or fully repair at Tenant's sole cost and expense provided this Lease is not
cancelled according to the provisions above.
Unless this Lease is terminated pursuant to the foregoing provisions, this
Lease shall remain in full force and effect. Tenant hereby expressly waives the
provisions of Section 1932, Subdivision 2, in Section 1933, Subdivision 4 of the
California Civil Code.
In the event that the building in which the premises are situated is
damaged or destroyed to the extent of not less than 33 1/3% of the replacement
cost thereof, Landlord may elect to terminate this Lease, whether the Premises
be injured or not. Notwithstanding anything to the contrary herein, Landlord may
terminate this Lease in the event of an uninsured event or if insurance proceeds
are insufficient to cover 100% of the rebuilding costs net of the deductible.
25. EMINENT DOMAIN If all or any part of the Premises shall be taken by an
public or quasi-public authority under the power of eminent domain or conveyance
in lieu thereof, this Lease shall terminate as to any portion of the Premises so
taken or conveyed on the date when title vests in the condemnor, and Landlord
shall be entitled to any and all payment, income, rent, award, or any interest
therein whatsoever which may be paid or made in connection with such taking or
conveyance, and Tenant shall have no claim against Landlord or otherwise for the
value of any unexpired term of this Lease. Notwithstanding the foregoing
paragraph, any compensation specifically awarded Tenant for loss of business,
Tenant's personal property, moving cost or loss of goodwill, shall be and remain
the property of Tenant.
If (i) any action or proceeding is commenced for such taking of the
Premises or any part thereof, or if Landlord is advised in writing by any entity
or body having the right or power of condemnation of its intention to condemn
the premises or any portion thereof, or (ii) any of the foregoing events occur
with respect to the taking of any space in the Complex not leased hereby, or if
any such spaces so taken or conveyed in lieu of such taking and Landlord shall
decide to discontinue the use and operation of the Complex, or decide to
demolish, alter or rebuild the Complex, then, in any of such events Landlord
shall have the right to terminate this Lease by giving Tenant written notice
thereof within sixty (60) days of the date of receipt of said written advice, or
commencement of said action or proceeding, or taking conveyance, which
termination shall take place as of the first to occur of the last day of the
calendar month next following the month in which such notice is given or the
date on which title to the Premises shall vest in the condemnor.
In the event of such a partial taking or conveyance of the Premises, if the
portion of the Premises taken or conveyed is so substantial that the Tenant can
no longer reasonably conduct its business, Tenant shall have the privilege of
terminating this Lease within sixty (60) days from the date of such taking or
conveyance, upon written notice to Landlord of its intention so to do, and upon
giving of such notice this Lease shall terminate on the last day of the calendar
month next following the month in which such notice is given, upon payment by
Tenant of the rent from the date of such taking or conveyance to the date of
termination.
If a portion of the Premises be taken by condemnation or conveyance in lieu
thereof and neither Landlord nor Tenant shall terminate this Lease as provided
herein, this Lease shall continue in full force and effect as to the part of the
Premises not so taken or conveyed, and the rent herein shall be apportioned as
of the date of such taking or conveyance so that thereafter the rent to be paid
by Tenant shall be in the ratio that the area of the portion of the Premises not
so taken or conveyed bears to the total area of the Premises prior to such
taking.
26. SALE OR CONVEYANCE BY LANDLORD In the event of a sale or conveyance of the
Complex or any interest therein, by any owner of the reversion then constituting
Landlord, the transferor shall thereby be released from any further liability
upon any of the terms, covenants or conditions (express or implied) herein
contained in favor of Tenant, and in such event, insofar as such transfer is
concerned, Tenant agrees to look solely to the responsibility of the successor
in interest of such transferor in and to the Complex and this Lease. This Lease
shall not be affected by any such sale or conveyance, and Tenant agrees to
attorn to the successor in interest of such transferor.
27. ATTORNMENT TO LENDER OR THIRD PARTY In the event the interest of Landlord
in the land and buildings in which the leased Premises are located (whether such
interest of Landlord is a fee title interest or a leasehold interest) is
encumbered by deed of trust, and such interest is acquired by the lender or any
third party through judicial foreclosure or by exercise of a power of sale at
private trustee's foreclosure sale, Tenant hereby agrees to attorn to the
purchaser at any such foreclosure sale and to recognize such purchaser as the
Landlord under this Lease. In the event the lien of the deed of trust securing
the loan from a Lender to Landlord is prior and paramount to the Lease, this
Lease shall nonetheless continue in full force and effect for the remainder of
the unexpired term hereof, at the same rental herein reserved and upon all the
other terms, conditions and covenants herein contained.
28. HOLDING OVER Any holding over by Tenant after expiration or other
termination of the term of this Lease with the written consent of Landlord
delivered to Tenant shall not constitute a renewal or extension of the Lease or
give Tenant any rights in or to the leased Premises except as expressly provided
in this Lease. Any holding over after the expiration or other termination of the
term of this Lease, with the consent of Landlord, shall be construed to be a
tenancy from month to month, on the same terms and conditions herein specified
insofar as applicable except that the monthly Basic Rent shall be increased to
an amount equal to one hundred fifty (150%) percent of the monthly Basic Rent
required during the last month of the Lease term.
6
<PAGE> 7
29. CERTIFICATE OF ESTOPPEL Tenant shall at any time upon not less than ten
(10) days' prior written notice from Landlord execute, acknowledge and deliver
to Landlord a statement in writing (i) certifying that this Lease is unmodified
and in full force and effect (or, if modified, stating the nature of such
modification and certifying that this Lease, as so modified, is in full force
and effect) and the date to which the rent and other charges are paid in
advance, if any, and (ii) acknowledging that there are not, to Tenant's
knowledge, any uncured defaults on the part of Landlord hereunder, or specifying
such defaults, if any, are claimed. Any such statement may be conclusively
relied upon by any prospective purchaser or encumbrancer of the Premises.
Tenant's failure to deliver such statement within such time shall be conclusive
upon performance, and that not more than one month's rent has been paid in
advance.
30. CONSTRUCTION CHANGES It is understood that the description of the Premises
and the location of ductwork, plumbing and other facilities therein are subject
to such minor changes as Landlord or Landlord's architect determines to be
desirable in the course of construction of the Premises, and no such changes, or
any changes in plans for any other portions of the Complex shall affect this
Lease or entitle Tenant to any reduction of rent hereunder or result in any
liability of Landlord to Tenant. Landlord does not guarantee the accuracy of any
drawings supplied to Tenant and verification of the accuracy of such drawings
rests with Tenant.
31. RIGHT OF LANDLORD TO PERFORM. All terms, covenants and conditions of this
Lease to be performed or observed by Tenant shall be performed or observed by
tenant at Tenant's sole cost and expense and without any reduction of rent. If
Tenant shall fail to pay any sum of money, or other rent, required to be paid by
it hereunder and such failure shall continue for five (5) days after written
notice by Landlord, or shall fail to perform any other term or covenant
hereunder on its part to be performed, and such failure shall continue for
thirty (30) days after written notice thereof by Landlord. Landlord, without
waiving or releasing Tenant from any obligation of Tenant hereunder, may, but
shall not be obligated to, make any such payment or perform any such other term
or covenant on Tenant's part to be performed. All sums so paid by Landlord and
all necessary costs of such performance by Landlord together with interest
thereon at the rate of the prime rate of interest per annum as quoted by the
Bank of America from the date of such payment or performance by Landlord, shall
be paid (and Tenant covenants to make such payment) to Landlord on demand by
Landlord, and Landlord shall have (in addition to any other right or remedy of
Landlord) the same rights and remedies in the event of nonpayment by Tenant as
in the case of failure by Tenant in the payment of rent hereunder.
32. ATTORNEYS' FEES.
(A) In the event that either Landlord or Tenant should bring suit for
the possession of the Premises, for the recovery of any sum due under this
Lease, or because of the breach of any provision of this Lease, or for any other
relief against the other party hereunder, then all costs and expenses,
including reasonable attorneys' fees, incurred by the prevailing party therein
shall be paid by the other party, which obligation on the party of the other
party shall be deemed to have accrued on the date of the commencement of such
action and shall be enforceable whether or not the action is prosecuted to
judgement.
(B) Should Landlord be named as a defendant in any suit brought against
Tenant in connection with or arising out of Tenants' occupancy hereunder, Tenant
shall pay to Landlord its costs and expenses incurred in such suit, including a
reasonable attorney's fee.
33. WAIVER. The waiver by either party of the other party's failure to
perform or observe any term, covenant or condition herein contained to be
performed or observed by such waiving party shall not be deemed to be a waiver
of such term, covenant or condition or of any subsequent failure of the party
failing to perform or observe the same or any other such term, covenant or
condition therein contained, and no custom or practice which may develop
between the parties hereto during the term hereof shall be deemed a waiver of,
or in any way affect, the right of either party to insist upon performance and
observance by the other party in strict accordance with the terms hereof.
34. NOTICES. All notices, demands, requests, advices or designations which may
be or are required to be given by either party to the other hereunder shall be
in writing. All notices, demands, requests, advices or designation by Landlord
to Tenant shall be sufficiently given, made or delivered if personally served on
Tenant by leaving the same at the Premises or if sent by United States certified
or registered mail, postage prepaid, addressed to Tenant at the Premises. All
notices demands, requests, advices or designations by Tenant to Landlord shall
be sent by United States certified or registered mail, postage prepaid,
addressed to Landlord at its offices at Peery/Arrillaga, 2560 Mission College
Blvd., #101, Santa Clara, CA 95054. Each notice, request, demand, advice or
designation referred to in this paragraph shall be deemed received on the date
of the personal service or mailing thereof in the manner herein provided, as the
case may be.
35. EXAMINATION OF LEASE. Submission of this instrument for examination or
signature by Tenant does not constitute a reservation of or option for a lease,
and this instrument is not effective as a lease or otherwise until its
execution and delivery by both Landlord and Tenant.
36. DEFAULT BY LANDLORD. Landlord shall not be in default unless Landlord
fails to perform obligations required of Landlord within a reasonable time, but
in no event earlier than thirty (30) days after written notice by Tenant to
Landlord and to the holder of any first mortgage or deed of trust covering the
Premises whose name and address shall have heretofore been furnished to Tenant
in writing, specifying wherein Landlord has failed to perform such obligations;
provided, however, that if the nature of Landlord's obligations is such that
more than thirty (30) days are required for performance, then Landlord shall not
be in default if Landlord commences performance within such thirty (30) day
period and thereafter diligently prosecutes the same to completion.
37. CORPORATE AUTHORITY. If Tenant is a corporation, (or a partnership) each
individual executing this Lease on behalf of said corporation (or partnership)
represents and warrants that he is duly authorized to execute and deliver this
Lease on behalf of said corporation (or partnership) in accordance with the
by-laws of said corporation (or partnership in accordance with the partnership
agreement) and that this Lease is binding upon said corporation (or
partnership) in accordance with its terms. If Tenant is a corporation, Tenant
shall, within thirty (30) days after execution of this Lease, deliver to
Landlord a certified copy of the resolution of the Board of Directors of said
corporation authorizing or ratifying the execution of this Lease.
39. LIMITATION OF LIABILITY. In consideration of the benefits accruing
hereunder, Tenant and all successors and assigns covenant and agree that, in
the event of any actual or alleged failure, breach or default hereunder by
Landlord:
(i) the sole and exclusive remedy shall be against Landlord's interest
in the Premises leased herein;
(ii) no partner of Landlord shall be sued or named as a party in any
suite or action (except as may be necessary to secure jurisdiction of the
partnership);
(iii) no service of process shall be made against any partner of Landlord
(except as may be necessary to secure jurisdiction of the partnership);
(iv) no partner of Landlord shall be required to answer or otherwise
plead to any service of process;
(v) no judgment will be taken against any partner of Landlord;
(vi) any judgement taken against any partner of Landlord may be vacated
and set aside at any time without hearing;
(vii) no writ of execution will ever be levied against the assets of any
partner of Landlord;
(viii)these covenants and agreements are enforceable both by Landlord and
also by any partner of Landlord.
Tenant agrees that each of the foregoing covenants and agreements shall be
applicable to any covenant or agreement either expressly contained in this Lease
or imposed by statute or at common law.
7
<PAGE> 8
40. MISCELLANEOUS AND GENERAL PROVISIONS
a. Tenant shall not, without the written consent of Landlord, use the name
of the building for any purpose other than as the address of the business
conducted by Tenant in the Premises.
b. This Lease shall in all respects be governed by and construed in
accordance with the laws of the State of California. If any provision of
this Lease shall be invalid, unenforceable or ineffective for any reason
whatsoever, all other provisions hereof shall be and remain in full force
and effect.
c. The term "Premises" includes the space leased hereby and any
improvements now or hereafter installed therein or attached thereto. The
term "Landlord" or any pronoun used in place thereof includes the plural
as well as the singular and the successors and assigns of Landlord. The
term "Tenant" or any pronoun used in place thereof includes the plural as
well as the singular and individuals, firms, associations, partnerships
and corporations, and their and each of their respective heirs, executors,
administrators, successors and permitted assigns, according to the context
hereof, and the provisions of this Lease shall inure to the benefit of and
bind such heirs, executors, administrators, successors and permitted
assigns.
The term "person" includes the plural as well as the singular and
individuals, firms, associations, partnerships and corporations. Words
used in any gender include other genders. If there be more than one Tenant
the obligations of Tenant hereunder are joint and several. The paragraph
headings of this Lease are for convenience of reference only and shall
have no effect upon the construction or interpretation of any provision
hereof.
d. Time is of the essence of this Lease and of each and all of its
provisions.
e. At the expiration or earlier termination of this Lease, Tenant shall
execute, acknowledge and deliver to Landlord, within ten (10) days after
written demand from Landlord to Tenant, any quitclaim deed or other
document required by any reputable title company, licensed to operate in
the State of California, to remove the cloud or encumbrance created by
this Lease from the real property of which Tenant's Premises are a part.
f. This instrument along with any exhibits and attachments hereto
constitutes the entire agreement between Landlord and Tenant relative to
the Premises and this agreement and the exhibits and attachments may be
altered, amended or revoked only by an instrument in writing signed by
both Landlord and Tenant. Landlord and Tenant agree hereby that all prior
or contemporaneous oral agreements between and among themselves and their
agents or representatives relative to the leasing of the Premises are
merged in or revoked by this agreement.
g. Neither Landlord nor Tenant shall record this Lease or a short form
memorandum hereof without the consent of the other.
h. Tenant further agrees to execute any amendments required by a lender to
enable Landlord to obtain financing, so long as Tenant's rights hereunder
are not substantially affected.
i. Paragraphs 43 through 56 are added hereto and are included as a part
of this Lease.
j. Clauses, plats and riders, if any, signed by Landlord and Tenant and
endorsed on or affixed to this Lease are a part hereof.
k. Tenant covenants and agrees that no diminution or shutting off of
light, air or view by any structure which may be hereafter erected
(whether or not by Landlord) shall in any way affect his Lease, entitle
Tenant to any reduction of rent hereunder or result in any liability of
Landlord to Tenant.
41. BROKERS Tenant warrants that it had dealings with only the following real
estate brokers or agents in connection with the negotiation of this Lease:
none
- --------------------------------------------------------------------------------
and that it knows of no other real estate broker or agent who is entitled to a
commission in connection with this Lease.
42. SIGNS No sign, placard, picture, advertisement, name or notice shall be
inscribed, displayed or printed or affixed on or to any part of the outside of
the Premises or any exterior windows of the Premises without the written
consent of Landlord first had and obtained and Landlord shall have the right to
remove any such sign, placard, picture, advertisement, name or notice without
notice to and at the expense of Tenant. If Tenant is allows to print or affix
or in any way place a sign in, on, or about the Premises, upon expiration or
other sooner termination of this Lease. Tenant at Tenant's sole cost and
expense shall both remove such sign and repair all damage in such a manner as to
restore all aspects of the appearance of the Premises to the condition prior to
the placement of said sign.
All approved signs or lettering on outside doors shall be printed,
painted, affixed or inscribed at the expense of Tenant by a person approved of
by Landlord.
Tenant shall not place anything or allow anything to be placed near the
glass of any window, door partition or wall which may appear unsightly from
outside the Premises.
IN WITNESS WHEREOF, Landlord and Tenant have executed and delivered this
Lease as of the day and year last written below.
LANDLORD: TENANT:
JOHN ARRILLAGA SURVIVOR'S TRUST NEOFORMA, INC.
a Delaware corporation
By: By:
------------------------------- -------------------------------------
John Arrillaga, Trustee
Date: Title:
----------------------------- ----------------------------------
RICHARD T. PEERY SEPARATE PROPERTY Type or Print Name
TRUST ----------------------
Date:
-----------------------------------
By:
-------------------------------
Richard T. Peery, Trustee
Date:
-----------------------------
8
<PAGE> 9
Paragraph 43 through 56 to Lease Agreement dated August 16, 1999, By and Between
the John Arrillaga Survivor's Trust and the Richard T. Peery Separate Property
Trust, as Landlord, and Neoforma, Inc., a Delaware corporation, as Tenant for
10,878+ Square Feet of Space Located at 3255-6 Scott Blvd., Suite 101, Santa
Clara, California.
43. BASIC RENT: In accordance with Paragraph 4A herein, the total aggregate
sum of TWO MILLION SIX HUNDRED FORTY NINE THOUSAND EIGHT HUNDRED EIGHTY AND
80/100 DOLLARS ($2,649,880.80), shall be payable as follows:
On October 1, 1999, the sum of TWENTY EIGHT THOUSAND TWO HUNDRED EIGHTY TWO
AND 80/100 DOLLARS ($28,282.80) shall be due, and a like sum due on the first
day of each month thereafter, through and including September 1, 2000.
On October 1, 2000, the sum of TWENTY NINE THOUSAND THREE HUNDRED SEVENTY
AND 60/100 DOLLARS ($29,370.60) shall be due, and a like sum due on the first
day of each month thereafter, through and including September 1, 2001.
On October 1, 2001, the sum of THIRTY THOUSAND FOUR HUNDRED FIFTY EIGHT AND
40/100 DOLLARS ($30,458.40) shall be due, and a like sum due on the first day of
each month thereafter, through and including September 1, 2002.
On October 1, 2002, the sum of THIRTY ONE THOUSAND FIVE HUNDRED FORTY SIX
AND 20/100 DOLLARS ($31,546.20) shall be due, and a like sum due on the first
day of each month thereafter, through and including September 1, 2003.
On October 1, 2003, the sum of THIRTY TWO THOUSAND SIX HUNDRED THIRTY FOUR
AND NO/100 DOLLARS ($32,634.00) shall be due, and a like sum due on the first
day of each month thereafter, through and including September 1, 2004.
On October 1, 2004, the sum of THIRTY THREE THOUSAND SEVEN HUNDRED TWENTY
ONE AND 80/100 DOLLARS ($33,721.80) shall be due, and a like sum due on the
first day of each month thereafter, through and including September 1, 2005.
On October 1, 2005, the sum of THIRTY FOUR THOUSAND EIGHT HUNDRED NINE AND
60/100 DOLLARS ($34,809.60) shall be due, and a like sum due on the first day of
each month thereafter, through and including September 1, 2006; or until the
entire aggregate sum of TWO MILLION SIX HUNDRED FORTY NINE THOUSAND EIGHT
HUNDRED EIGHTY AND 80/100 DOLLARS ($2,649,880.80) has been paid.
44. "AS-IS" BASIS: It is hereby agreed that the Premises leased hereunder is
leased strictly on an "as-is" basis and in its present condition, and in the
configuration as shown on Exhibit B to be attached hereto, and by reference
made a part hereof. It is specifically agreed between the parties that Landlord
shall not be required to make, nor be responsible for any cost, in connection
with any repair, restoration, and/or improvement to the Premises in order for
this Lease to commence, or thereafter, throughout the Term of this Lease.
Notwithstanding anything to the contrary within this Lease, Landlord makes no
warranty or representation of any kind or nature whatsoever as to the condition
or repair of the Premises, nor as to the use or occupancy which may be made
thereof.
45. CONSENT: Whenever the consent of one party to the other is required
hereunder, such consent shall not be unreasonably withheld.
46. CHOICE OF LAW; SEVERABILITY. This Lease shall in all respects be governed
by and construed in accordance with the laws of the State of California. If any
provisions of this Lease shall be invalid, unenforceable, or ineffective for
any reason whatsoever, all other provisions hereof shall be and remain in full
force and effect.
9
<PAGE> 10
47. AUTHORITY TO EXECUTE. The parties executing this Lease Agreement hereby
warrant and represent that they are properly authorized to execute this Lease
Agreement and bind the parties on behalf of whom they execute this Lease
Agreement and to all of the terms, covenants and conditions of this Lease
Agreement as they relate to the respective parties hereto.
48. ASSESSMENT CREDITS: The demised property herein may be subject to a
special assessment levied by the City of Santa Clara as part of an Improvement
District. As a part of said special assessment proceedings (if any), additional
bonds were or may be sold and assessments were or may be levied to provide for
construction contingencies and reserve funds. Interest shall be earned on such
funds created for contingencies and on reserve funds which will be credited for
the benefit of said assessment district. To the extent surpluses are created in
said district through unused contingency funds, interest earnings or reserve
funds, such surpluses shall be deemed the property of Landlord. Notwithstanding
that such surpluses may be credited on assessments otherwise due against the
Leased Premises, Tenant shall pay to Landlord, as additional rent if, and at the
time of any such credit of surpluses, an amount equal to all such surpluses so
credited. For example: if (i) the property is subject to an annual assessment of
$1,000.00, and (ii) a surplus of $200.00 is credited towards the current year's
assessment which reduces the assessment amount shown on the property tax bill
from $1,000.00 to $800.00, Tenant shall, upon receipt of notice from Landlord,
pay to Landlord said $200.00 credit as Additional Rent.
49. ASSIGNMENT AND SUBLETTING (Continued):
A. Notwithstanding the foregoing, Landlord and Tenant agree that it shall
not be unreasonable for Landlord to refuse to consent to a proposed assignment,
sublease or other transfer ("Proposed Transfer") if the Premises or any other
portion of the Property would become subject to additional or different
Government Requirements as a direct or indirect consequence of the Proposed
Transfer and/or the Proposed Transferee's use and occupancy of the Premises and
the Property. However, Landlord may, in its sole discretion, consent to such a
Proposed Transfer where Landlord is indemnified by Tenant and (i) Subtenant or
(ii) Assignee, in form and substance satisfactory to Landlord's counsel, by
Tenant and/or the Proposed Transferee from and against any and all costs,
expenses, obligations and liability arising out of the Proposed Transfer and/or
the Proposed Transferee's use and occupancy of the Premises and the Property.
B. Any and all sublease agreement(s) between Tenant and any and all
subtenant(s) (which agreements must be consented to by Landlord, pursuant to the
requirements of this Lease) shall contain the following language:
"If Landlord and Tenant jointly and voluntarily elect, for any reason
whatsoever, to terminate the Master Lease prior to the scheduled Master
Lease termination date, then this Sublease (if then still in effect) shall
terminate concurrently with the termination of the Master Lease. Subtenant
expressly acknowledges and agrees that (1) the voluntary termination of the
Master Lease by Landlord and Tenant and the resulting termination of this
Sublease shall not give Subtenant any right or power to make any legal or
equitable claim against Landlord, including without limitation any claim
for interference with contract or interference with prospective economic
advantage, and (2) Subtenant hereby waives any and all rights it may have
under law or at equity against Landlord to challenge such an early
termination of the Sublease, and unconditionally releases and relieves
Landlord, and its officers, directors, employees and agents, from any and
all claims, demands, and/or causes of action whatsoever (collectively,
"Claims"), whether such matters are known or unknown, latent or apparent,
suspected or unsuspected, foreseeable or unforeseeable, which Subtenant may
have arising out of or in connection with any such early termination of
this Sublease. Subtenant knowingly and intentionally waives any and all
protection which is or may be given by Section 1542 of the California Civil
Code which provides as follows: "A general release does not extend to
claims which the creditor does not know or suspect to exist in his favor at
the time of executing the release, which if known by him must have
materially affected his settlement with debtor.
The term of this Sublease is therefore subject to early termination.
Subtenant's initials here below evidence (a) Subtenant's consideration of
and agreement to this early termination provision, (b) Subtenant's
acknowledgement that, in determining the net benefits to be derived by
Subtenant under the terms of this
10
<PAGE> 11
Sublease, Subtenant has anticipated the potential for early termination,
and (c) Subtenant's agreement to the general waiver and release of Claims
above.
Initials: _________ Initials: _______"
Subtenant Tenant
50. BANKRUPTCY AND DEFAULT: Paragraph 22 is modified to provide that with
respect to non-monetary defaults not involving Tenant's failure to pay Basic
Rent or Additional Rent, Tenant shall not be in default of any non-monetary
obligation if (i) more than thirty (30) days is required to cure such
non-monetary default, and (ii) Tenant commences cure of such default as soon as
reasonably practicable after receiving written notice of such default from
Landlord and thereafter continuously and with due diligence prosecutes such
cure to completion.
51. ABANDONMENT: Paragraph 23 is modified to provide that Tenant shall not be
in default under the Lease if it leaves all or any part of Premises vacant so
long as (i) Tenant is performing all of its other obligations under the Lease
including the obligation to pay Basic Rent and Additional Rent (ii) Tenant
provides on-site security during normal business hours for those parts of the
Premises left vacant, (iii) such vacancy does not materially and adversely
affect the validity or coverage of any policy of insurance carried by Landlord
with respect to the Premises, and (iv) the utilities and heating and ventilation
system are operated and maintained to the extent necessary to prevent damage to
the Premises or its systems.
52. HAZARDOUS MATERIALS: Landlord and Tenant agrees as follows with respect to
the existence or use of "Hazardous Materials" (as defined herein) on, in, under
or about the Premises and real property located beneath said Premises and the
common areas of the Complex (hereinafter collectively referred to as the
"Property"):
A. As used herein, the term "Hazardous Materials" shall mean any
material, waste, chemical, mixture or byproduct which is or hereafter is
defined, listed or designated under Environmental Laws (defined below) as a
pollutant, or as a contaminant, or as a toxic or hazardous substance, waste or
material, or any other unwholesome, hazardous, toxic, biohazardous, or
radioactive material, waste, chemical, mixture or byproduct, or which is listed,
regulated or restricted by any Environmental Law (including, without
limitation, petroleum hydrocarbons or any distillates or derivatives or
fractions thereof, polychlorinated biphenyls, or asbestos). As used herein, the
term "Environmental Law" shall mean any applicable Federal, State of California
or local government law (including common law), statute, regulation, rule,
ordinance, permit, license, order, requirement, agreement, or approval, or any
determination, judgment, directive, or order of any executive or judicial
authority at any level of Federal, State of California or local government
whether now existing or subsequently adopted or promulgated) relating to
pollution or the protection of the environment, ecology, natural resources, or
public health and safety.
B. Tenant shall obtain Landlord's written consent, which may be withheld
in Landlord's discretion, prior to the occurrence of any Tenant's Hazardous
Materials Activities (defined below); provided, however, that Landlord's consent
shall not be required for normal use in compliance with applicable Environmental
Laws of customary household and office supplies (Tenant shall first provide
Landlord with a list of said materials use), such as mild cleaners, lubricants
and copier toner. As used herein, the term "Tenant's Hazardous Materials
Activities" shall mean any and all use, handling, generation, storage, disposal,
treatment, transportation, release, discharge, or emission of any Hazardous
Materials on, in, beneath, to, from, at or about the Property, in connection
with Tenant's use of the Property, or by Tenant or by any of Tenant's agents,
employees, contractors, vendors, invitees, visitors or its future subtenants or
assignees. Tenant agrees that any and all Tenant's Hazardous Materials
Activities shall be conducted in strict, full compliance with applicable
Environmental Laws at Tenant's expense, and shall not result in any
contamination of the Property or the environment. Tenant agrees to provide
Landlord with prompt written notice of any spill or release of Hazardous
Materials at the Property during the term of the Lease of which Tenant becomes
aware, and further agrees to provide Landlord with prompt written notice of any
violation of Environmental Laws in connection with Tenant's Hazardous Materials
Activities of which Tenant becomes aware. If Tenant's Hazardous Materials
Activities involve Hazardous Materials other than normal use of customary
household and office supplies, Tenant also agrees at Tenant's expense: (i) to
install such Hazardous Materials monitoring, storage and containment devices as
Landlord reasonably deems necessary (Landlord shall have no obligation to
11
<PAGE> 12
evaluate the need for any such installation or to require any such
installation); (ii) provide Landlord with a written inventory of such Hazardous
Materials, including an update of same each year upon the anniversary date of
the Commencement Date of the Lease ("Anniversary Date"); and (iii) on each
Anniversary Date, to retain a qualified environmental consultant, acceptable to
Landlord, to evaluate whether Tenant is in compliance with all applicable
Environmental Laws with respect to Tenant's Hazardous Materials Activities.
Tenant, at its expense, shall submit to Landlord a report from such
environmental consultant which discusses the environmental consultant's findings
within two (2) months of each Anniversary Date. Tenant, at its expense, shall
promptly undertake and complete any and all steps necessary, and in full
compliance with applicable Environmental Laws, to fully correct any and all
problems or deficiencies identified by the environmental consultant, and
promptly provide Landlord with documentation of all such corrections.
C. Prior to termination or expiration of the Lease, Tenant, at its
expense, shall (i) properly remove from the Property all Hazardous Materials
which come to be located at the Property in connection with Tenant's Hazardous
Materials Activities, and (ii) fully comply with and complete all facility
closure requirements of applicable Environmental Laws regarding Tenant's
Hazardous Materials Activities, including but not limited to (x) properly
restoring and repairing the Property to the extent damaged by such closure
activities, and (y) obtaining from the local Fire Department or other
appropriate governmental authority with jurisdiction a written concurrence that
closure has been completed in compliance with applicable Environmental Laws.
Tenant shall promptly provide Landlord with copies of any claims, notices, work
plans, data and reports prepared, received or submitted in connection with any
such closure activities.
D. If Landlord, in its sole discretion, believes that the Property has
become contaminated as a result of Tenant's Hazardous Materials Activities,
Landlord in addition to any other rights it may have under this Lease or under
Environmental Laws or other laws, may enter upon the Property and conduct
inspection, sampling and analysis, including but not limited to obtaining and
analyzing samples of soil and groundwater, for the purpose of determining the
nature and extent of such contamination. Tenant shall promptly reimburse
Landlord for the costs of such an investigation, including but not limited to
reasonable attorneys' fees Landlord incurs with respect to such investigation,
that discloses Hazardous Materials contamination for which Tenant is liable
under this Lease. Notwithstanding the above, Landlord may, at its option and in
its sole and absolute discretion, choose to perform remediation and obtain
reimbursement for cleanup costs as set forth herein from Tenant. Any cleanup
costs incurred by Landlord as the result of Tenant's Hazardous Materials
Activities shall be reimbursed by Tenant within thirty (30) days of presentation
of written documentation of the expense to Tenant by Landlord. Such reimbursable
costs shall include, but not be limited to, any reasonable consultant and
attorney fees incurred by Landlord. Tenant shall take all actions necessary to
preserve any claims it has against third parties, including, but not limited to,
its insurers, for claims related to its operation, management of Hazardous
Materials or contamination of the Property. Except as may be required of Tenant
by applicable Environmental Laws, Tenant shall not perform any sampling,
testing, or drilling to identify the presence of any Hazardous Materials at the
Property, without Landlord's prior written consent which may be withheld in
Landlord's discretion. Tenant shall promptly provide Landlord with copies of any
claims, notices, work plans, data and reports prepared, received or submitted in
connection with any sampling, testing or drilling performed pursuant to the
preceding sentence.
E. Tenant shall indemnify, defend (with legal counsel to Landlord, whose
consent shall not unreasonably be withheld) and hold harmless Landlord, its
employees, assigns, successors, successors-in-interest, agents and
representatives from and against any and all claims (including but not limited
to third party claims from a private party or a government authority),
liabilities, obligations, losses, causes of action, demands, governmental
proceedings or directives, fines, penalties, expenses, costs (including but not
limited to reasonably attorneys', consultants' and other experts' fees and
costs), and damages, which arise from or relate to: (i) Tenant's Hazardous
Materials Activities; (ii) any Hazardous Materials contamination caused by
Tenant prior to the Commencement Date of the Lease; or (iii) the breach of any
obligation of Tenant under this Paragraph 52 (collectively, "Tenant's
Environmental Indemnification"). Tenant's Environmental Indemnification shall
include but is not limited to the obligation to promptly and fully reimburse
Landlord for losses in or reductions to rental income, and diminution in fair
market value of the Property. Tenant's Environmental Indemnification shall
further include but is not limited to the obligation to diligently and properly
implement to completion, at Tenant's expense, any and all environmental
investigation, removal, remediation, monitoring, reporting, closure activities,
or other environmental response action (collectively, "Response Actions").
Tenant shall promptly provide Landlord with copies of any claims, notices, work
plans, data and reports prepared, received or submitted in connection with any
Response Actions.
It is agreed that the Tenant's responsibilities related to Hazardous Materials
will survive the
12
<PAGE> 13
expiration or termination of this Lease and that Landlord may obtain specific
performance of Tenant's responsibilities under this Paragraph 52.
53. ADDITIONAL RENT CONTINUED: The following items shall be excluded from
"Additional Rent":
A. Leasing commissions, attorney's fees, costs, disbursements, and other
expenses incurred in connection with negotiations with other tenants, or
disputes between Landlord and other third party tenant not related to Tenant
(hereinafter referred to as "Third Party Tenant"), or in connection with
marketing, leasing, renovating, or improving space for other current or
prospective tenants or other current or prospective occupants of the Complex;
notwithstanding anything to the contrary herein, any costs and expenses Landlord
is entitled to be reimbursed for as stated under Paragraph 22 ("Bankruptcy and
Default") ARE NOT excluded Additional Rent items as reflected in this Paragraph
53.
B. The cost of any service sold to any other Third Party Tenant or other
occupant whose leased premises are not part of the Premises leased herein and
for which Landlord is entitled to be reimbursed as an additional charge or
rental over and above the basic rent and additional rent payable under the lease
agreement with said other tenant (including, without limitation, after-hours
HVAC costs or over-standard electrical consumption costs incurred by other
tenants).
C. Any costs for which Landlord is entitled to be reimbursed by any other
Third Party Tenant or other occupant whose leased premises are not part of the
Premises leased herein.
D. Any costs, fines, or penalties incurred due to violations by Landlord
of any governmental rule or authority, provided Tenant is not responsible under
the Lease for such costs, fines and/or penalties, and/or provided Tenant's
actions or inactions did not cause, in whole or in part, such costs, fines
and/or penalties.
E. Wages, salaries, or other compensation paid to executive employees
above the grade of Property Manager.
F. Repairs or other work occasioned by fire, windstorm, or other insured
peril, to the extent that Landlord shall receive proceeds of such insurance or
would have received such proceeds had Landlord maintained the insurance coverage
required under this Lease provided said insurance coverage was available and
Tenant paid its share of the premium as required under the Lease and any
insurance deductible(s) which Tenant is responsible for paying and provided
Tenant is not responsible for the damage to the Premises.
G. Except as otherwise noted in this Lease, any mortgage debt, or ground
rents or any other amounts payable under any ground lease for the Property.
H. Any amounts paid to any person, firm, or corporation related or
otherwise affiliated with Landlord or any general partner, officer, or director
of Landlord or any general partners, to the extent same exceeds arms-length
competitive prices paid in the Santa Clara, California metropolitan area for the
services or goods provided.
54. TAXES CONTINUED: Notwithstanding anything within Paragraph 12, (i) the
amount of Real Property Taxes payable by Tenant hereunder shall be prorated to
reflect the dates of Lease Commencement and Lease Termination, and (ii) it is
agreed that if any special assessments for capital improvements are assessed,
and if Landlord has the option to either pay the entire assessment in cash or go
to bond, and if Landlord elects to pay the entire assessment in cash in lieu of
going to bond, the entire portion of the assessment assigned to Tenant's Leased
Premises will be prorated over the same period that the assessment would have
been prorated had the assessment gone to bond.
55. NOTICES: Any notice required under this Lease that is sent by mail shall be
deemed received, if properly addressed, no later than five (5) business days
after any such notice is stamped by the U.S. Post Office as deposited in the
United States mail certified, postage prepaid, return receipt requested.
13
<PAGE> 14
56. CROSS DEFAULT: It is understood that Landlord and Tenant have previously
entered into another lease dated March 1, 1999 for premises located at 3255-7
Scott Blvd., Santa Clara, California (the "Existing Lease"). As a material part
of the consideration for the execution of this Lease by Landlord, it is agreed
between Landlord and Tenant that a default under this Lease, or a default under
said Existing Lease may, at the option of Landlord, be considered a default
under both leases, in which event Landlord shall be entitled (but in no event
required) to apply all rights and remedies of Landlord under the terms of one
lease to both leases including, but not limited to, the right to terminate one
or both of said leases by reason of a default under said Existing Lease or
hereunder.
14
<PAGE> 15
EXHIBIT A TO
EXHIBIT 10.25
[SITE PLAN]
PARK SQUARE - PHASE 1
3255 SCOTT BLVD. BUILDINGS 1-7
SANTA CLARA, CALIFORNIA 95054
PSI-6
15
<PAGE> 16
EXHIBIT B TO
EXHIBIT 10.25
[FIRST FLOOR PLAN]
PARK SQUARE - PHASE 1
3255-6 SCOTT BLVD. BUILDING 6
SANTA CLARA, CALIFORNIA 95054
PSI-6
16
<PAGE> 1
EXHIBIT 21.01
SUBSIDIARY OF THE REGISTRANT
Neoforma GAR, Inc., a Delaware corporation, is a wholly owned subsidiary
of the Registrant.
<PAGE> 1
EXHIBIT 23.02
CONSENT OF INDEPENDENT ACCOUNTANTS
We consent to the inclusion in this registration statement on Form S-1 of
our report dated [ ], 1999 on our audits of the financial statements
and financial statement schedule of Neoforma.com, Inc. We also consent to the
references to our firm under the captions "Experts" and "Selected Financial
Data." However, it should be noted that Arthur Andersen has not prepared or
certified such "Selected Financial Data."
/s/ ARTHUR ANDERSEN LLP
, California
October , 1999
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM
NEOFORMA.COM, INC.'S PROSPECTUS ON FORM S-1 FOR THE YEAR ENDED DECEMBER 31, 1998
AND SIX MONTHS ENDED JUNE 30, 1999 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE
TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
<S> <C> <C>
<PERIOD-TYPE> YEAR 6-MOS
<FISCAL-YEAR-END> DEC-31-1998 DEC-31-1999
<PERIOD-START> JAN-01-1998 JAN-01-1999
<PERIOD-END> DEC-31-1998 JUN-30-1999
<CASH> 812 7,063
<SECURITIES> 0 0
<RECEIVABLES> 0 0
<ALLOWANCES> 0 0
<INVENTORY> 0 0
<CURRENT-ASSETS> 868 7,410
<PP&E> 741 2,011
<DEPRECIATION> 98 332
<TOTAL-ASSETS> 1,672 9,759
<CURRENT-LIABILITIES> 654 2,541
<BONDS> 279 1,624
3,884 15,870
12 12
<COMMON> 1 1
<OTHER-SE> (3,142) (10,942)
<TOTAL-LIABILITY-AND-EQUITY> (3,155) (10,955)
<SALES> 0 0
<TOTAL-REVENUES> 0 7
<CGS> 0 0
<TOTAL-COSTS> 4,563 8,127
<OTHER-EXPENSES> 66 128
<LOSS-PROVISION> 0 0
<INTEREST-EXPENSE> 22 95
<INCOME-PRETAX> (4,563) (8,127)
<INCOME-TAX> 0 0
<INCOME-CONTINUING> (4,563) (8,127)
<DISCONTINUED> 0 0
<EXTRAORDINARY> 0 0
<CHANGES> 0 0
<NET-INCOME> (4,563) (8,127)
<EPS-BASIC> (1.65) (7.95)
<EPS-DILUTED> (1.65) (7.95)
</TABLE>
